data_1x2l_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1x2l _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mt . . . . . 0 C--O 1.238 0.494 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -72.94 104.17 3.99 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 122.004 0.906 . . . . 0.0 108.688 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 p -66.84 -38.21 85.97 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.457 0.703 . . . . 0.0 110.02 -173.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.07 -29.07 67.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.757 0.708 . . . . 0.0 110.899 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -76.09 -49.28 17.84 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 127.032 2.133 . . . . 0.0 108.836 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 82.1 mt -57.01 -47.0 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 119.078 0.854 . . . . 0.0 109.293 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.46 -53.93 51.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.417 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -51.94 -67.79 0.22 Allowed 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.222 1.809 . . . . 0.0 109.245 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -51.72 -37.58 51.51 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.653 1.981 . . . . 0.0 112.945 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -62.94 -52.39 59.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 CA-C-N 119.183 0.901 . . . . 0.0 109.446 174.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -55.15 -42.55 73.23 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.418 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -57.66 -56.34 23.18 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.556 0.743 . . . . 0.0 110.775 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -62.19 -35.07 77.72 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.901 0.88 . . . . 0.0 112.589 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.38 -51.39 60.74 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -35.56 73.24 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.372 0.987 . . . . 0.0 112.399 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 tttt -49.95 -33.32 17.25 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 126.636 1.974 . . . . 0.0 110.869 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -128.18 16.29 6.69 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.936 1.294 . . . . 0.0 112.027 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.3 m120 60.16 36.03 21.08 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.878 2.471 . . . . 0.0 112.128 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.5 mt -83.33 157.7 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.44 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -101.36 144.84 16.65 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.923 1.249 . . . . 0.0 112.48 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -55.97 -35.24 66.5 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.943 2.097 . . . . 0.0 113.882 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -59.73 -58.98 6.21 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 120.47 1.486 . . . . 0.0 109.744 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 t -56.44 -44.43 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 119.256 0.934 . . . . 0.0 109.697 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -57.68 -49.7 75.63 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.538 0.608 . . . . 0.0 111.184 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.94 -24.99 74.93 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-O 118.093 -1.393 . . . . 0.0 111.887 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -77.95 -43.15 30.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 118.989 1.394 . . . . 0.0 109.632 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -87.62 -68.19 0.77 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.654 0.381 . . . . 0.0 111.259 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.7 t -62.79 -42.44 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 124.308 1.043 . . . . 0.0 108.268 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.8 mt -96.08 -43.92 7.55 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.811 -172.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.23 20.16 57.62 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 123.798 0.686 . . . . 0.0 111.863 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -107.81 173.05 6.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.748 1.219 . . . . 0.0 107.9 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.4 m -68.59 159.54 31.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.055 -1.028 . . . . 0.0 111.539 166.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.42 -55.14 11.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.496 1.518 . . . . 0.0 110.337 168.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.53 -34.14 87.35 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 m -62.46 -64.6 0.88 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 116.842 -1.551 . . . . 0.0 110.176 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.9 m -60.2 -36.25 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 120.943 1.701 . . . . 0.0 111.867 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.2 t -53.71 -42.33 67.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.585 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.25 -46.73 89.16 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 119.079 0.854 . . . . 0.0 109.805 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mt -61.86 -38.08 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.1 mt -72.53 -32.8 66.41 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.878 1.271 . . . . 0.0 111.346 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.6 -52.3 27.33 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.19 1.396 . . . . 0.0 110.018 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -133.81 71.83 73.88 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 125.792 1.637 . . . . 0.0 108.436 -162.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.11 78.27 3.24 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.411 3.407 . . . . 0.0 110.584 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 30.6 mtmt -54.77 157.13 5.75 Favored Pre-proline 0 N--CA 1.442 -0.859 0 C-N-CA 124.481 1.112 . . . . 0.0 110.306 -176.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 60' ' ' LYS . 11.3 Cg_exo -55.34 143.8 74.88 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.132 2.555 . . . . 0.0 110.253 -172.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -55.11 -48.76 73.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.395 0.543 . . . . 0.0 109.935 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -26.28 32.52 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 172.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -34.62 45.87 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 119.703 1.138 . . . . 0.0 111.986 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.2 mt -77.73 148.02 35.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.959 0.885 . . . . 0.0 110.331 -171.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -82.54 178.16 8.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.848 1.659 . . . . 0.0 108.823 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.81 -47.64 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 120.883 1.674 . . . . 0.0 109.177 170.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -66.17 -8.74 25.93 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.878 -1.139 . . . . 0.0 113.724 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.43 -39.09 6.06 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 126.186 1.851 . . . . 0.0 111.655 169.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -78.6 -22.15 47.49 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.531 1.532 . . . . 0.0 111.565 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -44.94 -58.1 6.04 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 127.176 2.191 . . . . 0.0 110.681 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.59 -49.55 7.04 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.613 2.209 . . . . 0.0 111.562 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -60.09 -35.69 75.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 117.685 -1.15 . . . . 0.0 112.816 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.92 -54.41 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -56.42 -42.59 78.29 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.485 1.114 . . . . 0.0 110.69 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 71.1 mtm -67.47 -49.38 63.83 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.787 0.835 . . . . 0.0 111.984 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -64.12 -36.11 82.95 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.781 -1.2 . . . . 0.0 110.286 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -63.47 -42.84 98.6 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.397 1.479 . . . . 0.0 110.882 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.457 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 35.5 t80 -54.08 -51.57 63.69 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.684 1.193 . . . . 0.0 108.508 172.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.7 mt -68.51 -13.68 62.48 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m -72.45 -10.05 59.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.938 1.245 . . . . 0.0 112.178 172.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -154.46 115.96 4.13 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.715 1.143 . . . . 0.0 110.17 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -56.41 -26.81 54.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.504 1.522 . . . . 0.0 113.786 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -60.21 -25.05 65.31 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 120.321 1.419 . . . . 0.0 111.838 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.457 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 60.8 m-80 -59.53 -45.41 91.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.425 0.557 . . . . 0.0 110.972 176.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 p -71.39 -36.15 59.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 CA-C-N 118.543 0.611 . . . . 0.0 109.893 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.0 mt -63.13 -42.39 99.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.56 73.73 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.33 -25.78 66.99 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.154 -0.966 . . . . 0.0 111.771 176.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -61.74 -41.25 97.41 Favored 'General case' 0 C--O 1.228 -0.065 0 CA-C-N 119.223 0.919 . . . . 0.0 110.116 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.5 m -55.65 -46.52 77.46 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.689 1.196 . . . . 0.0 110.008 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.4 mt -64.19 -33.91 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.911 -0.493 . . . . 0.0 110.133 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 8.5 tp-100 . . . . . 0 CA--C 1.537 0.473 0 O-C-N 121.152 -0.967 . . . . 0.0 113.088 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.234 0.271 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.1 107.61 1.32 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.121 0.486 . . . . 0.0 110.464 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.9 p -68.91 -39.56 79.62 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.707 -0.62 . . . . 0.0 111.976 -169.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.01 73.1 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.992 0.815 . . . . 0.0 110.191 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -78.09 -51.36 10.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.225 1.41 . . . . 0.0 108.463 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.8 mt -55.94 -43.71 75.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 119.209 0.913 . . . . 0.0 109.095 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.28 -53.45 58.1 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.359 0.664 . . . . 0.0 110.397 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -55.85 -51.14 68.57 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.332 1.053 . . . . 0.0 111.263 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -64.59 -39.74 94.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.698 1.599 . . . . 0.0 110.708 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.6 t -60.85 -49.12 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 O-C-N 120.942 -1.098 . . . . 0.0 109.643 171.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -62.34 -46.18 89.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 117.929 -1.034 . . . . 0.0 111.075 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -64.21 -42.86 96.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.116 0.871 . . . . 0.0 111.223 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -58.1 -44.55 87.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.486 1.114 . . . . 0.0 111.481 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mt -63.55 -49.73 72.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -49.13 -43.51 41.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.509 0.724 . . . . 0.0 111.684 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -60.37 -21.7 62.45 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.469 1.508 . . . . 0.0 113.634 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -128.33 13.25 6.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.892 1.277 . . . . 0.0 113.329 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.5 m120 50.74 71.22 0.44 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.955 2.102 . . . . 0.0 111.561 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.0 mt -118.92 155.41 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 120.658 -1.276 . . . . 0.0 108.392 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.27 145.98 16.74 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.463 1.03 . . . . 0.0 111.177 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -56.89 -34.96 68.4 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.095 1.358 . . . . 0.0 111.69 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -51.78 -61.89 1.97 Allowed 'General case' 0 C--N 1.337 0.063 0 C-N-CA 123.784 0.834 . . . . 0.0 111.606 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.26 -46.68 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.921 0.782 . . . . 0.0 109.588 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -54.85 -46.7 74.71 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.029 0.831 . . . . 0.0 111.762 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.11 -30.95 64.58 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-O 118.25 -1.305 . . . . 0.0 111.752 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -69.81 -36.99 76.12 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.379 1.59 . . . . 0.0 110.54 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -96.22 -67.93 0.82 Allowed 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.999 0.92 . . . . 0.0 111.34 -173.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.7 t -62.68 -60.45 2.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -172.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.0 mt -76.28 -36.62 58.3 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.929 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.71 16.09 73.93 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.446 -1.196 . . . . 0.0 112.355 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.8 mt -110.64 166.41 11.03 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.239 1.815 . . . . 0.0 109.931 -171.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -60.21 152.61 24.26 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.536 0.684 . . . . 0.0 110.822 168.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -55.29 -38.9 69.22 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.088 1.355 . . . . 0.0 110.338 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.89 -63.95 4.83 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 m -42.4 -69.33 0.14 Allowed 'General case' 0 C--N 1.342 0.268 0 CA-C-O 117.065 -1.445 . . . . 0.0 110.8 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 m -57.75 -42.09 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 120.832 1.651 . . . . 0.0 112.951 -171.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.0 t -60.13 -38.6 83.57 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.286 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -60.08 -47.76 84.55 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.275 1.03 . . . . 0.0 109.868 168.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mt -56.57 -42.39 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.59 -27.52 41.12 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.614 1.166 . . . . 0.0 112.302 -176.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.7 -44.5 56.37 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.495 1.518 . . . . 0.0 110.546 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -133.3 73.85 73.29 Favored Pre-proline 0 C--O 1.236 0.359 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 -172.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.46 87.76 1.06 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.174 1.916 . . . . 0.0 107.197 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -57.53 157.04 14.6 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.06 155.86 67.97 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 121.429 1.419 . . . . 0.0 109.23 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -55.33 -42.61 74.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.7 0.4 . . . . 0.0 111.195 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -9.86 40.27 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 175.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -93.58 7.11 45.94 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.314 -1.491 . . . . 0.0 112.922 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.6 mt -124.39 153.8 41.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.463 1.105 . . . . 0.0 108.479 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.1 p -100.56 -175.36 2.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.714 0.806 . . . . 0.0 109.001 172.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.2 t -45.38 -45.35 3.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 119.154 0.888 . . . . 0.0 110.897 169.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -70.48 -38.29 74.36 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.898 1.226 . . . . 0.0 112.873 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.64 -35.01 84.4 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.82 0.724 . . . . 0.0 112.079 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -90.67 -19.69 23.33 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 125.568 1.547 . . . . 0.0 111.723 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -43.28 -55.7 7.7 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 127.572 2.349 . . . . 0.0 109.384 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.61 -50.38 2.53 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.291 1.994 . . . . 0.0 111.354 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -58.0 -35.96 71.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 120.222 1.374 . . . . 0.0 113.702 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.6 mt -57.59 -60.3 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.591 1.556 . . . . 0.0 107.474 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -52.27 -52.04 55.02 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.421 1.089 . . . . 0.0 110.212 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.8 mtm -55.39 -51.59 66.34 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.694 0.797 . . . . 0.0 111.464 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -59.75 -38.75 82.62 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.196 -0.94 . . . . 0.0 111.226 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -65.98 -45.09 82.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.423 1.01 . . . . 0.0 110.427 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 19.6 t80 -49.31 -46.91 47.23 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.963 1.705 . . . . 0.0 110.301 172.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.1 mt -71.84 -13.82 61.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.32 1.11 34.06 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.809 1.644 . . . . 0.0 112.45 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -160.03 118.55 2.7 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.891 1.223 . . . . 0.0 108.635 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -63.1 -19.45 64.44 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.69 1.196 . . . . 0.0 111.781 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -57.23 -30.05 64.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 120.157 -1.589 . . . . 0.0 112.054 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.4 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 75.1 m-80 -65.42 -38.21 89.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 119.018 -0.515 . . . . 0.0 110.174 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.83 -34.77 23.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 119.258 0.936 . . . . 0.0 110.317 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.9 mt -63.14 -40.77 98.56 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 123.261 0.624 . . . . 0.0 109.858 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.47 92.89 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.98 0.512 . . . . 0.0 111.252 173.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.46 -26.31 67.89 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.08 0.952 . . . . 0.0 112.2 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -61.68 -45.19 95.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 118.489 0.586 . . . . 0.0 109.561 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.9 m -49.77 -50.05 46.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.215 1.006 . . . . 0.0 109.442 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.0 mt -65.57 -37.44 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.771 -173.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.48 175.542 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 C--O 1.236 0.364 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.41 101.46 4.8 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 122.291 1.043 . . . . 0.0 109.256 171.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.0 p -62.95 -38.96 93.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.586 -0.696 . . . . 0.0 111.477 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.77 70.72 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.107 0.867 . . . . 0.0 111.9 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -75.39 -53.05 9.35 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.357 1.463 . . . . 0.0 108.124 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.0 mt -55.34 -44.02 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.35 0.66 . . . . 0.0 109.306 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.26 -47.88 83.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.406 0.682 . . . . 0.0 111.008 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.437 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 27.5 t80 -60.68 -50.22 74.38 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.329 1.052 . . . . 0.0 110.345 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -59.69 -45.4 92.2 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.746 1.618 . . . . 0.0 110.327 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.95 -50.83 78.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 O-C-N 120.424 -1.422 . . . . 0.0 109.077 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 50.0 mtmt -54.99 -41.88 71.76 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.455 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.41 -36.71 68.71 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 117.471 -1.252 . . . . 0.0 113.336 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -62.3 -41.23 98.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.415 1.916 . . . . 0.0 111.608 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.27 -44.71 95.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.21 -0.932 . . . . 0.0 108.54 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -58.07 -48.04 81.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 171.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -55.56 -30.3 60.54 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 127.051 2.141 . . . . 0.0 111.791 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -128.27 11.91 6.47 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.62 64.27 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.779 2.032 . . . . 0.0 112.111 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -107.63 150.84 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.496 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -82.8 135.3 13.83 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.79 1.186 . . . . 0.0 110.876 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -54.07 -37.37 64.13 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.609 0.764 . . . . 0.0 110.552 169.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -54.05 -64.48 0.81 Allowed 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.409 -1.281 . . . . 0.0 111.198 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t -52.74 -48.12 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 120.141 1.337 . . . . 0.0 110.07 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -55.3 -46.4 76.22 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.431 0.56 . . . . 0.0 111.88 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.39 -34.64 57.29 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-O 118.081 -1.4 . . . . 0.0 111.597 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.92 -32.23 73.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 119.331 1.565 . . . . 0.0 109.505 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -103.15 -72.57 0.69 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.563 1.145 . . . . 0.0 111.907 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.75 -43.85 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -168.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.7 mt -96.48 -33.4 11.87 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.03 30.32 38.64 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 123.439 0.462 . . . . 0.0 112.017 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.7 mt -125.07 157.8 35.37 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.765 1.283 . . . . 0.0 110.464 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.8 t -60.39 160.48 8.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.683 1.193 . . . . 0.0 110.367 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.82 -55.82 26.07 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.342 1.057 . . . . 0.0 110.886 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.18 -30.42 75.61 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-O 119.095 -0.836 . . . . 0.0 111.711 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.9 m -58.84 -57.81 11.4 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 116.832 -1.556 . . . . 0.0 109.856 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 m -66.78 -36.69 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 121.857 2.117 . . . . 0.0 113.617 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.1 t -62.43 -31.22 71.9 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.694 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -59.81 -49.72 76.61 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.857 1.208 . . . . 0.0 110.964 164.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 mt -55.44 -43.94 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.062 0.846 . . . . 0.0 108.986 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -79.3 -13.72 59.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.501 1.121 . . . . 0.0 112.861 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.86 -58.07 2.68 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.717 1.607 . . . . 0.0 109.905 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 mtp85 -124.64 78.29 63.47 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 125.089 1.355 . . . . 0.0 107.876 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.33 93.76 0.75 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.07 2.513 . . . . 0.0 107.523 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -63.26 165.85 9.98 Favored Pre-proline 0 N--CA 1.436 -1.146 0 C-N-CA 123.79 0.836 . . . . 0.0 110.266 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -56.13 142.45 86.37 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.611 2.207 . . . . 0.0 110.331 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -53.3 -47.31 69.32 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.964 0.802 . . . . 0.0 109.804 173.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -20.31 33.87 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 174.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -85.15 -24.37 28.0 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.874 1.215 . . . . 0.0 111.77 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.6 mt -86.38 167.34 14.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.42 0.688 . . . . 0.0 109.155 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.5 p -129.12 -172.25 2.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 117.081 -1.437 . . . . 0.0 108.62 172.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.5 t -43.58 -56.43 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 120.756 1.616 . . . . 0.0 111.63 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -74.51 -15.87 60.86 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.234 -1.541 . . . . 0.0 113.665 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.68 -42.42 47.01 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.374 1.464 . . . . 0.0 111.45 167.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -85.81 -26.13 25.91 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 127.045 2.138 . . . . 0.0 111.669 -173.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -42.15 -57.28 4.48 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 127.817 2.447 . . . . 0.0 111.475 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.07 -49.71 4.6 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.531 1.487 . . . . 0.0 109.69 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -57.23 -39.38 75.42 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.654 -1.165 . . . . 0.0 112.976 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.3 mt -57.69 -55.52 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.559 1.144 . . . . 0.0 108.367 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -59.51 -45.06 92.79 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.032 0.533 . . . . 0.0 109.592 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 67.0 mtm -57.8 -50.08 74.47 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 123.505 0.722 . . . . 0.0 111.07 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -59.8 -44.1 94.12 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.794 -0.566 . . . . 0.0 110.278 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -73.82 -28.04 61.42 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.298 -0.876 . . . . 0.0 112.133 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -60.87 -53.15 60.82 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.926 1.291 . . . . 0.0 107.943 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.0 mt -64.82 -22.4 66.98 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.319 1.047 . . . . 0.0 113.307 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.9 m -62.8 -21.58 65.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.914 1.234 . . . . 0.0 111.0 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -143.99 115.8 8.25 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.112 1.323 . . . . 0.0 109.947 -173.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.7 -18.56 64.13 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.569 1.148 . . . . 0.0 111.861 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -64.68 -21.14 66.67 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.482 -2.011 . . . . 0.0 112.181 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -67.36 -53.36 30.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.854 1.206 . . . . 0.0 110.053 174.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.87 -35.09 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.033 -1.042 . . . . 0.0 111.133 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.58 -34.66 78.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.661 0.664 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.45 81.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 111.533 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.95 -26.02 68.4 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.399 -0.813 . . . . 0.0 110.873 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 mtp-105 -60.18 -50.89 71.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 118.529 0.604 . . . . 0.0 110.581 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.0 m -50.06 -45.69 52.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.032 0.833 . . . . 0.0 110.163 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 66.1 mt -64.51 -32.97 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.871 -0.518 . . . . 0.0 111.117 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.496 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 6.9 tp-100 . . . . . 0 N--CA 1.452 -0.355 0 O-C-N 121.186 -0.946 . . . . 0.0 111.373 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--O 1.233 0.205 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -69.75 98.38 1.2 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.052 0.453 . . . . 0.0 110.03 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 p -63.38 -41.15 98.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.529 -0.732 . . . . 0.0 111.818 -175.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.02 77.74 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.847 0.749 . . . . 0.0 111.334 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -75.12 -47.89 26.42 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 126.218 1.807 . . . . 0.0 108.653 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.3 mt -55.08 -50.86 59.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.51 -52.17 62.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.64 0.776 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -52.52 -69.79 0.1 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 126.533 1.933 . . . . 0.0 108.666 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -49.8 -40.41 41.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.645 1.978 . . . . 0.0 112.897 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.2 t -64.75 -51.43 67.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 118.976 0.807 . . . . 0.0 109.645 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -49.85 -38.34 34.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.356 0.98 . . . . 0.0 109.785 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.93 -53.63 43.36 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.466 1.03 . . . . 0.0 111.68 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.64 -43.88 80.72 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.366 0.53 . . . . 0.0 111.142 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.9 mt -63.36 -43.46 97.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -27.81 69.29 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.446 1.021 . . . . 0.0 112.69 174.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -59.73 -32.81 70.9 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.822 1.249 . . . . 0.0 111.419 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -128.42 16.72 6.53 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.387 1.475 . . . . 0.0 112.196 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 39.75 75.59 0.08 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 128.783 2.833 . . . . 0.0 112.417 -169.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.4 mt -110.05 147.54 14.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 121.386 -0.821 . . . . 0.0 109.826 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.05 127.75 8.4 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -58.45 -29.6 66.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.748 0.819 . . . . 0.0 111.242 171.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -55.6 -53.98 49.73 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 117.789 -1.101 . . . . 0.0 111.508 167.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -60.18 -51.27 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 119.526 1.057 . . . . 0.0 109.114 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -54.38 -46.48 73.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.325 0.511 . . . . 0.0 111.347 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.08 -34.97 64.52 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-O 117.417 -1.768 . . . . 0.0 111.967 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -64.49 -29.67 70.71 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 120.398 2.099 . . . . 0.0 110.887 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -106.63 -78.73 0.58 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.458 1.103 . . . . 0.0 111.654 -172.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 74.1 t -56.5 -38.75 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 125.531 1.532 . . . . 0.0 109.363 -170.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.6 mt -102.19 -33.24 9.72 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.582 -0.723 . . . . 0.0 110.853 -173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.74 30.59 61.54 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.52 168.66 10.47 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.078 1.351 . . . . 0.0 109.175 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.0 163.6 27.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.456 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -59.56 -46.76 87.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.414 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.42 -30.96 77.49 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.001 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.6 m -61.03 -67.06 0.44 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.832 0.816 . . . . 0.0 109.328 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 m -58.66 -35.77 56.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-N 119.893 1.224 . . . . 0.0 112.438 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.3 t -54.95 -43.36 73.36 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.369 1.068 . . . . 0.0 111.708 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -57.36 -49.37 76.37 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 120.084 1.311 . . . . 0.0 110.106 168.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.3 mt -58.95 -39.64 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.6 mt -76.76 -29.56 56.17 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.901 1.281 . . . . 0.0 112.413 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.33 -57.58 4.69 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.652 1.581 . . . . 0.0 109.997 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -123.57 84.6 53.07 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 125.604 1.562 . . . . 0.0 107.399 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 84.04 1.4 Allowed 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 122.245 1.963 . . . . 0.0 107.525 171.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -59.41 153.27 50.08 Favored Pre-proline 0 N--CA 1.436 -1.161 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.01 147.54 80.16 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.296 1.997 . . . . 0.0 107.363 -171.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -51.93 -38.94 58.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.127 0.571 . . . . 0.0 111.143 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -28.11 69.05 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -26.79 62.37 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.789 -1.195 . . . . 0.0 111.633 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.6 mt -83.79 167.16 17.36 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.456 0.646 . . . . 0.0 110.526 -168.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.2 p -117.78 -171.61 2.09 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.689 2.395 . . . . 0.0 109.533 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.7 p -47.16 -63.41 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.648 1.113 . . . . 0.0 111.543 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -72.94 -10.35 59.71 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.43 -52.12 32.89 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.157 -0.964 . . . . 0.0 110.707 162.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -87.54 -23.83 24.24 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 126.016 1.727 . . . . 0.0 112.298 -166.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -44.55 -55.6 9.95 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 126.334 1.854 . . . . 0.0 111.669 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.46 -45.86 13.52 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.498 1.466 . . . . 0.0 110.835 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -61.19 -38.23 85.8 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.88 1.218 . . . . 0.0 113.044 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.6 mt -55.61 -54.44 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -58.77 -50.66 73.1 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.931 1.292 . . . . 0.0 110.516 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 58.0 mtm -55.52 -47.89 75.53 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.135 0.974 . . . . 0.0 111.974 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -61.64 -46.03 91.51 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.94 -0.475 . . . . 0.0 110.263 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -61.26 -42.53 98.8 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.666 0.787 . . . . 0.0 111.198 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -53.17 -38.39 62.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.033 1.733 . . . . 0.0 110.719 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.2 mt -73.71 -23.75 59.83 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.378 -0.826 . . . . 0.0 113.082 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -77.97 0.25 25.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 120.134 1.334 . . . . 0.0 113.069 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -145.52 115.22 7.28 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 125.391 1.476 . . . . 0.0 107.173 170.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -69.49 -15.64 63.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.556 0.342 . . . . 0.0 111.816 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -67.06 -16.48 64.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 120.294 -1.504 . . . . 0.0 112.353 174.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -66.51 -47.38 73.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 119.61 1.096 . . . . 0.0 109.591 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.8 -30.86 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 120.665 -1.272 . . . . 0.0 111.299 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.35 -24.04 64.76 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.753 -0.592 . . . . 0.0 110.808 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.6 -39.47 31.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.21 -0.931 . . . . 0.0 111.381 168.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.81 -29.76 68.18 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.013 -1.68 . . . . 0.0 110.5 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -66.6 -36.75 83.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.394 0.997 . . . . 0.0 111.672 169.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.3 m -56.01 -36.65 68.17 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.743 0.817 . . . . 0.0 110.167 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.0 mt -80.24 -29.29 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.701 1.6 . . . . 0.0 111.494 177.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? . . . . . 0 C--N 1.329 -0.326 0 O-C-N 120.578 -1.326 . . . . 0.0 109.646 -179.303 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 mt . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.58 104.56 17.03 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.401 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 21.2 p -59.77 -40.97 89.99 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.344 -0.847 . . . . 0.0 111.51 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.21 75.07 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.182 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.27 -52.24 20.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.91 1.284 . . . . 0.0 108.337 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 85.2 mt -52.9 -49.48 48.11 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.83 63.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.259 0.624 . . . . 0.0 110.355 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -55.81 -57.75 10.74 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.939 1.296 . . . . 0.0 110.486 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -49.75 -51.54 38.28 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 127.391 2.276 . . . . 0.0 111.688 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.58 -44.04 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.906 -1.121 . . . . 0.0 109.015 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -57.47 -37.56 73.1 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.589 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.58 -54.67 36.23 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.948 1.299 . . . . 0.0 110.551 174.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -61.45 -43.1 99.46 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.978 1.311 . . . . 0.0 111.513 -173.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.58 -46.6 78.8 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -43.92 65.71 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.569 0.748 . . . . 0.0 111.123 173.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -50.47 -44.44 55.74 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 126.364 1.865 . . . . 0.0 111.684 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -112.76 9.42 19.11 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.993 0.917 . . . . 0.0 112.297 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 46.62 71.76 0.28 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.428 2.291 . . . . 0.0 112.183 -166.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.2 mt -111.22 151.02 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 172.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.57 142.13 15.42 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -57.74 -31.59 66.62 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.674 1.59 . . . . 0.0 113.345 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ttp-105 -56.41 -59.38 5.05 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 120.029 1.286 . . . . 0.0 109.691 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -58.98 -47.27 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -176.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -55.46 -47.15 76.53 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.831 0.741 . . . . 0.0 111.725 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.5 -33.72 63.84 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-O 117.797 -1.557 . . . . 0.0 111.806 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -69.88 -33.08 71.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.635 1.718 . . . . 0.0 110.524 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -96.73 -76.98 0.5 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.048 0.939 . . . . 0.0 111.217 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.55 -40.48 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 124.729 1.212 . . . . 0.0 109.151 -170.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.3 mt -93.9 -46.79 7.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 123.758 0.661 . . . . 0.0 109.803 -173.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.01 19.08 48.39 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.636 0.636 . . . . 0.0 112.691 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.0 mt -114.42 164.96 13.24 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.501 1.52 . . . . 0.0 108.988 -172.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 m -62.08 156.58 21.09 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.167 0.508 . . . . 0.0 110.841 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -56.92 -34.82 68.35 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.075 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.04 -62.05 5.55 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.8 m -43.91 -66.77 0.34 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.942 1.697 . . . . 0.0 112.522 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 m -57.09 -38.83 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 120.283 1.401 . . . . 0.0 111.674 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 m -61.6 -41.28 97.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.858 -1.068 . . . . 0.0 110.818 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.82 -45.84 78.25 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.629 1.104 . . . . 0.0 110.007 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.8 mt -57.52 -46.46 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.27 -31.8 64.29 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.97 1.708 . . . . 0.0 112.656 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.9 -47.4 71.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.934 1.694 . . . . 0.0 110.096 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mtp-105 -137.94 82.98 24.37 Favored Pre-proline 0 C--O 1.239 0.506 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -63.75 102.63 0.36 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.103 2.535 . . . . 0.0 108.34 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -63.06 157.39 62.24 Favored Pre-proline 0 N--CA 1.429 -1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.523 167.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.82 151.96 36.5 Favored 'Trans proline' 0 N--CA 1.441 -1.572 0 C-N-CA 122.64 2.227 . . . . 0.0 107.428 -172.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.417 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 62.0 t-105 -51.78 -41.93 62.02 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.692 0.797 . . . . 0.0 111.532 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -23.09 66.96 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -74.06 -25.76 60.02 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 120.23 1.377 . . . . 0.0 111.72 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.4 mt -93.25 153.28 18.68 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.162 0.892 . . . . 0.0 110.34 -158.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.8 t -90.38 -179.97 5.73 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 171.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.45 -42.65 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 O-C-N 120.999 -1.063 . . . . 0.0 112.419 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -69.8 -14.9 62.99 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.755 -1.216 . . . . 0.0 113.585 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.77 -37.43 26.32 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 125.45 1.5 . . . . 0.0 110.936 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 91.2 mttt -79.86 -25.92 40.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 117.847 -1.073 . . . . 0.0 112.344 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -43.83 -60.98 2.2 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 125.691 1.596 . . . . 0.0 110.445 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.28 -45.49 15.17 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 121.394 1.396 . . . . 0.0 110.032 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.401 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 64.2 m-85 -64.04 -35.25 80.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 119.752 1.16 . . . . 0.0 113.337 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.1 mt -59.16 -57.19 12.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -52.88 -43.18 65.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.175 0.99 . . . . 0.0 110.45 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 64.7 mtm -66.76 -50.29 63.19 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.891 1.276 . . . . 0.0 112.567 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -60.62 -41.33 94.64 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.816 -1.177 . . . . 0.0 110.193 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.79 -26.63 57.49 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.839 0.456 . . . . 0.0 111.441 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -57.25 -50.98 71.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.917 0.887 . . . . 0.0 109.112 167.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.2 mt -64.02 -20.14 65.7 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.466 1.106 . . . . 0.0 113.439 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.4 m -61.53 -33.4 73.77 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.279 0.945 . . . . 0.0 111.531 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -130.49 104.77 7.43 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.637 -0.665 . . . . 0.0 109.988 -170.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -53.61 -29.2 36.73 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.204 1.401 . . . . 0.0 111.716 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -55.19 -25.93 35.91 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 119.803 -1.81 . . . . 0.0 112.45 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -66.08 -50.56 63.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.529 0.732 . . . . 0.0 110.817 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.43 -37.19 78.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 119.221 0.919 . . . . 0.0 109.568 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 78.0 mt -64.55 -34.12 77.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.17 0.588 . . . . 0.0 110.481 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.98 -32.5 59.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.92 0.888 . . . . 0.0 111.43 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -27.85 66.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.298 1.039 . . . . 0.0 110.691 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.1 mtm105 -56.8 -54.15 49.66 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 119.092 0.86 . . . . 0.0 109.464 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -52.87 -36.66 59.38 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.853 0.751 . . . . 0.0 111.319 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 52.1 mt -73.68 -38.23 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.865 -1.147 . . . . 0.0 110.338 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 . . . . . 0 N--CA 1.452 -0.371 0 C-N-CA 125.668 1.587 . . . . 0.0 111.001 179.297 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.6 mt . . . . . 0 C--O 1.238 0.469 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.8 99.27 5.85 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 122.014 0.911 . . . . 0.0 109.079 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 p -63.16 -38.98 93.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.818 -1.176 . . . . 0.0 111.402 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.83 70.35 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.543 -0.741 . . . . 0.0 111.434 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -78.92 -55.57 5.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.016 2.126 . . . . 0.0 108.758 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.8 mt -54.57 -44.2 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.91 -49.06 78.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.529 0.732 . . . . 0.0 111.273 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -61.07 -53.36 58.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.839 1.256 . . . . 0.0 110.283 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -60.56 -39.7 88.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.68 1.992 . . . . 0.0 111.772 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 t -60.91 -47.12 94.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 O-C-N 120.691 -1.255 . . . . 0.0 109.374 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -61.14 -27.49 68.42 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 117.373 -1.299 . . . . 0.0 111.548 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -65.04 -63.12 1.18 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 120.125 1.329 . . . . 0.0 109.805 170.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -63.78 -29.08 70.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.058 0.845 . . . . 0.0 111.806 -170.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.52 -37.78 74.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.976 1.262 . . . . 0.0 109.587 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.26 -37.35 85.27 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.186 1.357 . . . . 0.0 111.862 169.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -58.59 -32.75 69.25 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.952 2.101 . . . . 0.0 113.707 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -126.39 15.93 7.7 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.482 1.913 . . . . 0.0 111.214 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.8 m120 42.33 72.73 0.16 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.282 2.233 . . . . 0.0 111.41 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.4 mt -106.26 153.84 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.69 131.64 10.87 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.801 1.191 . . . . 0.0 110.556 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -36.05 74.6 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.428 1.491 . . . . 0.0 111.71 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.6 ptt85 -53.5 -56.06 20.18 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.351 1.06 . . . . 0.0 111.965 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.46 -39.7 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -63.29 -45.68 90.26 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.091 -1.006 . . . . 0.0 109.573 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -67.35 -24.61 73.63 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-O 117.352 -1.804 . . . . 0.0 112.518 173.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -78.12 -21.02 51.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.788 2.294 . . . . 0.0 112.076 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -121.99 -61.1 1.52 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 119.484 1.038 . . . . 0.0 111.436 -174.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.7 t -63.46 -36.98 78.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.4 mt -106.49 -34.95 7.23 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.423 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.55 31.5 78.84 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.13 161.62 18.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.352 1.461 . . . . 0.0 107.932 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m -59.67 147.95 35.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.765 1.226 . . . . 0.0 110.599 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -63.67 -16.73 61.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.633 1.573 . . . . 0.0 114.06 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.54 -56.63 2.61 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 166.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.7 m -43.65 -59.57 2.14 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 125.851 1.66 . . . . 0.0 113.21 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -55.65 -34.62 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 121.017 1.735 . . . . 0.0 114.074 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.9 t -63.2 -36.24 82.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.243 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.36 -41.78 80.79 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.792 1.633 . . . . 0.0 109.736 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 mt -62.79 -45.35 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.8 -32.03 61.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.779 0.832 . . . . 0.0 111.628 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.24 -53.94 31.02 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.628 1.971 . . . . 0.0 111.042 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -134.45 71.78 71.15 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -168.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -68.41 98.91 0.58 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.937 2.425 . . . . 0.0 107.985 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -69.06 160.63 77.63 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -59.34 150.49 74.44 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.351 2.701 . . . . 0.0 109.109 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -52.79 -52.54 56.37 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.664 0.786 . . . . 0.0 111.5 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -5.99 2.02 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 174.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -116.31 18.98 15.06 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.414 1.886 . . . . 0.0 110.842 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.1 mt -124.05 149.44 46.11 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.564 1.546 . . . . 0.0 106.874 166.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.2 t -90.73 -177.72 5.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.641 1.176 . . . . 0.0 108.852 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 p -46.33 -54.01 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.446 1.098 . . . . 0.0 111.16 172.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -74.73 -4.88 40.15 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.25 -35.19 15.31 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.326 1.917 . . . . 0.0 111.297 163.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -87.91 -23.27 23.98 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.566 1.546 . . . . 0.0 112.971 -173.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -39.14 -59.91 1.35 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.15 1.78 . . . . 0.0 110.36 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.27 -51.11 2.91 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.467 2.112 . . . . 0.0 111.489 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -59.58 -38.15 80.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.528 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.2 mt -55.85 -54.02 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -60.7 -46.57 89.87 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.35 1.06 . . . . 0.0 110.498 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.9 mtm -59.37 -46.07 89.69 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 124.075 0.95 . . . . 0.0 111.299 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -60.96 -45.76 93.43 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.39 -0.819 . . . . 0.0 110.183 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -59.61 -43.99 93.57 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.723 0.809 . . . . 0.0 110.314 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.467 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 37.7 t80 -53.61 -51.36 63.31 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.103 1.761 . . . . 0.0 110.127 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.8 mt -66.27 -18.94 65.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.357 0.663 . . . . 0.0 112.133 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -6.52 47.29 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.253 1.421 . . . . 0.0 112.681 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -156.86 115.75 3.36 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.885 1.274 . . . . 0.0 109.139 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.22 -27.81 68.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.851 1.26 . . . . 0.0 112.431 -169.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -60.71 -19.28 58.34 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 120.768 -1.208 . . . . 0.0 112.525 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.467 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 38.1 m-80 -60.33 -50.9 71.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.993 1.269 . . . . 0.0 110.181 174.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 p -71.28 -30.67 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 120.851 -1.155 . . . . 0.0 110.135 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.9 mt -64.2 -37.38 87.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.15 69.83 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.402 0.546 . . . . 0.0 111.649 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.08 -28.49 62.33 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.245 -0.91 . . . . 0.0 111.37 176.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -58.26 -37.04 74.14 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.017 0.826 . . . . 0.0 110.207 173.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 m -55.95 -56.32 22.12 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.327 1.051 . . . . 0.0 110.086 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.1 mt -65.13 -31.78 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 123.463 0.705 . . . . 0.0 110.008 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 . . . . . 0 N--CA 1.444 -0.773 0 O-C-N 121.689 -0.632 . . . . 0.0 111.728 178.852 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mt . . . . . 0 C--O 1.237 0.423 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.52 103.17 8.29 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.96 -1.087 . . . . 0.0 110.916 -172.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 33.3 p -64.14 -46.23 84.99 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.983 -1.073 . . . . 0.0 112.93 -169.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.97 -18.57 64.09 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.289 0.636 . . . . 0.0 111.327 -176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.92 -56.74 4.05 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.764 1.626 . . . . 0.0 108.875 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.7 mt -51.6 -43.94 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.415 1.086 . . . . 0.0 109.992 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.66 -68.24 0.19 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.378 1.071 . . . . 0.0 110.047 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -45.22 -56.46 4.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.167 1.787 . . . . 0.0 112.232 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -54.78 -43.68 73.03 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 127.942 2.497 . . . . 0.0 111.227 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.96 -48.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 120.806 -1.184 . . . . 0.0 108.628 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -57.45 -43.46 83.97 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.385 1.448 . . . . 0.0 110.128 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -65.51 -44.87 85.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 118.718 0.69 . . . . 0.0 112.063 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -58.49 -46.75 86.05 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.299 1.04 . . . . 0.0 112.549 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.8 mt -58.78 -50.19 74.86 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -51.69 -45.68 63.59 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 120.261 1.391 . . . . 0.0 113.629 170.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -53.93 -32.11 52.53 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.881 1.672 . . . . 0.0 112.927 -173.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -123.39 15.63 9.69 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.567 1.547 . . . . 0.0 111.452 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 43.95 41.95 4.3 Favored 'General case' 0 CA--C 1.542 0.641 1 C-N-CA 132.379 4.272 . . . . 0.0 114.612 -176.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.3 mt -84.41 131.11 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.079 0.952 . . . . 0.0 108.726 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.09 115.71 4.07 Favored Glycine 0 C--O 1.228 -0.219 0 C-N-CA 125.0 1.286 . . . . 0.0 111.691 -169.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -39.62 -35.99 0.36 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.405 2.282 . . . . 0.0 115.725 -167.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -50.06 -50.12 48.98 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.249 1.386 . . . . 0.0 111.507 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.75 -50.69 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 119.044 0.838 . . . . 0.0 109.242 -173.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -54.74 -46.94 74.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.772 -0.58 . . . . 0.0 111.065 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.5 -15.52 68.42 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-O 117.026 -1.986 . . . . 0.0 113.232 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -94.25 -26.25 16.7 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.617 2.208 . . . . 0.0 112.575 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -118.44 -24.06 6.97 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -172.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.45 -37.74 6.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.138 0.975 . . . . 0.0 109.593 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.3 mt -112.19 -30.73 7.1 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -171.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.39 13.16 83.12 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 123.961 0.791 . . . . 0.0 113.469 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 99.0 mt -101.84 170.33 8.22 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.254 1.822 . . . . 0.0 109.16 -174.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.09 166.57 13.6 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.411 -0.806 . . . . 0.0 112.025 173.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.2 tm0? -64.23 -44.34 92.18 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.31 -56.83 8.76 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 125.281 1.42 . . . . 0.0 112.068 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.7 m -52.13 -69.06 0.12 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 118.341 -0.838 . . . . 0.0 111.359 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.8 -37.1 70.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 120.482 1.492 . . . . 0.0 111.566 -171.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 t -55.26 -38.52 68.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 117.828 -1.082 . . . . 0.0 112.115 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.14 -48.58 79.47 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.921 1.237 . . . . 0.0 110.202 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 mt -59.03 -35.07 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.0 mt -81.22 -37.23 28.94 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 123.603 0.761 . . . . 0.0 112.099 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.55 -48.12 83.16 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.977 0.911 . . . . 0.0 110.751 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -136.94 82.0 32.1 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.36 73.86 4.38 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.554 2.836 . . . . 0.0 109.096 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -56.34 148.39 43.23 Favored Pre-proline 0 N--CA 1.441 -0.911 0 C-N-CA 124.8 1.24 . . . . 0.0 109.103 -172.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.02 147.26 91.78 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 124.46 3.44 . . . . 0.0 109.098 -164.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 60.3 t-105 -54.13 -38.07 65.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.735 0.414 . . . . 0.0 110.555 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -25.75 67.12 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -37.2 65.27 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.66 -1.275 . . . . 0.0 110.212 173.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.7 mt -74.54 172.44 12.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.298 1.047 . . . . 0.0 110.13 -171.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.6 p -129.15 -175.98 3.73 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.774 2.83 . . . . 0.0 107.834 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 89.9 t -47.54 -57.52 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 120.543 1.519 . . . . 0.0 111.229 173.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -70.09 -27.56 64.7 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.342 -1.474 . . . . 0.0 112.855 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.8 97.24 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 170.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -88.24 -26.12 22.51 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 126.949 2.1 . . . . 0.0 111.974 -171.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -44.45 -54.66 11.7 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.705 1.602 . . . . 0.0 110.566 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.04 -48.77 4.59 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.994 1.796 . . . . 0.0 110.982 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -57.48 -37.63 73.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.458 1.026 . . . . 0.0 113.401 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.0 -59.55 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 172.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -55.01 -38.89 68.48 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.099 0.56 . . . . 0.0 110.934 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 57.8 mtm -66.01 -50.56 63.83 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.768 0.827 . . . . 0.0 111.912 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -58.8 -41.26 86.3 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.908 -1.12 . . . . 0.0 110.778 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -70.29 -35.8 73.95 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.139 1.375 . . . . 0.0 110.576 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -56.5 -54.45 45.63 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.28 1.832 . . . . 0.0 109.105 171.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.3 mt -64.39 -18.15 64.41 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.709 0.803 . . . . 0.0 112.442 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.83 -10.13 59.4 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.532 -0.73 . . . . 0.0 111.604 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -144.41 110.13 5.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.368 0.985 . . . . 0.0 108.345 171.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -52.43 -30.44 29.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.833 1.253 . . . . 0.0 112.076 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -61.7 -16.04 45.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.149 -1.594 . . . . 0.0 112.969 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -66.79 -50.28 63.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.834 1.197 . . . . 0.0 110.692 169.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.1 p -64.06 -37.46 79.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 CA-C-N 119.359 0.982 . . . . 0.0 109.223 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.07 -39.91 93.91 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 118.241 0.473 . . . . 0.0 110.559 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.34 -34.39 76.01 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.858 0.463 . . . . 0.0 111.741 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.8 -27.81 66.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.84 0.856 . . . . 0.0 111.549 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 mtm105 -55.17 -50.36 69.53 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.5 m -53.3 -40.75 64.99 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.75 1.62 . . . . 0.0 109.348 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.2 mt -69.75 -31.4 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 O-C-N 120.656 -1.277 . . . . 0.0 111.21 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 . . . . . 0 N--CA 1.451 -0.414 0 CA-C-N 119.028 0.831 . . . . 0.0 110.873 170.274 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.7 mt . . . . . 0 C--O 1.237 0.413 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.92 102.48 5.59 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 123.06 1.41 . . . . 0.0 109.489 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 p -70.23 -35.06 73.59 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.722 -174.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.57 65.94 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 120.262 1.392 . . . . 0.0 110.914 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -77.84 -50.88 11.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.856 2.062 . . . . 0.0 108.981 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -54.03 -53.24 29.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.83 -46.23 78.17 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.313 0.645 . . . . 0.0 112.096 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.417 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 50.6 t80 -58.54 -66.48 0.48 Allowed 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.382 1.073 . . . . 0.0 108.23 174.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -47.29 -40.6 17.21 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.354 1.462 . . . . 0.0 112.643 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.7 t -57.98 -53.8 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 123.684 0.794 . . . . 0.0 109.873 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 43.0 mtmt -52.71 -51.09 61.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -59.29 -44.41 92.49 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.765 0.826 . . . . 0.0 112.582 -175.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.415 ' HG3' ' CD2' ' A' ' 80' ' ' LEU . 9.9 mm-40 -61.32 -49.59 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.954 1.702 . . . . 0.0 112.349 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.49 -49.47 77.67 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.48 -42.91 67.74 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.833 1.253 . . . . 0.0 114.056 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -53.83 -28.31 34.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.676 1.19 . . . . 0.0 111.568 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -124.76 15.66 8.69 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.872 1.669 . . . . 0.0 112.579 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 38.4 54.31 1.81 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.727 2.811 . . . . 0.0 113.893 -172.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.5 mt -89.89 151.7 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.29 131.9 10.8 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 126.236 1.874 . . . . 0.0 111.681 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -60.43 -20.1 58.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.216 1.006 . . . . 0.0 113.211 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -65.68 -60.82 2.51 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 119.775 1.171 . . . . 0.0 109.222 171.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.73 -47.54 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 C-N-CA 123.632 0.773 . . . . 0.0 109.97 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -53.55 -51.04 64.17 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.653 0.66 . . . . 0.0 111.907 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.48 -28.85 72.98 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-O 117.845 -1.531 . . . . 0.0 112.061 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -72.38 -23.55 61.13 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.794 1.797 . . . . 0.0 112.023 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -116.27 -60.32 1.87 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.751 1.159 . . . . 0.0 112.841 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.16 -44.67 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.9 mt -95.1 -41.76 8.95 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.21 0.604 . . . . 0.0 110.755 -173.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.92 30.19 44.04 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.179 0.895 . . . . 0.0 112.223 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.8 mt -121.13 164.42 16.88 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 126.725 2.01 . . . . 0.0 107.802 -173.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.2 t -65.4 162.41 17.79 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.518 0.675 . . . . 0.0 110.737 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -58.85 -54.06 51.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.806 0.842 . . . . 0.0 109.586 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.55 -42.88 99.85 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.0 m -52.56 -60.42 3.27 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.805 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 m -63.58 -39.31 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 120.885 1.675 . . . . 0.0 113.984 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.32 -35.97 78.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 119.179 0.899 . . . . 0.0 109.376 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.18 -44.13 87.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.516 0.726 . . . . 0.0 111.212 169.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mt -59.98 -40.04 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.8 -38.26 62.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.754 0.822 . . . . 0.0 111.042 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.16 -49.52 56.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.402 1.881 . . . . 0.0 112.204 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -127.32 75.21 77.28 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 127.023 2.129 . . . . 0.0 108.111 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.33 103.0 0.61 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 N-CA-C 106.429 -2.181 . . . . 0.0 106.429 167.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -66.61 170.96 4.87 Favored Pre-proline 0 N--CA 1.439 -0.992 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.4 146.26 79.86 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.112 2.542 . . . . 0.0 109.681 168.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -55.26 -48.33 74.15 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.88 0.872 . . . . 0.0 110.773 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.72 -21.22 3.81 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 172.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -94.89 5.27 52.37 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 120.219 -1.551 . . . . 0.0 112.51 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.4 mt -113.71 174.94 5.68 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.687 1.595 . . . . 0.0 109.215 173.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -128.13 -173.98 3.09 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.14 1.776 . . . . 0.0 108.313 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 96.8 t -47.28 -55.56 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.908 1.231 . . . . 0.0 111.015 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -60.54 -32.21 71.27 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 120.862 -1.149 . . . . 0.0 112.926 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.8 -45.48 94.86 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.666 1.127 . . . . 0.0 112.428 171.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -90.69 -17.85 26.08 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.707 2.003 . . . . 0.0 112.266 -164.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -41.6 -53.62 7.29 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.308 2.243 . . . . 0.0 111.648 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -65.84 -50.77 1.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.341 2.027 . . . . 0.0 111.129 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -57.62 -38.96 75.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 117.69 -1.148 . . . . 0.0 112.481 -174.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.1 mt -58.01 -54.29 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -56.35 -47.41 78.87 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.769 0.827 . . . . 0.0 110.486 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 64.7 mtm -61.42 -47.86 83.85 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 123.066 0.546 . . . . 0.0 110.705 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -58.72 -40.99 85.31 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.57 -0.707 . . . . 0.0 111.339 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.71 -41.56 92.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.063 0.847 . . . . 0.0 111.008 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.6 t80 -56.57 -41.65 77.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.557 0.743 . . . . 0.0 109.48 177.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.415 ' CD2' ' HG3' ' A' ' 29' ' ' GLN . 81.7 mt -75.75 -15.24 60.3 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.765 1.226 . . . . 0.0 113.938 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.9 m -81.65 -14.19 56.97 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.234 0.924 . . . . 0.0 111.035 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -145.24 97.12 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -47.31 -25.63 1.04 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.192 1.797 . . . . 0.0 112.746 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -58.41 -28.77 65.53 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 119.643 -1.911 . . . . 0.0 112.138 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.416 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 66.7 m-80 -62.06 -54.23 44.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.19 -37.49 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.1 -0.375 . . . . 0.0 110.15 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.6 -39.4 93.63 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.42 0.688 . . . . 0.0 110.703 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.92 -35.29 67.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.558 0.743 . . . . 0.0 111.996 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.99 -25.09 66.63 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.132 0.973 . . . . 0.0 110.774 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -58.06 -49.53 76.6 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 118.359 0.527 . . . . 0.0 109.915 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 m -60.29 -38.26 83.06 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.403 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mt -63.04 -42.33 96.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 119.68 1.127 . . . . 0.0 109.692 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 . . . . . 0 N--CA 1.451 -0.394 0 C-N-CA 123.445 0.698 . . . . 0.0 111.273 -179.134 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mt . . . . . 0 C--O 1.239 0.521 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -85.33 104.07 14.83 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.029 1.395 . . . . 0.0 108.122 162.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.437 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 19.4 p -56.2 -41.65 75.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.988 172.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 -37.74 71.95 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.475 0.71 . . . . 0.0 111.558 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -71.14 -54.77 9.87 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.328 1.451 . . . . 0.0 108.434 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -54.09 -51.05 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.36 -49.82 63.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.826 0.85 . . . . 0.0 111.362 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -55.42 -63.75 1.06 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.483 1.113 . . . . 0.0 109.617 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -50.88 -41.24 58.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.566 1.946 . . . . 0.0 112.933 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.3 t -62.54 -47.85 91.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 121.011 -1.056 . . . . 0.0 110.079 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -55.89 -39.61 71.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.657 -1.163 . . . . 0.0 109.337 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -59.39 -55.81 29.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.45 1.023 . . . . 0.0 112.024 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -63.86 -39.66 94.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 112.318 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.12 -46.43 89.06 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 120.091 1.314 . . . . 0.0 107.601 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -16.73 64.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.06 0.846 . . . . 0.0 113.263 175.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -66.8 -30.66 70.92 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.083 -1.011 . . . . 0.0 110.832 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -127.99 10.35 6.43 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.322 1.049 . . . . 0.0 111.699 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 41.01 85.11 0.02 OUTLIER 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.24 2.616 . . . . 0.0 111.171 -164.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.2 mt -115.99 150.96 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.971 0.909 . . . . 0.0 108.921 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.96 142.14 17.45 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 123.954 0.788 . . . . 0.0 111.499 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -66.09 -33.46 75.84 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 118.57 -0.729 . . . . 0.0 111.965 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -59.97 -46.72 88.52 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 118.832 0.742 . . . . 0.0 109.767 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 t -61.88 -54.04 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 119.151 0.887 . . . . 0.0 109.294 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -51.3 -47.87 62.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.668 0.27 . . . . 0.0 111.714 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.34 -27.71 57.11 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-O 117.017 -1.991 . . . . 0.0 112.573 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -78.81 -26.75 44.29 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.738 2.269 . . . . 0.0 110.769 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -96.31 -78.5 0.46 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.68 0.792 . . . . 0.0 109.386 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.3 t -53.42 -52.28 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 C-N-CA 126.489 1.916 . . . . 0.0 107.896 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.9 mt -90.17 -34.44 15.84 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 118.026 -0.988 . . . . 0.0 111.595 -170.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.97 12.72 80.72 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 124.2 0.937 . . . . 0.0 112.791 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.0 mt -102.79 172.29 6.92 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.172 1.389 . . . . 0.0 109.688 -171.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 63.5 p -67.33 159.79 28.56 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.291 -0.881 . . . . 0.0 109.594 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -61.22 -46.43 90.45 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.017 -1.052 . . . . 0.0 109.209 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.88 -32.68 70.83 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.83 -0.984 . . . . 0.0 112.043 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -60.19 -69.36 0.22 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.919 1.359 . . . . 0.0 108.69 169.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 m -57.25 -40.05 71.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 120.09 1.314 . . . . 0.0 113.63 -173.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.0 t -55.01 -45.72 75.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.753 0.821 . . . . 0.0 109.638 176.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -57.42 -46.07 83.94 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 119.361 0.982 . . . . 0.0 110.702 172.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.42 ' CG2' ' CZ ' ' A' ' 73' ' ' PHE . 5.1 mt -58.72 -41.21 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -70.41 -41.51 72.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.444 1.098 . . . . 0.0 111.174 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.69 -48.89 73.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.878 2.071 . . . . 0.0 112.557 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.3 79.38 61.36 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.48 95.77 0.63 Allowed 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 106.987 -1.966 . . . . 0.0 106.987 173.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -62.54 154.73 71.98 Favored Pre-proline 0 N--CA 1.436 -1.125 0 O-C-N 120.945 -1.097 . . . . 0.0 108.099 172.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -65.09 150.2 88.15 Favored 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 122.139 1.893 . . . . 0.0 108.368 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -52.25 -43.67 64.48 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.786 0.834 . . . . 0.0 110.789 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -21.59 52.02 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -83.46 -28.86 28.47 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.943 1.247 . . . . 0.0 113.039 175.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.9 mt -85.21 157.18 20.7 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.902 0.774 . . . . 0.0 109.436 -169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.1 t -97.63 -178.44 4.12 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 166.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -47.28 -51.09 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 125.358 1.463 . . . . 0.0 111.356 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.88 -22.75 67.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.1 -40.22 17.22 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 125.732 1.634 . . . . 0.0 111.44 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -76.63 -26.44 54.93 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 125.65 1.58 . . . . 0.0 111.742 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -46.1 -55.8 12.35 Favored Pre-proline 0 N--CA 1.455 -0.195 0 C-N-CA 126.485 1.914 . . . . 0.0 112.184 -176.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.64 -48.62 8.75 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 121.434 1.423 . . . . 0.0 110.025 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.437 ' CZ ' ' HB ' ' A' ' 19' ' ' THR . 64.5 m-85 -58.9 -37.75 77.33 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 117.508 -1.234 . . . . 0.0 113.133 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.1 mt -57.72 -58.77 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 C-N-CA 124.45 1.1 . . . . 0.0 108.06 173.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -52.46 -45.7 66.19 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.881 0.872 . . . . 0.0 110.173 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 64.7 mtm -65.54 -46.7 78.55 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.478 -0.764 . . . . 0.0 112.213 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -62.66 -38.45 90.37 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.034 -1.041 . . . . 0.0 110.252 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -66.47 -40.4 89.33 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.043 1.337 . . . . 0.0 110.502 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.9 t80 -57.34 -51.7 68.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.27 1.428 . . . . 0.0 108.394 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.2 mt -66.8 -10.91 52.63 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.72 1.208 . . . . 0.0 113.868 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -38.69 87.52 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.174 -0.954 . . . . 0.0 109.975 171.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -132.34 112.03 11.85 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.385 0.993 . . . . 0.0 110.147 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -53.82 -22.29 9.3 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.729 1.612 . . . . 0.0 112.413 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -53.86 -28.55 36.69 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 119.85 -1.781 . . . . 0.0 113.016 171.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.414 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 51.6 m-80 -62.04 -48.85 78.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.964 0.505 . . . . 0.0 110.031 175.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -37.16 79.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 CA-C-N 119.237 0.926 . . . . 0.0 109.814 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.4 mt -66.69 -35.05 79.22 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.836 0.454 . . . . 0.0 110.182 -173.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.42 -35.42 70.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.493 0.717 . . . . 0.0 112.052 172.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.39 -27.34 69.24 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.845 0.858 . . . . 0.0 111.338 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -59.26 -44.46 92.41 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.44 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.1 m -50.8 -46.53 59.77 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.282 0.946 . . . . 0.0 110.967 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.4 mt -67.84 -32.44 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.474 0.71 . . . . 0.0 110.134 -174.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 123.68 0.792 . . . . 0.0 110.795 173.967 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mt . . . . . 0 C--O 1.238 0.498 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.5 93.95 4.87 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.2 p -58.13 -40.49 81.41 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.96 -1.088 . . . . 0.0 111.635 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.96 -34.79 76.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.94 0.496 . . . . 0.0 110.315 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.83 -55.44 7.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.564 1.145 . . . . 0.0 108.779 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.3 mt -56.25 -44.38 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.49 -48.61 78.76 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.735 -0.603 . . . . 0.0 111.536 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.505 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 29.7 t80 -56.36 -64.97 0.69 Allowed 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.231 1.012 . . . . 0.0 108.999 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -54.57 -35.63 63.51 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 127.106 2.162 . . . . 0.0 112.935 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.1 t -61.76 -53.13 52.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 119.191 0.905 . . . . 0.0 110.188 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 47.1 mtmt -52.38 -42.51 64.05 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 117.6 -1.191 . . . . 0.0 109.185 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.47 -58.1 10.1 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.238 1.015 . . . . 0.0 110.556 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -62.08 -34.17 75.79 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.67 -50.33 72.91 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 170.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.64 -42.41 74.96 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.107 0.867 . . . . 0.0 110.981 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -54.39 -30.1 51.0 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.129 2.171 . . . . 0.0 113.006 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -127.23 14.82 7.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.614 1.565 . . . . 0.0 110.928 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.7 m120 44.76 43.31 6.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 129.036 2.934 . . . . 0.0 113.073 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -82.15 147.17 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.81 -1.182 . . . . 0.0 109.421 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.13 130.99 10.17 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -56.62 -37.0 70.1 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.992 1.317 . . . . 0.0 112.512 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.2 ttp85 -54.63 -50.13 68.85 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.133 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.54 -49.41 83.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 119.107 0.867 . . . . 0.0 109.565 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -54.13 -49.2 69.73 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.18 -29.08 67.06 Favored Glycine 0 C--O 1.216 -0.987 0 CA-C-O 117.45 -1.75 . . . . 0.0 113.576 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -78.57 -30.08 46.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.729 2.265 . . . . 0.0 111.568 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.4 -58.44 1.88 Allowed 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.553 0.741 . . . . 0.0 110.393 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 t -68.23 -53.42 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -172.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.0 mt -89.47 -37.08 15.04 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.2 0.6 . . . . 0.0 110.528 -173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.14 36.25 60.39 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.7 mt -121.51 163.43 18.84 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.731 1.612 . . . . 0.0 108.534 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.2 t -54.6 144.48 21.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.473 1.109 . . . . 0.0 109.919 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -58.28 -26.97 63.62 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 117.775 0.261 . . . . 0.0 110.841 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.59 -36.29 43.91 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.346 0.974 . . . . 0.0 112.054 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.1 m -67.56 -59.56 3.26 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.081 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 m -58.75 -35.18 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 120.381 1.446 . . . . 0.0 113.691 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.2 p -61.88 -38.82 89.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.981 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.3 -38.59 68.86 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.742 1.155 . . . . 0.0 110.104 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.9 mt -68.54 -47.22 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -173.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.8 mt -73.45 -30.36 63.14 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.145 0.578 . . . . 0.0 111.857 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.2 -57.46 5.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.02 1.728 . . . . 0.0 110.969 173.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -130.25 74.42 80.4 Favored Pre-proline 0 CA--C 1.519 -0.24 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -170.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.68 97.2 0.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 122.709 2.272 . . . . 0.0 107.167 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -63.68 159.53 51.96 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -70.31 150.05 64.31 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.093 1.862 . . . . 0.0 107.328 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.446 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 67.4 t-105 -51.69 -42.15 61.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -14.66 52.67 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.96 -16.95 34.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.144 1.793 . . . . 0.0 112.363 171.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.64 149.37 21.29 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.44 1.018 . . . . 0.0 108.85 -169.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -98.03 179.93 4.61 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 165.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.8 t -49.05 -51.05 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 119.649 1.113 . . . . 0.0 112.163 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt -59.56 -34.48 72.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.46 1.482 . . . . 0.0 112.569 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.78 -35.2 90.61 Favored Glycine 0 CA--C 1.529 0.92 0 O-C-N 121.35 -0.844 . . . . 0.0 112.705 173.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 93.5 mttt -80.4 -27.91 38.0 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.348 1.459 . . . . 0.0 112.162 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -42.18 -52.64 9.48 Favored Pre-proline 0 N--CA 1.448 -0.563 0 C-N-CA 128.365 2.666 . . . . 0.0 111.883 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.97 -56.08 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.103 1.869 . . . . 0.0 110.27 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -58.05 -32.03 67.62 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 117.482 -1.247 . . . . 0.0 113.303 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.23 -58.81 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 119.449 1.022 . . . . 0.0 108.278 171.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -53.85 -48.85 69.58 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 58.3 mtm -72.31 -33.68 67.55 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 119.713 1.142 . . . . 0.0 113.034 -168.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -62.21 -41.44 98.38 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.622 171.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -66.72 -35.04 79.19 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.579 1.152 . . . . 0.0 111.644 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -58.65 -57.28 13.67 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 126.312 1.845 . . . . 0.0 108.062 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.03 -4.8 7.9 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.445 1.498 . . . . 0.0 113.124 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.7 -7.64 59.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.771 1.228 . . . . 0.0 112.729 171.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -152.26 134.39 15.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.223 1.829 . . . . 0.0 111.538 171.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -60.4 -35.71 76.4 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.249 1.42 . . . . 0.0 111.104 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -58.2 -27.07 63.54 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.545 -0.722 . . . . 0.0 110.555 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -63.27 -42.61 99.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.227 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 p -75.8 -33.6 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.731 1.151 . . . . 0.0 110.267 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.6 mt -66.53 -38.72 87.77 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.647 0.658 . . . . 0.0 110.277 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.37 97.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.204 0.526 . . . . 0.0 110.791 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.51 -27.41 68.45 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.964 0.905 . . . . 0.0 111.234 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -57.0 -38.59 73.29 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.165 0.893 . . . . 0.0 109.649 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -65.83 -46.35 78.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.762 0.71 . . . . 0.0 111.232 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.9 mt -62.83 -32.01 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 119.307 0.958 . . . . 0.0 110.538 -176.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? . . . . . 0 N--CA 1.448 -0.552 0 C-N-CA 123.499 0.72 . . . . 0.0 110.767 178.028 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 C--O 1.234 0.273 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.25 111.57 19.97 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.624 1.102 . . . . 0.0 108.577 171.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.9 p -69.18 -39.43 78.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 121.22 -0.925 . . . . 0.0 111.915 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 -21.49 63.83 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.508 1.049 . . . . 0.0 112.119 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -75.67 -55.36 5.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.727 1.611 . . . . 0.0 107.088 172.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.3 mt -53.96 -44.22 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 119.779 1.172 . . . . 0.0 109.427 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.63 -53.76 50.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.754 1.221 . . . . 0.0 111.248 173.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -57.57 -53.46 57.9 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.284 1.034 . . . . 0.0 110.539 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -58.48 -43.43 88.98 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.618 2.367 . . . . 0.0 110.624 -176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.64 -55.03 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 O-C-N 120.861 -1.15 . . . . 0.0 109.023 172.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -51.47 -46.06 62.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.324 0.965 . . . . 0.0 110.932 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.97 -40.03 75.62 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 116.565 -1.683 . . . . 0.0 111.927 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -64.35 -36.16 83.23 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 121.627 2.012 . . . . 0.0 111.451 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.5 mt -61.07 -52.07 66.5 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 mt -65.02 -28.46 69.51 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -58.24 -36.34 73.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.963 1.305 . . . . 0.0 109.809 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -121.77 8.27 9.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.248 1.019 . . . . 0.0 112.405 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 52.3 79.29 0.11 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 128.04 2.536 . . . . 0.0 111.876 -169.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.7 mt -121.89 150.37 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.72 141.88 15.76 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.931 0.777 . . . . 0.0 111.269 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -57.81 -33.1 68.22 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.21 1.404 . . . . 0.0 112.253 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 -59.01 -62.8 1.61 Allowed 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.274 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.49 -36.48 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.968 1.258 . . . . 0.0 111.066 -176.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -59.78 -53.93 52.18 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 120.531 -1.356 . . . . 0.0 110.637 172.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.11 -24.22 74.62 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-O 118.017 -1.435 . . . . 0.0 112.62 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -81.3 -20.45 40.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.838 1.819 . . . . 0.0 111.429 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -120.94 -51.42 2.13 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.327 0.967 . . . . 0.0 112.289 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.1 t -68.84 -52.16 37.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.6 mt -93.89 -29.06 15.49 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.208 -173.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.08 18.12 76.21 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 122.892 0.282 . . . . 0.0 112.563 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.7 169.9 8.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.558 1.543 . . . . 0.0 107.789 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.3 156.78 37.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 168.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -53.78 -51.15 64.33 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.205 0.602 . . . . 0.0 110.024 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.5 -26.44 68.2 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.321 -0.71 . . . . 0.0 112.54 -174.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 m -63.74 -69.05 0.3 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 m -56.65 -35.93 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 120.367 1.44 . . . . 0.0 112.59 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t -60.78 -40.2 91.68 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.272 1.829 . . . . 0.0 110.576 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.84 -47.0 87.49 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.139 1.336 . . . . 0.0 109.272 167.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.0 mt -61.43 -31.8 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 99.3 mt -84.7 -22.66 29.68 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.944 0.897 . . . . 0.0 112.608 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.45 -49.16 23.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.802 1.241 . . . . 0.0 110.121 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.9 mtt85 -135.04 86.84 30.87 Favored Pre-proline 0 CA--C 1.516 -0.339 0 C-N-CA 125.373 1.469 . . . . 0.0 107.865 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.24 93.56 0.48 Allowed 'Trans proline' 0 N--CA 1.445 -1.335 0 N-CA-C 107.05 -1.942 . . . . 0.0 107.05 167.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -65.53 158.44 73.66 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -72.33 152.17 55.03 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.04 2.494 . . . . 0.0 108.958 -167.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.435 ' CD2' ' HE2' ' A' ' 70' ' ' LYS . 74.7 t-105 -52.43 -41.28 63.11 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.649 0.38 . . . . 0.0 111.478 175.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -18.02 58.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -89.03 -37.1 15.41 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 120.831 -1.168 . . . . 0.0 110.852 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.7 mt -74.69 146.15 42.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.543 0.687 . . . . 0.0 110.656 -162.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 t -71.3 174.59 6.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.289 1.035 . . . . 0.0 110.671 166.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.0 p -49.69 -56.09 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 124.423 1.089 . . . . 0.0 111.586 170.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -70.12 -5.07 24.42 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.62 -41.63 7.21 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.814 1.673 . . . . 0.0 110.288 167.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HE2' ' CD2' ' A' ' 62' ' ' TRP . 88.1 mttt -76.84 -26.1 53.92 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 126.264 1.825 . . . . 0.0 112.497 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -40.99 -62.04 1.12 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 127.266 2.226 . . . . 0.0 110.698 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -61.73 -44.5 21.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.393 2.062 . . . . 0.0 110.365 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -60.63 -39.93 90.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 117.67 -1.157 . . . . 0.0 112.845 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.9 mt -56.14 -51.59 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -59.65 -46.9 87.63 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.456 1.102 . . . . 0.0 110.861 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 70.5 mtm -61.84 -48.14 81.88 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 123.868 0.867 . . . . 0.0 110.823 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -60.78 -40.89 94.27 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.116 -0.99 . . . . 0.0 110.494 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -67.55 -36.01 80.15 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.116 0.967 . . . . 0.0 111.232 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -57.25 -48.04 79.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.011 0.925 . . . . 0.0 109.015 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.8 mt -71.07 -13.14 61.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.791 1.236 . . . . 0.0 113.631 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -25.73 68.21 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.146 0.885 . . . . 0.0 111.947 173.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -145.72 105.17 3.95 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -162.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -61.13 -23.24 65.38 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.382 0.673 . . . . 0.0 111.011 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -60.09 -23.42 63.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 119.783 -1.823 . . . . 0.0 112.036 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -62.45 -38.89 91.52 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.066 1.303 . . . . 0.0 111.48 175.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 p -73.19 -35.4 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.608 1.094 . . . . 0.0 109.506 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.9 mt -70.52 -23.65 62.68 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.288 1.035 . . . . 0.0 111.283 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.3 -49.26 35.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.125 0.97 . . . . 0.0 110.615 167.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -28.93 69.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.336 1.454 . . . . 0.0 111.549 -170.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -57.45 -46.15 83.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.4 m -60.54 -37.51 81.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.653 0.781 . . . . 0.0 110.362 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mt -68.28 -30.3 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.353 0.978 . . . . 0.0 109.974 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 . . . . . 0 N--CA 1.451 -0.398 0 O-C-N 121.684 -0.635 . . . . 0.0 111.372 179.629 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt . . . . . 0 C--O 1.238 0.46 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.95 98.35 4.9 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.371 0.987 . . . . 0.0 108.571 175.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.4 p -58.34 -43.42 88.3 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.678 -1.264 . . . . 0.0 112.241 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.1 -26.24 66.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 118.805 -0.617 . . . . 0.0 110.992 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -70.86 -57.87 4.18 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 171.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.0 mt -54.92 -44.76 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.659 1.118 . . . . 0.0 109.936 -173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.35 -51.73 68.66 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.914 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.534 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 81.9 t80 -53.19 -68.66 0.15 Allowed 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 125.292 1.437 . . . . 0.0 108.556 175.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -41.79 -46.04 3.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.955 2.502 . . . . 0.0 112.458 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.65 -50.08 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.951 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 47.9 mtmt -48.26 -45.85 34.99 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.421 1.464 . . . . 0.0 109.864 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.59 -54.8 30.31 Favored 'General case' 0 C--O 1.225 -0.186 0 O-C-N 124.451 1.094 . . . . 0.0 110.688 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.478 ' NE2' ' HZ2' ' A' ' 32' ' ' LYS . 19.5 mm-40 -56.02 -40.58 73.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.889 1.676 . . . . 0.0 112.433 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.57 -49.67 68.0 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.8 -37.35 65.98 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.824 0.738 . . . . 0.0 111.831 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.478 ' HZ2' ' NE2' ' A' ' 29' ' ' GLN . 17.4 ttpt -55.39 -25.33 34.9 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.832 2.053 . . . . 0.0 112.922 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -126.45 16.43 7.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.153 0.981 . . . . 0.0 111.909 175.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.4 m120 40.22 75.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 129.686 3.194 . . . . 0.0 111.481 -166.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.8 mt -114.66 152.22 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -99.22 172.64 25.58 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -95.09 -20.19 19.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -172.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -58.82 -55.24 37.64 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 118.854 0.752 . . . . 0.0 110.229 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 t -60.0 -53.65 45.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -54.26 -45.1 72.32 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.819 1.191 . . . . 0.0 111.015 -174.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.65 -24.5 76.67 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-O 117.273 -1.849 . . . . 0.0 112.882 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -79.71 -37.48 35.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.569 2.185 . . . . 0.0 111.632 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -91.21 -70.4 0.69 Allowed 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.486 -0.759 . . . . 0.0 109.5 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.15 -50.44 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 125.087 1.355 . . . . 0.0 108.342 -172.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.4 mt -95.73 -37.18 10.89 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.612 -170.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.61 6.03 86.08 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 118.501 0.591 . . . . 0.0 113.713 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.6 mt -92.02 173.74 7.68 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.993 1.717 . . . . 0.0 109.438 -172.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 t -63.66 154.14 33.91 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.549 0.69 . . . . 0.0 109.845 164.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -62.98 -22.84 67.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.343 1.457 . . . . 0.0 111.449 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.09 -59.9 4.43 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 171.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.1 m -49.47 -52.57 28.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 116.728 -1.606 . . . . 0.0 112.041 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 m -66.38 -37.87 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 121.495 1.952 . . . . 0.0 113.375 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.8 t -60.2 -34.93 74.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 118.419 -0.8 . . . . 0.0 110.521 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -57.96 -48.98 78.36 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.073 0.851 . . . . 0.0 110.758 168.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.5 mt -58.16 -39.63 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.2 mt -77.65 -35.06 52.9 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.964 1.306 . . . . 0.0 113.779 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.5 -60.45 3.13 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -134.67 72.7 68.9 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 125.064 1.346 . . . . 0.0 108.792 -165.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.04 108.0 1.23 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.57 2.18 . . . . 0.0 106.655 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -66.92 159.66 74.52 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 163.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.26 149.2 81.3 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 122.529 2.153 . . . . 0.0 109.316 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -45.48 -46.71 13.86 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.56 1.544 . . . . 0.0 111.148 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -56.74 -32.38 65.51 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -71.52 -29.46 64.81 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.389 0.995 . . . . 0.0 111.319 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.4 mt -80.93 157.89 25.43 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.439 0.638 . . . . 0.0 111.249 -160.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.9 p -78.9 175.45 10.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.716 0.806 . . . . 0.0 108.917 165.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -53.79 -50.65 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.001 1.32 . . . . 0.0 112.39 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -72.6 -19.78 61.41 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 120.146 -1.596 . . . . 0.0 112.251 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.84 96.78 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 163.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -85.3 -28.17 25.46 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 117.215 -1.374 . . . . 0.0 113.089 -176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -45.04 -52.26 20.36 Favored Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 124.564 1.146 . . . . 0.0 111.964 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.76 -52.02 4.21 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.374 1.383 . . . . 0.0 110.065 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -59.51 -32.86 70.68 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 117.71 -1.138 . . . . 0.0 113.082 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.4 mt -61.16 -56.5 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -53.71 -43.79 69.31 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.541 1.136 . . . . 0.0 111.089 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -66.24 -45.25 81.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.12 -1.613 . . . . 0.0 114.711 172.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -63.48 -33.77 76.3 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.343 -1.473 . . . . 0.0 109.911 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -62.44 -49.57 74.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.224 1.809 . . . . 0.0 110.074 172.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -51.52 -48.7 62.9 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.25 1.42 . . . . 0.0 110.332 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.85 -8.57 29.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.382 1.073 . . . . 0.0 113.882 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -68.99 -25.07 64.34 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.183 -0.948 . . . . 0.0 111.942 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -147.45 141.11 25.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.913 1.233 . . . . 0.0 108.958 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -62.32 -32.68 73.47 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.237 1.015 . . . . 0.0 111.194 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -30.05 61.7 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.827 -1.171 . . . . 0.0 110.864 -175.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -64.0 -36.13 82.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 118.687 0.676 . . . . 0.0 110.245 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.0 p -77.37 -31.5 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.114 -0.991 . . . . 0.0 110.469 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 42.1 mt -61.85 -41.4 97.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.838 0.855 . . . . 0.0 109.827 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.78 84.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.218 0.607 . . . . 0.0 110.106 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -30.24 70.22 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.158 177.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -61.0 -43.64 98.59 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 119.612 1.096 . . . . 0.0 109.835 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.5 m -53.09 -49.16 67.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.324 0.65 . . . . 0.0 110.094 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.3 mt -64.55 -34.4 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.417 -0.802 . . . . 0.0 110.423 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.05 177.396 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.4 mt . . . . . 0 C--O 1.238 0.473 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.76 95.74 4.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 122.372 1.082 . . . . 0.0 108.483 175.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.6 p -61.21 -42.55 98.8 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.287 -0.883 . . . . 0.0 111.374 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.52 -34.91 73.23 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.973 0.909 . . . . 0.0 110.92 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -70.82 -54.18 12.54 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.1 mt -55.93 -42.75 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.98 -55.78 28.65 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.159 0.984 . . . . 0.0 110.765 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -53.08 -62.73 1.47 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.117 1.367 . . . . 0.0 110.276 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -55.47 -36.61 66.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.059 1.743 . . . . 0.0 113.381 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.1 t -63.9 -47.59 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -58.14 -37.93 75.6 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 116.986 -1.483 . . . . 0.0 110.465 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -61.11 -58.11 9.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.4 1.0 . . . . 0.0 110.559 173.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -61.66 -34.23 75.36 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.214 -0.929 . . . . 0.0 112.127 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.3 mt -72.08 -33.87 68.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.174 1.79 . . . . 0.0 109.753 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 mt -65.45 -37.63 87.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 120.06 1.3 . . . . 0.0 112.177 168.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HZ2' ' CE1' ' A' ' 33' ' ' HIS . 55.0 tttm -58.26 -36.38 73.16 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.107 1.763 . . . . 0.0 113.459 -163.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.445 ' CE1' ' HZ2' ' A' ' 32' ' ' LYS . 78.9 m-70 -124.41 12.3 8.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.915 2.486 . . . . 0.0 111.406 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 m120 44.18 78.48 0.06 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.874 2.469 . . . . 0.0 111.506 -171.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.1 mt -116.87 151.68 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.88 151.01 19.92 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.706 0.615 . . . . 0.0 111.735 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -57.81 -38.05 74.85 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.237 1.415 . . . . 0.0 110.668 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -56.76 -61.14 2.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.614 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.96 -49.0 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 119.48 1.036 . . . . 0.0 109.358 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.36 -47.1 79.56 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.918 0.781 . . . . 0.0 111.541 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.17 -31.19 69.17 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-O 118.275 -1.291 . . . . 0.0 111.264 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -71.09 -30.07 66.08 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.738 1.769 . . . . 0.0 111.056 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -108.39 -57.83 2.07 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.189 0.995 . . . . 0.0 113.035 -171.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.6 -48.27 53.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -175.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 20.9 mt -93.17 -29.5 15.7 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 122.045 -0.409 . . . . 0.0 111.737 -171.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.06 19.76 79.72 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.374 -0.681 . . . . 0.0 112.149 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.4 mt -109.14 165.03 11.91 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.005 1.322 . . . . 0.0 107.603 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.53 162.06 29.97 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.071 0.939 . . . . 0.0 109.342 174.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -49.72 75.78 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.071 0.948 . . . . 0.0 110.692 -172.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.57 -41.56 95.61 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.4 m -55.95 -67.17 0.32 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 117.459 -1.258 . . . . 0.0 110.886 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 m -55.46 -36.24 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 121.261 1.846 . . . . 0.0 112.884 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 m -68.87 -23.69 64.25 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.669 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -66.67 -45.69 78.09 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.481 1.491 . . . . 0.0 108.552 162.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 mt -60.81 -40.42 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt -74.56 -31.5 62.11 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.399 1.079 . . . . 0.0 112.589 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.12 -50.31 64.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.536 0.734 . . . . 0.0 109.704 173.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 mtp85 -136.9 78.32 41.81 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 125.23 1.412 . . . . 0.0 108.516 -166.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.15 107.67 1.98 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.151 1.901 . . . . 0.0 107.39 169.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -64.32 173.51 1.48 Allowed Pre-proline 0 N--CA 1.442 -0.856 0 C-N-CA 124.342 1.057 . . . . 0.0 109.022 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -59.3 142.37 99.03 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.826 1.684 . . . . 0.0 108.699 165.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -54.37 -49.18 70.43 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.829 1.195 . . . . 0.0 110.494 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -21.32 4.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 mmtm -77.47 -31.06 53.47 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 120.359 -1.463 . . . . 0.0 111.383 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 mt -70.24 151.46 45.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.746 0.784 . . . . 0.0 109.549 -172.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.7 t -84.47 179.53 7.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 160.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.05 -57.11 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.098 1.359 . . . . 0.0 110.782 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -64.86 -19.44 65.89 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.836 -1.165 . . . . 0.0 112.863 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.16 -50.01 69.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 126.118 1.818 . . . . 0.0 111.769 165.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -74.62 -25.58 59.32 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 125.046 1.339 . . . . 0.0 112.338 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -43.72 -54.77 9.97 Favored Pre-proline 0 N--CA 1.446 -0.669 0 C-N-CA 127.083 2.153 . . . . 0.0 112.094 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.15 -47.83 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.083 1.856 . . . . 0.0 110.557 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -59.88 -36.6 77.28 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.901 -1.047 . . . . 0.0 112.73 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.7 mt -60.75 -55.02 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 174.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -55.75 -45.85 77.96 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.389 0.675 . . . . 0.0 109.751 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.3 mtm -59.5 -52.74 64.27 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 123.403 0.681 . . . . 0.0 111.437 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -60.01 -40.05 87.91 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.983 -1.073 . . . . 0.0 111.589 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -70.03 -31.96 69.86 Favored 'General case' 0 C--O 1.229 -0.025 0 C-N-CA 123.588 0.755 . . . . 0.0 111.42 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 22.8 t80 -61.56 -50.91 70.73 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.722 1.209 . . . . 0.0 108.123 171.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.1 mt -72.43 4.54 3.69 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.959 1.703 . . . . 0.0 113.241 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -91.02 -6.37 54.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 117.722 -1.132 . . . . 0.0 110.773 168.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.79 107.05 1.28 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.329 1.422 . . . . 0.0 109.389 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -55.13 -20.76 10.92 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.983 1.313 . . . . 0.0 113.945 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -58.94 -23.57 61.62 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 121.248 1.84 . . . . 0.0 111.204 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.439 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 65.4 m-80 -64.85 -48.2 75.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 173.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.1 p -65.45 -37.36 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.088 1.313 . . . . 0.0 109.565 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.5 mt -65.72 -30.1 70.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.586 0.754 . . . . 0.0 110.036 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.22 -45.46 73.22 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.849 0.86 . . . . 0.0 111.23 170.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.23 -24.25 66.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.497 1.119 . . . . 0.0 111.15 -175.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mtm105 -55.15 -52.88 61.89 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.827 0.74 . . . . 0.0 109.929 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.5 m -54.95 -41.29 70.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.486 1.514 . . . . 0.0 110.245 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.5 mt -67.52 -35.58 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.243 -0.911 . . . . 0.0 110.111 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-N 119.097 0.862 . . . . 0.0 110.774 177.783 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.29 97.79 3.65 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.3 p -59.58 -36.32 76.01 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.175 -0.953 . . . . 0.0 112.173 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 -28.45 66.42 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.912 0.778 . . . . 0.0 110.998 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -77.79 -49.42 14.39 Favored 'General case' 0 C--O 1.215 -0.753 0 C-N-CA 125.188 1.395 . . . . 0.0 108.423 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.8 mt -56.32 -46.52 81.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.0 -53.17 59.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.533 -0.729 . . . . 0.0 110.492 174.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -57.45 -58.07 9.88 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.241 1.016 . . . . 0.0 111.174 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -56.39 -39.03 72.31 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.356 2.262 . . . . 0.0 111.02 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.8 t -63.73 -51.77 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 120.227 -1.546 . . . . 0.0 110.002 172.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -59.4 -43.67 92.93 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.84 -0.537 . . . . 0.0 110.348 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.58 -49.7 76.47 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.355 0.662 . . . . 0.0 109.918 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -54.91 -47.58 74.19 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.307 1.843 . . . . 0.0 113.645 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.7 mt -60.8 -43.51 98.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 121.12 -0.987 . . . . 0.0 108.479 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -41.81 99.28 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 120.026 1.285 . . . . 0.0 112.406 172.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -58.37 -39.91 80.86 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.763 2.825 . . . . 0.0 111.051 -173.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -115.07 13.23 16.84 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.246 0.619 . . . . 0.0 112.319 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.7 t30 38.7 77.2 0.05 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.189 2.596 . . . . 0.0 112.859 -170.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.0 149.89 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.499 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -89.57 142.56 16.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.905 0.764 . . . . 0.0 111.378 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -36.47 77.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.323 1.049 . . . . 0.0 112.874 -175.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -55.92 -57.32 12.57 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 119.211 0.914 . . . . 0.0 110.022 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -57.9 -44.06 85.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 118.518 0.599 . . . . 0.0 109.689 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -54.54 -50.61 67.5 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.679 -0.638 . . . . 0.0 112.005 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.57 -26.03 73.97 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-O 117.697 -1.613 . . . . 0.0 112.145 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -79.11 -32.09 44.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.649 1.725 . . . . 0.0 111.271 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -108.33 -44.95 4.0 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.238 1.015 . . . . 0.0 113.319 -174.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.01 -46.07 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.7 mt -98.05 -30.85 12.45 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.068 0.23 . . . . 0.0 111.489 -171.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.29 4.21 90.27 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 123.97 0.794 . . . . 0.0 112.662 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 73.4 mt -93.23 178.63 5.67 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.61 1.564 . . . . 0.0 109.512 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 p -72.75 159.65 33.47 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.655 -0.653 . . . . 0.0 109.701 169.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -51.95 -44.2 63.84 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.952 1.301 . . . . 0.0 109.378 167.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.4 -54.88 31.52 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.073 1.32 . . . . 0.0 111.697 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.2 m -56.46 -64.85 0.73 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 117.684 -1.15 . . . . 0.0 110.697 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.2 m -58.08 -36.82 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 120.524 1.511 . . . . 0.0 111.872 -172.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.2 m -62.91 -29.28 70.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.09 -1.433 . . . . 0.0 112.979 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.02 -48.71 77.61 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 120.363 1.438 . . . . 0.0 108.887 166.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.7 -42.6 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.9 mt -77.83 -27.27 49.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.784 0.834 . . . . 0.0 113.0 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.71 -41.91 61.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.067 1.347 . . . . 0.0 111.257 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.32 82.43 9.72 Favored Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 126.813 2.045 . . . . 0.0 107.352 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.49 95.66 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.648 2.232 . . . . 0.0 107.484 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -61.76 157.44 49.04 Favored Pre-proline 0 N--CA 1.443 -0.81 0 O-C-N 121.016 -1.052 . . . . 0.0 108.799 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.05 149.14 92.41 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 122.725 2.284 . . . . 0.0 108.536 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 66.4 t-105 -56.21 -44.05 79.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.524 0.602 . . . . 0.0 110.573 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -12.63 9.26 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.57 -7.05 45.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.713 1.605 . . . . 0.0 113.61 175.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.5 mt -106.4 151.14 25.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.622 0.769 . . . . 0.0 110.517 -173.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 p -85.68 179.06 7.16 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.218 1.007 . . . . 0.0 109.784 171.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 t -52.07 -43.46 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.199 -0.938 . . . . 0.0 111.339 165.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -63.91 -42.1 97.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 118.52 0.6 . . . . 0.0 109.981 175.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.88 -31.34 67.91 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-O 119.193 -0.782 . . . . 0.0 113.526 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -91.37 -18.55 24.1 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.733 1.613 . . . . 0.0 111.987 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -42.22 -56.33 5.52 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 127.05 2.14 . . . . 0.0 111.874 175.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -66.86 -45.05 4.68 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.502 1.468 . . . . 0.0 110.349 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -64.86 -34.42 78.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.316 -1.326 . . . . 0.0 112.517 -173.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.88 -53.94 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 120.068 1.304 . . . . 0.0 107.683 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -53.04 -45.79 68.18 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.757 0.823 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 69.9 mtm -63.44 -49.75 72.47 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.274 -0.891 . . . . 0.0 111.787 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.7 tttm -58.59 -40.56 83.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.02 -1.05 . . . . 0.0 110.343 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -64.77 -44.75 89.0 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.527 1.131 . . . . 0.0 110.23 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -52.38 -45.05 65.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.49 1.116 . . . . 0.0 110.919 173.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.8 mt -78.26 -9.72 59.35 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.819 1.248 . . . . 0.0 113.686 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.3 t -75.66 -11.99 60.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.762 0.825 . . . . 0.0 111.014 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -162.86 95.43 0.88 Allowed 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.989 -1.069 . . . . 0.0 108.279 -155.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.74 -29.34 18.21 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.904 1.282 . . . . 0.0 111.098 -173.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -54.25 -22.86 12.78 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.256 -1.527 . . . . 0.0 113.884 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -66.34 -44.52 83.06 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.447 1.021 . . . . 0.0 111.917 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.17 -36.6 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 120.572 -1.33 . . . . 0.0 109.755 -175.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -34.97 71.2 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.788 2.035 . . . . 0.0 110.521 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.83 -45.01 60.71 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.637 1.175 . . . . 0.0 111.978 172.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.57 -29.43 67.94 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 120.93 -1.106 . . . . 0.0 110.793 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.8 mtp-105 -61.76 -41.04 97.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 118.406 -0.807 . . . . 0.0 110.225 173.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -58.31 -45.63 87.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.267 1.394 . . . . 0.0 109.784 173.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.8 mt -60.16 -32.68 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.927 0.785 . . . . 0.0 109.886 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.499 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 11.5 tp-100 . . . . . 0 N--CA 1.448 -0.53 0 O-C-N 121.036 -1.04 . . . . 0.0 112.458 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.234 0.265 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.54 101.38 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.099 -1.001 . . . . 0.0 110.068 175.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.1 p -65.25 -40.98 94.7 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 120.679 -1.263 . . . . 0.0 112.689 -172.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.03 -29.53 70.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.836 0.744 . . . . 0.0 110.854 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -76.71 -50.95 12.41 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.498 2.319 . . . . 0.0 108.522 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt -56.83 -45.96 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.94 0.896 . . . . 0.0 109.119 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.85 72.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.986 -1.071 . . . . 0.0 110.696 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.406 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 51.5 t80 -54.19 -65.94 0.48 Allowed 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.917 1.287 . . . . 0.0 109.057 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -44.04 -44.31 7.32 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.687 1.995 . . . . 0.0 112.556 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.97 -43.94 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 O-C-N 121.345 -0.847 . . . . 0.0 111.283 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 41.9 mtmt -55.24 -35.56 65.1 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.561 1.073 . . . . 0.0 109.593 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -67.61 -56.58 8.87 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 123.36 0.664 . . . . 0.0 110.937 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -59.21 -39.38 82.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.582 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.42 -46.96 86.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 119.757 1.162 . . . . 0.0 108.091 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.18 -41.41 79.26 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.232 0.924 . . . . 0.0 111.472 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -53.98 -31.76 51.83 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.723 1.609 . . . . 0.0 114.072 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -119.77 7.21 10.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.95 1.3 . . . . 0.0 112.524 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m120 51.38 79.47 0.1 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 127.939 2.496 . . . . 0.0 111.226 -170.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.3 mt -119.64 137.27 54.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.638 0.732 . . . . 0.0 109.376 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.83 132.94 12.79 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 126.486 1.993 . . . . 0.0 109.805 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.429 HE21 HD11 ' A' ' 56' ' ' LEU . 8.1 mt-30 -54.01 -31.77 52.19 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.064 1.346 . . . . 0.0 113.265 -175.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -58.08 -48.56 79.78 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.576 -1.202 . . . . 0.0 111.341 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -60.27 -50.23 81.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 119.665 1.12 . . . . 0.0 108.839 -176.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -56.96 -40.59 76.75 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.656 -0.653 . . . . 0.0 111.665 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.23 -34.31 64.34 Favored Glycine 0 N--CA 1.437 -1.298 0 CA-C-O 117.596 -1.669 . . . . 0.0 111.592 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -70.02 -38.76 76.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.102 1.951 . . . . 0.0 110.548 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -97.61 -58.88 1.89 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.74 0.7 . . . . 0.0 112.667 -171.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.4 t -72.35 -47.13 54.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -172.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.2 mt -89.31 -40.34 12.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 119.075 -0.488 . . . . 0.0 110.667 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.47 22.01 71.21 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.766 -1.019 . . . . 0.0 111.753 -174.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.5 mt -110.62 160.05 17.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.424 1.89 . . . . 0.0 109.397 -174.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 m -63.72 152.6 38.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.575 1.15 . . . . 0.0 109.541 174.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -53.33 -43.06 67.35 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.11 0.964 . . . . 0.0 111.248 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.38 -10.4 80.02 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 118.076 -1.402 . . . . 0.0 113.368 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 m -68.26 -68.59 0.38 Allowed 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.869 1.835 . . . . 0.0 106.996 161.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -56.14 -37.7 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.449 1.477 . . . . 0.0 113.692 -171.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -42.84 94.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.859 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -47.01 74.83 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.448 1.022 . . . . 0.0 109.666 171.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.7 mt -60.12 -43.96 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.429 HD11 HE21 ' A' ' 37' ' ' GLN . 92.8 mt -70.85 -35.72 72.54 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.747 1.219 . . . . 0.0 111.802 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.92 -51.7 30.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.059 1.744 . . . . 0.0 110.509 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -133.36 81.87 54.22 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 124.693 1.197 . . . . 0.0 108.898 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -69.3 95.55 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.707 2.938 . . . . 0.0 108.443 171.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -62.0 156.55 57.16 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 171.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -61.73 152.53 73.6 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.551 2.167 . . . . 0.0 108.218 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -53.75 -47.63 70.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.634 0.774 . . . . 0.0 110.038 175.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 3.66 0.32 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 173.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 2.2 mmpt? -107.41 -13.83 15.01 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 119.759 -1.838 . . . . 0.0 112.983 167.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.6 mt -92.77 150.41 20.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 119.084 0.856 . . . . 0.0 109.145 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t -94.15 -179.96 5.12 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 167.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 t -49.76 -49.45 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.238 1.415 . . . . 0.0 111.306 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -64.72 -28.26 69.47 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 120.208 1.367 . . . . 0.0 112.386 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.0 -40.11 73.51 Favored Glycine 0 CA--C 1.527 0.783 0 O-C-N 120.99 -1.069 . . . . 0.0 112.41 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -77.18 -25.61 52.03 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 126.908 2.083 . . . . 0.0 112.068 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -41.64 -54.24 6.81 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 128.72 2.808 . . . . 0.0 112.116 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.67 -58.6 0.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.247 2.631 . . . . 0.0 111.28 173.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -56.19 -33.29 65.15 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -171.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.0 mt -58.01 -58.35 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -52.61 -52.13 56.81 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 124.588 1.155 . . . . 0.0 109.007 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -57.96 -48.64 79.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -58.89 -42.63 89.99 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -71.16 -32.9 69.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.513 0.725 . . . . 0.0 110.857 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -59.19 -46.58 88.05 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.975 1.31 . . . . 0.0 109.402 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.1 mt -66.57 -21.5 66.14 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.0 m -82.89 1.14 40.89 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.981 0.81 . . . . 0.0 112.644 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -148.38 99.04 2.98 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 120.348 1.431 . . . . 0.0 108.747 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -61.87 -22.03 65.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.574 0.75 . . . . 0.0 112.743 -168.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -57.29 -23.16 46.66 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.523 -1.36 . . . . 0.0 112.878 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -64.47 -47.31 79.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.195 0.907 . . . . 0.0 110.508 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.0 p -72.1 -31.98 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.404 -0.81 . . . . 0.0 110.506 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.9 mt -69.7 -23.01 63.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.781 0.832 . . . . 0.0 111.097 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.51 -36.05 29.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.808 0.843 . . . . 0.0 110.499 171.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.23 -38.04 86.95 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 120.664 -1.273 . . . . 0.0 110.601 -176.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -62.95 -35.49 80.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.212 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.0 m -54.7 -51.33 65.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.768 0.713 . . . . 0.0 109.507 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.69 -39.29 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 122.946 0.498 . . . . 0.0 110.357 -175.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.593 0 C-N-CA 124.614 1.166 . . . . 0.0 111.502 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 C--O 1.238 0.478 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.76 100.78 8.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 174.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.0 p -62.94 -36.54 83.78 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.257 -0.902 . . . . 0.0 111.491 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.94 -24.67 61.66 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.824 1.193 . . . . 0.0 111.445 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -72.52 -55.67 6.59 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 173.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.4 mt -54.36 -51.39 49.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.95 -49.02 72.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.592 0.757 . . . . 0.0 111.604 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.409 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 66.2 t80 -55.97 -61.45 2.37 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 124.725 1.21 . . . . 0.0 109.419 175.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -52.86 -39.83 62.9 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.499 2.32 . . . . 0.0 112.08 -176.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.1 -51.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 121.455 -0.778 . . . . 0.0 109.661 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 45.8 mtmt -53.26 -39.55 63.95 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 116.811 -1.566 . . . . 0.0 110.642 175.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.93 -59.32 5.56 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.724 1.21 . . . . 0.0 110.671 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -62.16 -36.34 81.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.265 1.026 . . . . 0.0 111.574 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 mt -65.09 -51.62 60.35 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -55.9 -39.36 71.48 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.025 1.284 . . . . 0.0 112.014 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -51.33 -50.65 59.0 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.894 2.078 . . . . 0.0 109.786 -177.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -104.86 12.84 32.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.386 1.074 . . . . 0.0 111.458 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 t30 38.38 58.71 1.56 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 130.792 3.637 . . . . 0.0 112.011 -171.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 82.7 mt -93.01 156.8 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.413 1.485 . . . . 0.0 108.305 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.402 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -98.98 151.22 19.46 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.741 0.686 . . . . 0.0 112.202 -175.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -70.92 -30.12 66.36 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 117.825 -1.083 . . . . 0.0 113.752 -174.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -59.06 -59.14 5.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 120.357 1.435 . . . . 0.0 109.377 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.2 t -59.73 -43.46 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 123.478 0.486 . . . . 0.0 109.864 -174.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -56.18 -47.75 77.7 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.244 0.929 . . . . 0.0 110.973 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.93 -30.52 67.88 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-O 118.144 -1.364 . . . . 0.0 112.391 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -72.07 -29.97 64.66 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.165 1.482 . . . . 0.0 111.274 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -105.48 -68.87 0.84 Allowed 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.705 0.802 . . . . 0.0 111.122 -176.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.64 -38.59 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 123.301 0.64 . . . . 0.0 109.391 -169.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.0 mt -95.79 -42.03 8.55 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.47 32.77 67.86 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.3 mt -110.49 165.15 12.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.651 1.581 . . . . 0.0 107.111 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.61 161.65 30.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.706 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -46.6 86.85 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.637 0.775 . . . . 0.0 111.527 -171.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.85 -32.24 82.18 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.3 m -59.44 -65.56 0.65 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 118.169 -0.919 . . . . 0.0 108.576 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 m -59.65 -37.22 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 120.143 1.338 . . . . 0.0 112.893 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 t -57.47 -40.54 78.78 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.642 -0.661 . . . . 0.0 111.102 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.37 -45.13 95.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.468 0.707 . . . . 0.0 110.563 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.0 mt -60.28 -43.05 92.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -70.57 -35.89 73.3 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 123.743 0.817 . . . . 0.0 112.491 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.41 -45.71 79.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.308 1.043 . . . . 0.0 110.269 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -134.68 79.48 52.87 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 125.364 1.466 . . . . 0.0 109.336 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -72.03 103.96 1.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.733 2.289 . . . . 0.0 106.968 168.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -80.71 163.8 54.38 Favored Pre-proline 0 N--CA 1.443 -0.82 0 C-N-CA 125.335 1.454 . . . . 0.0 108.195 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -56.68 139.94 89.41 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.093 2.529 . . . . 0.0 108.83 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -50.65 -47.49 58.54 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.589 1.086 . . . . 0.0 110.537 173.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -21.38 32.83 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 176.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -77.74 -35.14 52.2 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.513 1.506 . . . . 0.0 110.418 177.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.4 mt -78.77 163.82 25.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.072 0.949 . . . . 0.0 108.756 -174.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.7 p -123.52 -177.33 3.69 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.449 1.9 . . . . 0.0 107.282 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.3 m -44.61 -53.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 121.855 2.116 . . . . 0.0 113.821 -170.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 -21.73 59.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.912 0.863 . . . . 0.0 112.844 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.25 -38.18 87.33 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.352 1.453 . . . . 0.0 112.624 165.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -90.58 -27.15 19.31 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.311 1.844 . . . . 0.0 112.204 -172.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -37.05 -58.39 1.12 Allowed Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 129.781 3.232 . . . . 0.0 111.282 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.47 -49.54 3.32 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.999 1.799 . . . . 0.0 110.431 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -58.93 -34.92 72.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.006 -0.997 . . . . 0.0 112.568 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.03 -54.52 33.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 119.423 1.01 . . . . 0.0 108.59 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -56.2 -50.52 70.99 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 124.224 1.009 . . . . 0.0 108.989 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 65.3 mtm -59.57 -48.97 79.56 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.856 -0.527 . . . . 0.0 111.991 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -58.4 -37.16 74.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.438 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -74.51 -38.1 62.93 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.086 1.312 . . . . 0.0 111.376 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.435 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 4.9 t80 -56.38 -40.06 73.96 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.556 1.142 . . . . 0.0 109.163 173.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.4 mt -73.46 -19.8 60.86 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 117.706 -1.14 . . . . 0.0 113.015 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.6 m -61.29 -32.44 72.28 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.642 1.565 . . . . 0.0 111.098 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -137.89 117.01 12.55 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.981 1.312 . . . . 0.0 108.549 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -57.86 -16.41 11.7 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.695 1.598 . . . . 0.0 112.84 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -57.78 -21.67 42.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 120.274 -1.516 . . . . 0.0 112.798 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.435 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 63.6 m-80 -70.43 -49.42 48.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.781 1.173 . . . . 0.0 110.813 177.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.24 -33.54 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 119.587 1.085 . . . . 0.0 110.572 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.4 mt -62.31 -43.47 98.74 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.92 -2.76 13.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.267 1.427 . . . . 0.0 113.851 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.86 -18.79 20.08 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.584 1.538 . . . . 0.0 115.145 167.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -65.96 -51.12 61.32 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.431 1.469 . . . . 0.0 111.484 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 m -53.99 -36.72 63.22 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 117.322 -1.323 . . . . 0.0 110.685 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.7 mt -64.62 -34.5 70.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 CA-C-N 120.622 1.556 . . . . 0.0 110.532 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.402 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 9.7 tp-100 . . . . . 0 N--CA 1.455 -0.224 0 O-C-N 121.113 -0.992 . . . . 0.0 110.662 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.3 mt . . . . . 0 N--CA 1.455 -0.211 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.45 100.98 10.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 122.373 1.082 . . . . 0.0 109.031 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 p -59.42 -47.77 84.18 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.138 1.375 . . . . 0.0 111.415 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.66 -24.2 66.59 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.553 0.741 . . . . 0.0 111.529 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -80.57 -55.75 4.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 117.454 -1.26 . . . . 0.0 108.588 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 57.0 mt -48.98 -51.82 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 120.03 1.287 . . . . 0.0 108.426 177.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.68 -49.15 65.86 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.632 1.173 . . . . 0.0 111.741 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -62.86 -50.76 69.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.814 0.846 . . . . 0.0 110.301 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -60.21 -39.52 86.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.773 1.229 . . . . 0.0 111.537 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.29 -49.73 83.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 O-C-N 120.902 -1.123 . . . . 0.0 108.82 172.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -59.99 -30.31 69.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 116.604 -1.665 . . . . 0.0 112.119 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.6 -65.25 0.71 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.514 1.506 . . . . 0.0 108.848 169.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -56.35 -39.71 73.3 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.66 1.184 . . . . 0.0 113.286 -171.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.8 mt -61.75 -51.03 70.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.58 -29.92 70.34 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.375 0.67 . . . . 0.0 112.276 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -57.95 -25.7 61.29 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.304 1.442 . . . . 0.0 111.645 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -128.34 16.51 6.59 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.074 1.35 . . . . 0.0 112.042 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 m120 35.88 70.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 128.478 2.711 . . . . 0.0 111.926 -167.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.0 mt -100.93 147.54 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.484 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -88.38 133.37 11.77 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -177.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -35.04 68.77 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.704 0.802 . . . . 0.0 112.987 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.4 ttt-85 -54.41 -54.68 37.44 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.299 0.64 . . . . 0.0 111.158 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.83 -47.93 87.81 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.13 -47.27 75.27 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.714 0.688 . . . . 0.0 111.229 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.4 -27.1 70.38 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-O 117.112 -1.938 . . . . 0.0 112.443 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -70.89 -45.41 64.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.061 2.431 . . . . 0.0 110.431 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -87.67 -67.84 0.8 Allowed 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 121.766 -0.584 . . . . 0.0 111.091 -170.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.45 -44.03 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -171.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.0 mt -99.06 -39.99 8.24 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.169 0.588 . . . . 0.0 111.983 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.91 50.36 53.23 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -172.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -129.12 167.84 16.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.648 1.979 . . . . 0.0 107.25 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 t -66.69 157.02 33.69 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.968 0.89 . . . . 0.0 109.629 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -59.89 -27.32 66.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.915 0.886 . . . . 0.0 111.445 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.04 -48.34 26.87 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -54.38 -63.7 1.07 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.601 1.16 . . . . 0.0 110.211 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -58.45 -39.01 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 119.294 0.952 . . . . 0.0 111.767 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -62.06 -38.43 88.73 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.24 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -59.41 -47.57 84.95 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.937 1.244 . . . . 0.0 108.993 169.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.6 mt -60.13 -41.56 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -70.13 -40.79 74.61 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 124.525 1.13 . . . . 0.0 111.537 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.77 -37.39 86.21 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.114 1.366 . . . . 0.0 110.747 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -139.16 70.38 40.97 Favored Pre-proline 0 C--O 1.235 0.295 0 C-N-CA 126.815 2.046 . . . . 0.0 107.658 -171.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.39 93.36 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.01 2.474 . . . . 0.0 107.609 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -67.11 160.36 71.19 Favored Pre-proline 0 N--CA 1.436 -1.157 0 O-C-N 121.736 -0.602 . . . . 0.0 109.557 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -58.44 144.65 96.41 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.367 2.044 . . . . 0.0 108.486 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.517 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 65.6 t-105 -52.77 -49.58 65.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.529 0.604 . . . . 0.0 110.734 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.6 -25.71 11.42 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 176.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.52 -18.74 47.57 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 120.005 1.275 . . . . 0.0 113.27 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.7 mt -86.95 162.57 17.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.451 0.643 . . . . 0.0 111.424 -169.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.6 p -94.04 -178.86 4.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.97 2.108 . . . . 0.0 109.892 168.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.4 m -58.57 -45.17 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 119.331 0.969 . . . . 0.0 111.724 169.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -60.31 -33.11 71.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 119.519 -0.276 . . . . 0.0 111.631 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.66 96.76 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.103 1.335 . . . . 0.0 112.516 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.517 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 91.1 mttt -79.61 -26.91 41.09 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.472 1.509 . . . . 0.0 112.934 -175.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -43.69 -57.8 5.33 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 125.892 1.677 . . . . 0.0 110.441 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.49 -43.49 13.58 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.727 1.618 . . . . 0.0 112.366 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -64.61 -36.45 84.27 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 120.273 -1.517 . . . . 0.0 112.24 -174.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.35 -55.28 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -51.52 -48.7 62.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.064 0.946 . . . . 0.0 110.204 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 62.7 mtm -61.86 -46.52 89.07 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 120.966 -1.084 . . . . 0.0 112.394 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -63.18 -39.65 95.26 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.07 -1.019 . . . . 0.0 110.936 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -67.2 -36.83 82.57 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.216 1.007 . . . . 0.0 110.107 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.2 t80 -61.21 -40.5 94.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.917 0.887 . . . . 0.0 110.517 174.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.4 mt -72.77 -8.82 57.28 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.346 1.058 . . . . 0.0 112.666 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.42 -13.1 59.42 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.871 1.269 . . . . 0.0 111.887 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -157.28 119.03 3.74 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.052 -1.03 . . . . 0.0 109.419 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -25.65 65.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.163 0.985 . . . . 0.0 113.645 -170.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -64.41 -18.64 64.9 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 119.705 -1.872 . . . . 0.0 111.909 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.453 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 55.2 m-80 -59.71 -48.52 81.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.826 0.739 . . . . 0.0 111.003 176.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 p -71.55 -33.82 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 121.811 -0.555 . . . . 0.0 109.87 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 mt -63.54 -42.4 98.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.87 73.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.057 0.39 . . . . 0.0 111.567 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.51 -24.64 62.87 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.947 0.899 . . . . 0.0 112.234 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.5 mtp-105 -61.97 -47.89 82.84 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 118.827 0.74 . . . . 0.0 110.298 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.0 m -51.78 -46.83 64.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.899 0.88 . . . . 0.0 109.318 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 53.6 mt -64.86 -35.24 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 122.908 0.483 . . . . 0.0 110.277 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.484 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 6.5 tp-100 . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 117.922 -1.037 . . . . 0.0 111.066 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mt . . . . . 0 C--O 1.234 0.254 0 N-CA-C 110.77 -0.085 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.96 105.44 3.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.876 0.846 . . . . 0.0 109.399 177.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.432 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 19.2 p -68.72 -40.63 79.83 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.513 -0.742 . . . . 0.0 112.268 -177.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.83 66.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.928 0.785 . . . . 0.0 111.044 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -81.03 -52.78 7.04 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.319 1.448 . . . . 0.0 109.068 176.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.7 mt -56.13 -44.39 78.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 119.099 0.863 . . . . 0.0 109.916 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.57 85.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.551 0.74 . . . . 0.0 110.867 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.424 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 48.3 t80 -61.91 -53.92 49.11 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.078 0.951 . . . . 0.0 110.835 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -56.91 -38.98 73.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.114 1.365 . . . . 0.0 110.543 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.18 -50.76 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 120.68 -1.263 . . . . 0.0 109.81 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 40.9 mtmt -54.52 -48.22 72.18 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 116.991 -1.481 . . . . 0.0 110.726 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -47.41 71.44 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 116.944 -1.503 . . . . 0.0 111.402 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -56.37 -45.07 80.67 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 121.044 1.747 . . . . 0.0 112.48 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.2 -49.25 72.74 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.72 -33.49 70.26 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.454 1.025 . . . . 0.0 111.948 174.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -59.1 -20.27 51.96 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 126.114 1.766 . . . . 0.0 111.992 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -128.69 15.62 6.45 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 169.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 44.96 60.48 2.94 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 128.042 2.537 . . . . 0.0 111.765 -168.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.6 mt -98.32 154.05 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 174.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.54 150.8 18.09 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.921 0.772 . . . . 0.0 111.725 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -73.99 -14.36 61.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.96 1.304 . . . . 0.0 114.359 -177.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -70.97 -57.72 4.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.502 1.501 . . . . 0.0 109.973 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -56.0 -48.07 79.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -57.95 -41.31 82.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.758 1.163 . . . . 0.0 111.179 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.3 -26.54 67.96 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-O 117.184 -1.898 . . . . 0.0 112.58 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -74.32 -40.76 62.01 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.35 2.075 . . . . 0.0 110.658 173.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -90.93 -64.11 1.18 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.541 1.137 . . . . 0.0 111.803 -169.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.29 -36.85 74.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.3 mt -109.21 -43.86 4.06 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.062 0.545 . . . . 0.0 110.865 -166.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.45 31.79 53.35 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.093 0.854 . . . . 0.0 112.146 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.9 mt -109.08 159.39 16.91 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.578 1.551 . . . . 0.0 108.824 -175.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t -63.0 160.56 14.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.461 0.648 . . . . 0.0 110.114 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -54.11 -42.48 69.47 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.426 1.09 . . . . 0.0 112.528 -165.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.02 -10.01 57.81 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 118.427 -1.207 . . . . 0.0 113.637 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 m -62.4 -57.96 9.39 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.343 1.571 . . . . 0.0 108.99 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.31 -35.47 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.193 0.906 . . . . 0.0 112.081 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.6 t -59.28 -40.34 85.78 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.007 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.4 -46.49 88.53 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 119.311 0.96 . . . . 0.0 109.779 169.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.409 HG23 ' CZ ' ' A' ' 73' ' ' PHE . 1.7 mt -58.18 -30.41 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.114 1.325 . . . . 0.0 110.022 -176.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -87.73 -26.11 23.1 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.985 0.914 . . . . 0.0 113.122 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.98 -41.72 22.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.684 1.594 . . . . 0.0 110.798 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 mmt-85 -135.27 73.62 63.58 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 129.635 3.174 . . . . 0.0 106.367 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -69.68 95.25 0.54 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 N-CA-C 105.825 -2.414 . . . . 0.0 105.825 168.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -67.05 155.9 89.14 Favored Pre-proline 0 N--CA 1.432 -1.373 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.28 149.61 72.11 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.628 2.219 . . . . 0.0 109.889 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -51.21 -50.25 59.46 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.52 0.328 . . . . 0.0 110.261 172.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.24 2.1 0.63 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 176.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -98.76 -20.7 16.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.522 1.51 . . . . 0.0 112.014 167.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.6 mt -99.81 149.84 22.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.627 0.649 . . . . 0.0 109.629 -164.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.3 t -87.53 179.39 6.56 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.3 p -43.14 -58.54 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 124.693 1.197 . . . . 0.0 112.101 173.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.78 -17.0 63.79 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.85 -39.61 23.97 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 126.34 1.924 . . . . 0.0 112.953 167.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -83.5 -25.12 31.36 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.451 2.301 . . . . 0.0 111.961 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -45.78 -53.29 21.03 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 128.219 2.608 . . . . 0.0 111.61 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.17 -48.4 10.12 Favored 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 121.338 1.359 . . . . 0.0 109.851 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 19' ' ' THR . 69.1 m-85 -63.35 -33.39 75.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.437 -174.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.8 mt -60.46 -54.51 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.969 1.259 . . . . 0.0 108.081 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -54.05 -51.42 64.1 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.803 0.841 . . . . 0.0 109.689 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.3 mtm -60.8 -47.04 88.14 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.833 0.853 . . . . 0.0 112.02 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -59.0 -38.79 80.01 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.953 -1.092 . . . . 0.0 110.492 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -71.05 -37.97 72.52 Favored 'General case' 0 C--O 1.227 -0.108 0 O-C-N 121.702 -0.624 . . . . 0.0 111.361 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.418 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 16.8 t80 -54.31 -42.96 70.71 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.664 1.186 . . . . 0.0 109.57 171.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.8 mt -74.89 -13.16 60.51 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.615 -0.678 . . . . 0.0 112.448 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 m -80.9 2.64 25.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.667 0.787 . . . . 0.0 112.294 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -157.3 132.3 8.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.984 1.266 . . . . 0.0 108.269 162.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.22 -26.59 60.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.793 0.837 . . . . 0.0 112.174 175.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -54.1 -28.6 40.37 Favored 'General case' 0 C--N 1.338 0.106 0 O-C-N 120.027 -1.671 . . . . 0.0 113.559 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.418 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 52.4 m-80 -64.9 -50.27 67.17 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 119.289 0.949 . . . . 0.0 110.135 177.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.64 -34.98 68.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 O-C-N 121.529 -0.732 . . . . 0.0 110.464 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.8 mt -59.68 -48.63 80.9 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.49 85.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 122.943 0.497 . . . . 0.0 111.666 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.85 -24.4 67.53 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.583 1.153 . . . . 0.0 111.683 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -58.47 -49.12 78.49 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 119.048 0.84 . . . . 0.0 110.242 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 m -55.94 -44.8 78.75 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.098 0.408 . . . . 0.0 110.161 177.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.3 mt -63.07 -31.19 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.234 -0.917 . . . . 0.0 111.131 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 123.376 0.67 . . . . 0.0 111.465 176.81 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--O 1.235 0.297 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -71.76 99.79 2.23 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 122.295 1.045 . . . . 0.0 108.572 176.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.401 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 24.2 p -59.57 -40.58 87.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.156 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.76 -31.05 72.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 119.102 -0.475 . . . . 0.0 111.908 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -74.96 -50.27 17.25 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.664 1.186 . . . . 0.0 108.907 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.2 mt -56.11 -47.39 80.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.31 92.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.269 -0.894 . . . . 0.0 111.987 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -62.92 -66.66 0.51 Allowed 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.461 1.504 . . . . 0.0 109.183 172.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -49.83 -38.67 35.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.24 1.816 . . . . 0.0 112.985 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 t -63.75 -43.53 98.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 121.293 -0.88 . . . . 0.0 110.25 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -60.44 -43.63 96.62 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.683 0.674 . . . . 0.0 109.413 175.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -57.01 -49.13 76.73 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.076 0.551 . . . . 0.0 110.467 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -63.25 -38.05 89.64 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.915 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mt -62.46 -43.07 99.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 120.515 1.507 . . . . 0.0 109.915 172.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.05 -45.33 79.29 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.992 0.815 . . . . 0.0 111.337 168.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -52.94 -40.81 63.93 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.626 1.97 . . . . 0.0 113.96 -168.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -121.83 16.19 10.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.963 1.305 . . . . 0.0 111.282 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 43.41 72.22 0.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.244 2.618 . . . . 0.0 111.561 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.3 mt -112.49 155.8 13.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.62 144.41 17.28 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 124.207 0.908 . . . . 0.0 110.935 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -62.52 -37.52 86.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.902 1.681 . . . . 0.0 112.194 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.8 ttt-85 -57.43 -54.51 46.06 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 117.66 -1.162 . . . . 0.0 109.822 173.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.3 -36.13 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.63 1.559 . . . . 0.0 111.338 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -61.11 -55.86 27.55 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.492 -0.755 . . . . 0.0 111.25 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.41 -26.31 74.67 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-O 118.008 -1.44 . . . . 0.0 112.458 -174.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -78.75 -27.81 44.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 120.083 1.942 . . . . 0.0 110.784 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -106.73 -62.25 1.42 Allowed 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.925 0.89 . . . . 0.0 112.049 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.57 -45.77 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.9 mt -94.99 -37.44 11.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.113 -174.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.18 2.66 90.58 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.682 0.658 . . . . 0.0 112.747 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.6 mt -89.77 168.18 12.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.048 1.424 . . . . 0.0 107.794 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.0 m -76.39 162.19 28.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.473 -0.767 . . . . 0.0 110.785 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -56.95 -46.9 81.8 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.667 0.787 . . . . 0.0 111.868 -172.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.49 73.12 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 119.57 -0.572 . . . . 0.0 112.022 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 m -65.41 -62.35 1.58 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.035 0.918 . . . . 0.0 109.454 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.69 -34.62 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 119.789 1.177 . . . . 0.0 112.041 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -57.0 -42.1 79.65 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.013 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.0 -44.91 87.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.48 0.582 . . . . 0.0 109.672 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 mt -62.28 -38.56 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -174.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.0 mt -83.98 -15.07 49.11 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.056 0.943 . . . . 0.0 112.771 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.7 -52.64 6.25 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.596 1.558 . . . . 0.0 108.525 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.9 81.45 58.0 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 127.972 2.509 . . . . 0.0 107.568 -173.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.43 101.83 0.91 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 N-CA-C 106.426 -2.182 . . . . 0.0 106.426 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -67.49 161.72 62.79 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -56.19 144.24 81.82 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.526 2.817 . . . . 0.0 109.505 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -52.11 -50.64 61.26 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.253 0.621 . . . . 0.0 109.808 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -17.91 12.57 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 175.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 1.9 mmpt? -82.84 -31.66 27.94 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.429 1.468 . . . . 0.0 111.103 174.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.6 mt -71.88 174.77 6.49 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.814 1.292 . . . . 0.0 111.591 -167.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 p -111.19 179.89 3.91 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.779 1.232 . . . . 0.0 108.135 167.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.7 m -52.67 -45.6 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.366 1.439 . . . . 0.0 113.02 169.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -66.4 -22.23 66.23 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.632 1.56 . . . . 0.0 111.888 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.42 -47.62 27.67 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 124.816 1.198 . . . . 0.0 111.548 171.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -71.95 -31.35 66.22 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.742 1.217 . . . . 0.0 111.398 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -42.8 -57.65 4.67 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 127.918 2.487 . . . . 0.0 111.109 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.5 -52.01 3.62 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.0 1.8 . . . . 0.0 110.594 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.401 ' CZ ' ' HB ' ' A' ' 19' ' ' THR . 57.3 m-85 -55.08 -38.08 67.62 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.938 1.244 . . . . 0.0 113.345 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.6 mt -58.74 -56.47 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 124.709 1.204 . . . . 0.0 107.993 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -56.91 -42.5 80.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.218 1.007 . . . . 0.0 109.679 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.4 mtm -65.14 -51.26 62.3 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 124.299 1.04 . . . . 0.0 112.336 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -62.29 -36.01 80.79 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.028 -1.045 . . . . 0.0 110.296 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -66.12 -42.07 89.69 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.807 -0.558 . . . . 0.0 109.85 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.423 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 14.5 t80 -57.39 -39.06 75.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.163 0.985 . . . . 0.0 110.068 175.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.5 mt -76.57 -12.27 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.7 m -83.17 -21.33 33.56 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.195 -0.941 . . . . 0.0 113.075 -174.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -132.72 130.09 39.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 170.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.15 -46.17 90.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.347 -171.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -53.95 -18.52 3.53 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.103 2.161 . . . . 0.0 113.321 -166.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.423 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 68.2 m-80 -53.81 -41.82 67.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.086 0.955 . . . . 0.0 111.658 170.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 p -73.35 -35.34 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 119.782 1.174 . . . . 0.0 110.97 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.514 HD22 ' H ' ' A' ' 87' ' ' LEU . 2.5 mm? -64.85 -26.77 68.48 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.436 1.094 . . . . 0.0 109.782 -175.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.45 60.22 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.396 1.078 . . . . 0.0 112.698 167.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -31.44 71.64 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.039 0.936 . . . . 0.0 110.768 -178.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.6 mtm105 -53.98 -42.79 69.37 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.274 0.488 . . . . 0.0 110.015 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.5 m -66.05 -43.36 87.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.646 0.778 . . . . 0.0 110.053 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.8 mt -69.03 -32.35 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.533 -0.73 . . . . 0.0 109.769 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 118.728 -0.654 . . . . 0.0 110.931 174.533 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 C--O 1.236 0.389 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.74 107.49 6.87 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 122.155 0.978 . . . . 0.0 110.256 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.5 p -63.11 -44.23 96.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.722 0.809 . . . . 0.0 110.555 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.63 -8.72 56.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.783 0.833 . . . . 0.0 111.732 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.42 -54.47 4.17 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.797 1.239 . . . . 0.0 108.904 167.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.7 mt -52.32 -50.72 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.204 1.366 . . . . 0.0 109.286 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.56 -33.29 65.98 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.24 1.016 . . . . 0.0 112.95 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -75.56 -57.86 3.63 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.128 0.971 . . . . 0.0 108.496 174.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -52.35 -32.76 39.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.339 1.456 . . . . 0.0 112.034 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.66 -57.09 10.73 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 C-N-CA 124.393 1.077 . . . . 0.0 110.729 170.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -51.52 -41.43 61.01 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.495 1.043 . . . . 0.0 111.116 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -53.11 -59.36 4.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.008 1.323 . . . . 0.0 110.128 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -62.03 -38.81 90.1 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.474 1.109 . . . . 0.0 113.351 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.1 mt -61.12 -48.09 83.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.08 -37.66 85.87 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.156 0.889 . . . . 0.0 112.856 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -55.87 -33.56 64.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.435 1.894 . . . . 0.0 110.674 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -123.49 11.31 9.24 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.286 1.034 . . . . 0.0 113.073 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 49.03 68.44 0.71 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.64 1.976 . . . . 0.0 112.136 -172.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt -112.23 156.29 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 121.264 -0.897 . . . . 0.0 110.047 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.56 130.71 10.44 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.958 2.218 . . . . 0.0 110.721 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -51.75 -35.79 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.42 1.488 . . . . 0.0 112.096 174.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -58.3 -54.28 48.75 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.773 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.62 -44.63 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -55.69 -51.78 66.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.636 0.255 . . . . 0.0 110.794 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.65 78.27 Favored Glycine 0 N--CA 1.428 -1.86 0 CA-C-O 116.338 -2.368 . . . . 0.0 111.563 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -78.31 -30.79 48.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.812 2.806 . . . . 0.0 111.956 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -101.56 -51.63 3.41 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 123.054 0.542 . . . . 0.0 111.384 -170.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.73 -46.29 24.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -175.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.0 mt -95.94 -34.53 11.77 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.924 -172.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.72 4.96 88.37 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.389 0.519 . . . . 0.0 112.913 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.5 mt -98.49 158.55 15.53 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.361 1.464 . . . . 0.0 107.41 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.6 m -71.64 164.43 25.92 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.433 -0.792 . . . . 0.0 110.239 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -58.56 -49.59 76.87 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.83 69.73 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.584 -0.564 . . . . 0.0 111.899 -178.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 m -70.88 -62.85 1.24 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.863 1.265 . . . . 0.0 111.357 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 m -60.07 -30.83 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 121.089 1.768 . . . . 0.0 112.273 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.7 t -58.06 -39.23 77.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.52 -1.229 . . . . 0.0 110.394 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.72 -43.28 85.13 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.023 1.283 . . . . 0.0 110.176 171.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mt -64.79 -42.59 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -173.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.2 mt -77.1 -29.57 54.92 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.465 0.706 . . . . 0.0 111.848 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.25 -56.41 6.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.746 1.618 . . . . 0.0 111.078 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -135.52 59.39 30.83 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 124.245 1.018 . . . . 0.0 109.708 -165.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -63.35 104.49 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.883 3.056 . . . . 0.0 110.281 -173.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -63.63 157.94 62.86 Favored Pre-proline 0 N--CA 1.434 -1.252 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -65.81 153.87 76.33 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.645 2.896 . . . . 0.0 110.471 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.464 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 73.4 t-105 -55.44 -43.85 75.78 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.368 1.067 . . . . 0.0 111.288 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.469 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -60.77 -19.98 60.43 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 176.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.55 -23.31 27.71 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.558 1.072 . . . . 0.0 112.327 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 29.6 mt -89.38 152.42 21.51 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 119.071 0.851 . . . . 0.0 109.302 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.8 p -105.07 -172.05 2.03 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.933 1.293 . . . . 0.0 109.666 172.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.1 t -47.7 -58.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 120.785 1.63 . . . . 0.0 110.49 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -71.68 -3.08 19.78 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.78 -42.35 6.08 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.881 1.705 . . . . 0.0 112.097 165.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.464 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 85.3 mttt -80.88 -25.04 37.89 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.895 2.078 . . . . 0.0 111.844 -174.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.33 -56.31 12.98 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 125.482 1.513 . . . . 0.0 111.328 -175.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.33 -44.53 18.36 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 121.423 1.416 . . . . 0.0 110.311 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -62.43 -37.46 85.92 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.993 1.269 . . . . 0.0 113.229 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.04 -49.38 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.634 1.106 . . . . 0.0 108.031 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -57.65 -53.29 59.9 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.664 0.786 . . . . 0.0 109.558 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 58.5 mtm -56.75 -50.55 71.91 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.4 0.68 . . . . 0.0 112.27 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tttp -61.72 -40.3 94.58 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.574 -0.704 . . . . 0.0 110.35 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -70.53 -32.06 69.37 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.327 0.967 . . . . 0.0 111.086 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -60.94 -43.23 98.97 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.8 mt -71.89 -9.88 58.97 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.194 0.997 . . . . 0.0 112.413 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.8 m -89.44 -2.35 58.36 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.297 1.439 . . . . 0.0 112.543 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -149.73 123.45 9.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 120.141 1.337 . . . . 0.0 109.35 163.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.98 -18.72 64.56 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.821 0.343 . . . . 0.0 111.283 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -68.35 -11.17 59.15 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 119.795 -1.816 . . . . 0.0 113.731 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -71.82 -57.08 4.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 167.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.41 -34.05 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 O-C-N 121.12 -0.987 . . . . 0.0 110.958 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.2 mt -65.22 -25.88 67.88 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.774 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.46 60.0 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.964 0.906 . . . . 0.0 110.967 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.31 -33.09 74.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.885 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -51.15 -50.58 58.64 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 118.706 0.684 . . . . 0.0 110.227 175.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.1 m -51.42 -50.12 60.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.768 1.227 . . . . 0.0 110.537 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.5 mt -62.94 -37.34 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.638 0.775 . . . . 0.0 109.902 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 . . . . . 0 N--CA 1.452 -0.334 0 O-C-N 121.622 -0.674 . . . . 0.0 110.9 -176.94 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.658 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.2 m 65.5 111.12 0.03 OUTLIER 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.6 1.56 . . . . 0.0 111.867 -174.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 t -131.8 -88.25 0.46 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.91 -177.24 37.37 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.2 p -160.44 131.84 5.8 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.864 0.832 . . . . 0.0 108.907 172.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.0 t -146.89 108.55 4.33 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.27 83.06 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.27 161.18 14.28 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.104 0.452 . . . . 0.0 110.105 174.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.52 71.81 0.04 OUTLIER Glycine 0 CA--C 1.526 0.759 0 CA-C-O 119.147 -0.807 . . . . 0.0 111.589 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -59.4 160.49 19.77 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.52 2.147 . . . . 0.0 110.253 170.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.45 166.82 39.89 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.57 56.01 1.22 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.248 1.419 . . . . 0.0 108.591 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.09 154.59 17.53 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.219 0.608 . . . . 0.0 109.439 167.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -76.38 132.52 39.77 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 147.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.88 179.41 5.87 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.047 1.339 . . . . 0.0 108.689 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -79.38 138.39 37.65 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 121.312 -0.868 . . . . 0.0 109.071 172.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 mt -128.51 134.39 48.68 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -72.94 104.17 3.99 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 122.004 0.906 . . . . 0.0 108.688 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 p -66.84 -38.21 85.97 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.457 0.703 . . . . 0.0 110.02 -173.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.07 -29.07 67.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.757 0.708 . . . . 0.0 110.899 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -76.09 -49.28 17.84 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 127.032 2.133 . . . . 0.0 108.836 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 82.1 mt -57.01 -47.0 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 119.078 0.854 . . . . 0.0 109.293 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.46 -53.93 51.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.417 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -51.94 -67.79 0.22 Allowed 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.222 1.809 . . . . 0.0 109.245 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -51.72 -37.58 51.51 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.653 1.981 . . . . 0.0 112.945 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -62.94 -52.39 59.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 CA-C-N 119.183 0.901 . . . . 0.0 109.446 174.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -55.15 -42.55 73.23 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.418 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -57.66 -56.34 23.18 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.556 0.743 . . . . 0.0 110.775 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -62.19 -35.07 77.72 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.901 0.88 . . . . 0.0 112.589 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.38 -51.39 60.74 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -35.56 73.24 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.372 0.987 . . . . 0.0 112.399 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 tttt -49.95 -33.32 17.25 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 126.636 1.974 . . . . 0.0 110.869 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -128.18 16.29 6.69 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.936 1.294 . . . . 0.0 112.027 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.3 m120 60.16 36.03 21.08 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.878 2.471 . . . . 0.0 112.128 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.5 mt -83.33 157.7 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.44 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -101.36 144.84 16.65 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.923 1.249 . . . . 0.0 112.48 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -55.97 -35.24 66.5 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.943 2.097 . . . . 0.0 113.882 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -59.73 -58.98 6.21 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 120.47 1.486 . . . . 0.0 109.744 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 t -56.44 -44.43 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 119.256 0.934 . . . . 0.0 109.697 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -57.68 -49.7 75.63 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.538 0.608 . . . . 0.0 111.184 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.94 -24.99 74.93 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-O 118.093 -1.393 . . . . 0.0 111.887 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -77.95 -43.15 30.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 118.989 1.394 . . . . 0.0 109.632 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -87.62 -68.19 0.77 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.654 0.381 . . . . 0.0 111.259 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.7 t -62.79 -42.44 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 124.308 1.043 . . . . 0.0 108.268 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.8 mt -96.08 -43.92 7.55 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.811 -172.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.23 20.16 57.62 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 123.798 0.686 . . . . 0.0 111.863 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -107.81 173.05 6.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.748 1.219 . . . . 0.0 107.9 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.4 m -68.59 159.54 31.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.055 -1.028 . . . . 0.0 111.539 166.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.42 -55.14 11.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.496 1.518 . . . . 0.0 110.337 168.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.53 -34.14 87.35 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 m -62.46 -64.6 0.88 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 116.842 -1.551 . . . . 0.0 110.176 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.9 m -60.2 -36.25 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 120.943 1.701 . . . . 0.0 111.867 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.2 t -53.71 -42.33 67.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.585 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.25 -46.73 89.16 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 119.079 0.854 . . . . 0.0 109.805 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mt -61.86 -38.08 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.1 mt -72.53 -32.8 66.41 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.878 1.271 . . . . 0.0 111.346 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.6 -52.3 27.33 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.19 1.396 . . . . 0.0 110.018 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -133.81 71.83 73.88 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 125.792 1.637 . . . . 0.0 108.436 -162.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.11 78.27 3.24 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.411 3.407 . . . . 0.0 110.584 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 30.6 mtmt -54.77 157.13 5.75 Favored Pre-proline 0 N--CA 1.442 -0.859 0 C-N-CA 124.481 1.112 . . . . 0.0 110.306 -176.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 60' ' ' LYS . 11.3 Cg_exo -55.34 143.8 74.88 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.132 2.555 . . . . 0.0 110.253 -172.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -55.11 -48.76 73.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.395 0.543 . . . . 0.0 109.935 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -26.28 32.52 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 172.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -34.62 45.87 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 119.703 1.138 . . . . 0.0 111.986 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.2 mt -77.73 148.02 35.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.959 0.885 . . . . 0.0 110.331 -171.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -82.54 178.16 8.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.848 1.659 . . . . 0.0 108.823 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.81 -47.64 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 120.883 1.674 . . . . 0.0 109.177 170.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -66.17 -8.74 25.93 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.878 -1.139 . . . . 0.0 113.724 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.43 -39.09 6.06 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 126.186 1.851 . . . . 0.0 111.655 169.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -78.6 -22.15 47.49 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.531 1.532 . . . . 0.0 111.565 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -44.94 -58.1 6.04 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 127.176 2.191 . . . . 0.0 110.681 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.59 -49.55 7.04 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.613 2.209 . . . . 0.0 111.562 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -60.09 -35.69 75.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 117.685 -1.15 . . . . 0.0 112.816 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.92 -54.41 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -56.42 -42.59 78.29 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.485 1.114 . . . . 0.0 110.69 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 71.1 mtm -67.47 -49.38 63.83 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.787 0.835 . . . . 0.0 111.984 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -64.12 -36.11 82.95 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.781 -1.2 . . . . 0.0 110.286 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -63.47 -42.84 98.6 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.397 1.479 . . . . 0.0 110.882 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.457 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 35.5 t80 -54.08 -51.57 63.69 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.684 1.193 . . . . 0.0 108.508 172.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.7 mt -68.51 -13.68 62.48 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m -72.45 -10.05 59.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.938 1.245 . . . . 0.0 112.178 172.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -154.46 115.96 4.13 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.715 1.143 . . . . 0.0 110.17 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -56.41 -26.81 54.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.504 1.522 . . . . 0.0 113.786 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -60.21 -25.05 65.31 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 120.321 1.419 . . . . 0.0 111.838 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.457 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 60.8 m-80 -59.53 -45.41 91.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.425 0.557 . . . . 0.0 110.972 176.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 p -71.39 -36.15 59.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 CA-C-N 118.543 0.611 . . . . 0.0 109.893 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.0 mt -63.13 -42.39 99.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.56 73.73 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.33 -25.78 66.99 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.154 -0.966 . . . . 0.0 111.771 176.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -61.74 -41.25 97.41 Favored 'General case' 0 C--O 1.228 -0.065 0 CA-C-N 119.223 0.919 . . . . 0.0 110.116 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.5 m -55.65 -46.52 77.46 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.689 1.196 . . . . 0.0 110.008 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.4 mt -64.19 -33.91 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.911 -0.493 . . . . 0.0 110.133 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 8.5 tp-100 -65.88 -24.12 66.79 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.152 -0.967 . . . . 0.0 113.088 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.2 t -70.26 -59.58 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 166.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -77.11 30.41 0.14 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.266 2.226 . . . . 0.0 112.807 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.0 t -84.76 -0.03 52.3 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.274 -0.891 . . . . 0.0 110.855 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 161.1 -172.45 37.36 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 108.039 -2.025 . . . . 0.0 108.039 -163.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.92 75.09 4.96 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.516 2.811 . . . . 0.0 111.748 -174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.1 t -77.73 79.18 4.22 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 164.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.6 m 63.9 171.07 0.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.553 1.941 . . . . 0.0 112.033 -164.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 N-CA-C 104.819 -3.312 . . . . 0.0 104.819 150.298 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.914 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m 67.06 175.29 0.25 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.712 1.205 . . . . 0.0 110.33 -167.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 t -145.77 155.89 43.24 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 164.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.5 116.97 0.61 Allowed Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 107.498 -2.241 . . . . 0.0 107.498 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.9 t -107.41 -48.07 3.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.0 m 59.25 -175.33 0.1 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.306 1.442 . . . . 0.0 111.738 -165.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.47 -95.65 2.05 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 106.893 -2.483 . . . . 0.0 106.893 -172.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 55.83 8.19 0.33 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.611 1.964 . . . . 0.0 115.369 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.81 102.41 2.06 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 117.685 -1.62 . . . . 0.0 111.069 -170.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.49 -159.71 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.238 3.292 . . . . 0.0 110.093 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.32 104.11 0.18 Allowed Glycine 0 C--N 1.337 0.586 0 O-C-N 120.487 -1.383 . . . . 0.0 110.494 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.5 176.73 5.06 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.563 1.145 . . . . 0.0 110.64 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 48.81 -155.09 0.09 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.027 1.331 . . . . 0.0 110.746 -172.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -107.44 174.35 5.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.926 1.69 . . . . 0.0 107.236 163.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -146.59 -175.09 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.187 0.995 . . . . 0.0 110.121 174.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -72.28 125.49 27.47 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 mt -117.49 114.83 24.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 -178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.1 107.61 1.32 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.121 0.486 . . . . 0.0 110.464 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.9 p -68.91 -39.56 79.62 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.707 -0.62 . . . . 0.0 111.976 -169.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.01 73.1 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.992 0.815 . . . . 0.0 110.191 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -78.09 -51.36 10.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.225 1.41 . . . . 0.0 108.463 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.8 mt -55.94 -43.71 75.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 119.209 0.913 . . . . 0.0 109.095 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.28 -53.45 58.1 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.359 0.664 . . . . 0.0 110.397 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -55.85 -51.14 68.57 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.332 1.053 . . . . 0.0 111.263 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -64.59 -39.74 94.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.698 1.599 . . . . 0.0 110.708 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.6 t -60.85 -49.12 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 O-C-N 120.942 -1.098 . . . . 0.0 109.643 171.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -62.34 -46.18 89.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 117.929 -1.034 . . . . 0.0 111.075 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -64.21 -42.86 96.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.116 0.871 . . . . 0.0 111.223 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -58.1 -44.55 87.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.486 1.114 . . . . 0.0 111.481 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mt -63.55 -49.73 72.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -49.13 -43.51 41.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.509 0.724 . . . . 0.0 111.684 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -60.37 -21.7 62.45 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.469 1.508 . . . . 0.0 113.634 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -128.33 13.25 6.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.892 1.277 . . . . 0.0 113.329 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.5 m120 50.74 71.22 0.44 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.955 2.102 . . . . 0.0 111.561 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.0 mt -118.92 155.41 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 120.658 -1.276 . . . . 0.0 108.392 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.27 145.98 16.74 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.463 1.03 . . . . 0.0 111.177 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -56.89 -34.96 68.4 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.095 1.358 . . . . 0.0 111.69 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -51.78 -61.89 1.97 Allowed 'General case' 0 C--N 1.337 0.063 0 C-N-CA 123.784 0.834 . . . . 0.0 111.606 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.26 -46.68 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.921 0.782 . . . . 0.0 109.588 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -54.85 -46.7 74.71 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.029 0.831 . . . . 0.0 111.762 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.11 -30.95 64.58 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-O 118.25 -1.305 . . . . 0.0 111.752 -178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -69.81 -36.99 76.12 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.379 1.59 . . . . 0.0 110.54 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -96.22 -67.93 0.82 Allowed 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.999 0.92 . . . . 0.0 111.34 -173.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.7 t -62.68 -60.45 2.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -172.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.0 mt -76.28 -36.62 58.3 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.929 -172.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.71 16.09 73.93 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.446 -1.196 . . . . 0.0 112.355 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.8 mt -110.64 166.41 11.03 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.239 1.815 . . . . 0.0 109.931 -171.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -60.21 152.61 24.26 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.536 0.684 . . . . 0.0 110.822 168.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -55.29 -38.9 69.22 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.088 1.355 . . . . 0.0 110.338 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.89 -63.95 4.83 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 m -42.4 -69.33 0.14 Allowed 'General case' 0 C--N 1.342 0.268 0 CA-C-O 117.065 -1.445 . . . . 0.0 110.8 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 m -57.75 -42.09 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 120.832 1.651 . . . . 0.0 112.951 -171.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.0 t -60.13 -38.6 83.57 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.286 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -60.08 -47.76 84.55 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.275 1.03 . . . . 0.0 109.868 168.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mt -56.57 -42.39 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.59 -27.52 41.12 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.614 1.166 . . . . 0.0 112.302 -176.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.7 -44.5 56.37 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.495 1.518 . . . . 0.0 110.546 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -133.3 73.85 73.29 Favored Pre-proline 0 C--O 1.236 0.359 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 -172.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.46 87.76 1.06 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.174 1.916 . . . . 0.0 107.197 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -57.53 157.04 14.6 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.06 155.86 67.97 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 121.429 1.419 . . . . 0.0 109.23 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -55.33 -42.61 74.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.7 0.4 . . . . 0.0 111.195 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -9.86 40.27 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 175.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -93.58 7.11 45.94 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.314 -1.491 . . . . 0.0 112.922 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.6 mt -124.39 153.8 41.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.463 1.105 . . . . 0.0 108.479 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.1 p -100.56 -175.36 2.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.714 0.806 . . . . 0.0 109.001 172.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.2 t -45.38 -45.35 3.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 119.154 0.888 . . . . 0.0 110.897 169.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -70.48 -38.29 74.36 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.898 1.226 . . . . 0.0 112.873 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.64 -35.01 84.4 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.82 0.724 . . . . 0.0 112.079 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -90.67 -19.69 23.33 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 125.568 1.547 . . . . 0.0 111.723 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -43.28 -55.7 7.7 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 127.572 2.349 . . . . 0.0 109.384 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.61 -50.38 2.53 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.291 1.994 . . . . 0.0 111.354 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -58.0 -35.96 71.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 120.222 1.374 . . . . 0.0 113.702 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.6 mt -57.59 -60.3 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.591 1.556 . . . . 0.0 107.474 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -52.27 -52.04 55.02 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.421 1.089 . . . . 0.0 110.212 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.8 mtm -55.39 -51.59 66.34 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.694 0.797 . . . . 0.0 111.464 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -59.75 -38.75 82.62 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.196 -0.94 . . . . 0.0 111.226 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -65.98 -45.09 82.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.423 1.01 . . . . 0.0 110.427 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 19.6 t80 -49.31 -46.91 47.23 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.963 1.705 . . . . 0.0 110.301 172.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.1 mt -71.84 -13.82 61.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.32 1.11 34.06 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.809 1.644 . . . . 0.0 112.45 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -160.03 118.55 2.7 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.891 1.223 . . . . 0.0 108.635 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -63.1 -19.45 64.44 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.69 1.196 . . . . 0.0 111.781 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -57.23 -30.05 64.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 120.157 -1.589 . . . . 0.0 112.054 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.4 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 75.1 m-80 -65.42 -38.21 89.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 119.018 -0.515 . . . . 0.0 110.174 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.83 -34.77 23.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 119.258 0.936 . . . . 0.0 110.317 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.9 mt -63.14 -40.77 98.56 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 123.261 0.624 . . . . 0.0 109.858 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.47 92.89 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.98 0.512 . . . . 0.0 111.252 173.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.46 -26.31 67.89 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.08 0.952 . . . . 0.0 112.2 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -61.68 -45.19 95.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 118.489 0.586 . . . . 0.0 109.561 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.9 m -49.77 -50.05 46.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.215 1.006 . . . . 0.0 109.442 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.0 mt -65.57 -37.44 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.771 -173.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -60.68 -46.04 91.85 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.48 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.4 m -61.64 -39.39 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 120.119 1.327 . . . . 0.0 109.745 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -76.95 -0.3 23.81 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.05 -1.031 . . . . 0.0 113.016 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.9 t -64.67 -37.44 87.57 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 120.265 1.393 . . . . 0.0 111.363 -173.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.6 -178.16 47.93 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.152 0.887 . . . . 0.0 112.498 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.27 -176.01 2.49 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.309 3.339 . . . . 0.0 111.406 173.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.3 t 62.11 -167.42 0.2 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.396 1.478 . . . . 0.0 110.043 -162.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.4 t -138.03 -168.38 2.34 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.883 1.673 . . . . 0.0 108.762 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 N-CA-C 106.896 -2.481 . . . . 0.0 106.896 -177.368 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.552 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.63 166.07 33.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.271 1.428 . . . . 0.0 107.378 173.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.3 p -109.32 156.22 20.24 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 164.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.52 131.55 1.88 Allowed Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 106.113 -2.795 . . . . 0.0 106.113 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.4 m -154.7 93.72 1.6 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.175 0.987 . . . . 0.0 108.386 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.78 169.25 13.39 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 122.034 -0.416 . . . . 0.0 110.598 171.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.21 -160.96 25.87 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 163.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.44 164.36 21.03 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.332 -0.511 . . . . 0.0 109.993 150.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.52 71.08 0.36 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 172.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.24 107.36 2.42 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.583 2.855 . . . . 0.0 111.571 -168.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.11 -153.52 20.24 Favored Glycine 0 C--O 1.243 0.682 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 165.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.34 159.43 41.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.412 1.485 . . . . 0.0 108.728 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 50.7 -151.57 0.21 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.146 1.779 . . . . 0.0 111.771 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.56 119.47 22.57 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -127.4 -147.61 0.36 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.405 1.082 . . . . 0.0 108.535 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -112.48 118.65 35.74 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.894 1.678 . . . . 0.0 106.619 171.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 mt -109.09 142.53 39.7 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.41 101.46 4.8 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 122.291 1.043 . . . . 0.0 109.256 171.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.0 p -62.95 -38.96 93.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.586 -0.696 . . . . 0.0 111.477 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.77 70.72 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.107 0.867 . . . . 0.0 111.9 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -75.39 -53.05 9.35 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.357 1.463 . . . . 0.0 108.124 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.0 mt -55.34 -44.02 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.35 0.66 . . . . 0.0 109.306 177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.26 -47.88 83.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.406 0.682 . . . . 0.0 111.008 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.437 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 27.5 t80 -60.68 -50.22 74.38 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.329 1.052 . . . . 0.0 110.345 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -59.69 -45.4 92.2 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.746 1.618 . . . . 0.0 110.327 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.95 -50.83 78.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 O-C-N 120.424 -1.422 . . . . 0.0 109.077 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 50.0 mtmt -54.99 -41.88 71.76 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.455 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.41 -36.71 68.71 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 117.471 -1.252 . . . . 0.0 113.336 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -62.3 -41.23 98.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.415 1.916 . . . . 0.0 111.608 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.27 -44.71 95.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.21 -0.932 . . . . 0.0 108.54 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -58.07 -48.04 81.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 171.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -55.56 -30.3 60.54 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 127.051 2.141 . . . . 0.0 111.791 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -128.27 11.91 6.47 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.62 64.27 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.779 2.032 . . . . 0.0 112.111 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -107.63 150.84 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.496 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -82.8 135.3 13.83 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.79 1.186 . . . . 0.0 110.876 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -54.07 -37.37 64.13 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.609 0.764 . . . . 0.0 110.552 169.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -54.05 -64.48 0.81 Allowed 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.409 -1.281 . . . . 0.0 111.198 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t -52.74 -48.12 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 120.141 1.337 . . . . 0.0 110.07 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -55.3 -46.4 76.22 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.431 0.56 . . . . 0.0 111.88 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -73.39 -34.64 57.29 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-O 118.081 -1.4 . . . . 0.0 111.597 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.92 -32.23 73.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 119.331 1.565 . . . . 0.0 109.505 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -103.15 -72.57 0.69 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.563 1.145 . . . . 0.0 111.907 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.75 -43.85 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -168.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.7 mt -96.48 -33.4 11.87 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.03 30.32 38.64 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 123.439 0.462 . . . . 0.0 112.017 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.7 mt -125.07 157.8 35.37 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.765 1.283 . . . . 0.0 110.464 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.8 t -60.39 160.48 8.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.683 1.193 . . . . 0.0 110.367 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.82 -55.82 26.07 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.342 1.057 . . . . 0.0 110.886 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.18 -30.42 75.61 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-O 119.095 -0.836 . . . . 0.0 111.711 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.9 m -58.84 -57.81 11.4 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 116.832 -1.556 . . . . 0.0 109.856 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 m -66.78 -36.69 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 121.857 2.117 . . . . 0.0 113.617 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.1 t -62.43 -31.22 71.9 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.694 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -59.81 -49.72 76.61 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.857 1.208 . . . . 0.0 110.964 164.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 mt -55.44 -43.94 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.062 0.846 . . . . 0.0 108.986 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -79.3 -13.72 59.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.501 1.121 . . . . 0.0 112.861 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.86 -58.07 2.68 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.717 1.607 . . . . 0.0 109.905 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 mtp85 -124.64 78.29 63.47 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 125.089 1.355 . . . . 0.0 107.876 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.33 93.76 0.75 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.07 2.513 . . . . 0.0 107.523 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -63.26 165.85 9.98 Favored Pre-proline 0 N--CA 1.436 -1.146 0 C-N-CA 123.79 0.836 . . . . 0.0 110.266 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -56.13 142.45 86.37 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.611 2.207 . . . . 0.0 110.331 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -53.3 -47.31 69.32 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.964 0.802 . . . . 0.0 109.804 173.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -20.31 33.87 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 174.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -85.15 -24.37 28.0 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.874 1.215 . . . . 0.0 111.77 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.6 mt -86.38 167.34 14.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.42 0.688 . . . . 0.0 109.155 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.5 p -129.12 -172.25 2.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 117.081 -1.437 . . . . 0.0 108.62 172.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.5 t -43.58 -56.43 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 120.756 1.616 . . . . 0.0 111.63 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -74.51 -15.87 60.86 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.234 -1.541 . . . . 0.0 113.665 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.68 -42.42 47.01 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.374 1.464 . . . . 0.0 111.45 167.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -85.81 -26.13 25.91 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 127.045 2.138 . . . . 0.0 111.669 -173.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -42.15 -57.28 4.48 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 127.817 2.447 . . . . 0.0 111.475 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.07 -49.71 4.6 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.531 1.487 . . . . 0.0 109.69 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -57.23 -39.38 75.42 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.654 -1.165 . . . . 0.0 112.976 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.3 mt -57.69 -55.52 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.559 1.144 . . . . 0.0 108.367 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -59.51 -45.06 92.79 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.032 0.533 . . . . 0.0 109.592 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 67.0 mtm -57.8 -50.08 74.47 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 123.505 0.722 . . . . 0.0 111.07 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -59.8 -44.1 94.12 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.794 -0.566 . . . . 0.0 110.278 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -73.82 -28.04 61.42 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.298 -0.876 . . . . 0.0 112.133 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -60.87 -53.15 60.82 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.926 1.291 . . . . 0.0 107.943 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.0 mt -64.82 -22.4 66.98 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.319 1.047 . . . . 0.0 113.307 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.9 m -62.8 -21.58 65.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.914 1.234 . . . . 0.0 111.0 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -143.99 115.8 8.25 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.112 1.323 . . . . 0.0 109.947 -173.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.7 -18.56 64.13 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.569 1.148 . . . . 0.0 111.861 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -64.68 -21.14 66.67 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.482 -2.011 . . . . 0.0 112.181 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -67.36 -53.36 30.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.854 1.206 . . . . 0.0 110.053 174.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.87 -35.09 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.033 -1.042 . . . . 0.0 111.133 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.58 -34.66 78.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.661 0.664 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.45 81.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 111.533 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.95 -26.02 68.4 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.399 -0.813 . . . . 0.0 110.873 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 mtp-105 -60.18 -50.89 71.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 118.529 0.604 . . . . 0.0 110.581 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.0 m -50.06 -45.69 52.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.032 0.833 . . . . 0.0 110.163 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 66.1 mt -64.51 -32.97 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.871 -0.518 . . . . 0.0 111.117 -178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.496 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 6.9 tp-100 -65.4 -40.67 93.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.186 -0.946 . . . . 0.0 111.373 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.13 -36.65 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -83.27 33.04 0.45 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.18 1.792 . . . . 0.0 111.186 171.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.6 t -122.54 -17.45 6.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.167 1.387 . . . . 0.0 109.744 170.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.46 -179.04 33.51 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.6 1.572 . . . . 0.0 110.14 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.69 99.79 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.127 2.551 . . . . 0.0 109.2 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 58.5 m -165.0 168.63 17.25 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 129.181 2.992 . . . . 0.0 106.724 166.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.1 t 57.38 80.33 0.17 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.778 1.231 . . . . 0.0 111.665 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 174.332 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.572 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 m 58.75 -179.15 0.08 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 117.698 0.749 . . . . 0.0 110.514 -164.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.1 m 53.69 2.78 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 119.004 2.964 . . . . 0.0 119.004 162.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.63 142.39 3.77 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 121.927 2.149 . . . . 0.0 111.736 172.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.7 m -144.52 101.54 3.69 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.843 1.657 . . . . 0.0 107.178 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.7 m -147.78 114.67 6.11 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 124.083 0.953 . . . . 0.0 108.792 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.75 100.86 0.53 Allowed Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.84 155.98 39.24 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 117.565 0.682 . . . . 0.0 109.512 164.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.22 118.34 4.94 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 168.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -81.93 154.76 17.42 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 CA-C-N 120.702 2.251 . . . . 0.0 110.495 172.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.2 -148.78 17.04 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -170.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.2 -105.41 0.27 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.989 1.715 . . . . 0.0 111.697 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -125.28 -166.97 1.61 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.652 1.181 . . . . 0.0 109.883 -172.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -79.0 76.64 5.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.806 1.642 . . . . 0.0 110.034 -167.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -62.1 161.61 10.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 127.483 2.313 . . . . 0.0 110.814 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -97.27 87.47 4.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 169.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt -56.72 134.57 54.94 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -69.75 98.38 1.2 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.052 0.453 . . . . 0.0 110.03 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 p -63.38 -41.15 98.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.529 -0.732 . . . . 0.0 111.818 -175.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.02 77.74 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.847 0.749 . . . . 0.0 111.334 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -75.12 -47.89 26.42 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 126.218 1.807 . . . . 0.0 108.653 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.3 mt -55.08 -50.86 59.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.51 -52.17 62.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.64 0.776 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -52.52 -69.79 0.1 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 126.533 1.933 . . . . 0.0 108.666 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -49.8 -40.41 41.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.645 1.978 . . . . 0.0 112.897 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.2 t -64.75 -51.43 67.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 118.976 0.807 . . . . 0.0 109.645 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -49.85 -38.34 34.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.356 0.98 . . . . 0.0 109.785 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.93 -53.63 43.36 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.466 1.03 . . . . 0.0 111.68 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.64 -43.88 80.72 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.366 0.53 . . . . 0.0 111.142 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.9 mt -63.36 -43.46 97.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -27.81 69.29 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.446 1.021 . . . . 0.0 112.69 174.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -59.73 -32.81 70.9 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.822 1.249 . . . . 0.0 111.419 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -128.42 16.72 6.53 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.387 1.475 . . . . 0.0 112.196 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 39.75 75.59 0.08 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 128.783 2.833 . . . . 0.0 112.417 -169.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.4 mt -110.05 147.54 14.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 121.386 -0.821 . . . . 0.0 109.826 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.05 127.75 8.4 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -58.45 -29.6 66.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.748 0.819 . . . . 0.0 111.242 171.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -55.6 -53.98 49.73 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 117.789 -1.101 . . . . 0.0 111.508 167.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -60.18 -51.27 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 119.526 1.057 . . . . 0.0 109.114 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -54.38 -46.48 73.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.325 0.511 . . . . 0.0 111.347 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.08 -34.97 64.52 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-O 117.417 -1.768 . . . . 0.0 111.967 177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -64.49 -29.67 70.71 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 120.398 2.099 . . . . 0.0 110.887 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -106.63 -78.73 0.58 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.458 1.103 . . . . 0.0 111.654 -172.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 74.1 t -56.5 -38.75 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 125.531 1.532 . . . . 0.0 109.363 -170.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.6 mt -102.19 -33.24 9.72 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.582 -0.723 . . . . 0.0 110.853 -173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.74 30.59 61.54 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.52 168.66 10.47 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.078 1.351 . . . . 0.0 109.175 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.0 163.6 27.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.456 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -59.56 -46.76 87.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.414 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.42 -30.96 77.49 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.001 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.6 m -61.03 -67.06 0.44 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.832 0.816 . . . . 0.0 109.328 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 m -58.66 -35.77 56.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-N 119.893 1.224 . . . . 0.0 112.438 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.3 t -54.95 -43.36 73.36 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.369 1.068 . . . . 0.0 111.708 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -57.36 -49.37 76.37 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 120.084 1.311 . . . . 0.0 110.106 168.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.3 mt -58.95 -39.64 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.6 mt -76.76 -29.56 56.17 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.901 1.281 . . . . 0.0 112.413 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.33 -57.58 4.69 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.652 1.581 . . . . 0.0 109.997 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -123.57 84.6 53.07 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 125.604 1.562 . . . . 0.0 107.399 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 84.04 1.4 Allowed 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 122.245 1.963 . . . . 0.0 107.525 171.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -59.41 153.27 50.08 Favored Pre-proline 0 N--CA 1.436 -1.161 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.01 147.54 80.16 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.296 1.997 . . . . 0.0 107.363 -171.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -51.93 -38.94 58.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.127 0.571 . . . . 0.0 111.143 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -28.11 69.05 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -26.79 62.37 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.789 -1.195 . . . . 0.0 111.633 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.6 mt -83.79 167.16 17.36 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.456 0.646 . . . . 0.0 110.526 -168.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.2 p -117.78 -171.61 2.09 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.689 2.395 . . . . 0.0 109.533 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.7 p -47.16 -63.41 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.648 1.113 . . . . 0.0 111.543 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -72.94 -10.35 59.71 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.43 -52.12 32.89 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.157 -0.964 . . . . 0.0 110.707 162.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -87.54 -23.83 24.24 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 126.016 1.727 . . . . 0.0 112.298 -166.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -44.55 -55.6 9.95 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 126.334 1.854 . . . . 0.0 111.669 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.46 -45.86 13.52 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.498 1.466 . . . . 0.0 110.835 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -61.19 -38.23 85.8 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.88 1.218 . . . . 0.0 113.044 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.6 mt -55.61 -54.44 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -58.77 -50.66 73.1 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.931 1.292 . . . . 0.0 110.516 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 58.0 mtm -55.52 -47.89 75.53 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.135 0.974 . . . . 0.0 111.974 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -61.64 -46.03 91.51 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.94 -0.475 . . . . 0.0 110.263 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -61.26 -42.53 98.8 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.666 0.787 . . . . 0.0 111.198 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -53.17 -38.39 62.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.033 1.733 . . . . 0.0 110.719 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.2 mt -73.71 -23.75 59.83 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.378 -0.826 . . . . 0.0 113.082 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -77.97 0.25 25.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 120.134 1.334 . . . . 0.0 113.069 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -145.52 115.22 7.28 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 125.391 1.476 . . . . 0.0 107.173 170.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -69.49 -15.64 63.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.556 0.342 . . . . 0.0 111.816 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -67.06 -16.48 64.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 120.294 -1.504 . . . . 0.0 112.353 174.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -66.51 -47.38 73.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 119.61 1.096 . . . . 0.0 109.591 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.8 -30.86 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 120.665 -1.272 . . . . 0.0 111.299 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.35 -24.04 64.76 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.753 -0.592 . . . . 0.0 110.808 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.6 -39.47 31.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.21 -0.931 . . . . 0.0 111.381 168.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.81 -29.76 68.18 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.013 -1.68 . . . . 0.0 110.5 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -66.6 -36.75 83.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.394 0.997 . . . . 0.0 111.672 169.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.3 m -56.01 -36.65 68.17 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.743 0.817 . . . . 0.0 110.167 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.0 mt -80.24 -29.29 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.701 1.6 . . . . 0.0 111.494 177.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -58.1 -45.16 87.68 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 120.578 -1.326 . . . . 0.0 109.646 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -27.63 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.879 -0.513 . . . . 0.0 110.557 177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -80.7 -2.61 47.48 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.678 1.991 . . . . 0.0 112.167 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.6 t -69.06 -47.32 65.64 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.539 1.518 . . . . 0.0 109.176 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -154.66 -177.2 27.76 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -77.43 46.99 2.14 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 124.647 3.565 . . . . 0.0 111.626 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.5 t -62.15 143.08 57.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 t -125.46 108.7 11.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -168.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 C-N-CA 123.977 0.798 . . . . 0.0 111.114 -171.404 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.972 0 N-CA-C 105.6 -3.0 . . . . 0.0 105.6 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p 174.69 108.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 -140.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -157.66 178.29 10.43 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.42 1.488 . . . . 0.0 107.658 -172.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.85 63.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.3 p -147.73 62.64 1.13 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.797 1.639 . . . . 0.0 107.46 -176.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t -112.56 96.26 5.89 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.552 1.141 . . . . 0.0 110.193 -161.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.28 -172.75 36.28 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.846 1.689 . . . . 0.0 109.699 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 66.82 168.14 0.23 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.661 2.384 . . . . 0.0 112.502 -174.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.83 74.86 0.28 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.016 -2.034 . . . . 0.0 108.016 -172.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.07 105.38 1.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.323 2.682 . . . . 0.0 110.238 -165.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.88 93.34 0.16 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 107.154 -2.379 . . . . 0.0 107.154 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.49 92.5 1.06 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 126.798 2.039 . . . . 0.0 107.149 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -139.71 179.6 6.48 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.521 1.528 . . . . 0.0 109.303 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -75.8 127.0 32.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 163.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -119.5 164.03 16.39 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.58 1.552 . . . . 0.0 108.275 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -78.2 113.0 15.75 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.732 1.151 . . . . 0.0 109.714 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 mt -86.72 162.86 17.65 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.406 1.482 . . . . 0.0 108.766 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.58 104.56 17.03 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.401 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 21.2 p -59.77 -40.97 89.99 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.344 -0.847 . . . . 0.0 111.51 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.21 75.07 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.182 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.27 -52.24 20.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.91 1.284 . . . . 0.0 108.337 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 85.2 mt -52.9 -49.48 48.11 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.83 63.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.259 0.624 . . . . 0.0 110.355 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -55.81 -57.75 10.74 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.939 1.296 . . . . 0.0 110.486 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -49.75 -51.54 38.28 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 127.391 2.276 . . . . 0.0 111.688 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.58 -44.04 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.906 -1.121 . . . . 0.0 109.015 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -57.47 -37.56 73.1 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.589 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.58 -54.67 36.23 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.948 1.299 . . . . 0.0 110.551 174.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -61.45 -43.1 99.46 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.978 1.311 . . . . 0.0 111.513 -173.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.58 -46.6 78.8 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -43.92 65.71 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.569 0.748 . . . . 0.0 111.123 173.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -50.47 -44.44 55.74 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 126.364 1.865 . . . . 0.0 111.684 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -112.76 9.42 19.11 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.993 0.917 . . . . 0.0 112.297 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 46.62 71.76 0.28 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.428 2.291 . . . . 0.0 112.183 -166.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.2 mt -111.22 151.02 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 172.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.57 142.13 15.42 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -57.74 -31.59 66.62 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.674 1.59 . . . . 0.0 113.345 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ttp-105 -56.41 -59.38 5.05 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 120.029 1.286 . . . . 0.0 109.691 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -58.98 -47.27 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -176.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -55.46 -47.15 76.53 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.831 0.741 . . . . 0.0 111.725 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.5 -33.72 63.84 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-O 117.797 -1.557 . . . . 0.0 111.806 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -69.88 -33.08 71.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.635 1.718 . . . . 0.0 110.524 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -96.73 -76.98 0.5 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.048 0.939 . . . . 0.0 111.217 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.55 -40.48 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 124.729 1.212 . . . . 0.0 109.151 -170.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.3 mt -93.9 -46.79 7.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 123.758 0.661 . . . . 0.0 109.803 -173.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.01 19.08 48.39 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.636 0.636 . . . . 0.0 112.691 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.0 mt -114.42 164.96 13.24 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.501 1.52 . . . . 0.0 108.988 -172.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 m -62.08 156.58 21.09 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.167 0.508 . . . . 0.0 110.841 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -56.92 -34.82 68.35 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.075 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.04 -62.05 5.55 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.8 m -43.91 -66.77 0.34 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.942 1.697 . . . . 0.0 112.522 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 m -57.09 -38.83 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 120.283 1.401 . . . . 0.0 111.674 -175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 m -61.6 -41.28 97.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.858 -1.068 . . . . 0.0 110.818 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.82 -45.84 78.25 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.629 1.104 . . . . 0.0 110.007 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.8 mt -57.52 -46.46 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.27 -31.8 64.29 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.97 1.708 . . . . 0.0 112.656 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.9 -47.4 71.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.934 1.694 . . . . 0.0 110.096 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mtp-105 -137.94 82.98 24.37 Favored Pre-proline 0 C--O 1.239 0.506 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -63.75 102.63 0.36 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.103 2.535 . . . . 0.0 108.34 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -63.06 157.39 62.24 Favored Pre-proline 0 N--CA 1.429 -1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.523 167.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.82 151.96 36.5 Favored 'Trans proline' 0 N--CA 1.441 -1.572 0 C-N-CA 122.64 2.227 . . . . 0.0 107.428 -172.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.417 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 62.0 t-105 -51.78 -41.93 62.02 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.692 0.797 . . . . 0.0 111.532 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -23.09 66.96 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -74.06 -25.76 60.02 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 120.23 1.377 . . . . 0.0 111.72 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.4 mt -93.25 153.28 18.68 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.162 0.892 . . . . 0.0 110.34 -158.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.8 t -90.38 -179.97 5.73 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 171.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.45 -42.65 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 O-C-N 120.999 -1.063 . . . . 0.0 112.419 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -69.8 -14.9 62.99 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.755 -1.216 . . . . 0.0 113.585 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.77 -37.43 26.32 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 125.45 1.5 . . . . 0.0 110.936 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 91.2 mttt -79.86 -25.92 40.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 117.847 -1.073 . . . . 0.0 112.344 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -43.83 -60.98 2.2 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 125.691 1.596 . . . . 0.0 110.445 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.28 -45.49 15.17 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 121.394 1.396 . . . . 0.0 110.032 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.401 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 64.2 m-85 -64.04 -35.25 80.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 119.752 1.16 . . . . 0.0 113.337 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.1 mt -59.16 -57.19 12.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -52.88 -43.18 65.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.175 0.99 . . . . 0.0 110.45 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 64.7 mtm -66.76 -50.29 63.19 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.891 1.276 . . . . 0.0 112.567 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -60.62 -41.33 94.64 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.816 -1.177 . . . . 0.0 110.193 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.79 -26.63 57.49 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.839 0.456 . . . . 0.0 111.441 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -57.25 -50.98 71.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.917 0.887 . . . . 0.0 109.112 167.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.2 mt -64.02 -20.14 65.7 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.466 1.106 . . . . 0.0 113.439 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.4 m -61.53 -33.4 73.77 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.279 0.945 . . . . 0.0 111.531 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -130.49 104.77 7.43 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.637 -0.665 . . . . 0.0 109.988 -170.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -53.61 -29.2 36.73 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.204 1.401 . . . . 0.0 111.716 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -55.19 -25.93 35.91 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 119.803 -1.81 . . . . 0.0 112.45 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -66.08 -50.56 63.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.529 0.732 . . . . 0.0 110.817 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.43 -37.19 78.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 119.221 0.919 . . . . 0.0 109.568 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 78.0 mt -64.55 -34.12 77.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.17 0.588 . . . . 0.0 110.481 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.98 -32.5 59.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.92 0.888 . . . . 0.0 111.43 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -27.85 66.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.298 1.039 . . . . 0.0 110.691 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.1 mtm105 -56.8 -54.15 49.66 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 119.092 0.86 . . . . 0.0 109.464 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -52.87 -36.66 59.38 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.853 0.751 . . . . 0.0 111.319 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 52.1 mt -73.68 -38.23 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.865 -1.147 . . . . 0.0 110.338 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -63.74 -47.62 80.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.668 1.587 . . . . 0.0 111.001 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.1 p -59.69 -33.6 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.547 0.612 . . . . 0.0 110.917 173.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -80.4 8.88 6.68 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.351 1.46 . . . . 0.0 113.359 176.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.6 t -58.45 131.57 51.11 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.914 1.234 . . . . 0.0 109.117 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.71 -164.68 50.69 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 122.982 0.325 . . . . 0.0 113.179 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -69.91 174.24 9.92 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.594 2.196 . . . . 0.0 109.558 165.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 56.4 m -82.77 -61.45 1.87 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 155.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 t 68.44 109.44 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.043 1.737 . . . . 0.0 108.433 -165.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.515 0 CA-C-O 117.704 -1.609 . . . . 0.0 109.246 -179.96 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.736 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.6 t -174.51 -70.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.441 2.296 . . . . 0.0 105.016 172.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 m -59.87 150.17 29.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.336 1.854 . . . . 0.0 111.445 -169.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.0 78.2 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.9 p -144.81 144.78 31.32 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.137 0.575 . . . . 0.0 110.12 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.7 m 69.37 157.97 0.16 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 128.204 2.602 . . . . 0.0 112.141 -177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.13 72.33 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 123.645 0.641 . . . . 0.0 111.913 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -137.64 143.94 41.65 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.829 0.852 . . . . 0.0 109.134 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.33 77.01 0.09 OUTLIER Glycine 0 CA--C 1.523 0.567 0 CA-C-O 118.772 -1.015 . . . . 0.0 110.764 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.59 -175.08 0.64 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.57 2.847 . . . . 0.0 110.935 170.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 129.75 75.85 0.16 Allowed Glycine 0 C--N 1.333 0.362 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.9 147.55 34.17 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.558 1.179 . . . . 0.0 110.213 167.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.77 -172.57 0.09 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.415 1.886 . . . . 0.0 111.774 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -87.3 106.27 17.81 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 168.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -125.35 -174.61 3.1 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.742 1.617 . . . . 0.0 108.603 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -75.86 113.8 13.75 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.481 -0.762 . . . . 0.0 109.635 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.6 mt -98.39 144.65 27.54 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.641 1.176 . . . . 0.0 107.968 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.8 99.27 5.85 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 122.014 0.911 . . . . 0.0 109.079 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 p -63.16 -38.98 93.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.818 -1.176 . . . . 0.0 111.402 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.83 70.35 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.543 -0.741 . . . . 0.0 111.434 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -78.92 -55.57 5.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.016 2.126 . . . . 0.0 108.758 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.8 mt -54.57 -44.2 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.91 -49.06 78.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.529 0.732 . . . . 0.0 111.273 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -61.07 -53.36 58.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.839 1.256 . . . . 0.0 110.283 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -60.56 -39.7 88.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.68 1.992 . . . . 0.0 111.772 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 t -60.91 -47.12 94.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 O-C-N 120.691 -1.255 . . . . 0.0 109.374 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -61.14 -27.49 68.42 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 117.373 -1.299 . . . . 0.0 111.548 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -65.04 -63.12 1.18 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 120.125 1.329 . . . . 0.0 109.805 170.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -63.78 -29.08 70.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.058 0.845 . . . . 0.0 111.806 -170.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.52 -37.78 74.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.976 1.262 . . . . 0.0 109.587 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.26 -37.35 85.27 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.186 1.357 . . . . 0.0 111.862 169.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -58.59 -32.75 69.25 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.952 2.101 . . . . 0.0 113.707 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -126.39 15.93 7.7 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.482 1.913 . . . . 0.0 111.214 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.8 m120 42.33 72.73 0.16 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.282 2.233 . . . . 0.0 111.41 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.4 mt -106.26 153.84 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.69 131.64 10.87 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.801 1.191 . . . . 0.0 110.556 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -36.05 74.6 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.428 1.491 . . . . 0.0 111.71 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.6 ptt85 -53.5 -56.06 20.18 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.351 1.06 . . . . 0.0 111.965 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.46 -39.7 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -63.29 -45.68 90.26 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.091 -1.006 . . . . 0.0 109.573 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -67.35 -24.61 73.63 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-O 117.352 -1.804 . . . . 0.0 112.518 173.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -78.12 -21.02 51.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.788 2.294 . . . . 0.0 112.076 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -121.99 -61.1 1.52 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 119.484 1.038 . . . . 0.0 111.436 -174.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.7 t -63.46 -36.98 78.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.4 mt -106.49 -34.95 7.23 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.423 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.55 31.5 78.84 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.13 161.62 18.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.352 1.461 . . . . 0.0 107.932 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m -59.67 147.95 35.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.765 1.226 . . . . 0.0 110.599 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -63.67 -16.73 61.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.633 1.573 . . . . 0.0 114.06 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.54 -56.63 2.61 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 166.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.7 m -43.65 -59.57 2.14 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 125.851 1.66 . . . . 0.0 113.21 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -55.65 -34.62 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 121.017 1.735 . . . . 0.0 114.074 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.9 t -63.2 -36.24 82.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.243 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.36 -41.78 80.79 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.792 1.633 . . . . 0.0 109.736 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 mt -62.79 -45.35 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -174.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.8 -32.03 61.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.779 0.832 . . . . 0.0 111.628 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.24 -53.94 31.02 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.628 1.971 . . . . 0.0 111.042 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -134.45 71.78 71.15 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -168.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -68.41 98.91 0.58 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.937 2.425 . . . . 0.0 107.985 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -69.06 160.63 77.63 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -59.34 150.49 74.44 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.351 2.701 . . . . 0.0 109.109 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -52.79 -52.54 56.37 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.664 0.786 . . . . 0.0 111.5 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -5.99 2.02 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 174.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -116.31 18.98 15.06 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.414 1.886 . . . . 0.0 110.842 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.1 mt -124.05 149.44 46.11 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.564 1.546 . . . . 0.0 106.874 166.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.2 t -90.73 -177.72 5.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.641 1.176 . . . . 0.0 108.852 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 p -46.33 -54.01 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.446 1.098 . . . . 0.0 111.16 172.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -74.73 -4.88 40.15 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.25 -35.19 15.31 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.326 1.917 . . . . 0.0 111.297 163.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -87.91 -23.27 23.98 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.566 1.546 . . . . 0.0 112.971 -173.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -39.14 -59.91 1.35 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.15 1.78 . . . . 0.0 110.36 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.27 -51.11 2.91 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.467 2.112 . . . . 0.0 111.489 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -59.58 -38.15 80.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.528 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.2 mt -55.85 -54.02 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -60.7 -46.57 89.87 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.35 1.06 . . . . 0.0 110.498 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 63.9 mtm -59.37 -46.07 89.69 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 124.075 0.95 . . . . 0.0 111.299 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -60.96 -45.76 93.43 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.39 -0.819 . . . . 0.0 110.183 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -59.61 -43.99 93.57 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.723 0.809 . . . . 0.0 110.314 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.467 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 37.7 t80 -53.61 -51.36 63.31 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.103 1.761 . . . . 0.0 110.127 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.8 mt -66.27 -18.94 65.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.357 0.663 . . . . 0.0 112.133 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -6.52 47.29 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.253 1.421 . . . . 0.0 112.681 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -156.86 115.75 3.36 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.885 1.274 . . . . 0.0 109.139 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.22 -27.81 68.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.851 1.26 . . . . 0.0 112.431 -169.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -60.71 -19.28 58.34 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 120.768 -1.208 . . . . 0.0 112.525 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.467 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 38.1 m-80 -60.33 -50.9 71.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.993 1.269 . . . . 0.0 110.181 174.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 p -71.28 -30.67 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 120.851 -1.155 . . . . 0.0 110.135 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.9 mt -64.2 -37.38 87.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.15 69.83 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.402 0.546 . . . . 0.0 111.649 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.08 -28.49 62.33 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.245 -0.91 . . . . 0.0 111.37 176.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -58.26 -37.04 74.14 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.017 0.826 . . . . 0.0 110.207 173.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 m -55.95 -56.32 22.12 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.327 1.051 . . . . 0.0 110.086 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.1 mt -65.13 -31.78 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 123.463 0.705 . . . . 0.0 110.008 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -61.34 -39.59 91.12 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 121.689 -0.632 . . . . 0.0 111.728 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -67.7 -29.43 45.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 118.785 0.72 . . . . 0.0 109.66 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -79.77 10.86 3.63 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.792 1.637 . . . . 0.0 111.934 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.8 t -52.05 157.58 1.28 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.6 1.16 . . . . 0.0 109.981 167.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.19 -174.76 14.64 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.279 1.419 . . . . 0.0 112.128 -175.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.47 60.82 6.61 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 124.91 3.74 . . . . 0.0 111.914 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.1 m -66.15 112.68 4.04 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 167.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.4 t -145.78 -88.28 0.1 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 170.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.153 -1.36 . . . . 0.0 110.056 -178.612 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.544 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 t -144.15 -170.52 3.37 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.551 1.176 . . . . 0.0 109.069 -172.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.9 t -135.03 161.61 34.81 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.636 1.974 . . . . 0.0 106.915 164.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.87 139.7 6.89 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.11 82.73 1.26 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -166.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.0 m -151.45 164.43 36.77 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.241 1.416 . . . . 0.0 109.723 172.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.41 134.99 3.18 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 174.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -165.46 168.73 16.33 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.403 1.101 . . . . 0.0 109.049 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.56 164.93 37.62 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 167.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.08 151.15 72.97 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.946 2.431 . . . . 0.0 109.847 170.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.54 40.62 2.99 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-O 119.013 -0.881 . . . . 0.0 111.007 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.81 168.88 18.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.655 1.582 . . . . 0.0 107.459 171.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -63.52 -1.99 1.44 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 -155.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -130.43 103.74 6.84 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.952 1.701 . . . . 0.0 109.419 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -119.4 -176.53 3.16 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.365 0.666 . . . . 0.0 111.043 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.62 91.63 7.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.968 0.889 . . . . 0.0 109.181 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mt -75.81 140.46 42.32 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.375 1.47 . . . . 0.0 109.021 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.52 103.17 8.29 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.96 -1.087 . . . . 0.0 110.916 -172.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 33.3 p -64.14 -46.23 84.99 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.983 -1.073 . . . . 0.0 112.93 -169.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.97 -18.57 64.09 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.289 0.636 . . . . 0.0 111.327 -176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.92 -56.74 4.05 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.764 1.626 . . . . 0.0 108.875 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.7 mt -51.6 -43.94 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.415 1.086 . . . . 0.0 109.992 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.66 -68.24 0.19 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.378 1.071 . . . . 0.0 110.047 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -45.22 -56.46 4.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.167 1.787 . . . . 0.0 112.232 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -54.78 -43.68 73.03 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 127.942 2.497 . . . . 0.0 111.227 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.96 -48.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 120.806 -1.184 . . . . 0.0 108.628 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -57.45 -43.46 83.97 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.385 1.448 . . . . 0.0 110.128 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -65.51 -44.87 85.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 118.718 0.69 . . . . 0.0 112.063 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -58.49 -46.75 86.05 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.299 1.04 . . . . 0.0 112.549 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.8 mt -58.78 -50.19 74.86 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -51.69 -45.68 63.59 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 120.261 1.391 . . . . 0.0 113.629 170.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -53.93 -32.11 52.53 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.881 1.672 . . . . 0.0 112.927 -173.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -123.39 15.63 9.69 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.567 1.547 . . . . 0.0 111.452 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 43.95 41.95 4.3 Favored 'General case' 0 CA--C 1.542 0.641 1 C-N-CA 132.379 4.272 . . . . 0.0 114.612 -176.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.3 mt -84.41 131.11 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.079 0.952 . . . . 0.0 108.726 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.09 115.71 4.07 Favored Glycine 0 C--O 1.228 -0.219 0 C-N-CA 125.0 1.286 . . . . 0.0 111.691 -169.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -39.62 -35.99 0.36 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.405 2.282 . . . . 0.0 115.725 -167.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -50.06 -50.12 48.98 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.249 1.386 . . . . 0.0 111.507 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.75 -50.69 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 119.044 0.838 . . . . 0.0 109.242 -173.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -54.74 -46.94 74.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.772 -0.58 . . . . 0.0 111.065 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.5 -15.52 68.42 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-O 117.026 -1.986 . . . . 0.0 113.232 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -94.25 -26.25 16.7 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.617 2.208 . . . . 0.0 112.575 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -118.44 -24.06 6.97 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -172.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.45 -37.74 6.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.138 0.975 . . . . 0.0 109.593 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.3 mt -112.19 -30.73 7.1 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -171.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.39 13.16 83.12 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 123.961 0.791 . . . . 0.0 113.469 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 99.0 mt -101.84 170.33 8.22 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.254 1.822 . . . . 0.0 109.16 -174.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.09 166.57 13.6 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.411 -0.806 . . . . 0.0 112.025 173.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.2 tm0? -64.23 -44.34 92.18 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.31 -56.83 8.76 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 125.281 1.42 . . . . 0.0 112.068 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.7 m -52.13 -69.06 0.12 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 118.341 -0.838 . . . . 0.0 111.359 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.8 -37.1 70.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 120.482 1.492 . . . . 0.0 111.566 -171.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 t -55.26 -38.52 68.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 117.828 -1.082 . . . . 0.0 112.115 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.14 -48.58 79.47 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.921 1.237 . . . . 0.0 110.202 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 mt -59.03 -35.07 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.0 mt -81.22 -37.23 28.94 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 123.603 0.761 . . . . 0.0 112.099 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.55 -48.12 83.16 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.977 0.911 . . . . 0.0 110.751 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -136.94 82.0 32.1 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.36 73.86 4.38 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.554 2.836 . . . . 0.0 109.096 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -56.34 148.39 43.23 Favored Pre-proline 0 N--CA 1.441 -0.911 0 C-N-CA 124.8 1.24 . . . . 0.0 109.103 -172.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.02 147.26 91.78 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 124.46 3.44 . . . . 0.0 109.098 -164.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 60.3 t-105 -54.13 -38.07 65.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.735 0.414 . . . . 0.0 110.555 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -25.75 67.12 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -37.2 65.27 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.66 -1.275 . . . . 0.0 110.212 173.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.7 mt -74.54 172.44 12.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.298 1.047 . . . . 0.0 110.13 -171.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.6 p -129.15 -175.98 3.73 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.774 2.83 . . . . 0.0 107.834 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 89.9 t -47.54 -57.52 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 120.543 1.519 . . . . 0.0 111.229 173.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -70.09 -27.56 64.7 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.342 -1.474 . . . . 0.0 112.855 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.8 97.24 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 170.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -88.24 -26.12 22.51 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 126.949 2.1 . . . . 0.0 111.974 -171.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -44.45 -54.66 11.7 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.705 1.602 . . . . 0.0 110.566 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.04 -48.77 4.59 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.994 1.796 . . . . 0.0 110.982 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -57.48 -37.63 73.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.458 1.026 . . . . 0.0 113.401 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.0 -59.55 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 172.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -55.01 -38.89 68.48 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.099 0.56 . . . . 0.0 110.934 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 57.8 mtm -66.01 -50.56 63.83 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.768 0.827 . . . . 0.0 111.912 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -58.8 -41.26 86.3 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.908 -1.12 . . . . 0.0 110.778 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -70.29 -35.8 73.95 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.139 1.375 . . . . 0.0 110.576 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -56.5 -54.45 45.63 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.28 1.832 . . . . 0.0 109.105 171.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.3 mt -64.39 -18.15 64.41 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.709 0.803 . . . . 0.0 112.442 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.83 -10.13 59.4 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.532 -0.73 . . . . 0.0 111.604 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -144.41 110.13 5.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.368 0.985 . . . . 0.0 108.345 171.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.6 tp10 -52.43 -30.44 29.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.833 1.253 . . . . 0.0 112.076 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -61.7 -16.04 45.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.149 -1.594 . . . . 0.0 112.969 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -66.79 -50.28 63.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.834 1.197 . . . . 0.0 110.692 169.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.1 p -64.06 -37.46 79.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 CA-C-N 119.359 0.982 . . . . 0.0 109.223 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.07 -39.91 93.91 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 118.241 0.473 . . . . 0.0 110.559 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.34 -34.39 76.01 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.858 0.463 . . . . 0.0 111.741 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.8 -27.81 66.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.84 0.856 . . . . 0.0 111.549 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 mtm105 -55.17 -50.36 69.53 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.5 m -53.3 -40.75 64.99 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.75 1.62 . . . . 0.0 109.348 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.2 mt -69.75 -31.4 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 O-C-N 120.656 -1.277 . . . . 0.0 111.21 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -63.63 -35.94 82.18 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 119.028 0.831 . . . . 0.0 110.873 170.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.18 -31.65 48.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 119.139 0.881 . . . . 0.0 109.81 176.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -76.78 27.06 0.13 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.925 1.69 . . . . 0.0 111.764 169.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.7 p -73.34 -15.17 61.39 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.756 1.616 . . . . 0.0 113.477 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -159.42 179.02 35.3 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -71.88 -23.25 22.38 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.463 2.108 . . . . 0.0 112.805 -170.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.0 p -69.69 11.6 0.26 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 129.473 3.109 . . . . 0.0 114.483 -174.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.7 t -73.26 83.22 1.37 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 CA-C-O 116.106 -2.497 . . . . 0.0 107.037 171.799 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.62 0 N-CA-C 106.744 -2.542 . . . . 0.0 106.744 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m 57.7 44.54 20.4 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 117.897 0.849 . . . . 0.0 111.366 144.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.6 m -145.65 153.84 41.46 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.937 1.295 . . . . 0.0 107.949 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.41 161.35 29.4 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 168.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.5 t -155.05 159.54 40.36 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.278 1.031 . . . . 0.0 109.23 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -155.02 166.9 32.13 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.013 1.725 . . . . 0.0 107.555 169.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.63 163.4 25.5 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 157.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -160.13 156.04 26.1 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.122 1.369 . . . . 0.0 107.793 166.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.01 73.7 0.1 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 173.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -78.06 136.88 15.03 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.294 1.996 . . . . 0.0 110.831 -171.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.34 -122.77 0.77 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.75 148.27 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.89 2.876 . . . . 0.0 114.717 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -163.63 158.68 20.83 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.118 1.367 . . . . 0.0 109.238 -170.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -75.21 105.48 6.25 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -145.46 177.9 8.51 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.809 -1.182 . . . . 0.0 110.185 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -73.51 119.69 18.09 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.7 mt -111.45 142.27 43.93 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.628 1.571 . . . . 0.0 107.878 -177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.92 102.48 5.59 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 123.06 1.41 . . . . 0.0 109.489 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 p -70.23 -35.06 73.59 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.722 -174.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.57 65.94 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 120.262 1.392 . . . . 0.0 110.914 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -77.84 -50.88 11.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.856 2.062 . . . . 0.0 108.981 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -54.03 -53.24 29.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.83 -46.23 78.17 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.313 0.645 . . . . 0.0 112.096 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.417 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 50.6 t80 -58.54 -66.48 0.48 Allowed 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.382 1.073 . . . . 0.0 108.23 174.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -47.29 -40.6 17.21 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.354 1.462 . . . . 0.0 112.643 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.7 t -57.98 -53.8 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 123.684 0.794 . . . . 0.0 109.873 174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 43.0 mtmt -52.71 -51.09 61.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -59.29 -44.41 92.49 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.765 0.826 . . . . 0.0 112.582 -175.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.415 ' HG3' ' CD2' ' A' ' 80' ' ' LEU . 9.9 mm-40 -61.32 -49.59 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.954 1.702 . . . . 0.0 112.349 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.49 -49.47 77.67 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.48 -42.91 67.74 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.833 1.253 . . . . 0.0 114.056 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -53.83 -28.31 34.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.676 1.19 . . . . 0.0 111.568 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -124.76 15.66 8.69 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.872 1.669 . . . . 0.0 112.579 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 38.4 54.31 1.81 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.727 2.811 . . . . 0.0 113.893 -172.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.5 mt -89.89 151.7 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.29 131.9 10.8 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 126.236 1.874 . . . . 0.0 111.681 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -60.43 -20.1 58.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.216 1.006 . . . . 0.0 113.211 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -65.68 -60.82 2.51 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 119.775 1.171 . . . . 0.0 109.222 171.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.73 -47.54 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 C-N-CA 123.632 0.773 . . . . 0.0 109.97 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -53.55 -51.04 64.17 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.653 0.66 . . . . 0.0 111.907 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.48 -28.85 72.98 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-O 117.845 -1.531 . . . . 0.0 112.061 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -72.38 -23.55 61.13 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.794 1.797 . . . . 0.0 112.023 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -116.27 -60.32 1.87 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.751 1.159 . . . . 0.0 112.841 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.16 -44.67 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.9 mt -95.1 -41.76 8.95 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.21 0.604 . . . . 0.0 110.755 -173.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.92 30.19 44.04 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.179 0.895 . . . . 0.0 112.223 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.8 mt -121.13 164.42 16.88 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 126.725 2.01 . . . . 0.0 107.802 -173.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.2 t -65.4 162.41 17.79 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.518 0.675 . . . . 0.0 110.737 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -58.85 -54.06 51.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.806 0.842 . . . . 0.0 109.586 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.55 -42.88 99.85 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.0 m -52.56 -60.42 3.27 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.805 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 m -63.58 -39.31 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 120.885 1.675 . . . . 0.0 113.984 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.32 -35.97 78.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 119.179 0.899 . . . . 0.0 109.376 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.18 -44.13 87.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.516 0.726 . . . . 0.0 111.212 169.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mt -59.98 -40.04 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.8 -38.26 62.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.754 0.822 . . . . 0.0 111.042 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.16 -49.52 56.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.402 1.881 . . . . 0.0 112.204 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -127.32 75.21 77.28 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 127.023 2.129 . . . . 0.0 108.111 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.33 103.0 0.61 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 N-CA-C 106.429 -2.181 . . . . 0.0 106.429 167.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -66.61 170.96 4.87 Favored Pre-proline 0 N--CA 1.439 -0.992 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.4 146.26 79.86 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.112 2.542 . . . . 0.0 109.681 168.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -55.26 -48.33 74.15 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.88 0.872 . . . . 0.0 110.773 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.72 -21.22 3.81 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 172.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -94.89 5.27 52.37 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 120.219 -1.551 . . . . 0.0 112.51 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.4 mt -113.71 174.94 5.68 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.687 1.595 . . . . 0.0 109.215 173.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -128.13 -173.98 3.09 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.14 1.776 . . . . 0.0 108.313 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 96.8 t -47.28 -55.56 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.908 1.231 . . . . 0.0 111.015 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -60.54 -32.21 71.27 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 120.862 -1.149 . . . . 0.0 112.926 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.8 -45.48 94.86 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.666 1.127 . . . . 0.0 112.428 171.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -90.69 -17.85 26.08 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.707 2.003 . . . . 0.0 112.266 -164.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -41.6 -53.62 7.29 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.308 2.243 . . . . 0.0 111.648 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -65.84 -50.77 1.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.341 2.027 . . . . 0.0 111.129 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -57.62 -38.96 75.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 117.69 -1.148 . . . . 0.0 112.481 -174.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.1 mt -58.01 -54.29 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -56.35 -47.41 78.87 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.769 0.827 . . . . 0.0 110.486 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 64.7 mtm -61.42 -47.86 83.85 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 123.066 0.546 . . . . 0.0 110.705 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -58.72 -40.99 85.31 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.57 -0.707 . . . . 0.0 111.339 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.71 -41.56 92.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.063 0.847 . . . . 0.0 111.008 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.6 t80 -56.57 -41.65 77.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.557 0.743 . . . . 0.0 109.48 177.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.415 ' CD2' ' HG3' ' A' ' 29' ' ' GLN . 81.7 mt -75.75 -15.24 60.3 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.765 1.226 . . . . 0.0 113.938 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.9 m -81.65 -14.19 56.97 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.234 0.924 . . . . 0.0 111.035 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -145.24 97.12 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -47.31 -25.63 1.04 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.192 1.797 . . . . 0.0 112.746 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -58.41 -28.77 65.53 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 119.643 -1.911 . . . . 0.0 112.138 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.416 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 66.7 m-80 -62.06 -54.23 44.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.19 -37.49 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.1 -0.375 . . . . 0.0 110.15 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.6 -39.4 93.63 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.42 0.688 . . . . 0.0 110.703 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.92 -35.29 67.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.558 0.743 . . . . 0.0 111.996 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.99 -25.09 66.63 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.132 0.973 . . . . 0.0 110.774 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -58.06 -49.53 76.6 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 118.359 0.527 . . . . 0.0 109.915 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 m -60.29 -38.26 83.06 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.403 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mt -63.04 -42.33 96.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 119.68 1.127 . . . . 0.0 109.692 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -59.0 -45.99 89.29 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.445 0.698 . . . . 0.0 111.273 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.274 1.4 p -68.72 -30.06 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 118.915 0.779 . . . . 0.0 111.196 174.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -76.69 1.35 17.31 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 116.671 -1.633 . . . . 0.0 112.932 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.39 155.29 0.53 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-N 120.589 1.54 . . . . 0.0 113.86 -174.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.3 176.1 10.59 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.334 166.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -78.18 62.92 8.19 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.707 2.938 . . . . 0.0 111.516 -168.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.4 m -151.26 130.84 13.03 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 120.291 -1.506 . . . . 0.0 107.633 173.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.7 p -149.29 108.54 3.94 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.069 0.948 . . . . 0.0 108.802 -170.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 -168.96 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.845 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.8 m -146.27 159.04 43.88 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.025 0.93 . . . . 0.0 108.965 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.0 m 54.48 174.65 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.711 1.204 . . . . 0.0 111.828 -161.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.51 -149.17 15.74 Favored Glycine 0 C--N 1.332 0.336 0 O-C-N 120.789 -1.194 . . . . 0.0 110.174 -166.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.7 m -54.42 120.99 7.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.161 1.384 . . . . 0.0 110.656 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 t -157.8 176.82 12.08 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.601 1.96 . . . . 0.0 107.819 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.25 71.37 0.89 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.44 119.93 20.24 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.115 0.966 . . . . 0.0 109.124 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.84 85.02 0.37 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -174.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.87 -12.75 31.23 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.694 2.263 . . . . 0.0 114.153 -165.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 137.27 -147.81 19.44 Favored Glycine 0 C--O 1.237 0.316 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.82 26.49 10.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.675 1.59 . . . . 0.0 111.367 -166.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -81.26 -176.22 5.87 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.945 1.298 . . . . 0.0 111.248 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -126.94 115.23 18.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.628 1.971 . . . . 0.0 107.218 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -154.15 178.72 9.67 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.446 1.498 . . . . 0.0 110.502 -154.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -71.86 95.77 1.58 Allowed 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.894 0.77 . . . . 0.0 111.058 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mt -78.91 154.93 29.28 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.801 1.24 . . . . 0.0 108.263 168.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -85.33 104.07 14.83 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.029 1.395 . . . . 0.0 108.122 162.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.437 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 19.4 p -56.2 -41.65 75.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.988 172.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 -37.74 71.95 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.475 0.71 . . . . 0.0 111.558 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -71.14 -54.77 9.87 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.328 1.451 . . . . 0.0 108.434 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -54.09 -51.05 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.36 -49.82 63.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.826 0.85 . . . . 0.0 111.362 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -55.42 -63.75 1.06 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.483 1.113 . . . . 0.0 109.617 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -50.88 -41.24 58.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.566 1.946 . . . . 0.0 112.933 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.3 t -62.54 -47.85 91.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 121.011 -1.056 . . . . 0.0 110.079 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -55.89 -39.61 71.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.657 -1.163 . . . . 0.0 109.337 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -59.39 -55.81 29.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.45 1.023 . . . . 0.0 112.024 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -63.86 -39.66 94.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 112.318 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.12 -46.43 89.06 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 120.091 1.314 . . . . 0.0 107.601 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -16.73 64.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.06 0.846 . . . . 0.0 113.263 175.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -66.8 -30.66 70.92 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.083 -1.011 . . . . 0.0 110.832 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -127.99 10.35 6.43 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.322 1.049 . . . . 0.0 111.699 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 41.01 85.11 0.02 OUTLIER 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.24 2.616 . . . . 0.0 111.171 -164.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.2 mt -115.99 150.96 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.971 0.909 . . . . 0.0 108.921 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.96 142.14 17.45 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 123.954 0.788 . . . . 0.0 111.499 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -66.09 -33.46 75.84 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 118.57 -0.729 . . . . 0.0 111.965 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -59.97 -46.72 88.52 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 118.832 0.742 . . . . 0.0 109.767 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 t -61.88 -54.04 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 119.151 0.887 . . . . 0.0 109.294 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -51.3 -47.87 62.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.668 0.27 . . . . 0.0 111.714 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -78.34 -27.71 57.11 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-O 117.017 -1.991 . . . . 0.0 112.573 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -78.81 -26.75 44.29 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.738 2.269 . . . . 0.0 110.769 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -96.31 -78.5 0.46 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.68 0.792 . . . . 0.0 109.386 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.3 t -53.42 -52.28 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 C-N-CA 126.489 1.916 . . . . 0.0 107.896 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.9 mt -90.17 -34.44 15.84 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 118.026 -0.988 . . . . 0.0 111.595 -170.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.97 12.72 80.72 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 124.2 0.937 . . . . 0.0 112.791 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.0 mt -102.79 172.29 6.92 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.172 1.389 . . . . 0.0 109.688 -171.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 63.5 p -67.33 159.79 28.56 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.291 -0.881 . . . . 0.0 109.594 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -61.22 -46.43 90.45 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.017 -1.052 . . . . 0.0 109.209 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.88 -32.68 70.83 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.83 -0.984 . . . . 0.0 112.043 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -60.19 -69.36 0.22 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.919 1.359 . . . . 0.0 108.69 169.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 m -57.25 -40.05 71.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 120.09 1.314 . . . . 0.0 113.63 -173.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.0 t -55.01 -45.72 75.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.753 0.821 . . . . 0.0 109.638 176.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -57.42 -46.07 83.94 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 119.361 0.982 . . . . 0.0 110.702 172.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.42 ' CG2' ' CZ ' ' A' ' 73' ' ' PHE . 5.1 mt -58.72 -41.21 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -70.41 -41.51 72.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.444 1.098 . . . . 0.0 111.174 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.69 -48.89 73.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.878 2.071 . . . . 0.0 112.557 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.3 79.38 61.36 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.48 95.77 0.63 Allowed 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 106.987 -1.966 . . . . 0.0 106.987 173.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -62.54 154.73 71.98 Favored Pre-proline 0 N--CA 1.436 -1.125 0 O-C-N 120.945 -1.097 . . . . 0.0 108.099 172.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -65.09 150.2 88.15 Favored 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 122.139 1.893 . . . . 0.0 108.368 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -52.25 -43.67 64.48 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.786 0.834 . . . . 0.0 110.789 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -21.59 52.02 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -83.46 -28.86 28.47 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.943 1.247 . . . . 0.0 113.039 175.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.9 mt -85.21 157.18 20.7 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.902 0.774 . . . . 0.0 109.436 -169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.1 t -97.63 -178.44 4.12 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 166.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -47.28 -51.09 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 125.358 1.463 . . . . 0.0 111.356 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.88 -22.75 67.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.1 -40.22 17.22 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 125.732 1.634 . . . . 0.0 111.44 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -76.63 -26.44 54.93 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 125.65 1.58 . . . . 0.0 111.742 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -46.1 -55.8 12.35 Favored Pre-proline 0 N--CA 1.455 -0.195 0 C-N-CA 126.485 1.914 . . . . 0.0 112.184 -176.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.64 -48.62 8.75 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 121.434 1.423 . . . . 0.0 110.025 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.437 ' CZ ' ' HB ' ' A' ' 19' ' ' THR . 64.5 m-85 -58.9 -37.75 77.33 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 117.508 -1.234 . . . . 0.0 113.133 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.1 mt -57.72 -58.77 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 C-N-CA 124.45 1.1 . . . . 0.0 108.06 173.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -52.46 -45.7 66.19 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.881 0.872 . . . . 0.0 110.173 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 64.7 mtm -65.54 -46.7 78.55 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.478 -0.764 . . . . 0.0 112.213 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -62.66 -38.45 90.37 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.034 -1.041 . . . . 0.0 110.252 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -66.47 -40.4 89.33 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.043 1.337 . . . . 0.0 110.502 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.9 t80 -57.34 -51.7 68.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.27 1.428 . . . . 0.0 108.394 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.2 mt -66.8 -10.91 52.63 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.72 1.208 . . . . 0.0 113.868 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -38.69 87.52 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.174 -0.954 . . . . 0.0 109.975 171.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -132.34 112.03 11.85 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.385 0.993 . . . . 0.0 110.147 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -53.82 -22.29 9.3 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.729 1.612 . . . . 0.0 112.413 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -53.86 -28.55 36.69 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 119.85 -1.781 . . . . 0.0 113.016 171.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.414 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 51.6 m-80 -62.04 -48.85 78.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.964 0.505 . . . . 0.0 110.031 175.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -37.16 79.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 CA-C-N 119.237 0.926 . . . . 0.0 109.814 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.4 mt -66.69 -35.05 79.22 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.836 0.454 . . . . 0.0 110.182 -173.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.42 -35.42 70.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.493 0.717 . . . . 0.0 112.052 172.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.39 -27.34 69.24 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.845 0.858 . . . . 0.0 111.338 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -59.26 -44.46 92.41 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.44 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.1 m -50.8 -46.53 59.77 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.282 0.946 . . . . 0.0 110.967 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.4 mt -67.84 -32.44 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.474 0.71 . . . . 0.0 110.134 -174.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -65.54 -34.58 78.58 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.68 0.792 . . . . 0.0 110.795 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -76.19 -5.99 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.387 0.675 . . . . 0.0 111.8 174.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -106.13 4.2 28.83 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.468 1.507 . . . . 0.0 111.233 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.9 t -56.67 -64.76 0.76 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.975 1.71 . . . . 0.0 111.137 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.88 -172.99 42.8 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.24 -0.913 . . . . 0.0 111.504 -168.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.53 105.92 1.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.022 3.148 . . . . 0.0 110.075 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 t 64.71 167.31 0.17 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.217 2.207 . . . . 0.0 112.09 -163.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.1 m -138.25 121.62 17.11 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 157.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.776 0 CA-C-O 117.303 -1.831 . . . . 0.0 111.538 -177.28 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.063 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 m 62.91 170.52 0.14 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.818 1.247 . . . . 0.0 111.617 -168.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -172.48 178.26 2.8 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.587 2.755 . . . . 0.0 105.839 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.2 134.02 1.63 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 172.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 m -169.29 116.55 0.61 Allowed 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 126.664 1.986 . . . . 0.0 106.702 172.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.3 m -160.27 161.19 33.32 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.014 1.326 . . . . 0.0 108.99 169.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.97 87.66 1.79 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 170.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -132.82 151.81 51.94 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 169.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.92 71.66 0.17 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.13 168.88 16.34 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.893 2.395 . . . . 0.0 111.232 167.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.58 145.7 35.43 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 124.542 1.068 . . . . 0.0 112.709 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.4 78.03 3.92 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.14 0.976 . . . . 0.0 108.673 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 39.77 -135.2 0.16 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.044 1.738 . . . . 0.0 110.94 -173.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -128.73 114.08 16.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.06 1.344 . . . . 0.0 108.314 -174.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -92.41 -158.35 0.58 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.576 1.551 . . . . 0.0 110.998 -169.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -117.61 93.59 4.22 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 126.976 2.11 . . . . 0.0 108.676 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mt -75.54 151.3 37.95 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.797 0.839 . . . . 0.0 110.394 -172.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.5 93.95 4.87 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.2 p -58.13 -40.49 81.41 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.96 -1.088 . . . . 0.0 111.635 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.96 -34.79 76.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.94 0.496 . . . . 0.0 110.315 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.83 -55.44 7.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.564 1.145 . . . . 0.0 108.779 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.3 mt -56.25 -44.38 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.49 -48.61 78.76 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.735 -0.603 . . . . 0.0 111.536 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.505 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 29.7 t80 -56.36 -64.97 0.69 Allowed 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.231 1.012 . . . . 0.0 108.999 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -54.57 -35.63 63.51 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 127.106 2.162 . . . . 0.0 112.935 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.1 t -61.76 -53.13 52.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 119.191 0.905 . . . . 0.0 110.188 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 47.1 mtmt -52.38 -42.51 64.05 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 117.6 -1.191 . . . . 0.0 109.185 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.47 -58.1 10.1 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.238 1.015 . . . . 0.0 110.556 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -62.08 -34.17 75.79 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.67 -50.33 72.91 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 170.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.64 -42.41 74.96 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.107 0.867 . . . . 0.0 110.981 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -54.39 -30.1 51.0 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.129 2.171 . . . . 0.0 113.006 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -127.23 14.82 7.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.614 1.565 . . . . 0.0 110.928 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.7 m120 44.76 43.31 6.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 129.036 2.934 . . . . 0.0 113.073 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -82.15 147.17 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.81 -1.182 . . . . 0.0 109.421 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.13 130.99 10.17 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -56.62 -37.0 70.1 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.992 1.317 . . . . 0.0 112.512 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.2 ttp85 -54.63 -50.13 68.85 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.133 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.54 -49.41 83.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 119.107 0.867 . . . . 0.0 109.565 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -54.13 -49.2 69.73 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.18 -29.08 67.06 Favored Glycine 0 C--O 1.216 -0.987 0 CA-C-O 117.45 -1.75 . . . . 0.0 113.576 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -78.57 -30.08 46.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.729 2.265 . . . . 0.0 111.568 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.4 -58.44 1.88 Allowed 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.553 0.741 . . . . 0.0 110.393 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 t -68.23 -53.42 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -172.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.0 mt -89.47 -37.08 15.04 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.2 0.6 . . . . 0.0 110.528 -173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.14 36.25 60.39 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.7 mt -121.51 163.43 18.84 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.731 1.612 . . . . 0.0 108.534 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.2 t -54.6 144.48 21.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.473 1.109 . . . . 0.0 109.919 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -58.28 -26.97 63.62 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 117.775 0.261 . . . . 0.0 110.841 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.59 -36.29 43.91 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.346 0.974 . . . . 0.0 112.054 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.1 m -67.56 -59.56 3.26 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.081 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 m -58.75 -35.18 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 120.381 1.446 . . . . 0.0 113.691 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.2 p -61.88 -38.82 89.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.981 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.3 -38.59 68.86 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.742 1.155 . . . . 0.0 110.104 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.9 mt -68.54 -47.22 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -173.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.8 mt -73.45 -30.36 63.14 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.145 0.578 . . . . 0.0 111.857 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.2 -57.46 5.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.02 1.728 . . . . 0.0 110.969 173.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -130.25 74.42 80.4 Favored Pre-proline 0 CA--C 1.519 -0.24 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -170.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.68 97.2 0.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 122.709 2.272 . . . . 0.0 107.167 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -63.68 159.53 51.96 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -70.31 150.05 64.31 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.093 1.862 . . . . 0.0 107.328 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.446 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 67.4 t-105 -51.69 -42.15 61.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -14.66 52.67 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.96 -16.95 34.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.144 1.793 . . . . 0.0 112.363 171.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.64 149.37 21.29 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.44 1.018 . . . . 0.0 108.85 -169.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -98.03 179.93 4.61 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 165.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.8 t -49.05 -51.05 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 119.649 1.113 . . . . 0.0 112.163 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt -59.56 -34.48 72.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.46 1.482 . . . . 0.0 112.569 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.78 -35.2 90.61 Favored Glycine 0 CA--C 1.529 0.92 0 O-C-N 121.35 -0.844 . . . . 0.0 112.705 173.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 93.5 mttt -80.4 -27.91 38.0 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.348 1.459 . . . . 0.0 112.162 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -42.18 -52.64 9.48 Favored Pre-proline 0 N--CA 1.448 -0.563 0 C-N-CA 128.365 2.666 . . . . 0.0 111.883 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.97 -56.08 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.103 1.869 . . . . 0.0 110.27 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -58.05 -32.03 67.62 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 117.482 -1.247 . . . . 0.0 113.303 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.23 -58.81 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 119.449 1.022 . . . . 0.0 108.278 171.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -53.85 -48.85 69.58 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 58.3 mtm -72.31 -33.68 67.55 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 119.713 1.142 . . . . 0.0 113.034 -168.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -62.21 -41.44 98.38 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.622 171.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -66.72 -35.04 79.19 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.579 1.152 . . . . 0.0 111.644 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -58.65 -57.28 13.67 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 126.312 1.845 . . . . 0.0 108.062 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.03 -4.8 7.9 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.445 1.498 . . . . 0.0 113.124 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.7 -7.64 59.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.771 1.228 . . . . 0.0 112.729 171.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -152.26 134.39 15.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.223 1.829 . . . . 0.0 111.538 171.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -60.4 -35.71 76.4 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.249 1.42 . . . . 0.0 111.104 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -58.2 -27.07 63.54 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.545 -0.722 . . . . 0.0 110.555 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -63.27 -42.61 99.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.227 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 p -75.8 -33.6 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.731 1.151 . . . . 0.0 110.267 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.6 mt -66.53 -38.72 87.77 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.647 0.658 . . . . 0.0 110.277 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.37 97.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.204 0.526 . . . . 0.0 110.791 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.51 -27.41 68.45 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.964 0.905 . . . . 0.0 111.234 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -57.0 -38.59 73.29 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.165 0.893 . . . . 0.0 109.649 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -65.83 -46.35 78.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.762 0.71 . . . . 0.0 111.232 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.9 mt -62.83 -32.01 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 119.307 0.958 . . . . 0.0 110.538 -176.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -55.97 -44.26 78.34 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.499 0.72 . . . . 0.0 110.767 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.8 -32.23 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.658 0.742 . . . . 0.0 110.024 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -76.58 -3.17 36.19 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.648 1.179 . . . . 0.0 111.625 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 t -61.46 -21.98 64.64 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.696 1.134 . . . . 0.0 112.289 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.52 174.26 37.19 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.022 1.296 . . . . 0.0 110.333 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -86.87 51.58 2.45 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.575 3.516 . . . . 0.0 111.173 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 69.86 157.4 0.16 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.617 1.967 . . . . 0.0 112.576 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.2 t 73.22 139.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 127.408 2.283 . . . . 0.0 111.803 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.423 0 C-N-CA 124.886 1.232 . . . . 0.0 111.048 -179.164 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.102 0 CA-C-O 118.991 -0.894 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.3 113.44 6.89 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 102.775 -3.046 . . . . 0.0 102.775 171.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.2 m -155.94 114.27 3.4 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.59 166.35 21.98 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 175.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 m -157.53 52.76 0.47 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.147 0.979 . . . . 0.0 108.79 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t -77.34 -170.88 1.89 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.153 0.981 . . . . 0.0 110.461 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.69 129.78 6.46 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.95 137.21 31.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.11 89.11 0.07 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.09 152.95 67.82 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.292 1.994 . . . . 0.0 110.937 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.41 170.57 34.0 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 128.058 2.742 . . . . 0.0 106.668 169.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.89 -6.27 0.09 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.578 1.189 . . . . 0.0 113.784 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.65 -177.43 3.36 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.339 1.056 . . . . 0.0 108.867 -173.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -73.89 111.18 8.8 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 154.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -123.56 -147.99 0.39 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.197 1.399 . . . . 0.0 108.487 -171.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -118.74 138.47 52.63 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.289 1.436 . . . . 0.0 107.528 169.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.8 mt -129.35 146.21 51.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -173.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.25 111.57 19.97 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.624 1.102 . . . . 0.0 108.577 171.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.9 p -69.18 -39.43 78.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 121.22 -0.925 . . . . 0.0 111.915 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 -21.49 63.83 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.508 1.049 . . . . 0.0 112.119 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -75.67 -55.36 5.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.727 1.611 . . . . 0.0 107.088 172.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.3 mt -53.96 -44.22 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 119.779 1.172 . . . . 0.0 109.427 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.63 -53.76 50.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.754 1.221 . . . . 0.0 111.248 173.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -57.57 -53.46 57.9 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.284 1.034 . . . . 0.0 110.539 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -58.48 -43.43 88.98 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.618 2.367 . . . . 0.0 110.624 -176.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.64 -55.03 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 O-C-N 120.861 -1.15 . . . . 0.0 109.023 172.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -51.47 -46.06 62.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.324 0.965 . . . . 0.0 110.932 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.97 -40.03 75.62 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 116.565 -1.683 . . . . 0.0 111.927 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -64.35 -36.16 83.23 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 121.627 2.012 . . . . 0.0 111.451 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.5 mt -61.07 -52.07 66.5 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 mt -65.02 -28.46 69.51 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -58.24 -36.34 73.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.963 1.305 . . . . 0.0 109.809 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -121.77 8.27 9.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.248 1.019 . . . . 0.0 112.405 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 52.3 79.29 0.11 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 128.04 2.536 . . . . 0.0 111.876 -169.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.7 mt -121.89 150.37 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.72 141.88 15.76 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.931 0.777 . . . . 0.0 111.269 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -57.81 -33.1 68.22 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.21 1.404 . . . . 0.0 112.253 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 -59.01 -62.8 1.61 Allowed 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.274 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.49 -36.48 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.968 1.258 . . . . 0.0 111.066 -176.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -59.78 -53.93 52.18 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 120.531 -1.356 . . . . 0.0 110.637 172.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.11 -24.22 74.62 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-O 118.017 -1.435 . . . . 0.0 112.62 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -81.3 -20.45 40.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.838 1.819 . . . . 0.0 111.429 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -120.94 -51.42 2.13 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.327 0.967 . . . . 0.0 112.289 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.1 t -68.84 -52.16 37.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.6 mt -93.89 -29.06 15.49 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.208 -173.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.08 18.12 76.21 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 122.892 0.282 . . . . 0.0 112.563 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.7 169.9 8.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.558 1.543 . . . . 0.0 107.789 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.3 156.78 37.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 168.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -53.78 -51.15 64.33 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.205 0.602 . . . . 0.0 110.024 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.5 -26.44 68.2 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.321 -0.71 . . . . 0.0 112.54 -174.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 m -63.74 -69.05 0.3 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 m -56.65 -35.93 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 120.367 1.44 . . . . 0.0 112.59 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t -60.78 -40.2 91.68 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.272 1.829 . . . . 0.0 110.576 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.84 -47.0 87.49 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.139 1.336 . . . . 0.0 109.272 167.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.0 mt -61.43 -31.8 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 99.3 mt -84.7 -22.66 29.68 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.944 0.897 . . . . 0.0 112.608 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.45 -49.16 23.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.802 1.241 . . . . 0.0 110.121 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.9 mtt85 -135.04 86.84 30.87 Favored Pre-proline 0 CA--C 1.516 -0.339 0 C-N-CA 125.373 1.469 . . . . 0.0 107.865 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.24 93.56 0.48 Allowed 'Trans proline' 0 N--CA 1.445 -1.335 0 N-CA-C 107.05 -1.942 . . . . 0.0 107.05 167.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -65.53 158.44 73.66 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -72.33 152.17 55.03 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.04 2.494 . . . . 0.0 108.958 -167.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.435 ' CD2' ' HE2' ' A' ' 70' ' ' LYS . 74.7 t-105 -52.43 -41.28 63.11 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.649 0.38 . . . . 0.0 111.478 175.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -18.02 58.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -89.03 -37.1 15.41 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 120.831 -1.168 . . . . 0.0 110.852 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.7 mt -74.69 146.15 42.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.543 0.687 . . . . 0.0 110.656 -162.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 t -71.3 174.59 6.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.289 1.035 . . . . 0.0 110.671 166.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.0 p -49.69 -56.09 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 124.423 1.089 . . . . 0.0 111.586 170.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -70.12 -5.07 24.42 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.62 -41.63 7.21 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.814 1.673 . . . . 0.0 110.288 167.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HE2' ' CD2' ' A' ' 62' ' ' TRP . 88.1 mttt -76.84 -26.1 53.92 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 126.264 1.825 . . . . 0.0 112.497 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -40.99 -62.04 1.12 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 127.266 2.226 . . . . 0.0 110.698 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -61.73 -44.5 21.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.393 2.062 . . . . 0.0 110.365 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -60.63 -39.93 90.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 117.67 -1.157 . . . . 0.0 112.845 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.9 mt -56.14 -51.59 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -59.65 -46.9 87.63 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.456 1.102 . . . . 0.0 110.861 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 70.5 mtm -61.84 -48.14 81.88 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 123.868 0.867 . . . . 0.0 110.823 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -60.78 -40.89 94.27 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.116 -0.99 . . . . 0.0 110.494 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -67.55 -36.01 80.15 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.116 0.967 . . . . 0.0 111.232 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -57.25 -48.04 79.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.011 0.925 . . . . 0.0 109.015 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.8 mt -71.07 -13.14 61.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.791 1.236 . . . . 0.0 113.631 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -25.73 68.21 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.146 0.885 . . . . 0.0 111.947 173.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -145.72 105.17 3.95 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -162.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -61.13 -23.24 65.38 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.382 0.673 . . . . 0.0 111.011 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -60.09 -23.42 63.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 119.783 -1.823 . . . . 0.0 112.036 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -62.45 -38.89 91.52 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.066 1.303 . . . . 0.0 111.48 175.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 p -73.19 -35.4 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.608 1.094 . . . . 0.0 109.506 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.9 mt -70.52 -23.65 62.68 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.288 1.035 . . . . 0.0 111.283 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.3 -49.26 35.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.125 0.97 . . . . 0.0 110.615 167.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -28.93 69.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.336 1.454 . . . . 0.0 111.549 -170.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -57.45 -46.15 83.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.4 m -60.54 -37.51 81.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.653 0.781 . . . . 0.0 110.362 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mt -68.28 -30.3 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.353 0.978 . . . . 0.0 109.974 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -69.99 -45.54 67.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.684 -0.635 . . . . 0.0 111.372 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.254 0.3 OUTLIER -63.31 -20.9 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 120.085 1.311 . . . . 0.0 111.165 172.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -87.86 20.22 3.17 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.536 1.535 . . . . 0.0 112.208 171.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 85.3 p -77.64 17.76 0.51 Allowed 'General case' 0 CA--C 1.547 0.854 0 O-C-N 119.985 -1.697 . . . . 0.0 113.575 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.84 -178.38 17.17 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 127.545 2.498 . . . . 0.0 109.326 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -79.65 57.9 6.71 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 124.381 3.387 . . . . 0.0 109.324 173.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.1 m 56.52 161.66 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.049 1.74 . . . . 0.0 113.134 -152.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.1 m 52.15 32.19 10.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.802 1.641 . . . . 0.0 114.621 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.349 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 151.254 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.658 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -150.04 165.8 31.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.868 1.267 . . . . 0.0 107.868 169.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.93 -177.41 6.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 172.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.34 -172.94 36.08 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 -167.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 p -147.67 150.09 33.7 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 117.449 0.624 . . . . 0.0 109.666 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 m -159.57 154.93 25.43 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.826 2.05 . . . . 0.0 110.019 167.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.16 76.56 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 107.049 -2.42 . . . . 0.0 107.049 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -158.18 108.35 2.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -174.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.63 82.52 0.11 Allowed Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.32 -1.267 . . . . 0.0 110.994 -173.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -66.49 166.03 23.11 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.024 2.483 . . . . 0.0 109.923 172.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 175.78 100.45 0.13 Allowed Glycine 0 C--N 1.333 0.398 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.68 -169.2 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.404 1.481 . . . . 0.0 107.893 174.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 58.86 -164.58 0.2 Allowed 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.522 0.729 . . . . 0.0 111.213 -178.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -100.33 101.79 12.86 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -105.23 -145.3 0.38 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 127.595 2.358 . . . . 0.0 110.263 -162.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -108.52 124.19 50.07 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.891 1.276 . . . . 0.0 108.465 168.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 mt -109.66 144.14 38.42 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.95 98.35 4.9 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.371 0.987 . . . . 0.0 108.571 175.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.4 p -58.34 -43.42 88.3 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.678 -1.264 . . . . 0.0 112.241 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.1 -26.24 66.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 118.805 -0.617 . . . . 0.0 110.992 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -70.86 -57.87 4.18 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 171.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.0 mt -54.92 -44.76 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.659 1.118 . . . . 0.0 109.936 -173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.35 -51.73 68.66 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.914 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.534 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 81.9 t80 -53.19 -68.66 0.15 Allowed 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 125.292 1.437 . . . . 0.0 108.556 175.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -41.79 -46.04 3.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.955 2.502 . . . . 0.0 112.458 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.65 -50.08 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.951 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 47.9 mtmt -48.26 -45.85 34.99 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.421 1.464 . . . . 0.0 109.864 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.59 -54.8 30.31 Favored 'General case' 0 C--O 1.225 -0.186 0 O-C-N 124.451 1.094 . . . . 0.0 110.688 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.478 ' NE2' ' HZ2' ' A' ' 32' ' ' LYS . 19.5 mm-40 -56.02 -40.58 73.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.889 1.676 . . . . 0.0 112.433 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.57 -49.67 68.0 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.8 -37.35 65.98 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.824 0.738 . . . . 0.0 111.831 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.478 ' HZ2' ' NE2' ' A' ' 29' ' ' GLN . 17.4 ttpt -55.39 -25.33 34.9 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.832 2.053 . . . . 0.0 112.922 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -126.45 16.43 7.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.153 0.981 . . . . 0.0 111.909 175.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.4 m120 40.22 75.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 129.686 3.194 . . . . 0.0 111.481 -166.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.8 mt -114.66 152.22 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -99.22 172.64 25.58 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -95.09 -20.19 19.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -172.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -58.82 -55.24 37.64 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 118.854 0.752 . . . . 0.0 110.229 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 t -60.0 -53.65 45.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -54.26 -45.1 72.32 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.819 1.191 . . . . 0.0 111.015 -174.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.65 -24.5 76.67 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-O 117.273 -1.849 . . . . 0.0 112.882 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -79.71 -37.48 35.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.569 2.185 . . . . 0.0 111.632 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -91.21 -70.4 0.69 Allowed 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.486 -0.759 . . . . 0.0 109.5 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.15 -50.44 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 125.087 1.355 . . . . 0.0 108.342 -172.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.4 mt -95.73 -37.18 10.89 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.612 -170.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.61 6.03 86.08 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 118.501 0.591 . . . . 0.0 113.713 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.6 mt -92.02 173.74 7.68 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.993 1.717 . . . . 0.0 109.438 -172.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 t -63.66 154.14 33.91 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.549 0.69 . . . . 0.0 109.845 164.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -62.98 -22.84 67.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.343 1.457 . . . . 0.0 111.449 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.09 -59.9 4.43 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 171.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.1 m -49.47 -52.57 28.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 116.728 -1.606 . . . . 0.0 112.041 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 m -66.38 -37.87 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 121.495 1.952 . . . . 0.0 113.375 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.8 t -60.2 -34.93 74.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 118.419 -0.8 . . . . 0.0 110.521 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -57.96 -48.98 78.36 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.073 0.851 . . . . 0.0 110.758 168.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.5 mt -58.16 -39.63 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.2 mt -77.65 -35.06 52.9 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.964 1.306 . . . . 0.0 113.779 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.5 -60.45 3.13 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -134.67 72.7 68.9 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 125.064 1.346 . . . . 0.0 108.792 -165.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.04 108.0 1.23 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.57 2.18 . . . . 0.0 106.655 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -66.92 159.66 74.52 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 163.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.26 149.2 81.3 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 122.529 2.153 . . . . 0.0 109.316 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -45.48 -46.71 13.86 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.56 1.544 . . . . 0.0 111.148 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -56.74 -32.38 65.51 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -71.52 -29.46 64.81 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.389 0.995 . . . . 0.0 111.319 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.4 mt -80.93 157.89 25.43 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.439 0.638 . . . . 0.0 111.249 -160.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.9 p -78.9 175.45 10.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.716 0.806 . . . . 0.0 108.917 165.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -53.79 -50.65 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.001 1.32 . . . . 0.0 112.39 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -72.6 -19.78 61.41 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 120.146 -1.596 . . . . 0.0 112.251 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.84 96.78 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 163.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -85.3 -28.17 25.46 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 117.215 -1.374 . . . . 0.0 113.089 -176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -45.04 -52.26 20.36 Favored Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 124.564 1.146 . . . . 0.0 111.964 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.76 -52.02 4.21 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.374 1.383 . . . . 0.0 110.065 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -59.51 -32.86 70.68 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 117.71 -1.138 . . . . 0.0 113.082 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.4 mt -61.16 -56.5 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -53.71 -43.79 69.31 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.541 1.136 . . . . 0.0 111.089 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -66.24 -45.25 81.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.12 -1.613 . . . . 0.0 114.711 172.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -63.48 -33.77 76.3 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.343 -1.473 . . . . 0.0 109.911 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -62.44 -49.57 74.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.224 1.809 . . . . 0.0 110.074 172.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -51.52 -48.7 62.9 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.25 1.42 . . . . 0.0 110.332 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.85 -8.57 29.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.382 1.073 . . . . 0.0 113.882 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -68.99 -25.07 64.34 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.183 -0.948 . . . . 0.0 111.942 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -147.45 141.11 25.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.913 1.233 . . . . 0.0 108.958 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -62.32 -32.68 73.47 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.237 1.015 . . . . 0.0 111.194 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.18 -30.05 61.7 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.827 -1.171 . . . . 0.0 110.864 -175.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -64.0 -36.13 82.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 118.687 0.676 . . . . 0.0 110.245 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.0 p -77.37 -31.5 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.114 -0.991 . . . . 0.0 110.469 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 42.1 mt -61.85 -41.4 97.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.838 0.855 . . . . 0.0 109.827 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.78 84.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.218 0.607 . . . . 0.0 110.106 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -30.24 70.22 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.158 177.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -61.0 -43.64 98.59 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 119.612 1.096 . . . . 0.0 109.835 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.5 m -53.09 -49.16 67.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.324 0.65 . . . . 0.0 110.094 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.3 mt -64.55 -34.4 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.417 -0.802 . . . . 0.0 110.423 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -67.25 -35.27 79.2 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.05 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.2 m -64.08 -39.21 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 120.147 1.34 . . . . 0.0 108.854 168.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 mtt85 -76.21 8.04 3.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.796 0.838 . . . . 0.0 112.296 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.7 t -70.82 142.82 51.27 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.17 -164.13 12.63 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.261 1.41 . . . . 0.0 111.977 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -66.86 156.75 64.69 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.569 2.846 . . . . 0.0 110.595 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.1 t 146.27 131.0 0.0 OUTLIER 'General case' 0 C--O 1.236 0.379 0 C-N-CA 130.718 3.607 . . . . 0.0 106.053 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.8 t -146.97 157.83 43.74 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 167.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.758 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -172.682 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.875 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 t -162.41 146.07 11.69 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 -176.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.4 t -157.65 179.8 8.89 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.25 0.932 . . . . 0.0 108.97 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.05 144.03 11.12 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.546 1.546 . . . . 0.0 112.993 171.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.52 -49.76 0.14 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.191 0.997 . . . . 0.0 110.452 166.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 m 57.42 -175.38 0.07 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.485 1.114 . . . . 0.0 110.976 -158.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.18 98.02 0.52 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -136.68 126.84 26.25 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.267 1.827 . . . . 0.0 108.519 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.21 73.88 0.42 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.453 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.38 143.78 59.34 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.004 1.802 . . . . 0.0 110.565 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.45 -173.64 16.9 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 127.242 2.353 . . . . 0.0 109.044 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.8 15.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.255 1.822 . . . . 0.0 112.141 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -129.92 174.46 9.72 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 120.339 -1.475 . . . . 0.0 110.867 -175.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -66.72 113.17 4.63 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 162.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -130.74 -152.24 0.5 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.662 1.985 . . . . 0.0 109.685 -168.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -100.31 110.13 22.35 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.243 1.017 . . . . 0.0 110.845 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.4 mt -99.28 149.85 22.7 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.037 0.935 . . . . 0.0 109.577 -173.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.76 95.74 4.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 122.372 1.082 . . . . 0.0 108.483 175.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.6 p -61.21 -42.55 98.8 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.287 -0.883 . . . . 0.0 111.374 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.52 -34.91 73.23 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.973 0.909 . . . . 0.0 110.92 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -70.82 -54.18 12.54 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.1 mt -55.93 -42.75 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.98 -55.78 28.65 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.159 0.984 . . . . 0.0 110.765 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -53.08 -62.73 1.47 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.117 1.367 . . . . 0.0 110.276 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -55.47 -36.61 66.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.059 1.743 . . . . 0.0 113.381 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.1 t -63.9 -47.59 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -58.14 -37.93 75.6 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 116.986 -1.483 . . . . 0.0 110.465 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -61.11 -58.11 9.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.4 1.0 . . . . 0.0 110.559 173.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -61.66 -34.23 75.36 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.214 -0.929 . . . . 0.0 112.127 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.3 mt -72.08 -33.87 68.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.174 1.79 . . . . 0.0 109.753 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 mt -65.45 -37.63 87.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 120.06 1.3 . . . . 0.0 112.177 168.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HZ2' ' CE1' ' A' ' 33' ' ' HIS . 55.0 tttm -58.26 -36.38 73.16 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.107 1.763 . . . . 0.0 113.459 -163.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.445 ' CE1' ' HZ2' ' A' ' 32' ' ' LYS . 78.9 m-70 -124.41 12.3 8.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.915 2.486 . . . . 0.0 111.406 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 m120 44.18 78.48 0.06 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.874 2.469 . . . . 0.0 111.506 -171.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.1 mt -116.87 151.68 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.88 151.01 19.92 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.706 0.615 . . . . 0.0 111.735 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -57.81 -38.05 74.85 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.237 1.415 . . . . 0.0 110.668 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -56.76 -61.14 2.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.614 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.96 -49.0 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 119.48 1.036 . . . . 0.0 109.358 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.36 -47.1 79.56 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.918 0.781 . . . . 0.0 111.541 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.17 -31.19 69.17 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-O 118.275 -1.291 . . . . 0.0 111.264 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -71.09 -30.07 66.08 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.738 1.769 . . . . 0.0 111.056 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -108.39 -57.83 2.07 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.189 0.995 . . . . 0.0 113.035 -171.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.6 -48.27 53.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -175.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 20.9 mt -93.17 -29.5 15.7 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 122.045 -0.409 . . . . 0.0 111.737 -171.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.06 19.76 79.72 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.374 -0.681 . . . . 0.0 112.149 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.4 mt -109.14 165.03 11.91 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.005 1.322 . . . . 0.0 107.603 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.53 162.06 29.97 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.071 0.939 . . . . 0.0 109.342 174.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -49.72 75.78 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.071 0.948 . . . . 0.0 110.692 -172.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.57 -41.56 95.61 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.4 m -55.95 -67.17 0.32 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 117.459 -1.258 . . . . 0.0 110.886 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 m -55.46 -36.24 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 121.261 1.846 . . . . 0.0 112.884 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 m -68.87 -23.69 64.25 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.669 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -66.67 -45.69 78.09 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.481 1.491 . . . . 0.0 108.552 162.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 mt -60.81 -40.42 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt -74.56 -31.5 62.11 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.399 1.079 . . . . 0.0 112.589 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.12 -50.31 64.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.536 0.734 . . . . 0.0 109.704 173.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 mtp85 -136.9 78.32 41.81 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 125.23 1.412 . . . . 0.0 108.516 -166.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.15 107.67 1.98 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.151 1.901 . . . . 0.0 107.39 169.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -64.32 173.51 1.48 Allowed Pre-proline 0 N--CA 1.442 -0.856 0 C-N-CA 124.342 1.057 . . . . 0.0 109.022 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -59.3 142.37 99.03 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.826 1.684 . . . . 0.0 108.699 165.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -54.37 -49.18 70.43 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.829 1.195 . . . . 0.0 110.494 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -21.32 4.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 mmtm -77.47 -31.06 53.47 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 120.359 -1.463 . . . . 0.0 111.383 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 mt -70.24 151.46 45.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.746 0.784 . . . . 0.0 109.549 -172.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.7 t -84.47 179.53 7.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 160.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.05 -57.11 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.098 1.359 . . . . 0.0 110.782 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -64.86 -19.44 65.89 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.836 -1.165 . . . . 0.0 112.863 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.16 -50.01 69.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 126.118 1.818 . . . . 0.0 111.769 165.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -74.62 -25.58 59.32 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 125.046 1.339 . . . . 0.0 112.338 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -43.72 -54.77 9.97 Favored Pre-proline 0 N--CA 1.446 -0.669 0 C-N-CA 127.083 2.153 . . . . 0.0 112.094 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.15 -47.83 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.083 1.856 . . . . 0.0 110.557 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -59.88 -36.6 77.28 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.901 -1.047 . . . . 0.0 112.73 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.7 mt -60.75 -55.02 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 174.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -55.75 -45.85 77.96 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.389 0.675 . . . . 0.0 109.751 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.3 mtm -59.5 -52.74 64.27 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 123.403 0.681 . . . . 0.0 111.437 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -60.01 -40.05 87.91 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.983 -1.073 . . . . 0.0 111.589 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -70.03 -31.96 69.86 Favored 'General case' 0 C--O 1.229 -0.025 0 C-N-CA 123.588 0.755 . . . . 0.0 111.42 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 22.8 t80 -61.56 -50.91 70.73 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.722 1.209 . . . . 0.0 108.123 171.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.1 mt -72.43 4.54 3.69 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.959 1.703 . . . . 0.0 113.241 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -91.02 -6.37 54.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 117.722 -1.132 . . . . 0.0 110.773 168.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.79 107.05 1.28 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.329 1.422 . . . . 0.0 109.389 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -55.13 -20.76 10.92 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.983 1.313 . . . . 0.0 113.945 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -58.94 -23.57 61.62 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 121.248 1.84 . . . . 0.0 111.204 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.439 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 65.4 m-80 -64.85 -48.2 75.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 173.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.1 p -65.45 -37.36 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.088 1.313 . . . . 0.0 109.565 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.5 mt -65.72 -30.1 70.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.586 0.754 . . . . 0.0 110.036 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.22 -45.46 73.22 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.849 0.86 . . . . 0.0 111.23 170.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.23 -24.25 66.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.497 1.119 . . . . 0.0 111.15 -175.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mtm105 -55.15 -52.88 61.89 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.827 0.74 . . . . 0.0 109.929 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.5 m -54.95 -41.29 70.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.486 1.514 . . . . 0.0 110.245 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.5 mt -67.52 -35.58 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.243 -0.911 . . . . 0.0 110.111 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -60.67 -47.51 85.92 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.097 0.862 . . . . 0.0 110.774 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.0 p -68.07 -19.73 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 O-C-N 121.852 -0.53 . . . . 0.0 111.676 175.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.08 16.91 16.71 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.872 -1.143 . . . . 0.0 111.849 168.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.8 t -59.63 146.1 42.2 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 120.305 1.411 . . . . 0.0 107.717 171.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.38 -167.57 21.85 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.199 1.856 . . . . 0.0 112.082 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.15 155.95 47.98 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.067 1.845 . . . . 0.0 109.322 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 75.8 m -125.85 -179.85 4.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.039 1.336 . . . . 0.0 107.706 172.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.4 p -142.73 35.65 1.43 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.052 0.941 . . . . 0.0 108.846 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -176.101 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.791 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.7 t -156.4 122.76 5.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.689 1.595 . . . . 0.0 107.746 -174.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 t 58.09 112.14 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.854 2.462 . . . . 0.0 110.187 -163.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.12 109.4 0.4 Allowed Glycine 0 C--N 1.339 0.727 0 O-C-N 121.317 -0.864 . . . . 0.0 113.567 -167.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.3 m -63.87 -41.34 97.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.215 1.006 . . . . 0.0 113.322 170.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 32.71 51.59 0.26 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.871 2.068 . . . . 0.0 113.46 -172.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.5 157.37 29.71 Favored Glycine 0 C--N 1.335 0.498 0 O-C-N 120.618 -1.301 . . . . 0.0 112.441 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -144.01 94.26 2.56 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 174.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.76 -164.43 51.3 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 -169.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -56.27 171.42 0.88 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 123.361 2.707 . . . . 0.0 114.448 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.92 174.16 27.73 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 172.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.13 -168.77 1.82 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.061 2.144 . . . . 0.0 107.857 177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.446 ' HG2' ' H ' ' A' ' 14' ' ' GLU . 8.4 tt0 56.11 -153.98 0.33 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.88 1.272 . . . . 0.0 110.983 -176.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 15.7 pt-20 -112.12 142.83 44.09 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 169.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -150.91 179.48 8.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.234 1.014 . . . . 0.0 108.488 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -66.81 136.29 55.22 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.288 0.495 . . . . 0.0 110.505 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.5 mt -127.86 141.21 51.62 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.29 97.79 3.65 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.3 p -59.58 -36.32 76.01 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.175 -0.953 . . . . 0.0 112.173 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 -28.45 66.42 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.912 0.778 . . . . 0.0 110.998 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -77.79 -49.42 14.39 Favored 'General case' 0 C--O 1.215 -0.753 0 C-N-CA 125.188 1.395 . . . . 0.0 108.423 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.8 mt -56.32 -46.52 81.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.0 -53.17 59.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.533 -0.729 . . . . 0.0 110.492 174.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -57.45 -58.07 9.88 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.241 1.016 . . . . 0.0 111.174 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -56.39 -39.03 72.31 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.356 2.262 . . . . 0.0 111.02 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.8 t -63.73 -51.77 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 120.227 -1.546 . . . . 0.0 110.002 172.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -59.4 -43.67 92.93 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.84 -0.537 . . . . 0.0 110.348 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.58 -49.7 76.47 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.355 0.662 . . . . 0.0 109.918 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -54.91 -47.58 74.19 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.307 1.843 . . . . 0.0 113.645 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.7 mt -60.8 -43.51 98.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 121.12 -0.987 . . . . 0.0 108.479 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -41.81 99.28 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 120.026 1.285 . . . . 0.0 112.406 172.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -58.37 -39.91 80.86 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.763 2.825 . . . . 0.0 111.051 -173.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -115.07 13.23 16.84 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.246 0.619 . . . . 0.0 112.319 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.7 t30 38.7 77.2 0.05 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.189 2.596 . . . . 0.0 112.859 -170.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.0 149.89 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.499 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -89.57 142.56 16.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.905 0.764 . . . . 0.0 111.378 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -36.47 77.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.323 1.049 . . . . 0.0 112.874 -175.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -55.92 -57.32 12.57 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 119.211 0.914 . . . . 0.0 110.022 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -57.9 -44.06 85.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 118.518 0.599 . . . . 0.0 109.689 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -54.54 -50.61 67.5 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.679 -0.638 . . . . 0.0 112.005 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.57 -26.03 73.97 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-O 117.697 -1.613 . . . . 0.0 112.145 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -79.11 -32.09 44.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.649 1.725 . . . . 0.0 111.271 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -108.33 -44.95 4.0 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.238 1.015 . . . . 0.0 113.319 -174.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.01 -46.07 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.7 mt -98.05 -30.85 12.45 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.068 0.23 . . . . 0.0 111.489 -171.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.29 4.21 90.27 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 123.97 0.794 . . . . 0.0 112.662 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 73.4 mt -93.23 178.63 5.67 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.61 1.564 . . . . 0.0 109.512 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 p -72.75 159.65 33.47 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.655 -0.653 . . . . 0.0 109.701 169.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -51.95 -44.2 63.84 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.952 1.301 . . . . 0.0 109.378 167.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.4 -54.88 31.52 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.073 1.32 . . . . 0.0 111.697 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.2 m -56.46 -64.85 0.73 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 117.684 -1.15 . . . . 0.0 110.697 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.2 m -58.08 -36.82 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 120.524 1.511 . . . . 0.0 111.872 -172.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.2 m -62.91 -29.28 70.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.09 -1.433 . . . . 0.0 112.979 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.02 -48.71 77.61 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 120.363 1.438 . . . . 0.0 108.887 166.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.7 -42.6 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.9 mt -77.83 -27.27 49.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.784 0.834 . . . . 0.0 113.0 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.71 -41.91 61.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.067 1.347 . . . . 0.0 111.257 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.32 82.43 9.72 Favored Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 126.813 2.045 . . . . 0.0 107.352 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.49 95.66 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.648 2.232 . . . . 0.0 107.484 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -61.76 157.44 49.04 Favored Pre-proline 0 N--CA 1.443 -0.81 0 O-C-N 121.016 -1.052 . . . . 0.0 108.799 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.05 149.14 92.41 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 122.725 2.284 . . . . 0.0 108.536 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 66.4 t-105 -56.21 -44.05 79.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.524 0.602 . . . . 0.0 110.573 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -12.63 9.26 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.57 -7.05 45.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.713 1.605 . . . . 0.0 113.61 175.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.5 mt -106.4 151.14 25.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.622 0.769 . . . . 0.0 110.517 -173.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 p -85.68 179.06 7.16 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.218 1.007 . . . . 0.0 109.784 171.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 t -52.07 -43.46 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.199 -0.938 . . . . 0.0 111.339 165.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -63.91 -42.1 97.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 118.52 0.6 . . . . 0.0 109.981 175.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.88 -31.34 67.91 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-O 119.193 -0.782 . . . . 0.0 113.526 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -91.37 -18.55 24.1 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.733 1.613 . . . . 0.0 111.987 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -42.22 -56.33 5.52 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 127.05 2.14 . . . . 0.0 111.874 175.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -66.86 -45.05 4.68 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.502 1.468 . . . . 0.0 110.349 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -64.86 -34.42 78.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.316 -1.326 . . . . 0.0 112.517 -173.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.88 -53.94 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 120.068 1.304 . . . . 0.0 107.683 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -53.04 -45.79 68.18 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.757 0.823 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 69.9 mtm -63.44 -49.75 72.47 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.274 -0.891 . . . . 0.0 111.787 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.7 tttm -58.59 -40.56 83.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.02 -1.05 . . . . 0.0 110.343 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -64.77 -44.75 89.0 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.527 1.131 . . . . 0.0 110.23 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -52.38 -45.05 65.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.49 1.116 . . . . 0.0 110.919 173.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.8 mt -78.26 -9.72 59.35 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.819 1.248 . . . . 0.0 113.686 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.3 t -75.66 -11.99 60.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.762 0.825 . . . . 0.0 111.014 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -162.86 95.43 0.88 Allowed 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.989 -1.069 . . . . 0.0 108.279 -155.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.74 -29.34 18.21 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.904 1.282 . . . . 0.0 111.098 -173.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -54.25 -22.86 12.78 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.256 -1.527 . . . . 0.0 113.884 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -66.34 -44.52 83.06 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.447 1.021 . . . . 0.0 111.917 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.17 -36.6 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 120.572 -1.33 . . . . 0.0 109.755 -175.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -34.97 71.2 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.788 2.035 . . . . 0.0 110.521 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.83 -45.01 60.71 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.637 1.175 . . . . 0.0 111.978 172.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.57 -29.43 67.94 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 120.93 -1.106 . . . . 0.0 110.793 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.8 mtp-105 -61.76 -41.04 97.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 118.406 -0.807 . . . . 0.0 110.225 173.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -58.31 -45.63 87.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.267 1.394 . . . . 0.0 109.784 173.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.8 mt -60.16 -32.68 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.927 0.785 . . . . 0.0 109.886 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.499 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 11.5 tp-100 -72.54 -42.24 64.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.036 -1.04 . . . . 0.0 112.458 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.254 0.2 OUTLIER -68.05 -19.74 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 119.659 1.118 . . . . 0.0 110.763 170.606 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -85.88 -2.03 57.86 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.626 1.17 . . . . 0.0 113.288 170.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 45.5 t -66.75 -26.09 66.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.527 1.058 . . . . 0.0 112.17 -165.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.7 -168.85 32.21 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.44 87.48 0.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.959 2.439 . . . . 0.0 110.743 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.6 t 54.88 49.6 17.45 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.246 1.818 . . . . 0.0 112.317 168.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.1 m -52.54 -45.06 66.19 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -170.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -167.313 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.877 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.64 -67.51 0.48 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.488 1.144 . . . . 0.0 109.276 173.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -68.37 153.19 44.25 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.876 0.846 . . . . 0.0 110.154 175.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.0 158.07 42.01 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 159.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.1 t -63.83 -50.78 67.53 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.918 0.487 . . . . 0.0 110.937 -174.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t 50.53 175.26 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.772 0.829 . . . . 0.0 111.343 -144.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.52 163.26 2.75 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.974 1.274 . . . . 0.0 115.69 171.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 178.12 74.79 0.01 OUTLIER 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.47 2.308 . . . . 0.0 109.817 172.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.22 156.77 7.74 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.466 1.031 . . . . 0.0 112.47 160.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.51 113.18 3.05 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.949 2.433 . . . . 0.0 109.373 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.83 99.58 0.37 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 124.79 1.186 . . . . 0.0 111.395 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.64 -177.08 6.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.841 2.057 . . . . 0.0 110.36 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 57.33 -179.86 0.05 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.212 1.805 . . . . 0.0 113.421 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -105.8 114.45 28.61 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 162.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -112.51 -155.44 0.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.287 2.235 . . . . 0.0 109.508 -176.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -110.51 85.49 2.12 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 168.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.4 154.62 31.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.54 101.38 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.099 -1.001 . . . . 0.0 110.068 175.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.1 p -65.25 -40.98 94.7 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 120.679 -1.263 . . . . 0.0 112.689 -172.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.03 -29.53 70.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.836 0.744 . . . . 0.0 110.854 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -76.71 -50.95 12.41 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.498 2.319 . . . . 0.0 108.522 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt -56.83 -45.96 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.94 0.896 . . . . 0.0 109.119 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.85 72.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.986 -1.071 . . . . 0.0 110.696 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.406 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 51.5 t80 -54.19 -65.94 0.48 Allowed 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.917 1.287 . . . . 0.0 109.057 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -44.04 -44.31 7.32 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.687 1.995 . . . . 0.0 112.556 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.97 -43.94 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 O-C-N 121.345 -0.847 . . . . 0.0 111.283 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 41.9 mtmt -55.24 -35.56 65.1 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.561 1.073 . . . . 0.0 109.593 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -67.61 -56.58 8.87 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 123.36 0.664 . . . . 0.0 110.937 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -59.21 -39.38 82.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.582 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.42 -46.96 86.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 119.757 1.162 . . . . 0.0 108.091 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.18 -41.41 79.26 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.232 0.924 . . . . 0.0 111.472 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -53.98 -31.76 51.83 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.723 1.609 . . . . 0.0 114.072 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -119.77 7.21 10.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.95 1.3 . . . . 0.0 112.524 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m120 51.38 79.47 0.1 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 127.939 2.496 . . . . 0.0 111.226 -170.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.3 mt -119.64 137.27 54.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.638 0.732 . . . . 0.0 109.376 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.83 132.94 12.79 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 126.486 1.993 . . . . 0.0 109.805 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.429 HE21 HD11 ' A' ' 56' ' ' LEU . 8.1 mt-30 -54.01 -31.77 52.19 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.064 1.346 . . . . 0.0 113.265 -175.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -58.08 -48.56 79.78 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.576 -1.202 . . . . 0.0 111.341 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -60.27 -50.23 81.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 119.665 1.12 . . . . 0.0 108.839 -176.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -56.96 -40.59 76.75 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.656 -0.653 . . . . 0.0 111.665 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.23 -34.31 64.34 Favored Glycine 0 N--CA 1.437 -1.298 0 CA-C-O 117.596 -1.669 . . . . 0.0 111.592 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -70.02 -38.76 76.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.102 1.951 . . . . 0.0 110.548 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -97.61 -58.88 1.89 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.74 0.7 . . . . 0.0 112.667 -171.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.4 t -72.35 -47.13 54.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -172.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.2 mt -89.31 -40.34 12.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 119.075 -0.488 . . . . 0.0 110.667 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.47 22.01 71.21 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.766 -1.019 . . . . 0.0 111.753 -174.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.5 mt -110.62 160.05 17.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.424 1.89 . . . . 0.0 109.397 -174.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 m -63.72 152.6 38.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.575 1.15 . . . . 0.0 109.541 174.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -53.33 -43.06 67.35 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.11 0.964 . . . . 0.0 111.248 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.38 -10.4 80.02 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 118.076 -1.402 . . . . 0.0 113.368 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 m -68.26 -68.59 0.38 Allowed 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.869 1.835 . . . . 0.0 106.996 161.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -56.14 -37.7 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.449 1.477 . . . . 0.0 113.692 -171.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -42.84 94.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.859 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -47.01 74.83 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.448 1.022 . . . . 0.0 109.666 171.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.7 mt -60.12 -43.96 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.429 HD11 HE21 ' A' ' 37' ' ' GLN . 92.8 mt -70.85 -35.72 72.54 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.747 1.219 . . . . 0.0 111.802 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.92 -51.7 30.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.059 1.744 . . . . 0.0 110.509 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -133.36 81.87 54.22 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 124.693 1.197 . . . . 0.0 108.898 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -69.3 95.55 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.707 2.938 . . . . 0.0 108.443 171.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -62.0 156.55 57.16 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 171.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -61.73 152.53 73.6 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.551 2.167 . . . . 0.0 108.218 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -53.75 -47.63 70.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.634 0.774 . . . . 0.0 110.038 175.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 3.66 0.32 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 173.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 2.2 mmpt? -107.41 -13.83 15.01 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 119.759 -1.838 . . . . 0.0 112.983 167.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.6 mt -92.77 150.41 20.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 119.084 0.856 . . . . 0.0 109.145 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t -94.15 -179.96 5.12 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 167.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 t -49.76 -49.45 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.238 1.415 . . . . 0.0 111.306 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -64.72 -28.26 69.47 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 120.208 1.367 . . . . 0.0 112.386 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.0 -40.11 73.51 Favored Glycine 0 CA--C 1.527 0.783 0 O-C-N 120.99 -1.069 . . . . 0.0 112.41 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -77.18 -25.61 52.03 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 126.908 2.083 . . . . 0.0 112.068 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -41.64 -54.24 6.81 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 128.72 2.808 . . . . 0.0 112.116 -177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.67 -58.6 0.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.247 2.631 . . . . 0.0 111.28 173.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -56.19 -33.29 65.15 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -171.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.0 mt -58.01 -58.35 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -52.61 -52.13 56.81 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 124.588 1.155 . . . . 0.0 109.007 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -57.96 -48.64 79.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -58.89 -42.63 89.99 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -71.16 -32.9 69.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.513 0.725 . . . . 0.0 110.857 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -59.19 -46.58 88.05 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.975 1.31 . . . . 0.0 109.402 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.1 mt -66.57 -21.5 66.14 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.0 m -82.89 1.14 40.89 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.981 0.81 . . . . 0.0 112.644 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -148.38 99.04 2.98 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 120.348 1.431 . . . . 0.0 108.747 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -61.87 -22.03 65.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.574 0.75 . . . . 0.0 112.743 -168.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -57.29 -23.16 46.66 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.523 -1.36 . . . . 0.0 112.878 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -64.47 -47.31 79.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.195 0.907 . . . . 0.0 110.508 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.0 p -72.1 -31.98 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.404 -0.81 . . . . 0.0 110.506 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.9 mt -69.7 -23.01 63.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.781 0.832 . . . . 0.0 111.097 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.51 -36.05 29.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.808 0.843 . . . . 0.0 110.499 171.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.23 -38.04 86.95 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 120.664 -1.273 . . . . 0.0 110.601 -176.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -62.95 -35.49 80.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.212 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.0 m -54.7 -51.33 65.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.768 0.713 . . . . 0.0 109.507 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.69 -39.29 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 122.946 0.498 . . . . 0.0 110.357 -175.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -45.91 84.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.614 1.166 . . . . 0.0 111.502 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.291 0.2 OUTLIER -64.85 -38.58 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.832 1.196 . . . . 0.0 109.841 172.518 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -76.82 24.9 0.15 Allowed 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.426 1.091 . . . . 0.0 112.798 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.2 t -71.94 156.38 39.32 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 120.364 -1.46 . . . . 0.0 109.602 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.22 -165.57 46.05 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.64 87.32 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 124.399 3.399 . . . . 0.0 111.577 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.5 t -138.77 83.32 1.95 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.566 1.546 . . . . 0.0 108.814 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.4 t -147.8 -164.5 2.02 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 166.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 170.746 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.837 0 N-CA-C 105.759 -2.936 . . . . 0.0 105.759 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.76 163.56 3.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -153.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 p -149.3 -79.43 0.13 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.94 -179.7 41.18 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.8 m -155.4 174.89 14.59 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.793 1.637 . . . . 0.0 107.234 172.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.0 t 57.82 -160.44 0.25 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.792 0.837 . . . . 0.0 111.184 -172.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.4 106.31 1.38 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -170.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.1 -172.34 3.46 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.798 0.839 . . . . 0.0 111.569 -172.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.01 165.5 26.57 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 126.097 1.808 . . . . 0.0 110.575 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.9 167.75 14.25 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 124.504 3.47 . . . . 0.0 111.438 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.81 127.07 1.61 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 173.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.12 80.75 1.78 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.999 1.319 . . . . 0.0 108.04 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -145.12 174.32 11.16 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.964 1.706 . . . . 0.0 108.779 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -62.89 139.6 58.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 157.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -146.2 179.64 7.37 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 172.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -74.97 150.86 38.9 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.905 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.4 mt -137.18 149.62 47.36 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -175.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.76 100.78 8.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 174.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.0 p -62.94 -36.54 83.78 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.257 -0.902 . . . . 0.0 111.491 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.94 -24.67 61.66 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.824 1.193 . . . . 0.0 111.445 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -72.52 -55.67 6.59 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 173.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 53.4 mt -54.36 -51.39 49.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.95 -49.02 72.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.592 0.757 . . . . 0.0 111.604 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.409 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 66.2 t80 -55.97 -61.45 2.37 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 124.725 1.21 . . . . 0.0 109.419 175.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -52.86 -39.83 62.9 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.499 2.32 . . . . 0.0 112.08 -176.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.1 -51.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 121.455 -0.778 . . . . 0.0 109.661 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 45.8 mtmt -53.26 -39.55 63.95 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 116.811 -1.566 . . . . 0.0 110.642 175.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.93 -59.32 5.56 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.724 1.21 . . . . 0.0 110.671 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -62.16 -36.34 81.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.265 1.026 . . . . 0.0 111.574 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 mt -65.09 -51.62 60.35 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -55.9 -39.36 71.48 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.025 1.284 . . . . 0.0 112.014 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -51.33 -50.65 59.0 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.894 2.078 . . . . 0.0 109.786 -177.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -104.86 12.84 32.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.386 1.074 . . . . 0.0 111.458 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 t30 38.38 58.71 1.56 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 130.792 3.637 . . . . 0.0 112.011 -171.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 82.7 mt -93.01 156.8 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.413 1.485 . . . . 0.0 108.305 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.402 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -98.98 151.22 19.46 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.741 0.686 . . . . 0.0 112.202 -175.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -70.92 -30.12 66.36 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 117.825 -1.083 . . . . 0.0 113.752 -174.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -59.06 -59.14 5.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 120.357 1.435 . . . . 0.0 109.377 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.2 t -59.73 -43.46 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 123.478 0.486 . . . . 0.0 109.864 -174.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -56.18 -47.75 77.7 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.244 0.929 . . . . 0.0 110.973 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.93 -30.52 67.88 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-O 118.144 -1.364 . . . . 0.0 112.391 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -72.07 -29.97 64.66 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.165 1.482 . . . . 0.0 111.274 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -105.48 -68.87 0.84 Allowed 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.705 0.802 . . . . 0.0 111.122 -176.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.64 -38.59 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 123.301 0.64 . . . . 0.0 109.391 -169.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.0 mt -95.79 -42.03 8.55 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.47 32.77 67.86 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.3 mt -110.49 165.15 12.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.651 1.581 . . . . 0.0 107.111 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.61 161.65 30.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.706 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -46.6 86.85 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.637 0.775 . . . . 0.0 111.527 -171.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.85 -32.24 82.18 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.3 m -59.44 -65.56 0.65 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 118.169 -0.919 . . . . 0.0 108.576 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 m -59.65 -37.22 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 120.143 1.338 . . . . 0.0 112.893 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 t -57.47 -40.54 78.78 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.642 -0.661 . . . . 0.0 111.102 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.37 -45.13 95.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.468 0.707 . . . . 0.0 110.563 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.0 mt -60.28 -43.05 92.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -70.57 -35.89 73.3 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 123.743 0.817 . . . . 0.0 112.491 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.41 -45.71 79.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.308 1.043 . . . . 0.0 110.269 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -134.68 79.48 52.87 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 125.364 1.466 . . . . 0.0 109.336 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -72.03 103.96 1.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.733 2.289 . . . . 0.0 106.968 168.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -80.71 163.8 54.38 Favored Pre-proline 0 N--CA 1.443 -0.82 0 C-N-CA 125.335 1.454 . . . . 0.0 108.195 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -56.68 139.94 89.41 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.093 2.529 . . . . 0.0 108.83 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -50.65 -47.49 58.54 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.589 1.086 . . . . 0.0 110.537 173.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -21.38 32.83 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 176.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -77.74 -35.14 52.2 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.513 1.506 . . . . 0.0 110.418 177.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.4 mt -78.77 163.82 25.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.072 0.949 . . . . 0.0 108.756 -174.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.7 p -123.52 -177.33 3.69 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.449 1.9 . . . . 0.0 107.282 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.3 m -44.61 -53.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 121.855 2.116 . . . . 0.0 113.821 -170.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 -21.73 59.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.912 0.863 . . . . 0.0 112.844 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.25 -38.18 87.33 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.352 1.453 . . . . 0.0 112.624 165.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -90.58 -27.15 19.31 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.311 1.844 . . . . 0.0 112.204 -172.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -37.05 -58.39 1.12 Allowed Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 129.781 3.232 . . . . 0.0 111.282 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.47 -49.54 3.32 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.999 1.799 . . . . 0.0 110.431 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -58.93 -34.92 72.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.006 -0.997 . . . . 0.0 112.568 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.03 -54.52 33.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 119.423 1.01 . . . . 0.0 108.59 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -56.2 -50.52 70.99 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 124.224 1.009 . . . . 0.0 108.989 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 65.3 mtm -59.57 -48.97 79.56 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.856 -0.527 . . . . 0.0 111.991 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -58.4 -37.16 74.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.438 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -74.51 -38.1 62.93 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.086 1.312 . . . . 0.0 111.376 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.435 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 4.9 t80 -56.38 -40.06 73.96 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.556 1.142 . . . . 0.0 109.163 173.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.4 mt -73.46 -19.8 60.86 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 117.706 -1.14 . . . . 0.0 113.015 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.6 m -61.29 -32.44 72.28 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.642 1.565 . . . . 0.0 111.098 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -137.89 117.01 12.55 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.981 1.312 . . . . 0.0 108.549 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -57.86 -16.41 11.7 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.695 1.598 . . . . 0.0 112.84 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -57.78 -21.67 42.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 120.274 -1.516 . . . . 0.0 112.798 171.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.435 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 63.6 m-80 -70.43 -49.42 48.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.781 1.173 . . . . 0.0 110.813 177.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.24 -33.54 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 119.587 1.085 . . . . 0.0 110.572 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.4 mt -62.31 -43.47 98.74 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.92 -2.76 13.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.267 1.427 . . . . 0.0 113.851 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.86 -18.79 20.08 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.584 1.538 . . . . 0.0 115.145 167.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -65.96 -51.12 61.32 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.431 1.469 . . . . 0.0 111.484 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 m -53.99 -36.72 63.22 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 117.322 -1.323 . . . . 0.0 110.685 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.7 mt -64.62 -34.5 70.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 CA-C-N 120.622 1.556 . . . . 0.0 110.532 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.402 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 9.7 tp-100 -66.09 -44.62 83.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.113 -0.992 . . . . 0.0 110.662 -175.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.342 0.1 OUTLIER -67.48 -0.85 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 125.213 1.405 . . . . 0.0 111.939 170.658 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.7 mtt-85 -117.59 16.87 14.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.618 1.967 . . . . 0.0 111.644 170.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 46.6 p -66.57 170.94 5.54 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.651 1.114 . . . . 0.0 109.401 163.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -161.8 177.95 37.85 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -62.4 131.16 32.78 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.171 2.58 . . . . 0.0 108.697 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 72.0 m 40.4 71.41 0.19 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.093 1.357 . . . . 0.0 111.64 -172.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.38 90.64 0.24 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 168.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 C-N-CA 128.251 2.834 . . . . 0.0 106.419 -171.096 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.68 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -142.62 -51.16 0.37 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.386 1.093 . . . . 0.0 110.855 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.8 m -57.72 146.23 31.81 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 119.533 1.06 . . . . 0.0 112.031 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.07 33.79 0.76 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.837 2.16 . . . . 0.0 113.946 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.7 t -52.93 94.46 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.952 2.501 . . . . 0.0 108.347 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.7 m -164.46 95.23 0.73 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.078 1.751 . . . . 0.0 107.79 -171.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.53 152.43 16.63 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 173.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.0 100.45 3.82 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.536 1.534 . . . . 0.0 109.96 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.81 126.25 6.41 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 106.385 -2.686 . . . . 0.0 106.385 164.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -79.0 46.69 2.26 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 123.461 2.774 . . . . 0.0 111.29 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.63 126.12 24.05 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 125.759 1.647 . . . . 0.0 110.806 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.56 8.53 2.4 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.661 0.784 . . . . 0.0 112.992 -176.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -110.34 -178.0 3.39 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.527 1.058 . . . . 0.0 109.173 173.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.31 107.38 2.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 166.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -121.8 175.31 6.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.146 1.778 . . . . 0.0 110.607 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -80.77 90.79 5.85 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.844 0.858 . . . . 0.0 109.638 -169.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.3 mt -76.4 146.91 38.37 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.611 0.765 . . . . 0.0 109.016 178.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.45 100.98 10.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 122.373 1.082 . . . . 0.0 109.031 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 p -59.42 -47.77 84.18 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.138 1.375 . . . . 0.0 111.415 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.66 -24.2 66.59 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.553 0.741 . . . . 0.0 111.529 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -80.57 -55.75 4.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 117.454 -1.26 . . . . 0.0 108.588 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 57.0 mt -48.98 -51.82 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 120.03 1.287 . . . . 0.0 108.426 177.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.68 -49.15 65.86 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.632 1.173 . . . . 0.0 111.741 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -62.86 -50.76 69.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.814 0.846 . . . . 0.0 110.301 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -60.21 -39.52 86.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.773 1.229 . . . . 0.0 111.537 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.6 t -61.29 -49.73 83.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 O-C-N 120.902 -1.123 . . . . 0.0 108.82 172.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -59.99 -30.31 69.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 116.604 -1.665 . . . . 0.0 112.119 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.6 -65.25 0.71 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.514 1.506 . . . . 0.0 108.848 169.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -56.35 -39.71 73.3 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.66 1.184 . . . . 0.0 113.286 -171.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.8 mt -61.75 -51.03 70.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.58 -29.92 70.34 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.375 0.67 . . . . 0.0 112.276 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -57.95 -25.7 61.29 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.304 1.442 . . . . 0.0 111.645 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -128.34 16.51 6.59 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.074 1.35 . . . . 0.0 112.042 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 m120 35.88 70.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 128.478 2.711 . . . . 0.0 111.926 -167.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.0 mt -100.93 147.54 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.484 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -88.38 133.37 11.77 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -177.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -35.04 68.77 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.704 0.802 . . . . 0.0 112.987 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.4 ttt-85 -54.41 -54.68 37.44 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.299 0.64 . . . . 0.0 111.158 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.83 -47.93 87.81 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.13 -47.27 75.27 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.714 0.688 . . . . 0.0 111.229 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.4 -27.1 70.38 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-O 117.112 -1.938 . . . . 0.0 112.443 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -70.89 -45.41 64.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.061 2.431 . . . . 0.0 110.431 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -87.67 -67.84 0.8 Allowed 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 121.766 -0.584 . . . . 0.0 111.091 -170.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.45 -44.03 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -171.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.0 mt -99.06 -39.99 8.24 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.169 0.588 . . . . 0.0 111.983 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.91 50.36 53.23 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -172.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -129.12 167.84 16.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.648 1.979 . . . . 0.0 107.25 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 t -66.69 157.02 33.69 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.968 0.89 . . . . 0.0 109.629 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -59.89 -27.32 66.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.915 0.886 . . . . 0.0 111.445 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.04 -48.34 26.87 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -54.38 -63.7 1.07 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.601 1.16 . . . . 0.0 110.211 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -58.45 -39.01 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 119.294 0.952 . . . . 0.0 111.767 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -62.06 -38.43 88.73 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.24 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -59.41 -47.57 84.95 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.937 1.244 . . . . 0.0 108.993 169.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.6 mt -60.13 -41.56 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -70.13 -40.79 74.61 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 124.525 1.13 . . . . 0.0 111.537 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.77 -37.39 86.21 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.114 1.366 . . . . 0.0 110.747 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -139.16 70.38 40.97 Favored Pre-proline 0 C--O 1.235 0.295 0 C-N-CA 126.815 2.046 . . . . 0.0 107.658 -171.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.39 93.36 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.01 2.474 . . . . 0.0 107.609 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -67.11 160.36 71.19 Favored Pre-proline 0 N--CA 1.436 -1.157 0 O-C-N 121.736 -0.602 . . . . 0.0 109.557 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -58.44 144.65 96.41 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.367 2.044 . . . . 0.0 108.486 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.517 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 65.6 t-105 -52.77 -49.58 65.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.529 0.604 . . . . 0.0 110.734 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.6 -25.71 11.42 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 176.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.52 -18.74 47.57 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 120.005 1.275 . . . . 0.0 113.27 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.7 mt -86.95 162.57 17.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.451 0.643 . . . . 0.0 111.424 -169.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.6 p -94.04 -178.86 4.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.97 2.108 . . . . 0.0 109.892 168.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.4 m -58.57 -45.17 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 119.331 0.969 . . . . 0.0 111.724 169.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -60.31 -33.11 71.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 119.519 -0.276 . . . . 0.0 111.631 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.66 96.76 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.103 1.335 . . . . 0.0 112.516 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.517 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 91.1 mttt -79.61 -26.91 41.09 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.472 1.509 . . . . 0.0 112.934 -175.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -43.69 -57.8 5.33 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 125.892 1.677 . . . . 0.0 110.441 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.49 -43.49 13.58 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.727 1.618 . . . . 0.0 112.366 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -64.61 -36.45 84.27 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 120.273 -1.517 . . . . 0.0 112.24 -174.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.35 -55.28 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -51.52 -48.7 62.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.064 0.946 . . . . 0.0 110.204 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 62.7 mtm -61.86 -46.52 89.07 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 120.966 -1.084 . . . . 0.0 112.394 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -63.18 -39.65 95.26 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.07 -1.019 . . . . 0.0 110.936 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -67.2 -36.83 82.57 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.216 1.007 . . . . 0.0 110.107 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.2 t80 -61.21 -40.5 94.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.917 0.887 . . . . 0.0 110.517 174.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.4 mt -72.77 -8.82 57.28 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.346 1.058 . . . . 0.0 112.666 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.42 -13.1 59.42 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.871 1.269 . . . . 0.0 111.887 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -157.28 119.03 3.74 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.052 -1.03 . . . . 0.0 109.419 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -25.65 65.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.163 0.985 . . . . 0.0 113.645 -170.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -64.41 -18.64 64.9 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 119.705 -1.872 . . . . 0.0 111.909 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.453 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 55.2 m-80 -59.71 -48.52 81.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.826 0.739 . . . . 0.0 111.003 176.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 p -71.55 -33.82 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 121.811 -0.555 . . . . 0.0 109.87 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 mt -63.54 -42.4 98.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.87 73.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.057 0.39 . . . . 0.0 111.567 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.51 -24.64 62.87 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.947 0.899 . . . . 0.0 112.234 178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.5 mtp-105 -61.97 -47.89 82.84 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 118.827 0.74 . . . . 0.0 110.298 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.0 m -51.78 -46.83 64.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.899 0.88 . . . . 0.0 109.318 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 53.6 mt -64.86 -35.24 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 122.908 0.483 . . . . 0.0 110.277 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.484 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 6.5 tp-100 -63.41 -51.24 66.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 117.922 -1.037 . . . . 0.0 111.066 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.275 0.2 OUTLIER -60.3 -39.84 82.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 119.727 1.149 . . . . 0.0 109.69 175.214 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.505 ' HB3' HH11 ' A' ' 95' ' ' ARG . 0.0 OUTLIER -76.14 9.76 2.33 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.983 -1.008 . . . . 0.0 113.137 179.401 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.2 p -65.34 -18.22 65.14 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.999 1.727 . . . . 0.0 112.383 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.78 -161.6 10.24 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 127.552 2.501 . . . . 0.0 107.91 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -65.53 170.07 11.67 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.065 1.843 . . . . 0.0 110.2 168.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.9 m -112.96 -177.44 3.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.029 1.332 . . . . 0.0 110.022 173.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 p -141.76 134.59 28.72 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.223 1.409 . . . . 0.0 107.651 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.7 0 N-CA-C 105.46 -3.056 . . . . 0.0 105.46 154.219 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.844 0 CA-C-O 119.108 -0.829 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -27.0 114.68 0.06 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 129.473 3.109 . . . . 0.0 114.307 -170.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -160.2 153.61 22.19 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.048 1.739 . . . . 0.0 110.271 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.25 -164.67 32.52 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 126.263 1.887 . . . . 0.0 110.256 -176.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.5 m 62.78 89.81 0.08 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.422 1.889 . . . . 0.0 113.392 171.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.43 165.73 26.6 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.817 1.647 . . . . 0.0 107.295 161.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.46 33.19 0.05 OUTLIER Glycine 0 CA--C 1.527 0.821 0 CA-C-N 119.414 1.007 . . . . 0.0 113.849 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -126.82 163.88 22.61 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.941 1.37 . . . . 0.0 108.392 167.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.96 84.1 0.08 OUTLIER Glycine 0 CA--C 1.527 0.81 0 CA-C-O 118.73 -1.039 . . . . 0.0 111.276 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.25 -170.09 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.195 2.597 . . . . 0.0 110.748 168.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.7 104.66 0.2 Allowed Glycine 0 C--N 1.332 0.359 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.33 159.16 41.08 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.738 1.215 . . . . 0.0 110.123 167.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.252 15.0 tt0 36.85 -117.44 0.14 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.744 2.418 . . . . 0.0 111.049 178.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -107.39 122.43 46.59 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 155.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -133.02 177.94 7.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.268 0.627 . . . . 0.0 110.182 167.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -99.7 68.93 1.57 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.379 0.671 . . . . 0.0 109.234 -152.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mt -55.86 135.29 52.11 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.976 0.91 . . . . 0.0 110.77 -168.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.96 105.44 3.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.876 0.846 . . . . 0.0 109.399 177.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.432 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 19.2 p -68.72 -40.63 79.83 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.513 -0.742 . . . . 0.0 112.268 -177.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.83 66.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.928 0.785 . . . . 0.0 111.044 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -81.03 -52.78 7.04 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.319 1.448 . . . . 0.0 109.068 176.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.7 mt -56.13 -44.39 78.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 119.099 0.863 . . . . 0.0 109.916 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.57 85.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.551 0.74 . . . . 0.0 110.867 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.424 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 48.3 t80 -61.91 -53.92 49.11 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.078 0.951 . . . . 0.0 110.835 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -56.91 -38.98 73.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.114 1.365 . . . . 0.0 110.543 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.18 -50.76 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 120.68 -1.263 . . . . 0.0 109.81 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 40.9 mtmt -54.52 -48.22 72.18 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 116.991 -1.481 . . . . 0.0 110.726 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -47.41 71.44 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 116.944 -1.503 . . . . 0.0 111.402 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -56.37 -45.07 80.67 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 121.044 1.747 . . . . 0.0 112.48 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.2 -49.25 72.74 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.72 -33.49 70.26 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.454 1.025 . . . . 0.0 111.948 174.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -59.1 -20.27 51.96 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 126.114 1.766 . . . . 0.0 111.992 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -128.69 15.62 6.45 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 169.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 44.96 60.48 2.94 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 128.042 2.537 . . . . 0.0 111.765 -168.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.6 mt -98.32 154.05 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 174.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.54 150.8 18.09 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.921 0.772 . . . . 0.0 111.725 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -73.99 -14.36 61.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.96 1.304 . . . . 0.0 114.359 -177.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -70.97 -57.72 4.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.502 1.501 . . . . 0.0 109.973 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -56.0 -48.07 79.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -57.95 -41.31 82.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.758 1.163 . . . . 0.0 111.179 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.3 -26.54 67.96 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-O 117.184 -1.898 . . . . 0.0 112.58 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -74.32 -40.76 62.01 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.35 2.075 . . . . 0.0 110.658 173.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -90.93 -64.11 1.18 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.541 1.137 . . . . 0.0 111.803 -169.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.29 -36.85 74.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.3 mt -109.21 -43.86 4.06 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.062 0.545 . . . . 0.0 110.865 -166.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.45 31.79 53.35 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.093 0.854 . . . . 0.0 112.146 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.9 mt -109.08 159.39 16.91 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.578 1.551 . . . . 0.0 108.824 -175.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t -63.0 160.56 14.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.461 0.648 . . . . 0.0 110.114 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -54.11 -42.48 69.47 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.426 1.09 . . . . 0.0 112.528 -165.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.02 -10.01 57.81 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 118.427 -1.207 . . . . 0.0 113.637 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 m -62.4 -57.96 9.39 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.343 1.571 . . . . 0.0 108.99 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.31 -35.47 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.193 0.906 . . . . 0.0 112.081 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.6 t -59.28 -40.34 85.78 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.007 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.4 -46.49 88.53 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 119.311 0.96 . . . . 0.0 109.779 169.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.409 HG23 ' CZ ' ' A' ' 73' ' ' PHE . 1.7 mt -58.18 -30.41 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.114 1.325 . . . . 0.0 110.022 -176.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -87.73 -26.11 23.1 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.985 0.914 . . . . 0.0 113.122 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.98 -41.72 22.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.684 1.594 . . . . 0.0 110.798 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 mmt-85 -135.27 73.62 63.58 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 129.635 3.174 . . . . 0.0 106.367 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -69.68 95.25 0.54 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 N-CA-C 105.825 -2.414 . . . . 0.0 105.825 168.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -67.05 155.9 89.14 Favored Pre-proline 0 N--CA 1.432 -1.373 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.28 149.61 72.11 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.628 2.219 . . . . 0.0 109.889 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -51.21 -50.25 59.46 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.52 0.328 . . . . 0.0 110.261 172.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.24 2.1 0.63 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 176.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -98.76 -20.7 16.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.522 1.51 . . . . 0.0 112.014 167.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.6 mt -99.81 149.84 22.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.627 0.649 . . . . 0.0 109.629 -164.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.3 t -87.53 179.39 6.56 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.3 p -43.14 -58.54 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 124.693 1.197 . . . . 0.0 112.101 173.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.78 -17.0 63.79 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.85 -39.61 23.97 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 126.34 1.924 . . . . 0.0 112.953 167.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -83.5 -25.12 31.36 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.451 2.301 . . . . 0.0 111.961 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -45.78 -53.29 21.03 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 128.219 2.608 . . . . 0.0 111.61 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.17 -48.4 10.12 Favored 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 121.338 1.359 . . . . 0.0 109.851 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CZ ' ' HB ' ' A' ' 19' ' ' THR . 69.1 m-85 -63.35 -33.39 75.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.437 -174.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.8 mt -60.46 -54.51 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.969 1.259 . . . . 0.0 108.081 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -54.05 -51.42 64.1 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.803 0.841 . . . . 0.0 109.689 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.3 mtm -60.8 -47.04 88.14 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.833 0.853 . . . . 0.0 112.02 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -59.0 -38.79 80.01 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.953 -1.092 . . . . 0.0 110.492 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -71.05 -37.97 72.52 Favored 'General case' 0 C--O 1.227 -0.108 0 O-C-N 121.702 -0.624 . . . . 0.0 111.361 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.418 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 16.8 t80 -54.31 -42.96 70.71 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.664 1.186 . . . . 0.0 109.57 171.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.8 mt -74.89 -13.16 60.51 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.615 -0.678 . . . . 0.0 112.448 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 m -80.9 2.64 25.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.667 0.787 . . . . 0.0 112.294 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -157.3 132.3 8.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.984 1.266 . . . . 0.0 108.269 162.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.22 -26.59 60.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.793 0.837 . . . . 0.0 112.174 175.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -54.1 -28.6 40.37 Favored 'General case' 0 C--N 1.338 0.106 0 O-C-N 120.027 -1.671 . . . . 0.0 113.559 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.418 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 52.4 m-80 -64.9 -50.27 67.17 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 119.289 0.949 . . . . 0.0 110.135 177.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.64 -34.98 68.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 O-C-N 121.529 -0.732 . . . . 0.0 110.464 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.8 mt -59.68 -48.63 80.9 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.49 85.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 122.943 0.497 . . . . 0.0 111.666 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.85 -24.4 67.53 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.583 1.153 . . . . 0.0 111.683 -178.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -58.47 -49.12 78.49 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 119.048 0.84 . . . . 0.0 110.242 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 m -55.94 -44.8 78.75 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.098 0.408 . . . . 0.0 110.161 177.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.3 mt -63.07 -31.19 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.234 -0.917 . . . . 0.0 111.131 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -71.14 -31.64 67.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.376 0.67 . . . . 0.0 111.465 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -67.02 -39.96 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 119.554 1.07 . . . . 0.0 108.75 169.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 -76.62 11.93 1.47 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.759 1.623 . . . . 0.0 111.962 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.9 t -73.82 165.67 24.7 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.422 -1.424 . . . . 0.0 108.792 171.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.33 171.19 36.99 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.386 0.517 . . . . 0.0 113.551 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -63.28 -65.35 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.803 3.002 . . . . 0.0 112.13 -164.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.1 p 49.04 84.33 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.236 1.414 . . . . 0.0 111.802 -170.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.1 p -130.59 102.99 6.37 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.325 1.05 . . . . 0.0 108.403 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.327 0 N-CA-C 106.793 -2.523 . . . . 0.0 106.793 -162.124 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.059 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 m 65.36 175.21 0.21 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.647 1.179 . . . . 0.0 110.926 -169.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m 60.14 179.04 0.09 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.37 1.468 . . . . 0.0 111.801 -166.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 112.78 135.46 6.39 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -173.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.5 t -163.46 162.21 24.6 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 126.345 1.858 . . . . 0.0 106.115 167.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.6 m -158.86 161.81 36.9 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.369 1.068 . . . . 0.0 108.81 174.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.58 97.44 0.13 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -138.77 89.99 2.41 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.79 101.08 0.15 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-O 118.463 -1.187 . . . . 0.0 110.331 -174.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -77.88 38.34 0.67 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.685 3.59 . . . . 0.0 111.243 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.28 -123.56 14.54 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -169.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.23 101.98 0.96 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 128.353 2.661 . . . . 0.0 104.267 167.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.5 176.43 10.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 168.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.47 105.97 0.49 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 166.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -82.67 -168.19 1.93 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.009 1.323 . . . . 0.0 112.669 -176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -101.41 107.26 18.53 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.979 0.912 . . . . 0.0 108.728 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 mt -92.56 134.37 35.05 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -71.76 99.79 2.23 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 122.295 1.045 . . . . 0.0 108.572 176.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.401 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 24.2 p -59.57 -40.58 87.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.156 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.76 -31.05 72.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 119.102 -0.475 . . . . 0.0 111.908 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -74.96 -50.27 17.25 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.664 1.186 . . . . 0.0 108.907 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.2 mt -56.11 -47.39 80.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.31 92.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.269 -0.894 . . . . 0.0 111.987 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -62.92 -66.66 0.51 Allowed 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.461 1.504 . . . . 0.0 109.183 172.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -49.83 -38.67 35.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.24 1.816 . . . . 0.0 112.985 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 t -63.75 -43.53 98.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 121.293 -0.88 . . . . 0.0 110.25 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -60.44 -43.63 96.62 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.683 0.674 . . . . 0.0 109.413 175.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -57.01 -49.13 76.73 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.076 0.551 . . . . 0.0 110.467 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -63.25 -38.05 89.64 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.915 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mt -62.46 -43.07 99.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 120.515 1.507 . . . . 0.0 109.915 172.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.05 -45.33 79.29 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.992 0.815 . . . . 0.0 111.337 168.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -52.94 -40.81 63.93 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.626 1.97 . . . . 0.0 113.96 -168.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -121.83 16.19 10.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.963 1.305 . . . . 0.0 111.282 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 43.41 72.22 0.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.244 2.618 . . . . 0.0 111.561 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.3 mt -112.49 155.8 13.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.62 144.41 17.28 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 124.207 0.908 . . . . 0.0 110.935 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -62.52 -37.52 86.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.902 1.681 . . . . 0.0 112.194 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.8 ttt-85 -57.43 -54.51 46.06 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 117.66 -1.162 . . . . 0.0 109.822 173.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.3 -36.13 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.63 1.559 . . . . 0.0 111.338 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -61.11 -55.86 27.55 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.492 -0.755 . . . . 0.0 111.25 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.41 -26.31 74.67 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-O 118.008 -1.44 . . . . 0.0 112.458 -174.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -78.75 -27.81 44.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 120.083 1.942 . . . . 0.0 110.784 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -106.73 -62.25 1.42 Allowed 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.925 0.89 . . . . 0.0 112.049 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.57 -45.77 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.9 mt -94.99 -37.44 11.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.113 -174.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.18 2.66 90.58 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.682 0.658 . . . . 0.0 112.747 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.6 mt -89.77 168.18 12.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.048 1.424 . . . . 0.0 107.794 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.0 m -76.39 162.19 28.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.473 -0.767 . . . . 0.0 110.785 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -56.95 -46.9 81.8 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.667 0.787 . . . . 0.0 111.868 -172.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.49 73.12 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 119.57 -0.572 . . . . 0.0 112.022 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 m -65.41 -62.35 1.58 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.035 0.918 . . . . 0.0 109.454 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.69 -34.62 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 119.789 1.177 . . . . 0.0 112.041 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -57.0 -42.1 79.65 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.013 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.0 -44.91 87.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.48 0.582 . . . . 0.0 109.672 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 mt -62.28 -38.56 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -174.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.0 mt -83.98 -15.07 49.11 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.056 0.943 . . . . 0.0 112.771 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.7 -52.64 6.25 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.596 1.558 . . . . 0.0 108.525 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.9 81.45 58.0 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 127.972 2.509 . . . . 0.0 107.568 -173.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.43 101.83 0.91 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 N-CA-C 106.426 -2.182 . . . . 0.0 106.426 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -67.49 161.72 62.79 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -56.19 144.24 81.82 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.526 2.817 . . . . 0.0 109.505 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -52.11 -50.64 61.26 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.253 0.621 . . . . 0.0 109.808 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -17.91 12.57 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 175.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 1.9 mmpt? -82.84 -31.66 27.94 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.429 1.468 . . . . 0.0 111.103 174.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.6 mt -71.88 174.77 6.49 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.814 1.292 . . . . 0.0 111.591 -167.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 p -111.19 179.89 3.91 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.779 1.232 . . . . 0.0 108.135 167.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.7 m -52.67 -45.6 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.366 1.439 . . . . 0.0 113.02 169.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -66.4 -22.23 66.23 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.632 1.56 . . . . 0.0 111.888 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.42 -47.62 27.67 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 124.816 1.198 . . . . 0.0 111.548 171.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -71.95 -31.35 66.22 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.742 1.217 . . . . 0.0 111.398 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -42.8 -57.65 4.67 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 127.918 2.487 . . . . 0.0 111.109 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.5 -52.01 3.62 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.0 1.8 . . . . 0.0 110.594 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.401 ' CZ ' ' HB ' ' A' ' 19' ' ' THR . 57.3 m-85 -55.08 -38.08 67.62 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.938 1.244 . . . . 0.0 113.345 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.6 mt -58.74 -56.47 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 124.709 1.204 . . . . 0.0 107.993 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -56.91 -42.5 80.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.218 1.007 . . . . 0.0 109.679 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.4 mtm -65.14 -51.26 62.3 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 124.299 1.04 . . . . 0.0 112.336 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -62.29 -36.01 80.79 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.028 -1.045 . . . . 0.0 110.296 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -66.12 -42.07 89.69 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.807 -0.558 . . . . 0.0 109.85 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.423 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 14.5 t80 -57.39 -39.06 75.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.163 0.985 . . . . 0.0 110.068 175.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.5 mt -76.57 -12.27 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.7 m -83.17 -21.33 33.56 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.195 -0.941 . . . . 0.0 113.075 -174.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -132.72 130.09 39.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 170.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.15 -46.17 90.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.347 -171.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -53.95 -18.52 3.53 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.103 2.161 . . . . 0.0 113.321 -166.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.423 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 68.2 m-80 -53.81 -41.82 67.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.086 0.955 . . . . 0.0 111.658 170.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 p -73.35 -35.34 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 119.782 1.174 . . . . 0.0 110.97 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.514 HD22 ' H ' ' A' ' 87' ' ' LEU . 2.5 mm? -64.85 -26.77 68.48 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.436 1.094 . . . . 0.0 109.782 -175.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.45 60.22 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.396 1.078 . . . . 0.0 112.698 167.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -31.44 71.64 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.039 0.936 . . . . 0.0 110.768 -178.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.6 mtm105 -53.98 -42.79 69.37 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.274 0.488 . . . . 0.0 110.015 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.5 m -66.05 -43.36 87.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.646 0.778 . . . . 0.0 110.053 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.8 mt -69.03 -32.35 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.533 -0.73 . . . . 0.0 109.769 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -58.0 -42.83 86.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.728 -0.654 . . . . 0.0 110.931 174.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -30.99 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 119.171 0.896 . . . . 0.0 110.269 176.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -76.46 -4.77 44.32 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.31 1.044 . . . . 0.0 111.877 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 t -61.95 161.24 10.91 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.812 1.187 . . . . 0.0 111.157 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.39 -176.98 39.5 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.062 1.315 . . . . 0.0 109.961 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -81.86 51.54 3.86 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 125.29 3.994 . . . . 0.0 110.614 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.6 t -80.63 92.37 5.96 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.0 t -172.42 81.96 0.06 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.212 2.205 . . . . 0.0 105.457 -170.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.616 0 N-CA-C 105.464 -3.054 . . . . 0.0 105.464 166.998 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.343 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 t -159.46 -150.24 0.23 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.696 2.398 . . . . 0.0 106.022 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -4.84 -79.78 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 130.968 3.707 . . . . 0.0 113.084 171.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.88 174.19 33.42 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 121.472 -0.768 . . . . 0.0 113.14 172.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.3 m -133.36 21.43 4.01 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.078 1.351 . . . . 0.0 111.38 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 p -62.16 163.05 8.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 162.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.99 99.93 2.64 Favored Glycine 0 C--O 1.239 0.411 0 N-CA-C 106.309 -2.717 . . . . 0.0 106.309 -162.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -149.85 166.12 30.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.541 0.736 . . . . 0.0 110.612 175.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.23 93.31 0.26 Allowed Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.07 169.35 22.78 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 CA-C-N 119.921 1.86 . . . . 0.0 109.682 164.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.42 174.58 45.59 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.65 156.54 42.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 166.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' A' ' 14' ' ' GLU . 4.5 tt0 57.24 -179.17 0.05 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.745 1.218 . . . . 0.0 111.071 -167.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.442 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 31.9 tt0 -72.27 122.33 20.92 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 171.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -105.75 -168.15 1.41 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.904 1.282 . . . . 0.0 109.565 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -97.53 135.2 39.72 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.654 0.782 . . . . 0.0 109.216 172.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.8 mt -124.89 129.93 51.36 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -170.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.74 107.49 6.87 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 122.155 0.978 . . . . 0.0 110.256 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.5 p -63.11 -44.23 96.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.722 0.809 . . . . 0.0 110.555 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.63 -8.72 56.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.783 0.833 . . . . 0.0 111.732 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.42 -54.47 4.17 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.797 1.239 . . . . 0.0 108.904 167.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.7 mt -52.32 -50.72 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.204 1.366 . . . . 0.0 109.286 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.56 -33.29 65.98 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.24 1.016 . . . . 0.0 112.95 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -75.56 -57.86 3.63 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.128 0.971 . . . . 0.0 108.496 174.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -52.35 -32.76 39.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.339 1.456 . . . . 0.0 112.034 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.66 -57.09 10.73 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 C-N-CA 124.393 1.077 . . . . 0.0 110.729 170.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -51.52 -41.43 61.01 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.495 1.043 . . . . 0.0 111.116 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -53.11 -59.36 4.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.008 1.323 . . . . 0.0 110.128 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -62.03 -38.81 90.1 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.474 1.109 . . . . 0.0 113.351 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.1 mt -61.12 -48.09 83.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.08 -37.66 85.87 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.156 0.889 . . . . 0.0 112.856 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -55.87 -33.56 64.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.435 1.894 . . . . 0.0 110.674 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -123.49 11.31 9.24 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.286 1.034 . . . . 0.0 113.073 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 49.03 68.44 0.71 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.64 1.976 . . . . 0.0 112.136 -172.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt -112.23 156.29 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 121.264 -0.897 . . . . 0.0 110.047 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.56 130.71 10.44 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.958 2.218 . . . . 0.0 110.721 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -51.75 -35.79 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.42 1.488 . . . . 0.0 112.096 174.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -58.3 -54.28 48.75 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.773 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.62 -44.63 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -55.69 -51.78 66.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.636 0.255 . . . . 0.0 110.794 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.65 78.27 Favored Glycine 0 N--CA 1.428 -1.86 0 CA-C-O 116.338 -2.368 . . . . 0.0 111.563 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -78.31 -30.79 48.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.812 2.806 . . . . 0.0 111.956 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -101.56 -51.63 3.41 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 123.054 0.542 . . . . 0.0 111.384 -170.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.73 -46.29 24.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -175.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.0 mt -95.94 -34.53 11.77 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.924 -172.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.72 4.96 88.37 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.389 0.519 . . . . 0.0 112.913 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.5 mt -98.49 158.55 15.53 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.361 1.464 . . . . 0.0 107.41 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.6 m -71.64 164.43 25.92 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.433 -0.792 . . . . 0.0 110.239 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -58.56 -49.59 76.87 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.83 69.73 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.584 -0.564 . . . . 0.0 111.899 -178.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 m -70.88 -62.85 1.24 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.863 1.265 . . . . 0.0 111.357 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 m -60.07 -30.83 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 121.089 1.768 . . . . 0.0 112.273 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.7 t -58.06 -39.23 77.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.52 -1.229 . . . . 0.0 110.394 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.72 -43.28 85.13 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.023 1.283 . . . . 0.0 110.176 171.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mt -64.79 -42.59 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -173.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.2 mt -77.1 -29.57 54.92 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.465 0.706 . . . . 0.0 111.848 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.25 -56.41 6.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.746 1.618 . . . . 0.0 111.078 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -135.52 59.39 30.83 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 124.245 1.018 . . . . 0.0 109.708 -165.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -63.35 104.49 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.883 3.056 . . . . 0.0 110.281 -173.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -63.63 157.94 62.86 Favored Pre-proline 0 N--CA 1.434 -1.252 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -65.81 153.87 76.33 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.645 2.896 . . . . 0.0 110.471 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.464 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 73.4 t-105 -55.44 -43.85 75.78 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.368 1.067 . . . . 0.0 111.288 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.469 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -60.77 -19.98 60.43 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 176.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.55 -23.31 27.71 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.558 1.072 . . . . 0.0 112.327 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 29.6 mt -89.38 152.42 21.51 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 119.071 0.851 . . . . 0.0 109.302 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.8 p -105.07 -172.05 2.03 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.933 1.293 . . . . 0.0 109.666 172.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.1 t -47.7 -58.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 120.785 1.63 . . . . 0.0 110.49 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -71.68 -3.08 19.78 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.78 -42.35 6.08 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.881 1.705 . . . . 0.0 112.097 165.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.464 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 85.3 mttt -80.88 -25.04 37.89 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.895 2.078 . . . . 0.0 111.844 -174.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.33 -56.31 12.98 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 125.482 1.513 . . . . 0.0 111.328 -175.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.33 -44.53 18.36 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 121.423 1.416 . . . . 0.0 110.311 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -62.43 -37.46 85.92 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.993 1.269 . . . . 0.0 113.229 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.04 -49.38 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.634 1.106 . . . . 0.0 108.031 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -57.65 -53.29 59.9 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.664 0.786 . . . . 0.0 109.558 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 58.5 mtm -56.75 -50.55 71.91 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.4 0.68 . . . . 0.0 112.27 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tttp -61.72 -40.3 94.58 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.574 -0.704 . . . . 0.0 110.35 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -70.53 -32.06 69.37 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.327 0.967 . . . . 0.0 111.086 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -60.94 -43.23 98.97 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.8 mt -71.89 -9.88 58.97 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.194 0.997 . . . . 0.0 112.413 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.8 m -89.44 -2.35 58.36 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.297 1.439 . . . . 0.0 112.543 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -149.73 123.45 9.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 120.141 1.337 . . . . 0.0 109.35 163.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.98 -18.72 64.56 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.821 0.343 . . . . 0.0 111.283 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -68.35 -11.17 59.15 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 119.795 -1.816 . . . . 0.0 113.731 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -71.82 -57.08 4.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 167.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.41 -34.05 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 O-C-N 121.12 -0.987 . . . . 0.0 110.958 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.2 mt -65.22 -25.88 67.88 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.774 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.46 60.0 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.964 0.906 . . . . 0.0 110.967 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.31 -33.09 74.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.885 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -51.15 -50.58 58.64 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 118.706 0.684 . . . . 0.0 110.227 175.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.1 m -51.42 -50.12 60.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.768 1.227 . . . . 0.0 110.537 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.5 mt -62.94 -37.34 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.638 0.775 . . . . 0.0 109.902 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -62.15 -52.07 65.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.622 -0.674 . . . . 0.0 110.9 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.79 -27.12 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 118.593 0.633 . . . . 0.0 110.264 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -76.54 -3.57 38.19 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 117.88 -1.057 . . . . 0.0 113.155 175.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.0 p -57.82 -29.2 64.74 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.362 1.437 . . . . 0.0 113.186 -174.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.84 -172.73 41.35 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 121.163 -0.96 . . . . 0.0 111.152 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.41 160.47 39.12 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.706 2.937 . . . . 0.0 111.464 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.8 m 54.09 -178.05 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.655 1.182 . . . . 0.0 111.316 -171.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.4 p -154.69 -178.52 7.25 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 120.886 -1.134 . . . . 0.0 108.739 162.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.987 0 N-CA-C 105.752 -2.939 . . . . 0.0 105.752 163.913 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.524 ' HB3' HD11 ' A' ' 22' ' ' ILE . 5.2 mt . . . . . 0 C--O 1.238 0.494 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -72.94 104.17 3.99 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 122.004 0.906 . . . . 0.0 108.688 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 p -66.84 -38.21 85.97 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.457 0.703 . . . . 0.0 110.02 -173.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.07 -29.07 67.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.757 0.708 . . . . 0.0 110.899 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -76.09 -49.28 17.84 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 127.032 2.133 . . . . 0.0 108.836 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' A' ' 17' ' ' LEU . 82.1 mt -57.01 -47.0 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 119.078 0.854 . . . . 0.0 109.293 174.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.426 ' O ' ' HE3' ' A' ' 27' ' ' LYS . . . -56.46 -53.93 51.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.417 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -51.94 -67.79 0.22 Allowed 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.222 1.809 . . . . 0.0 109.245 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -51.72 -37.58 51.51 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.653 1.981 . . . . 0.0 112.945 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -62.94 -52.39 59.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 CA-C-N 119.183 0.901 . . . . 0.0 109.446 174.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 23' ' ' ALA . 22.0 mtmt -55.15 -42.55 73.23 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.418 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -57.66 -56.34 23.18 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.556 0.743 . . . . 0.0 110.775 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -62.19 -35.07 77.72 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.901 0.88 . . . . 0.0 112.589 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.38 -51.39 60.74 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -35.56 73.24 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.372 0.987 . . . . 0.0 112.399 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 tttt -49.95 -33.32 17.25 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 126.636 1.974 . . . . 0.0 110.869 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -128.18 16.29 6.69 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.936 1.294 . . . . 0.0 112.027 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.3 m120 60.16 36.03 21.08 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.878 2.471 . . . . 0.0 112.128 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.5 mt -83.33 157.7 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.36 144.84 16.65 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.923 1.249 . . . . 0.0 112.48 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -55.97 -35.24 66.5 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.943 2.097 . . . . 0.0 113.882 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -59.73 -58.98 6.21 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 120.47 1.486 . . . . 0.0 109.744 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 t -56.44 -44.43 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 119.256 0.934 . . . . 0.0 109.697 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -57.68 -49.7 75.63 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.538 0.608 . . . . 0.0 111.184 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.469 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -72.94 -24.99 74.93 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-O 118.093 -1.393 . . . . 0.0 111.887 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -77.95 -43.15 30.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 118.989 1.394 . . . . 0.0 109.632 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.422 ' CE1' HG21 ' A' ' 92' ' ' ILE . 36.3 m-85 -87.62 -68.19 0.77 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.654 0.381 . . . . 0.0 111.259 -177.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.7 t -62.79 -42.44 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 124.308 1.043 . . . . 0.0 108.268 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.445 HD21 ' HG2' ' A' ' 76' ' ' MET . 28.8 mt -96.08 -43.92 7.55 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.811 -172.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.23 20.16 57.62 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 123.798 0.686 . . . . 0.0 111.863 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -107.81 173.05 6.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.748 1.219 . . . . 0.0 107.9 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.4 m -68.59 159.54 31.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.055 -1.028 . . . . 0.0 111.539 166.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.42 -55.14 11.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.496 1.518 . . . . 0.0 110.337 168.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.53 -34.14 87.35 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 m -62.46 -64.6 0.88 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 116.842 -1.551 . . . . 0.0 110.176 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.469 HG11 ' HA3' ' A' ' 41' ' ' GLY . 3.9 m -60.2 -36.25 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 120.943 1.701 . . . . 0.0 111.867 -176.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.2 t -53.71 -42.33 67.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.585 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.25 -46.73 89.16 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 119.079 0.854 . . . . 0.0 109.805 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.446 HD13 HG21 ' A' ' 55' ' ' ILE . 6.7 mt -61.86 -38.08 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.1 mt -72.53 -32.8 66.41 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.878 1.271 . . . . 0.0 111.346 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.6 -52.3 27.33 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.19 1.396 . . . . 0.0 110.018 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -133.81 71.83 73.88 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 125.792 1.637 . . . . 0.0 108.436 -162.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.11 78.27 3.24 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.411 3.407 . . . . 0.0 110.584 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -54.77 157.13 5.75 Favored Pre-proline 0 N--CA 1.442 -0.859 0 C-N-CA 124.481 1.112 . . . . 0.0 110.306 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -55.34 143.8 74.88 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.132 2.555 . . . . 0.0 110.253 -172.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -55.11 -48.76 73.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.395 0.543 . . . . 0.0 109.935 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -26.28 32.52 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 172.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -34.62 45.87 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 119.703 1.138 . . . . 0.0 111.986 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.2 mt -77.73 148.02 35.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.959 0.885 . . . . 0.0 110.331 -171.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -82.54 178.16 8.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.848 1.659 . . . . 0.0 108.823 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.81 -47.64 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 120.883 1.674 . . . . 0.0 109.177 170.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -66.17 -8.74 25.93 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.878 -1.139 . . . . 0.0 113.724 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.43 -39.09 6.06 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 126.186 1.851 . . . . 0.0 111.655 169.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -78.6 -22.15 47.49 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.531 1.532 . . . . 0.0 111.565 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -44.94 -58.1 6.04 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 127.176 2.191 . . . . 0.0 110.681 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.59 -49.55 7.04 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.613 2.209 . . . . 0.0 111.562 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -60.09 -35.69 75.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 117.685 -1.15 . . . . 0.0 112.816 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.92 -54.41 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -56.42 -42.59 78.29 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.485 1.114 . . . . 0.0 110.69 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.445 ' HG2' HD21 ' A' ' 45' ' ' LEU . 71.1 mtm -67.47 -49.38 63.83 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.787 0.835 . . . . 0.0 111.984 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.494 ' HD2' HD22 ' A' ' 17' ' ' LEU . 15.6 tttm -64.12 -36.11 82.95 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.781 -1.2 . . . . 0.0 110.286 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -63.47 -42.84 98.6 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.397 1.479 . . . . 0.0 110.882 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.53 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 35.5 t80 -54.08 -51.57 63.69 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.684 1.193 . . . . 0.0 108.508 172.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.7 mt -68.51 -13.68 62.48 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m -72.45 -10.05 59.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.938 1.245 . . . . 0.0 112.178 172.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -154.46 115.96 4.13 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.715 1.143 . . . . 0.0 110.17 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -56.41 -26.81 54.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.504 1.522 . . . . 0.0 113.786 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -60.21 -25.05 65.31 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 120.321 1.419 . . . . 0.0 111.838 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.53 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 60.8 m-80 -59.53 -45.41 91.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.425 0.557 . . . . 0.0 110.972 176.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 p -71.39 -36.15 59.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 CA-C-N 118.543 0.611 . . . . 0.0 109.893 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.0 mt -63.13 -42.39 99.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.56 73.73 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.33 -25.78 66.99 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.154 -0.966 . . . . 0.0 111.771 176.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -61.74 -41.25 97.41 Favored 'General case' 0 C--O 1.228 -0.065 0 CA-C-N 119.223 0.919 . . . . 0.0 110.116 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.5 m -55.65 -46.52 77.46 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.689 1.196 . . . . 0.0 110.008 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.422 HG21 ' CE1' ' A' ' 43' ' ' TYR . 44.4 mt -64.19 -33.91 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.911 -0.493 . . . . 0.0 110.133 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 . . . . . 0 CA--C 1.537 0.473 0 O-C-N 121.152 -0.967 . . . . 0.0 113.088 178.922 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.566 ' HB3' HD11 ' A' ' 22' ' ' ILE . 5.0 mt . . . . . 0 C--O 1.234 0.271 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.1 107.61 1.32 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.121 0.486 . . . . 0.0 110.464 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.9 p -68.91 -39.56 79.62 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.707 -0.62 . . . . 0.0 111.976 -169.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.01 73.1 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.992 0.815 . . . . 0.0 110.191 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -78.09 -51.36 10.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.225 1.41 . . . . 0.0 108.463 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 17' ' ' LEU . 74.8 mt -55.94 -43.71 75.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 119.209 0.913 . . . . 0.0 109.095 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.28 -53.45 58.1 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.359 0.664 . . . . 0.0 110.397 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -55.85 -51.14 68.57 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.332 1.053 . . . . 0.0 111.263 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -64.59 -39.74 94.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.698 1.599 . . . . 0.0 110.708 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.6 t -60.85 -49.12 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 O-C-N 120.942 -1.098 . . . . 0.0 109.643 171.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -62.34 -46.18 89.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 117.929 -1.034 . . . . 0.0 111.075 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -64.21 -42.86 96.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.116 0.871 . . . . 0.0 111.223 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -58.1 -44.55 87.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.486 1.114 . . . . 0.0 111.481 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mt -63.55 -49.73 72.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -49.13 -43.51 41.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.509 0.724 . . . . 0.0 111.684 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -60.37 -21.7 62.45 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.469 1.508 . . . . 0.0 113.634 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -128.33 13.25 6.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.892 1.277 . . . . 0.0 113.329 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.5 m120 50.74 71.22 0.44 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.955 2.102 . . . . 0.0 111.561 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.0 mt -118.92 155.41 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 120.658 -1.276 . . . . 0.0 108.392 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.27 145.98 16.74 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.463 1.03 . . . . 0.0 111.177 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -56.89 -34.96 68.4 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.095 1.358 . . . . 0.0 111.69 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -51.78 -61.89 1.97 Allowed 'General case' 0 C--N 1.337 0.063 0 C-N-CA 123.784 0.834 . . . . 0.0 111.606 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.26 -46.68 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.921 0.782 . . . . 0.0 109.588 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -54.85 -46.7 74.71 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.029 0.831 . . . . 0.0 111.762 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.551 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -72.11 -30.95 64.58 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-O 118.25 -1.305 . . . . 0.0 111.752 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -69.81 -36.99 76.12 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.379 1.59 . . . . 0.0 110.54 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -96.22 -67.93 0.82 Allowed 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.999 0.92 . . . . 0.0 111.34 -173.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.7 t -62.68 -60.45 2.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -172.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.529 HD21 ' HG2' ' A' ' 76' ' ' MET . 24.0 mt -76.28 -36.62 58.3 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.929 -172.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.71 16.09 73.93 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.446 -1.196 . . . . 0.0 112.355 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.8 mt -110.64 166.41 11.03 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.239 1.815 . . . . 0.0 109.931 -171.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -60.21 152.61 24.26 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.536 0.684 . . . . 0.0 110.822 168.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -55.29 -38.9 69.22 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.088 1.355 . . . . 0.0 110.338 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.89 -63.95 4.83 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 m -42.4 -69.33 0.14 Allowed 'General case' 0 C--N 1.342 0.268 0 CA-C-O 117.065 -1.445 . . . . 0.0 110.8 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.551 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.2 m -57.75 -42.09 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 120.832 1.651 . . . . 0.0 112.951 -171.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.0 t -60.13 -38.6 83.57 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.286 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -60.08 -47.76 84.55 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.275 1.03 . . . . 0.0 109.868 168.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mt -56.57 -42.39 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.59 -27.52 41.12 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.614 1.166 . . . . 0.0 112.302 -176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.7 -44.5 56.37 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.495 1.518 . . . . 0.0 110.546 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -133.3 73.85 73.29 Favored Pre-proline 0 C--O 1.236 0.359 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 -172.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.46 87.76 1.06 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.174 1.916 . . . . 0.0 107.197 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -57.53 157.04 14.6 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.06 155.86 67.97 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 121.429 1.419 . . . . 0.0 109.23 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -55.33 -42.61 74.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.7 0.4 . . . . 0.0 111.195 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -9.86 40.27 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 175.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -93.58 7.11 45.94 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.314 -1.491 . . . . 0.0 112.922 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.6 mt -124.39 153.8 41.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.463 1.105 . . . . 0.0 108.479 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.1 p -100.56 -175.36 2.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.714 0.806 . . . . 0.0 109.001 172.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.2 t -45.38 -45.35 3.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 119.154 0.888 . . . . 0.0 110.897 169.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -70.48 -38.29 74.36 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.898 1.226 . . . . 0.0 112.873 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.64 -35.01 84.4 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.82 0.724 . . . . 0.0 112.079 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -90.67 -19.69 23.33 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 125.568 1.547 . . . . 0.0 111.723 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -43.28 -55.7 7.7 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 127.572 2.349 . . . . 0.0 109.384 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.61 -50.38 2.53 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.291 1.994 . . . . 0.0 111.354 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -58.0 -35.96 71.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 120.222 1.374 . . . . 0.0 113.702 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.6 mt -57.59 -60.3 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.591 1.556 . . . . 0.0 107.474 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -52.27 -52.04 55.02 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.421 1.089 . . . . 0.0 110.212 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.529 ' HG2' HD21 ' A' ' 45' ' ' LEU . 63.8 mtm -55.39 -51.59 66.34 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.694 0.797 . . . . 0.0 111.464 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -59.75 -38.75 82.62 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.196 -0.94 . . . . 0.0 111.226 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -65.98 -45.09 82.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.423 1.01 . . . . 0.0 110.427 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.455 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 19.6 t80 -49.31 -46.91 47.23 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.963 1.705 . . . . 0.0 110.301 172.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.1 mt -71.84 -13.82 61.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.32 1.11 34.06 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.809 1.644 . . . . 0.0 112.45 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -160.03 118.55 2.7 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.891 1.223 . . . . 0.0 108.635 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -63.1 -19.45 64.44 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.69 1.196 . . . . 0.0 111.781 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -57.23 -30.05 64.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 120.157 -1.589 . . . . 0.0 112.054 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 75.1 m-80 -65.42 -38.21 89.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 119.018 -0.515 . . . . 0.0 110.174 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.83 -34.77 23.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 119.258 0.936 . . . . 0.0 110.317 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.9 mt -63.14 -40.77 98.56 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 123.261 0.624 . . . . 0.0 109.858 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.47 92.89 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.98 0.512 . . . . 0.0 111.252 173.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.482 HD22 HD12 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -65.46 -26.31 67.89 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.08 0.952 . . . . 0.0 112.2 -177.121 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -61.68 -45.19 95.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 118.489 0.586 . . . . 0.0 109.561 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.9 m -49.77 -50.05 46.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.215 1.006 . . . . 0.0 109.442 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.482 HD12 HD22 ' A' ' 89' ' ' LEU . 46.0 mt -65.57 -37.44 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.771 -173.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.48 175.542 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.53 HD22 ' HD2' ' A' ' 77' ' ' LYS . 3.3 mt . . . . . 0 C--O 1.236 0.364 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.41 101.46 4.8 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 122.291 1.043 . . . . 0.0 109.256 171.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.0 p -62.95 -38.96 93.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.586 -0.696 . . . . 0.0 111.477 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.77 70.72 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.107 0.867 . . . . 0.0 111.9 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -75.39 -53.05 9.35 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.357 1.463 . . . . 0.0 108.124 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 17' ' ' LEU . 72.0 mt -55.34 -44.02 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.35 0.66 . . . . 0.0 109.306 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.26 -47.88 83.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.406 0.682 . . . . 0.0 111.008 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.422 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 27.5 t80 -60.68 -50.22 74.38 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.329 1.052 . . . . 0.0 110.345 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -59.69 -45.4 92.2 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.746 1.618 . . . . 0.0 110.327 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.95 -50.83 78.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 O-C-N 120.424 -1.422 . . . . 0.0 109.077 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 50.0 mtmt -54.99 -41.88 71.76 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.455 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.41 -36.71 68.71 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 117.471 -1.252 . . . . 0.0 113.336 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.423 ' HB3' HG21 ' A' ' 86' ' ' VAL . 4.6 mm-40 -62.3 -41.23 98.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.415 1.916 . . . . 0.0 111.608 174.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.27 -44.71 95.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.21 -0.932 . . . . 0.0 108.54 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -58.07 -48.04 81.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 171.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -55.56 -30.3 60.54 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 127.051 2.141 . . . . 0.0 111.791 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -128.27 11.91 6.47 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.62 64.27 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.779 2.032 . . . . 0.0 112.111 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -107.63 150.84 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.8 135.3 13.83 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.79 1.186 . . . . 0.0 110.876 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -54.07 -37.37 64.13 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.609 0.764 . . . . 0.0 110.552 169.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -54.05 -64.48 0.81 Allowed 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.409 -1.281 . . . . 0.0 111.198 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t -52.74 -48.12 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 120.141 1.337 . . . . 0.0 110.07 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -55.3 -46.4 76.22 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.431 0.56 . . . . 0.0 111.88 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.536 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -73.39 -34.64 57.29 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-O 118.081 -1.4 . . . . 0.0 111.597 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.92 -32.23 73.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 119.331 1.565 . . . . 0.0 109.505 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.414 ' CE1' HG21 ' A' ' 92' ' ' ILE . 40.7 m-85 -103.15 -72.57 0.69 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.563 1.145 . . . . 0.0 111.907 -175.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.75 -43.85 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -168.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.527 HD21 ' HG2' ' A' ' 76' ' ' MET . 28.7 mt -96.48 -33.4 11.87 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -171.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.03 30.32 38.64 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 123.439 0.462 . . . . 0.0 112.017 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.7 mt -125.07 157.8 35.37 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.765 1.283 . . . . 0.0 110.464 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.8 t -60.39 160.48 8.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.683 1.193 . . . . 0.0 110.367 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.82 -55.82 26.07 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.342 1.057 . . . . 0.0 110.886 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.18 -30.42 75.61 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-O 119.095 -0.836 . . . . 0.0 111.711 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.9 m -58.84 -57.81 11.4 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 116.832 -1.556 . . . . 0.0 109.856 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.536 HG11 ' HA3' ' A' ' 41' ' ' GLY . 3.0 m -66.78 -36.69 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 121.857 2.117 . . . . 0.0 113.617 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.1 t -62.43 -31.22 71.9 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.694 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -59.81 -49.72 76.61 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.857 1.208 . . . . 0.0 110.964 164.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 mt -55.44 -43.94 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.062 0.846 . . . . 0.0 108.986 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -79.3 -13.72 59.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.501 1.121 . . . . 0.0 112.861 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.86 -58.07 2.68 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.717 1.607 . . . . 0.0 109.905 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 mtp85 -124.64 78.29 63.47 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 125.089 1.355 . . . . 0.0 107.876 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.33 93.76 0.75 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.07 2.513 . . . . 0.0 107.523 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -63.26 165.85 9.98 Favored Pre-proline 0 N--CA 1.436 -1.146 0 C-N-CA 123.79 0.836 . . . . 0.0 110.266 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -56.13 142.45 86.37 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.611 2.207 . . . . 0.0 110.331 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -53.3 -47.31 69.32 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.964 0.802 . . . . 0.0 109.804 173.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -20.31 33.87 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 174.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -85.15 -24.37 28.0 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.874 1.215 . . . . 0.0 111.77 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.6 mt -86.38 167.34 14.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.42 0.688 . . . . 0.0 109.155 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.5 p -129.12 -172.25 2.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 117.081 -1.437 . . . . 0.0 108.62 172.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.5 t -43.58 -56.43 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 120.756 1.616 . . . . 0.0 111.63 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -74.51 -15.87 60.86 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.234 -1.541 . . . . 0.0 113.665 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.68 -42.42 47.01 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.374 1.464 . . . . 0.0 111.45 167.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -85.81 -26.13 25.91 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 127.045 2.138 . . . . 0.0 111.669 -173.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -42.15 -57.28 4.48 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 127.817 2.447 . . . . 0.0 111.475 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.07 -49.71 4.6 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.531 1.487 . . . . 0.0 109.69 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -57.23 -39.38 75.42 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.654 -1.165 . . . . 0.0 112.976 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.3 mt -57.69 -55.52 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.559 1.144 . . . . 0.0 108.367 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -59.51 -45.06 92.79 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.032 0.533 . . . . 0.0 109.592 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.527 ' HG2' HD21 ' A' ' 45' ' ' LEU . 67.0 mtm -57.8 -50.08 74.47 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 123.505 0.722 . . . . 0.0 111.07 175.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.53 ' HD2' HD22 ' A' ' 17' ' ' LEU . 19.1 tttm -59.8 -44.1 94.12 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.794 -0.566 . . . . 0.0 110.278 -175.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -73.82 -28.04 61.42 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.298 -0.876 . . . . 0.0 112.133 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.443 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 34.3 t80 -60.87 -53.15 60.82 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.926 1.291 . . . . 0.0 107.943 169.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.0 mt -64.82 -22.4 66.98 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.319 1.047 . . . . 0.0 113.307 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.9 m -62.8 -21.58 65.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.914 1.234 . . . . 0.0 111.0 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -143.99 115.8 8.25 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.112 1.323 . . . . 0.0 109.947 -173.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.7 -18.56 64.13 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.569 1.148 . . . . 0.0 111.861 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -64.68 -21.14 66.67 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.482 -2.011 . . . . 0.0 112.181 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.443 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 69.9 m-80 -67.36 -53.36 30.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.854 1.206 . . . . 0.0 110.053 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 29' ' ' GLN . 12.5 p -60.87 -35.09 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.033 -1.042 . . . . 0.0 111.133 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.58 -34.66 78.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.661 0.664 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.45 81.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 111.533 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.95 -26.02 68.4 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.399 -0.813 . . . . 0.0 110.873 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 mtp-105 -60.18 -50.89 71.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 118.529 0.604 . . . . 0.0 110.581 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.0 m -50.06 -45.69 52.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.032 0.833 . . . . 0.0 110.163 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.414 HG21 ' CE1' ' A' ' 43' ' ' TYR . 66.1 mt -64.51 -32.97 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.871 -0.518 . . . . 0.0 111.117 -178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 . . . . . 0 N--CA 1.452 -0.355 0 O-C-N 121.186 -0.946 . . . . 0.0 111.373 177.156 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--O 1.233 0.205 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -69.75 98.38 1.2 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.052 0.453 . . . . 0.0 110.03 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 p -63.38 -41.15 98.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.529 -0.732 . . . . 0.0 111.818 -175.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.02 77.74 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.847 0.749 . . . . 0.0 111.334 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -75.12 -47.89 26.42 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 126.218 1.807 . . . . 0.0 108.653 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.3 mt -55.08 -50.86 59.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.51 -52.17 62.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.64 0.776 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -52.52 -69.79 0.1 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 126.533 1.933 . . . . 0.0 108.666 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -49.8 -40.41 41.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.645 1.978 . . . . 0.0 112.897 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 40' ' ' PHE . 67.2 t -64.75 -51.43 67.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 118.976 0.807 . . . . 0.0 109.645 174.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -49.85 -38.34 34.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.356 0.98 . . . . 0.0 109.785 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.93 -53.63 43.36 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.466 1.03 . . . . 0.0 111.68 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.64 -43.88 80.72 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.366 0.53 . . . . 0.0 111.142 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.9 mt -63.36 -43.46 97.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -27.81 69.29 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.446 1.021 . . . . 0.0 112.69 174.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -59.73 -32.81 70.9 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.822 1.249 . . . . 0.0 111.419 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -128.42 16.72 6.53 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.387 1.475 . . . . 0.0 112.196 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 39.75 75.59 0.08 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 128.783 2.833 . . . . 0.0 112.417 -169.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.4 mt -110.05 147.54 14.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 121.386 -0.821 . . . . 0.0 109.826 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.05 127.75 8.4 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -58.45 -29.6 66.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.748 0.819 . . . . 0.0 111.242 171.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -55.6 -53.98 49.73 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 117.789 -1.101 . . . . 0.0 111.508 167.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -60.18 -51.27 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 119.526 1.057 . . . . 0.0 109.114 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.43 ' CE2' HG11 ' A' ' 26' ' ' VAL . 89.3 t80 -54.38 -46.48 73.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.325 0.511 . . . . 0.0 111.347 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.464 ' CA ' HG11 ' A' ' 52' ' ' VAL . . . -71.08 -34.97 64.52 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-O 117.417 -1.768 . . . . 0.0 111.967 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -64.49 -29.67 70.71 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 120.398 2.099 . . . . 0.0 110.887 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.414 ' CE1' HG21 ' A' ' 92' ' ' ILE . 38.8 m-85 -106.63 -78.73 0.58 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.458 1.103 . . . . 0.0 111.654 -172.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 74.1 t -56.5 -38.75 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 125.531 1.532 . . . . 0.0 109.363 -170.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.429 HD21 ' CG ' ' A' ' 76' ' ' MET . 37.6 mt -102.19 -33.24 9.72 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.582 -0.723 . . . . 0.0 110.853 -173.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.74 30.59 61.54 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.52 168.66 10.47 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.078 1.351 . . . . 0.0 109.175 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.0 163.6 27.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.456 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -59.56 -46.76 87.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.414 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.42 -30.96 77.49 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.001 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.6 m -61.03 -67.06 0.44 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.832 0.816 . . . . 0.0 109.328 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.464 HG11 ' CA ' ' A' ' 41' ' ' GLY . 3.0 m -58.66 -35.77 56.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-N 119.893 1.224 . . . . 0.0 112.438 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.3 t -54.95 -43.36 73.36 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.369 1.068 . . . . 0.0 111.708 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -57.36 -49.37 76.37 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 120.084 1.311 . . . . 0.0 110.106 168.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.3 mt -58.95 -39.64 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.6 mt -76.76 -29.56 56.17 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.901 1.281 . . . . 0.0 112.413 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.33 -57.58 4.69 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.652 1.581 . . . . 0.0 109.997 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -123.57 84.6 53.07 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 125.604 1.562 . . . . 0.0 107.399 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 84.04 1.4 Allowed 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 122.245 1.963 . . . . 0.0 107.525 171.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.412 ' HB2' HD21 ' A' ' 65' ' ' LEU . 14.3 mtpt -59.41 153.27 50.08 Favored Pre-proline 0 N--CA 1.436 -1.161 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 60' ' ' LYS . 36.0 Cg_endo -67.01 147.54 80.16 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.296 1.997 . . . . 0.0 107.363 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -51.93 -38.94 58.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.127 0.571 . . . . 0.0 111.143 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -28.11 69.05 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -26.79 62.37 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.789 -1.195 . . . . 0.0 111.633 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 60' ' ' LYS . 70.6 mt -83.79 167.16 17.36 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.456 0.646 . . . . 0.0 110.526 -168.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.2 p -117.78 -171.61 2.09 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.689 2.395 . . . . 0.0 109.533 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.7 p -47.16 -63.41 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.648 1.113 . . . . 0.0 111.543 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -72.94 -10.35 59.71 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.43 -52.12 32.89 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.157 -0.964 . . . . 0.0 110.707 162.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -87.54 -23.83 24.24 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 126.016 1.727 . . . . 0.0 112.298 -166.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -44.55 -55.6 9.95 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 126.334 1.854 . . . . 0.0 111.669 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.46 -45.86 13.52 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.498 1.466 . . . . 0.0 110.835 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -61.19 -38.23 85.8 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.88 1.218 . . . . 0.0 113.044 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.6 mt -55.61 -54.44 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -58.77 -50.66 73.1 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.931 1.292 . . . . 0.0 110.516 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.429 ' CG ' HD21 ' A' ' 45' ' ' LEU . 58.0 mtm -55.52 -47.89 75.53 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.135 0.974 . . . . 0.0 111.974 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -61.64 -46.03 91.51 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.94 -0.475 . . . . 0.0 110.263 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -61.26 -42.53 98.8 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.666 0.787 . . . . 0.0 111.198 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.466 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 44.6 t80 -53.17 -38.39 62.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.033 1.733 . . . . 0.0 110.719 175.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.2 mt -73.71 -23.75 59.83 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.378 -0.826 . . . . 0.0 113.082 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -77.97 0.25 25.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 120.134 1.334 . . . . 0.0 113.069 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -145.52 115.22 7.28 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 125.391 1.476 . . . . 0.0 107.173 170.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -69.49 -15.64 63.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.556 0.342 . . . . 0.0 111.816 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -67.06 -16.48 64.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 120.294 -1.504 . . . . 0.0 112.353 174.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.466 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 75.2 m-20 -66.51 -47.38 73.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 119.61 1.096 . . . . 0.0 109.591 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.8 -30.86 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 120.665 -1.272 . . . . 0.0 111.299 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.35 -24.04 64.76 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.753 -0.592 . . . . 0.0 110.808 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.6 -39.47 31.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.21 -0.931 . . . . 0.0 111.381 168.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.81 -29.76 68.18 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.013 -1.68 . . . . 0.0 110.5 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -66.6 -36.75 83.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.394 0.997 . . . . 0.0 111.672 169.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.3 m -56.01 -36.65 68.17 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.743 0.817 . . . . 0.0 110.167 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.414 HG21 ' CE1' ' A' ' 43' ' ' TYR . 69.0 mt -80.24 -29.29 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.701 1.6 . . . . 0.0 111.494 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? . . . . . 0 C--N 1.329 -0.326 0 O-C-N 120.578 -1.326 . . . . 0.0 109.646 -179.303 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.738 HD22 ' HD2' ' A' ' 77' ' ' LYS . 9.2 mt . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.58 104.56 17.03 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.452 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 21.2 p -59.77 -40.97 89.99 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.344 -0.847 . . . . 0.0 111.51 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.21 75.07 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.182 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.27 -52.24 20.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.91 1.284 . . . . 0.0 108.337 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 85.2 mt -52.9 -49.48 48.11 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.83 63.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.259 0.624 . . . . 0.0 110.355 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -55.81 -57.75 10.74 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.939 1.296 . . . . 0.0 110.486 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -49.75 -51.54 38.28 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 127.391 2.276 . . . . 0.0 111.688 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.472 HG11 ' CE2' ' A' ' 40' ' ' PHE . 72.3 t -63.58 -44.04 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.906 -1.121 . . . . 0.0 109.015 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -57.47 -37.56 73.1 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.589 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.58 -54.67 36.23 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.948 1.299 . . . . 0.0 110.551 174.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -61.45 -43.1 99.46 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.978 1.311 . . . . 0.0 111.513 -173.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.58 -46.6 78.8 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -43.92 65.71 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.569 0.748 . . . . 0.0 111.123 173.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -50.47 -44.44 55.74 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 126.364 1.865 . . . . 0.0 111.684 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -112.76 9.42 19.11 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.993 0.917 . . . . 0.0 112.297 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 46.62 71.76 0.28 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.428 2.291 . . . . 0.0 112.183 -166.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.2 mt -111.22 151.02 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 172.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.57 142.13 15.42 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -57.74 -31.59 66.62 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.674 1.59 . . . . 0.0 113.345 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ttp-105 -56.41 -59.38 5.05 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 120.029 1.286 . . . . 0.0 109.691 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -58.98 -47.27 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -176.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.472 ' CE2' HG11 ' A' ' 26' ' ' VAL . 93.2 t80 -55.46 -47.15 76.53 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.831 0.741 . . . . 0.0 111.725 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.441 ' CA ' HG11 ' A' ' 52' ' ' VAL . . . -71.5 -33.72 63.84 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-O 117.797 -1.557 . . . . 0.0 111.806 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -69.88 -33.08 71.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.635 1.718 . . . . 0.0 110.524 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -96.73 -76.98 0.5 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.048 0.939 . . . . 0.0 111.217 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.55 -40.48 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 124.729 1.212 . . . . 0.0 109.151 -170.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.426 HD21 ' HG2' ' A' ' 76' ' ' MET . 25.3 mt -93.9 -46.79 7.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 123.758 0.661 . . . . 0.0 109.803 -173.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.01 19.08 48.39 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.636 0.636 . . . . 0.0 112.691 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.0 mt -114.42 164.96 13.24 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.501 1.52 . . . . 0.0 108.988 -172.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 m -62.08 156.58 21.09 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.167 0.508 . . . . 0.0 110.841 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -56.92 -34.82 68.35 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.075 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.04 -62.05 5.55 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.8 m -43.91 -66.77 0.34 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.942 1.697 . . . . 0.0 112.522 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.441 HG11 ' CA ' ' A' ' 41' ' ' GLY . 3.2 m -57.09 -38.83 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 120.283 1.401 . . . . 0.0 111.674 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 m -61.6 -41.28 97.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.858 -1.068 . . . . 0.0 110.818 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.82 -45.84 78.25 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.629 1.104 . . . . 0.0 110.007 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.489 HD13 HG21 ' A' ' 55' ' ' ILE . 32.8 mt -57.52 -46.46 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -177.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.27 -31.8 64.29 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.97 1.708 . . . . 0.0 112.656 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.9 -47.4 71.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.934 1.694 . . . . 0.0 110.096 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mtp-105 -137.94 82.98 24.37 Favored Pre-proline 0 C--O 1.239 0.506 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -63.75 102.63 0.36 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.103 2.535 . . . . 0.0 108.34 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -63.06 157.39 62.24 Favored Pre-proline 0 N--CA 1.429 -1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.523 167.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.82 151.96 36.5 Favored 'Trans proline' 0 N--CA 1.441 -1.572 0 C-N-CA 122.64 2.227 . . . . 0.0 107.428 -172.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.522 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 62.0 t-105 -51.78 -41.93 62.02 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.692 0.797 . . . . 0.0 111.532 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.428 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -65.25 -23.09 66.96 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.336 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 5.0 mmpt? -74.06 -25.76 60.02 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 120.23 1.377 . . . . 0.0 111.72 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.4 mt -93.25 153.28 18.68 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.162 0.892 . . . . 0.0 110.34 -158.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.8 t -90.38 -179.97 5.73 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 171.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.45 -42.65 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 O-C-N 120.999 -1.063 . . . . 0.0 112.419 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -69.8 -14.9 62.99 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.755 -1.216 . . . . 0.0 113.585 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.77 -37.43 26.32 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 125.45 1.5 . . . . 0.0 110.936 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.86 -25.92 40.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 117.847 -1.073 . . . . 0.0 112.344 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -43.83 -60.98 2.2 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 125.691 1.596 . . . . 0.0 110.445 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.28 -45.49 15.17 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 121.394 1.396 . . . . 0.0 110.032 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.452 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 64.2 m-85 -64.04 -35.25 80.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 119.752 1.16 . . . . 0.0 113.337 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.1 mt -59.16 -57.19 12.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -52.88 -43.18 65.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.175 0.99 . . . . 0.0 110.45 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.426 ' HG2' HD21 ' A' ' 45' ' ' LEU . 64.7 mtm -66.76 -50.29 63.19 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.891 1.276 . . . . 0.0 112.567 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.738 ' HD2' HD22 ' A' ' 17' ' ' LEU . 27.2 tttt -60.62 -41.33 94.64 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.816 -1.177 . . . . 0.0 110.193 -177.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.79 -26.63 57.49 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.839 0.456 . . . . 0.0 111.441 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.428 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 35.9 t80 -57.25 -50.98 71.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.917 0.887 . . . . 0.0 109.112 167.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.2 mt -64.02 -20.14 65.7 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.466 1.106 . . . . 0.0 113.439 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.4 m -61.53 -33.4 73.77 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.279 0.945 . . . . 0.0 111.531 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -130.49 104.77 7.43 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.637 -0.665 . . . . 0.0 109.988 -170.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -53.61 -29.2 36.73 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.204 1.401 . . . . 0.0 111.716 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -55.19 -25.93 35.91 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 119.803 -1.81 . . . . 0.0 112.45 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.428 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 85.2 m-20 -66.08 -50.56 63.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.529 0.732 . . . . 0.0 110.817 175.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.43 -37.19 78.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 119.221 0.919 . . . . 0.0 109.568 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 78.0 mt -64.55 -34.12 77.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.17 0.588 . . . . 0.0 110.481 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.98 -32.5 59.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.92 0.888 . . . . 0.0 111.43 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -27.85 66.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.298 1.039 . . . . 0.0 110.691 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.1 mtm105 -56.8 -54.15 49.66 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 119.092 0.86 . . . . 0.0 109.464 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -52.87 -36.66 59.38 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.853 0.751 . . . . 0.0 111.319 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 52.1 mt -73.68 -38.23 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.865 -1.147 . . . . 0.0 110.338 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 . . . . . 0 N--CA 1.452 -0.371 0 C-N-CA 125.668 1.587 . . . . 0.0 111.001 179.297 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.731 HD22 ' HD2' ' A' ' 77' ' ' LYS . 9.6 mt . . . . . 0 C--O 1.238 0.469 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -77.8 99.27 5.85 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 122.014 0.911 . . . . 0.0 109.079 179.226 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 p -63.16 -38.98 93.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.818 -1.176 . . . . 0.0 111.402 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.83 70.35 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.543 -0.741 . . . . 0.0 111.434 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 5.8 tt0 -78.92 -55.57 5.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.016 2.126 . . . . 0.0 108.758 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 17' ' ' LEU . 75.8 mt -54.57 -44.2 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.91 -49.06 78.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.529 0.732 . . . . 0.0 111.273 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -61.07 -53.36 58.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.839 1.256 . . . . 0.0 110.283 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -60.56 -39.7 88.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.68 1.992 . . . . 0.0 111.772 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 t -60.91 -47.12 94.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 O-C-N 120.691 -1.255 . . . . 0.0 109.374 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -61.14 -27.49 68.42 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 117.373 -1.299 . . . . 0.0 111.548 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -65.04 -63.12 1.18 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 120.125 1.329 . . . . 0.0 109.805 170.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -63.78 -29.08 70.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.058 0.845 . . . . 0.0 111.806 -170.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.52 -37.78 74.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.976 1.262 . . . . 0.0 109.587 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.26 -37.35 85.27 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.186 1.357 . . . . 0.0 111.862 169.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -58.59 -32.75 69.25 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.952 2.101 . . . . 0.0 113.707 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -126.39 15.93 7.7 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.482 1.913 . . . . 0.0 111.214 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.8 m120 42.33 72.73 0.16 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.282 2.233 . . . . 0.0 111.41 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.466 HD11 ' CG ' ' A' ' 90' ' ' ARG . 93.4 mt -106.26 153.84 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.69 131.64 10.87 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.801 1.191 . . . . 0.0 110.556 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -36.05 74.6 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.428 1.491 . . . . 0.0 111.71 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.6 ptt85 -53.5 -56.06 20.18 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.351 1.06 . . . . 0.0 111.965 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.46 -39.7 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -63.29 -45.68 90.26 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.091 -1.006 . . . . 0.0 109.573 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.41 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -67.35 -24.61 73.63 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-O 117.352 -1.804 . . . . 0.0 112.518 173.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -78.12 -21.02 51.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.788 2.294 . . . . 0.0 112.076 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -121.99 -61.1 1.52 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 119.484 1.038 . . . . 0.0 111.436 -174.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.7 t -63.46 -36.98 78.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.493 HD21 ' HG2' ' A' ' 76' ' ' MET . 21.4 mt -106.49 -34.95 7.23 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.423 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.55 31.5 78.84 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.13 161.62 18.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.352 1.461 . . . . 0.0 107.932 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m -59.67 147.95 35.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.765 1.226 . . . . 0.0 110.599 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -63.67 -16.73 61.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.633 1.573 . . . . 0.0 114.06 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.54 -56.63 2.61 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 166.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.7 m -43.65 -59.57 2.14 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 125.851 1.66 . . . . 0.0 113.21 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.41 HG11 ' HA3' ' A' ' 41' ' ' GLY . 4.1 m -55.65 -34.62 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 121.017 1.735 . . . . 0.0 114.074 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.9 t -63.2 -36.24 82.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.243 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.36 -41.78 80.79 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.792 1.633 . . . . 0.0 109.736 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.432 HG23 ' CE2' ' A' ' 73' ' ' PHE . 15.3 mt -62.79 -45.35 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -174.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.8 -32.03 61.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.779 0.832 . . . . 0.0 111.628 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.24 -53.94 31.02 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.628 1.971 . . . . 0.0 111.042 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -134.45 71.78 71.15 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -168.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -68.41 98.91 0.58 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.937 2.425 . . . . 0.0 107.985 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -69.06 160.63 77.63 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -59.34 150.49 74.44 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.351 2.701 . . . . 0.0 109.109 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.449 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 70.4 t-105 -52.79 -52.54 56.37 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.664 0.786 . . . . 0.0 111.5 177.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.432 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.4 -5.99 2.02 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 174.717 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -116.31 18.98 15.06 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.414 1.886 . . . . 0.0 110.842 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.1 mt -124.05 149.44 46.11 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.564 1.546 . . . . 0.0 106.874 166.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.2 t -90.73 -177.72 5.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.641 1.176 . . . . 0.0 108.852 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 p -46.33 -54.01 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.446 1.098 . . . . 0.0 111.16 172.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -74.73 -4.88 40.15 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.25 -35.19 15.31 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.326 1.917 . . . . 0.0 111.297 163.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -87.91 -23.27 23.98 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.566 1.546 . . . . 0.0 112.971 -173.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -39.14 -59.91 1.35 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.15 1.78 . . . . 0.0 110.36 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.27 -51.11 2.91 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.467 2.112 . . . . 0.0 111.489 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CE2' HG23 ' A' ' 55' ' ' ILE . 44.1 m-85 -59.58 -38.15 80.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.528 -175.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.2 mt -55.85 -54.02 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -60.7 -46.57 89.87 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.35 1.06 . . . . 0.0 110.498 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.493 ' HG2' HD21 ' A' ' 45' ' ' LEU . 63.9 mtm -59.37 -46.07 89.69 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 124.075 0.95 . . . . 0.0 111.299 177.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.731 ' HD2' HD22 ' A' ' 17' ' ' LEU . 13.8 tttm -60.96 -45.76 93.43 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.39 -0.819 . . . . 0.0 110.183 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -59.61 -43.99 93.57 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.723 0.809 . . . . 0.0 110.314 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.54 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 37.7 t80 -53.61 -51.36 63.31 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.103 1.761 . . . . 0.0 110.127 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.8 mt -66.27 -18.94 65.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.357 0.663 . . . . 0.0 112.133 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -6.52 47.29 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.253 1.421 . . . . 0.0 112.681 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -156.86 115.75 3.36 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.885 1.274 . . . . 0.0 109.139 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.22 -27.81 68.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.851 1.26 . . . . 0.0 112.431 -169.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -60.71 -19.28 58.34 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 120.768 -1.208 . . . . 0.0 112.525 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.54 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 38.1 m-80 -60.33 -50.9 71.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.993 1.269 . . . . 0.0 110.181 174.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.424 HG22 HD12 ' A' ' 35' ' ' ILE . 3.2 p -71.28 -30.67 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 120.851 -1.155 . . . . 0.0 110.135 -177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.9 mt -64.2 -37.38 87.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.15 69.83 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.402 0.546 . . . . 0.0 111.649 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.08 -28.49 62.33 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.245 -0.91 . . . . 0.0 111.37 176.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.466 ' CG ' HD11 ' A' ' 35' ' ' ILE . 63.5 mtp180 -58.26 -37.04 74.14 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.017 0.826 . . . . 0.0 110.207 173.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 m -55.95 -56.32 22.12 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.327 1.051 . . . . 0.0 110.086 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.1 mt -65.13 -31.78 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 123.463 0.705 . . . . 0.0 110.008 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 . . . . . 0 N--CA 1.444 -0.773 0 O-C-N 121.689 -0.632 . . . . 0.0 111.728 178.852 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.624 HD22 ' HD2' ' A' ' 77' ' ' LYS . 3.2 mt . . . . . 0 C--O 1.237 0.423 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.52 103.17 8.29 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.96 -1.087 . . . . 0.0 110.916 -172.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 33.3 p -64.14 -46.23 84.99 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.983 -1.073 . . . . 0.0 112.93 -169.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.97 -18.57 64.09 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.289 0.636 . . . . 0.0 111.327 -176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.92 -56.74 4.05 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.764 1.626 . . . . 0.0 108.875 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.453 HD11 ' HB3' ' A' ' 17' ' ' LEU . 71.7 mt -51.6 -43.94 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.415 1.086 . . . . 0.0 109.992 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.66 -68.24 0.19 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.378 1.071 . . . . 0.0 110.047 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -45.22 -56.46 4.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.167 1.787 . . . . 0.0 112.232 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -54.78 -43.68 73.03 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 127.942 2.497 . . . . 0.0 111.227 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.96 -48.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 120.806 -1.184 . . . . 0.0 108.628 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -57.45 -43.46 83.97 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.385 1.448 . . . . 0.0 110.128 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -65.51 -44.87 85.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 118.718 0.69 . . . . 0.0 112.063 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -58.49 -46.75 86.05 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.299 1.04 . . . . 0.0 112.549 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.8 mt -58.78 -50.19 74.86 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -51.69 -45.68 63.59 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 120.261 1.391 . . . . 0.0 113.629 170.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -53.93 -32.11 52.53 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.881 1.672 . . . . 0.0 112.927 -173.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -123.39 15.63 9.69 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.567 1.547 . . . . 0.0 111.452 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 43.95 41.95 4.3 Favored 'General case' 0 CA--C 1.542 0.641 1 C-N-CA 132.379 4.272 . . . . 0.0 114.612 -176.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.3 mt -84.41 131.11 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.079 0.952 . . . . 0.0 108.726 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.09 115.71 4.07 Favored Glycine 0 C--O 1.228 -0.219 0 C-N-CA 125.0 1.286 . . . . 0.0 111.691 -169.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -39.62 -35.99 0.36 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.405 2.282 . . . . 0.0 115.725 -167.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -50.06 -50.12 48.98 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.249 1.386 . . . . 0.0 111.507 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.75 -50.69 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 119.044 0.838 . . . . 0.0 109.242 -173.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -54.74 -46.94 74.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.772 -0.58 . . . . 0.0 111.065 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.5 -15.52 68.42 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-O 117.026 -1.986 . . . . 0.0 113.232 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -94.25 -26.25 16.7 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.617 2.208 . . . . 0.0 112.575 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -118.44 -24.06 6.97 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -172.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.45 -37.74 6.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.138 0.975 . . . . 0.0 109.593 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.439 HD21 ' HG2' ' A' ' 76' ' ' MET . 29.3 mt -112.19 -30.73 7.1 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -171.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.39 13.16 83.12 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 123.961 0.791 . . . . 0.0 113.469 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 99.0 mt -101.84 170.33 8.22 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.254 1.822 . . . . 0.0 109.16 -174.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.09 166.57 13.6 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.411 -0.806 . . . . 0.0 112.025 173.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.2 tm0? -64.23 -44.34 92.18 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.31 -56.83 8.76 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 125.281 1.42 . . . . 0.0 112.068 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.7 m -52.13 -69.06 0.12 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 118.341 -0.838 . . . . 0.0 111.359 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.8 -37.1 70.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 120.482 1.492 . . . . 0.0 111.566 -171.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 t -55.26 -38.52 68.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 117.828 -1.082 . . . . 0.0 112.115 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.14 -48.58 79.47 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.921 1.237 . . . . 0.0 110.202 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 mt -59.03 -35.07 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.0 mt -81.22 -37.23 28.94 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 123.603 0.761 . . . . 0.0 112.099 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.55 -48.12 83.16 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.977 0.911 . . . . 0.0 110.751 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -136.94 82.0 32.1 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.36 73.86 4.38 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.554 2.836 . . . . 0.0 109.096 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -56.34 148.39 43.23 Favored Pre-proline 0 N--CA 1.441 -0.911 0 C-N-CA 124.8 1.24 . . . . 0.0 109.103 -172.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.02 147.26 91.78 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 124.46 3.44 . . . . 0.0 109.098 -164.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.447 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 60.3 t-105 -54.13 -38.07 65.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.735 0.414 . . . . 0.0 110.555 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -25.75 67.12 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -37.2 65.27 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.66 -1.275 . . . . 0.0 110.212 173.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.7 mt -74.54 172.44 12.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.298 1.047 . . . . 0.0 110.13 -171.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.6 p -129.15 -175.98 3.73 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.774 2.83 . . . . 0.0 107.834 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 89.9 t -47.54 -57.52 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 120.543 1.519 . . . . 0.0 111.229 173.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -70.09 -27.56 64.7 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.342 -1.474 . . . . 0.0 112.855 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.8 97.24 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 170.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -88.24 -26.12 22.51 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 126.949 2.1 . . . . 0.0 111.974 -171.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -44.45 -54.66 11.7 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.705 1.602 . . . . 0.0 110.566 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.04 -48.77 4.59 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.994 1.796 . . . . 0.0 110.982 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -57.48 -37.63 73.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.458 1.026 . . . . 0.0 113.401 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.0 -59.55 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 172.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -55.01 -38.89 68.48 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.099 0.56 . . . . 0.0 110.934 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.439 ' HG2' HD21 ' A' ' 45' ' ' LEU . 57.8 mtm -66.01 -50.56 63.83 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.768 0.827 . . . . 0.0 111.912 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.624 ' HD2' HD22 ' A' ' 17' ' ' LEU . 21.6 tttt -58.8 -41.26 86.3 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.908 -1.12 . . . . 0.0 110.778 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -70.29 -35.8 73.95 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.139 1.375 . . . . 0.0 110.576 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.473 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 44.0 t80 -56.5 -54.45 45.63 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.28 1.832 . . . . 0.0 109.105 171.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.3 mt -64.39 -18.15 64.41 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.709 0.803 . . . . 0.0 112.442 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.83 -10.13 59.4 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.532 -0.73 . . . . 0.0 111.604 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -144.41 110.13 5.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.368 0.985 . . . . 0.0 108.345 171.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 86' ' ' VAL . 38.6 tp10 -52.43 -30.44 29.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.833 1.253 . . . . 0.0 112.076 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -61.7 -16.04 45.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.149 -1.594 . . . . 0.0 112.969 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.473 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 71.3 m-80 -66.79 -50.28 63.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.834 1.197 . . . . 0.0 110.692 169.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 83' ' ' GLU . 9.1 p -64.06 -37.46 79.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 CA-C-N 119.359 0.982 . . . . 0.0 109.223 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.07 -39.91 93.91 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 118.241 0.473 . . . . 0.0 110.559 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.34 -34.39 76.01 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.858 0.463 . . . . 0.0 111.741 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.8 -27.81 66.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.84 0.856 . . . . 0.0 111.549 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 mtm105 -55.17 -50.36 69.53 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.5 m -53.3 -40.75 64.99 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.75 1.62 . . . . 0.0 109.348 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.2 mt -69.75 -31.4 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 O-C-N 120.656 -1.277 . . . . 0.0 111.21 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 . . . . . 0 N--CA 1.451 -0.414 0 CA-C-N 119.028 0.831 . . . . 0.0 110.873 170.274 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.7 mt . . . . . 0 C--O 1.237 0.413 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.92 102.48 5.59 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 123.06 1.41 . . . . 0.0 109.489 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.442 HG22 ' CD1' ' A' ' 73' ' ' PHE . 5.4 p -70.23 -35.06 73.59 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.722 -174.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.57 65.94 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 120.262 1.392 . . . . 0.0 110.914 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -77.84 -50.88 11.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.856 2.062 . . . . 0.0 108.981 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -54.03 -53.24 29.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.83 -46.23 78.17 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.313 0.645 . . . . 0.0 112.096 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -58.54 -66.48 0.48 Allowed 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.382 1.073 . . . . 0.0 108.23 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -47.29 -40.6 17.21 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.354 1.462 . . . . 0.0 112.643 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.522 HG21 ' SD ' ' A' ' 76' ' ' MET . 38.7 t -57.98 -53.8 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 123.684 0.794 . . . . 0.0 109.873 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -52.71 -51.09 61.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -59.29 -44.41 92.49 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.765 0.826 . . . . 0.0 112.582 -175.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.456 ' HG3' ' CD2' ' A' ' 80' ' ' LEU . 9.9 mm-40 -61.32 -49.59 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.954 1.702 . . . . 0.0 112.349 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.49 -49.47 77.67 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.48 -42.91 67.74 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.833 1.253 . . . . 0.0 114.056 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -53.83 -28.31 34.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.676 1.19 . . . . 0.0 111.568 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -124.76 15.66 8.69 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.872 1.669 . . . . 0.0 112.579 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 38.4 54.31 1.81 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.727 2.811 . . . . 0.0 113.893 -172.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.5 mt -89.89 151.7 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.29 131.9 10.8 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 126.236 1.874 . . . . 0.0 111.681 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -60.43 -20.1 58.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.216 1.006 . . . . 0.0 113.211 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -65.68 -60.82 2.51 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 119.775 1.171 . . . . 0.0 109.222 171.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.73 -47.54 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 C-N-CA 123.632 0.773 . . . . 0.0 109.97 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -53.55 -51.04 64.17 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.653 0.66 . . . . 0.0 111.907 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.426 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -68.48 -28.85 72.98 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-O 117.845 -1.531 . . . . 0.0 112.061 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -72.38 -23.55 61.13 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.794 1.797 . . . . 0.0 112.023 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -116.27 -60.32 1.87 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.751 1.159 . . . . 0.0 112.841 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.16 -44.67 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.562 HD21 ' HG2' ' A' ' 76' ' ' MET . 35.9 mt -95.1 -41.76 8.95 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.21 0.604 . . . . 0.0 110.755 -173.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.92 30.19 44.04 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.179 0.895 . . . . 0.0 112.223 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' A' ' 45' ' ' LEU . 24.8 mt -121.13 164.42 16.88 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 126.725 2.01 . . . . 0.0 107.802 -173.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.2 t -65.4 162.41 17.79 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.518 0.675 . . . . 0.0 110.737 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -58.85 -54.06 51.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.806 0.842 . . . . 0.0 109.586 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.55 -42.88 99.85 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.0 m -52.56 -60.42 3.27 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.805 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.426 HG11 ' HA3' ' A' ' 41' ' ' GLY . 3.3 m -63.58 -39.31 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 120.885 1.675 . . . . 0.0 113.984 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.32 -35.97 78.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 119.179 0.899 . . . . 0.0 109.376 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.18 -44.13 87.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.516 0.726 . . . . 0.0 111.212 169.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.403 HG23 ' CE2' ' A' ' 73' ' ' PHE . 3.2 mt -59.98 -40.04 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.8 -38.26 62.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.754 0.822 . . . . 0.0 111.042 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.16 -49.52 56.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.402 1.881 . . . . 0.0 112.204 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -127.32 75.21 77.28 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 127.023 2.129 . . . . 0.0 108.111 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.33 103.0 0.61 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 N-CA-C 106.429 -2.181 . . . . 0.0 106.429 167.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -66.61 170.96 4.87 Favored Pre-proline 0 N--CA 1.439 -0.992 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.4 146.26 79.86 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.112 2.542 . . . . 0.0 109.681 168.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -55.26 -48.33 74.15 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.88 0.872 . . . . 0.0 110.773 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.461 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -52.72 -21.22 3.81 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 172.716 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -94.89 5.27 52.37 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 120.219 -1.551 . . . . 0.0 112.51 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.414 ' HB3' ' HA3' ' A' ' 69' ' ' GLY . 82.4 mt -113.71 174.94 5.68 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.687 1.595 . . . . 0.0 109.215 173.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -128.13 -173.98 3.09 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.14 1.776 . . . . 0.0 108.313 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 96.8 t -47.28 -55.56 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.908 1.231 . . . . 0.0 111.015 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -60.54 -32.21 71.27 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 120.862 -1.149 . . . . 0.0 112.926 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -58.8 -45.48 94.86 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.666 1.127 . . . . 0.0 112.428 171.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -90.69 -17.85 26.08 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.707 2.003 . . . . 0.0 112.266 -164.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 1.5 tt0 -41.6 -53.62 7.29 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.308 2.243 . . . . 0.0 111.648 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 71' ' ' GLU . 22.2 Cg_endo -65.84 -50.77 1.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.341 2.027 . . . . 0.0 111.129 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CD1' HG22 ' A' ' 19' ' ' THR . 43.0 m-85 -57.62 -38.96 75.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 117.69 -1.148 . . . . 0.0 112.481 -174.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.1 mt -58.01 -54.29 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -56.35 -47.41 78.87 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.769 0.827 . . . . 0.0 110.486 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.562 ' HG2' HD21 ' A' ' 45' ' ' LEU . 64.7 mtm -61.42 -47.86 83.85 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 123.066 0.546 . . . . 0.0 110.705 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -58.72 -40.99 85.31 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.57 -0.707 . . . . 0.0 111.339 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.71 -41.56 92.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.063 0.847 . . . . 0.0 111.008 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.492 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.6 t80 -56.57 -41.65 77.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.557 0.743 . . . . 0.0 109.48 177.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.456 ' CD2' ' HG3' ' A' ' 29' ' ' GLN . 81.7 mt -75.75 -15.24 60.3 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.765 1.226 . . . . 0.0 113.938 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.9 m -81.65 -14.19 56.97 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.234 0.924 . . . . 0.0 111.035 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -145.24 97.12 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -47.31 -25.63 1.04 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.192 1.797 . . . . 0.0 112.746 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -58.41 -28.77 65.53 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 119.643 -1.911 . . . . 0.0 112.138 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.492 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 66.7 m-80 -62.06 -54.23 44.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.19 -37.49 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.1 -0.375 . . . . 0.0 110.15 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.6 -39.4 93.63 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.42 0.688 . . . . 0.0 110.703 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.92 -35.29 67.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.558 0.743 . . . . 0.0 111.996 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.99 -25.09 66.63 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.132 0.973 . . . . 0.0 110.774 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -58.06 -49.53 76.6 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 118.359 0.527 . . . . 0.0 109.915 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 m -60.29 -38.26 83.06 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.403 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mt -63.04 -42.33 96.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 119.68 1.127 . . . . 0.0 109.692 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 . . . . . 0 N--CA 1.451 -0.394 0 C-N-CA 123.445 0.698 . . . . 0.0 111.273 -179.134 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.544 HD22 ' CD ' ' A' ' 77' ' ' LYS . 5.5 mt . . . . . 0 C--O 1.239 0.521 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -85.33 104.07 14.83 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.029 1.395 . . . . 0.0 108.122 162.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.481 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 19.4 p -56.2 -41.65 75.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.988 172.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 -37.74 71.95 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.475 0.71 . . . . 0.0 111.558 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -71.14 -54.77 9.87 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.328 1.451 . . . . 0.0 108.434 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -54.09 -51.05 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.36 -49.82 63.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.826 0.85 . . . . 0.0 111.362 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -55.42 -63.75 1.06 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.483 1.113 . . . . 0.0 109.617 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -50.88 -41.24 58.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.566 1.946 . . . . 0.0 112.933 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.424 HG21 ' SD ' ' A' ' 76' ' ' MET . 75.3 t -62.54 -47.85 91.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 121.011 -1.056 . . . . 0.0 110.079 176.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -55.89 -39.61 71.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.657 -1.163 . . . . 0.0 109.337 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -59.39 -55.81 29.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.45 1.023 . . . . 0.0 112.024 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -63.86 -39.66 94.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 112.318 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.12 -46.43 89.06 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 120.091 1.314 . . . . 0.0 107.601 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -16.73 64.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.06 0.846 . . . . 0.0 113.263 175.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -66.8 -30.66 70.92 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.083 -1.011 . . . . 0.0 110.832 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -127.99 10.35 6.43 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.322 1.049 . . . . 0.0 111.699 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 41.01 85.11 0.02 OUTLIER 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.24 2.616 . . . . 0.0 111.171 -164.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.451 HD11 ' CG ' ' A' ' 90' ' ' ARG . 92.2 mt -115.99 150.96 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.971 0.909 . . . . 0.0 108.921 174.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.96 142.14 17.45 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 123.954 0.788 . . . . 0.0 111.499 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -66.09 -33.46 75.84 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 118.57 -0.729 . . . . 0.0 111.965 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -59.97 -46.72 88.52 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 118.832 0.742 . . . . 0.0 109.767 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 t -61.88 -54.04 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 119.151 0.887 . . . . 0.0 109.294 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -51.3 -47.87 62.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.668 0.27 . . . . 0.0 111.714 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.499 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -78.34 -27.71 57.11 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-O 117.017 -1.991 . . . . 0.0 112.573 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -78.81 -26.75 44.29 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.738 2.269 . . . . 0.0 110.769 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -96.31 -78.5 0.46 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.68 0.792 . . . . 0.0 109.386 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.3 t -53.42 -52.28 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 C-N-CA 126.489 1.916 . . . . 0.0 107.896 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.498 HD21 ' HG2' ' A' ' 76' ' ' MET . 37.9 mt -90.17 -34.44 15.84 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 118.026 -0.988 . . . . 0.0 111.595 -170.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.97 12.72 80.72 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 124.2 0.937 . . . . 0.0 112.791 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.0 mt -102.79 172.29 6.92 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.172 1.389 . . . . 0.0 109.688 -171.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 63.5 p -67.33 159.79 28.56 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.291 -0.881 . . . . 0.0 109.594 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -61.22 -46.43 90.45 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.017 -1.052 . . . . 0.0 109.209 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.88 -32.68 70.83 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.83 -0.984 . . . . 0.0 112.043 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -60.19 -69.36 0.22 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.919 1.359 . . . . 0.0 108.69 169.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.499 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.7 m -57.25 -40.05 71.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 120.09 1.314 . . . . 0.0 113.63 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.0 t -55.01 -45.72 75.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.753 0.821 . . . . 0.0 109.638 176.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -57.42 -46.07 83.94 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 119.361 0.982 . . . . 0.0 110.702 172.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.42 ' CG2' ' CZ ' ' A' ' 73' ' ' PHE . 5.1 mt -58.72 -41.21 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -70.41 -41.51 72.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.444 1.098 . . . . 0.0 111.174 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.69 -48.89 73.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.878 2.071 . . . . 0.0 112.557 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.3 79.38 61.36 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.48 95.77 0.63 Allowed 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 106.987 -1.966 . . . . 0.0 106.987 173.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -62.54 154.73 71.98 Favored Pre-proline 0 N--CA 1.436 -1.125 0 O-C-N 120.945 -1.097 . . . . 0.0 108.099 172.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -65.09 150.2 88.15 Favored 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 122.139 1.893 . . . . 0.0 108.368 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -52.25 -43.67 64.48 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.786 0.834 . . . . 0.0 110.789 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -21.59 52.02 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -83.46 -28.86 28.47 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.943 1.247 . . . . 0.0 113.039 175.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.9 mt -85.21 157.18 20.7 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.902 0.774 . . . . 0.0 109.436 -169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.1 t -97.63 -178.44 4.12 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 166.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -47.28 -51.09 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 125.358 1.463 . . . . 0.0 111.356 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.401 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -63.88 -22.75 67.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 178.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.1 -40.22 17.22 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 125.732 1.634 . . . . 0.0 111.44 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -76.63 -26.44 54.93 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 125.65 1.58 . . . . 0.0 111.742 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -46.1 -55.8 12.35 Favored Pre-proline 0 N--CA 1.455 -0.195 0 C-N-CA 126.485 1.914 . . . . 0.0 112.184 -176.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.64 -48.62 8.75 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 121.434 1.423 . . . . 0.0 110.025 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.481 ' CZ ' ' HB ' ' A' ' 19' ' ' THR . 64.5 m-85 -58.9 -37.75 77.33 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 117.508 -1.234 . . . . 0.0 113.133 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.1 mt -57.72 -58.77 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 C-N-CA 124.45 1.1 . . . . 0.0 108.06 173.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -52.46 -45.7 66.19 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.881 0.872 . . . . 0.0 110.173 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.498 ' HG2' HD21 ' A' ' 45' ' ' LEU . 64.7 mtm -65.54 -46.7 78.55 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.478 -0.764 . . . . 0.0 112.213 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.544 ' CD ' HD22 ' A' ' 17' ' ' LEU . 21.1 tttp -62.66 -38.45 90.37 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.034 -1.041 . . . . 0.0 110.252 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -66.47 -40.4 89.33 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.043 1.337 . . . . 0.0 110.502 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.9 t80 -57.34 -51.7 68.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.27 1.428 . . . . 0.0 108.394 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.2 mt -66.8 -10.91 52.63 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.72 1.208 . . . . 0.0 113.868 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -38.69 87.52 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.174 -0.954 . . . . 0.0 109.975 171.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -132.34 112.03 11.85 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.385 0.993 . . . . 0.0 110.147 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -53.82 -22.29 9.3 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.729 1.612 . . . . 0.0 112.413 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -53.86 -28.55 36.69 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 119.85 -1.781 . . . . 0.0 113.016 171.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.486 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 51.6 m-80 -62.04 -48.85 78.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.964 0.505 . . . . 0.0 110.031 175.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -37.16 79.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 CA-C-N 119.237 0.926 . . . . 0.0 109.814 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.4 mt -66.69 -35.05 79.22 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.836 0.454 . . . . 0.0 110.182 -173.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.42 -35.42 70.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.493 0.717 . . . . 0.0 112.052 172.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.39 -27.34 69.24 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.845 0.858 . . . . 0.0 111.338 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.451 ' CG ' HD11 ' A' ' 35' ' ' ILE . 77.8 mtp180 -59.26 -44.46 92.41 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.44 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.1 m -50.8 -46.53 59.77 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.282 0.946 . . . . 0.0 110.967 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.4 mt -67.84 -32.44 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.474 0.71 . . . . 0.0 110.134 -174.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 123.68 0.792 . . . . 0.0 110.795 173.967 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.649 HD22 ' HD2' ' A' ' 77' ' ' LYS . 1.4 mt . . . . . 0 C--O 1.238 0.498 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.5 93.95 4.87 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.2 p -58.13 -40.49 81.41 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.96 -1.088 . . . . 0.0 111.635 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.96 -34.79 76.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.94 0.496 . . . . 0.0 110.315 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.83 -55.44 7.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.564 1.145 . . . . 0.0 108.779 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.415 HD11 ' HB3' ' A' ' 17' ' ' LEU . 52.3 mt -56.25 -44.38 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.49 -48.61 78.76 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.735 -0.603 . . . . 0.0 111.536 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.493 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 29.7 t80 -56.36 -64.97 0.69 Allowed 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.231 1.012 . . . . 0.0 108.999 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -54.57 -35.63 63.51 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 127.106 2.162 . . . . 0.0 112.935 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.1 t -61.76 -53.13 52.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 119.191 0.905 . . . . 0.0 110.188 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 47.1 mtmt -52.38 -42.51 64.05 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 117.6 -1.191 . . . . 0.0 109.185 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.47 -58.1 10.1 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.238 1.015 . . . . 0.0 110.556 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -62.08 -34.17 75.79 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.67 -50.33 72.91 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 170.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.64 -42.41 74.96 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.107 0.867 . . . . 0.0 110.981 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -54.39 -30.1 51.0 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.129 2.171 . . . . 0.0 113.006 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -127.23 14.82 7.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.614 1.565 . . . . 0.0 110.928 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.7 m120 44.76 43.31 6.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 129.036 2.934 . . . . 0.0 113.073 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -82.15 147.17 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.81 -1.182 . . . . 0.0 109.421 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.13 130.99 10.17 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -56.62 -37.0 70.1 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.992 1.317 . . . . 0.0 112.512 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.2 ttp85 -54.63 -50.13 68.85 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.133 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.54 -49.41 83.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 119.107 0.867 . . . . 0.0 109.565 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -54.13 -49.2 69.73 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.446 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -72.18 -29.08 67.06 Favored Glycine 0 C--O 1.216 -0.987 0 CA-C-O 117.45 -1.75 . . . . 0.0 113.576 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -78.57 -30.08 46.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.729 2.265 . . . . 0.0 111.568 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.4 -58.44 1.88 Allowed 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.553 0.741 . . . . 0.0 110.393 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.54 HG22 HD21 ' A' ' 89' ' ' LEU . 11.3 t -68.23 -53.42 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -172.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.61 HD21 ' HG2' ' A' ' 76' ' ' MET . 46.0 mt -89.47 -37.08 15.04 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.2 0.6 . . . . 0.0 110.528 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.14 36.25 60.39 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.7 mt -121.51 163.43 18.84 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.731 1.612 . . . . 0.0 108.534 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.2 t -54.6 144.48 21.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.473 1.109 . . . . 0.0 109.919 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -58.28 -26.97 63.62 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 117.775 0.261 . . . . 0.0 110.841 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.59 -36.29 43.91 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.346 0.974 . . . . 0.0 112.054 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.1 m -67.56 -59.56 3.26 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.081 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.446 HG11 ' HA3' ' A' ' 41' ' ' GLY . 3.5 m -58.75 -35.18 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 120.381 1.446 . . . . 0.0 113.691 -177.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.2 p -61.88 -38.82 89.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.981 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.3 -38.59 68.86 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.742 1.155 . . . . 0.0 110.104 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.458 HG23 ' CZ ' ' A' ' 73' ' ' PHE . 14.9 mt -68.54 -47.22 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -173.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.8 mt -73.45 -30.36 63.14 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.145 0.578 . . . . 0.0 111.857 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.2 -57.46 5.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.02 1.728 . . . . 0.0 110.969 173.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -130.25 74.42 80.4 Favored Pre-proline 0 CA--C 1.519 -0.24 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -170.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.68 97.2 0.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 122.709 2.272 . . . . 0.0 107.167 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -63.68 159.53 51.96 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -70.31 150.05 64.31 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.093 1.862 . . . . 0.0 107.328 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.423 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 67.4 t-105 -51.69 -42.15 61.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -14.66 52.67 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.96 -16.95 34.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.144 1.793 . . . . 0.0 112.363 171.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.64 149.37 21.29 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.44 1.018 . . . . 0.0 108.85 -169.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -98.03 179.93 4.61 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 165.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.8 t -49.05 -51.05 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 119.649 1.113 . . . . 0.0 112.163 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt -59.56 -34.48 72.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.46 1.482 . . . . 0.0 112.569 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.78 -35.2 90.61 Favored Glycine 0 CA--C 1.529 0.92 0 O-C-N 121.35 -0.844 . . . . 0.0 112.705 173.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.423 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 93.5 mttt -80.4 -27.91 38.0 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.348 1.459 . . . . 0.0 112.162 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -42.18 -52.64 9.48 Favored Pre-proline 0 N--CA 1.448 -0.563 0 C-N-CA 128.365 2.666 . . . . 0.0 111.883 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.97 -56.08 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.103 1.869 . . . . 0.0 110.27 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.458 ' CZ ' HG23 ' A' ' 55' ' ' ILE . 80.5 m-85 -58.05 -32.03 67.62 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 117.482 -1.247 . . . . 0.0 113.303 -173.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.23 -58.81 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 119.449 1.022 . . . . 0.0 108.278 171.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -53.85 -48.85 69.58 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.61 ' HG2' HD21 ' A' ' 45' ' ' LEU . 58.3 mtm -72.31 -33.68 67.55 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 119.713 1.142 . . . . 0.0 113.034 -168.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.649 ' HD2' HD22 ' A' ' 17' ' ' LEU . 3.5 tttm -62.21 -41.44 98.38 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.622 171.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -66.72 -35.04 79.19 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.579 1.152 . . . . 0.0 111.644 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -58.65 -57.28 13.67 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 126.312 1.845 . . . . 0.0 108.062 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.03 -4.8 7.9 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.445 1.498 . . . . 0.0 113.124 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.7 -7.64 59.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.771 1.228 . . . . 0.0 112.729 171.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -152.26 134.39 15.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.223 1.829 . . . . 0.0 111.538 171.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 86' ' ' VAL . 2.1 tp10 -60.4 -35.71 76.4 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.249 1.42 . . . . 0.0 111.104 176.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -58.2 -27.07 63.54 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.545 -0.722 . . . . 0.0 110.555 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -63.27 -42.61 99.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.227 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 83' ' ' GLU . 5.3 p -75.8 -33.6 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.731 1.151 . . . . 0.0 110.267 176.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.6 mt -66.53 -38.72 87.77 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.647 0.658 . . . . 0.0 110.277 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.37 97.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.204 0.526 . . . . 0.0 110.791 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.54 HD21 HG22 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -65.51 -27.41 68.45 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.964 0.905 . . . . 0.0 111.234 -178.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -57.0 -38.59 73.29 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.165 0.893 . . . . 0.0 109.649 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -65.83 -46.35 78.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.762 0.71 . . . . 0.0 111.232 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.445 HD12 HD22 ' A' ' 89' ' ' LEU . 47.9 mt -62.83 -32.01 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 119.307 0.958 . . . . 0.0 110.538 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? . . . . . 0 N--CA 1.448 -0.552 0 C-N-CA 123.499 0.72 . . . . 0.0 110.767 178.028 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.75 HD22 ' HD2' ' A' ' 77' ' ' LYS . 7.8 mt . . . . . 0 C--O 1.234 0.273 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -85.25 111.57 19.97 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.624 1.102 . . . . 0.0 108.577 171.573 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.9 p -69.18 -39.43 78.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 121.22 -0.925 . . . . 0.0 111.915 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 -21.49 63.83 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.508 1.049 . . . . 0.0 112.119 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 2.5 tp10 -75.67 -55.36 5.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.727 1.611 . . . . 0.0 107.088 172.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.468 HD11 ' HB3' ' A' ' 17' ' ' LEU . 84.3 mt -53.96 -44.22 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 119.779 1.172 . . . . 0.0 109.427 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.63 -53.76 50.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.754 1.221 . . . . 0.0 111.248 173.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -57.57 -53.46 57.9 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.284 1.034 . . . . 0.0 110.539 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -58.48 -43.43 88.98 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.618 2.367 . . . . 0.0 110.624 -176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.64 -55.03 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 O-C-N 120.861 -1.15 . . . . 0.0 109.023 172.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -51.47 -46.06 62.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.324 0.965 . . . . 0.0 110.932 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.97 -40.03 75.62 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 116.565 -1.683 . . . . 0.0 111.927 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -64.35 -36.16 83.23 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 121.627 2.012 . . . . 0.0 111.451 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.5 mt -61.07 -52.07 66.5 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 mt -65.02 -28.46 69.51 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -58.24 -36.34 73.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.963 1.305 . . . . 0.0 109.809 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -121.77 8.27 9.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.248 1.019 . . . . 0.0 112.405 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 52.3 79.29 0.11 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 128.04 2.536 . . . . 0.0 111.876 -169.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.563 HD11 ' HG3' ' A' ' 90' ' ' ARG . 70.7 mt -121.89 150.37 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.72 141.88 15.76 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.931 0.777 . . . . 0.0 111.269 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -57.81 -33.1 68.22 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.21 1.404 . . . . 0.0 112.253 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 -59.01 -62.8 1.61 Allowed 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.274 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.49 -36.48 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.968 1.258 . . . . 0.0 111.066 -176.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -59.78 -53.93 52.18 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 120.531 -1.356 . . . . 0.0 110.637 172.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.483 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -68.11 -24.22 74.62 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-O 118.017 -1.435 . . . . 0.0 112.62 -177.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -81.3 -20.45 40.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.838 1.819 . . . . 0.0 111.429 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -120.94 -51.42 2.13 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.327 0.967 . . . . 0.0 112.289 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.1 t -68.84 -52.16 37.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.6 mt -93.89 -29.06 15.49 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.208 -173.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.08 18.12 76.21 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 122.892 0.282 . . . . 0.0 112.563 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.7 169.9 8.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.558 1.543 . . . . 0.0 107.789 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.3 156.78 37.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 168.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -53.78 -51.15 64.33 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.205 0.602 . . . . 0.0 110.024 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.5 -26.44 68.2 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.321 -0.71 . . . . 0.0 112.54 -174.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 m -63.74 -69.05 0.3 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.483 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.2 m -56.65 -35.93 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 120.367 1.44 . . . . 0.0 112.59 -175.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t -60.78 -40.2 91.68 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.272 1.829 . . . . 0.0 110.576 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.84 -47.0 87.49 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.139 1.336 . . . . 0.0 109.272 167.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.0 mt -61.43 -31.8 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 99.3 mt -84.7 -22.66 29.68 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.944 0.897 . . . . 0.0 112.608 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.45 -49.16 23.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.802 1.241 . . . . 0.0 110.121 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.9 mtt85 -135.04 86.84 30.87 Favored Pre-proline 0 CA--C 1.516 -0.339 0 C-N-CA 125.373 1.469 . . . . 0.0 107.865 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.24 93.56 0.48 Allowed 'Trans proline' 0 N--CA 1.445 -1.335 0 N-CA-C 107.05 -1.942 . . . . 0.0 107.05 167.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -65.53 158.44 73.66 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -72.33 152.17 55.03 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.04 2.494 . . . . 0.0 108.958 -167.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.42 ' CD2' ' HE2' ' A' ' 70' ' ' LYS . 74.7 t-105 -52.43 -41.28 63.11 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.649 0.38 . . . . 0.0 111.478 175.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -18.02 58.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -89.03 -37.1 15.41 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 120.831 -1.168 . . . . 0.0 110.852 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.7 mt -74.69 146.15 42.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.543 0.687 . . . . 0.0 110.656 -162.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 t -71.3 174.59 6.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.289 1.035 . . . . 0.0 110.671 166.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.0 p -49.69 -56.09 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 124.423 1.089 . . . . 0.0 111.586 170.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -70.12 -5.07 24.42 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.62 -41.63 7.21 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.814 1.673 . . . . 0.0 110.288 167.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HE2' ' CD2' ' A' ' 62' ' ' TRP . 88.1 mttt -76.84 -26.1 53.92 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 126.264 1.825 . . . . 0.0 112.497 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -40.99 -62.04 1.12 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 127.266 2.226 . . . . 0.0 110.698 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -61.73 -44.5 21.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.393 2.062 . . . . 0.0 110.365 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -60.63 -39.93 90.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 117.67 -1.157 . . . . 0.0 112.845 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.9 mt -56.14 -51.59 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -59.65 -46.9 87.63 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.456 1.102 . . . . 0.0 110.861 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 70.5 mtm -61.84 -48.14 81.88 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 123.868 0.867 . . . . 0.0 110.823 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.75 ' HD2' HD22 ' A' ' 17' ' ' LEU . 10.3 tttt -60.78 -40.89 94.27 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.116 -0.99 . . . . 0.0 110.494 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -67.55 -36.01 80.15 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.116 0.967 . . . . 0.0 111.232 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 24.4 t80 -57.25 -48.04 79.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.011 0.925 . . . . 0.0 109.015 173.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.8 mt -71.07 -13.14 61.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.791 1.236 . . . . 0.0 113.631 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -25.73 68.21 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.146 0.885 . . . . 0.0 111.947 173.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -145.72 105.17 3.95 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -162.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -61.13 -23.24 65.38 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.382 0.673 . . . . 0.0 111.011 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -60.09 -23.42 63.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 119.783 -1.823 . . . . 0.0 112.036 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.446 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 71.3 m-80 -62.45 -38.89 91.52 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.066 1.303 . . . . 0.0 111.48 175.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 p -73.19 -35.4 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.608 1.094 . . . . 0.0 109.506 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.9 mt -70.52 -23.65 62.68 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.288 1.035 . . . . 0.0 111.283 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.3 -49.26 35.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.125 0.97 . . . . 0.0 110.615 167.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -28.93 69.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.336 1.454 . . . . 0.0 111.549 -170.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.563 ' HG3' HD11 ' A' ' 35' ' ' ILE . 68.4 mtp180 -57.45 -46.15 83.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.4 m -60.54 -37.51 81.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.653 0.781 . . . . 0.0 110.362 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mt -68.28 -30.3 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.353 0.978 . . . . 0.0 109.974 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 . . . . . 0 N--CA 1.451 -0.398 0 O-C-N 121.684 -0.635 . . . . 0.0 111.372 179.629 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.456 ' HB3' HD11 ' A' ' 22' ' ' ILE . 5.3 mt . . . . . 0 C--O 1.238 0.46 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.95 98.35 4.9 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.371 0.987 . . . . 0.0 108.571 175.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.4 p -58.34 -43.42 88.3 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.678 -1.264 . . . . 0.0 112.241 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.1 -26.24 66.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 118.805 -0.617 . . . . 0.0 110.992 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -70.86 -57.87 4.18 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 171.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.456 HD11 ' HB3' ' A' ' 17' ' ' LEU . 64.0 mt -54.92 -44.76 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.659 1.118 . . . . 0.0 109.936 -173.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.35 -51.73 68.66 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.914 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.537 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 81.9 t80 -53.19 -68.66 0.15 Allowed 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 125.292 1.437 . . . . 0.0 108.556 175.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -41.79 -46.04 3.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.955 2.502 . . . . 0.0 112.458 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.65 -50.08 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.951 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 47.9 mtmt -48.26 -45.85 34.99 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.421 1.464 . . . . 0.0 109.864 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.59 -54.8 30.31 Favored 'General case' 0 C--O 1.225 -0.186 0 O-C-N 124.451 1.094 . . . . 0.0 110.688 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.431 ' NE2' HG11 ' A' ' 86' ' ' VAL . 4.0 mm100 -56.02 -40.58 73.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.889 1.676 . . . . 0.0 112.433 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.57 -49.67 68.0 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.8 -37.35 65.98 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.824 0.738 . . . . 0.0 111.831 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -55.39 -25.33 34.9 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.832 2.053 . . . . 0.0 112.922 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -126.45 16.43 7.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.153 0.981 . . . . 0.0 111.909 175.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.4 m120 40.22 75.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 129.686 3.194 . . . . 0.0 111.481 -166.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.417 HD11 ' CG ' ' A' ' 90' ' ' ARG . 91.8 mt -114.66 152.22 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -99.22 172.64 25.58 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -95.09 -20.19 19.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -172.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -58.82 -55.24 37.64 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 118.854 0.752 . . . . 0.0 110.229 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 t -60.0 -53.65 45.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -54.26 -45.1 72.32 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.819 1.191 . . . . 0.0 111.015 -174.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.407 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -71.65 -24.5 76.67 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-O 117.273 -1.849 . . . . 0.0 112.882 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -79.71 -37.48 35.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.569 2.185 . . . . 0.0 111.632 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -91.21 -70.4 0.69 Allowed 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.486 -0.759 . . . . 0.0 109.5 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.15 -50.44 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 125.087 1.355 . . . . 0.0 108.342 -172.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.572 HD21 ' SD ' ' A' ' 76' ' ' MET . 57.4 mt -95.73 -37.18 10.89 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.612 -170.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.61 6.03 86.08 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 118.501 0.591 . . . . 0.0 113.713 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.6 mt -92.02 173.74 7.68 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.993 1.717 . . . . 0.0 109.438 -172.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 t -63.66 154.14 33.91 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.549 0.69 . . . . 0.0 109.845 164.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -62.98 -22.84 67.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.343 1.457 . . . . 0.0 111.449 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.09 -59.9 4.43 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 171.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.1 m -49.47 -52.57 28.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 116.728 -1.606 . . . . 0.0 112.041 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.407 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.8 m -66.38 -37.87 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 121.495 1.952 . . . . 0.0 113.375 177.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.8 t -60.2 -34.93 74.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 118.419 -0.8 . . . . 0.0 110.521 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -57.96 -48.98 78.36 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.073 0.851 . . . . 0.0 110.758 168.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.432 HG23 ' CZ ' ' A' ' 73' ' ' PHE . 5.5 mt -58.16 -39.63 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.2 mt -77.65 -35.06 52.9 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.964 1.306 . . . . 0.0 113.779 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.5 -60.45 3.13 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -134.67 72.7 68.9 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 125.064 1.346 . . . . 0.0 108.792 -165.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.04 108.0 1.23 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.57 2.18 . . . . 0.0 106.655 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -66.92 159.66 74.52 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 163.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.26 149.2 81.3 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 122.529 2.153 . . . . 0.0 109.316 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -45.48 -46.71 13.86 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.56 1.544 . . . . 0.0 111.148 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -56.74 -32.38 65.51 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -71.52 -29.46 64.81 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.389 0.995 . . . . 0.0 111.319 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.4 mt -80.93 157.89 25.43 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.439 0.638 . . . . 0.0 111.249 -160.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.9 p -78.9 175.45 10.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.716 0.806 . . . . 0.0 108.917 165.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -53.79 -50.65 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.001 1.32 . . . . 0.0 112.39 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -72.6 -19.78 61.41 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 120.146 -1.596 . . . . 0.0 112.251 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.84 96.78 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 163.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -85.3 -28.17 25.46 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 117.215 -1.374 . . . . 0.0 113.089 -176.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -45.04 -52.26 20.36 Favored Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 124.564 1.146 . . . . 0.0 111.964 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.76 -52.02 4.21 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.374 1.383 . . . . 0.0 110.065 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CZ ' HG23 ' A' ' 55' ' ' ILE . 78.4 m-85 -59.51 -32.86 70.68 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 117.71 -1.138 . . . . 0.0 113.082 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.4 mt -61.16 -56.5 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -53.71 -43.79 69.31 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.541 1.136 . . . . 0.0 111.089 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.572 ' SD ' HD21 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -66.24 -45.25 81.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.12 -1.613 . . . . 0.0 114.711 172.807 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -63.48 -33.77 76.3 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.343 -1.473 . . . . 0.0 109.911 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -62.44 -49.57 74.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.224 1.809 . . . . 0.0 110.074 172.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -51.52 -48.7 62.9 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.25 1.42 . . . . 0.0 110.332 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.85 -8.57 29.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.382 1.073 . . . . 0.0 113.882 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -68.99 -25.07 64.34 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.183 -0.948 . . . . 0.0 111.942 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -147.45 141.11 25.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.913 1.233 . . . . 0.0 108.958 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.474 ' O ' HG12 ' A' ' 86' ' ' VAL . 18.9 tt0 -62.32 -32.68 73.47 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.237 1.015 . . . . 0.0 111.194 -175.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.645 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -56.18 -30.05 61.7 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.827 -1.171 . . . . 0.0 110.864 -175.702 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -64.0 -36.13 82.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 118.687 0.676 . . . . 0.0 110.245 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 83' ' ' GLU . 10.0 p -77.37 -31.5 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.114 -0.991 . . . . 0.0 110.469 175.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 84' ' ' GLN . 42.1 mt -61.85 -41.4 97.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.838 0.855 . . . . 0.0 109.827 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.78 84.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.218 0.607 . . . . 0.0 110.106 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -30.24 70.22 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.158 177.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.417 ' CG ' HD11 ' A' ' 35' ' ' ILE . 71.3 mtp180 -61.0 -43.64 98.59 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 119.612 1.096 . . . . 0.0 109.835 174.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.5 m -53.09 -49.16 67.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.324 0.65 . . . . 0.0 110.094 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.3 mt -64.55 -34.4 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.417 -0.802 . . . . 0.0 110.423 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.05 177.396 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.404 ' HB3' HD11 ' A' ' 22' ' ' ILE . 8.4 mt . . . . . 0 C--O 1.238 0.473 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.76 95.74 4.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 122.372 1.082 . . . . 0.0 108.483 175.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.6 p -61.21 -42.55 98.8 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.287 -0.883 . . . . 0.0 111.374 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.52 -34.91 73.23 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.973 0.909 . . . . 0.0 110.92 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -70.82 -54.18 12.54 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.404 HD11 ' HB3' ' A' ' 17' ' ' LEU . 67.1 mt -55.93 -42.75 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -177.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.98 -55.78 28.65 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.159 0.984 . . . . 0.0 110.765 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -53.08 -62.73 1.47 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.117 1.367 . . . . 0.0 110.276 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -55.47 -36.61 66.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.059 1.743 . . . . 0.0 113.381 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.448 HG23 HD11 ' A' ' 80' ' ' LEU . 24.1 t -63.9 -47.59 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -58.14 -37.93 75.6 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 116.986 -1.483 . . . . 0.0 110.465 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -61.11 -58.11 9.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.4 1.0 . . . . 0.0 110.559 173.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -61.66 -34.23 75.36 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.214 -0.929 . . . . 0.0 112.127 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.3 mt -72.08 -33.87 68.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.174 1.79 . . . . 0.0 109.753 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 mt -65.45 -37.63 87.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 120.06 1.3 . . . . 0.0 112.177 168.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.48 ' HZ2' ' CE1' ' A' ' 33' ' ' HIS . 55.0 tttm -58.26 -36.38 73.16 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.107 1.763 . . . . 0.0 113.459 -163.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.48 ' CE1' ' HZ2' ' A' ' 32' ' ' LYS . 78.9 m-70 -124.41 12.3 8.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.915 2.486 . . . . 0.0 111.406 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 m120 44.18 78.48 0.06 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.874 2.469 . . . . 0.0 111.506 -171.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.1 mt -116.87 151.68 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.88 151.01 19.92 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.706 0.615 . . . . 0.0 111.735 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -57.81 -38.05 74.85 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.237 1.415 . . . . 0.0 110.668 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -56.76 -61.14 2.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.614 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.96 -49.0 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 119.48 1.036 . . . . 0.0 109.358 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.36 -47.1 79.56 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.918 0.781 . . . . 0.0 111.541 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.429 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -70.17 -31.19 69.17 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-O 118.275 -1.291 . . . . 0.0 111.264 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -71.09 -30.07 66.08 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.738 1.769 . . . . 0.0 111.056 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -108.39 -57.83 2.07 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.189 0.995 . . . . 0.0 113.035 -171.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.6 -48.27 53.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -175.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.481 HD21 ' HG2' ' A' ' 76' ' ' MET . 20.9 mt -93.17 -29.5 15.7 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 122.045 -0.409 . . . . 0.0 111.737 -171.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.06 19.76 79.72 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.374 -0.681 . . . . 0.0 112.149 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.4 mt -109.14 165.03 11.91 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.005 1.322 . . . . 0.0 107.603 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.53 162.06 29.97 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.071 0.939 . . . . 0.0 109.342 174.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -49.72 75.78 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.071 0.948 . . . . 0.0 110.692 -172.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.57 -41.56 95.61 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.4 m -55.95 -67.17 0.32 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 117.459 -1.258 . . . . 0.0 110.886 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.429 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.8 m -55.46 -36.24 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 121.261 1.846 . . . . 0.0 112.884 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 m -68.87 -23.69 64.25 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.669 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -66.67 -45.69 78.09 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.481 1.491 . . . . 0.0 108.552 162.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 mt -60.81 -40.42 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt -74.56 -31.5 62.11 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.399 1.079 . . . . 0.0 112.589 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.12 -50.31 64.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.536 0.734 . . . . 0.0 109.704 173.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 mtp85 -136.9 78.32 41.81 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 125.23 1.412 . . . . 0.0 108.516 -166.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.15 107.67 1.98 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.151 1.901 . . . . 0.0 107.39 169.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -64.32 173.51 1.48 Allowed Pre-proline 0 N--CA 1.442 -0.856 0 C-N-CA 124.342 1.057 . . . . 0.0 109.022 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -59.3 142.37 99.03 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.826 1.684 . . . . 0.0 108.699 165.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -54.37 -49.18 70.43 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.829 1.195 . . . . 0.0 110.494 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -21.32 4.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 mmtm -77.47 -31.06 53.47 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 120.359 -1.463 . . . . 0.0 111.383 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 mt -70.24 151.46 45.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.746 0.784 . . . . 0.0 109.549 -172.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.7 t -84.47 179.53 7.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 160.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.05 -57.11 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.098 1.359 . . . . 0.0 110.782 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -64.86 -19.44 65.89 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.836 -1.165 . . . . 0.0 112.863 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.16 -50.01 69.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 126.118 1.818 . . . . 0.0 111.769 165.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -74.62 -25.58 59.32 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 125.046 1.339 . . . . 0.0 112.338 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -43.72 -54.77 9.97 Favored Pre-proline 0 N--CA 1.446 -0.669 0 C-N-CA 127.083 2.153 . . . . 0.0 112.094 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.15 -47.83 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.083 1.856 . . . . 0.0 110.557 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -59.88 -36.6 77.28 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.901 -1.047 . . . . 0.0 112.73 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.7 mt -60.75 -55.02 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 174.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -55.75 -45.85 77.96 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.389 0.675 . . . . 0.0 109.751 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.481 ' HG2' HD21 ' A' ' 45' ' ' LEU . 66.3 mtm -59.5 -52.74 64.27 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 123.403 0.681 . . . . 0.0 111.437 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -60.01 -40.05 87.91 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.983 -1.073 . . . . 0.0 111.589 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -70.03 -31.96 69.86 Favored 'General case' 0 C--O 1.229 -0.025 0 C-N-CA 123.588 0.755 . . . . 0.0 111.42 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.521 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 22.8 t80 -61.56 -50.91 70.73 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.722 1.209 . . . . 0.0 108.123 171.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.448 HD11 HG23 ' A' ' 26' ' ' VAL . 36.1 mt -72.43 4.54 3.69 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.959 1.703 . . . . 0.0 113.241 175.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -91.02 -6.37 54.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 117.722 -1.132 . . . . 0.0 110.773 168.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.79 107.05 1.28 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.329 1.422 . . . . 0.0 109.389 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -55.13 -20.76 10.92 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.983 1.313 . . . . 0.0 113.945 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -58.94 -23.57 61.62 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 121.248 1.84 . . . . 0.0 111.204 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.521 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 65.4 m-80 -64.85 -48.2 75.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 173.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.1 p -65.45 -37.36 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.088 1.313 . . . . 0.0 109.565 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.5 mt -65.72 -30.1 70.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.586 0.754 . . . . 0.0 110.036 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.22 -45.46 73.22 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.849 0.86 . . . . 0.0 111.23 170.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.443 HD22 HD12 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -66.23 -24.25 66.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.497 1.119 . . . . 0.0 111.15 -175.385 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mtm105 -55.15 -52.88 61.89 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.827 0.74 . . . . 0.0 109.929 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.5 m -54.95 -41.29 70.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.486 1.514 . . . . 0.0 110.245 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.443 HD12 HD22 ' A' ' 89' ' ' LEU . 58.5 mt -67.52 -35.58 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.243 -0.911 . . . . 0.0 110.111 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-N 119.097 0.862 . . . . 0.0 110.774 177.783 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.534 ' HB3' HD11 ' A' ' 22' ' ' ILE . 12.5 mt . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.29 97.79 3.65 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.414 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 23.3 p -59.58 -36.32 76.01 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.175 -0.953 . . . . 0.0 112.173 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 -28.45 66.42 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.912 0.778 . . . . 0.0 110.998 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -77.79 -49.42 14.39 Favored 'General case' 0 C--O 1.215 -0.753 0 C-N-CA 125.188 1.395 . . . . 0.0 108.423 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 17' ' ' LEU . 74.8 mt -56.32 -46.52 81.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.0 -53.17 59.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.533 -0.729 . . . . 0.0 110.492 174.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -57.45 -58.07 9.88 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.241 1.016 . . . . 0.0 111.174 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -56.39 -39.03 72.31 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.356 2.262 . . . . 0.0 111.02 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.513 HG23 HD11 ' A' ' 80' ' ' LEU . 16.8 t -63.73 -51.77 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 120.227 -1.546 . . . . 0.0 110.002 172.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -59.4 -43.67 92.93 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.84 -0.537 . . . . 0.0 110.348 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.58 -49.7 76.47 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.355 0.662 . . . . 0.0 109.918 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -54.91 -47.58 74.19 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.307 1.843 . . . . 0.0 113.645 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.7 mt -60.8 -43.51 98.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 121.12 -0.987 . . . . 0.0 108.479 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -41.81 99.28 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 120.026 1.285 . . . . 0.0 112.406 172.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -58.37 -39.91 80.86 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.763 2.825 . . . . 0.0 111.051 -173.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -115.07 13.23 16.84 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.246 0.619 . . . . 0.0 112.319 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.7 t30 38.7 77.2 0.05 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.189 2.596 . . . . 0.0 112.859 -170.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.427 HD11 ' HG3' ' A' ' 90' ' ' ARG . 85.8 mt -119.0 149.89 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.57 142.56 16.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.905 0.764 . . . . 0.0 111.378 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -36.47 77.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.323 1.049 . . . . 0.0 112.874 -175.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -55.92 -57.32 12.57 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 119.211 0.914 . . . . 0.0 110.022 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -57.9 -44.06 85.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 118.518 0.599 . . . . 0.0 109.689 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -54.54 -50.61 67.5 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.679 -0.638 . . . . 0.0 112.005 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.436 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -71.57 -26.03 73.97 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-O 117.697 -1.613 . . . . 0.0 112.145 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -79.11 -32.09 44.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.649 1.725 . . . . 0.0 111.271 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -108.33 -44.95 4.0 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.238 1.015 . . . . 0.0 113.319 -174.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.01 -46.07 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.51 HD21 ' HG2' ' A' ' 76' ' ' MET . 21.7 mt -98.05 -30.85 12.45 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.068 0.23 . . . . 0.0 111.489 -171.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.29 4.21 90.27 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 123.97 0.794 . . . . 0.0 112.662 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 73.4 mt -93.23 178.63 5.67 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.61 1.564 . . . . 0.0 109.512 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 p -72.75 159.65 33.47 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.655 -0.653 . . . . 0.0 109.701 169.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -51.95 -44.2 63.84 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.952 1.301 . . . . 0.0 109.378 167.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.4 -54.88 31.52 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.073 1.32 . . . . 0.0 111.697 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.2 m -56.46 -64.85 0.73 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 117.684 -1.15 . . . . 0.0 110.697 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.436 HG11 ' HA3' ' A' ' 41' ' ' GLY . 4.2 m -58.08 -36.82 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 120.524 1.511 . . . . 0.0 111.872 -172.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.2 m -62.91 -29.28 70.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.09 -1.433 . . . . 0.0 112.979 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.02 -48.71 77.61 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 120.363 1.438 . . . . 0.0 108.887 166.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.7 -42.6 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.9 mt -77.83 -27.27 49.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.784 0.834 . . . . 0.0 113.0 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.71 -41.91 61.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.067 1.347 . . . . 0.0 111.257 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.32 82.43 9.72 Favored Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 126.813 2.045 . . . . 0.0 107.352 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.49 95.66 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.648 2.232 . . . . 0.0 107.484 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -61.76 157.44 49.04 Favored Pre-proline 0 N--CA 1.443 -0.81 0 O-C-N 121.016 -1.052 . . . . 0.0 108.799 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.05 149.14 92.41 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 122.725 2.284 . . . . 0.0 108.536 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.409 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 66.4 t-105 -56.21 -44.05 79.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.524 0.602 . . . . 0.0 110.573 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -12.63 9.26 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.57 -7.05 45.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.713 1.605 . . . . 0.0 113.61 175.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.5 mt -106.4 151.14 25.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.622 0.769 . . . . 0.0 110.517 -173.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 p -85.68 179.06 7.16 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.218 1.007 . . . . 0.0 109.784 171.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 t -52.07 -43.46 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.199 -0.938 . . . . 0.0 111.339 165.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -63.91 -42.1 97.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 118.52 0.6 . . . . 0.0 109.981 175.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.88 -31.34 67.91 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-O 119.193 -0.782 . . . . 0.0 113.526 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -91.37 -18.55 24.1 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.733 1.613 . . . . 0.0 111.987 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -42.22 -56.33 5.52 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 127.05 2.14 . . . . 0.0 111.874 175.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -66.86 -45.05 4.68 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.502 1.468 . . . . 0.0 110.349 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 58.9 m-85 -64.86 -34.42 78.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.316 -1.326 . . . . 0.0 112.517 -173.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.88 -53.94 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 120.068 1.304 . . . . 0.0 107.683 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -53.04 -45.79 68.18 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.757 0.823 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.51 ' HG2' HD21 ' A' ' 45' ' ' LEU . 69.9 mtm -63.44 -49.75 72.47 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.274 -0.891 . . . . 0.0 111.787 176.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.492 ' HD2' HD22 ' A' ' 17' ' ' LEU . 18.7 tttm -58.59 -40.56 83.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.02 -1.05 . . . . 0.0 110.343 -178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -64.77 -44.75 89.0 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.527 1.131 . . . . 0.0 110.23 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.472 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 51.6 t80 -52.38 -45.05 65.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.49 1.116 . . . . 0.0 110.919 173.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.513 HD11 HG23 ' A' ' 26' ' ' VAL . 57.8 mt -78.26 -9.72 59.35 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.819 1.248 . . . . 0.0 113.686 -176.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.3 t -75.66 -11.99 60.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.762 0.825 . . . . 0.0 111.014 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -162.86 95.43 0.88 Allowed 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.989 -1.069 . . . . 0.0 108.279 -155.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.74 -29.34 18.21 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.904 1.282 . . . . 0.0 111.098 -173.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -54.25 -22.86 12.78 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.256 -1.527 . . . . 0.0 113.884 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.472 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 33.4 m-80 -66.34 -44.52 83.06 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.447 1.021 . . . . 0.0 111.917 171.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.17 -36.6 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 120.572 -1.33 . . . . 0.0 109.755 -175.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -34.97 71.2 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.788 2.035 . . . . 0.0 110.521 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.83 -45.01 60.71 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.637 1.175 . . . . 0.0 111.978 172.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.57 -29.43 67.94 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 120.93 -1.106 . . . . 0.0 110.793 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.427 ' HG3' HD11 ' A' ' 35' ' ' ILE . 38.8 mtp-105 -61.76 -41.04 97.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 118.406 -0.807 . . . . 0.0 110.225 173.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -58.31 -45.63 87.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.267 1.394 . . . . 0.0 109.784 173.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.8 mt -60.16 -32.68 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.927 0.785 . . . . 0.0 109.886 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 . . . . . 0 N--CA 1.448 -0.53 0 O-C-N 121.036 -1.04 . . . . 0.0 112.458 -177.92 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.703 HD22 ' HD2' ' A' ' 77' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--O 1.234 0.265 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.54 101.38 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.099 -1.001 . . . . 0.0 110.068 175.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.416 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 24.1 p -65.25 -40.98 94.7 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 120.679 -1.263 . . . . 0.0 112.689 -172.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.03 -29.53 70.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.836 0.744 . . . . 0.0 110.854 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -76.71 -50.95 12.41 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.498 2.319 . . . . 0.0 108.522 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt -56.83 -45.96 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.94 0.896 . . . . 0.0 109.119 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.85 72.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.986 -1.071 . . . . 0.0 110.696 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -54.19 -65.94 0.48 Allowed 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.917 1.287 . . . . 0.0 109.057 177.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -44.04 -44.31 7.32 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.687 1.995 . . . . 0.0 112.556 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.97 -43.94 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 O-C-N 121.345 -0.847 . . . . 0.0 111.283 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG3' HD22 ' A' ' 56' ' ' LEU . 41.9 mtmt -55.24 -35.56 65.1 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.561 1.073 . . . . 0.0 109.593 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -67.61 -56.58 8.87 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 123.36 0.664 . . . . 0.0 110.937 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -59.21 -39.38 82.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.582 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.42 -46.96 86.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 119.757 1.162 . . . . 0.0 108.091 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.18 -41.41 79.26 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.232 0.924 . . . . 0.0 111.472 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -53.98 -31.76 51.83 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.723 1.609 . . . . 0.0 114.072 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -119.77 7.21 10.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.95 1.3 . . . . 0.0 112.524 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m120 51.38 79.47 0.1 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 127.939 2.496 . . . . 0.0 111.226 -170.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.3 mt -119.64 137.27 54.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.638 0.732 . . . . 0.0 109.376 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.83 132.94 12.79 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 126.486 1.993 . . . . 0.0 109.805 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -54.01 -31.77 52.19 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.064 1.346 . . . . 0.0 113.265 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -58.08 -48.56 79.78 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.576 -1.202 . . . . 0.0 111.341 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -60.27 -50.23 81.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 119.665 1.12 . . . . 0.0 108.839 -176.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -56.96 -40.59 76.75 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.656 -0.653 . . . . 0.0 111.665 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.4 ' CA ' HG11 ' A' ' 52' ' ' VAL . . . -71.23 -34.31 64.34 Favored Glycine 0 N--CA 1.437 -1.298 0 CA-C-O 117.596 -1.669 . . . . 0.0 111.592 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -70.02 -38.76 76.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.102 1.951 . . . . 0.0 110.548 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -97.61 -58.88 1.89 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.74 0.7 . . . . 0.0 112.667 -171.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.4 t -72.35 -47.13 54.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -172.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.505 HD21 ' SD ' ' A' ' 76' ' ' MET . 45.2 mt -89.31 -40.34 12.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 119.075 -0.488 . . . . 0.0 110.667 -174.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.47 22.01 71.21 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.766 -1.019 . . . . 0.0 111.753 -174.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.5 mt -110.62 160.05 17.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.424 1.89 . . . . 0.0 109.397 -174.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 m -63.72 152.6 38.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.575 1.15 . . . . 0.0 109.541 174.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -53.33 -43.06 67.35 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.11 0.964 . . . . 0.0 111.248 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.38 -10.4 80.02 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 118.076 -1.402 . . . . 0.0 113.368 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 m -68.26 -68.59 0.38 Allowed 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.869 1.835 . . . . 0.0 106.996 161.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.445 ' CG1' HD12 ' A' ' 45' ' ' LEU . 1.5 m -56.14 -37.7 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.449 1.477 . . . . 0.0 113.692 -171.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -42.84 94.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.859 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -47.01 74.83 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.448 1.022 . . . . 0.0 109.666 171.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 55' ' ' ILE . 13.7 mt -60.12 -43.96 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.407 HD22 ' HG3' ' A' ' 27' ' ' LYS . 92.8 mt -70.85 -35.72 72.54 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.747 1.219 . . . . 0.0 111.802 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.92 -51.7 30.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.059 1.744 . . . . 0.0 110.509 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -133.36 81.87 54.22 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 124.693 1.197 . . . . 0.0 108.898 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -69.3 95.55 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.707 2.938 . . . . 0.0 108.443 171.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -62.0 156.55 57.16 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 171.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -61.73 152.53 73.6 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.551 2.167 . . . . 0.0 108.218 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -53.75 -47.63 70.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.634 0.774 . . . . 0.0 110.038 175.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.429 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -63.6 3.66 0.32 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 173.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 2.2 mmpt? -107.41 -13.83 15.01 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 119.759 -1.838 . . . . 0.0 112.983 167.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.6 mt -92.77 150.41 20.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 119.084 0.856 . . . . 0.0 109.145 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t -94.15 -179.96 5.12 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 167.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 t -49.76 -49.45 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.238 1.415 . . . . 0.0 111.306 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -64.72 -28.26 69.47 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 120.208 1.367 . . . . 0.0 112.386 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.0 -40.11 73.51 Favored Glycine 0 CA--C 1.527 0.783 0 O-C-N 120.99 -1.069 . . . . 0.0 112.41 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -77.18 -25.61 52.03 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 126.908 2.083 . . . . 0.0 112.068 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 11.8 tt0 -41.64 -54.24 6.81 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 128.72 2.808 . . . . 0.0 112.116 -177.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 71' ' ' GLU . 19.1 Cg_endo -59.67 -58.6 0.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.247 2.631 . . . . 0.0 111.28 173.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.416 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 77.4 m-85 -56.19 -33.29 65.15 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -171.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.0 mt -58.01 -58.35 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -52.61 -52.13 56.81 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 124.588 1.155 . . . . 0.0 109.007 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.505 ' SD ' HD21 ' A' ' 45' ' ' LEU . 1.0 OUTLIER -57.96 -48.64 79.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 178.698 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.703 ' HD2' HD22 ' A' ' 17' ' ' LEU . 10.3 tttt -58.89 -42.63 89.99 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -71.16 -32.9 69.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.513 0.725 . . . . 0.0 110.857 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -59.19 -46.58 88.05 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.975 1.31 . . . . 0.0 109.402 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.1 mt -66.57 -21.5 66.14 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.0 m -82.89 1.14 40.89 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.981 0.81 . . . . 0.0 112.644 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -148.38 99.04 2.98 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 120.348 1.431 . . . . 0.0 108.747 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -61.87 -22.03 65.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.574 0.75 . . . . 0.0 112.743 -168.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -57.29 -23.16 46.66 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.523 -1.36 . . . . 0.0 112.878 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -64.47 -47.31 79.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.195 0.907 . . . . 0.0 110.508 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.0 p -72.1 -31.98 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.404 -0.81 . . . . 0.0 110.506 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.9 mt -69.7 -23.01 63.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.781 0.832 . . . . 0.0 111.097 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.51 -36.05 29.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.808 0.843 . . . . 0.0 110.499 171.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -66.23 -38.04 86.95 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 120.664 -1.273 . . . . 0.0 110.601 -176.773 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -62.95 -35.49 80.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.212 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.0 m -54.7 -51.33 65.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.768 0.713 . . . . 0.0 109.507 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 89' ' ' LEU . 70.6 mt -59.69 -39.29 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 122.946 0.498 . . . . 0.0 110.357 -175.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.593 0 C-N-CA 124.614 1.166 . . . . 0.0 111.502 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.748 HD22 ' HD2' ' A' ' 77' ' ' LYS . 7.4 mt . . . . . 0 C--O 1.238 0.478 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -80.76 100.78 8.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 174.969 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.0 p -62.94 -36.54 83.78 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.257 -0.902 . . . . 0.0 111.491 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.94 -24.67 61.66 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.824 1.193 . . . . 0.0 111.445 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 12.8 tt0 -72.52 -55.67 6.59 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 173.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.43 HD11 ' HB3' ' A' ' 17' ' ' LEU . 53.4 mt -54.36 -51.39 49.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.95 -49.02 72.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.592 0.757 . . . . 0.0 111.604 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.41 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 66.2 t80 -55.97 -61.45 2.37 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 124.725 1.21 . . . . 0.0 109.419 175.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -52.86 -39.83 62.9 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.499 2.32 . . . . 0.0 112.08 -176.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.1 -51.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 121.455 -0.778 . . . . 0.0 109.661 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 45.8 mtmt -53.26 -39.55 63.95 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 116.811 -1.566 . . . . 0.0 110.642 175.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.93 -59.32 5.56 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.724 1.21 . . . . 0.0 110.671 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -62.16 -36.34 81.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.265 1.026 . . . . 0.0 111.574 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 mt -65.09 -51.62 60.35 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -55.9 -39.36 71.48 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.025 1.284 . . . . 0.0 112.014 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -51.33 -50.65 59.0 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.894 2.078 . . . . 0.0 109.786 -177.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -104.86 12.84 32.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.386 1.074 . . . . 0.0 111.458 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 t30 38.38 58.71 1.56 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 130.792 3.637 . . . . 0.0 112.011 -171.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 82.7 mt -93.01 156.8 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.413 1.485 . . . . 0.0 108.305 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.98 151.22 19.46 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.741 0.686 . . . . 0.0 112.202 -175.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -70.92 -30.12 66.36 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 117.825 -1.083 . . . . 0.0 113.752 -174.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -59.06 -59.14 5.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 120.357 1.435 . . . . 0.0 109.377 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.2 t -59.73 -43.46 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 123.478 0.486 . . . . 0.0 109.864 -174.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -56.18 -47.75 77.7 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.244 0.929 . . . . 0.0 110.973 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.426 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -70.93 -30.52 67.88 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-O 118.144 -1.364 . . . . 0.0 112.391 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -72.07 -29.97 64.66 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.165 1.482 . . . . 0.0 111.274 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -105.48 -68.87 0.84 Allowed 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.705 0.802 . . . . 0.0 111.122 -176.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.64 -38.59 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 123.301 0.64 . . . . 0.0 109.391 -169.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.508 HD21 ' HG2' ' A' ' 76' ' ' MET . 28.0 mt -95.79 -42.03 8.55 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.47 32.77 67.86 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.3 mt -110.49 165.15 12.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.651 1.581 . . . . 0.0 107.111 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.61 161.65 30.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.706 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -46.6 86.85 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.637 0.775 . . . . 0.0 111.527 -171.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.85 -32.24 82.18 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.3 m -59.44 -65.56 0.65 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 118.169 -0.919 . . . . 0.0 108.576 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.426 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.7 m -59.65 -37.22 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 120.143 1.338 . . . . 0.0 112.893 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 t -57.47 -40.54 78.78 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.642 -0.661 . . . . 0.0 111.102 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.37 -45.13 95.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.468 0.707 . . . . 0.0 110.563 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.0 mt -60.28 -43.05 92.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -70.57 -35.89 73.3 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 123.743 0.817 . . . . 0.0 112.491 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.41 -45.71 79.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.308 1.043 . . . . 0.0 110.269 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -134.68 79.48 52.87 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 125.364 1.466 . . . . 0.0 109.336 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -72.03 103.96 1.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.733 2.289 . . . . 0.0 106.968 168.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -80.71 163.8 54.38 Favored Pre-proline 0 N--CA 1.443 -0.82 0 C-N-CA 125.335 1.454 . . . . 0.0 108.195 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -56.68 139.94 89.41 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.093 2.529 . . . . 0.0 108.83 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.412 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 33.0 t-105 -50.65 -47.49 58.54 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.589 1.086 . . . . 0.0 110.537 173.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -21.38 32.83 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 176.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -77.74 -35.14 52.2 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.513 1.506 . . . . 0.0 110.418 177.707 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.4 mt -78.77 163.82 25.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.072 0.949 . . . . 0.0 108.756 -174.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.7 p -123.52 -177.33 3.69 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.449 1.9 . . . . 0.0 107.282 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.3 m -44.61 -53.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 121.855 2.116 . . . . 0.0 113.821 -170.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 -21.73 59.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.912 0.863 . . . . 0.0 112.844 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.25 -38.18 87.33 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.352 1.453 . . . . 0.0 112.624 165.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -90.58 -27.15 19.31 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.311 1.844 . . . . 0.0 112.204 -172.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -37.05 -58.39 1.12 Allowed Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 129.781 3.232 . . . . 0.0 111.282 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.47 -49.54 3.32 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.999 1.799 . . . . 0.0 110.431 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -58.93 -34.92 72.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.006 -0.997 . . . . 0.0 112.568 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.03 -54.52 33.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 119.423 1.01 . . . . 0.0 108.59 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -56.2 -50.52 70.99 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 124.224 1.009 . . . . 0.0 108.989 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.508 ' HG2' HD21 ' A' ' 45' ' ' LEU . 65.3 mtm -59.57 -48.97 79.56 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.856 -0.527 . . . . 0.0 111.991 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.748 ' HD2' HD22 ' A' ' 17' ' ' LEU . 8.8 tttm -58.4 -37.16 74.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.438 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -74.51 -38.1 62.93 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.086 1.312 . . . . 0.0 111.376 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.5 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 4.9 t80 -56.38 -40.06 73.96 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.556 1.142 . . . . 0.0 109.163 173.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.4 mt -73.46 -19.8 60.86 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 117.706 -1.14 . . . . 0.0 113.015 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.6 m -61.29 -32.44 72.28 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.642 1.565 . . . . 0.0 111.098 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -137.89 117.01 12.55 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.981 1.312 . . . . 0.0 108.549 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -57.86 -16.41 11.7 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.695 1.598 . . . . 0.0 112.84 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.46 ' HA ' HD12 ' A' ' 87' ' ' LEU . 16.8 mm-40 -57.78 -21.67 42.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 120.274 -1.516 . . . . 0.0 112.798 171.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.5 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 63.6 m-80 -70.43 -49.42 48.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.781 1.173 . . . . 0.0 110.813 177.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.24 -33.54 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 119.587 1.085 . . . . 0.0 110.572 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 84' ' ' GLN . 38.4 mt -62.31 -43.47 98.74 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.92 -2.76 13.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.267 1.427 . . . . 0.0 113.851 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.86 -18.79 20.08 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.584 1.538 . . . . 0.0 115.145 167.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -65.96 -51.12 61.32 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.431 1.469 . . . . 0.0 111.484 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 m -53.99 -36.72 63.22 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 117.322 -1.323 . . . . 0.0 110.685 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.7 mt -64.62 -34.5 70.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 CA-C-N 120.622 1.556 . . . . 0.0 110.532 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 . . . . . 0 N--CA 1.455 -0.224 0 O-C-N 121.113 -0.992 . . . . 0.0 110.662 -175.673 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.541 HD22 ' CD ' ' A' ' 77' ' ' LYS . 8.3 mt . . . . . 0 N--CA 1.455 -0.211 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.45 100.98 10.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 122.373 1.082 . . . . 0.0 109.031 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 p -59.42 -47.77 84.18 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.138 1.375 . . . . 0.0 111.415 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.66 -24.2 66.59 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.553 0.741 . . . . 0.0 111.529 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -80.57 -55.75 4.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 117.454 -1.26 . . . . 0.0 108.588 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.489 HD11 ' HB3' ' A' ' 17' ' ' LEU . 57.0 mt -48.98 -51.82 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 120.03 1.287 . . . . 0.0 108.426 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.68 -49.15 65.86 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.632 1.173 . . . . 0.0 111.741 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -62.86 -50.76 69.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.814 0.846 . . . . 0.0 110.301 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -60.21 -39.52 86.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.773 1.229 . . . . 0.0 111.537 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.5 HG21 ' SD ' ' A' ' 76' ' ' MET . 90.6 t -61.29 -49.73 83.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 O-C-N 120.902 -1.123 . . . . 0.0 108.82 172.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -59.99 -30.31 69.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 116.604 -1.665 . . . . 0.0 112.119 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.6 -65.25 0.71 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.514 1.506 . . . . 0.0 108.848 169.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.563 ' HB3' HG21 ' A' ' 86' ' ' VAL . 5.1 mm-40 -56.35 -39.71 73.3 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.66 1.184 . . . . 0.0 113.286 -171.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.8 mt -61.75 -51.03 70.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.58 -29.92 70.34 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.375 0.67 . . . . 0.0 112.276 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -57.95 -25.7 61.29 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.304 1.442 . . . . 0.0 111.645 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -128.34 16.51 6.59 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.074 1.35 . . . . 0.0 112.042 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 m120 35.88 70.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 128.478 2.711 . . . . 0.0 111.926 -167.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.0 mt -100.93 147.54 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.38 133.37 11.77 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -35.04 68.77 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.704 0.802 . . . . 0.0 112.987 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.4 ttt-85 -54.41 -54.68 37.44 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.299 0.64 . . . . 0.0 111.158 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.83 -47.93 87.81 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.13 -47.27 75.27 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.714 0.688 . . . . 0.0 111.229 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.4 -27.1 70.38 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-O 117.112 -1.938 . . . . 0.0 112.443 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -70.89 -45.41 64.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.061 2.431 . . . . 0.0 110.431 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -87.67 -67.84 0.8 Allowed 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 121.766 -0.584 . . . . 0.0 111.091 -170.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.45 -44.03 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -171.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.0 mt -99.06 -39.99 8.24 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.169 0.588 . . . . 0.0 111.983 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.91 50.36 53.23 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -172.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -129.12 167.84 16.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.648 1.979 . . . . 0.0 107.25 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 t -66.69 157.02 33.69 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.968 0.89 . . . . 0.0 109.629 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -59.89 -27.32 66.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.915 0.886 . . . . 0.0 111.445 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.04 -48.34 26.87 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -54.38 -63.7 1.07 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.601 1.16 . . . . 0.0 110.211 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -58.45 -39.01 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 119.294 0.952 . . . . 0.0 111.767 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -62.06 -38.43 88.73 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.24 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -59.41 -47.57 84.95 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.937 1.244 . . . . 0.0 108.993 169.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.437 HG21 HD13 ' A' ' 55' ' ' ILE . 16.6 mt -60.13 -41.56 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -176.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -70.13 -40.79 74.61 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 124.525 1.13 . . . . 0.0 111.537 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.77 -37.39 86.21 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.114 1.366 . . . . 0.0 110.747 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -139.16 70.38 40.97 Favored Pre-proline 0 C--O 1.235 0.295 0 C-N-CA 126.815 2.046 . . . . 0.0 107.658 -171.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.39 93.36 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.01 2.474 . . . . 0.0 107.609 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -67.11 160.36 71.19 Favored Pre-proline 0 N--CA 1.436 -1.157 0 O-C-N 121.736 -0.602 . . . . 0.0 109.557 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -58.44 144.65 96.41 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.367 2.044 . . . . 0.0 108.486 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.498 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 65.6 t-105 -52.77 -49.58 65.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.529 0.604 . . . . 0.0 110.734 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.6 -25.71 11.42 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 176.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.52 -18.74 47.57 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 120.005 1.275 . . . . 0.0 113.27 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.7 mt -86.95 162.57 17.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.451 0.643 . . . . 0.0 111.424 -169.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.6 p -94.04 -178.86 4.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.97 2.108 . . . . 0.0 109.892 168.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.4 m -58.57 -45.17 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 119.331 0.969 . . . . 0.0 111.724 169.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -60.31 -33.11 71.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 119.519 -0.276 . . . . 0.0 111.631 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.66 96.76 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.103 1.335 . . . . 0.0 112.516 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 91.1 mttt -79.61 -26.91 41.09 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.472 1.509 . . . . 0.0 112.934 -175.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -43.69 -57.8 5.33 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 125.892 1.677 . . . . 0.0 110.441 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.49 -43.49 13.58 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.727 1.618 . . . . 0.0 112.366 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -64.61 -36.45 84.27 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 120.273 -1.517 . . . . 0.0 112.24 -174.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.35 -55.28 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -51.52 -48.7 62.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.064 0.946 . . . . 0.0 110.204 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.5 ' SD ' HG21 ' A' ' 26' ' ' VAL . 62.7 mtm -61.86 -46.52 89.07 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 120.966 -1.084 . . . . 0.0 112.394 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.541 ' CD ' HD22 ' A' ' 17' ' ' LEU . 16.9 tttm -63.18 -39.65 95.26 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.07 -1.019 . . . . 0.0 110.936 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -67.2 -36.83 82.57 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.216 1.007 . . . . 0.0 110.107 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.496 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.2 t80 -61.21 -40.5 94.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.917 0.887 . . . . 0.0 110.517 174.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.4 mt -72.77 -8.82 57.28 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.346 1.058 . . . . 0.0 112.666 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.42 -13.1 59.42 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.871 1.269 . . . . 0.0 111.887 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -157.28 119.03 3.74 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.052 -1.03 . . . . 0.0 109.419 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -25.65 65.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.163 0.985 . . . . 0.0 113.645 -170.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -64.41 -18.64 64.9 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 119.705 -1.872 . . . . 0.0 111.909 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.496 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 55.2 m-80 -59.71 -48.52 81.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.826 0.739 . . . . 0.0 111.003 176.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.563 HG21 ' HB3' ' A' ' 29' ' ' GLN . 4.0 p -71.55 -33.82 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 121.811 -0.555 . . . . 0.0 109.87 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 mt -63.54 -42.4 98.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.87 73.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.057 0.39 . . . . 0.0 111.567 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.49 HD22 HD12 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -70.51 -24.64 62.87 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.947 0.899 . . . . 0.0 112.234 178.736 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.5 mtp-105 -61.97 -47.89 82.84 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 118.827 0.74 . . . . 0.0 110.298 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.0 m -51.78 -46.83 64.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.899 0.88 . . . . 0.0 109.318 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.49 HD12 HD22 ' A' ' 89' ' ' LEU . 53.6 mt -64.86 -35.24 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 122.908 0.483 . . . . 0.0 110.277 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 117.922 -1.037 . . . . 0.0 111.066 178.721 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.421 ' HB3' HD11 ' A' ' 22' ' ' ILE . 3.8 mt . . . . . 0 C--O 1.234 0.254 0 N-CA-C 110.77 -0.085 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -71.96 105.44 3.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.876 0.846 . . . . 0.0 109.399 177.466 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.452 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 19.2 p -68.72 -40.63 79.83 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.513 -0.742 . . . . 0.0 112.268 -177.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.83 66.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.928 0.785 . . . . 0.0 111.044 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 4.0 tt0 -81.03 -52.78 7.04 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.319 1.448 . . . . 0.0 109.068 176.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' A' ' 17' ' ' LEU . 66.7 mt -56.13 -44.39 78.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 119.099 0.863 . . . . 0.0 109.916 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.57 85.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.551 0.74 . . . . 0.0 110.867 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.437 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 48.3 t80 -61.91 -53.92 49.11 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.078 0.951 . . . . 0.0 110.835 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -56.91 -38.98 73.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.114 1.365 . . . . 0.0 110.543 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.18 -50.76 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 120.68 -1.263 . . . . 0.0 109.81 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 40.9 mtmt -54.52 -48.22 72.18 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 116.991 -1.481 . . . . 0.0 110.726 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -47.41 71.44 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 116.944 -1.503 . . . . 0.0 111.402 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -56.37 -45.07 80.67 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 121.044 1.747 . . . . 0.0 112.48 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.2 -49.25 72.74 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.72 -33.49 70.26 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.454 1.025 . . . . 0.0 111.948 174.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -59.1 -20.27 51.96 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 126.114 1.766 . . . . 0.0 111.992 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -128.69 15.62 6.45 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 169.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 44.96 60.48 2.94 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 128.042 2.537 . . . . 0.0 111.765 -168.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.6 mt -98.32 154.05 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 174.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.54 150.8 18.09 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.921 0.772 . . . . 0.0 111.725 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -73.99 -14.36 61.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.96 1.304 . . . . 0.0 114.359 -177.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -70.97 -57.72 4.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.502 1.501 . . . . 0.0 109.973 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -56.0 -48.07 79.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -57.95 -41.31 82.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.758 1.163 . . . . 0.0 111.179 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.3 -26.54 67.96 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-O 117.184 -1.898 . . . . 0.0 112.58 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -74.32 -40.76 62.01 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.35 2.075 . . . . 0.0 110.658 173.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -90.93 -64.11 1.18 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.541 1.137 . . . . 0.0 111.803 -169.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.29 -36.85 74.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.3 mt -109.21 -43.86 4.06 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.062 0.545 . . . . 0.0 110.865 -166.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.45 31.79 53.35 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.093 0.854 . . . . 0.0 112.146 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.9 mt -109.08 159.39 16.91 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.578 1.551 . . . . 0.0 108.824 -175.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t -63.0 160.56 14.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.461 0.648 . . . . 0.0 110.114 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -54.11 -42.48 69.47 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.426 1.09 . . . . 0.0 112.528 -165.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.02 -10.01 57.81 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 118.427 -1.207 . . . . 0.0 113.637 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 m -62.4 -57.96 9.39 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.343 1.571 . . . . 0.0 108.99 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.31 -35.47 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.193 0.906 . . . . 0.0 112.081 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.6 t -59.28 -40.34 85.78 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.007 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.4 -46.49 88.53 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 119.311 0.96 . . . . 0.0 109.779 169.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.487 HG23 ' CZ ' ' A' ' 73' ' ' PHE . 1.7 mt -58.18 -30.41 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.114 1.325 . . . . 0.0 110.022 -176.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -87.73 -26.11 23.1 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.985 0.914 . . . . 0.0 113.122 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.98 -41.72 22.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.684 1.594 . . . . 0.0 110.798 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 mmt-85 -135.27 73.62 63.58 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 129.635 3.174 . . . . 0.0 106.367 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -69.68 95.25 0.54 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 N-CA-C 105.825 -2.414 . . . . 0.0 105.825 168.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -67.05 155.9 89.14 Favored Pre-proline 0 N--CA 1.432 -1.373 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.481 ' HD2' ' HG3' ' A' ' 64' ' ' LYS . 6.1 Cg_exo -58.28 149.61 72.11 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.628 2.219 . . . . 0.0 109.889 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -51.21 -50.25 59.46 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.52 0.328 . . . . 0.0 110.261 172.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.417 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -64.24 2.1 0.63 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 176.152 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HG3' ' HD2' ' A' ' 61' ' ' PRO . 14.6 mmmt -98.76 -20.7 16.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.522 1.51 . . . . 0.0 112.014 167.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.6 mt -99.81 149.84 22.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.627 0.649 . . . . 0.0 109.629 -164.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.3 t -87.53 179.39 6.56 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.3 p -43.14 -58.54 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 124.693 1.197 . . . . 0.0 112.101 173.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.78 -17.0 63.79 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.85 -39.61 23.97 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 126.34 1.924 . . . . 0.0 112.953 167.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -83.5 -25.12 31.36 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.451 2.301 . . . . 0.0 111.961 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -45.78 -53.29 21.03 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 128.219 2.608 . . . . 0.0 111.61 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.17 -48.4 10.12 Favored 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 121.338 1.359 . . . . 0.0 109.851 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 55' ' ' ILE . 69.1 m-85 -63.35 -33.39 75.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.437 -174.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.8 mt -60.46 -54.51 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.969 1.259 . . . . 0.0 108.081 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -54.05 -51.42 64.1 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.803 0.841 . . . . 0.0 109.689 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.3 mtm -60.8 -47.04 88.14 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.833 0.853 . . . . 0.0 112.02 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -59.0 -38.79 80.01 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.953 -1.092 . . . . 0.0 110.492 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -71.05 -37.97 72.52 Favored 'General case' 0 C--O 1.227 -0.108 0 O-C-N 121.702 -0.624 . . . . 0.0 111.361 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.494 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 16.8 t80 -54.31 -42.96 70.71 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.664 1.186 . . . . 0.0 109.57 171.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.8 mt -74.89 -13.16 60.51 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.615 -0.678 . . . . 0.0 112.448 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 m -80.9 2.64 25.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.667 0.787 . . . . 0.0 112.294 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -157.3 132.3 8.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.984 1.266 . . . . 0.0 108.269 162.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.22 -26.59 60.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.793 0.837 . . . . 0.0 112.174 175.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.412 ' HA ' HD12 ' A' ' 87' ' ' LEU . 14.2 mm-40 -54.1 -28.6 40.37 Favored 'General case' 0 C--N 1.338 0.106 0 O-C-N 120.027 -1.671 . . . . 0.0 113.559 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.494 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 52.4 m-80 -64.9 -50.27 67.17 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 119.289 0.949 . . . . 0.0 110.135 177.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.64 -34.98 68.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 O-C-N 121.529 -0.732 . . . . 0.0 110.464 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 84' ' ' GLN . 83.8 mt -59.68 -48.63 80.9 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.49 85.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 122.943 0.497 . . . . 0.0 111.666 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.426 HD22 HD12 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -64.85 -24.4 67.53 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.583 1.153 . . . . 0.0 111.683 -178.552 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -58.47 -49.12 78.49 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 119.048 0.84 . . . . 0.0 110.242 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 m -55.94 -44.8 78.75 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.098 0.408 . . . . 0.0 110.161 177.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.426 HD12 HD22 ' A' ' 89' ' ' LEU . 18.3 mt -63.07 -31.19 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.234 -0.917 . . . . 0.0 111.131 -177.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 123.376 0.67 . . . . 0.0 111.465 176.81 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.499 ' HB3' HD11 ' A' ' 22' ' ' ILE . 5.8 mt . . . . . 0 C--O 1.235 0.297 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -71.76 99.79 2.23 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 122.295 1.045 . . . . 0.0 108.572 176.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 24.2 p -59.57 -40.58 87.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.156 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.76 -31.05 72.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 119.102 -0.475 . . . . 0.0 111.908 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -74.96 -50.27 17.25 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.664 1.186 . . . . 0.0 108.907 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 17' ' ' LEU . 67.2 mt -56.11 -47.39 80.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.31 92.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.269 -0.894 . . . . 0.0 111.987 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -62.92 -66.66 0.51 Allowed 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.461 1.504 . . . . 0.0 109.183 172.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -49.83 -38.67 35.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.24 1.816 . . . . 0.0 112.985 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 t -63.75 -43.53 98.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 121.293 -0.88 . . . . 0.0 110.25 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -60.44 -43.63 96.62 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.683 0.674 . . . . 0.0 109.413 175.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -57.01 -49.13 76.73 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.076 0.551 . . . . 0.0 110.467 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -63.25 -38.05 89.64 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.915 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mt -62.46 -43.07 99.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 120.515 1.507 . . . . 0.0 109.915 172.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.05 -45.33 79.29 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.992 0.815 . . . . 0.0 111.337 168.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -52.94 -40.81 63.93 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.626 1.97 . . . . 0.0 113.96 -168.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -121.83 16.19 10.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.963 1.305 . . . . 0.0 111.282 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 43.41 72.22 0.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.244 2.618 . . . . 0.0 111.561 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.3 mt -112.49 155.8 13.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.62 144.41 17.28 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 124.207 0.908 . . . . 0.0 110.935 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -62.52 -37.52 86.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.902 1.681 . . . . 0.0 112.194 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.8 ttt-85 -57.43 -54.51 46.06 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 117.66 -1.162 . . . . 0.0 109.822 173.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.3 -36.13 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.63 1.559 . . . . 0.0 111.338 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -61.11 -55.86 27.55 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.492 -0.755 . . . . 0.0 111.25 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.41 -26.31 74.67 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-O 118.008 -1.44 . . . . 0.0 112.458 -174.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -78.75 -27.81 44.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 120.083 1.942 . . . . 0.0 110.784 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -106.73 -62.25 1.42 Allowed 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.925 0.89 . . . . 0.0 112.049 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.57 -45.77 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.48 HD21 ' HG2' ' A' ' 76' ' ' MET . 28.9 mt -94.99 -37.44 11.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.113 -174.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.18 2.66 90.58 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.682 0.658 . . . . 0.0 112.747 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.6 mt -89.77 168.18 12.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.048 1.424 . . . . 0.0 107.794 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.0 m -76.39 162.19 28.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.473 -0.767 . . . . 0.0 110.785 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -56.95 -46.9 81.8 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.667 0.787 . . . . 0.0 111.868 -172.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.49 73.12 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 119.57 -0.572 . . . . 0.0 112.022 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 m -65.41 -62.35 1.58 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.035 0.918 . . . . 0.0 109.454 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.69 -34.62 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 119.789 1.177 . . . . 0.0 112.041 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -57.0 -42.1 79.65 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.013 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.0 -44.91 87.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.48 0.582 . . . . 0.0 109.672 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 mt -62.28 -38.56 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -174.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.0 mt -83.98 -15.07 49.11 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.056 0.943 . . . . 0.0 112.771 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.7 -52.64 6.25 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.596 1.558 . . . . 0.0 108.525 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.9 81.45 58.0 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 127.972 2.509 . . . . 0.0 107.568 -173.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.43 101.83 0.91 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 N-CA-C 106.426 -2.182 . . . . 0.0 106.426 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -67.49 161.72 62.79 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -56.19 144.24 81.82 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.526 2.817 . . . . 0.0 109.505 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -52.11 -50.64 61.26 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.253 0.621 . . . . 0.0 109.808 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -17.91 12.57 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 175.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 1.9 mmpt? -82.84 -31.66 27.94 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.429 1.468 . . . . 0.0 111.103 174.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.6 mt -71.88 174.77 6.49 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.814 1.292 . . . . 0.0 111.591 -167.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 p -111.19 179.89 3.91 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.779 1.232 . . . . 0.0 108.135 167.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.7 m -52.67 -45.6 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.366 1.439 . . . . 0.0 113.02 169.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -66.4 -22.23 66.23 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.632 1.56 . . . . 0.0 111.888 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.42 -47.62 27.67 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 124.816 1.198 . . . . 0.0 111.548 171.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -71.95 -31.35 66.22 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.742 1.217 . . . . 0.0 111.398 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -42.8 -57.65 4.67 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 127.918 2.487 . . . . 0.0 111.109 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.5 -52.01 3.62 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.0 1.8 . . . . 0.0 110.594 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 19' ' ' THR . 57.3 m-85 -55.08 -38.08 67.62 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.938 1.244 . . . . 0.0 113.345 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.6 mt -58.74 -56.47 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 124.709 1.204 . . . . 0.0 107.993 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -56.91 -42.5 80.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.218 1.007 . . . . 0.0 109.679 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.48 ' HG2' HD21 ' A' ' 45' ' ' LEU . 66.4 mtm -65.14 -51.26 62.3 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 124.299 1.04 . . . . 0.0 112.336 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -62.29 -36.01 80.79 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.028 -1.045 . . . . 0.0 110.296 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -66.12 -42.07 89.69 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.807 -0.558 . . . . 0.0 109.85 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.48 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 14.5 t80 -57.39 -39.06 75.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.163 0.985 . . . . 0.0 110.068 175.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.5 mt -76.57 -12.27 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.7 m -83.17 -21.33 33.56 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.195 -0.941 . . . . 0.0 113.075 -174.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -132.72 130.09 39.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 170.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.15 -46.17 90.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.347 -171.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.671 ' HA ' HD23 ' A' ' 87' ' ' LEU . 9.5 mm-40 -53.95 -18.52 3.53 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.103 2.161 . . . . 0.0 113.321 -166.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.48 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 68.2 m-80 -53.81 -41.82 67.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.086 0.955 . . . . 0.0 111.658 170.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.712 HG12 HD22 ' A' ' 87' ' ' LEU . 4.8 p -73.35 -35.34 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 119.782 1.174 . . . . 0.0 110.97 178.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.712 HD22 HG12 ' A' ' 86' ' ' VAL . 2.5 mm? -64.85 -26.77 68.48 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.436 1.094 . . . . 0.0 109.782 -175.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.45 60.22 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.396 1.078 . . . . 0.0 112.698 167.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -31.44 71.64 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.039 0.936 . . . . 0.0 110.768 -178.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.6 mtm105 -53.98 -42.79 69.37 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.274 0.488 . . . . 0.0 110.015 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.5 m -66.05 -43.36 87.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.646 0.778 . . . . 0.0 110.053 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.8 mt -69.03 -32.35 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.533 -0.73 . . . . 0.0 109.769 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 118.728 -0.654 . . . . 0.0 110.931 174.533 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.48 ' HB3' HD11 ' A' ' 22' ' ' ILE . 7.8 mt . . . . . 0 C--O 1.236 0.389 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.74 107.49 6.87 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 122.155 0.978 . . . . 0.0 110.256 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.429 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 24.5 p -63.11 -44.23 96.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.722 0.809 . . . . 0.0 110.555 -173.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.63 -8.72 56.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.783 0.833 . . . . 0.0 111.732 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.42 -54.47 4.17 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.797 1.239 . . . . 0.0 108.904 167.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 17' ' ' LEU . 68.7 mt -52.32 -50.72 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.204 1.366 . . . . 0.0 109.286 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.56 -33.29 65.98 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.24 1.016 . . . . 0.0 112.95 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -75.56 -57.86 3.63 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.128 0.971 . . . . 0.0 108.496 174.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -52.35 -32.76 39.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.339 1.456 . . . . 0.0 112.034 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.524 HG23 HD11 ' A' ' 80' ' ' LEU . 53.8 t -67.66 -57.09 10.73 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 C-N-CA 124.393 1.077 . . . . 0.0 110.729 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -51.52 -41.43 61.01 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.495 1.043 . . . . 0.0 111.116 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -53.11 -59.36 4.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.008 1.323 . . . . 0.0 110.128 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -62.03 -38.81 90.1 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.474 1.109 . . . . 0.0 113.351 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.1 mt -61.12 -48.09 83.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.08 -37.66 85.87 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.156 0.889 . . . . 0.0 112.856 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -55.87 -33.56 64.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.435 1.894 . . . . 0.0 110.674 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -123.49 11.31 9.24 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.286 1.034 . . . . 0.0 113.073 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 49.03 68.44 0.71 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.64 1.976 . . . . 0.0 112.136 -172.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt -112.23 156.29 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 121.264 -0.897 . . . . 0.0 110.047 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.56 130.71 10.44 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.958 2.218 . . . . 0.0 110.721 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -51.75 -35.79 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.42 1.488 . . . . 0.0 112.096 174.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -58.3 -54.28 48.75 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.773 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.62 -44.63 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -55.69 -51.78 66.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.636 0.255 . . . . 0.0 110.794 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.65 78.27 Favored Glycine 0 N--CA 1.428 -1.86 0 CA-C-O 116.338 -2.368 . . . . 0.0 111.563 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -78.31 -30.79 48.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.812 2.806 . . . . 0.0 111.956 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -101.56 -51.63 3.41 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 123.054 0.542 . . . . 0.0 111.384 -170.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.73 -46.29 24.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -175.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.481 HD21 ' HG2' ' A' ' 76' ' ' MET . 34.0 mt -95.94 -34.53 11.77 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.924 -172.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.72 4.96 88.37 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.389 0.519 . . . . 0.0 112.913 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.5 mt -98.49 158.55 15.53 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.361 1.464 . . . . 0.0 107.41 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.6 m -71.64 164.43 25.92 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.433 -0.792 . . . . 0.0 110.239 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -58.56 -49.59 76.87 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.83 69.73 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.584 -0.564 . . . . 0.0 111.899 -178.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 m -70.88 -62.85 1.24 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.863 1.265 . . . . 0.0 111.357 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 m -60.07 -30.83 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 121.089 1.768 . . . . 0.0 112.273 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.7 t -58.06 -39.23 77.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.52 -1.229 . . . . 0.0 110.394 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.72 -43.28 85.13 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.023 1.283 . . . . 0.0 110.176 171.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.415 HG23 ' CE2' ' A' ' 73' ' ' PHE . 12.0 mt -64.79 -42.59 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -173.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.2 mt -77.1 -29.57 54.92 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.465 0.706 . . . . 0.0 111.848 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.25 -56.41 6.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.746 1.618 . . . . 0.0 111.078 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -135.52 59.39 30.83 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 124.245 1.018 . . . . 0.0 109.708 -165.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -63.35 104.49 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.883 3.056 . . . . 0.0 110.281 -173.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -63.63 157.94 62.86 Favored Pre-proline 0 N--CA 1.434 -1.252 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -65.81 153.87 76.33 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.645 2.896 . . . . 0.0 110.471 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.451 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 73.4 t-105 -55.44 -43.85 75.78 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.368 1.067 . . . . 0.0 111.288 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.529 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -60.77 -19.98 60.43 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 176.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.55 -23.31 27.71 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.558 1.072 . . . . 0.0 112.327 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 29.6 mt -89.38 152.42 21.51 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 119.071 0.851 . . . . 0.0 109.302 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.8 p -105.07 -172.05 2.03 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.933 1.293 . . . . 0.0 109.666 172.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.1 t -47.7 -58.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 120.785 1.63 . . . . 0.0 110.49 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -71.68 -3.08 19.78 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.78 -42.35 6.08 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.881 1.705 . . . . 0.0 112.097 165.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 85.3 mttt -80.88 -25.04 37.89 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.895 2.078 . . . . 0.0 111.844 -174.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.33 -56.31 12.98 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 125.482 1.513 . . . . 0.0 111.328 -175.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.33 -44.53 18.36 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 121.423 1.416 . . . . 0.0 110.311 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.429 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 70.4 m-85 -62.43 -37.46 85.92 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.993 1.269 . . . . 0.0 113.229 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.04 -49.38 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.634 1.106 . . . . 0.0 108.031 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -57.65 -53.29 59.9 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.664 0.786 . . . . 0.0 109.558 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.481 ' HG2' HD21 ' A' ' 45' ' ' LEU . 58.5 mtm -56.75 -50.55 71.91 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.4 0.68 . . . . 0.0 112.27 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tttp -61.72 -40.3 94.58 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.574 -0.704 . . . . 0.0 110.35 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -70.53 -32.06 69.37 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.327 0.967 . . . . 0.0 111.086 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.449 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 11.0 t80 -60.94 -43.23 98.97 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.524 HD11 HG23 ' A' ' 26' ' ' VAL . 19.8 mt -71.89 -9.88 58.97 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.194 0.997 . . . . 0.0 112.413 177.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.8 m -89.44 -2.35 58.36 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.297 1.439 . . . . 0.0 112.543 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -149.73 123.45 9.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 120.141 1.337 . . . . 0.0 109.35 163.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.98 -18.72 64.56 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.821 0.343 . . . . 0.0 111.283 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -68.35 -11.17 59.15 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 119.795 -1.816 . . . . 0.0 113.731 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.449 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 69.0 m-80 -71.82 -57.08 4.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 167.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.41 -34.05 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 O-C-N 121.12 -0.987 . . . . 0.0 110.958 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.2 mt -65.22 -25.88 67.88 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.774 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.46 60.0 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.964 0.906 . . . . 0.0 110.967 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.31 -33.09 74.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.885 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -51.15 -50.58 58.64 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 118.706 0.684 . . . . 0.0 110.227 175.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.1 m -51.42 -50.12 60.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.768 1.227 . . . . 0.0 110.537 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.5 mt -62.94 -37.34 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.638 0.775 . . . . 0.0 109.902 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 . . . . . 0 N--CA 1.452 -0.334 0 O-C-N 121.622 -0.674 . . . . 0.0 110.9 -176.94 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.658 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.2 m 65.5 111.12 0.03 OUTLIER 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.6 1.56 . . . . 0.0 111.867 -174.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 t -131.8 -88.25 0.46 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.91 -177.24 37.37 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.2 p -160.44 131.84 5.8 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.864 0.832 . . . . 0.0 108.907 172.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.0 t -146.89 108.55 4.33 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.27 83.06 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.27 161.18 14.28 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.104 0.452 . . . . 0.0 110.105 174.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.52 71.81 0.04 OUTLIER Glycine 0 CA--C 1.526 0.759 0 CA-C-O 119.147 -0.807 . . . . 0.0 111.589 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -59.4 160.49 19.77 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.52 2.147 . . . . 0.0 110.253 170.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.45 166.82 39.89 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.57 56.01 1.22 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.248 1.419 . . . . 0.0 108.591 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.09 154.59 17.53 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.219 0.608 . . . . 0.0 109.439 167.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -76.38 132.52 39.77 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 147.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.88 179.41 5.87 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.047 1.339 . . . . 0.0 108.689 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -79.38 138.39 37.65 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 121.312 -0.868 . . . . 0.0 109.071 172.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.524 ' HB3' HD11 ' A' ' 22' ' ' ILE . 5.2 mt -128.51 134.39 48.68 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -177.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -72.94 104.17 3.99 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 122.004 0.906 . . . . 0.0 108.688 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 p -66.84 -38.21 85.97 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.457 0.703 . . . . 0.0 110.02 -173.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.07 -29.07 67.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.757 0.708 . . . . 0.0 110.899 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -76.09 -49.28 17.84 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 127.032 2.133 . . . . 0.0 108.836 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' A' ' 17' ' ' LEU . 82.1 mt -57.01 -47.0 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 119.078 0.854 . . . . 0.0 109.293 174.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.426 ' O ' ' HE3' ' A' ' 27' ' ' LYS . . . -56.46 -53.93 51.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.417 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -51.94 -67.79 0.22 Allowed 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.222 1.809 . . . . 0.0 109.245 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -51.72 -37.58 51.51 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.653 1.981 . . . . 0.0 112.945 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -62.94 -52.39 59.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 CA-C-N 119.183 0.901 . . . . 0.0 109.446 174.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 23' ' ' ALA . 22.0 mtmt -55.15 -42.55 73.23 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.418 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -57.66 -56.34 23.18 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.556 0.743 . . . . 0.0 110.775 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -62.19 -35.07 77.72 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.901 0.88 . . . . 0.0 112.589 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.38 -51.39 60.74 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -35.56 73.24 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.372 0.987 . . . . 0.0 112.399 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 tttt -49.95 -33.32 17.25 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 126.636 1.974 . . . . 0.0 110.869 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -128.18 16.29 6.69 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.936 1.294 . . . . 0.0 112.027 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.3 m120 60.16 36.03 21.08 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.878 2.471 . . . . 0.0 112.128 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.5 mt -83.33 157.7 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.36 144.84 16.65 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.923 1.249 . . . . 0.0 112.48 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -55.97 -35.24 66.5 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.943 2.097 . . . . 0.0 113.882 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -59.73 -58.98 6.21 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 120.47 1.486 . . . . 0.0 109.744 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 t -56.44 -44.43 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 119.256 0.934 . . . . 0.0 109.697 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -57.68 -49.7 75.63 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.538 0.608 . . . . 0.0 111.184 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.469 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -72.94 -24.99 74.93 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-O 118.093 -1.393 . . . . 0.0 111.887 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -77.95 -43.15 30.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 118.989 1.394 . . . . 0.0 109.632 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.422 ' CE1' HG21 ' A' ' 92' ' ' ILE . 36.3 m-85 -87.62 -68.19 0.77 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.654 0.381 . . . . 0.0 111.259 -177.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.7 t -62.79 -42.44 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 124.308 1.043 . . . . 0.0 108.268 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.445 HD21 ' HG2' ' A' ' 76' ' ' MET . 28.8 mt -96.08 -43.92 7.55 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.811 -172.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.23 20.16 57.62 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 123.798 0.686 . . . . 0.0 111.863 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -107.81 173.05 6.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.748 1.219 . . . . 0.0 107.9 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.4 m -68.59 159.54 31.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.055 -1.028 . . . . 0.0 111.539 166.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.42 -55.14 11.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.496 1.518 . . . . 0.0 110.337 168.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.53 -34.14 87.35 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 m -62.46 -64.6 0.88 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 116.842 -1.551 . . . . 0.0 110.176 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.469 HG11 ' HA3' ' A' ' 41' ' ' GLY . 3.9 m -60.2 -36.25 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 120.943 1.701 . . . . 0.0 111.867 -176.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.2 t -53.71 -42.33 67.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.585 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.25 -46.73 89.16 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 119.079 0.854 . . . . 0.0 109.805 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.446 HD13 HG21 ' A' ' 55' ' ' ILE . 6.7 mt -61.86 -38.08 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.1 mt -72.53 -32.8 66.41 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.878 1.271 . . . . 0.0 111.346 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.6 -52.3 27.33 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.19 1.396 . . . . 0.0 110.018 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -133.81 71.83 73.88 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 125.792 1.637 . . . . 0.0 108.436 -162.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.11 78.27 3.24 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.411 3.407 . . . . 0.0 110.584 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -54.77 157.13 5.75 Favored Pre-proline 0 N--CA 1.442 -0.859 0 C-N-CA 124.481 1.112 . . . . 0.0 110.306 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -55.34 143.8 74.88 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.132 2.555 . . . . 0.0 110.253 -172.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -55.11 -48.76 73.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.395 0.543 . . . . 0.0 109.935 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -26.28 32.52 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 172.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -34.62 45.87 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 119.703 1.138 . . . . 0.0 111.986 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.2 mt -77.73 148.02 35.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.959 0.885 . . . . 0.0 110.331 -171.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -82.54 178.16 8.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.848 1.659 . . . . 0.0 108.823 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.81 -47.64 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 120.883 1.674 . . . . 0.0 109.177 170.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -66.17 -8.74 25.93 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.878 -1.139 . . . . 0.0 113.724 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.43 -39.09 6.06 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 126.186 1.851 . . . . 0.0 111.655 169.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -78.6 -22.15 47.49 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.531 1.532 . . . . 0.0 111.565 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -44.94 -58.1 6.04 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 127.176 2.191 . . . . 0.0 110.681 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.59 -49.55 7.04 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.613 2.209 . . . . 0.0 111.562 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -60.09 -35.69 75.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 117.685 -1.15 . . . . 0.0 112.816 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.92 -54.41 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -56.42 -42.59 78.29 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.485 1.114 . . . . 0.0 110.69 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.445 ' HG2' HD21 ' A' ' 45' ' ' LEU . 71.1 mtm -67.47 -49.38 63.83 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.787 0.835 . . . . 0.0 111.984 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.494 ' HD2' HD22 ' A' ' 17' ' ' LEU . 15.6 tttm -64.12 -36.11 82.95 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.781 -1.2 . . . . 0.0 110.286 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -63.47 -42.84 98.6 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.397 1.479 . . . . 0.0 110.882 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.53 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 35.5 t80 -54.08 -51.57 63.69 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.684 1.193 . . . . 0.0 108.508 172.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.7 mt -68.51 -13.68 62.48 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m -72.45 -10.05 59.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.938 1.245 . . . . 0.0 112.178 172.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -154.46 115.96 4.13 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.715 1.143 . . . . 0.0 110.17 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -56.41 -26.81 54.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.504 1.522 . . . . 0.0 113.786 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -60.21 -25.05 65.31 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 120.321 1.419 . . . . 0.0 111.838 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.53 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 60.8 m-80 -59.53 -45.41 91.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.425 0.557 . . . . 0.0 110.972 176.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 p -71.39 -36.15 59.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 CA-C-N 118.543 0.611 . . . . 0.0 109.893 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.0 mt -63.13 -42.39 99.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.56 73.73 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.33 -25.78 66.99 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.154 -0.966 . . . . 0.0 111.771 176.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -61.74 -41.25 97.41 Favored 'General case' 0 C--O 1.228 -0.065 0 CA-C-N 119.223 0.919 . . . . 0.0 110.116 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.5 m -55.65 -46.52 77.46 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.689 1.196 . . . . 0.0 110.008 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.422 HG21 ' CE1' ' A' ' 43' ' ' TYR . 44.4 mt -64.19 -33.91 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.911 -0.493 . . . . 0.0 110.133 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -65.88 -24.12 66.79 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.152 -0.967 . . . . 0.0 113.088 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.2 t -70.26 -59.58 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 166.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -77.11 30.41 0.14 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.266 2.226 . . . . 0.0 112.807 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.0 t -84.76 -0.03 52.3 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.274 -0.891 . . . . 0.0 110.855 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 161.1 -172.45 37.36 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 108.039 -2.025 . . . . 0.0 108.039 -163.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.92 75.09 4.96 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.516 2.811 . . . . 0.0 111.748 -174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.1 t -77.73 79.18 4.22 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 164.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.6 m 63.9 171.07 0.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.553 1.941 . . . . 0.0 112.033 -164.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 N-CA-C 104.819 -3.312 . . . . 0.0 104.819 150.298 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.914 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m 67.06 175.29 0.25 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.712 1.205 . . . . 0.0 110.33 -167.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 t -145.77 155.89 43.24 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 164.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.5 116.97 0.61 Allowed Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 107.498 -2.241 . . . . 0.0 107.498 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.9 t -107.41 -48.07 3.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.0 m 59.25 -175.33 0.1 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.306 1.442 . . . . 0.0 111.738 -165.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.47 -95.65 2.05 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 106.893 -2.483 . . . . 0.0 106.893 -172.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 55.83 8.19 0.33 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.611 1.964 . . . . 0.0 115.369 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.81 102.41 2.06 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 117.685 -1.62 . . . . 0.0 111.069 -170.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.49 -159.71 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.238 3.292 . . . . 0.0 110.093 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.32 104.11 0.18 Allowed Glycine 0 C--N 1.337 0.586 0 O-C-N 120.487 -1.383 . . . . 0.0 110.494 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.5 176.73 5.06 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.563 1.145 . . . . 0.0 110.64 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 48.81 -155.09 0.09 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.027 1.331 . . . . 0.0 110.746 -172.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -107.44 174.35 5.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.926 1.69 . . . . 0.0 107.236 163.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -146.59 -175.09 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.187 0.995 . . . . 0.0 110.121 174.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -72.28 125.49 27.47 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.566 ' HB3' HD11 ' A' ' 22' ' ' ILE . 5.0 mt -117.49 114.83 24.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.1 107.61 1.32 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.121 0.486 . . . . 0.0 110.464 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.9 p -68.91 -39.56 79.62 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.707 -0.62 . . . . 0.0 111.976 -169.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.01 73.1 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.992 0.815 . . . . 0.0 110.191 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -78.09 -51.36 10.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.225 1.41 . . . . 0.0 108.463 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 17' ' ' LEU . 74.8 mt -55.94 -43.71 75.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 119.209 0.913 . . . . 0.0 109.095 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.28 -53.45 58.1 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.359 0.664 . . . . 0.0 110.397 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -55.85 -51.14 68.57 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.332 1.053 . . . . 0.0 111.263 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -64.59 -39.74 94.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.698 1.599 . . . . 0.0 110.708 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.6 t -60.85 -49.12 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 O-C-N 120.942 -1.098 . . . . 0.0 109.643 171.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -62.34 -46.18 89.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 117.929 -1.034 . . . . 0.0 111.075 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -64.21 -42.86 96.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.116 0.871 . . . . 0.0 111.223 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -58.1 -44.55 87.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.486 1.114 . . . . 0.0 111.481 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mt -63.55 -49.73 72.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -49.13 -43.51 41.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.509 0.724 . . . . 0.0 111.684 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -60.37 -21.7 62.45 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.469 1.508 . . . . 0.0 113.634 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -128.33 13.25 6.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.892 1.277 . . . . 0.0 113.329 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.5 m120 50.74 71.22 0.44 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.955 2.102 . . . . 0.0 111.561 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.0 mt -118.92 155.41 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 120.658 -1.276 . . . . 0.0 108.392 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.27 145.98 16.74 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.463 1.03 . . . . 0.0 111.177 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -56.89 -34.96 68.4 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.095 1.358 . . . . 0.0 111.69 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -51.78 -61.89 1.97 Allowed 'General case' 0 C--N 1.337 0.063 0 C-N-CA 123.784 0.834 . . . . 0.0 111.606 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.26 -46.68 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.921 0.782 . . . . 0.0 109.588 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -54.85 -46.7 74.71 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.029 0.831 . . . . 0.0 111.762 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.551 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -72.11 -30.95 64.58 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-O 118.25 -1.305 . . . . 0.0 111.752 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -69.81 -36.99 76.12 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.379 1.59 . . . . 0.0 110.54 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -96.22 -67.93 0.82 Allowed 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.999 0.92 . . . . 0.0 111.34 -173.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.7 t -62.68 -60.45 2.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -172.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.529 HD21 ' HG2' ' A' ' 76' ' ' MET . 24.0 mt -76.28 -36.62 58.3 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.929 -172.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.71 16.09 73.93 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.446 -1.196 . . . . 0.0 112.355 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.8 mt -110.64 166.41 11.03 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.239 1.815 . . . . 0.0 109.931 -171.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -60.21 152.61 24.26 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.536 0.684 . . . . 0.0 110.822 168.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -55.29 -38.9 69.22 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.088 1.355 . . . . 0.0 110.338 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.89 -63.95 4.83 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 m -42.4 -69.33 0.14 Allowed 'General case' 0 C--N 1.342 0.268 0 CA-C-O 117.065 -1.445 . . . . 0.0 110.8 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.551 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.2 m -57.75 -42.09 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 120.832 1.651 . . . . 0.0 112.951 -171.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.0 t -60.13 -38.6 83.57 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.286 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -60.08 -47.76 84.55 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.275 1.03 . . . . 0.0 109.868 168.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mt -56.57 -42.39 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.59 -27.52 41.12 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.614 1.166 . . . . 0.0 112.302 -176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.7 -44.5 56.37 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.495 1.518 . . . . 0.0 110.546 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -133.3 73.85 73.29 Favored Pre-proline 0 C--O 1.236 0.359 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 -172.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.46 87.76 1.06 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.174 1.916 . . . . 0.0 107.197 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -57.53 157.04 14.6 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.06 155.86 67.97 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 121.429 1.419 . . . . 0.0 109.23 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -55.33 -42.61 74.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.7 0.4 . . . . 0.0 111.195 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -9.86 40.27 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 175.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -93.58 7.11 45.94 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.314 -1.491 . . . . 0.0 112.922 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.6 mt -124.39 153.8 41.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.463 1.105 . . . . 0.0 108.479 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.1 p -100.56 -175.36 2.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.714 0.806 . . . . 0.0 109.001 172.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.2 t -45.38 -45.35 3.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 119.154 0.888 . . . . 0.0 110.897 169.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -70.48 -38.29 74.36 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.898 1.226 . . . . 0.0 112.873 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.64 -35.01 84.4 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.82 0.724 . . . . 0.0 112.079 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -90.67 -19.69 23.33 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 125.568 1.547 . . . . 0.0 111.723 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -43.28 -55.7 7.7 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 127.572 2.349 . . . . 0.0 109.384 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.61 -50.38 2.53 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.291 1.994 . . . . 0.0 111.354 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -58.0 -35.96 71.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 120.222 1.374 . . . . 0.0 113.702 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.6 mt -57.59 -60.3 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.591 1.556 . . . . 0.0 107.474 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -52.27 -52.04 55.02 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.421 1.089 . . . . 0.0 110.212 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.529 ' HG2' HD21 ' A' ' 45' ' ' LEU . 63.8 mtm -55.39 -51.59 66.34 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.694 0.797 . . . . 0.0 111.464 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -59.75 -38.75 82.62 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.196 -0.94 . . . . 0.0 111.226 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -65.98 -45.09 82.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.423 1.01 . . . . 0.0 110.427 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.455 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 19.6 t80 -49.31 -46.91 47.23 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.963 1.705 . . . . 0.0 110.301 172.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.1 mt -71.84 -13.82 61.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.32 1.11 34.06 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.809 1.644 . . . . 0.0 112.45 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -160.03 118.55 2.7 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.891 1.223 . . . . 0.0 108.635 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -63.1 -19.45 64.44 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.69 1.196 . . . . 0.0 111.781 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -57.23 -30.05 64.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 120.157 -1.589 . . . . 0.0 112.054 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 75.1 m-80 -65.42 -38.21 89.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 119.018 -0.515 . . . . 0.0 110.174 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.83 -34.77 23.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 119.258 0.936 . . . . 0.0 110.317 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.9 mt -63.14 -40.77 98.56 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 123.261 0.624 . . . . 0.0 109.858 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.47 92.89 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.98 0.512 . . . . 0.0 111.252 173.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.482 HD22 HD12 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -65.46 -26.31 67.89 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.08 0.952 . . . . 0.0 112.2 -177.121 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -61.68 -45.19 95.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 118.489 0.586 . . . . 0.0 109.561 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.9 m -49.77 -50.05 46.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.215 1.006 . . . . 0.0 109.442 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.482 HD12 HD22 ' A' ' 89' ' ' LEU . 46.0 mt -65.57 -37.44 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.771 -173.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -60.68 -46.04 91.85 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.48 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.4 m -61.64 -39.39 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 120.119 1.327 . . . . 0.0 109.745 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -76.95 -0.3 23.81 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.05 -1.031 . . . . 0.0 113.016 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.9 t -64.67 -37.44 87.57 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 120.265 1.393 . . . . 0.0 111.363 -173.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.6 -178.16 47.93 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.152 0.887 . . . . 0.0 112.498 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.27 -176.01 2.49 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.309 3.339 . . . . 0.0 111.406 173.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.3 t 62.11 -167.42 0.2 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.396 1.478 . . . . 0.0 110.043 -162.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.4 t -138.03 -168.38 2.34 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.883 1.673 . . . . 0.0 108.762 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 N-CA-C 106.896 -2.481 . . . . 0.0 106.896 -177.368 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.552 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.63 166.07 33.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.271 1.428 . . . . 0.0 107.378 173.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.3 p -109.32 156.22 20.24 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 164.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.52 131.55 1.88 Allowed Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 106.113 -2.795 . . . . 0.0 106.113 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.4 m -154.7 93.72 1.6 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.175 0.987 . . . . 0.0 108.386 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.78 169.25 13.39 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 122.034 -0.416 . . . . 0.0 110.598 171.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.21 -160.96 25.87 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 163.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.44 164.36 21.03 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.332 -0.511 . . . . 0.0 109.993 150.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.52 71.08 0.36 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 172.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.24 107.36 2.42 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.583 2.855 . . . . 0.0 111.571 -168.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.11 -153.52 20.24 Favored Glycine 0 C--O 1.243 0.682 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 165.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.34 159.43 41.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.412 1.485 . . . . 0.0 108.728 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 50.7 -151.57 0.21 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.146 1.779 . . . . 0.0 111.771 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.56 119.47 22.57 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.453 ' HG3' HD23 ' A' ' 17' ' ' LEU . 11.7 pt-20 -127.4 -147.61 0.36 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.405 1.082 . . . . 0.0 108.535 -173.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -112.48 118.65 35.74 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.894 1.678 . . . . 0.0 106.619 171.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.53 HD22 ' HD2' ' A' ' 77' ' ' LYS . 3.3 mt -109.09 142.53 39.7 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.41 101.46 4.8 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 122.291 1.043 . . . . 0.0 109.256 171.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.0 p -62.95 -38.96 93.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.586 -0.696 . . . . 0.0 111.477 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.77 70.72 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.107 0.867 . . . . 0.0 111.9 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -75.39 -53.05 9.35 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.357 1.463 . . . . 0.0 108.124 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 17' ' ' LEU . 72.0 mt -55.34 -44.02 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.35 0.66 . . . . 0.0 109.306 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.26 -47.88 83.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.406 0.682 . . . . 0.0 111.008 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.422 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 27.5 t80 -60.68 -50.22 74.38 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.329 1.052 . . . . 0.0 110.345 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -59.69 -45.4 92.2 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.746 1.618 . . . . 0.0 110.327 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.95 -50.83 78.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 O-C-N 120.424 -1.422 . . . . 0.0 109.077 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 50.0 mtmt -54.99 -41.88 71.76 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.455 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.41 -36.71 68.71 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 117.471 -1.252 . . . . 0.0 113.336 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.423 ' HB3' HG21 ' A' ' 86' ' ' VAL . 4.6 mm-40 -62.3 -41.23 98.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.415 1.916 . . . . 0.0 111.608 174.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.27 -44.71 95.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.21 -0.932 . . . . 0.0 108.54 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -58.07 -48.04 81.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 171.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -55.56 -30.3 60.54 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 127.051 2.141 . . . . 0.0 111.791 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -128.27 11.91 6.47 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.62 64.27 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.779 2.032 . . . . 0.0 112.111 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -107.63 150.84 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.8 135.3 13.83 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.79 1.186 . . . . 0.0 110.876 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -54.07 -37.37 64.13 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.609 0.764 . . . . 0.0 110.552 169.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -54.05 -64.48 0.81 Allowed 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.409 -1.281 . . . . 0.0 111.198 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t -52.74 -48.12 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 120.141 1.337 . . . . 0.0 110.07 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -55.3 -46.4 76.22 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.431 0.56 . . . . 0.0 111.88 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.536 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -73.39 -34.64 57.29 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-O 118.081 -1.4 . . . . 0.0 111.597 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.92 -32.23 73.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 119.331 1.565 . . . . 0.0 109.505 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.414 ' CE1' HG21 ' A' ' 92' ' ' ILE . 40.7 m-85 -103.15 -72.57 0.69 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.563 1.145 . . . . 0.0 111.907 -175.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.75 -43.85 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -168.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.527 HD21 ' HG2' ' A' ' 76' ' ' MET . 28.7 mt -96.48 -33.4 11.87 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -171.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.03 30.32 38.64 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 123.439 0.462 . . . . 0.0 112.017 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.7 mt -125.07 157.8 35.37 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.765 1.283 . . . . 0.0 110.464 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.8 t -60.39 160.48 8.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.683 1.193 . . . . 0.0 110.367 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.82 -55.82 26.07 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.342 1.057 . . . . 0.0 110.886 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.18 -30.42 75.61 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-O 119.095 -0.836 . . . . 0.0 111.711 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.9 m -58.84 -57.81 11.4 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 116.832 -1.556 . . . . 0.0 109.856 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.536 HG11 ' HA3' ' A' ' 41' ' ' GLY . 3.0 m -66.78 -36.69 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 121.857 2.117 . . . . 0.0 113.617 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.1 t -62.43 -31.22 71.9 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.694 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -59.81 -49.72 76.61 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.857 1.208 . . . . 0.0 110.964 164.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 mt -55.44 -43.94 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.062 0.846 . . . . 0.0 108.986 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -79.3 -13.72 59.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.501 1.121 . . . . 0.0 112.861 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.86 -58.07 2.68 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.717 1.607 . . . . 0.0 109.905 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 mtp85 -124.64 78.29 63.47 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 125.089 1.355 . . . . 0.0 107.876 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.33 93.76 0.75 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.07 2.513 . . . . 0.0 107.523 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -63.26 165.85 9.98 Favored Pre-proline 0 N--CA 1.436 -1.146 0 C-N-CA 123.79 0.836 . . . . 0.0 110.266 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -56.13 142.45 86.37 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.611 2.207 . . . . 0.0 110.331 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -53.3 -47.31 69.32 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.964 0.802 . . . . 0.0 109.804 173.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -20.31 33.87 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 174.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -85.15 -24.37 28.0 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.874 1.215 . . . . 0.0 111.77 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.6 mt -86.38 167.34 14.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.42 0.688 . . . . 0.0 109.155 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.5 p -129.12 -172.25 2.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 117.081 -1.437 . . . . 0.0 108.62 172.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.5 t -43.58 -56.43 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 120.756 1.616 . . . . 0.0 111.63 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -74.51 -15.87 60.86 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.234 -1.541 . . . . 0.0 113.665 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.68 -42.42 47.01 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.374 1.464 . . . . 0.0 111.45 167.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -85.81 -26.13 25.91 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 127.045 2.138 . . . . 0.0 111.669 -173.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -42.15 -57.28 4.48 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 127.817 2.447 . . . . 0.0 111.475 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.07 -49.71 4.6 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.531 1.487 . . . . 0.0 109.69 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -57.23 -39.38 75.42 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.654 -1.165 . . . . 0.0 112.976 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.3 mt -57.69 -55.52 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.559 1.144 . . . . 0.0 108.367 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -59.51 -45.06 92.79 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.032 0.533 . . . . 0.0 109.592 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.527 ' HG2' HD21 ' A' ' 45' ' ' LEU . 67.0 mtm -57.8 -50.08 74.47 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 123.505 0.722 . . . . 0.0 111.07 175.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.53 ' HD2' HD22 ' A' ' 17' ' ' LEU . 19.1 tttm -59.8 -44.1 94.12 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.794 -0.566 . . . . 0.0 110.278 -175.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -73.82 -28.04 61.42 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.298 -0.876 . . . . 0.0 112.133 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.443 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 34.3 t80 -60.87 -53.15 60.82 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.926 1.291 . . . . 0.0 107.943 169.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.0 mt -64.82 -22.4 66.98 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.319 1.047 . . . . 0.0 113.307 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.9 m -62.8 -21.58 65.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.914 1.234 . . . . 0.0 111.0 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -143.99 115.8 8.25 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.112 1.323 . . . . 0.0 109.947 -173.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.7 -18.56 64.13 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.569 1.148 . . . . 0.0 111.861 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -64.68 -21.14 66.67 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.482 -2.011 . . . . 0.0 112.181 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.443 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 69.9 m-80 -67.36 -53.36 30.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.854 1.206 . . . . 0.0 110.053 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 29' ' ' GLN . 12.5 p -60.87 -35.09 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.033 -1.042 . . . . 0.0 111.133 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.58 -34.66 78.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.661 0.664 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.45 81.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 111.533 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.95 -26.02 68.4 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.399 -0.813 . . . . 0.0 110.873 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 mtp-105 -60.18 -50.89 71.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 118.529 0.604 . . . . 0.0 110.581 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.0 m -50.06 -45.69 52.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.032 0.833 . . . . 0.0 110.163 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.414 HG21 ' CE1' ' A' ' 43' ' ' TYR . 66.1 mt -64.51 -32.97 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.871 -0.518 . . . . 0.0 111.117 -178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -65.4 -40.67 93.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.186 -0.946 . . . . 0.0 111.373 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.471 HG12 ' HB3' ' A' ' 100' ' ' SER . 0.8 OUTLIER -65.13 -36.65 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -83.27 33.04 0.45 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.18 1.792 . . . . 0.0 111.186 171.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.6 t -122.54 -17.45 6.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.167 1.387 . . . . 0.0 109.744 170.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.46 -179.04 33.51 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.6 1.572 . . . . 0.0 110.14 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.69 99.79 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.127 2.551 . . . . 0.0 109.2 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 58.5 m -165.0 168.63 17.25 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 129.181 2.992 . . . . 0.0 106.724 166.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.471 ' HB3' HG12 ' A' ' 94' ' ' VAL . 7.1 t 57.38 80.33 0.17 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.778 1.231 . . . . 0.0 111.665 175.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 174.332 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.572 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 m 58.75 -179.15 0.08 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 117.698 0.749 . . . . 0.0 110.514 -164.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.1 m 53.69 2.78 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 119.004 2.964 . . . . 0.0 119.004 162.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.63 142.39 3.77 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 121.927 2.149 . . . . 0.0 111.736 172.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.7 m -144.52 101.54 3.69 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.843 1.657 . . . . 0.0 107.178 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.7 m -147.78 114.67 6.11 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 124.083 0.953 . . . . 0.0 108.792 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.75 100.86 0.53 Allowed Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.84 155.98 39.24 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 117.565 0.682 . . . . 0.0 109.512 164.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.22 118.34 4.94 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 168.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -81.93 154.76 17.42 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 CA-C-N 120.702 2.251 . . . . 0.0 110.495 172.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.2 -148.78 17.04 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -170.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.2 -105.41 0.27 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.989 1.715 . . . . 0.0 111.697 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -125.28 -166.97 1.61 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.652 1.181 . . . . 0.0 109.883 -172.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -79.0 76.64 5.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.806 1.642 . . . . 0.0 110.034 -167.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -62.1 161.61 10.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 127.483 2.313 . . . . 0.0 110.814 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.426 ' HA ' ' CD1' ' A' ' 62' ' ' TRP . 10.0 mp0 -97.27 87.47 4.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 169.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt -56.72 134.57 54.94 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -69.75 98.38 1.2 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.052 0.453 . . . . 0.0 110.03 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 p -63.38 -41.15 98.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.529 -0.732 . . . . 0.0 111.818 -175.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.02 77.74 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.847 0.749 . . . . 0.0 111.334 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -75.12 -47.89 26.42 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 126.218 1.807 . . . . 0.0 108.653 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.3 mt -55.08 -50.86 59.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.51 -52.17 62.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.64 0.776 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -52.52 -69.79 0.1 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 126.533 1.933 . . . . 0.0 108.666 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -49.8 -40.41 41.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.645 1.978 . . . . 0.0 112.897 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 40' ' ' PHE . 67.2 t -64.75 -51.43 67.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 118.976 0.807 . . . . 0.0 109.645 174.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -49.85 -38.34 34.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.356 0.98 . . . . 0.0 109.785 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.93 -53.63 43.36 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.466 1.03 . . . . 0.0 111.68 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.64 -43.88 80.72 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.366 0.53 . . . . 0.0 111.142 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.9 mt -63.36 -43.46 97.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -27.81 69.29 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.446 1.021 . . . . 0.0 112.69 174.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -59.73 -32.81 70.9 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.822 1.249 . . . . 0.0 111.419 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -128.42 16.72 6.53 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.387 1.475 . . . . 0.0 112.196 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 39.75 75.59 0.08 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 128.783 2.833 . . . . 0.0 112.417 -169.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.4 mt -110.05 147.54 14.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 121.386 -0.821 . . . . 0.0 109.826 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.05 127.75 8.4 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -58.45 -29.6 66.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.748 0.819 . . . . 0.0 111.242 171.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -55.6 -53.98 49.73 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 117.789 -1.101 . . . . 0.0 111.508 167.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -60.18 -51.27 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 119.526 1.057 . . . . 0.0 109.114 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.43 ' CE2' HG11 ' A' ' 26' ' ' VAL . 89.3 t80 -54.38 -46.48 73.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.325 0.511 . . . . 0.0 111.347 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.464 ' CA ' HG11 ' A' ' 52' ' ' VAL . . . -71.08 -34.97 64.52 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-O 117.417 -1.768 . . . . 0.0 111.967 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -64.49 -29.67 70.71 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 120.398 2.099 . . . . 0.0 110.887 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.414 ' CE1' HG21 ' A' ' 92' ' ' ILE . 38.8 m-85 -106.63 -78.73 0.58 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.458 1.103 . . . . 0.0 111.654 -172.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 74.1 t -56.5 -38.75 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 125.531 1.532 . . . . 0.0 109.363 -170.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.429 HD21 ' CG ' ' A' ' 76' ' ' MET . 37.6 mt -102.19 -33.24 9.72 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.582 -0.723 . . . . 0.0 110.853 -173.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.74 30.59 61.54 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.52 168.66 10.47 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.078 1.351 . . . . 0.0 109.175 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.0 163.6 27.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.456 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -59.56 -46.76 87.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.414 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.42 -30.96 77.49 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.001 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.6 m -61.03 -67.06 0.44 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.832 0.816 . . . . 0.0 109.328 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.464 HG11 ' CA ' ' A' ' 41' ' ' GLY . 3.0 m -58.66 -35.77 56.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-N 119.893 1.224 . . . . 0.0 112.438 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.3 t -54.95 -43.36 73.36 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.369 1.068 . . . . 0.0 111.708 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -57.36 -49.37 76.37 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 120.084 1.311 . . . . 0.0 110.106 168.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.3 mt -58.95 -39.64 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.6 mt -76.76 -29.56 56.17 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.901 1.281 . . . . 0.0 112.413 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.33 -57.58 4.69 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.652 1.581 . . . . 0.0 109.997 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -123.57 84.6 53.07 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 125.604 1.562 . . . . 0.0 107.399 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 84.04 1.4 Allowed 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 122.245 1.963 . . . . 0.0 107.525 171.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.412 ' HB2' HD21 ' A' ' 65' ' ' LEU . 14.3 mtpt -59.41 153.27 50.08 Favored Pre-proline 0 N--CA 1.436 -1.161 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 60' ' ' LYS . 36.0 Cg_endo -67.01 147.54 80.16 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.296 1.997 . . . . 0.0 107.363 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.426 ' CD1' ' HA ' ' A' ' 16' ' ' GLN . 67.2 t-105 -51.93 -38.94 58.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.127 0.571 . . . . 0.0 111.143 -175.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -28.11 69.05 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -26.79 62.37 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.789 -1.195 . . . . 0.0 111.633 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 60' ' ' LYS . 70.6 mt -83.79 167.16 17.36 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.456 0.646 . . . . 0.0 110.526 -168.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.2 p -117.78 -171.61 2.09 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.689 2.395 . . . . 0.0 109.533 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.7 p -47.16 -63.41 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.648 1.113 . . . . 0.0 111.543 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -72.94 -10.35 59.71 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.43 -52.12 32.89 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.157 -0.964 . . . . 0.0 110.707 162.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -87.54 -23.83 24.24 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 126.016 1.727 . . . . 0.0 112.298 -166.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -44.55 -55.6 9.95 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 126.334 1.854 . . . . 0.0 111.669 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.46 -45.86 13.52 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.498 1.466 . . . . 0.0 110.835 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -61.19 -38.23 85.8 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.88 1.218 . . . . 0.0 113.044 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.6 mt -55.61 -54.44 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -58.77 -50.66 73.1 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.931 1.292 . . . . 0.0 110.516 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.429 ' CG ' HD21 ' A' ' 45' ' ' LEU . 58.0 mtm -55.52 -47.89 75.53 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.135 0.974 . . . . 0.0 111.974 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -61.64 -46.03 91.51 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.94 -0.475 . . . . 0.0 110.263 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -61.26 -42.53 98.8 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.666 0.787 . . . . 0.0 111.198 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.466 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 44.6 t80 -53.17 -38.39 62.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.033 1.733 . . . . 0.0 110.719 175.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.2 mt -73.71 -23.75 59.83 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.378 -0.826 . . . . 0.0 113.082 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -77.97 0.25 25.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 120.134 1.334 . . . . 0.0 113.069 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -145.52 115.22 7.28 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 125.391 1.476 . . . . 0.0 107.173 170.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -69.49 -15.64 63.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.556 0.342 . . . . 0.0 111.816 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -67.06 -16.48 64.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 120.294 -1.504 . . . . 0.0 112.353 174.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.466 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 75.2 m-20 -66.51 -47.38 73.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 119.61 1.096 . . . . 0.0 109.591 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.8 -30.86 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 120.665 -1.272 . . . . 0.0 111.299 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.35 -24.04 64.76 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.753 -0.592 . . . . 0.0 110.808 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.6 -39.47 31.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.21 -0.931 . . . . 0.0 111.381 168.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.81 -29.76 68.18 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.013 -1.68 . . . . 0.0 110.5 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -66.6 -36.75 83.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.394 0.997 . . . . 0.0 111.672 169.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.3 m -56.01 -36.65 68.17 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.743 0.817 . . . . 0.0 110.167 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.414 HG21 ' CE1' ' A' ' 43' ' ' TYR . 69.0 mt -80.24 -29.29 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.701 1.6 . . . . 0.0 111.494 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -58.1 -45.16 87.68 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 120.578 -1.326 . . . . 0.0 109.646 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -27.63 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.879 -0.513 . . . . 0.0 110.557 177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -80.7 -2.61 47.48 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.678 1.991 . . . . 0.0 112.167 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.6 t -69.06 -47.32 65.64 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.539 1.518 . . . . 0.0 109.176 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -154.66 -177.2 27.76 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -77.43 46.99 2.14 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 124.647 3.565 . . . . 0.0 111.626 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.5 t -62.15 143.08 57.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 t -125.46 108.7 11.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -168.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 C-N-CA 123.977 0.798 . . . . 0.0 111.114 -171.404 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.972 0 N-CA-C 105.6 -3.0 . . . . 0.0 105.6 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p 174.69 108.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 -140.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -157.66 178.29 10.43 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.42 1.488 . . . . 0.0 107.658 -172.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.85 63.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.3 p -147.73 62.64 1.13 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.797 1.639 . . . . 0.0 107.46 -176.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t -112.56 96.26 5.89 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.552 1.141 . . . . 0.0 110.193 -161.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.28 -172.75 36.28 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.846 1.689 . . . . 0.0 109.699 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 66.82 168.14 0.23 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.661 2.384 . . . . 0.0 112.502 -174.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.83 74.86 0.28 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.016 -2.034 . . . . 0.0 108.016 -172.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.07 105.38 1.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.323 2.682 . . . . 0.0 110.238 -165.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.88 93.34 0.16 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 107.154 -2.379 . . . . 0.0 107.154 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.49 92.5 1.06 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 126.798 2.039 . . . . 0.0 107.149 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -139.71 179.6 6.48 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.521 1.528 . . . . 0.0 109.303 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -75.8 127.0 32.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 163.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -119.5 164.03 16.39 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.58 1.552 . . . . 0.0 108.275 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -78.2 113.0 15.75 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.732 1.151 . . . . 0.0 109.714 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.738 HD22 ' HD2' ' A' ' 77' ' ' LYS . 9.2 mt -86.72 162.86 17.65 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.406 1.482 . . . . 0.0 108.766 173.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.58 104.56 17.03 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.452 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 21.2 p -59.77 -40.97 89.99 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.344 -0.847 . . . . 0.0 111.51 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.21 75.07 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.182 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.27 -52.24 20.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.91 1.284 . . . . 0.0 108.337 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 85.2 mt -52.9 -49.48 48.11 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.83 63.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.259 0.624 . . . . 0.0 110.355 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -55.81 -57.75 10.74 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.939 1.296 . . . . 0.0 110.486 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -49.75 -51.54 38.28 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 127.391 2.276 . . . . 0.0 111.688 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.472 HG11 ' CE2' ' A' ' 40' ' ' PHE . 72.3 t -63.58 -44.04 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.906 -1.121 . . . . 0.0 109.015 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -57.47 -37.56 73.1 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.589 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.58 -54.67 36.23 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.948 1.299 . . . . 0.0 110.551 174.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -61.45 -43.1 99.46 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.978 1.311 . . . . 0.0 111.513 -173.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.58 -46.6 78.8 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -43.92 65.71 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.569 0.748 . . . . 0.0 111.123 173.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -50.47 -44.44 55.74 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 126.364 1.865 . . . . 0.0 111.684 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -112.76 9.42 19.11 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.993 0.917 . . . . 0.0 112.297 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 46.62 71.76 0.28 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.428 2.291 . . . . 0.0 112.183 -166.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.2 mt -111.22 151.02 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 172.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.57 142.13 15.42 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -57.74 -31.59 66.62 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.674 1.59 . . . . 0.0 113.345 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ttp-105 -56.41 -59.38 5.05 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 120.029 1.286 . . . . 0.0 109.691 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -58.98 -47.27 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -176.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.472 ' CE2' HG11 ' A' ' 26' ' ' VAL . 93.2 t80 -55.46 -47.15 76.53 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.831 0.741 . . . . 0.0 111.725 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.441 ' CA ' HG11 ' A' ' 52' ' ' VAL . . . -71.5 -33.72 63.84 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-O 117.797 -1.557 . . . . 0.0 111.806 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -69.88 -33.08 71.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.635 1.718 . . . . 0.0 110.524 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -96.73 -76.98 0.5 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.048 0.939 . . . . 0.0 111.217 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.55 -40.48 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 124.729 1.212 . . . . 0.0 109.151 -170.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.426 HD21 ' HG2' ' A' ' 76' ' ' MET . 25.3 mt -93.9 -46.79 7.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 123.758 0.661 . . . . 0.0 109.803 -173.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.01 19.08 48.39 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.636 0.636 . . . . 0.0 112.691 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.0 mt -114.42 164.96 13.24 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.501 1.52 . . . . 0.0 108.988 -172.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 m -62.08 156.58 21.09 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.167 0.508 . . . . 0.0 110.841 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -56.92 -34.82 68.35 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.075 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.04 -62.05 5.55 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.8 m -43.91 -66.77 0.34 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.942 1.697 . . . . 0.0 112.522 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.441 HG11 ' CA ' ' A' ' 41' ' ' GLY . 3.2 m -57.09 -38.83 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 120.283 1.401 . . . . 0.0 111.674 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 m -61.6 -41.28 97.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.858 -1.068 . . . . 0.0 110.818 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.82 -45.84 78.25 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.629 1.104 . . . . 0.0 110.007 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.489 HD13 HG21 ' A' ' 55' ' ' ILE . 32.8 mt -57.52 -46.46 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -177.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.27 -31.8 64.29 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.97 1.708 . . . . 0.0 112.656 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.9 -47.4 71.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.934 1.694 . . . . 0.0 110.096 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mtp-105 -137.94 82.98 24.37 Favored Pre-proline 0 C--O 1.239 0.506 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -63.75 102.63 0.36 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.103 2.535 . . . . 0.0 108.34 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -63.06 157.39 62.24 Favored Pre-proline 0 N--CA 1.429 -1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.523 167.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.82 151.96 36.5 Favored 'Trans proline' 0 N--CA 1.441 -1.572 0 C-N-CA 122.64 2.227 . . . . 0.0 107.428 -172.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.522 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 62.0 t-105 -51.78 -41.93 62.02 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.692 0.797 . . . . 0.0 111.532 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.428 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -65.25 -23.09 66.96 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.336 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 5.0 mmpt? -74.06 -25.76 60.02 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 120.23 1.377 . . . . 0.0 111.72 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.4 mt -93.25 153.28 18.68 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.162 0.892 . . . . 0.0 110.34 -158.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.8 t -90.38 -179.97 5.73 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 171.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.45 -42.65 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 O-C-N 120.999 -1.063 . . . . 0.0 112.419 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -69.8 -14.9 62.99 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.755 -1.216 . . . . 0.0 113.585 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.77 -37.43 26.32 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 125.45 1.5 . . . . 0.0 110.936 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.86 -25.92 40.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 117.847 -1.073 . . . . 0.0 112.344 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -43.83 -60.98 2.2 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 125.691 1.596 . . . . 0.0 110.445 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.28 -45.49 15.17 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 121.394 1.396 . . . . 0.0 110.032 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.452 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 64.2 m-85 -64.04 -35.25 80.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 119.752 1.16 . . . . 0.0 113.337 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.1 mt -59.16 -57.19 12.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -52.88 -43.18 65.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.175 0.99 . . . . 0.0 110.45 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.426 ' HG2' HD21 ' A' ' 45' ' ' LEU . 64.7 mtm -66.76 -50.29 63.19 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.891 1.276 . . . . 0.0 112.567 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.738 ' HD2' HD22 ' A' ' 17' ' ' LEU . 27.2 tttt -60.62 -41.33 94.64 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.816 -1.177 . . . . 0.0 110.193 -177.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.79 -26.63 57.49 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.839 0.456 . . . . 0.0 111.441 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.428 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 35.9 t80 -57.25 -50.98 71.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.917 0.887 . . . . 0.0 109.112 167.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.2 mt -64.02 -20.14 65.7 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.466 1.106 . . . . 0.0 113.439 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.4 m -61.53 -33.4 73.77 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.279 0.945 . . . . 0.0 111.531 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -130.49 104.77 7.43 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.637 -0.665 . . . . 0.0 109.988 -170.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -53.61 -29.2 36.73 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.204 1.401 . . . . 0.0 111.716 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -55.19 -25.93 35.91 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 119.803 -1.81 . . . . 0.0 112.45 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.428 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 85.2 m-20 -66.08 -50.56 63.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.529 0.732 . . . . 0.0 110.817 175.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.43 -37.19 78.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 119.221 0.919 . . . . 0.0 109.568 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 78.0 mt -64.55 -34.12 77.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.17 0.588 . . . . 0.0 110.481 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.98 -32.5 59.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.92 0.888 . . . . 0.0 111.43 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -27.85 66.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.298 1.039 . . . . 0.0 110.691 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.1 mtm105 -56.8 -54.15 49.66 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 119.092 0.86 . . . . 0.0 109.464 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -52.87 -36.66 59.38 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.853 0.751 . . . . 0.0 111.319 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 52.1 mt -73.68 -38.23 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.865 -1.147 . . . . 0.0 110.338 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -63.74 -47.62 80.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.668 1.587 . . . . 0.0 111.001 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.1 p -59.69 -33.6 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.547 0.612 . . . . 0.0 110.917 173.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -80.4 8.88 6.68 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.351 1.46 . . . . 0.0 113.359 176.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.6 t -58.45 131.57 51.11 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.914 1.234 . . . . 0.0 109.117 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.71 -164.68 50.69 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 122.982 0.325 . . . . 0.0 113.179 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -69.91 174.24 9.92 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.594 2.196 . . . . 0.0 109.558 165.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 56.4 m -82.77 -61.45 1.87 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 155.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 t 68.44 109.44 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.043 1.737 . . . . 0.0 108.433 -165.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.515 0 CA-C-O 117.704 -1.609 . . . . 0.0 109.246 -179.96 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.736 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.6 t -174.51 -70.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.441 2.296 . . . . 0.0 105.016 172.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 m -59.87 150.17 29.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.336 1.854 . . . . 0.0 111.445 -169.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.0 78.2 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.9 p -144.81 144.78 31.32 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.137 0.575 . . . . 0.0 110.12 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.7 m 69.37 157.97 0.16 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 128.204 2.602 . . . . 0.0 112.141 -177.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.13 72.33 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 123.645 0.641 . . . . 0.0 111.913 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -137.64 143.94 41.65 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.829 0.852 . . . . 0.0 109.134 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.33 77.01 0.09 OUTLIER Glycine 0 CA--C 1.523 0.567 0 CA-C-O 118.772 -1.015 . . . . 0.0 110.764 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.59 -175.08 0.64 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.57 2.847 . . . . 0.0 110.935 170.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 129.75 75.85 0.16 Allowed Glycine 0 C--N 1.333 0.362 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.9 147.55 34.17 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.558 1.179 . . . . 0.0 110.213 167.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.77 -172.57 0.09 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.415 1.886 . . . . 0.0 111.774 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -87.3 106.27 17.81 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 168.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -125.35 -174.61 3.1 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.742 1.617 . . . . 0.0 108.603 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -75.86 113.8 13.75 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.481 -0.762 . . . . 0.0 109.635 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.731 HD22 ' HD2' ' A' ' 77' ' ' LYS . 9.6 mt -98.39 144.65 27.54 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.641 1.176 . . . . 0.0 107.968 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -77.8 99.27 5.85 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 122.014 0.911 . . . . 0.0 109.079 179.226 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 p -63.16 -38.98 93.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.818 -1.176 . . . . 0.0 111.402 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.83 70.35 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.543 -0.741 . . . . 0.0 111.434 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 5.8 tt0 -78.92 -55.57 5.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.016 2.126 . . . . 0.0 108.758 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 17' ' ' LEU . 75.8 mt -54.57 -44.2 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.91 -49.06 78.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.529 0.732 . . . . 0.0 111.273 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -61.07 -53.36 58.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.839 1.256 . . . . 0.0 110.283 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -60.56 -39.7 88.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.68 1.992 . . . . 0.0 111.772 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 t -60.91 -47.12 94.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 O-C-N 120.691 -1.255 . . . . 0.0 109.374 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -61.14 -27.49 68.42 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 117.373 -1.299 . . . . 0.0 111.548 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -65.04 -63.12 1.18 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 120.125 1.329 . . . . 0.0 109.805 170.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -63.78 -29.08 70.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.058 0.845 . . . . 0.0 111.806 -170.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.52 -37.78 74.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.976 1.262 . . . . 0.0 109.587 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.26 -37.35 85.27 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.186 1.357 . . . . 0.0 111.862 169.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -58.59 -32.75 69.25 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.952 2.101 . . . . 0.0 113.707 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -126.39 15.93 7.7 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.482 1.913 . . . . 0.0 111.214 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.8 m120 42.33 72.73 0.16 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.282 2.233 . . . . 0.0 111.41 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.466 HD11 ' CG ' ' A' ' 90' ' ' ARG . 93.4 mt -106.26 153.84 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.69 131.64 10.87 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.801 1.191 . . . . 0.0 110.556 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -36.05 74.6 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.428 1.491 . . . . 0.0 111.71 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.6 ptt85 -53.5 -56.06 20.18 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.351 1.06 . . . . 0.0 111.965 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.46 -39.7 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -63.29 -45.68 90.26 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.091 -1.006 . . . . 0.0 109.573 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.41 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -67.35 -24.61 73.63 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-O 117.352 -1.804 . . . . 0.0 112.518 173.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -78.12 -21.02 51.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.788 2.294 . . . . 0.0 112.076 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -121.99 -61.1 1.52 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 119.484 1.038 . . . . 0.0 111.436 -174.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.7 t -63.46 -36.98 78.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.493 HD21 ' HG2' ' A' ' 76' ' ' MET . 21.4 mt -106.49 -34.95 7.23 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.423 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.55 31.5 78.84 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.13 161.62 18.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.352 1.461 . . . . 0.0 107.932 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m -59.67 147.95 35.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.765 1.226 . . . . 0.0 110.599 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -63.67 -16.73 61.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.633 1.573 . . . . 0.0 114.06 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.54 -56.63 2.61 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 166.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.7 m -43.65 -59.57 2.14 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 125.851 1.66 . . . . 0.0 113.21 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.41 HG11 ' HA3' ' A' ' 41' ' ' GLY . 4.1 m -55.65 -34.62 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 121.017 1.735 . . . . 0.0 114.074 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.9 t -63.2 -36.24 82.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.243 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.36 -41.78 80.79 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.792 1.633 . . . . 0.0 109.736 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.432 HG23 ' CE2' ' A' ' 73' ' ' PHE . 15.3 mt -62.79 -45.35 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -174.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.8 -32.03 61.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.779 0.832 . . . . 0.0 111.628 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.24 -53.94 31.02 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.628 1.971 . . . . 0.0 111.042 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -134.45 71.78 71.15 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -168.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -68.41 98.91 0.58 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.937 2.425 . . . . 0.0 107.985 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -69.06 160.63 77.63 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -59.34 150.49 74.44 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.351 2.701 . . . . 0.0 109.109 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.449 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 70.4 t-105 -52.79 -52.54 56.37 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.664 0.786 . . . . 0.0 111.5 177.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.432 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.4 -5.99 2.02 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 174.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -116.31 18.98 15.06 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.414 1.886 . . . . 0.0 110.842 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.1 mt -124.05 149.44 46.11 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.564 1.546 . . . . 0.0 106.874 166.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.2 t -90.73 -177.72 5.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.641 1.176 . . . . 0.0 108.852 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 p -46.33 -54.01 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.446 1.098 . . . . 0.0 111.16 172.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -74.73 -4.88 40.15 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.25 -35.19 15.31 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.326 1.917 . . . . 0.0 111.297 163.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -87.91 -23.27 23.98 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.566 1.546 . . . . 0.0 112.971 -173.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -39.14 -59.91 1.35 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.15 1.78 . . . . 0.0 110.36 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.27 -51.11 2.91 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.467 2.112 . . . . 0.0 111.489 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CE2' HG23 ' A' ' 55' ' ' ILE . 44.1 m-85 -59.58 -38.15 80.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.528 -175.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.2 mt -55.85 -54.02 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -60.7 -46.57 89.87 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.35 1.06 . . . . 0.0 110.498 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.493 ' HG2' HD21 ' A' ' 45' ' ' LEU . 63.9 mtm -59.37 -46.07 89.69 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 124.075 0.95 . . . . 0.0 111.299 177.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.731 ' HD2' HD22 ' A' ' 17' ' ' LEU . 13.8 tttm -60.96 -45.76 93.43 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.39 -0.819 . . . . 0.0 110.183 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -59.61 -43.99 93.57 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.723 0.809 . . . . 0.0 110.314 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.54 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 37.7 t80 -53.61 -51.36 63.31 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.103 1.761 . . . . 0.0 110.127 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.8 mt -66.27 -18.94 65.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.357 0.663 . . . . 0.0 112.133 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -6.52 47.29 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.253 1.421 . . . . 0.0 112.681 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -156.86 115.75 3.36 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.885 1.274 . . . . 0.0 109.139 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.22 -27.81 68.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.851 1.26 . . . . 0.0 112.431 -169.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -60.71 -19.28 58.34 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 120.768 -1.208 . . . . 0.0 112.525 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.54 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 38.1 m-80 -60.33 -50.9 71.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.993 1.269 . . . . 0.0 110.181 174.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.424 HG22 HD12 ' A' ' 35' ' ' ILE . 3.2 p -71.28 -30.67 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 120.851 -1.155 . . . . 0.0 110.135 -177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.9 mt -64.2 -37.38 87.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.15 69.83 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.402 0.546 . . . . 0.0 111.649 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.08 -28.49 62.33 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.245 -0.91 . . . . 0.0 111.37 176.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.466 ' CG ' HD11 ' A' ' 35' ' ' ILE . 63.5 mtp180 -58.26 -37.04 74.14 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.017 0.826 . . . . 0.0 110.207 173.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 m -55.95 -56.32 22.12 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.327 1.051 . . . . 0.0 110.086 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.1 mt -65.13 -31.78 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 123.463 0.705 . . . . 0.0 110.008 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -61.34 -39.59 91.12 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 121.689 -0.632 . . . . 0.0 111.728 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -67.7 -29.43 45.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 118.785 0.72 . . . . 0.0 109.66 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -79.77 10.86 3.63 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.792 1.637 . . . . 0.0 111.934 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.8 t -52.05 157.58 1.28 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.6 1.16 . . . . 0.0 109.981 167.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.19 -174.76 14.64 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.279 1.419 . . . . 0.0 112.128 -175.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.47 60.82 6.61 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 124.91 3.74 . . . . 0.0 111.914 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.1 m -66.15 112.68 4.04 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 167.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.4 t -145.78 -88.28 0.1 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 170.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.153 -1.36 . . . . 0.0 110.056 -178.612 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.544 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 t -144.15 -170.52 3.37 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.551 1.176 . . . . 0.0 109.069 -172.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.9 t -135.03 161.61 34.81 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.636 1.974 . . . . 0.0 106.915 164.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.87 139.7 6.89 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.11 82.73 1.26 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -166.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.0 m -151.45 164.43 36.77 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.241 1.416 . . . . 0.0 109.723 172.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.41 134.99 3.18 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 174.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -165.46 168.73 16.33 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.403 1.101 . . . . 0.0 109.049 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.56 164.93 37.62 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 167.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.08 151.15 72.97 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.946 2.431 . . . . 0.0 109.847 170.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.54 40.62 2.99 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-O 119.013 -0.881 . . . . 0.0 111.007 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.81 168.88 18.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.655 1.582 . . . . 0.0 107.459 171.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -63.52 -1.99 1.44 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 -155.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -130.43 103.74 6.84 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.952 1.701 . . . . 0.0 109.419 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -119.4 -176.53 3.16 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.365 0.666 . . . . 0.0 111.043 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.62 91.63 7.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.968 0.889 . . . . 0.0 109.181 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.624 HD22 ' HD2' ' A' ' 77' ' ' LYS . 3.2 mt -75.81 140.46 42.32 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.375 1.47 . . . . 0.0 109.021 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.52 103.17 8.29 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.96 -1.087 . . . . 0.0 110.916 -172.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 33.3 p -64.14 -46.23 84.99 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.983 -1.073 . . . . 0.0 112.93 -169.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.97 -18.57 64.09 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.289 0.636 . . . . 0.0 111.327 -176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.92 -56.74 4.05 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.764 1.626 . . . . 0.0 108.875 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.453 HD11 ' HB3' ' A' ' 17' ' ' LEU . 71.7 mt -51.6 -43.94 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.415 1.086 . . . . 0.0 109.992 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.66 -68.24 0.19 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.378 1.071 . . . . 0.0 110.047 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -45.22 -56.46 4.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.167 1.787 . . . . 0.0 112.232 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -54.78 -43.68 73.03 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 127.942 2.497 . . . . 0.0 111.227 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.96 -48.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 120.806 -1.184 . . . . 0.0 108.628 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -57.45 -43.46 83.97 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.385 1.448 . . . . 0.0 110.128 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -65.51 -44.87 85.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 118.718 0.69 . . . . 0.0 112.063 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -58.49 -46.75 86.05 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.299 1.04 . . . . 0.0 112.549 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.8 mt -58.78 -50.19 74.86 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -51.69 -45.68 63.59 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 120.261 1.391 . . . . 0.0 113.629 170.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -53.93 -32.11 52.53 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.881 1.672 . . . . 0.0 112.927 -173.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -123.39 15.63 9.69 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.567 1.547 . . . . 0.0 111.452 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 43.95 41.95 4.3 Favored 'General case' 0 CA--C 1.542 0.641 1 C-N-CA 132.379 4.272 . . . . 0.0 114.612 -176.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.3 mt -84.41 131.11 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.079 0.952 . . . . 0.0 108.726 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.09 115.71 4.07 Favored Glycine 0 C--O 1.228 -0.219 0 C-N-CA 125.0 1.286 . . . . 0.0 111.691 -169.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -39.62 -35.99 0.36 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.405 2.282 . . . . 0.0 115.725 -167.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -50.06 -50.12 48.98 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.249 1.386 . . . . 0.0 111.507 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.75 -50.69 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 119.044 0.838 . . . . 0.0 109.242 -173.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -54.74 -46.94 74.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.772 -0.58 . . . . 0.0 111.065 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.5 -15.52 68.42 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-O 117.026 -1.986 . . . . 0.0 113.232 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -94.25 -26.25 16.7 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.617 2.208 . . . . 0.0 112.575 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -118.44 -24.06 6.97 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -172.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.45 -37.74 6.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.138 0.975 . . . . 0.0 109.593 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.439 HD21 ' HG2' ' A' ' 76' ' ' MET . 29.3 mt -112.19 -30.73 7.1 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -171.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.39 13.16 83.12 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 123.961 0.791 . . . . 0.0 113.469 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 99.0 mt -101.84 170.33 8.22 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.254 1.822 . . . . 0.0 109.16 -174.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.09 166.57 13.6 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.411 -0.806 . . . . 0.0 112.025 173.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.2 tm0? -64.23 -44.34 92.18 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.31 -56.83 8.76 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 125.281 1.42 . . . . 0.0 112.068 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.7 m -52.13 -69.06 0.12 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 118.341 -0.838 . . . . 0.0 111.359 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.8 -37.1 70.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 120.482 1.492 . . . . 0.0 111.566 -171.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 t -55.26 -38.52 68.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 117.828 -1.082 . . . . 0.0 112.115 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.14 -48.58 79.47 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.921 1.237 . . . . 0.0 110.202 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 mt -59.03 -35.07 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.0 mt -81.22 -37.23 28.94 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 123.603 0.761 . . . . 0.0 112.099 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.55 -48.12 83.16 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.977 0.911 . . . . 0.0 110.751 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -136.94 82.0 32.1 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.36 73.86 4.38 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.554 2.836 . . . . 0.0 109.096 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -56.34 148.39 43.23 Favored Pre-proline 0 N--CA 1.441 -0.911 0 C-N-CA 124.8 1.24 . . . . 0.0 109.103 -172.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.02 147.26 91.78 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 124.46 3.44 . . . . 0.0 109.098 -164.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.447 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 60.3 t-105 -54.13 -38.07 65.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.735 0.414 . . . . 0.0 110.555 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -25.75 67.12 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -37.2 65.27 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.66 -1.275 . . . . 0.0 110.212 173.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.7 mt -74.54 172.44 12.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.298 1.047 . . . . 0.0 110.13 -171.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.6 p -129.15 -175.98 3.73 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.774 2.83 . . . . 0.0 107.834 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 89.9 t -47.54 -57.52 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 120.543 1.519 . . . . 0.0 111.229 173.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -70.09 -27.56 64.7 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.342 -1.474 . . . . 0.0 112.855 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.8 97.24 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 170.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -88.24 -26.12 22.51 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 126.949 2.1 . . . . 0.0 111.974 -171.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -44.45 -54.66 11.7 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.705 1.602 . . . . 0.0 110.566 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.04 -48.77 4.59 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.994 1.796 . . . . 0.0 110.982 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -57.48 -37.63 73.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.458 1.026 . . . . 0.0 113.401 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.0 -59.55 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 172.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -55.01 -38.89 68.48 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.099 0.56 . . . . 0.0 110.934 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.439 ' HG2' HD21 ' A' ' 45' ' ' LEU . 57.8 mtm -66.01 -50.56 63.83 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.768 0.827 . . . . 0.0 111.912 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.624 ' HD2' HD22 ' A' ' 17' ' ' LEU . 21.6 tttt -58.8 -41.26 86.3 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.908 -1.12 . . . . 0.0 110.778 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -70.29 -35.8 73.95 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.139 1.375 . . . . 0.0 110.576 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.473 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 44.0 t80 -56.5 -54.45 45.63 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.28 1.832 . . . . 0.0 109.105 171.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.3 mt -64.39 -18.15 64.41 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.709 0.803 . . . . 0.0 112.442 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.83 -10.13 59.4 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.532 -0.73 . . . . 0.0 111.604 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -144.41 110.13 5.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.368 0.985 . . . . 0.0 108.345 171.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 86' ' ' VAL . 38.6 tp10 -52.43 -30.44 29.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.833 1.253 . . . . 0.0 112.076 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -61.7 -16.04 45.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.149 -1.594 . . . . 0.0 112.969 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.473 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 71.3 m-80 -66.79 -50.28 63.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.834 1.197 . . . . 0.0 110.692 169.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 83' ' ' GLU . 9.1 p -64.06 -37.46 79.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 CA-C-N 119.359 0.982 . . . . 0.0 109.223 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.07 -39.91 93.91 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 118.241 0.473 . . . . 0.0 110.559 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.34 -34.39 76.01 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.858 0.463 . . . . 0.0 111.741 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.8 -27.81 66.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.84 0.856 . . . . 0.0 111.549 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 mtm105 -55.17 -50.36 69.53 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.5 m -53.3 -40.75 64.99 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.75 1.62 . . . . 0.0 109.348 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.2 mt -69.75 -31.4 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 O-C-N 120.656 -1.277 . . . . 0.0 111.21 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -63.63 -35.94 82.18 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 119.028 0.831 . . . . 0.0 110.873 170.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.18 -31.65 48.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 119.139 0.881 . . . . 0.0 109.81 176.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -76.78 27.06 0.13 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.925 1.69 . . . . 0.0 111.764 169.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.7 p -73.34 -15.17 61.39 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.756 1.616 . . . . 0.0 113.477 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -159.42 179.02 35.3 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -71.88 -23.25 22.38 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.463 2.108 . . . . 0.0 112.805 -170.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.0 p -69.69 11.6 0.26 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 129.473 3.109 . . . . 0.0 114.483 -174.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.7 t -73.26 83.22 1.37 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 CA-C-O 116.106 -2.497 . . . . 0.0 107.037 171.799 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.62 0 N-CA-C 106.744 -2.542 . . . . 0.0 106.744 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m 57.7 44.54 20.4 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 117.897 0.849 . . . . 0.0 111.366 144.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.6 m -145.65 153.84 41.46 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.937 1.295 . . . . 0.0 107.949 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.41 161.35 29.4 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 168.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.5 t -155.05 159.54 40.36 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.278 1.031 . . . . 0.0 109.23 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -155.02 166.9 32.13 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.013 1.725 . . . . 0.0 107.555 169.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.63 163.4 25.5 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 157.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -160.13 156.04 26.1 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.122 1.369 . . . . 0.0 107.793 166.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.01 73.7 0.1 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 173.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -78.06 136.88 15.03 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.294 1.996 . . . . 0.0 110.831 -171.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.34 -122.77 0.77 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.75 148.27 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.89 2.876 . . . . 0.0 114.717 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -163.63 158.68 20.83 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.118 1.367 . . . . 0.0 109.238 -170.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -75.21 105.48 6.25 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -145.46 177.9 8.51 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.809 -1.182 . . . . 0.0 110.185 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -73.51 119.69 18.09 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.7 mt -111.45 142.27 43.93 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.628 1.571 . . . . 0.0 107.878 -177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.92 102.48 5.59 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 123.06 1.41 . . . . 0.0 109.489 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.442 HG22 ' CD1' ' A' ' 73' ' ' PHE . 5.4 p -70.23 -35.06 73.59 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.722 -174.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.57 65.94 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 120.262 1.392 . . . . 0.0 110.914 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -77.84 -50.88 11.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.856 2.062 . . . . 0.0 108.981 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -54.03 -53.24 29.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.83 -46.23 78.17 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.313 0.645 . . . . 0.0 112.096 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -58.54 -66.48 0.48 Allowed 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.382 1.073 . . . . 0.0 108.23 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -47.29 -40.6 17.21 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.354 1.462 . . . . 0.0 112.643 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.522 HG21 ' SD ' ' A' ' 76' ' ' MET . 38.7 t -57.98 -53.8 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 123.684 0.794 . . . . 0.0 109.873 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -52.71 -51.09 61.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -59.29 -44.41 92.49 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.765 0.826 . . . . 0.0 112.582 -175.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.456 ' HG3' ' CD2' ' A' ' 80' ' ' LEU . 9.9 mm-40 -61.32 -49.59 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.954 1.702 . . . . 0.0 112.349 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.49 -49.47 77.67 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.48 -42.91 67.74 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.833 1.253 . . . . 0.0 114.056 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -53.83 -28.31 34.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.676 1.19 . . . . 0.0 111.568 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -124.76 15.66 8.69 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.872 1.669 . . . . 0.0 112.579 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 38.4 54.31 1.81 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.727 2.811 . . . . 0.0 113.893 -172.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.5 mt -89.89 151.7 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.29 131.9 10.8 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 126.236 1.874 . . . . 0.0 111.681 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -60.43 -20.1 58.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.216 1.006 . . . . 0.0 113.211 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -65.68 -60.82 2.51 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 119.775 1.171 . . . . 0.0 109.222 171.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.73 -47.54 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 C-N-CA 123.632 0.773 . . . . 0.0 109.97 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -53.55 -51.04 64.17 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.653 0.66 . . . . 0.0 111.907 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -68.48 -28.85 72.98 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-O 117.845 -1.531 . . . . 0.0 112.061 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -72.38 -23.55 61.13 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.794 1.797 . . . . 0.0 112.023 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -116.27 -60.32 1.87 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.751 1.159 . . . . 0.0 112.841 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.16 -44.67 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.562 HD21 ' HG2' ' A' ' 76' ' ' MET . 35.9 mt -95.1 -41.76 8.95 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.21 0.604 . . . . 0.0 110.755 -173.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.92 30.19 44.04 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.179 0.895 . . . . 0.0 112.223 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' A' ' 45' ' ' LEU . 24.8 mt -121.13 164.42 16.88 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 126.725 2.01 . . . . 0.0 107.802 -173.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.2 t -65.4 162.41 17.79 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.518 0.675 . . . . 0.0 110.737 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -58.85 -54.06 51.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.806 0.842 . . . . 0.0 109.586 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.55 -42.88 99.85 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.0 m -52.56 -60.42 3.27 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.805 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.426 HG11 ' HA3' ' A' ' 41' ' ' GLY . 3.3 m -63.58 -39.31 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 120.885 1.675 . . . . 0.0 113.984 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.32 -35.97 78.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 119.179 0.899 . . . . 0.0 109.376 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.18 -44.13 87.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.516 0.726 . . . . 0.0 111.212 169.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.403 HG23 ' CE2' ' A' ' 73' ' ' PHE . 3.2 mt -59.98 -40.04 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.8 -38.26 62.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.754 0.822 . . . . 0.0 111.042 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.16 -49.52 56.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.402 1.881 . . . . 0.0 112.204 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -127.32 75.21 77.28 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 127.023 2.129 . . . . 0.0 108.111 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.33 103.0 0.61 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 N-CA-C 106.429 -2.181 . . . . 0.0 106.429 167.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -66.61 170.96 4.87 Favored Pre-proline 0 N--CA 1.439 -0.992 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.4 146.26 79.86 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.112 2.542 . . . . 0.0 109.681 168.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -55.26 -48.33 74.15 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.88 0.872 . . . . 0.0 110.773 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.461 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -52.72 -21.22 3.81 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 172.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -94.89 5.27 52.37 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 120.219 -1.551 . . . . 0.0 112.51 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.414 ' HB3' ' HA3' ' A' ' 69' ' ' GLY . 82.4 mt -113.71 174.94 5.68 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.687 1.595 . . . . 0.0 109.215 173.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -128.13 -173.98 3.09 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.14 1.776 . . . . 0.0 108.313 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 96.8 t -47.28 -55.56 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.908 1.231 . . . . 0.0 111.015 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -60.54 -32.21 71.27 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 120.862 -1.149 . . . . 0.0 112.926 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -58.8 -45.48 94.86 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.666 1.127 . . . . 0.0 112.428 171.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -90.69 -17.85 26.08 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.707 2.003 . . . . 0.0 112.266 -164.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 1.5 tt0 -41.6 -53.62 7.29 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.308 2.243 . . . . 0.0 111.648 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 71' ' ' GLU . 22.2 Cg_endo -65.84 -50.77 1.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.341 2.027 . . . . 0.0 111.129 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CD1' HG22 ' A' ' 19' ' ' THR . 43.0 m-85 -57.62 -38.96 75.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 117.69 -1.148 . . . . 0.0 112.481 -174.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.1 mt -58.01 -54.29 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -56.35 -47.41 78.87 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.769 0.827 . . . . 0.0 110.486 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.562 ' HG2' HD21 ' A' ' 45' ' ' LEU . 64.7 mtm -61.42 -47.86 83.85 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 123.066 0.546 . . . . 0.0 110.705 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -58.72 -40.99 85.31 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.57 -0.707 . . . . 0.0 111.339 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.71 -41.56 92.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.063 0.847 . . . . 0.0 111.008 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.492 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.6 t80 -56.57 -41.65 77.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.557 0.743 . . . . 0.0 109.48 177.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.456 ' CD2' ' HG3' ' A' ' 29' ' ' GLN . 81.7 mt -75.75 -15.24 60.3 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.765 1.226 . . . . 0.0 113.938 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.9 m -81.65 -14.19 56.97 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.234 0.924 . . . . 0.0 111.035 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -145.24 97.12 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -47.31 -25.63 1.04 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.192 1.797 . . . . 0.0 112.746 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -58.41 -28.77 65.53 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 119.643 -1.911 . . . . 0.0 112.138 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.492 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 66.7 m-80 -62.06 -54.23 44.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.19 -37.49 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.1 -0.375 . . . . 0.0 110.15 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.6 -39.4 93.63 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.42 0.688 . . . . 0.0 110.703 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.92 -35.29 67.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.558 0.743 . . . . 0.0 111.996 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.99 -25.09 66.63 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.132 0.973 . . . . 0.0 110.774 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -58.06 -49.53 76.6 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 118.359 0.527 . . . . 0.0 109.915 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 m -60.29 -38.26 83.06 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.403 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mt -63.04 -42.33 96.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 119.68 1.127 . . . . 0.0 109.692 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -59.0 -45.99 89.29 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.445 0.698 . . . . 0.0 111.273 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.274 1.4 p -68.72 -30.06 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 118.915 0.779 . . . . 0.0 111.196 174.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -76.69 1.35 17.31 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 116.671 -1.633 . . . . 0.0 112.932 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.39 155.29 0.53 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-N 120.589 1.54 . . . . 0.0 113.86 -174.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.3 176.1 10.59 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.334 166.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -78.18 62.92 8.19 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.707 2.938 . . . . 0.0 111.516 -168.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.4 m -151.26 130.84 13.03 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 120.291 -1.506 . . . . 0.0 107.633 173.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.7 p -149.29 108.54 3.94 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.069 0.948 . . . . 0.0 108.802 -170.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 -168.96 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.845 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.8 m -146.27 159.04 43.88 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.025 0.93 . . . . 0.0 108.965 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.0 m 54.48 174.65 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.711 1.204 . . . . 0.0 111.828 -161.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.51 -149.17 15.74 Favored Glycine 0 C--N 1.332 0.336 0 O-C-N 120.789 -1.194 . . . . 0.0 110.174 -166.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.7 m -54.42 120.99 7.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.161 1.384 . . . . 0.0 110.656 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 t -157.8 176.82 12.08 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.601 1.96 . . . . 0.0 107.819 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.25 71.37 0.89 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.44 119.93 20.24 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.115 0.966 . . . . 0.0 109.124 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.84 85.02 0.37 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -174.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.87 -12.75 31.23 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.694 2.263 . . . . 0.0 114.153 -165.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 137.27 -147.81 19.44 Favored Glycine 0 C--O 1.237 0.316 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.82 26.49 10.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.675 1.59 . . . . 0.0 111.367 -166.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -81.26 -176.22 5.87 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.945 1.298 . . . . 0.0 111.248 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -126.94 115.23 18.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.628 1.971 . . . . 0.0 107.218 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -154.15 178.72 9.67 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.446 1.498 . . . . 0.0 110.502 -154.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -71.86 95.77 1.58 Allowed 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.894 0.77 . . . . 0.0 111.058 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.544 HD22 ' CD ' ' A' ' 77' ' ' LYS . 5.5 mt -78.91 154.93 29.28 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.801 1.24 . . . . 0.0 108.263 168.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -85.33 104.07 14.83 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.029 1.395 . . . . 0.0 108.122 162.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.481 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 19.4 p -56.2 -41.65 75.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.988 172.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 -37.74 71.95 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.475 0.71 . . . . 0.0 111.558 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -71.14 -54.77 9.87 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.328 1.451 . . . . 0.0 108.434 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -54.09 -51.05 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.36 -49.82 63.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.826 0.85 . . . . 0.0 111.362 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -55.42 -63.75 1.06 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.483 1.113 . . . . 0.0 109.617 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -50.88 -41.24 58.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.566 1.946 . . . . 0.0 112.933 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.424 HG21 ' SD ' ' A' ' 76' ' ' MET . 75.3 t -62.54 -47.85 91.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 121.011 -1.056 . . . . 0.0 110.079 176.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -55.89 -39.61 71.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.657 -1.163 . . . . 0.0 109.337 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -59.39 -55.81 29.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.45 1.023 . . . . 0.0 112.024 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -63.86 -39.66 94.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 112.318 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.12 -46.43 89.06 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 120.091 1.314 . . . . 0.0 107.601 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -16.73 64.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.06 0.846 . . . . 0.0 113.263 175.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -66.8 -30.66 70.92 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.083 -1.011 . . . . 0.0 110.832 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -127.99 10.35 6.43 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.322 1.049 . . . . 0.0 111.699 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 41.01 85.11 0.02 OUTLIER 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.24 2.616 . . . . 0.0 111.171 -164.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.451 HD11 ' CG ' ' A' ' 90' ' ' ARG . 92.2 mt -115.99 150.96 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.971 0.909 . . . . 0.0 108.921 174.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.96 142.14 17.45 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 123.954 0.788 . . . . 0.0 111.499 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -66.09 -33.46 75.84 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 118.57 -0.729 . . . . 0.0 111.965 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -59.97 -46.72 88.52 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 118.832 0.742 . . . . 0.0 109.767 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 t -61.88 -54.04 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 119.151 0.887 . . . . 0.0 109.294 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -51.3 -47.87 62.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.668 0.27 . . . . 0.0 111.714 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.499 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -78.34 -27.71 57.11 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-O 117.017 -1.991 . . . . 0.0 112.573 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -78.81 -26.75 44.29 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.738 2.269 . . . . 0.0 110.769 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -96.31 -78.5 0.46 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.68 0.792 . . . . 0.0 109.386 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.3 t -53.42 -52.28 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 C-N-CA 126.489 1.916 . . . . 0.0 107.896 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.498 HD21 ' HG2' ' A' ' 76' ' ' MET . 37.9 mt -90.17 -34.44 15.84 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 118.026 -0.988 . . . . 0.0 111.595 -170.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.97 12.72 80.72 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 124.2 0.937 . . . . 0.0 112.791 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.0 mt -102.79 172.29 6.92 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.172 1.389 . . . . 0.0 109.688 -171.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 63.5 p -67.33 159.79 28.56 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.291 -0.881 . . . . 0.0 109.594 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -61.22 -46.43 90.45 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.017 -1.052 . . . . 0.0 109.209 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.88 -32.68 70.83 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.83 -0.984 . . . . 0.0 112.043 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -60.19 -69.36 0.22 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.919 1.359 . . . . 0.0 108.69 169.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.499 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.7 m -57.25 -40.05 71.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 120.09 1.314 . . . . 0.0 113.63 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.0 t -55.01 -45.72 75.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.753 0.821 . . . . 0.0 109.638 176.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -57.42 -46.07 83.94 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 119.361 0.982 . . . . 0.0 110.702 172.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.42 ' CG2' ' CZ ' ' A' ' 73' ' ' PHE . 5.1 mt -58.72 -41.21 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -70.41 -41.51 72.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.444 1.098 . . . . 0.0 111.174 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.69 -48.89 73.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.878 2.071 . . . . 0.0 112.557 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.3 79.38 61.36 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.48 95.77 0.63 Allowed 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 106.987 -1.966 . . . . 0.0 106.987 173.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -62.54 154.73 71.98 Favored Pre-proline 0 N--CA 1.436 -1.125 0 O-C-N 120.945 -1.097 . . . . 0.0 108.099 172.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -65.09 150.2 88.15 Favored 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 122.139 1.893 . . . . 0.0 108.368 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -52.25 -43.67 64.48 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.786 0.834 . . . . 0.0 110.789 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -21.59 52.02 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -83.46 -28.86 28.47 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.943 1.247 . . . . 0.0 113.039 175.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.9 mt -85.21 157.18 20.7 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.902 0.774 . . . . 0.0 109.436 -169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.1 t -97.63 -178.44 4.12 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 166.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -47.28 -51.09 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 125.358 1.463 . . . . 0.0 111.356 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.401 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -63.88 -22.75 67.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 178.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.1 -40.22 17.22 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 125.732 1.634 . . . . 0.0 111.44 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -76.63 -26.44 54.93 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 125.65 1.58 . . . . 0.0 111.742 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -46.1 -55.8 12.35 Favored Pre-proline 0 N--CA 1.455 -0.195 0 C-N-CA 126.485 1.914 . . . . 0.0 112.184 -176.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.64 -48.62 8.75 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 121.434 1.423 . . . . 0.0 110.025 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.481 ' CZ ' ' HB ' ' A' ' 19' ' ' THR . 64.5 m-85 -58.9 -37.75 77.33 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 117.508 -1.234 . . . . 0.0 113.133 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.1 mt -57.72 -58.77 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 C-N-CA 124.45 1.1 . . . . 0.0 108.06 173.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -52.46 -45.7 66.19 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.881 0.872 . . . . 0.0 110.173 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.498 ' HG2' HD21 ' A' ' 45' ' ' LEU . 64.7 mtm -65.54 -46.7 78.55 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.478 -0.764 . . . . 0.0 112.213 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.544 ' CD ' HD22 ' A' ' 17' ' ' LEU . 21.1 tttp -62.66 -38.45 90.37 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.034 -1.041 . . . . 0.0 110.252 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -66.47 -40.4 89.33 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.043 1.337 . . . . 0.0 110.502 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.9 t80 -57.34 -51.7 68.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.27 1.428 . . . . 0.0 108.394 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.2 mt -66.8 -10.91 52.63 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.72 1.208 . . . . 0.0 113.868 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -38.69 87.52 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.174 -0.954 . . . . 0.0 109.975 171.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -132.34 112.03 11.85 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.385 0.993 . . . . 0.0 110.147 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -53.82 -22.29 9.3 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.729 1.612 . . . . 0.0 112.413 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -53.86 -28.55 36.69 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 119.85 -1.781 . . . . 0.0 113.016 171.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.486 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 51.6 m-80 -62.04 -48.85 78.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.964 0.505 . . . . 0.0 110.031 175.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -37.16 79.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 CA-C-N 119.237 0.926 . . . . 0.0 109.814 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.4 mt -66.69 -35.05 79.22 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.836 0.454 . . . . 0.0 110.182 -173.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.42 -35.42 70.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.493 0.717 . . . . 0.0 112.052 172.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.39 -27.34 69.24 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.845 0.858 . . . . 0.0 111.338 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.451 ' CG ' HD11 ' A' ' 35' ' ' ILE . 77.8 mtp180 -59.26 -44.46 92.41 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.44 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.1 m -50.8 -46.53 59.77 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.282 0.946 . . . . 0.0 110.967 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.4 mt -67.84 -32.44 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.474 0.71 . . . . 0.0 110.134 -174.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -65.54 -34.58 78.58 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.68 0.792 . . . . 0.0 110.795 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -76.19 -5.99 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.387 0.675 . . . . 0.0 111.8 174.227 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -106.13 4.2 28.83 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.468 1.507 . . . . 0.0 111.233 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.9 t -56.67 -64.76 0.76 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.975 1.71 . . . . 0.0 111.137 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.88 -172.99 42.8 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.24 -0.913 . . . . 0.0 111.504 -168.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.53 105.92 1.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.022 3.148 . . . . 0.0 110.075 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 t 64.71 167.31 0.17 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.217 2.207 . . . . 0.0 112.09 -163.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.1 m -138.25 121.62 17.11 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 157.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.776 0 CA-C-O 117.303 -1.831 . . . . 0.0 111.538 -177.28 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.063 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 m 62.91 170.52 0.14 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.818 1.247 . . . . 0.0 111.617 -168.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -172.48 178.26 2.8 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.587 2.755 . . . . 0.0 105.839 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.2 134.02 1.63 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 172.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 m -169.29 116.55 0.61 Allowed 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 126.664 1.986 . . . . 0.0 106.702 172.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.3 m -160.27 161.19 33.32 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.014 1.326 . . . . 0.0 108.99 169.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.97 87.66 1.79 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 170.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -132.82 151.81 51.94 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 169.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.92 71.66 0.17 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.13 168.88 16.34 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.893 2.395 . . . . 0.0 111.232 167.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.58 145.7 35.43 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 124.542 1.068 . . . . 0.0 112.709 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.4 78.03 3.92 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.14 0.976 . . . . 0.0 108.673 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 39.77 -135.2 0.16 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.044 1.738 . . . . 0.0 110.94 -173.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -128.73 114.08 16.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.06 1.344 . . . . 0.0 108.314 -174.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -92.41 -158.35 0.58 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.576 1.551 . . . . 0.0 110.998 -169.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -117.61 93.59 4.22 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 126.976 2.11 . . . . 0.0 108.676 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.649 HD22 ' HD2' ' A' ' 77' ' ' LYS . 1.4 mt -75.54 151.3 37.95 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.797 0.839 . . . . 0.0 110.394 -172.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.5 93.95 4.87 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.2 p -58.13 -40.49 81.41 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.96 -1.088 . . . . 0.0 111.635 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.96 -34.79 76.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.94 0.496 . . . . 0.0 110.315 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.83 -55.44 7.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.564 1.145 . . . . 0.0 108.779 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.415 HD11 ' HB3' ' A' ' 17' ' ' LEU . 52.3 mt -56.25 -44.38 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.49 -48.61 78.76 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.735 -0.603 . . . . 0.0 111.536 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.493 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 29.7 t80 -56.36 -64.97 0.69 Allowed 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.231 1.012 . . . . 0.0 108.999 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -54.57 -35.63 63.51 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 127.106 2.162 . . . . 0.0 112.935 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.1 t -61.76 -53.13 52.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 119.191 0.905 . . . . 0.0 110.188 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 47.1 mtmt -52.38 -42.51 64.05 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 117.6 -1.191 . . . . 0.0 109.185 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.47 -58.1 10.1 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.238 1.015 . . . . 0.0 110.556 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -62.08 -34.17 75.79 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.67 -50.33 72.91 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 170.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.64 -42.41 74.96 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.107 0.867 . . . . 0.0 110.981 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -54.39 -30.1 51.0 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.129 2.171 . . . . 0.0 113.006 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -127.23 14.82 7.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.614 1.565 . . . . 0.0 110.928 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.7 m120 44.76 43.31 6.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 129.036 2.934 . . . . 0.0 113.073 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -82.15 147.17 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.81 -1.182 . . . . 0.0 109.421 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.13 130.99 10.17 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -56.62 -37.0 70.1 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.992 1.317 . . . . 0.0 112.512 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.2 ttp85 -54.63 -50.13 68.85 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.133 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.54 -49.41 83.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 119.107 0.867 . . . . 0.0 109.565 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -54.13 -49.2 69.73 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.446 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -72.18 -29.08 67.06 Favored Glycine 0 C--O 1.216 -0.987 0 CA-C-O 117.45 -1.75 . . . . 0.0 113.576 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -78.57 -30.08 46.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.729 2.265 . . . . 0.0 111.568 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.4 -58.44 1.88 Allowed 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.553 0.741 . . . . 0.0 110.393 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.54 HG22 HD21 ' A' ' 89' ' ' LEU . 11.3 t -68.23 -53.42 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -172.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.61 HD21 ' HG2' ' A' ' 76' ' ' MET . 46.0 mt -89.47 -37.08 15.04 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.2 0.6 . . . . 0.0 110.528 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.14 36.25 60.39 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.7 mt -121.51 163.43 18.84 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.731 1.612 . . . . 0.0 108.534 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.2 t -54.6 144.48 21.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.473 1.109 . . . . 0.0 109.919 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -58.28 -26.97 63.62 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 117.775 0.261 . . . . 0.0 110.841 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.59 -36.29 43.91 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.346 0.974 . . . . 0.0 112.054 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.1 m -67.56 -59.56 3.26 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.081 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.446 HG11 ' HA3' ' A' ' 41' ' ' GLY . 3.5 m -58.75 -35.18 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 120.381 1.446 . . . . 0.0 113.691 -177.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.2 p -61.88 -38.82 89.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.981 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.3 -38.59 68.86 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.742 1.155 . . . . 0.0 110.104 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.458 HG23 ' CZ ' ' A' ' 73' ' ' PHE . 14.9 mt -68.54 -47.22 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -173.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.8 mt -73.45 -30.36 63.14 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.145 0.578 . . . . 0.0 111.857 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.2 -57.46 5.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.02 1.728 . . . . 0.0 110.969 173.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -130.25 74.42 80.4 Favored Pre-proline 0 CA--C 1.519 -0.24 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -170.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.68 97.2 0.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 122.709 2.272 . . . . 0.0 107.167 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -63.68 159.53 51.96 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -70.31 150.05 64.31 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.093 1.862 . . . . 0.0 107.328 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.423 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 67.4 t-105 -51.69 -42.15 61.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -14.66 52.67 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.96 -16.95 34.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.144 1.793 . . . . 0.0 112.363 171.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.64 149.37 21.29 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.44 1.018 . . . . 0.0 108.85 -169.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -98.03 179.93 4.61 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 165.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.8 t -49.05 -51.05 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 119.649 1.113 . . . . 0.0 112.163 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt -59.56 -34.48 72.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.46 1.482 . . . . 0.0 112.569 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.78 -35.2 90.61 Favored Glycine 0 CA--C 1.529 0.92 0 O-C-N 121.35 -0.844 . . . . 0.0 112.705 173.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.423 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 93.5 mttt -80.4 -27.91 38.0 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.348 1.459 . . . . 0.0 112.162 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -42.18 -52.64 9.48 Favored Pre-proline 0 N--CA 1.448 -0.563 0 C-N-CA 128.365 2.666 . . . . 0.0 111.883 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.97 -56.08 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.103 1.869 . . . . 0.0 110.27 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.458 ' CZ ' HG23 ' A' ' 55' ' ' ILE . 80.5 m-85 -58.05 -32.03 67.62 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 117.482 -1.247 . . . . 0.0 113.303 -173.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.23 -58.81 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 119.449 1.022 . . . . 0.0 108.278 171.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -53.85 -48.85 69.58 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.61 ' HG2' HD21 ' A' ' 45' ' ' LEU . 58.3 mtm -72.31 -33.68 67.55 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 119.713 1.142 . . . . 0.0 113.034 -168.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.649 ' HD2' HD22 ' A' ' 17' ' ' LEU . 3.5 tttm -62.21 -41.44 98.38 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.622 171.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -66.72 -35.04 79.19 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.579 1.152 . . . . 0.0 111.644 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -58.65 -57.28 13.67 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 126.312 1.845 . . . . 0.0 108.062 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.03 -4.8 7.9 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.445 1.498 . . . . 0.0 113.124 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.7 -7.64 59.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.771 1.228 . . . . 0.0 112.729 171.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -152.26 134.39 15.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.223 1.829 . . . . 0.0 111.538 171.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 86' ' ' VAL . 2.1 tp10 -60.4 -35.71 76.4 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.249 1.42 . . . . 0.0 111.104 176.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -58.2 -27.07 63.54 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.545 -0.722 . . . . 0.0 110.555 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -63.27 -42.61 99.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.227 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 83' ' ' GLU . 5.3 p -75.8 -33.6 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.731 1.151 . . . . 0.0 110.267 176.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.6 mt -66.53 -38.72 87.77 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.647 0.658 . . . . 0.0 110.277 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.37 97.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.204 0.526 . . . . 0.0 110.791 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.54 HD21 HG22 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -65.51 -27.41 68.45 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.964 0.905 . . . . 0.0 111.234 -178.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -57.0 -38.59 73.29 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.165 0.893 . . . . 0.0 109.649 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -65.83 -46.35 78.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.762 0.71 . . . . 0.0 111.232 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.445 HD12 HD22 ' A' ' 89' ' ' LEU . 47.9 mt -62.83 -32.01 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 119.307 0.958 . . . . 0.0 110.538 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -55.97 -44.26 78.34 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.499 0.72 . . . . 0.0 110.767 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.8 -32.23 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.658 0.742 . . . . 0.0 110.024 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -76.58 -3.17 36.19 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.648 1.179 . . . . 0.0 111.625 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 t -61.46 -21.98 64.64 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.696 1.134 . . . . 0.0 112.289 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.52 174.26 37.19 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.022 1.296 . . . . 0.0 110.333 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -86.87 51.58 2.45 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.575 3.516 . . . . 0.0 111.173 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 69.86 157.4 0.16 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.617 1.967 . . . . 0.0 112.576 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.2 t 73.22 139.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 127.408 2.283 . . . . 0.0 111.803 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.423 0 C-N-CA 124.886 1.232 . . . . 0.0 111.048 -179.164 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.102 0 CA-C-O 118.991 -0.894 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.3 113.44 6.89 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 102.775 -3.046 . . . . 0.0 102.775 171.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.2 m -155.94 114.27 3.4 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.59 166.35 21.98 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 175.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 m -157.53 52.76 0.47 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.147 0.979 . . . . 0.0 108.79 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t -77.34 -170.88 1.89 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.153 0.981 . . . . 0.0 110.461 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.69 129.78 6.46 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.95 137.21 31.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.11 89.11 0.07 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.09 152.95 67.82 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.292 1.994 . . . . 0.0 110.937 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.41 170.57 34.0 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 128.058 2.742 . . . . 0.0 106.668 169.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.89 -6.27 0.09 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.578 1.189 . . . . 0.0 113.784 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.65 -177.43 3.36 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.339 1.056 . . . . 0.0 108.867 -173.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -73.89 111.18 8.8 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 154.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -123.56 -147.99 0.39 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.197 1.399 . . . . 0.0 108.487 -171.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -118.74 138.47 52.63 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.289 1.436 . . . . 0.0 107.528 169.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.75 HD22 ' HD2' ' A' ' 77' ' ' LYS . 7.8 mt -129.35 146.21 51.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -173.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -85.25 111.57 19.97 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.624 1.102 . . . . 0.0 108.577 171.573 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.9 p -69.18 -39.43 78.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 121.22 -0.925 . . . . 0.0 111.915 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 -21.49 63.83 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.508 1.049 . . . . 0.0 112.119 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 2.5 tp10 -75.67 -55.36 5.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.727 1.611 . . . . 0.0 107.088 172.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.468 HD11 ' HB3' ' A' ' 17' ' ' LEU . 84.3 mt -53.96 -44.22 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 119.779 1.172 . . . . 0.0 109.427 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.63 -53.76 50.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.754 1.221 . . . . 0.0 111.248 173.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -57.57 -53.46 57.9 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.284 1.034 . . . . 0.0 110.539 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -58.48 -43.43 88.98 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.618 2.367 . . . . 0.0 110.624 -176.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.64 -55.03 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 O-C-N 120.861 -1.15 . . . . 0.0 109.023 172.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -51.47 -46.06 62.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.324 0.965 . . . . 0.0 110.932 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.97 -40.03 75.62 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 116.565 -1.683 . . . . 0.0 111.927 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -64.35 -36.16 83.23 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 121.627 2.012 . . . . 0.0 111.451 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.5 mt -61.07 -52.07 66.5 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 mt -65.02 -28.46 69.51 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -58.24 -36.34 73.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.963 1.305 . . . . 0.0 109.809 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -121.77 8.27 9.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.248 1.019 . . . . 0.0 112.405 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 52.3 79.29 0.11 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 128.04 2.536 . . . . 0.0 111.876 -169.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.563 HD11 ' HG3' ' A' ' 90' ' ' ARG . 70.7 mt -121.89 150.37 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.72 141.88 15.76 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.931 0.777 . . . . 0.0 111.269 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -57.81 -33.1 68.22 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.21 1.404 . . . . 0.0 112.253 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 -59.01 -62.8 1.61 Allowed 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.274 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.49 -36.48 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.968 1.258 . . . . 0.0 111.066 -176.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -59.78 -53.93 52.18 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 120.531 -1.356 . . . . 0.0 110.637 172.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.483 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -68.11 -24.22 74.62 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-O 118.017 -1.435 . . . . 0.0 112.62 -177.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -81.3 -20.45 40.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.838 1.819 . . . . 0.0 111.429 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -120.94 -51.42 2.13 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.327 0.967 . . . . 0.0 112.289 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.1 t -68.84 -52.16 37.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.6 mt -93.89 -29.06 15.49 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.208 -173.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.08 18.12 76.21 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 122.892 0.282 . . . . 0.0 112.563 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.7 169.9 8.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.558 1.543 . . . . 0.0 107.789 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.3 156.78 37.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 168.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -53.78 -51.15 64.33 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.205 0.602 . . . . 0.0 110.024 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.5 -26.44 68.2 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.321 -0.71 . . . . 0.0 112.54 -174.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 m -63.74 -69.05 0.3 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.483 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.2 m -56.65 -35.93 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 120.367 1.44 . . . . 0.0 112.59 -175.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t -60.78 -40.2 91.68 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.272 1.829 . . . . 0.0 110.576 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.84 -47.0 87.49 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.139 1.336 . . . . 0.0 109.272 167.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.0 mt -61.43 -31.8 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 99.3 mt -84.7 -22.66 29.68 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.944 0.897 . . . . 0.0 112.608 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.45 -49.16 23.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.802 1.241 . . . . 0.0 110.121 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.9 mtt85 -135.04 86.84 30.87 Favored Pre-proline 0 CA--C 1.516 -0.339 0 C-N-CA 125.373 1.469 . . . . 0.0 107.865 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.24 93.56 0.48 Allowed 'Trans proline' 0 N--CA 1.445 -1.335 0 N-CA-C 107.05 -1.942 . . . . 0.0 107.05 167.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -65.53 158.44 73.66 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -72.33 152.17 55.03 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.04 2.494 . . . . 0.0 108.958 -167.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.42 ' CD2' ' HE2' ' A' ' 70' ' ' LYS . 74.7 t-105 -52.43 -41.28 63.11 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.649 0.38 . . . . 0.0 111.478 175.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -18.02 58.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -89.03 -37.1 15.41 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 120.831 -1.168 . . . . 0.0 110.852 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.7 mt -74.69 146.15 42.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.543 0.687 . . . . 0.0 110.656 -162.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 t -71.3 174.59 6.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.289 1.035 . . . . 0.0 110.671 166.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.0 p -49.69 -56.09 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 124.423 1.089 . . . . 0.0 111.586 170.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -70.12 -5.07 24.42 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.62 -41.63 7.21 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.814 1.673 . . . . 0.0 110.288 167.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HE2' ' CD2' ' A' ' 62' ' ' TRP . 88.1 mttt -76.84 -26.1 53.92 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 126.264 1.825 . . . . 0.0 112.497 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -40.99 -62.04 1.12 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 127.266 2.226 . . . . 0.0 110.698 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -61.73 -44.5 21.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.393 2.062 . . . . 0.0 110.365 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -60.63 -39.93 90.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 117.67 -1.157 . . . . 0.0 112.845 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.9 mt -56.14 -51.59 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -59.65 -46.9 87.63 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.456 1.102 . . . . 0.0 110.861 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 70.5 mtm -61.84 -48.14 81.88 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 123.868 0.867 . . . . 0.0 110.823 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.75 ' HD2' HD22 ' A' ' 17' ' ' LEU . 10.3 tttt -60.78 -40.89 94.27 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.116 -0.99 . . . . 0.0 110.494 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -67.55 -36.01 80.15 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.116 0.967 . . . . 0.0 111.232 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 24.4 t80 -57.25 -48.04 79.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.011 0.925 . . . . 0.0 109.015 173.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.8 mt -71.07 -13.14 61.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.791 1.236 . . . . 0.0 113.631 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -25.73 68.21 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.146 0.885 . . . . 0.0 111.947 173.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -145.72 105.17 3.95 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -162.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -61.13 -23.24 65.38 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.382 0.673 . . . . 0.0 111.011 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -60.09 -23.42 63.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 119.783 -1.823 . . . . 0.0 112.036 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.446 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 71.3 m-80 -62.45 -38.89 91.52 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.066 1.303 . . . . 0.0 111.48 175.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 p -73.19 -35.4 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.608 1.094 . . . . 0.0 109.506 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.9 mt -70.52 -23.65 62.68 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.288 1.035 . . . . 0.0 111.283 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.3 -49.26 35.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.125 0.97 . . . . 0.0 110.615 167.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -28.93 69.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.336 1.454 . . . . 0.0 111.549 -170.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.563 ' HG3' HD11 ' A' ' 35' ' ' ILE . 68.4 mtp180 -57.45 -46.15 83.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.4 m -60.54 -37.51 81.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.653 0.781 . . . . 0.0 110.362 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mt -68.28 -30.3 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.353 0.978 . . . . 0.0 109.974 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -69.99 -45.54 67.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.684 -0.635 . . . . 0.0 111.372 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.254 0.3 OUTLIER -63.31 -20.9 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 120.085 1.311 . . . . 0.0 111.165 172.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -87.86 20.22 3.17 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.536 1.535 . . . . 0.0 112.208 171.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 85.3 p -77.64 17.76 0.51 Allowed 'General case' 0 CA--C 1.547 0.854 0 O-C-N 119.985 -1.697 . . . . 0.0 113.575 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.84 -178.38 17.17 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 127.545 2.498 . . . . 0.0 109.326 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -79.65 57.9 6.71 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 124.381 3.387 . . . . 0.0 109.324 173.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.1 m 56.52 161.66 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.049 1.74 . . . . 0.0 113.134 -152.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.1 m 52.15 32.19 10.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.802 1.641 . . . . 0.0 114.621 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.349 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 151.254 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.658 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -150.04 165.8 31.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.868 1.267 . . . . 0.0 107.868 169.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.93 -177.41 6.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 172.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.34 -172.94 36.08 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 -167.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 p -147.67 150.09 33.7 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 117.449 0.624 . . . . 0.0 109.666 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 m -159.57 154.93 25.43 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.826 2.05 . . . . 0.0 110.019 167.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.16 76.56 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 107.049 -2.42 . . . . 0.0 107.049 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -158.18 108.35 2.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -174.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.63 82.52 0.11 Allowed Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.32 -1.267 . . . . 0.0 110.994 -173.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -66.49 166.03 23.11 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.024 2.483 . . . . 0.0 109.923 172.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 175.78 100.45 0.13 Allowed Glycine 0 C--N 1.333 0.398 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.68 -169.2 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.404 1.481 . . . . 0.0 107.893 174.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 58.86 -164.58 0.2 Allowed 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.522 0.729 . . . . 0.0 111.213 -178.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -100.33 101.79 12.86 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -105.23 -145.3 0.38 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 127.595 2.358 . . . . 0.0 110.263 -162.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -108.52 124.19 50.07 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.891 1.276 . . . . 0.0 108.465 168.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.456 ' HB3' HD11 ' A' ' 22' ' ' ILE . 5.3 mt -109.66 144.14 38.42 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.95 98.35 4.9 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.371 0.987 . . . . 0.0 108.571 175.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.4 p -58.34 -43.42 88.3 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.678 -1.264 . . . . 0.0 112.241 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.1 -26.24 66.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 118.805 -0.617 . . . . 0.0 110.992 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -70.86 -57.87 4.18 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 171.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.456 HD11 ' HB3' ' A' ' 17' ' ' LEU . 64.0 mt -54.92 -44.76 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.659 1.118 . . . . 0.0 109.936 -173.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.35 -51.73 68.66 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.914 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.537 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 81.9 t80 -53.19 -68.66 0.15 Allowed 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 125.292 1.437 . . . . 0.0 108.556 175.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -41.79 -46.04 3.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.955 2.502 . . . . 0.0 112.458 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.65 -50.08 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.951 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 47.9 mtmt -48.26 -45.85 34.99 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.421 1.464 . . . . 0.0 109.864 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.59 -54.8 30.31 Favored 'General case' 0 C--O 1.225 -0.186 0 O-C-N 124.451 1.094 . . . . 0.0 110.688 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.431 ' NE2' HG11 ' A' ' 86' ' ' VAL . 4.0 mm100 -56.02 -40.58 73.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.889 1.676 . . . . 0.0 112.433 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.57 -49.67 68.0 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.8 -37.35 65.98 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.824 0.738 . . . . 0.0 111.831 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -55.39 -25.33 34.9 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.832 2.053 . . . . 0.0 112.922 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -126.45 16.43 7.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.153 0.981 . . . . 0.0 111.909 175.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.4 m120 40.22 75.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 129.686 3.194 . . . . 0.0 111.481 -166.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.417 HD11 ' CG ' ' A' ' 90' ' ' ARG . 91.8 mt -114.66 152.22 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -99.22 172.64 25.58 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -95.09 -20.19 19.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -172.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -58.82 -55.24 37.64 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 118.854 0.752 . . . . 0.0 110.229 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 t -60.0 -53.65 45.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -54.26 -45.1 72.32 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.819 1.191 . . . . 0.0 111.015 -174.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.407 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -71.65 -24.5 76.67 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-O 117.273 -1.849 . . . . 0.0 112.882 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -79.71 -37.48 35.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.569 2.185 . . . . 0.0 111.632 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -91.21 -70.4 0.69 Allowed 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.486 -0.759 . . . . 0.0 109.5 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.15 -50.44 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 125.087 1.355 . . . . 0.0 108.342 -172.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.572 HD21 ' SD ' ' A' ' 76' ' ' MET . 57.4 mt -95.73 -37.18 10.89 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.612 -170.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.61 6.03 86.08 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 118.501 0.591 . . . . 0.0 113.713 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.6 mt -92.02 173.74 7.68 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.993 1.717 . . . . 0.0 109.438 -172.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 t -63.66 154.14 33.91 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.549 0.69 . . . . 0.0 109.845 164.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -62.98 -22.84 67.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.343 1.457 . . . . 0.0 111.449 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.09 -59.9 4.43 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 171.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.1 m -49.47 -52.57 28.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 116.728 -1.606 . . . . 0.0 112.041 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.407 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.8 m -66.38 -37.87 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 121.495 1.952 . . . . 0.0 113.375 177.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.8 t -60.2 -34.93 74.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 118.419 -0.8 . . . . 0.0 110.521 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -57.96 -48.98 78.36 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.073 0.851 . . . . 0.0 110.758 168.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.432 HG23 ' CZ ' ' A' ' 73' ' ' PHE . 5.5 mt -58.16 -39.63 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.2 mt -77.65 -35.06 52.9 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.964 1.306 . . . . 0.0 113.779 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.5 -60.45 3.13 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -134.67 72.7 68.9 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 125.064 1.346 . . . . 0.0 108.792 -165.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.04 108.0 1.23 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.57 2.18 . . . . 0.0 106.655 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -66.92 159.66 74.52 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 163.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.26 149.2 81.3 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 122.529 2.153 . . . . 0.0 109.316 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -45.48 -46.71 13.86 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.56 1.544 . . . . 0.0 111.148 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -56.74 -32.38 65.51 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -71.52 -29.46 64.81 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.389 0.995 . . . . 0.0 111.319 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.4 mt -80.93 157.89 25.43 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.439 0.638 . . . . 0.0 111.249 -160.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.9 p -78.9 175.45 10.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.716 0.806 . . . . 0.0 108.917 165.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -53.79 -50.65 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.001 1.32 . . . . 0.0 112.39 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -72.6 -19.78 61.41 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 120.146 -1.596 . . . . 0.0 112.251 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.84 96.78 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 163.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -85.3 -28.17 25.46 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 117.215 -1.374 . . . . 0.0 113.089 -176.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -45.04 -52.26 20.36 Favored Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 124.564 1.146 . . . . 0.0 111.964 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.76 -52.02 4.21 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.374 1.383 . . . . 0.0 110.065 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CZ ' HG23 ' A' ' 55' ' ' ILE . 78.4 m-85 -59.51 -32.86 70.68 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 117.71 -1.138 . . . . 0.0 113.082 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.4 mt -61.16 -56.5 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -53.71 -43.79 69.31 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.541 1.136 . . . . 0.0 111.089 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.572 ' SD ' HD21 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -66.24 -45.25 81.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.12 -1.613 . . . . 0.0 114.711 172.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -63.48 -33.77 76.3 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.343 -1.473 . . . . 0.0 109.911 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -62.44 -49.57 74.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.224 1.809 . . . . 0.0 110.074 172.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -51.52 -48.7 62.9 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.25 1.42 . . . . 0.0 110.332 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.85 -8.57 29.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.382 1.073 . . . . 0.0 113.882 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -68.99 -25.07 64.34 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.183 -0.948 . . . . 0.0 111.942 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -147.45 141.11 25.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.913 1.233 . . . . 0.0 108.958 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.474 ' O ' HG12 ' A' ' 86' ' ' VAL . 18.9 tt0 -62.32 -32.68 73.47 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.237 1.015 . . . . 0.0 111.194 -175.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.645 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -56.18 -30.05 61.7 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.827 -1.171 . . . . 0.0 110.864 -175.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -64.0 -36.13 82.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 118.687 0.676 . . . . 0.0 110.245 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 83' ' ' GLU . 10.0 p -77.37 -31.5 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.114 -0.991 . . . . 0.0 110.469 175.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 84' ' ' GLN . 42.1 mt -61.85 -41.4 97.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.838 0.855 . . . . 0.0 109.827 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.78 84.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.218 0.607 . . . . 0.0 110.106 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -30.24 70.22 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.158 177.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.417 ' CG ' HD11 ' A' ' 35' ' ' ILE . 71.3 mtp180 -61.0 -43.64 98.59 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 119.612 1.096 . . . . 0.0 109.835 174.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.5 m -53.09 -49.16 67.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.324 0.65 . . . . 0.0 110.094 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.3 mt -64.55 -34.4 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.417 -0.802 . . . . 0.0 110.423 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -67.25 -35.27 79.2 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.05 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.2 m -64.08 -39.21 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 120.147 1.34 . . . . 0.0 108.854 168.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 mtt85 -76.21 8.04 3.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.796 0.838 . . . . 0.0 112.296 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.7 t -70.82 142.82 51.27 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.17 -164.13 12.63 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.261 1.41 . . . . 0.0 111.977 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -66.86 156.75 64.69 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.569 2.846 . . . . 0.0 110.595 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.1 t 146.27 131.0 0.0 OUTLIER 'General case' 0 C--O 1.236 0.379 0 C-N-CA 130.718 3.607 . . . . 0.0 106.053 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.8 t -146.97 157.83 43.74 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 167.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.758 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -172.682 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.875 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 t -162.41 146.07 11.69 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 -176.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.4 t -157.65 179.8 8.89 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.25 0.932 . . . . 0.0 108.97 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.05 144.03 11.12 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.546 1.546 . . . . 0.0 112.993 171.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.52 -49.76 0.14 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.191 0.997 . . . . 0.0 110.452 166.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 m 57.42 -175.38 0.07 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.485 1.114 . . . . 0.0 110.976 -158.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.18 98.02 0.52 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -136.68 126.84 26.25 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.267 1.827 . . . . 0.0 108.519 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.21 73.88 0.42 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.453 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.38 143.78 59.34 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.004 1.802 . . . . 0.0 110.565 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.45 -173.64 16.9 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 127.242 2.353 . . . . 0.0 109.044 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.8 15.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.255 1.822 . . . . 0.0 112.141 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -129.92 174.46 9.72 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 120.339 -1.475 . . . . 0.0 110.867 -175.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -66.72 113.17 4.63 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 162.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -130.74 -152.24 0.5 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.662 1.985 . . . . 0.0 109.685 -168.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -100.31 110.13 22.35 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.243 1.017 . . . . 0.0 110.845 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.404 ' HB3' HD11 ' A' ' 22' ' ' ILE . 8.4 mt -99.28 149.85 22.7 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.037 0.935 . . . . 0.0 109.577 -173.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.76 95.74 4.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 122.372 1.082 . . . . 0.0 108.483 175.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.6 p -61.21 -42.55 98.8 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.287 -0.883 . . . . 0.0 111.374 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.52 -34.91 73.23 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.973 0.909 . . . . 0.0 110.92 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -70.82 -54.18 12.54 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.404 HD11 ' HB3' ' A' ' 17' ' ' LEU . 67.1 mt -55.93 -42.75 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -177.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.98 -55.78 28.65 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.159 0.984 . . . . 0.0 110.765 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -53.08 -62.73 1.47 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.117 1.367 . . . . 0.0 110.276 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -55.47 -36.61 66.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.059 1.743 . . . . 0.0 113.381 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.448 HG23 HD11 ' A' ' 80' ' ' LEU . 24.1 t -63.9 -47.59 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -58.14 -37.93 75.6 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 116.986 -1.483 . . . . 0.0 110.465 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -61.11 -58.11 9.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.4 1.0 . . . . 0.0 110.559 173.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -61.66 -34.23 75.36 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.214 -0.929 . . . . 0.0 112.127 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.3 mt -72.08 -33.87 68.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.174 1.79 . . . . 0.0 109.753 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 mt -65.45 -37.63 87.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 120.06 1.3 . . . . 0.0 112.177 168.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.48 ' HZ2' ' CE1' ' A' ' 33' ' ' HIS . 55.0 tttm -58.26 -36.38 73.16 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.107 1.763 . . . . 0.0 113.459 -163.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.48 ' CE1' ' HZ2' ' A' ' 32' ' ' LYS . 78.9 m-70 -124.41 12.3 8.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.915 2.486 . . . . 0.0 111.406 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 m120 44.18 78.48 0.06 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.874 2.469 . . . . 0.0 111.506 -171.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.1 mt -116.87 151.68 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.88 151.01 19.92 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.706 0.615 . . . . 0.0 111.735 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -57.81 -38.05 74.85 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.237 1.415 . . . . 0.0 110.668 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -56.76 -61.14 2.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.614 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.96 -49.0 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 119.48 1.036 . . . . 0.0 109.358 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.36 -47.1 79.56 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.918 0.781 . . . . 0.0 111.541 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.429 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -70.17 -31.19 69.17 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-O 118.275 -1.291 . . . . 0.0 111.264 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -71.09 -30.07 66.08 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.738 1.769 . . . . 0.0 111.056 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -108.39 -57.83 2.07 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.189 0.995 . . . . 0.0 113.035 -171.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.6 -48.27 53.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -175.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.481 HD21 ' HG2' ' A' ' 76' ' ' MET . 20.9 mt -93.17 -29.5 15.7 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 122.045 -0.409 . . . . 0.0 111.737 -171.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.06 19.76 79.72 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.374 -0.681 . . . . 0.0 112.149 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.4 mt -109.14 165.03 11.91 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.005 1.322 . . . . 0.0 107.603 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.53 162.06 29.97 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.071 0.939 . . . . 0.0 109.342 174.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -49.72 75.78 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.071 0.948 . . . . 0.0 110.692 -172.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.57 -41.56 95.61 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.4 m -55.95 -67.17 0.32 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 117.459 -1.258 . . . . 0.0 110.886 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.429 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.8 m -55.46 -36.24 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 121.261 1.846 . . . . 0.0 112.884 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 m -68.87 -23.69 64.25 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.669 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -66.67 -45.69 78.09 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.481 1.491 . . . . 0.0 108.552 162.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 mt -60.81 -40.42 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt -74.56 -31.5 62.11 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.399 1.079 . . . . 0.0 112.589 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.12 -50.31 64.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.536 0.734 . . . . 0.0 109.704 173.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 mtp85 -136.9 78.32 41.81 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 125.23 1.412 . . . . 0.0 108.516 -166.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.15 107.67 1.98 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.151 1.901 . . . . 0.0 107.39 169.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -64.32 173.51 1.48 Allowed Pre-proline 0 N--CA 1.442 -0.856 0 C-N-CA 124.342 1.057 . . . . 0.0 109.022 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -59.3 142.37 99.03 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.826 1.684 . . . . 0.0 108.699 165.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -54.37 -49.18 70.43 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.829 1.195 . . . . 0.0 110.494 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -21.32 4.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 mmtm -77.47 -31.06 53.47 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 120.359 -1.463 . . . . 0.0 111.383 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 mt -70.24 151.46 45.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.746 0.784 . . . . 0.0 109.549 -172.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.7 t -84.47 179.53 7.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 160.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.05 -57.11 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.098 1.359 . . . . 0.0 110.782 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -64.86 -19.44 65.89 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.836 -1.165 . . . . 0.0 112.863 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.16 -50.01 69.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 126.118 1.818 . . . . 0.0 111.769 165.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -74.62 -25.58 59.32 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 125.046 1.339 . . . . 0.0 112.338 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -43.72 -54.77 9.97 Favored Pre-proline 0 N--CA 1.446 -0.669 0 C-N-CA 127.083 2.153 . . . . 0.0 112.094 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.15 -47.83 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.083 1.856 . . . . 0.0 110.557 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -59.88 -36.6 77.28 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.901 -1.047 . . . . 0.0 112.73 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.7 mt -60.75 -55.02 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 174.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -55.75 -45.85 77.96 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.389 0.675 . . . . 0.0 109.751 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.481 ' HG2' HD21 ' A' ' 45' ' ' LEU . 66.3 mtm -59.5 -52.74 64.27 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 123.403 0.681 . . . . 0.0 111.437 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -60.01 -40.05 87.91 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.983 -1.073 . . . . 0.0 111.589 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -70.03 -31.96 69.86 Favored 'General case' 0 C--O 1.229 -0.025 0 C-N-CA 123.588 0.755 . . . . 0.0 111.42 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.521 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 22.8 t80 -61.56 -50.91 70.73 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.722 1.209 . . . . 0.0 108.123 171.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.448 HD11 HG23 ' A' ' 26' ' ' VAL . 36.1 mt -72.43 4.54 3.69 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.959 1.703 . . . . 0.0 113.241 175.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -91.02 -6.37 54.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 117.722 -1.132 . . . . 0.0 110.773 168.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.79 107.05 1.28 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.329 1.422 . . . . 0.0 109.389 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -55.13 -20.76 10.92 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.983 1.313 . . . . 0.0 113.945 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -58.94 -23.57 61.62 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 121.248 1.84 . . . . 0.0 111.204 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.521 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 65.4 m-80 -64.85 -48.2 75.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 173.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.1 p -65.45 -37.36 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.088 1.313 . . . . 0.0 109.565 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.5 mt -65.72 -30.1 70.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.586 0.754 . . . . 0.0 110.036 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.22 -45.46 73.22 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.849 0.86 . . . . 0.0 111.23 170.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.443 HD22 HD12 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -66.23 -24.25 66.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.497 1.119 . . . . 0.0 111.15 -175.385 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mtm105 -55.15 -52.88 61.89 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.827 0.74 . . . . 0.0 109.929 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.5 m -54.95 -41.29 70.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.486 1.514 . . . . 0.0 110.245 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.443 HD12 HD22 ' A' ' 89' ' ' LEU . 58.5 mt -67.52 -35.58 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.243 -0.911 . . . . 0.0 110.111 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -60.67 -47.51 85.92 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.097 0.862 . . . . 0.0 110.774 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 94' ' ' VAL . 2.0 p -68.07 -19.73 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 O-C-N 121.852 -0.53 . . . . 0.0 111.676 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.08 16.91 16.71 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.872 -1.143 . . . . 0.0 111.849 168.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.8 t -59.63 146.1 42.2 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 120.305 1.411 . . . . 0.0 107.717 171.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.38 -167.57 21.85 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.199 1.856 . . . . 0.0 112.082 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.15 155.95 47.98 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.067 1.845 . . . . 0.0 109.322 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 75.8 m -125.85 -179.85 4.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.039 1.336 . . . . 0.0 107.706 172.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.4 p -142.73 35.65 1.43 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.052 0.941 . . . . 0.0 108.846 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -176.101 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.791 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.7 t -156.4 122.76 5.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.689 1.595 . . . . 0.0 107.746 -174.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 t 58.09 112.14 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.854 2.462 . . . . 0.0 110.187 -163.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.12 109.4 0.4 Allowed Glycine 0 C--N 1.339 0.727 0 O-C-N 121.317 -0.864 . . . . 0.0 113.567 -167.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.3 m -63.87 -41.34 97.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.215 1.006 . . . . 0.0 113.322 170.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 32.71 51.59 0.26 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.871 2.068 . . . . 0.0 113.46 -172.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.5 157.37 29.71 Favored Glycine 0 C--N 1.335 0.498 0 O-C-N 120.618 -1.301 . . . . 0.0 112.441 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -144.01 94.26 2.56 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 174.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.76 -164.43 51.3 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 -169.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -56.27 171.42 0.88 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 123.361 2.707 . . . . 0.0 114.448 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.92 174.16 27.73 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 172.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.13 -168.77 1.82 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.061 2.144 . . . . 0.0 107.857 177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.53 ' HG2' ' H ' ' A' ' 14' ' ' GLU . 8.4 tt0 56.11 -153.98 0.33 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.88 1.272 . . . . 0.0 110.983 -176.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.53 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 15.7 pt-20 -112.12 142.83 44.09 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 169.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -150.91 179.48 8.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.234 1.014 . . . . 0.0 108.488 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -66.81 136.29 55.22 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.288 0.495 . . . . 0.0 110.505 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.534 ' HB3' HD11 ' A' ' 22' ' ' ILE . 12.5 mt -127.86 141.21 51.62 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.29 97.79 3.65 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.414 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 23.3 p -59.58 -36.32 76.01 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.175 -0.953 . . . . 0.0 112.173 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 -28.45 66.42 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.912 0.778 . . . . 0.0 110.998 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -77.79 -49.42 14.39 Favored 'General case' 0 C--O 1.215 -0.753 0 C-N-CA 125.188 1.395 . . . . 0.0 108.423 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 17' ' ' LEU . 74.8 mt -56.32 -46.52 81.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.0 -53.17 59.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.533 -0.729 . . . . 0.0 110.492 174.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -57.45 -58.07 9.88 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.241 1.016 . . . . 0.0 111.174 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -56.39 -39.03 72.31 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.356 2.262 . . . . 0.0 111.02 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.513 HG23 HD11 ' A' ' 80' ' ' LEU . 16.8 t -63.73 -51.77 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 120.227 -1.546 . . . . 0.0 110.002 172.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -59.4 -43.67 92.93 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.84 -0.537 . . . . 0.0 110.348 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.58 -49.7 76.47 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.355 0.662 . . . . 0.0 109.918 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -54.91 -47.58 74.19 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.307 1.843 . . . . 0.0 113.645 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.7 mt -60.8 -43.51 98.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 121.12 -0.987 . . . . 0.0 108.479 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -41.81 99.28 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 120.026 1.285 . . . . 0.0 112.406 172.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -58.37 -39.91 80.86 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.763 2.825 . . . . 0.0 111.051 -173.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -115.07 13.23 16.84 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.246 0.619 . . . . 0.0 112.319 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.7 t30 38.7 77.2 0.05 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.189 2.596 . . . . 0.0 112.859 -170.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.427 HD11 ' HG3' ' A' ' 90' ' ' ARG . 85.8 mt -119.0 149.89 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.57 142.56 16.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.905 0.764 . . . . 0.0 111.378 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -36.47 77.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.323 1.049 . . . . 0.0 112.874 -175.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -55.92 -57.32 12.57 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 119.211 0.914 . . . . 0.0 110.022 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -57.9 -44.06 85.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 118.518 0.599 . . . . 0.0 109.689 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -54.54 -50.61 67.5 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.679 -0.638 . . . . 0.0 112.005 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.436 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -71.57 -26.03 73.97 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-O 117.697 -1.613 . . . . 0.0 112.145 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -79.11 -32.09 44.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.649 1.725 . . . . 0.0 111.271 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -108.33 -44.95 4.0 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.238 1.015 . . . . 0.0 113.319 -174.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.01 -46.07 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.51 HD21 ' HG2' ' A' ' 76' ' ' MET . 21.7 mt -98.05 -30.85 12.45 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.068 0.23 . . . . 0.0 111.489 -171.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.29 4.21 90.27 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 123.97 0.794 . . . . 0.0 112.662 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 73.4 mt -93.23 178.63 5.67 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.61 1.564 . . . . 0.0 109.512 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 p -72.75 159.65 33.47 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.655 -0.653 . . . . 0.0 109.701 169.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -51.95 -44.2 63.84 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.952 1.301 . . . . 0.0 109.378 167.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.4 -54.88 31.52 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.073 1.32 . . . . 0.0 111.697 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.2 m -56.46 -64.85 0.73 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 117.684 -1.15 . . . . 0.0 110.697 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.436 HG11 ' HA3' ' A' ' 41' ' ' GLY . 4.2 m -58.08 -36.82 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 120.524 1.511 . . . . 0.0 111.872 -172.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.2 m -62.91 -29.28 70.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.09 -1.433 . . . . 0.0 112.979 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.02 -48.71 77.61 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 120.363 1.438 . . . . 0.0 108.887 166.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.7 -42.6 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.9 mt -77.83 -27.27 49.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.784 0.834 . . . . 0.0 113.0 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.71 -41.91 61.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.067 1.347 . . . . 0.0 111.257 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.32 82.43 9.72 Favored Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 126.813 2.045 . . . . 0.0 107.352 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.49 95.66 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.648 2.232 . . . . 0.0 107.484 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -61.76 157.44 49.04 Favored Pre-proline 0 N--CA 1.443 -0.81 0 O-C-N 121.016 -1.052 . . . . 0.0 108.799 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.05 149.14 92.41 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 122.725 2.284 . . . . 0.0 108.536 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.409 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 66.4 t-105 -56.21 -44.05 79.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.524 0.602 . . . . 0.0 110.573 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -12.63 9.26 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.57 -7.05 45.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.713 1.605 . . . . 0.0 113.61 175.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.5 mt -106.4 151.14 25.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.622 0.769 . . . . 0.0 110.517 -173.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 p -85.68 179.06 7.16 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.218 1.007 . . . . 0.0 109.784 171.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 t -52.07 -43.46 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.199 -0.938 . . . . 0.0 111.339 165.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -63.91 -42.1 97.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 118.52 0.6 . . . . 0.0 109.981 175.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.88 -31.34 67.91 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-O 119.193 -0.782 . . . . 0.0 113.526 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -91.37 -18.55 24.1 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.733 1.613 . . . . 0.0 111.987 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -42.22 -56.33 5.52 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 127.05 2.14 . . . . 0.0 111.874 175.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -66.86 -45.05 4.68 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.502 1.468 . . . . 0.0 110.349 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 58.9 m-85 -64.86 -34.42 78.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.316 -1.326 . . . . 0.0 112.517 -173.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.88 -53.94 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 120.068 1.304 . . . . 0.0 107.683 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -53.04 -45.79 68.18 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.757 0.823 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.51 ' HG2' HD21 ' A' ' 45' ' ' LEU . 69.9 mtm -63.44 -49.75 72.47 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.274 -0.891 . . . . 0.0 111.787 176.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.492 ' HD2' HD22 ' A' ' 17' ' ' LEU . 18.7 tttm -58.59 -40.56 83.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.02 -1.05 . . . . 0.0 110.343 -178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -64.77 -44.75 89.0 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.527 1.131 . . . . 0.0 110.23 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.472 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 51.6 t80 -52.38 -45.05 65.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.49 1.116 . . . . 0.0 110.919 173.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.513 HD11 HG23 ' A' ' 26' ' ' VAL . 57.8 mt -78.26 -9.72 59.35 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.819 1.248 . . . . 0.0 113.686 -176.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.3 t -75.66 -11.99 60.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.762 0.825 . . . . 0.0 111.014 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -162.86 95.43 0.88 Allowed 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.989 -1.069 . . . . 0.0 108.279 -155.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.74 -29.34 18.21 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.904 1.282 . . . . 0.0 111.098 -173.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -54.25 -22.86 12.78 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.256 -1.527 . . . . 0.0 113.884 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.472 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 33.4 m-80 -66.34 -44.52 83.06 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.447 1.021 . . . . 0.0 111.917 171.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.17 -36.6 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 120.572 -1.33 . . . . 0.0 109.755 -175.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -34.97 71.2 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.788 2.035 . . . . 0.0 110.521 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.83 -45.01 60.71 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.637 1.175 . . . . 0.0 111.978 172.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.57 -29.43 67.94 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 120.93 -1.106 . . . . 0.0 110.793 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.427 ' HG3' HD11 ' A' ' 35' ' ' ILE . 38.8 mtp-105 -61.76 -41.04 97.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 118.406 -0.807 . . . . 0.0 110.225 173.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -58.31 -45.63 87.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.267 1.394 . . . . 0.0 109.784 173.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.8 mt -60.16 -32.68 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.927 0.785 . . . . 0.0 109.886 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -72.54 -42.24 64.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.036 -1.04 . . . . 0.0 112.458 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.254 0.2 OUTLIER -68.05 -19.74 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 119.659 1.118 . . . . 0.0 110.763 170.606 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -85.88 -2.03 57.86 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.626 1.17 . . . . 0.0 113.288 170.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 45.5 t -66.75 -26.09 66.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.527 1.058 . . . . 0.0 112.17 -165.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.7 -168.85 32.21 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.44 87.48 0.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.959 2.439 . . . . 0.0 110.743 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.6 t 54.88 49.6 17.45 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.246 1.818 . . . . 0.0 112.317 168.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.1 m -52.54 -45.06 66.19 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -170.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -167.313 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.877 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.64 -67.51 0.48 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.488 1.144 . . . . 0.0 109.276 173.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -68.37 153.19 44.25 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.876 0.846 . . . . 0.0 110.154 175.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.0 158.07 42.01 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 159.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.1 t -63.83 -50.78 67.53 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.918 0.487 . . . . 0.0 110.937 -174.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t 50.53 175.26 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.772 0.829 . . . . 0.0 111.343 -144.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.52 163.26 2.75 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.974 1.274 . . . . 0.0 115.69 171.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 178.12 74.79 0.01 OUTLIER 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.47 2.308 . . . . 0.0 109.817 172.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.22 156.77 7.74 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.466 1.031 . . . . 0.0 112.47 160.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.51 113.18 3.05 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.949 2.433 . . . . 0.0 109.373 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.83 99.58 0.37 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 124.79 1.186 . . . . 0.0 111.395 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.64 -177.08 6.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.841 2.057 . . . . 0.0 110.36 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 57.33 -179.86 0.05 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.212 1.805 . . . . 0.0 113.421 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -105.8 114.45 28.61 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 162.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.417 ' CG ' HD23 ' A' ' 17' ' ' LEU . 11.5 pt-20 -112.51 -155.44 0.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.287 2.235 . . . . 0.0 109.508 -176.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -110.51 85.49 2.12 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 168.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.703 HD22 ' HD2' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -63.4 154.62 31.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.112 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.54 101.38 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.099 -1.001 . . . . 0.0 110.068 175.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.416 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 24.1 p -65.25 -40.98 94.7 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 120.679 -1.263 . . . . 0.0 112.689 -172.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.03 -29.53 70.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.836 0.744 . . . . 0.0 110.854 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -76.71 -50.95 12.41 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.498 2.319 . . . . 0.0 108.522 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt -56.83 -45.96 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.94 0.896 . . . . 0.0 109.119 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.85 72.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.986 -1.071 . . . . 0.0 110.696 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -54.19 -65.94 0.48 Allowed 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.917 1.287 . . . . 0.0 109.057 177.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -44.04 -44.31 7.32 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.687 1.995 . . . . 0.0 112.556 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.97 -43.94 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 O-C-N 121.345 -0.847 . . . . 0.0 111.283 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG3' HD22 ' A' ' 56' ' ' LEU . 41.9 mtmt -55.24 -35.56 65.1 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.561 1.073 . . . . 0.0 109.593 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -67.61 -56.58 8.87 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 123.36 0.664 . . . . 0.0 110.937 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -59.21 -39.38 82.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.582 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.42 -46.96 86.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 119.757 1.162 . . . . 0.0 108.091 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.18 -41.41 79.26 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.232 0.924 . . . . 0.0 111.472 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -53.98 -31.76 51.83 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.723 1.609 . . . . 0.0 114.072 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -119.77 7.21 10.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.95 1.3 . . . . 0.0 112.524 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m120 51.38 79.47 0.1 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 127.939 2.496 . . . . 0.0 111.226 -170.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.3 mt -119.64 137.27 54.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.638 0.732 . . . . 0.0 109.376 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.83 132.94 12.79 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 126.486 1.993 . . . . 0.0 109.805 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -54.01 -31.77 52.19 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.064 1.346 . . . . 0.0 113.265 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -58.08 -48.56 79.78 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.576 -1.202 . . . . 0.0 111.341 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -60.27 -50.23 81.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 119.665 1.12 . . . . 0.0 108.839 -176.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -56.96 -40.59 76.75 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.656 -0.653 . . . . 0.0 111.665 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.4 ' CA ' HG11 ' A' ' 52' ' ' VAL . . . -71.23 -34.31 64.34 Favored Glycine 0 N--CA 1.437 -1.298 0 CA-C-O 117.596 -1.669 . . . . 0.0 111.592 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -70.02 -38.76 76.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.102 1.951 . . . . 0.0 110.548 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -97.61 -58.88 1.89 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.74 0.7 . . . . 0.0 112.667 -171.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.4 t -72.35 -47.13 54.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -172.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.505 HD21 ' SD ' ' A' ' 76' ' ' MET . 45.2 mt -89.31 -40.34 12.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 119.075 -0.488 . . . . 0.0 110.667 -174.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.47 22.01 71.21 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.766 -1.019 . . . . 0.0 111.753 -174.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.5 mt -110.62 160.05 17.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.424 1.89 . . . . 0.0 109.397 -174.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 m -63.72 152.6 38.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.575 1.15 . . . . 0.0 109.541 174.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -53.33 -43.06 67.35 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.11 0.964 . . . . 0.0 111.248 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.38 -10.4 80.02 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 118.076 -1.402 . . . . 0.0 113.368 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 m -68.26 -68.59 0.38 Allowed 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.869 1.835 . . . . 0.0 106.996 161.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.445 ' CG1' HD12 ' A' ' 45' ' ' LEU . 1.5 m -56.14 -37.7 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.449 1.477 . . . . 0.0 113.692 -171.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -42.84 94.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.859 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -47.01 74.83 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.448 1.022 . . . . 0.0 109.666 171.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 55' ' ' ILE . 13.7 mt -60.12 -43.96 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.407 HD22 ' HG3' ' A' ' 27' ' ' LYS . 92.8 mt -70.85 -35.72 72.54 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.747 1.219 . . . . 0.0 111.802 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.92 -51.7 30.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.059 1.744 . . . . 0.0 110.509 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -133.36 81.87 54.22 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 124.693 1.197 . . . . 0.0 108.898 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -69.3 95.55 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.707 2.938 . . . . 0.0 108.443 171.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -62.0 156.55 57.16 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 171.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -61.73 152.53 73.6 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.551 2.167 . . . . 0.0 108.218 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -53.75 -47.63 70.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.634 0.774 . . . . 0.0 110.038 175.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.429 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -63.6 3.66 0.32 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 173.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 2.2 mmpt? -107.41 -13.83 15.01 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 119.759 -1.838 . . . . 0.0 112.983 167.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.6 mt -92.77 150.41 20.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 119.084 0.856 . . . . 0.0 109.145 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t -94.15 -179.96 5.12 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 167.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 t -49.76 -49.45 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.238 1.415 . . . . 0.0 111.306 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -64.72 -28.26 69.47 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 120.208 1.367 . . . . 0.0 112.386 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.0 -40.11 73.51 Favored Glycine 0 CA--C 1.527 0.783 0 O-C-N 120.99 -1.069 . . . . 0.0 112.41 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -77.18 -25.61 52.03 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 126.908 2.083 . . . . 0.0 112.068 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 11.8 tt0 -41.64 -54.24 6.81 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 128.72 2.808 . . . . 0.0 112.116 -177.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 71' ' ' GLU . 19.1 Cg_endo -59.67 -58.6 0.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.247 2.631 . . . . 0.0 111.28 173.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.416 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 77.4 m-85 -56.19 -33.29 65.15 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -171.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.0 mt -58.01 -58.35 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -52.61 -52.13 56.81 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 124.588 1.155 . . . . 0.0 109.007 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.505 ' SD ' HD21 ' A' ' 45' ' ' LEU . 1.0 OUTLIER -57.96 -48.64 79.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 178.698 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.703 ' HD2' HD22 ' A' ' 17' ' ' LEU . 10.3 tttt -58.89 -42.63 89.99 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -71.16 -32.9 69.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.513 0.725 . . . . 0.0 110.857 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -59.19 -46.58 88.05 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.975 1.31 . . . . 0.0 109.402 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.1 mt -66.57 -21.5 66.14 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.0 m -82.89 1.14 40.89 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.981 0.81 . . . . 0.0 112.644 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -148.38 99.04 2.98 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 120.348 1.431 . . . . 0.0 108.747 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -61.87 -22.03 65.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.574 0.75 . . . . 0.0 112.743 -168.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -57.29 -23.16 46.66 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.523 -1.36 . . . . 0.0 112.878 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -64.47 -47.31 79.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.195 0.907 . . . . 0.0 110.508 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.0 p -72.1 -31.98 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.404 -0.81 . . . . 0.0 110.506 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.9 mt -69.7 -23.01 63.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.781 0.832 . . . . 0.0 111.097 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.51 -36.05 29.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.808 0.843 . . . . 0.0 110.499 171.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -66.23 -38.04 86.95 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 120.664 -1.273 . . . . 0.0 110.601 -176.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -62.95 -35.49 80.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.212 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.0 m -54.7 -51.33 65.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.768 0.713 . . . . 0.0 109.507 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 89' ' ' LEU . 70.6 mt -59.69 -39.29 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 122.946 0.498 . . . . 0.0 110.357 -175.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -45.91 84.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.614 1.166 . . . . 0.0 111.502 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.291 0.2 OUTLIER -64.85 -38.58 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.832 1.196 . . . . 0.0 109.841 172.518 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -76.82 24.9 0.15 Allowed 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.426 1.091 . . . . 0.0 112.798 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.2 t -71.94 156.38 39.32 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 120.364 -1.46 . . . . 0.0 109.602 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.22 -165.57 46.05 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.64 87.32 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 124.399 3.399 . . . . 0.0 111.577 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.5 t -138.77 83.32 1.95 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.566 1.546 . . . . 0.0 108.814 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.4 t -147.8 -164.5 2.02 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 166.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 170.746 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.837 0 N-CA-C 105.759 -2.936 . . . . 0.0 105.759 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.76 163.56 3.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -153.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 p -149.3 -79.43 0.13 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.94 -179.7 41.18 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.8 m -155.4 174.89 14.59 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.793 1.637 . . . . 0.0 107.234 172.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.0 t 57.82 -160.44 0.25 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.792 0.837 . . . . 0.0 111.184 -172.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.4 106.31 1.38 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -170.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.1 -172.34 3.46 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.798 0.839 . . . . 0.0 111.569 -172.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.01 165.5 26.57 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 126.097 1.808 . . . . 0.0 110.575 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.9 167.75 14.25 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 124.504 3.47 . . . . 0.0 111.438 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.81 127.07 1.61 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 173.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.12 80.75 1.78 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.999 1.319 . . . . 0.0 108.04 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -145.12 174.32 11.16 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.964 1.706 . . . . 0.0 108.779 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -62.89 139.6 58.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 157.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -146.2 179.64 7.37 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 172.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -74.97 150.86 38.9 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.905 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.748 HD22 ' HD2' ' A' ' 77' ' ' LYS . 7.4 mt -137.18 149.62 47.36 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -80.76 100.78 8.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 174.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.0 p -62.94 -36.54 83.78 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.257 -0.902 . . . . 0.0 111.491 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.94 -24.67 61.66 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.824 1.193 . . . . 0.0 111.445 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 12.8 tt0 -72.52 -55.67 6.59 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 173.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.43 HD11 ' HB3' ' A' ' 17' ' ' LEU . 53.4 mt -54.36 -51.39 49.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.95 -49.02 72.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.592 0.757 . . . . 0.0 111.604 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.41 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 66.2 t80 -55.97 -61.45 2.37 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 124.725 1.21 . . . . 0.0 109.419 175.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -52.86 -39.83 62.9 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.499 2.32 . . . . 0.0 112.08 -176.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.1 -51.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 121.455 -0.778 . . . . 0.0 109.661 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 45.8 mtmt -53.26 -39.55 63.95 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 116.811 -1.566 . . . . 0.0 110.642 175.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.93 -59.32 5.56 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.724 1.21 . . . . 0.0 110.671 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -62.16 -36.34 81.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.265 1.026 . . . . 0.0 111.574 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 mt -65.09 -51.62 60.35 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -55.9 -39.36 71.48 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.025 1.284 . . . . 0.0 112.014 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -51.33 -50.65 59.0 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.894 2.078 . . . . 0.0 109.786 -177.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -104.86 12.84 32.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.386 1.074 . . . . 0.0 111.458 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 t30 38.38 58.71 1.56 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 130.792 3.637 . . . . 0.0 112.011 -171.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 82.7 mt -93.01 156.8 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.413 1.485 . . . . 0.0 108.305 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.98 151.22 19.46 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.741 0.686 . . . . 0.0 112.202 -175.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -70.92 -30.12 66.36 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 117.825 -1.083 . . . . 0.0 113.752 -174.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -59.06 -59.14 5.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 120.357 1.435 . . . . 0.0 109.377 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.2 t -59.73 -43.46 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 123.478 0.486 . . . . 0.0 109.864 -174.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -56.18 -47.75 77.7 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.244 0.929 . . . . 0.0 110.973 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -70.93 -30.52 67.88 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-O 118.144 -1.364 . . . . 0.0 112.391 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -72.07 -29.97 64.66 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.165 1.482 . . . . 0.0 111.274 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -105.48 -68.87 0.84 Allowed 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.705 0.802 . . . . 0.0 111.122 -176.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.64 -38.59 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 123.301 0.64 . . . . 0.0 109.391 -169.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.508 HD21 ' HG2' ' A' ' 76' ' ' MET . 28.0 mt -95.79 -42.03 8.55 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.47 32.77 67.86 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.3 mt -110.49 165.15 12.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.651 1.581 . . . . 0.0 107.111 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.61 161.65 30.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.706 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -46.6 86.85 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.637 0.775 . . . . 0.0 111.527 -171.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.85 -32.24 82.18 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.3 m -59.44 -65.56 0.65 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 118.169 -0.919 . . . . 0.0 108.576 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.426 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.7 m -59.65 -37.22 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 120.143 1.338 . . . . 0.0 112.893 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 t -57.47 -40.54 78.78 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.642 -0.661 . . . . 0.0 111.102 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.37 -45.13 95.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.468 0.707 . . . . 0.0 110.563 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.0 mt -60.28 -43.05 92.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -70.57 -35.89 73.3 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 123.743 0.817 . . . . 0.0 112.491 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.41 -45.71 79.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.308 1.043 . . . . 0.0 110.269 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -134.68 79.48 52.87 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 125.364 1.466 . . . . 0.0 109.336 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -72.03 103.96 1.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.733 2.289 . . . . 0.0 106.968 168.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -80.71 163.8 54.38 Favored Pre-proline 0 N--CA 1.443 -0.82 0 C-N-CA 125.335 1.454 . . . . 0.0 108.195 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -56.68 139.94 89.41 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.093 2.529 . . . . 0.0 108.83 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.412 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 33.0 t-105 -50.65 -47.49 58.54 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.589 1.086 . . . . 0.0 110.537 173.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -21.38 32.83 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 176.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -77.74 -35.14 52.2 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.513 1.506 . . . . 0.0 110.418 177.707 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.4 mt -78.77 163.82 25.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.072 0.949 . . . . 0.0 108.756 -174.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.7 p -123.52 -177.33 3.69 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.449 1.9 . . . . 0.0 107.282 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.3 m -44.61 -53.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 121.855 2.116 . . . . 0.0 113.821 -170.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 -21.73 59.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.912 0.863 . . . . 0.0 112.844 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.25 -38.18 87.33 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.352 1.453 . . . . 0.0 112.624 165.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -90.58 -27.15 19.31 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.311 1.844 . . . . 0.0 112.204 -172.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -37.05 -58.39 1.12 Allowed Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 129.781 3.232 . . . . 0.0 111.282 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.47 -49.54 3.32 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.999 1.799 . . . . 0.0 110.431 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -58.93 -34.92 72.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.006 -0.997 . . . . 0.0 112.568 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.03 -54.52 33.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 119.423 1.01 . . . . 0.0 108.59 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -56.2 -50.52 70.99 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 124.224 1.009 . . . . 0.0 108.989 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.508 ' HG2' HD21 ' A' ' 45' ' ' LEU . 65.3 mtm -59.57 -48.97 79.56 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.856 -0.527 . . . . 0.0 111.991 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.748 ' HD2' HD22 ' A' ' 17' ' ' LEU . 8.8 tttm -58.4 -37.16 74.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.438 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -74.51 -38.1 62.93 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.086 1.312 . . . . 0.0 111.376 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.5 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 4.9 t80 -56.38 -40.06 73.96 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.556 1.142 . . . . 0.0 109.163 173.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.4 mt -73.46 -19.8 60.86 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 117.706 -1.14 . . . . 0.0 113.015 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.6 m -61.29 -32.44 72.28 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.642 1.565 . . . . 0.0 111.098 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -137.89 117.01 12.55 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.981 1.312 . . . . 0.0 108.549 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -57.86 -16.41 11.7 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.695 1.598 . . . . 0.0 112.84 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.46 ' HA ' HD12 ' A' ' 87' ' ' LEU . 16.8 mm-40 -57.78 -21.67 42.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 120.274 -1.516 . . . . 0.0 112.798 171.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.5 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 63.6 m-80 -70.43 -49.42 48.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.781 1.173 . . . . 0.0 110.813 177.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.24 -33.54 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 119.587 1.085 . . . . 0.0 110.572 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 84' ' ' GLN . 38.4 mt -62.31 -43.47 98.74 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.92 -2.76 13.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.267 1.427 . . . . 0.0 113.851 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.86 -18.79 20.08 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.584 1.538 . . . . 0.0 115.145 167.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -65.96 -51.12 61.32 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.431 1.469 . . . . 0.0 111.484 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 m -53.99 -36.72 63.22 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 117.322 -1.323 . . . . 0.0 110.685 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.7 mt -64.62 -34.5 70.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 CA-C-N 120.622 1.556 . . . . 0.0 110.532 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -66.09 -44.62 83.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.113 -0.992 . . . . 0.0 110.662 -175.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.342 0.1 OUTLIER -67.48 -0.85 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 125.213 1.405 . . . . 0.0 111.939 170.658 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.7 mtt-85 -117.59 16.87 14.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.618 1.967 . . . . 0.0 111.644 170.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 46.6 p -66.57 170.94 5.54 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.651 1.114 . . . . 0.0 109.401 163.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -161.8 177.95 37.85 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -62.4 131.16 32.78 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.171 2.58 . . . . 0.0 108.697 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 72.0 m 40.4 71.41 0.19 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.093 1.357 . . . . 0.0 111.64 -172.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.38 90.64 0.24 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 168.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 C-N-CA 128.251 2.834 . . . . 0.0 106.419 -171.096 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.68 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -142.62 -51.16 0.37 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.386 1.093 . . . . 0.0 110.855 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.8 m -57.72 146.23 31.81 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 119.533 1.06 . . . . 0.0 112.031 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.07 33.79 0.76 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.837 2.16 . . . . 0.0 113.946 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.7 t -52.93 94.46 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.952 2.501 . . . . 0.0 108.347 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.7 m -164.46 95.23 0.73 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.078 1.751 . . . . 0.0 107.79 -171.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.53 152.43 16.63 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 173.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.0 100.45 3.82 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.536 1.534 . . . . 0.0 109.96 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.81 126.25 6.41 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 106.385 -2.686 . . . . 0.0 106.385 164.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -79.0 46.69 2.26 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 123.461 2.774 . . . . 0.0 111.29 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.63 126.12 24.05 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 125.759 1.647 . . . . 0.0 110.806 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.56 8.53 2.4 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.661 0.784 . . . . 0.0 112.992 -176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -110.34 -178.0 3.39 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.527 1.058 . . . . 0.0 109.173 173.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.31 107.38 2.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 166.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -121.8 175.31 6.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.146 1.778 . . . . 0.0 110.607 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 62' ' ' TRP . 4.9 mm-40 -80.77 90.79 5.85 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.844 0.858 . . . . 0.0 109.638 -169.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.541 HD22 ' CD ' ' A' ' 77' ' ' LYS . 8.3 mt -76.4 146.91 38.37 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.611 0.765 . . . . 0.0 109.016 178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.45 100.98 10.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 122.373 1.082 . . . . 0.0 109.031 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 p -59.42 -47.77 84.18 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.138 1.375 . . . . 0.0 111.415 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.66 -24.2 66.59 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.553 0.741 . . . . 0.0 111.529 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -80.57 -55.75 4.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 117.454 -1.26 . . . . 0.0 108.588 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.489 HD11 ' HB3' ' A' ' 17' ' ' LEU . 57.0 mt -48.98 -51.82 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 120.03 1.287 . . . . 0.0 108.426 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.68 -49.15 65.86 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.632 1.173 . . . . 0.0 111.741 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -62.86 -50.76 69.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.814 0.846 . . . . 0.0 110.301 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -60.21 -39.52 86.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.773 1.229 . . . . 0.0 111.537 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.5 HG21 ' SD ' ' A' ' 76' ' ' MET . 90.6 t -61.29 -49.73 83.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 O-C-N 120.902 -1.123 . . . . 0.0 108.82 172.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -59.99 -30.31 69.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 116.604 -1.665 . . . . 0.0 112.119 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.6 -65.25 0.71 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.514 1.506 . . . . 0.0 108.848 169.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.563 ' HB3' HG21 ' A' ' 86' ' ' VAL . 5.1 mm-40 -56.35 -39.71 73.3 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.66 1.184 . . . . 0.0 113.286 -171.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.8 mt -61.75 -51.03 70.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.58 -29.92 70.34 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.375 0.67 . . . . 0.0 112.276 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -57.95 -25.7 61.29 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.304 1.442 . . . . 0.0 111.645 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -128.34 16.51 6.59 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.074 1.35 . . . . 0.0 112.042 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 m120 35.88 70.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 128.478 2.711 . . . . 0.0 111.926 -167.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.0 mt -100.93 147.54 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.38 133.37 11.77 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -35.04 68.77 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.704 0.802 . . . . 0.0 112.987 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.4 ttt-85 -54.41 -54.68 37.44 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.299 0.64 . . . . 0.0 111.158 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.83 -47.93 87.81 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.13 -47.27 75.27 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.714 0.688 . . . . 0.0 111.229 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.4 -27.1 70.38 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-O 117.112 -1.938 . . . . 0.0 112.443 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -70.89 -45.41 64.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.061 2.431 . . . . 0.0 110.431 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -87.67 -67.84 0.8 Allowed 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 121.766 -0.584 . . . . 0.0 111.091 -170.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.45 -44.03 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -171.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.0 mt -99.06 -39.99 8.24 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.169 0.588 . . . . 0.0 111.983 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.91 50.36 53.23 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -172.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -129.12 167.84 16.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.648 1.979 . . . . 0.0 107.25 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 t -66.69 157.02 33.69 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.968 0.89 . . . . 0.0 109.629 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -59.89 -27.32 66.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.915 0.886 . . . . 0.0 111.445 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.04 -48.34 26.87 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -54.38 -63.7 1.07 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.601 1.16 . . . . 0.0 110.211 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -58.45 -39.01 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 119.294 0.952 . . . . 0.0 111.767 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -62.06 -38.43 88.73 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.24 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -59.41 -47.57 84.95 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.937 1.244 . . . . 0.0 108.993 169.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.437 HG21 HD13 ' A' ' 55' ' ' ILE . 16.6 mt -60.13 -41.56 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -176.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -70.13 -40.79 74.61 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 124.525 1.13 . . . . 0.0 111.537 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.77 -37.39 86.21 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.114 1.366 . . . . 0.0 110.747 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -139.16 70.38 40.97 Favored Pre-proline 0 C--O 1.235 0.295 0 C-N-CA 126.815 2.046 . . . . 0.0 107.658 -171.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.39 93.36 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.01 2.474 . . . . 0.0 107.609 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -67.11 160.36 71.19 Favored Pre-proline 0 N--CA 1.436 -1.157 0 O-C-N 121.736 -0.602 . . . . 0.0 109.557 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -58.44 144.65 96.41 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.367 2.044 . . . . 0.0 108.486 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.498 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 65.6 t-105 -52.77 -49.58 65.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.529 0.604 . . . . 0.0 110.734 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.6 -25.71 11.42 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 176.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.52 -18.74 47.57 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 120.005 1.275 . . . . 0.0 113.27 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.7 mt -86.95 162.57 17.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.451 0.643 . . . . 0.0 111.424 -169.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.6 p -94.04 -178.86 4.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.97 2.108 . . . . 0.0 109.892 168.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.4 m -58.57 -45.17 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 119.331 0.969 . . . . 0.0 111.724 169.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -60.31 -33.11 71.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 119.519 -0.276 . . . . 0.0 111.631 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.66 96.76 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.103 1.335 . . . . 0.0 112.516 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 91.1 mttt -79.61 -26.91 41.09 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.472 1.509 . . . . 0.0 112.934 -175.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -43.69 -57.8 5.33 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 125.892 1.677 . . . . 0.0 110.441 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.49 -43.49 13.58 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.727 1.618 . . . . 0.0 112.366 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -64.61 -36.45 84.27 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 120.273 -1.517 . . . . 0.0 112.24 -174.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.35 -55.28 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -51.52 -48.7 62.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.064 0.946 . . . . 0.0 110.204 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.5 ' SD ' HG21 ' A' ' 26' ' ' VAL . 62.7 mtm -61.86 -46.52 89.07 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 120.966 -1.084 . . . . 0.0 112.394 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.541 ' CD ' HD22 ' A' ' 17' ' ' LEU . 16.9 tttm -63.18 -39.65 95.26 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.07 -1.019 . . . . 0.0 110.936 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -67.2 -36.83 82.57 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.216 1.007 . . . . 0.0 110.107 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.496 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.2 t80 -61.21 -40.5 94.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.917 0.887 . . . . 0.0 110.517 174.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.4 mt -72.77 -8.82 57.28 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.346 1.058 . . . . 0.0 112.666 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.42 -13.1 59.42 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.871 1.269 . . . . 0.0 111.887 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -157.28 119.03 3.74 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.052 -1.03 . . . . 0.0 109.419 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -25.65 65.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.163 0.985 . . . . 0.0 113.645 -170.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -64.41 -18.64 64.9 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 119.705 -1.872 . . . . 0.0 111.909 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.496 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 55.2 m-80 -59.71 -48.52 81.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.826 0.739 . . . . 0.0 111.003 176.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.563 HG21 ' HB3' ' A' ' 29' ' ' GLN . 4.0 p -71.55 -33.82 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 121.811 -0.555 . . . . 0.0 109.87 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 mt -63.54 -42.4 98.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.87 73.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.057 0.39 . . . . 0.0 111.567 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.49 HD22 HD12 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -70.51 -24.64 62.87 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.947 0.899 . . . . 0.0 112.234 178.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.5 mtp-105 -61.97 -47.89 82.84 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 118.827 0.74 . . . . 0.0 110.298 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.0 m -51.78 -46.83 64.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.899 0.88 . . . . 0.0 109.318 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.49 HD12 HD22 ' A' ' 89' ' ' LEU . 53.6 mt -64.86 -35.24 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 122.908 0.483 . . . . 0.0 110.277 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -63.41 -51.24 66.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 117.922 -1.037 . . . . 0.0 111.066 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.275 0.2 OUTLIER -60.3 -39.84 82.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 119.727 1.149 . . . . 0.0 109.69 175.214 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.617 ' HB3' HH11 ' A' ' 95' ' ' ARG . 0.0 OUTLIER -76.14 9.76 2.33 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.983 -1.008 . . . . 0.0 113.137 179.401 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.2 p -65.34 -18.22 65.14 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.999 1.727 . . . . 0.0 112.383 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.78 -161.6 10.24 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 127.552 2.501 . . . . 0.0 107.91 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -65.53 170.07 11.67 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.065 1.843 . . . . 0.0 110.2 168.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.9 m -112.96 -177.44 3.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.029 1.332 . . . . 0.0 110.022 173.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 p -141.76 134.59 28.72 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.223 1.409 . . . . 0.0 107.651 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.7 0 N-CA-C 105.46 -3.056 . . . . 0.0 105.46 154.219 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.844 0 CA-C-O 119.108 -0.829 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -27.0 114.68 0.06 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 129.473 3.109 . . . . 0.0 114.307 -170.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -160.2 153.61 22.19 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.048 1.739 . . . . 0.0 110.271 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.25 -164.67 32.52 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 126.263 1.887 . . . . 0.0 110.256 -176.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.5 m 62.78 89.81 0.08 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.422 1.889 . . . . 0.0 113.392 171.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.43 165.73 26.6 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.817 1.647 . . . . 0.0 107.295 161.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.46 33.19 0.05 OUTLIER Glycine 0 CA--C 1.527 0.821 0 CA-C-N 119.414 1.007 . . . . 0.0 113.849 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -126.82 163.88 22.61 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.941 1.37 . . . . 0.0 108.392 167.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.96 84.1 0.08 OUTLIER Glycine 0 CA--C 1.527 0.81 0 CA-C-O 118.73 -1.039 . . . . 0.0 111.276 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.25 -170.09 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.195 2.597 . . . . 0.0 110.748 168.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.7 104.66 0.2 Allowed Glycine 0 C--N 1.332 0.359 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.33 159.16 41.08 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.738 1.215 . . . . 0.0 110.123 167.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.252 15.0 tt0 36.85 -117.44 0.14 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.744 2.418 . . . . 0.0 111.049 178.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -107.39 122.43 46.59 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 155.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -133.02 177.94 7.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.268 0.627 . . . . 0.0 110.182 167.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -99.7 68.93 1.57 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.379 0.671 . . . . 0.0 109.234 -152.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.421 ' HB3' HD11 ' A' ' 22' ' ' ILE . 3.8 mt -55.86 135.29 52.11 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.976 0.91 . . . . 0.0 110.77 -168.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -71.96 105.44 3.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.876 0.846 . . . . 0.0 109.399 177.466 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.452 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 19.2 p -68.72 -40.63 79.83 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.513 -0.742 . . . . 0.0 112.268 -177.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.83 66.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.928 0.785 . . . . 0.0 111.044 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 4.0 tt0 -81.03 -52.78 7.04 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.319 1.448 . . . . 0.0 109.068 176.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' A' ' 17' ' ' LEU . 66.7 mt -56.13 -44.39 78.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 119.099 0.863 . . . . 0.0 109.916 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.57 85.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.551 0.74 . . . . 0.0 110.867 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.437 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 48.3 t80 -61.91 -53.92 49.11 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.078 0.951 . . . . 0.0 110.835 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -56.91 -38.98 73.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.114 1.365 . . . . 0.0 110.543 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.18 -50.76 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 120.68 -1.263 . . . . 0.0 109.81 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 40.9 mtmt -54.52 -48.22 72.18 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 116.991 -1.481 . . . . 0.0 110.726 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -47.41 71.44 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 116.944 -1.503 . . . . 0.0 111.402 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -56.37 -45.07 80.67 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 121.044 1.747 . . . . 0.0 112.48 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.2 -49.25 72.74 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.72 -33.49 70.26 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.454 1.025 . . . . 0.0 111.948 174.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -59.1 -20.27 51.96 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 126.114 1.766 . . . . 0.0 111.992 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -128.69 15.62 6.45 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 169.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 44.96 60.48 2.94 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 128.042 2.537 . . . . 0.0 111.765 -168.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.6 mt -98.32 154.05 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 174.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.54 150.8 18.09 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.921 0.772 . . . . 0.0 111.725 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -73.99 -14.36 61.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.96 1.304 . . . . 0.0 114.359 -177.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -70.97 -57.72 4.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.502 1.501 . . . . 0.0 109.973 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -56.0 -48.07 79.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -57.95 -41.31 82.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.758 1.163 . . . . 0.0 111.179 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.3 -26.54 67.96 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-O 117.184 -1.898 . . . . 0.0 112.58 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -74.32 -40.76 62.01 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.35 2.075 . . . . 0.0 110.658 173.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -90.93 -64.11 1.18 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.541 1.137 . . . . 0.0 111.803 -169.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.29 -36.85 74.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.3 mt -109.21 -43.86 4.06 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.062 0.545 . . . . 0.0 110.865 -166.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.45 31.79 53.35 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.093 0.854 . . . . 0.0 112.146 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.9 mt -109.08 159.39 16.91 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.578 1.551 . . . . 0.0 108.824 -175.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t -63.0 160.56 14.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.461 0.648 . . . . 0.0 110.114 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -54.11 -42.48 69.47 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.426 1.09 . . . . 0.0 112.528 -165.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.02 -10.01 57.81 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 118.427 -1.207 . . . . 0.0 113.637 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 m -62.4 -57.96 9.39 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.343 1.571 . . . . 0.0 108.99 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.31 -35.47 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.193 0.906 . . . . 0.0 112.081 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.6 t -59.28 -40.34 85.78 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.007 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.4 -46.49 88.53 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 119.311 0.96 . . . . 0.0 109.779 169.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.487 HG23 ' CZ ' ' A' ' 73' ' ' PHE . 1.7 mt -58.18 -30.41 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.114 1.325 . . . . 0.0 110.022 -176.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -87.73 -26.11 23.1 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.985 0.914 . . . . 0.0 113.122 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.98 -41.72 22.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.684 1.594 . . . . 0.0 110.798 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 mmt-85 -135.27 73.62 63.58 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 129.635 3.174 . . . . 0.0 106.367 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -69.68 95.25 0.54 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 N-CA-C 105.825 -2.414 . . . . 0.0 105.825 168.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -67.05 155.9 89.14 Favored Pre-proline 0 N--CA 1.432 -1.373 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.481 ' HD2' ' HG3' ' A' ' 64' ' ' LYS . 6.1 Cg_exo -58.28 149.61 72.11 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.628 2.219 . . . . 0.0 109.889 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -51.21 -50.25 59.46 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.52 0.328 . . . . 0.0 110.261 172.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.417 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -64.24 2.1 0.63 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 176.152 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HG3' ' HD2' ' A' ' 61' ' ' PRO . 14.6 mmmt -98.76 -20.7 16.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.522 1.51 . . . . 0.0 112.014 167.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.6 mt -99.81 149.84 22.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.627 0.649 . . . . 0.0 109.629 -164.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.3 t -87.53 179.39 6.56 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.3 p -43.14 -58.54 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 124.693 1.197 . . . . 0.0 112.101 173.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.78 -17.0 63.79 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.85 -39.61 23.97 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 126.34 1.924 . . . . 0.0 112.953 167.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -83.5 -25.12 31.36 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.451 2.301 . . . . 0.0 111.961 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -45.78 -53.29 21.03 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 128.219 2.608 . . . . 0.0 111.61 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.17 -48.4 10.12 Favored 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 121.338 1.359 . . . . 0.0 109.851 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 55' ' ' ILE . 69.1 m-85 -63.35 -33.39 75.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.437 -174.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.8 mt -60.46 -54.51 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.969 1.259 . . . . 0.0 108.081 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -54.05 -51.42 64.1 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.803 0.841 . . . . 0.0 109.689 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.3 mtm -60.8 -47.04 88.14 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.833 0.853 . . . . 0.0 112.02 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -59.0 -38.79 80.01 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.953 -1.092 . . . . 0.0 110.492 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -71.05 -37.97 72.52 Favored 'General case' 0 C--O 1.227 -0.108 0 O-C-N 121.702 -0.624 . . . . 0.0 111.361 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.494 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 16.8 t80 -54.31 -42.96 70.71 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.664 1.186 . . . . 0.0 109.57 171.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.8 mt -74.89 -13.16 60.51 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.615 -0.678 . . . . 0.0 112.448 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 m -80.9 2.64 25.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.667 0.787 . . . . 0.0 112.294 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -157.3 132.3 8.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.984 1.266 . . . . 0.0 108.269 162.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.22 -26.59 60.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.793 0.837 . . . . 0.0 112.174 175.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.412 ' HA ' HD12 ' A' ' 87' ' ' LEU . 14.2 mm-40 -54.1 -28.6 40.37 Favored 'General case' 0 C--N 1.338 0.106 0 O-C-N 120.027 -1.671 . . . . 0.0 113.559 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.494 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 52.4 m-80 -64.9 -50.27 67.17 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 119.289 0.949 . . . . 0.0 110.135 177.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.64 -34.98 68.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 O-C-N 121.529 -0.732 . . . . 0.0 110.464 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 84' ' ' GLN . 83.8 mt -59.68 -48.63 80.9 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.49 85.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 122.943 0.497 . . . . 0.0 111.666 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.426 HD22 HD12 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -64.85 -24.4 67.53 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.583 1.153 . . . . 0.0 111.683 -178.552 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -58.47 -49.12 78.49 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 119.048 0.84 . . . . 0.0 110.242 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 m -55.94 -44.8 78.75 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.098 0.408 . . . . 0.0 110.161 177.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.426 HD12 HD22 ' A' ' 89' ' ' LEU . 18.3 mt -63.07 -31.19 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.234 -0.917 . . . . 0.0 111.131 -177.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -71.14 -31.64 67.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.376 0.67 . . . . 0.0 111.465 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -67.02 -39.96 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 119.554 1.07 . . . . 0.0 108.75 169.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 -76.62 11.93 1.47 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.759 1.623 . . . . 0.0 111.962 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.9 t -73.82 165.67 24.7 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.422 -1.424 . . . . 0.0 108.792 171.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.33 171.19 36.99 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.386 0.517 . . . . 0.0 113.551 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -63.28 -65.35 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.803 3.002 . . . . 0.0 112.13 -164.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.1 p 49.04 84.33 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.236 1.414 . . . . 0.0 111.802 -170.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.1 p -130.59 102.99 6.37 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.325 1.05 . . . . 0.0 108.403 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.327 0 N-CA-C 106.793 -2.523 . . . . 0.0 106.793 -162.124 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.059 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 m 65.36 175.21 0.21 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.647 1.179 . . . . 0.0 110.926 -169.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m 60.14 179.04 0.09 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.37 1.468 . . . . 0.0 111.801 -166.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 112.78 135.46 6.39 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -173.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.5 t -163.46 162.21 24.6 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 126.345 1.858 . . . . 0.0 106.115 167.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.6 m -158.86 161.81 36.9 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.369 1.068 . . . . 0.0 108.81 174.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.58 97.44 0.13 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -138.77 89.99 2.41 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.79 101.08 0.15 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-O 118.463 -1.187 . . . . 0.0 110.331 -174.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -77.88 38.34 0.67 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.685 3.59 . . . . 0.0 111.243 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.28 -123.56 14.54 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -169.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.23 101.98 0.96 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 128.353 2.661 . . . . 0.0 104.267 167.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.5 176.43 10.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 168.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.47 105.97 0.49 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 166.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -82.67 -168.19 1.93 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.009 1.323 . . . . 0.0 112.669 -176.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -101.41 107.26 18.53 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.979 0.912 . . . . 0.0 108.728 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.499 ' HB3' HD11 ' A' ' 22' ' ' ILE . 5.8 mt -92.56 134.37 35.05 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -71.76 99.79 2.23 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 122.295 1.045 . . . . 0.0 108.572 176.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 24.2 p -59.57 -40.58 87.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.156 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.76 -31.05 72.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 119.102 -0.475 . . . . 0.0 111.908 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -74.96 -50.27 17.25 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.664 1.186 . . . . 0.0 108.907 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 17' ' ' LEU . 67.2 mt -56.11 -47.39 80.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.31 92.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.269 -0.894 . . . . 0.0 111.987 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -62.92 -66.66 0.51 Allowed 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.461 1.504 . . . . 0.0 109.183 172.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -49.83 -38.67 35.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.24 1.816 . . . . 0.0 112.985 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 t -63.75 -43.53 98.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 121.293 -0.88 . . . . 0.0 110.25 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -60.44 -43.63 96.62 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.683 0.674 . . . . 0.0 109.413 175.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -57.01 -49.13 76.73 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.076 0.551 . . . . 0.0 110.467 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -63.25 -38.05 89.64 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.915 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mt -62.46 -43.07 99.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 120.515 1.507 . . . . 0.0 109.915 172.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.05 -45.33 79.29 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.992 0.815 . . . . 0.0 111.337 168.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -52.94 -40.81 63.93 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.626 1.97 . . . . 0.0 113.96 -168.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -121.83 16.19 10.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.963 1.305 . . . . 0.0 111.282 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 43.41 72.22 0.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.244 2.618 . . . . 0.0 111.561 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.3 mt -112.49 155.8 13.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.62 144.41 17.28 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 124.207 0.908 . . . . 0.0 110.935 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -62.52 -37.52 86.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.902 1.681 . . . . 0.0 112.194 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.8 ttt-85 -57.43 -54.51 46.06 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 117.66 -1.162 . . . . 0.0 109.822 173.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.3 -36.13 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.63 1.559 . . . . 0.0 111.338 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -61.11 -55.86 27.55 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.492 -0.755 . . . . 0.0 111.25 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.41 -26.31 74.67 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-O 118.008 -1.44 . . . . 0.0 112.458 -174.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -78.75 -27.81 44.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 120.083 1.942 . . . . 0.0 110.784 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -106.73 -62.25 1.42 Allowed 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.925 0.89 . . . . 0.0 112.049 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.57 -45.77 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.48 HD21 ' HG2' ' A' ' 76' ' ' MET . 28.9 mt -94.99 -37.44 11.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.113 -174.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.18 2.66 90.58 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.682 0.658 . . . . 0.0 112.747 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.6 mt -89.77 168.18 12.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.048 1.424 . . . . 0.0 107.794 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.0 m -76.39 162.19 28.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.473 -0.767 . . . . 0.0 110.785 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -56.95 -46.9 81.8 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.667 0.787 . . . . 0.0 111.868 -172.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.49 73.12 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 119.57 -0.572 . . . . 0.0 112.022 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 m -65.41 -62.35 1.58 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.035 0.918 . . . . 0.0 109.454 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.69 -34.62 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 119.789 1.177 . . . . 0.0 112.041 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -57.0 -42.1 79.65 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.013 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.0 -44.91 87.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.48 0.582 . . . . 0.0 109.672 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 mt -62.28 -38.56 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -174.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.0 mt -83.98 -15.07 49.11 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.056 0.943 . . . . 0.0 112.771 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.7 -52.64 6.25 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.596 1.558 . . . . 0.0 108.525 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.9 81.45 58.0 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 127.972 2.509 . . . . 0.0 107.568 -173.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.43 101.83 0.91 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 N-CA-C 106.426 -2.182 . . . . 0.0 106.426 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -67.49 161.72 62.79 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -56.19 144.24 81.82 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.526 2.817 . . . . 0.0 109.505 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -52.11 -50.64 61.26 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.253 0.621 . . . . 0.0 109.808 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -17.91 12.57 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 175.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 1.9 mmpt? -82.84 -31.66 27.94 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.429 1.468 . . . . 0.0 111.103 174.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.6 mt -71.88 174.77 6.49 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.814 1.292 . . . . 0.0 111.591 -167.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 p -111.19 179.89 3.91 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.779 1.232 . . . . 0.0 108.135 167.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.7 m -52.67 -45.6 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.366 1.439 . . . . 0.0 113.02 169.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -66.4 -22.23 66.23 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.632 1.56 . . . . 0.0 111.888 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.42 -47.62 27.67 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 124.816 1.198 . . . . 0.0 111.548 171.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -71.95 -31.35 66.22 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.742 1.217 . . . . 0.0 111.398 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -42.8 -57.65 4.67 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 127.918 2.487 . . . . 0.0 111.109 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.5 -52.01 3.62 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.0 1.8 . . . . 0.0 110.594 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 19' ' ' THR . 57.3 m-85 -55.08 -38.08 67.62 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.938 1.244 . . . . 0.0 113.345 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.6 mt -58.74 -56.47 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 124.709 1.204 . . . . 0.0 107.993 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -56.91 -42.5 80.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.218 1.007 . . . . 0.0 109.679 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.48 ' HG2' HD21 ' A' ' 45' ' ' LEU . 66.4 mtm -65.14 -51.26 62.3 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 124.299 1.04 . . . . 0.0 112.336 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -62.29 -36.01 80.79 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.028 -1.045 . . . . 0.0 110.296 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -66.12 -42.07 89.69 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.807 -0.558 . . . . 0.0 109.85 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.48 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 14.5 t80 -57.39 -39.06 75.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.163 0.985 . . . . 0.0 110.068 175.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.5 mt -76.57 -12.27 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.7 m -83.17 -21.33 33.56 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.195 -0.941 . . . . 0.0 113.075 -174.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -132.72 130.09 39.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 170.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.15 -46.17 90.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.347 -171.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.671 ' HA ' HD23 ' A' ' 87' ' ' LEU . 9.5 mm-40 -53.95 -18.52 3.53 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.103 2.161 . . . . 0.0 113.321 -166.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.48 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 68.2 m-80 -53.81 -41.82 67.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.086 0.955 . . . . 0.0 111.658 170.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.712 HG12 HD22 ' A' ' 87' ' ' LEU . 4.8 p -73.35 -35.34 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 119.782 1.174 . . . . 0.0 110.97 178.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.712 HD22 HG12 ' A' ' 86' ' ' VAL . 2.5 mm? -64.85 -26.77 68.48 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.436 1.094 . . . . 0.0 109.782 -175.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.45 60.22 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.396 1.078 . . . . 0.0 112.698 167.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -31.44 71.64 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.039 0.936 . . . . 0.0 110.768 -178.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.6 mtm105 -53.98 -42.79 69.37 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.274 0.488 . . . . 0.0 110.015 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.5 m -66.05 -43.36 87.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.646 0.778 . . . . 0.0 110.053 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.8 mt -69.03 -32.35 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.533 -0.73 . . . . 0.0 109.769 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -58.0 -42.83 86.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.728 -0.654 . . . . 0.0 110.931 174.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -30.99 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 119.171 0.896 . . . . 0.0 110.269 176.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -76.46 -4.77 44.32 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.31 1.044 . . . . 0.0 111.877 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 t -61.95 161.24 10.91 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.812 1.187 . . . . 0.0 111.157 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.39 -176.98 39.5 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.062 1.315 . . . . 0.0 109.961 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -81.86 51.54 3.86 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 125.29 3.994 . . . . 0.0 110.614 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.6 t -80.63 92.37 5.96 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.0 t -172.42 81.96 0.06 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.212 2.205 . . . . 0.0 105.457 -170.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.616 0 N-CA-C 105.464 -3.054 . . . . 0.0 105.464 166.998 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.343 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 t -159.46 -150.24 0.23 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.696 2.398 . . . . 0.0 106.022 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -4.84 -79.78 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 130.968 3.707 . . . . 0.0 113.084 171.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.88 174.19 33.42 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 121.472 -0.768 . . . . 0.0 113.14 172.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.3 m -133.36 21.43 4.01 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.078 1.351 . . . . 0.0 111.38 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 p -62.16 163.05 8.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 162.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.99 99.93 2.64 Favored Glycine 0 C--O 1.239 0.411 0 N-CA-C 106.309 -2.717 . . . . 0.0 106.309 -162.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -149.85 166.12 30.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.541 0.736 . . . . 0.0 110.612 175.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.23 93.31 0.26 Allowed Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.07 169.35 22.78 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 CA-C-N 119.921 1.86 . . . . 0.0 109.682 164.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.42 174.58 45.59 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.65 156.54 42.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 166.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 57.24 -179.17 0.05 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.745 1.218 . . . . 0.0 111.071 -167.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -72.27 122.33 20.92 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 171.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -105.75 -168.15 1.41 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.904 1.282 . . . . 0.0 109.565 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -97.53 135.2 39.72 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.654 0.782 . . . . 0.0 109.216 172.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.48 ' HB3' HD11 ' A' ' 22' ' ' ILE . 7.8 mt -124.89 129.93 51.36 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -170.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.74 107.49 6.87 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 122.155 0.978 . . . . 0.0 110.256 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.429 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 24.5 p -63.11 -44.23 96.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.722 0.809 . . . . 0.0 110.555 -173.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.63 -8.72 56.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.783 0.833 . . . . 0.0 111.732 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.42 -54.47 4.17 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.797 1.239 . . . . 0.0 108.904 167.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 17' ' ' LEU . 68.7 mt -52.32 -50.72 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.204 1.366 . . . . 0.0 109.286 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.56 -33.29 65.98 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.24 1.016 . . . . 0.0 112.95 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -75.56 -57.86 3.63 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.128 0.971 . . . . 0.0 108.496 174.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -52.35 -32.76 39.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.339 1.456 . . . . 0.0 112.034 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.524 HG23 HD11 ' A' ' 80' ' ' LEU . 53.8 t -67.66 -57.09 10.73 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 C-N-CA 124.393 1.077 . . . . 0.0 110.729 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -51.52 -41.43 61.01 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.495 1.043 . . . . 0.0 111.116 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -53.11 -59.36 4.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.008 1.323 . . . . 0.0 110.128 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -62.03 -38.81 90.1 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.474 1.109 . . . . 0.0 113.351 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.1 mt -61.12 -48.09 83.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.08 -37.66 85.87 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.156 0.889 . . . . 0.0 112.856 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -55.87 -33.56 64.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.435 1.894 . . . . 0.0 110.674 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -123.49 11.31 9.24 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.286 1.034 . . . . 0.0 113.073 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 49.03 68.44 0.71 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.64 1.976 . . . . 0.0 112.136 -172.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt -112.23 156.29 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 121.264 -0.897 . . . . 0.0 110.047 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.56 130.71 10.44 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.958 2.218 . . . . 0.0 110.721 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -51.75 -35.79 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.42 1.488 . . . . 0.0 112.096 174.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -58.3 -54.28 48.75 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.773 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.62 -44.63 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -55.69 -51.78 66.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.636 0.255 . . . . 0.0 110.794 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.65 78.27 Favored Glycine 0 N--CA 1.428 -1.86 0 CA-C-O 116.338 -2.368 . . . . 0.0 111.563 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -78.31 -30.79 48.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.812 2.806 . . . . 0.0 111.956 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -101.56 -51.63 3.41 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 123.054 0.542 . . . . 0.0 111.384 -170.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.73 -46.29 24.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -175.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.481 HD21 ' HG2' ' A' ' 76' ' ' MET . 34.0 mt -95.94 -34.53 11.77 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.924 -172.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.72 4.96 88.37 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.389 0.519 . . . . 0.0 112.913 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.5 mt -98.49 158.55 15.53 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.361 1.464 . . . . 0.0 107.41 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.6 m -71.64 164.43 25.92 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.433 -0.792 . . . . 0.0 110.239 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -58.56 -49.59 76.87 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.83 69.73 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.584 -0.564 . . . . 0.0 111.899 -178.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 m -70.88 -62.85 1.24 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.863 1.265 . . . . 0.0 111.357 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 m -60.07 -30.83 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 121.089 1.768 . . . . 0.0 112.273 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.7 t -58.06 -39.23 77.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.52 -1.229 . . . . 0.0 110.394 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.72 -43.28 85.13 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.023 1.283 . . . . 0.0 110.176 171.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.415 HG23 ' CE2' ' A' ' 73' ' ' PHE . 12.0 mt -64.79 -42.59 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -173.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.2 mt -77.1 -29.57 54.92 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.465 0.706 . . . . 0.0 111.848 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.25 -56.41 6.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.746 1.618 . . . . 0.0 111.078 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -135.52 59.39 30.83 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 124.245 1.018 . . . . 0.0 109.708 -165.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -63.35 104.49 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.883 3.056 . . . . 0.0 110.281 -173.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -63.63 157.94 62.86 Favored Pre-proline 0 N--CA 1.434 -1.252 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -65.81 153.87 76.33 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.645 2.896 . . . . 0.0 110.471 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.451 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 73.4 t-105 -55.44 -43.85 75.78 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.368 1.067 . . . . 0.0 111.288 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.529 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -60.77 -19.98 60.43 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 176.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.55 -23.31 27.71 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.558 1.072 . . . . 0.0 112.327 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 29.6 mt -89.38 152.42 21.51 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 119.071 0.851 . . . . 0.0 109.302 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.8 p -105.07 -172.05 2.03 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.933 1.293 . . . . 0.0 109.666 172.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.1 t -47.7 -58.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 120.785 1.63 . . . . 0.0 110.49 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -71.68 -3.08 19.78 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.78 -42.35 6.08 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.881 1.705 . . . . 0.0 112.097 165.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 85.3 mttt -80.88 -25.04 37.89 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.895 2.078 . . . . 0.0 111.844 -174.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.33 -56.31 12.98 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 125.482 1.513 . . . . 0.0 111.328 -175.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.33 -44.53 18.36 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 121.423 1.416 . . . . 0.0 110.311 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.429 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 70.4 m-85 -62.43 -37.46 85.92 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.993 1.269 . . . . 0.0 113.229 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.04 -49.38 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.634 1.106 . . . . 0.0 108.031 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -57.65 -53.29 59.9 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.664 0.786 . . . . 0.0 109.558 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.481 ' HG2' HD21 ' A' ' 45' ' ' LEU . 58.5 mtm -56.75 -50.55 71.91 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.4 0.68 . . . . 0.0 112.27 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tttp -61.72 -40.3 94.58 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.574 -0.704 . . . . 0.0 110.35 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -70.53 -32.06 69.37 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.327 0.967 . . . . 0.0 111.086 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.449 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 11.0 t80 -60.94 -43.23 98.97 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.524 HD11 HG23 ' A' ' 26' ' ' VAL . 19.8 mt -71.89 -9.88 58.97 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.194 0.997 . . . . 0.0 112.413 177.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.8 m -89.44 -2.35 58.36 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.297 1.439 . . . . 0.0 112.543 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -149.73 123.45 9.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 120.141 1.337 . . . . 0.0 109.35 163.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.98 -18.72 64.56 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.821 0.343 . . . . 0.0 111.283 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -68.35 -11.17 59.15 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 119.795 -1.816 . . . . 0.0 113.731 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.449 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 69.0 m-80 -71.82 -57.08 4.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 167.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.41 -34.05 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 O-C-N 121.12 -0.987 . . . . 0.0 110.958 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.2 mt -65.22 -25.88 67.88 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.774 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.46 60.0 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.964 0.906 . . . . 0.0 110.967 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.31 -33.09 74.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.885 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -51.15 -50.58 58.64 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 118.706 0.684 . . . . 0.0 110.227 175.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.1 m -51.42 -50.12 60.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.768 1.227 . . . . 0.0 110.537 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.5 mt -62.94 -37.34 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.638 0.775 . . . . 0.0 109.902 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -62.15 -52.07 65.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.622 -0.674 . . . . 0.0 110.9 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.79 -27.12 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 118.593 0.633 . . . . 0.0 110.264 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -76.54 -3.57 38.19 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 117.88 -1.057 . . . . 0.0 113.155 175.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.0 p -57.82 -29.2 64.74 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.362 1.437 . . . . 0.0 113.186 -174.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.84 -172.73 41.35 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 121.163 -0.96 . . . . 0.0 111.152 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.41 160.47 39.12 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.706 2.937 . . . . 0.0 111.464 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.8 m 54.09 -178.05 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.655 1.182 . . . . 0.0 111.316 -171.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.4 p -154.69 -178.52 7.25 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 120.886 -1.134 . . . . 0.0 108.739 162.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.987 0 N-CA-C 105.752 -2.939 . . . . 0.0 105.752 163.913 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.524 ' HB3' HD11 ' A' ' 22' ' ' ILE . 5.2 mt . . . . . 0 C--O 1.238 0.494 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -72.94 104.17 3.99 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 122.004 0.906 . . . . 0.0 108.688 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 p -66.84 -38.21 85.97 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.457 0.703 . . . . 0.0 110.02 -173.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.07 -29.07 67.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.757 0.708 . . . . 0.0 110.899 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -76.09 -49.28 17.84 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 127.032 2.133 . . . . 0.0 108.836 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' A' ' 17' ' ' LEU . 82.1 mt -57.01 -47.0 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 119.078 0.854 . . . . 0.0 109.293 174.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.426 ' O ' ' HE3' ' A' ' 27' ' ' LYS . . . -56.46 -53.93 51.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.417 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -51.94 -67.79 0.22 Allowed 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.222 1.809 . . . . 0.0 109.245 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -51.72 -37.58 51.51 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.653 1.981 . . . . 0.0 112.945 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -62.94 -52.39 59.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 CA-C-N 119.183 0.901 . . . . 0.0 109.446 174.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 23' ' ' ALA . 22.0 mtmt -55.15 -42.55 73.23 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.418 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -57.66 -56.34 23.18 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.556 0.743 . . . . 0.0 110.775 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -62.19 -35.07 77.72 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.901 0.88 . . . . 0.0 112.589 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.38 -51.39 60.74 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -35.56 73.24 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.372 0.987 . . . . 0.0 112.399 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 tttt -49.95 -33.32 17.25 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 126.636 1.974 . . . . 0.0 110.869 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -128.18 16.29 6.69 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.936 1.294 . . . . 0.0 112.027 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.3 m120 60.16 36.03 21.08 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.878 2.471 . . . . 0.0 112.128 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.5 mt -83.33 157.7 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.467 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -101.36 144.84 16.65 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.923 1.249 . . . . 0.0 112.48 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -55.97 -35.24 66.5 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.943 2.097 . . . . 0.0 113.882 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -59.73 -58.98 6.21 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 120.47 1.486 . . . . 0.0 109.744 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 t -56.44 -44.43 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 119.256 0.934 . . . . 0.0 109.697 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -57.68 -49.7 75.63 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.538 0.608 . . . . 0.0 111.184 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.469 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -72.94 -24.99 74.93 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-O 118.093 -1.393 . . . . 0.0 111.887 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -77.95 -43.15 30.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 118.989 1.394 . . . . 0.0 109.632 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.422 ' CE1' HG21 ' A' ' 92' ' ' ILE . 36.3 m-85 -87.62 -68.19 0.77 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.654 0.381 . . . . 0.0 111.259 -177.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.7 t -62.79 -42.44 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 124.308 1.043 . . . . 0.0 108.268 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.445 HD21 ' HG2' ' A' ' 76' ' ' MET . 28.8 mt -96.08 -43.92 7.55 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.811 -172.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.23 20.16 57.62 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 123.798 0.686 . . . . 0.0 111.863 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -107.81 173.05 6.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.748 1.219 . . . . 0.0 107.9 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.4 m -68.59 159.54 31.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.055 -1.028 . . . . 0.0 111.539 166.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.42 -55.14 11.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.496 1.518 . . . . 0.0 110.337 168.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.53 -34.14 87.35 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 m -62.46 -64.6 0.88 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 116.842 -1.551 . . . . 0.0 110.176 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.469 HG11 ' HA3' ' A' ' 41' ' ' GLY . 3.9 m -60.2 -36.25 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 120.943 1.701 . . . . 0.0 111.867 -176.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.2 t -53.71 -42.33 67.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.585 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.25 -46.73 89.16 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 119.079 0.854 . . . . 0.0 109.805 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.446 HD13 HG21 ' A' ' 55' ' ' ILE . 6.7 mt -61.86 -38.08 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.1 mt -72.53 -32.8 66.41 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.878 1.271 . . . . 0.0 111.346 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.6 -52.3 27.33 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.19 1.396 . . . . 0.0 110.018 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -133.81 71.83 73.88 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 125.792 1.637 . . . . 0.0 108.436 -162.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.11 78.27 3.24 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.411 3.407 . . . . 0.0 110.584 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -54.77 157.13 5.75 Favored Pre-proline 0 N--CA 1.442 -0.859 0 C-N-CA 124.481 1.112 . . . . 0.0 110.306 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -55.34 143.8 74.88 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.132 2.555 . . . . 0.0 110.253 -172.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -55.11 -48.76 73.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.395 0.543 . . . . 0.0 109.935 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -26.28 32.52 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 172.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -34.62 45.87 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 119.703 1.138 . . . . 0.0 111.986 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.2 mt -77.73 148.02 35.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.959 0.885 . . . . 0.0 110.331 -171.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -82.54 178.16 8.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.848 1.659 . . . . 0.0 108.823 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.81 -47.64 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 120.883 1.674 . . . . 0.0 109.177 170.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -66.17 -8.74 25.93 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.878 -1.139 . . . . 0.0 113.724 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.43 -39.09 6.06 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 126.186 1.851 . . . . 0.0 111.655 169.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -78.6 -22.15 47.49 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.531 1.532 . . . . 0.0 111.565 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -44.94 -58.1 6.04 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 127.176 2.191 . . . . 0.0 110.681 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.59 -49.55 7.04 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.613 2.209 . . . . 0.0 111.562 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -60.09 -35.69 75.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 117.685 -1.15 . . . . 0.0 112.816 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.92 -54.41 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -56.42 -42.59 78.29 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.485 1.114 . . . . 0.0 110.69 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.445 ' HG2' HD21 ' A' ' 45' ' ' LEU . 71.1 mtm -67.47 -49.38 63.83 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.787 0.835 . . . . 0.0 111.984 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.494 ' HD2' HD22 ' A' ' 17' ' ' LEU . 15.6 tttm -64.12 -36.11 82.95 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.781 -1.2 . . . . 0.0 110.286 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -63.47 -42.84 98.6 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.397 1.479 . . . . 0.0 110.882 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.53 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 35.5 t80 -54.08 -51.57 63.69 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.684 1.193 . . . . 0.0 108.508 172.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.7 mt -68.51 -13.68 62.48 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m -72.45 -10.05 59.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.938 1.245 . . . . 0.0 112.178 172.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -154.46 115.96 4.13 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.715 1.143 . . . . 0.0 110.17 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -56.41 -26.81 54.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.504 1.522 . . . . 0.0 113.786 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -60.21 -25.05 65.31 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 120.321 1.419 . . . . 0.0 111.838 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.53 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 60.8 m-80 -59.53 -45.41 91.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.425 0.557 . . . . 0.0 110.972 176.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 p -71.39 -36.15 59.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 CA-C-N 118.543 0.611 . . . . 0.0 109.893 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.0 mt -63.13 -42.39 99.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.56 73.73 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.33 -25.78 66.99 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.154 -0.966 . . . . 0.0 111.771 176.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -61.74 -41.25 97.41 Favored 'General case' 0 C--O 1.228 -0.065 0 CA-C-N 119.223 0.919 . . . . 0.0 110.116 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.5 m -55.65 -46.52 77.46 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.689 1.196 . . . . 0.0 110.008 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.422 HG21 ' CE1' ' A' ' 43' ' ' TYR . 44.4 mt -64.19 -33.91 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.911 -0.493 . . . . 0.0 110.133 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.467 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 8.5 tp-100 . . . . . 0 CA--C 1.537 0.473 0 O-C-N 121.152 -0.967 . . . . 0.0 113.088 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.566 ' HB3' HD11 ' A' ' 22' ' ' ILE . 5.0 mt . . . . . 0 C--O 1.234 0.271 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.1 107.61 1.32 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.121 0.486 . . . . 0.0 110.464 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.9 p -68.91 -39.56 79.62 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.707 -0.62 . . . . 0.0 111.976 -169.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.01 73.1 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.992 0.815 . . . . 0.0 110.191 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -78.09 -51.36 10.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.225 1.41 . . . . 0.0 108.463 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 17' ' ' LEU . 74.8 mt -55.94 -43.71 75.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 119.209 0.913 . . . . 0.0 109.095 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.28 -53.45 58.1 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.359 0.664 . . . . 0.0 110.397 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -55.85 -51.14 68.57 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.332 1.053 . . . . 0.0 111.263 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -64.59 -39.74 94.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.698 1.599 . . . . 0.0 110.708 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.6 t -60.85 -49.12 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 O-C-N 120.942 -1.098 . . . . 0.0 109.643 171.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -62.34 -46.18 89.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 117.929 -1.034 . . . . 0.0 111.075 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -64.21 -42.86 96.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.116 0.871 . . . . 0.0 111.223 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -58.1 -44.55 87.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.486 1.114 . . . . 0.0 111.481 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mt -63.55 -49.73 72.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -49.13 -43.51 41.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.509 0.724 . . . . 0.0 111.684 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -60.37 -21.7 62.45 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.469 1.508 . . . . 0.0 113.634 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -128.33 13.25 6.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.892 1.277 . . . . 0.0 113.329 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.5 m120 50.74 71.22 0.44 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.955 2.102 . . . . 0.0 111.561 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.0 mt -118.92 155.41 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 120.658 -1.276 . . . . 0.0 108.392 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.27 145.98 16.74 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.463 1.03 . . . . 0.0 111.177 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -56.89 -34.96 68.4 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.095 1.358 . . . . 0.0 111.69 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -51.78 -61.89 1.97 Allowed 'General case' 0 C--N 1.337 0.063 0 C-N-CA 123.784 0.834 . . . . 0.0 111.606 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.26 -46.68 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.921 0.782 . . . . 0.0 109.588 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -54.85 -46.7 74.71 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.029 0.831 . . . . 0.0 111.762 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.551 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -72.11 -30.95 64.58 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-O 118.25 -1.305 . . . . 0.0 111.752 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -69.81 -36.99 76.12 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.379 1.59 . . . . 0.0 110.54 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -96.22 -67.93 0.82 Allowed 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.999 0.92 . . . . 0.0 111.34 -173.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.7 t -62.68 -60.45 2.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -172.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.529 HD21 ' HG2' ' A' ' 76' ' ' MET . 24.0 mt -76.28 -36.62 58.3 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.929 -172.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.71 16.09 73.93 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.446 -1.196 . . . . 0.0 112.355 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.8 mt -110.64 166.41 11.03 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.239 1.815 . . . . 0.0 109.931 -171.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -60.21 152.61 24.26 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.536 0.684 . . . . 0.0 110.822 168.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -55.29 -38.9 69.22 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.088 1.355 . . . . 0.0 110.338 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.89 -63.95 4.83 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 m -42.4 -69.33 0.14 Allowed 'General case' 0 C--N 1.342 0.268 0 CA-C-O 117.065 -1.445 . . . . 0.0 110.8 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.551 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.2 m -57.75 -42.09 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 120.832 1.651 . . . . 0.0 112.951 -171.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.0 t -60.13 -38.6 83.57 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.286 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -60.08 -47.76 84.55 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.275 1.03 . . . . 0.0 109.868 168.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mt -56.57 -42.39 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.59 -27.52 41.12 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.614 1.166 . . . . 0.0 112.302 -176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.7 -44.5 56.37 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.495 1.518 . . . . 0.0 110.546 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -133.3 73.85 73.29 Favored Pre-proline 0 C--O 1.236 0.359 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 -172.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.46 87.76 1.06 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.174 1.916 . . . . 0.0 107.197 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -57.53 157.04 14.6 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.06 155.86 67.97 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 121.429 1.419 . . . . 0.0 109.23 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -55.33 -42.61 74.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.7 0.4 . . . . 0.0 111.195 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -9.86 40.27 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 175.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -93.58 7.11 45.94 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.314 -1.491 . . . . 0.0 112.922 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.6 mt -124.39 153.8 41.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.463 1.105 . . . . 0.0 108.479 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.1 p -100.56 -175.36 2.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.714 0.806 . . . . 0.0 109.001 172.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.2 t -45.38 -45.35 3.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 119.154 0.888 . . . . 0.0 110.897 169.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -70.48 -38.29 74.36 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.898 1.226 . . . . 0.0 112.873 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.64 -35.01 84.4 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.82 0.724 . . . . 0.0 112.079 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -90.67 -19.69 23.33 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 125.568 1.547 . . . . 0.0 111.723 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -43.28 -55.7 7.7 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 127.572 2.349 . . . . 0.0 109.384 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.61 -50.38 2.53 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.291 1.994 . . . . 0.0 111.354 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -58.0 -35.96 71.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 120.222 1.374 . . . . 0.0 113.702 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.6 mt -57.59 -60.3 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.591 1.556 . . . . 0.0 107.474 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -52.27 -52.04 55.02 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.421 1.089 . . . . 0.0 110.212 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.529 ' HG2' HD21 ' A' ' 45' ' ' LEU . 63.8 mtm -55.39 -51.59 66.34 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.694 0.797 . . . . 0.0 111.464 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -59.75 -38.75 82.62 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.196 -0.94 . . . . 0.0 111.226 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -65.98 -45.09 82.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.423 1.01 . . . . 0.0 110.427 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.455 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 19.6 t80 -49.31 -46.91 47.23 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.963 1.705 . . . . 0.0 110.301 172.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.1 mt -71.84 -13.82 61.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.32 1.11 34.06 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.809 1.644 . . . . 0.0 112.45 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -160.03 118.55 2.7 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.891 1.223 . . . . 0.0 108.635 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -63.1 -19.45 64.44 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.69 1.196 . . . . 0.0 111.781 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -57.23 -30.05 64.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 120.157 -1.589 . . . . 0.0 112.054 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 75.1 m-80 -65.42 -38.21 89.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 119.018 -0.515 . . . . 0.0 110.174 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.83 -34.77 23.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 119.258 0.936 . . . . 0.0 110.317 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.9 mt -63.14 -40.77 98.56 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 123.261 0.624 . . . . 0.0 109.858 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.47 92.89 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.98 0.512 . . . . 0.0 111.252 173.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.482 HD22 HD12 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -65.46 -26.31 67.89 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.08 0.952 . . . . 0.0 112.2 -177.121 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -61.68 -45.19 95.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 118.489 0.586 . . . . 0.0 109.561 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.9 m -49.77 -50.05 46.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.215 1.006 . . . . 0.0 109.442 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.482 HD12 HD22 ' A' ' 89' ' ' LEU . 46.0 mt -65.57 -37.44 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.771 -173.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.48 175.542 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.53 HD22 ' HD2' ' A' ' 77' ' ' LYS . 3.3 mt . . . . . 0 C--O 1.236 0.364 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.41 101.46 4.8 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 122.291 1.043 . . . . 0.0 109.256 171.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.0 p -62.95 -38.96 93.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.586 -0.696 . . . . 0.0 111.477 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.77 70.72 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.107 0.867 . . . . 0.0 111.9 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -75.39 -53.05 9.35 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.357 1.463 . . . . 0.0 108.124 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 17' ' ' LEU . 72.0 mt -55.34 -44.02 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.35 0.66 . . . . 0.0 109.306 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.26 -47.88 83.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.406 0.682 . . . . 0.0 111.008 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.422 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 27.5 t80 -60.68 -50.22 74.38 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.329 1.052 . . . . 0.0 110.345 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -59.69 -45.4 92.2 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.746 1.618 . . . . 0.0 110.327 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.95 -50.83 78.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 O-C-N 120.424 -1.422 . . . . 0.0 109.077 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 50.0 mtmt -54.99 -41.88 71.76 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.455 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.41 -36.71 68.71 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 117.471 -1.252 . . . . 0.0 113.336 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.423 ' HB3' HG21 ' A' ' 86' ' ' VAL . 4.6 mm-40 -62.3 -41.23 98.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.415 1.916 . . . . 0.0 111.608 174.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.27 -44.71 95.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.21 -0.932 . . . . 0.0 108.54 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -58.07 -48.04 81.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 171.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -55.56 -30.3 60.54 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 127.051 2.141 . . . . 0.0 111.791 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -128.27 11.91 6.47 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.62 64.27 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.779 2.032 . . . . 0.0 112.111 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -107.63 150.84 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.521 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -82.8 135.3 13.83 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.79 1.186 . . . . 0.0 110.876 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -54.07 -37.37 64.13 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.609 0.764 . . . . 0.0 110.552 169.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -54.05 -64.48 0.81 Allowed 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.409 -1.281 . . . . 0.0 111.198 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t -52.74 -48.12 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 120.141 1.337 . . . . 0.0 110.07 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -55.3 -46.4 76.22 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.431 0.56 . . . . 0.0 111.88 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.536 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -73.39 -34.64 57.29 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-O 118.081 -1.4 . . . . 0.0 111.597 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.92 -32.23 73.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 119.331 1.565 . . . . 0.0 109.505 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.414 ' CE1' HG21 ' A' ' 92' ' ' ILE . 40.7 m-85 -103.15 -72.57 0.69 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.563 1.145 . . . . 0.0 111.907 -175.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.75 -43.85 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -168.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.527 HD21 ' HG2' ' A' ' 76' ' ' MET . 28.7 mt -96.48 -33.4 11.87 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -171.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.03 30.32 38.64 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 123.439 0.462 . . . . 0.0 112.017 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.7 mt -125.07 157.8 35.37 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.765 1.283 . . . . 0.0 110.464 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.8 t -60.39 160.48 8.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.683 1.193 . . . . 0.0 110.367 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.82 -55.82 26.07 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.342 1.057 . . . . 0.0 110.886 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.18 -30.42 75.61 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-O 119.095 -0.836 . . . . 0.0 111.711 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.9 m -58.84 -57.81 11.4 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 116.832 -1.556 . . . . 0.0 109.856 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.536 HG11 ' HA3' ' A' ' 41' ' ' GLY . 3.0 m -66.78 -36.69 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 121.857 2.117 . . . . 0.0 113.617 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.1 t -62.43 -31.22 71.9 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.694 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -59.81 -49.72 76.61 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.857 1.208 . . . . 0.0 110.964 164.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 mt -55.44 -43.94 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.062 0.846 . . . . 0.0 108.986 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -79.3 -13.72 59.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.501 1.121 . . . . 0.0 112.861 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.86 -58.07 2.68 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.717 1.607 . . . . 0.0 109.905 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 mtp85 -124.64 78.29 63.47 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 125.089 1.355 . . . . 0.0 107.876 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.33 93.76 0.75 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.07 2.513 . . . . 0.0 107.523 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -63.26 165.85 9.98 Favored Pre-proline 0 N--CA 1.436 -1.146 0 C-N-CA 123.79 0.836 . . . . 0.0 110.266 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -56.13 142.45 86.37 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.611 2.207 . . . . 0.0 110.331 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -53.3 -47.31 69.32 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.964 0.802 . . . . 0.0 109.804 173.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -20.31 33.87 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 174.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -85.15 -24.37 28.0 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.874 1.215 . . . . 0.0 111.77 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.6 mt -86.38 167.34 14.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.42 0.688 . . . . 0.0 109.155 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.5 p -129.12 -172.25 2.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 117.081 -1.437 . . . . 0.0 108.62 172.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.5 t -43.58 -56.43 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 120.756 1.616 . . . . 0.0 111.63 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -74.51 -15.87 60.86 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.234 -1.541 . . . . 0.0 113.665 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.68 -42.42 47.01 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.374 1.464 . . . . 0.0 111.45 167.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -85.81 -26.13 25.91 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 127.045 2.138 . . . . 0.0 111.669 -173.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -42.15 -57.28 4.48 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 127.817 2.447 . . . . 0.0 111.475 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.07 -49.71 4.6 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.531 1.487 . . . . 0.0 109.69 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -57.23 -39.38 75.42 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.654 -1.165 . . . . 0.0 112.976 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.3 mt -57.69 -55.52 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.559 1.144 . . . . 0.0 108.367 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -59.51 -45.06 92.79 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.032 0.533 . . . . 0.0 109.592 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.527 ' HG2' HD21 ' A' ' 45' ' ' LEU . 67.0 mtm -57.8 -50.08 74.47 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 123.505 0.722 . . . . 0.0 111.07 175.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.53 ' HD2' HD22 ' A' ' 17' ' ' LEU . 19.1 tttm -59.8 -44.1 94.12 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.794 -0.566 . . . . 0.0 110.278 -175.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -73.82 -28.04 61.42 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.298 -0.876 . . . . 0.0 112.133 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.443 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 34.3 t80 -60.87 -53.15 60.82 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.926 1.291 . . . . 0.0 107.943 169.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.0 mt -64.82 -22.4 66.98 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.319 1.047 . . . . 0.0 113.307 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.9 m -62.8 -21.58 65.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.914 1.234 . . . . 0.0 111.0 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -143.99 115.8 8.25 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.112 1.323 . . . . 0.0 109.947 -173.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.7 -18.56 64.13 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.569 1.148 . . . . 0.0 111.861 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -64.68 -21.14 66.67 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.482 -2.011 . . . . 0.0 112.181 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.443 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 69.9 m-80 -67.36 -53.36 30.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.854 1.206 . . . . 0.0 110.053 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 29' ' ' GLN . 12.5 p -60.87 -35.09 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.033 -1.042 . . . . 0.0 111.133 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.58 -34.66 78.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.661 0.664 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.45 81.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 111.533 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.95 -26.02 68.4 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.399 -0.813 . . . . 0.0 110.873 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 mtp-105 -60.18 -50.89 71.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 118.529 0.604 . . . . 0.0 110.581 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.0 m -50.06 -45.69 52.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.032 0.833 . . . . 0.0 110.163 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.414 HG21 ' CE1' ' A' ' 43' ' ' TYR . 66.1 mt -64.51 -32.97 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.871 -0.518 . . . . 0.0 111.117 -178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.521 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 6.9 tp-100 . . . . . 0 N--CA 1.452 -0.355 0 O-C-N 121.186 -0.946 . . . . 0.0 111.373 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--O 1.233 0.205 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -69.75 98.38 1.2 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.052 0.453 . . . . 0.0 110.03 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 p -63.38 -41.15 98.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.529 -0.732 . . . . 0.0 111.818 -175.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.02 77.74 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.847 0.749 . . . . 0.0 111.334 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -75.12 -47.89 26.42 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 126.218 1.807 . . . . 0.0 108.653 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.3 mt -55.08 -50.86 59.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.51 -52.17 62.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.64 0.776 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -52.52 -69.79 0.1 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 126.533 1.933 . . . . 0.0 108.666 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -49.8 -40.41 41.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.645 1.978 . . . . 0.0 112.897 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 40' ' ' PHE . 67.2 t -64.75 -51.43 67.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 118.976 0.807 . . . . 0.0 109.645 174.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -49.85 -38.34 34.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.356 0.98 . . . . 0.0 109.785 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.93 -53.63 43.36 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.466 1.03 . . . . 0.0 111.68 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.64 -43.88 80.72 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.366 0.53 . . . . 0.0 111.142 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.9 mt -63.36 -43.46 97.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -27.81 69.29 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.446 1.021 . . . . 0.0 112.69 174.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -59.73 -32.81 70.9 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.822 1.249 . . . . 0.0 111.419 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -128.42 16.72 6.53 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.387 1.475 . . . . 0.0 112.196 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 39.75 75.59 0.08 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 128.783 2.833 . . . . 0.0 112.417 -169.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.4 mt -110.05 147.54 14.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 121.386 -0.821 . . . . 0.0 109.826 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.05 127.75 8.4 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -58.45 -29.6 66.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.748 0.819 . . . . 0.0 111.242 171.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -55.6 -53.98 49.73 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 117.789 -1.101 . . . . 0.0 111.508 167.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -60.18 -51.27 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 119.526 1.057 . . . . 0.0 109.114 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.43 ' CE2' HG11 ' A' ' 26' ' ' VAL . 89.3 t80 -54.38 -46.48 73.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.325 0.511 . . . . 0.0 111.347 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.464 ' CA ' HG11 ' A' ' 52' ' ' VAL . . . -71.08 -34.97 64.52 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-O 117.417 -1.768 . . . . 0.0 111.967 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -64.49 -29.67 70.71 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 120.398 2.099 . . . . 0.0 110.887 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.414 ' CE1' HG21 ' A' ' 92' ' ' ILE . 38.8 m-85 -106.63 -78.73 0.58 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.458 1.103 . . . . 0.0 111.654 -172.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 74.1 t -56.5 -38.75 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 125.531 1.532 . . . . 0.0 109.363 -170.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.429 HD21 ' CG ' ' A' ' 76' ' ' MET . 37.6 mt -102.19 -33.24 9.72 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.582 -0.723 . . . . 0.0 110.853 -173.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.74 30.59 61.54 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.52 168.66 10.47 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.078 1.351 . . . . 0.0 109.175 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.0 163.6 27.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.456 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -59.56 -46.76 87.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.414 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.42 -30.96 77.49 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.001 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.6 m -61.03 -67.06 0.44 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.832 0.816 . . . . 0.0 109.328 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.464 HG11 ' CA ' ' A' ' 41' ' ' GLY . 3.0 m -58.66 -35.77 56.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-N 119.893 1.224 . . . . 0.0 112.438 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.3 t -54.95 -43.36 73.36 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.369 1.068 . . . . 0.0 111.708 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -57.36 -49.37 76.37 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 120.084 1.311 . . . . 0.0 110.106 168.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.3 mt -58.95 -39.64 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.6 mt -76.76 -29.56 56.17 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.901 1.281 . . . . 0.0 112.413 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.33 -57.58 4.69 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.652 1.581 . . . . 0.0 109.997 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -123.57 84.6 53.07 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 125.604 1.562 . . . . 0.0 107.399 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 84.04 1.4 Allowed 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 122.245 1.963 . . . . 0.0 107.525 171.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.412 ' HB2' HD21 ' A' ' 65' ' ' LEU . 14.3 mtpt -59.41 153.27 50.08 Favored Pre-proline 0 N--CA 1.436 -1.161 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 60' ' ' LYS . 36.0 Cg_endo -67.01 147.54 80.16 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.296 1.997 . . . . 0.0 107.363 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -51.93 -38.94 58.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.127 0.571 . . . . 0.0 111.143 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -28.11 69.05 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -26.79 62.37 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.789 -1.195 . . . . 0.0 111.633 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 60' ' ' LYS . 70.6 mt -83.79 167.16 17.36 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.456 0.646 . . . . 0.0 110.526 -168.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.2 p -117.78 -171.61 2.09 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.689 2.395 . . . . 0.0 109.533 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.7 p -47.16 -63.41 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.648 1.113 . . . . 0.0 111.543 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -72.94 -10.35 59.71 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.43 -52.12 32.89 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.157 -0.964 . . . . 0.0 110.707 162.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -87.54 -23.83 24.24 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 126.016 1.727 . . . . 0.0 112.298 -166.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -44.55 -55.6 9.95 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 126.334 1.854 . . . . 0.0 111.669 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.46 -45.86 13.52 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.498 1.466 . . . . 0.0 110.835 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -61.19 -38.23 85.8 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.88 1.218 . . . . 0.0 113.044 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.6 mt -55.61 -54.44 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -58.77 -50.66 73.1 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.931 1.292 . . . . 0.0 110.516 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.429 ' CG ' HD21 ' A' ' 45' ' ' LEU . 58.0 mtm -55.52 -47.89 75.53 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.135 0.974 . . . . 0.0 111.974 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -61.64 -46.03 91.51 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.94 -0.475 . . . . 0.0 110.263 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -61.26 -42.53 98.8 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.666 0.787 . . . . 0.0 111.198 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.466 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 44.6 t80 -53.17 -38.39 62.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.033 1.733 . . . . 0.0 110.719 175.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.2 mt -73.71 -23.75 59.83 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.378 -0.826 . . . . 0.0 113.082 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -77.97 0.25 25.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 120.134 1.334 . . . . 0.0 113.069 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -145.52 115.22 7.28 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 125.391 1.476 . . . . 0.0 107.173 170.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -69.49 -15.64 63.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.556 0.342 . . . . 0.0 111.816 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -67.06 -16.48 64.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 120.294 -1.504 . . . . 0.0 112.353 174.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.466 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 75.2 m-20 -66.51 -47.38 73.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 119.61 1.096 . . . . 0.0 109.591 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.8 -30.86 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 120.665 -1.272 . . . . 0.0 111.299 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.35 -24.04 64.76 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.753 -0.592 . . . . 0.0 110.808 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.6 -39.47 31.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.21 -0.931 . . . . 0.0 111.381 168.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.81 -29.76 68.18 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.013 -1.68 . . . . 0.0 110.5 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -66.6 -36.75 83.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.394 0.997 . . . . 0.0 111.672 169.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.3 m -56.01 -36.65 68.17 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.743 0.817 . . . . 0.0 110.167 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.414 HG21 ' CE1' ' A' ' 43' ' ' TYR . 69.0 mt -80.24 -29.29 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.701 1.6 . . . . 0.0 111.494 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? . . . . . 0 C--N 1.329 -0.326 0 O-C-N 120.578 -1.326 . . . . 0.0 109.646 -179.303 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.738 HD22 ' HD2' ' A' ' 77' ' ' LYS . 9.2 mt . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.58 104.56 17.03 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.452 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 21.2 p -59.77 -40.97 89.99 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.344 -0.847 . . . . 0.0 111.51 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.21 75.07 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.182 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.27 -52.24 20.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.91 1.284 . . . . 0.0 108.337 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 85.2 mt -52.9 -49.48 48.11 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.83 63.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.259 0.624 . . . . 0.0 110.355 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -55.81 -57.75 10.74 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.939 1.296 . . . . 0.0 110.486 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -49.75 -51.54 38.28 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 127.391 2.276 . . . . 0.0 111.688 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.472 HG11 ' CE2' ' A' ' 40' ' ' PHE . 72.3 t -63.58 -44.04 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.906 -1.121 . . . . 0.0 109.015 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -57.47 -37.56 73.1 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.589 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.58 -54.67 36.23 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.948 1.299 . . . . 0.0 110.551 174.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -61.45 -43.1 99.46 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.978 1.311 . . . . 0.0 111.513 -173.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.58 -46.6 78.8 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -43.92 65.71 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.569 0.748 . . . . 0.0 111.123 173.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -50.47 -44.44 55.74 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 126.364 1.865 . . . . 0.0 111.684 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -112.76 9.42 19.11 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.993 0.917 . . . . 0.0 112.297 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 46.62 71.76 0.28 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.428 2.291 . . . . 0.0 112.183 -166.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.2 mt -111.22 151.02 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 172.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.57 142.13 15.42 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -57.74 -31.59 66.62 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.674 1.59 . . . . 0.0 113.345 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ttp-105 -56.41 -59.38 5.05 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 120.029 1.286 . . . . 0.0 109.691 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -58.98 -47.27 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -176.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.472 ' CE2' HG11 ' A' ' 26' ' ' VAL . 93.2 t80 -55.46 -47.15 76.53 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.831 0.741 . . . . 0.0 111.725 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.441 ' CA ' HG11 ' A' ' 52' ' ' VAL . . . -71.5 -33.72 63.84 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-O 117.797 -1.557 . . . . 0.0 111.806 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -69.88 -33.08 71.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.635 1.718 . . . . 0.0 110.524 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -96.73 -76.98 0.5 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.048 0.939 . . . . 0.0 111.217 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.55 -40.48 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 124.729 1.212 . . . . 0.0 109.151 -170.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.426 HD21 ' HG2' ' A' ' 76' ' ' MET . 25.3 mt -93.9 -46.79 7.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 123.758 0.661 . . . . 0.0 109.803 -173.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.01 19.08 48.39 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.636 0.636 . . . . 0.0 112.691 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.0 mt -114.42 164.96 13.24 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.501 1.52 . . . . 0.0 108.988 -172.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 m -62.08 156.58 21.09 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.167 0.508 . . . . 0.0 110.841 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -56.92 -34.82 68.35 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.075 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.04 -62.05 5.55 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.8 m -43.91 -66.77 0.34 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.942 1.697 . . . . 0.0 112.522 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.441 HG11 ' CA ' ' A' ' 41' ' ' GLY . 3.2 m -57.09 -38.83 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 120.283 1.401 . . . . 0.0 111.674 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 m -61.6 -41.28 97.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.858 -1.068 . . . . 0.0 110.818 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.82 -45.84 78.25 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.629 1.104 . . . . 0.0 110.007 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.489 HD13 HG21 ' A' ' 55' ' ' ILE . 32.8 mt -57.52 -46.46 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -177.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.27 -31.8 64.29 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.97 1.708 . . . . 0.0 112.656 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.9 -47.4 71.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.934 1.694 . . . . 0.0 110.096 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mtp-105 -137.94 82.98 24.37 Favored Pre-proline 0 C--O 1.239 0.506 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -63.75 102.63 0.36 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.103 2.535 . . . . 0.0 108.34 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -63.06 157.39 62.24 Favored Pre-proline 0 N--CA 1.429 -1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.523 167.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.82 151.96 36.5 Favored 'Trans proline' 0 N--CA 1.441 -1.572 0 C-N-CA 122.64 2.227 . . . . 0.0 107.428 -172.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.522 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 62.0 t-105 -51.78 -41.93 62.02 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.692 0.797 . . . . 0.0 111.532 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.428 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -65.25 -23.09 66.96 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 5.0 mmpt? -74.06 -25.76 60.02 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 120.23 1.377 . . . . 0.0 111.72 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.4 mt -93.25 153.28 18.68 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.162 0.892 . . . . 0.0 110.34 -158.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.8 t -90.38 -179.97 5.73 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 171.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.45 -42.65 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 O-C-N 120.999 -1.063 . . . . 0.0 112.419 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -69.8 -14.9 62.99 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.755 -1.216 . . . . 0.0 113.585 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.77 -37.43 26.32 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 125.45 1.5 . . . . 0.0 110.936 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.86 -25.92 40.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 117.847 -1.073 . . . . 0.0 112.344 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -43.83 -60.98 2.2 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 125.691 1.596 . . . . 0.0 110.445 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.28 -45.49 15.17 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 121.394 1.396 . . . . 0.0 110.032 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.452 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 64.2 m-85 -64.04 -35.25 80.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 119.752 1.16 . . . . 0.0 113.337 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.1 mt -59.16 -57.19 12.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -52.88 -43.18 65.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.175 0.99 . . . . 0.0 110.45 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.426 ' HG2' HD21 ' A' ' 45' ' ' LEU . 64.7 mtm -66.76 -50.29 63.19 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.891 1.276 . . . . 0.0 112.567 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.738 ' HD2' HD22 ' A' ' 17' ' ' LEU . 27.2 tttt -60.62 -41.33 94.64 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.816 -1.177 . . . . 0.0 110.193 -177.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.79 -26.63 57.49 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.839 0.456 . . . . 0.0 111.441 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.428 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 35.9 t80 -57.25 -50.98 71.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.917 0.887 . . . . 0.0 109.112 167.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.2 mt -64.02 -20.14 65.7 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.466 1.106 . . . . 0.0 113.439 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.4 m -61.53 -33.4 73.77 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.279 0.945 . . . . 0.0 111.531 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -130.49 104.77 7.43 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.637 -0.665 . . . . 0.0 109.988 -170.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -53.61 -29.2 36.73 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.204 1.401 . . . . 0.0 111.716 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -55.19 -25.93 35.91 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 119.803 -1.81 . . . . 0.0 112.45 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.428 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 85.2 m-20 -66.08 -50.56 63.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.529 0.732 . . . . 0.0 110.817 175.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.43 -37.19 78.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 119.221 0.919 . . . . 0.0 109.568 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 78.0 mt -64.55 -34.12 77.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.17 0.588 . . . . 0.0 110.481 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.98 -32.5 59.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.92 0.888 . . . . 0.0 111.43 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -27.85 66.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.298 1.039 . . . . 0.0 110.691 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.1 mtm105 -56.8 -54.15 49.66 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 119.092 0.86 . . . . 0.0 109.464 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -52.87 -36.66 59.38 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.853 0.751 . . . . 0.0 111.319 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 52.1 mt -73.68 -38.23 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.865 -1.147 . . . . 0.0 110.338 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 . . . . . 0 N--CA 1.452 -0.371 0 C-N-CA 125.668 1.587 . . . . 0.0 111.001 179.297 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.731 HD22 ' HD2' ' A' ' 77' ' ' LYS . 9.6 mt . . . . . 0 C--O 1.238 0.469 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -77.8 99.27 5.85 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 122.014 0.911 . . . . 0.0 109.079 179.226 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 p -63.16 -38.98 93.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.818 -1.176 . . . . 0.0 111.402 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.83 70.35 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.543 -0.741 . . . . 0.0 111.434 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 5.8 tt0 -78.92 -55.57 5.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.016 2.126 . . . . 0.0 108.758 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 17' ' ' LEU . 75.8 mt -54.57 -44.2 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.91 -49.06 78.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.529 0.732 . . . . 0.0 111.273 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -61.07 -53.36 58.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.839 1.256 . . . . 0.0 110.283 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -60.56 -39.7 88.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.68 1.992 . . . . 0.0 111.772 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 t -60.91 -47.12 94.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 O-C-N 120.691 -1.255 . . . . 0.0 109.374 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -61.14 -27.49 68.42 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 117.373 -1.299 . . . . 0.0 111.548 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -65.04 -63.12 1.18 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 120.125 1.329 . . . . 0.0 109.805 170.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -63.78 -29.08 70.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.058 0.845 . . . . 0.0 111.806 -170.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.52 -37.78 74.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.976 1.262 . . . . 0.0 109.587 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.26 -37.35 85.27 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.186 1.357 . . . . 0.0 111.862 169.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -58.59 -32.75 69.25 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.952 2.101 . . . . 0.0 113.707 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -126.39 15.93 7.7 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.482 1.913 . . . . 0.0 111.214 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.8 m120 42.33 72.73 0.16 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.282 2.233 . . . . 0.0 111.41 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.466 HD11 ' CG ' ' A' ' 90' ' ' ARG . 93.4 mt -106.26 153.84 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.69 131.64 10.87 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.801 1.191 . . . . 0.0 110.556 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -36.05 74.6 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.428 1.491 . . . . 0.0 111.71 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.6 ptt85 -53.5 -56.06 20.18 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.351 1.06 . . . . 0.0 111.965 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.46 -39.7 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -63.29 -45.68 90.26 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.091 -1.006 . . . . 0.0 109.573 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.41 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -67.35 -24.61 73.63 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-O 117.352 -1.804 . . . . 0.0 112.518 173.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -78.12 -21.02 51.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.788 2.294 . . . . 0.0 112.076 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -121.99 -61.1 1.52 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 119.484 1.038 . . . . 0.0 111.436 -174.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.7 t -63.46 -36.98 78.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.493 HD21 ' HG2' ' A' ' 76' ' ' MET . 21.4 mt -106.49 -34.95 7.23 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.423 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.55 31.5 78.84 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.13 161.62 18.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.352 1.461 . . . . 0.0 107.932 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m -59.67 147.95 35.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.765 1.226 . . . . 0.0 110.599 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -63.67 -16.73 61.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.633 1.573 . . . . 0.0 114.06 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.54 -56.63 2.61 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 166.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.7 m -43.65 -59.57 2.14 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 125.851 1.66 . . . . 0.0 113.21 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.41 HG11 ' HA3' ' A' ' 41' ' ' GLY . 4.1 m -55.65 -34.62 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 121.017 1.735 . . . . 0.0 114.074 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.9 t -63.2 -36.24 82.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.243 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.36 -41.78 80.79 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.792 1.633 . . . . 0.0 109.736 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.432 HG23 ' CE2' ' A' ' 73' ' ' PHE . 15.3 mt -62.79 -45.35 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -174.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.8 -32.03 61.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.779 0.832 . . . . 0.0 111.628 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.24 -53.94 31.02 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.628 1.971 . . . . 0.0 111.042 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -134.45 71.78 71.15 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -168.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -68.41 98.91 0.58 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.937 2.425 . . . . 0.0 107.985 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -69.06 160.63 77.63 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -59.34 150.49 74.44 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.351 2.701 . . . . 0.0 109.109 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.449 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 70.4 t-105 -52.79 -52.54 56.37 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.664 0.786 . . . . 0.0 111.5 177.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.432 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.4 -5.99 2.02 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 174.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -116.31 18.98 15.06 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.414 1.886 . . . . 0.0 110.842 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.1 mt -124.05 149.44 46.11 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.564 1.546 . . . . 0.0 106.874 166.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.2 t -90.73 -177.72 5.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.641 1.176 . . . . 0.0 108.852 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 p -46.33 -54.01 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.446 1.098 . . . . 0.0 111.16 172.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -74.73 -4.88 40.15 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.25 -35.19 15.31 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.326 1.917 . . . . 0.0 111.297 163.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -87.91 -23.27 23.98 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.566 1.546 . . . . 0.0 112.971 -173.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -39.14 -59.91 1.35 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.15 1.78 . . . . 0.0 110.36 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.27 -51.11 2.91 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.467 2.112 . . . . 0.0 111.489 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CE2' HG23 ' A' ' 55' ' ' ILE . 44.1 m-85 -59.58 -38.15 80.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.528 -175.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.2 mt -55.85 -54.02 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -60.7 -46.57 89.87 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.35 1.06 . . . . 0.0 110.498 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.493 ' HG2' HD21 ' A' ' 45' ' ' LEU . 63.9 mtm -59.37 -46.07 89.69 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 124.075 0.95 . . . . 0.0 111.299 177.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.731 ' HD2' HD22 ' A' ' 17' ' ' LEU . 13.8 tttm -60.96 -45.76 93.43 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.39 -0.819 . . . . 0.0 110.183 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -59.61 -43.99 93.57 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.723 0.809 . . . . 0.0 110.314 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.54 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 37.7 t80 -53.61 -51.36 63.31 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.103 1.761 . . . . 0.0 110.127 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.8 mt -66.27 -18.94 65.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.357 0.663 . . . . 0.0 112.133 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -6.52 47.29 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.253 1.421 . . . . 0.0 112.681 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -156.86 115.75 3.36 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.885 1.274 . . . . 0.0 109.139 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.22 -27.81 68.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.851 1.26 . . . . 0.0 112.431 -169.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -60.71 -19.28 58.34 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 120.768 -1.208 . . . . 0.0 112.525 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.54 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 38.1 m-80 -60.33 -50.9 71.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.993 1.269 . . . . 0.0 110.181 174.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.424 HG22 HD12 ' A' ' 35' ' ' ILE . 3.2 p -71.28 -30.67 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 120.851 -1.155 . . . . 0.0 110.135 -177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.9 mt -64.2 -37.38 87.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.15 69.83 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.402 0.546 . . . . 0.0 111.649 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.08 -28.49 62.33 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.245 -0.91 . . . . 0.0 111.37 176.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.466 ' CG ' HD11 ' A' ' 35' ' ' ILE . 63.5 mtp180 -58.26 -37.04 74.14 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.017 0.826 . . . . 0.0 110.207 173.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 m -55.95 -56.32 22.12 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.327 1.051 . . . . 0.0 110.086 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.1 mt -65.13 -31.78 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 123.463 0.705 . . . . 0.0 110.008 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 . . . . . 0 N--CA 1.444 -0.773 0 O-C-N 121.689 -0.632 . . . . 0.0 111.728 178.852 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.624 HD22 ' HD2' ' A' ' 77' ' ' LYS . 3.2 mt . . . . . 0 C--O 1.237 0.423 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.52 103.17 8.29 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.96 -1.087 . . . . 0.0 110.916 -172.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 33.3 p -64.14 -46.23 84.99 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.983 -1.073 . . . . 0.0 112.93 -169.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.97 -18.57 64.09 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.289 0.636 . . . . 0.0 111.327 -176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.92 -56.74 4.05 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.764 1.626 . . . . 0.0 108.875 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.453 HD11 ' HB3' ' A' ' 17' ' ' LEU . 71.7 mt -51.6 -43.94 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.415 1.086 . . . . 0.0 109.992 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.66 -68.24 0.19 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.378 1.071 . . . . 0.0 110.047 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -45.22 -56.46 4.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.167 1.787 . . . . 0.0 112.232 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -54.78 -43.68 73.03 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 127.942 2.497 . . . . 0.0 111.227 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.96 -48.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 120.806 -1.184 . . . . 0.0 108.628 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -57.45 -43.46 83.97 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.385 1.448 . . . . 0.0 110.128 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -65.51 -44.87 85.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 118.718 0.69 . . . . 0.0 112.063 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -58.49 -46.75 86.05 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.299 1.04 . . . . 0.0 112.549 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.8 mt -58.78 -50.19 74.86 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -51.69 -45.68 63.59 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 120.261 1.391 . . . . 0.0 113.629 170.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -53.93 -32.11 52.53 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.881 1.672 . . . . 0.0 112.927 -173.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -123.39 15.63 9.69 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.567 1.547 . . . . 0.0 111.452 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 43.95 41.95 4.3 Favored 'General case' 0 CA--C 1.542 0.641 1 C-N-CA 132.379 4.272 . . . . 0.0 114.612 -176.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.3 mt -84.41 131.11 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.079 0.952 . . . . 0.0 108.726 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.09 115.71 4.07 Favored Glycine 0 C--O 1.228 -0.219 0 C-N-CA 125.0 1.286 . . . . 0.0 111.691 -169.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -39.62 -35.99 0.36 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.405 2.282 . . . . 0.0 115.725 -167.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -50.06 -50.12 48.98 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.249 1.386 . . . . 0.0 111.507 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.75 -50.69 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 119.044 0.838 . . . . 0.0 109.242 -173.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -54.74 -46.94 74.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.772 -0.58 . . . . 0.0 111.065 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.5 -15.52 68.42 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-O 117.026 -1.986 . . . . 0.0 113.232 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -94.25 -26.25 16.7 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.617 2.208 . . . . 0.0 112.575 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -118.44 -24.06 6.97 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -172.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.45 -37.74 6.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.138 0.975 . . . . 0.0 109.593 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.439 HD21 ' HG2' ' A' ' 76' ' ' MET . 29.3 mt -112.19 -30.73 7.1 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -171.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.39 13.16 83.12 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 123.961 0.791 . . . . 0.0 113.469 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 99.0 mt -101.84 170.33 8.22 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.254 1.822 . . . . 0.0 109.16 -174.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.09 166.57 13.6 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.411 -0.806 . . . . 0.0 112.025 173.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.2 tm0? -64.23 -44.34 92.18 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.31 -56.83 8.76 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 125.281 1.42 . . . . 0.0 112.068 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.7 m -52.13 -69.06 0.12 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 118.341 -0.838 . . . . 0.0 111.359 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.8 -37.1 70.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 120.482 1.492 . . . . 0.0 111.566 -171.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 t -55.26 -38.52 68.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 117.828 -1.082 . . . . 0.0 112.115 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.14 -48.58 79.47 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.921 1.237 . . . . 0.0 110.202 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 mt -59.03 -35.07 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.0 mt -81.22 -37.23 28.94 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 123.603 0.761 . . . . 0.0 112.099 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.55 -48.12 83.16 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.977 0.911 . . . . 0.0 110.751 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -136.94 82.0 32.1 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.36 73.86 4.38 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.554 2.836 . . . . 0.0 109.096 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -56.34 148.39 43.23 Favored Pre-proline 0 N--CA 1.441 -0.911 0 C-N-CA 124.8 1.24 . . . . 0.0 109.103 -172.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.02 147.26 91.78 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 124.46 3.44 . . . . 0.0 109.098 -164.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.447 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 60.3 t-105 -54.13 -38.07 65.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.735 0.414 . . . . 0.0 110.555 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -25.75 67.12 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -37.2 65.27 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.66 -1.275 . . . . 0.0 110.212 173.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.7 mt -74.54 172.44 12.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.298 1.047 . . . . 0.0 110.13 -171.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.6 p -129.15 -175.98 3.73 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.774 2.83 . . . . 0.0 107.834 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 89.9 t -47.54 -57.52 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 120.543 1.519 . . . . 0.0 111.229 173.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -70.09 -27.56 64.7 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.342 -1.474 . . . . 0.0 112.855 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.8 97.24 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 170.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -88.24 -26.12 22.51 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 126.949 2.1 . . . . 0.0 111.974 -171.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -44.45 -54.66 11.7 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.705 1.602 . . . . 0.0 110.566 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.04 -48.77 4.59 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.994 1.796 . . . . 0.0 110.982 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -57.48 -37.63 73.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.458 1.026 . . . . 0.0 113.401 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.0 -59.55 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 172.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -55.01 -38.89 68.48 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.099 0.56 . . . . 0.0 110.934 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.439 ' HG2' HD21 ' A' ' 45' ' ' LEU . 57.8 mtm -66.01 -50.56 63.83 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.768 0.827 . . . . 0.0 111.912 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.624 ' HD2' HD22 ' A' ' 17' ' ' LEU . 21.6 tttt -58.8 -41.26 86.3 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.908 -1.12 . . . . 0.0 110.778 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -70.29 -35.8 73.95 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.139 1.375 . . . . 0.0 110.576 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.473 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 44.0 t80 -56.5 -54.45 45.63 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.28 1.832 . . . . 0.0 109.105 171.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.3 mt -64.39 -18.15 64.41 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.709 0.803 . . . . 0.0 112.442 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.83 -10.13 59.4 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.532 -0.73 . . . . 0.0 111.604 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -144.41 110.13 5.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.368 0.985 . . . . 0.0 108.345 171.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 86' ' ' VAL . 38.6 tp10 -52.43 -30.44 29.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.833 1.253 . . . . 0.0 112.076 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -61.7 -16.04 45.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.149 -1.594 . . . . 0.0 112.969 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.473 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 71.3 m-80 -66.79 -50.28 63.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.834 1.197 . . . . 0.0 110.692 169.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 83' ' ' GLU . 9.1 p -64.06 -37.46 79.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 CA-C-N 119.359 0.982 . . . . 0.0 109.223 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.07 -39.91 93.91 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 118.241 0.473 . . . . 0.0 110.559 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.34 -34.39 76.01 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.858 0.463 . . . . 0.0 111.741 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.8 -27.81 66.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.84 0.856 . . . . 0.0 111.549 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 mtm105 -55.17 -50.36 69.53 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.5 m -53.3 -40.75 64.99 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.75 1.62 . . . . 0.0 109.348 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.2 mt -69.75 -31.4 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 O-C-N 120.656 -1.277 . . . . 0.0 111.21 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 . . . . . 0 N--CA 1.451 -0.414 0 CA-C-N 119.028 0.831 . . . . 0.0 110.873 170.274 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.7 mt . . . . . 0 C--O 1.237 0.413 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.92 102.48 5.59 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 123.06 1.41 . . . . 0.0 109.489 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.442 HG22 ' CD1' ' A' ' 73' ' ' PHE . 5.4 p -70.23 -35.06 73.59 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.722 -174.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.57 65.94 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 120.262 1.392 . . . . 0.0 110.914 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -77.84 -50.88 11.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.856 2.062 . . . . 0.0 108.981 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -54.03 -53.24 29.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.83 -46.23 78.17 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.313 0.645 . . . . 0.0 112.096 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -58.54 -66.48 0.48 Allowed 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.382 1.073 . . . . 0.0 108.23 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -47.29 -40.6 17.21 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.354 1.462 . . . . 0.0 112.643 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.522 HG21 ' SD ' ' A' ' 76' ' ' MET . 38.7 t -57.98 -53.8 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 123.684 0.794 . . . . 0.0 109.873 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -52.71 -51.09 61.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -59.29 -44.41 92.49 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.765 0.826 . . . . 0.0 112.582 -175.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.456 ' HG3' ' CD2' ' A' ' 80' ' ' LEU . 9.9 mm-40 -61.32 -49.59 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.954 1.702 . . . . 0.0 112.349 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.49 -49.47 77.67 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.48 -42.91 67.74 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.833 1.253 . . . . 0.0 114.056 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -53.83 -28.31 34.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.676 1.19 . . . . 0.0 111.568 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -124.76 15.66 8.69 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.872 1.669 . . . . 0.0 112.579 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 38.4 54.31 1.81 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.727 2.811 . . . . 0.0 113.893 -172.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.5 mt -89.89 151.7 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.29 131.9 10.8 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 126.236 1.874 . . . . 0.0 111.681 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -60.43 -20.1 58.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.216 1.006 . . . . 0.0 113.211 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -65.68 -60.82 2.51 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 119.775 1.171 . . . . 0.0 109.222 171.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.73 -47.54 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 C-N-CA 123.632 0.773 . . . . 0.0 109.97 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -53.55 -51.04 64.17 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.653 0.66 . . . . 0.0 111.907 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.426 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -68.48 -28.85 72.98 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-O 117.845 -1.531 . . . . 0.0 112.061 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -72.38 -23.55 61.13 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.794 1.797 . . . . 0.0 112.023 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -116.27 -60.32 1.87 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.751 1.159 . . . . 0.0 112.841 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.16 -44.67 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.562 HD21 ' HG2' ' A' ' 76' ' ' MET . 35.9 mt -95.1 -41.76 8.95 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.21 0.604 . . . . 0.0 110.755 -173.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.92 30.19 44.04 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.179 0.895 . . . . 0.0 112.223 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' A' ' 45' ' ' LEU . 24.8 mt -121.13 164.42 16.88 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 126.725 2.01 . . . . 0.0 107.802 -173.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.2 t -65.4 162.41 17.79 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.518 0.675 . . . . 0.0 110.737 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -58.85 -54.06 51.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.806 0.842 . . . . 0.0 109.586 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.55 -42.88 99.85 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.0 m -52.56 -60.42 3.27 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.805 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.426 HG11 ' HA3' ' A' ' 41' ' ' GLY . 3.3 m -63.58 -39.31 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 120.885 1.675 . . . . 0.0 113.984 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.32 -35.97 78.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 119.179 0.899 . . . . 0.0 109.376 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.18 -44.13 87.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.516 0.726 . . . . 0.0 111.212 169.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.403 HG23 ' CE2' ' A' ' 73' ' ' PHE . 3.2 mt -59.98 -40.04 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.8 -38.26 62.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.754 0.822 . . . . 0.0 111.042 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.16 -49.52 56.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.402 1.881 . . . . 0.0 112.204 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -127.32 75.21 77.28 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 127.023 2.129 . . . . 0.0 108.111 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.33 103.0 0.61 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 N-CA-C 106.429 -2.181 . . . . 0.0 106.429 167.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -66.61 170.96 4.87 Favored Pre-proline 0 N--CA 1.439 -0.992 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.4 146.26 79.86 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.112 2.542 . . . . 0.0 109.681 168.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -55.26 -48.33 74.15 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.88 0.872 . . . . 0.0 110.773 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.461 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -52.72 -21.22 3.81 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 172.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -94.89 5.27 52.37 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 120.219 -1.551 . . . . 0.0 112.51 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.414 ' HB3' ' HA3' ' A' ' 69' ' ' GLY . 82.4 mt -113.71 174.94 5.68 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.687 1.595 . . . . 0.0 109.215 173.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -128.13 -173.98 3.09 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.14 1.776 . . . . 0.0 108.313 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 96.8 t -47.28 -55.56 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.908 1.231 . . . . 0.0 111.015 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -60.54 -32.21 71.27 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 120.862 -1.149 . . . . 0.0 112.926 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -58.8 -45.48 94.86 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.666 1.127 . . . . 0.0 112.428 171.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -90.69 -17.85 26.08 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.707 2.003 . . . . 0.0 112.266 -164.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 1.5 tt0 -41.6 -53.62 7.29 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.308 2.243 . . . . 0.0 111.648 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 71' ' ' GLU . 22.2 Cg_endo -65.84 -50.77 1.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.341 2.027 . . . . 0.0 111.129 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CD1' HG22 ' A' ' 19' ' ' THR . 43.0 m-85 -57.62 -38.96 75.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 117.69 -1.148 . . . . 0.0 112.481 -174.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.1 mt -58.01 -54.29 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -56.35 -47.41 78.87 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.769 0.827 . . . . 0.0 110.486 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.562 ' HG2' HD21 ' A' ' 45' ' ' LEU . 64.7 mtm -61.42 -47.86 83.85 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 123.066 0.546 . . . . 0.0 110.705 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -58.72 -40.99 85.31 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.57 -0.707 . . . . 0.0 111.339 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.71 -41.56 92.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.063 0.847 . . . . 0.0 111.008 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.492 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.6 t80 -56.57 -41.65 77.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.557 0.743 . . . . 0.0 109.48 177.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.456 ' CD2' ' HG3' ' A' ' 29' ' ' GLN . 81.7 mt -75.75 -15.24 60.3 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.765 1.226 . . . . 0.0 113.938 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.9 m -81.65 -14.19 56.97 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.234 0.924 . . . . 0.0 111.035 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -145.24 97.12 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -47.31 -25.63 1.04 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.192 1.797 . . . . 0.0 112.746 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -58.41 -28.77 65.53 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 119.643 -1.911 . . . . 0.0 112.138 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.492 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 66.7 m-80 -62.06 -54.23 44.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.19 -37.49 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.1 -0.375 . . . . 0.0 110.15 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.6 -39.4 93.63 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.42 0.688 . . . . 0.0 110.703 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.92 -35.29 67.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.558 0.743 . . . . 0.0 111.996 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.99 -25.09 66.63 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.132 0.973 . . . . 0.0 110.774 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -58.06 -49.53 76.6 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 118.359 0.527 . . . . 0.0 109.915 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 m -60.29 -38.26 83.06 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.403 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mt -63.04 -42.33 96.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 119.68 1.127 . . . . 0.0 109.692 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 . . . . . 0 N--CA 1.451 -0.394 0 C-N-CA 123.445 0.698 . . . . 0.0 111.273 -179.134 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.544 HD22 ' CD ' ' A' ' 77' ' ' LYS . 5.5 mt . . . . . 0 C--O 1.239 0.521 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -85.33 104.07 14.83 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.029 1.395 . . . . 0.0 108.122 162.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.481 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 19.4 p -56.2 -41.65 75.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.988 172.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 -37.74 71.95 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.475 0.71 . . . . 0.0 111.558 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -71.14 -54.77 9.87 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.328 1.451 . . . . 0.0 108.434 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -54.09 -51.05 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.36 -49.82 63.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.826 0.85 . . . . 0.0 111.362 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -55.42 -63.75 1.06 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.483 1.113 . . . . 0.0 109.617 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -50.88 -41.24 58.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.566 1.946 . . . . 0.0 112.933 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.424 HG21 ' SD ' ' A' ' 76' ' ' MET . 75.3 t -62.54 -47.85 91.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 121.011 -1.056 . . . . 0.0 110.079 176.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -55.89 -39.61 71.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.657 -1.163 . . . . 0.0 109.337 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -59.39 -55.81 29.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.45 1.023 . . . . 0.0 112.024 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -63.86 -39.66 94.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 112.318 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.12 -46.43 89.06 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 120.091 1.314 . . . . 0.0 107.601 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -16.73 64.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.06 0.846 . . . . 0.0 113.263 175.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -66.8 -30.66 70.92 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.083 -1.011 . . . . 0.0 110.832 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -127.99 10.35 6.43 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.322 1.049 . . . . 0.0 111.699 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 41.01 85.11 0.02 OUTLIER 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.24 2.616 . . . . 0.0 111.171 -164.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.451 HD11 ' CG ' ' A' ' 90' ' ' ARG . 92.2 mt -115.99 150.96 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.971 0.909 . . . . 0.0 108.921 174.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.96 142.14 17.45 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 123.954 0.788 . . . . 0.0 111.499 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -66.09 -33.46 75.84 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 118.57 -0.729 . . . . 0.0 111.965 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -59.97 -46.72 88.52 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 118.832 0.742 . . . . 0.0 109.767 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 t -61.88 -54.04 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 119.151 0.887 . . . . 0.0 109.294 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -51.3 -47.87 62.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.668 0.27 . . . . 0.0 111.714 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.499 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -78.34 -27.71 57.11 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-O 117.017 -1.991 . . . . 0.0 112.573 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -78.81 -26.75 44.29 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.738 2.269 . . . . 0.0 110.769 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -96.31 -78.5 0.46 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.68 0.792 . . . . 0.0 109.386 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.3 t -53.42 -52.28 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 C-N-CA 126.489 1.916 . . . . 0.0 107.896 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.498 HD21 ' HG2' ' A' ' 76' ' ' MET . 37.9 mt -90.17 -34.44 15.84 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 118.026 -0.988 . . . . 0.0 111.595 -170.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.97 12.72 80.72 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 124.2 0.937 . . . . 0.0 112.791 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.0 mt -102.79 172.29 6.92 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.172 1.389 . . . . 0.0 109.688 -171.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 63.5 p -67.33 159.79 28.56 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.291 -0.881 . . . . 0.0 109.594 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -61.22 -46.43 90.45 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.017 -1.052 . . . . 0.0 109.209 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.88 -32.68 70.83 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.83 -0.984 . . . . 0.0 112.043 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -60.19 -69.36 0.22 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.919 1.359 . . . . 0.0 108.69 169.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.499 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.7 m -57.25 -40.05 71.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 120.09 1.314 . . . . 0.0 113.63 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.0 t -55.01 -45.72 75.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.753 0.821 . . . . 0.0 109.638 176.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -57.42 -46.07 83.94 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 119.361 0.982 . . . . 0.0 110.702 172.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.42 ' CG2' ' CZ ' ' A' ' 73' ' ' PHE . 5.1 mt -58.72 -41.21 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -70.41 -41.51 72.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.444 1.098 . . . . 0.0 111.174 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.69 -48.89 73.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.878 2.071 . . . . 0.0 112.557 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.3 79.38 61.36 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.48 95.77 0.63 Allowed 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 106.987 -1.966 . . . . 0.0 106.987 173.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -62.54 154.73 71.98 Favored Pre-proline 0 N--CA 1.436 -1.125 0 O-C-N 120.945 -1.097 . . . . 0.0 108.099 172.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -65.09 150.2 88.15 Favored 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 122.139 1.893 . . . . 0.0 108.368 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -52.25 -43.67 64.48 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.786 0.834 . . . . 0.0 110.789 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -21.59 52.02 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -83.46 -28.86 28.47 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.943 1.247 . . . . 0.0 113.039 175.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.9 mt -85.21 157.18 20.7 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.902 0.774 . . . . 0.0 109.436 -169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.1 t -97.63 -178.44 4.12 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 166.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -47.28 -51.09 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 125.358 1.463 . . . . 0.0 111.356 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.401 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -63.88 -22.75 67.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 178.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.1 -40.22 17.22 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 125.732 1.634 . . . . 0.0 111.44 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -76.63 -26.44 54.93 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 125.65 1.58 . . . . 0.0 111.742 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -46.1 -55.8 12.35 Favored Pre-proline 0 N--CA 1.455 -0.195 0 C-N-CA 126.485 1.914 . . . . 0.0 112.184 -176.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.64 -48.62 8.75 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 121.434 1.423 . . . . 0.0 110.025 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.481 ' CZ ' ' HB ' ' A' ' 19' ' ' THR . 64.5 m-85 -58.9 -37.75 77.33 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 117.508 -1.234 . . . . 0.0 113.133 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.1 mt -57.72 -58.77 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 C-N-CA 124.45 1.1 . . . . 0.0 108.06 173.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -52.46 -45.7 66.19 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.881 0.872 . . . . 0.0 110.173 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.498 ' HG2' HD21 ' A' ' 45' ' ' LEU . 64.7 mtm -65.54 -46.7 78.55 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.478 -0.764 . . . . 0.0 112.213 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.544 ' CD ' HD22 ' A' ' 17' ' ' LEU . 21.1 tttp -62.66 -38.45 90.37 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.034 -1.041 . . . . 0.0 110.252 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -66.47 -40.4 89.33 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.043 1.337 . . . . 0.0 110.502 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.9 t80 -57.34 -51.7 68.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.27 1.428 . . . . 0.0 108.394 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.2 mt -66.8 -10.91 52.63 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.72 1.208 . . . . 0.0 113.868 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -38.69 87.52 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.174 -0.954 . . . . 0.0 109.975 171.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -132.34 112.03 11.85 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.385 0.993 . . . . 0.0 110.147 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -53.82 -22.29 9.3 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.729 1.612 . . . . 0.0 112.413 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -53.86 -28.55 36.69 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 119.85 -1.781 . . . . 0.0 113.016 171.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.486 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 51.6 m-80 -62.04 -48.85 78.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.964 0.505 . . . . 0.0 110.031 175.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -37.16 79.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 CA-C-N 119.237 0.926 . . . . 0.0 109.814 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.4 mt -66.69 -35.05 79.22 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.836 0.454 . . . . 0.0 110.182 -173.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.42 -35.42 70.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.493 0.717 . . . . 0.0 112.052 172.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.39 -27.34 69.24 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.845 0.858 . . . . 0.0 111.338 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.451 ' CG ' HD11 ' A' ' 35' ' ' ILE . 77.8 mtp180 -59.26 -44.46 92.41 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.44 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.1 m -50.8 -46.53 59.77 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.282 0.946 . . . . 0.0 110.967 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.4 mt -67.84 -32.44 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.474 0.71 . . . . 0.0 110.134 -174.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 123.68 0.792 . . . . 0.0 110.795 173.967 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.649 HD22 ' HD2' ' A' ' 77' ' ' LYS . 1.4 mt . . . . . 0 C--O 1.238 0.498 0 CA-C-O 119.539 -0.267 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.5 93.95 4.87 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.2 p -58.13 -40.49 81.41 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.96 -1.088 . . . . 0.0 111.635 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.96 -34.79 76.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.94 0.496 . . . . 0.0 110.315 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.83 -55.44 7.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.564 1.145 . . . . 0.0 108.779 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.415 HD11 ' HB3' ' A' ' 17' ' ' LEU . 52.3 mt -56.25 -44.38 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.49 -48.61 78.76 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.735 -0.603 . . . . 0.0 111.536 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.493 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 29.7 t80 -56.36 -64.97 0.69 Allowed 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.231 1.012 . . . . 0.0 108.999 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -54.57 -35.63 63.51 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 127.106 2.162 . . . . 0.0 112.935 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.1 t -61.76 -53.13 52.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 119.191 0.905 . . . . 0.0 110.188 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 47.1 mtmt -52.38 -42.51 64.05 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 117.6 -1.191 . . . . 0.0 109.185 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.47 -58.1 10.1 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.238 1.015 . . . . 0.0 110.556 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -62.08 -34.17 75.79 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.67 -50.33 72.91 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 170.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.64 -42.41 74.96 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.107 0.867 . . . . 0.0 110.981 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -54.39 -30.1 51.0 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.129 2.171 . . . . 0.0 113.006 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -127.23 14.82 7.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.614 1.565 . . . . 0.0 110.928 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.7 m120 44.76 43.31 6.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 129.036 2.934 . . . . 0.0 113.073 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -82.15 147.17 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.81 -1.182 . . . . 0.0 109.421 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.13 130.99 10.17 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -56.62 -37.0 70.1 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.992 1.317 . . . . 0.0 112.512 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.2 ttp85 -54.63 -50.13 68.85 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.133 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.54 -49.41 83.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 119.107 0.867 . . . . 0.0 109.565 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -54.13 -49.2 69.73 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.446 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -72.18 -29.08 67.06 Favored Glycine 0 C--O 1.216 -0.987 0 CA-C-O 117.45 -1.75 . . . . 0.0 113.576 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -78.57 -30.08 46.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.729 2.265 . . . . 0.0 111.568 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.4 -58.44 1.88 Allowed 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.553 0.741 . . . . 0.0 110.393 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.54 HG22 HD21 ' A' ' 89' ' ' LEU . 11.3 t -68.23 -53.42 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -172.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.61 HD21 ' HG2' ' A' ' 76' ' ' MET . 46.0 mt -89.47 -37.08 15.04 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.2 0.6 . . . . 0.0 110.528 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.14 36.25 60.39 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.7 mt -121.51 163.43 18.84 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.731 1.612 . . . . 0.0 108.534 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.2 t -54.6 144.48 21.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.473 1.109 . . . . 0.0 109.919 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -58.28 -26.97 63.62 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 117.775 0.261 . . . . 0.0 110.841 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.59 -36.29 43.91 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.346 0.974 . . . . 0.0 112.054 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.1 m -67.56 -59.56 3.26 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.081 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.446 HG11 ' HA3' ' A' ' 41' ' ' GLY . 3.5 m -58.75 -35.18 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 120.381 1.446 . . . . 0.0 113.691 -177.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.2 p -61.88 -38.82 89.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.981 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.3 -38.59 68.86 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.742 1.155 . . . . 0.0 110.104 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.458 HG23 ' CZ ' ' A' ' 73' ' ' PHE . 14.9 mt -68.54 -47.22 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -173.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.8 mt -73.45 -30.36 63.14 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.145 0.578 . . . . 0.0 111.857 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.2 -57.46 5.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.02 1.728 . . . . 0.0 110.969 173.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -130.25 74.42 80.4 Favored Pre-proline 0 CA--C 1.519 -0.24 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -170.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.68 97.2 0.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 122.709 2.272 . . . . 0.0 107.167 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -63.68 159.53 51.96 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -70.31 150.05 64.31 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.093 1.862 . . . . 0.0 107.328 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.423 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 67.4 t-105 -51.69 -42.15 61.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -14.66 52.67 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.96 -16.95 34.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.144 1.793 . . . . 0.0 112.363 171.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.64 149.37 21.29 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.44 1.018 . . . . 0.0 108.85 -169.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -98.03 179.93 4.61 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 165.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.8 t -49.05 -51.05 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 119.649 1.113 . . . . 0.0 112.163 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt -59.56 -34.48 72.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.46 1.482 . . . . 0.0 112.569 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.78 -35.2 90.61 Favored Glycine 0 CA--C 1.529 0.92 0 O-C-N 121.35 -0.844 . . . . 0.0 112.705 173.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.423 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 93.5 mttt -80.4 -27.91 38.0 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.348 1.459 . . . . 0.0 112.162 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -42.18 -52.64 9.48 Favored Pre-proline 0 N--CA 1.448 -0.563 0 C-N-CA 128.365 2.666 . . . . 0.0 111.883 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.97 -56.08 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.103 1.869 . . . . 0.0 110.27 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.458 ' CZ ' HG23 ' A' ' 55' ' ' ILE . 80.5 m-85 -58.05 -32.03 67.62 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 117.482 -1.247 . . . . 0.0 113.303 -173.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.23 -58.81 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 119.449 1.022 . . . . 0.0 108.278 171.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -53.85 -48.85 69.58 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.61 ' HG2' HD21 ' A' ' 45' ' ' LEU . 58.3 mtm -72.31 -33.68 67.55 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 119.713 1.142 . . . . 0.0 113.034 -168.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.649 ' HD2' HD22 ' A' ' 17' ' ' LEU . 3.5 tttm -62.21 -41.44 98.38 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.622 171.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -66.72 -35.04 79.19 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.579 1.152 . . . . 0.0 111.644 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -58.65 -57.28 13.67 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 126.312 1.845 . . . . 0.0 108.062 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.03 -4.8 7.9 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.445 1.498 . . . . 0.0 113.124 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.7 -7.64 59.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.771 1.228 . . . . 0.0 112.729 171.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -152.26 134.39 15.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.223 1.829 . . . . 0.0 111.538 171.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 86' ' ' VAL . 2.1 tp10 -60.4 -35.71 76.4 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.249 1.42 . . . . 0.0 111.104 176.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -58.2 -27.07 63.54 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.545 -0.722 . . . . 0.0 110.555 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -63.27 -42.61 99.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.227 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 83' ' ' GLU . 5.3 p -75.8 -33.6 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.731 1.151 . . . . 0.0 110.267 176.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.6 mt -66.53 -38.72 87.77 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.647 0.658 . . . . 0.0 110.277 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.37 97.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.204 0.526 . . . . 0.0 110.791 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.54 HD21 HG22 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -65.51 -27.41 68.45 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.964 0.905 . . . . 0.0 111.234 -178.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -57.0 -38.59 73.29 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.165 0.893 . . . . 0.0 109.649 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -65.83 -46.35 78.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.762 0.71 . . . . 0.0 111.232 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.445 HD12 HD22 ' A' ' 89' ' ' LEU . 47.9 mt -62.83 -32.01 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 119.307 0.958 . . . . 0.0 110.538 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? . . . . . 0 N--CA 1.448 -0.552 0 C-N-CA 123.499 0.72 . . . . 0.0 110.767 178.028 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.75 HD22 ' HD2' ' A' ' 77' ' ' LYS . 7.8 mt . . . . . 0 C--O 1.234 0.273 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -85.25 111.57 19.97 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.624 1.102 . . . . 0.0 108.577 171.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.9 p -69.18 -39.43 78.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 121.22 -0.925 . . . . 0.0 111.915 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 -21.49 63.83 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.508 1.049 . . . . 0.0 112.119 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 2.5 tp10 -75.67 -55.36 5.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.727 1.611 . . . . 0.0 107.088 172.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.468 HD11 ' HB3' ' A' ' 17' ' ' LEU . 84.3 mt -53.96 -44.22 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 119.779 1.172 . . . . 0.0 109.427 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.63 -53.76 50.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.754 1.221 . . . . 0.0 111.248 173.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -57.57 -53.46 57.9 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.284 1.034 . . . . 0.0 110.539 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -58.48 -43.43 88.98 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.618 2.367 . . . . 0.0 110.624 -176.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.64 -55.03 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 O-C-N 120.861 -1.15 . . . . 0.0 109.023 172.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -51.47 -46.06 62.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.324 0.965 . . . . 0.0 110.932 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.97 -40.03 75.62 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 116.565 -1.683 . . . . 0.0 111.927 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -64.35 -36.16 83.23 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 121.627 2.012 . . . . 0.0 111.451 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.5 mt -61.07 -52.07 66.5 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 mt -65.02 -28.46 69.51 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -58.24 -36.34 73.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.963 1.305 . . . . 0.0 109.809 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -121.77 8.27 9.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.248 1.019 . . . . 0.0 112.405 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 52.3 79.29 0.11 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 128.04 2.536 . . . . 0.0 111.876 -169.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.563 HD11 ' HG3' ' A' ' 90' ' ' ARG . 70.7 mt -121.89 150.37 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.72 141.88 15.76 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.931 0.777 . . . . 0.0 111.269 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -57.81 -33.1 68.22 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.21 1.404 . . . . 0.0 112.253 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 -59.01 -62.8 1.61 Allowed 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.274 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.49 -36.48 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.968 1.258 . . . . 0.0 111.066 -176.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -59.78 -53.93 52.18 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 120.531 -1.356 . . . . 0.0 110.637 172.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.483 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -68.11 -24.22 74.62 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-O 118.017 -1.435 . . . . 0.0 112.62 -177.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -81.3 -20.45 40.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.838 1.819 . . . . 0.0 111.429 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -120.94 -51.42 2.13 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.327 0.967 . . . . 0.0 112.289 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.1 t -68.84 -52.16 37.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.6 mt -93.89 -29.06 15.49 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.208 -173.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.08 18.12 76.21 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 122.892 0.282 . . . . 0.0 112.563 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.7 169.9 8.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.558 1.543 . . . . 0.0 107.789 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.3 156.78 37.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 168.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -53.78 -51.15 64.33 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.205 0.602 . . . . 0.0 110.024 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.5 -26.44 68.2 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.321 -0.71 . . . . 0.0 112.54 -174.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 m -63.74 -69.05 0.3 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.483 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.2 m -56.65 -35.93 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 120.367 1.44 . . . . 0.0 112.59 -175.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t -60.78 -40.2 91.68 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.272 1.829 . . . . 0.0 110.576 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.84 -47.0 87.49 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.139 1.336 . . . . 0.0 109.272 167.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.0 mt -61.43 -31.8 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 99.3 mt -84.7 -22.66 29.68 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.944 0.897 . . . . 0.0 112.608 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.45 -49.16 23.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.802 1.241 . . . . 0.0 110.121 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.9 mtt85 -135.04 86.84 30.87 Favored Pre-proline 0 CA--C 1.516 -0.339 0 C-N-CA 125.373 1.469 . . . . 0.0 107.865 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.24 93.56 0.48 Allowed 'Trans proline' 0 N--CA 1.445 -1.335 0 N-CA-C 107.05 -1.942 . . . . 0.0 107.05 167.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -65.53 158.44 73.66 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -72.33 152.17 55.03 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.04 2.494 . . . . 0.0 108.958 -167.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.42 ' CD2' ' HE2' ' A' ' 70' ' ' LYS . 74.7 t-105 -52.43 -41.28 63.11 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.649 0.38 . . . . 0.0 111.478 175.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -18.02 58.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -89.03 -37.1 15.41 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 120.831 -1.168 . . . . 0.0 110.852 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.7 mt -74.69 146.15 42.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.543 0.687 . . . . 0.0 110.656 -162.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 t -71.3 174.59 6.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.289 1.035 . . . . 0.0 110.671 166.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.0 p -49.69 -56.09 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 124.423 1.089 . . . . 0.0 111.586 170.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -70.12 -5.07 24.42 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.62 -41.63 7.21 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.814 1.673 . . . . 0.0 110.288 167.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HE2' ' CD2' ' A' ' 62' ' ' TRP . 88.1 mttt -76.84 -26.1 53.92 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 126.264 1.825 . . . . 0.0 112.497 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -40.99 -62.04 1.12 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 127.266 2.226 . . . . 0.0 110.698 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -61.73 -44.5 21.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.393 2.062 . . . . 0.0 110.365 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -60.63 -39.93 90.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 117.67 -1.157 . . . . 0.0 112.845 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.9 mt -56.14 -51.59 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -59.65 -46.9 87.63 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.456 1.102 . . . . 0.0 110.861 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 70.5 mtm -61.84 -48.14 81.88 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 123.868 0.867 . . . . 0.0 110.823 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.75 ' HD2' HD22 ' A' ' 17' ' ' LEU . 10.3 tttt -60.78 -40.89 94.27 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.116 -0.99 . . . . 0.0 110.494 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -67.55 -36.01 80.15 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.116 0.967 . . . . 0.0 111.232 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 24.4 t80 -57.25 -48.04 79.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.011 0.925 . . . . 0.0 109.015 173.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.8 mt -71.07 -13.14 61.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.791 1.236 . . . . 0.0 113.631 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -25.73 68.21 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.146 0.885 . . . . 0.0 111.947 173.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -145.72 105.17 3.95 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -162.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -61.13 -23.24 65.38 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.382 0.673 . . . . 0.0 111.011 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -60.09 -23.42 63.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 119.783 -1.823 . . . . 0.0 112.036 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.446 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 71.3 m-80 -62.45 -38.89 91.52 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.066 1.303 . . . . 0.0 111.48 175.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 p -73.19 -35.4 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.608 1.094 . . . . 0.0 109.506 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.9 mt -70.52 -23.65 62.68 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.288 1.035 . . . . 0.0 111.283 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.3 -49.26 35.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.125 0.97 . . . . 0.0 110.615 167.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -28.93 69.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.336 1.454 . . . . 0.0 111.549 -170.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.563 ' HG3' HD11 ' A' ' 35' ' ' ILE . 68.4 mtp180 -57.45 -46.15 83.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.4 m -60.54 -37.51 81.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.653 0.781 . . . . 0.0 110.362 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mt -68.28 -30.3 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.353 0.978 . . . . 0.0 109.974 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 . . . . . 0 N--CA 1.451 -0.398 0 O-C-N 121.684 -0.635 . . . . 0.0 111.372 179.629 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.456 ' HB3' HD11 ' A' ' 22' ' ' ILE . 5.3 mt . . . . . 0 C--O 1.238 0.46 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.95 98.35 4.9 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.371 0.987 . . . . 0.0 108.571 175.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.4 p -58.34 -43.42 88.3 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.678 -1.264 . . . . 0.0 112.241 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.1 -26.24 66.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 118.805 -0.617 . . . . 0.0 110.992 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -70.86 -57.87 4.18 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 171.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.456 HD11 ' HB3' ' A' ' 17' ' ' LEU . 64.0 mt -54.92 -44.76 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.659 1.118 . . . . 0.0 109.936 -173.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.35 -51.73 68.66 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.914 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.537 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 81.9 t80 -53.19 -68.66 0.15 Allowed 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 125.292 1.437 . . . . 0.0 108.556 175.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -41.79 -46.04 3.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.955 2.502 . . . . 0.0 112.458 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.65 -50.08 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.951 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 47.9 mtmt -48.26 -45.85 34.99 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.421 1.464 . . . . 0.0 109.864 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.59 -54.8 30.31 Favored 'General case' 0 C--O 1.225 -0.186 0 O-C-N 124.451 1.094 . . . . 0.0 110.688 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -56.02 -40.58 73.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.889 1.676 . . . . 0.0 112.433 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.57 -49.67 68.0 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.8 -37.35 65.98 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.824 0.738 . . . . 0.0 111.831 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -55.39 -25.33 34.9 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.832 2.053 . . . . 0.0 112.922 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -126.45 16.43 7.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.153 0.981 . . . . 0.0 111.909 175.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.4 m120 40.22 75.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 129.686 3.194 . . . . 0.0 111.481 -166.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.417 HD11 ' CG ' ' A' ' 90' ' ' ARG . 91.8 mt -114.66 152.22 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -99.22 172.64 25.58 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -95.09 -20.19 19.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -172.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -58.82 -55.24 37.64 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 118.854 0.752 . . . . 0.0 110.229 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 t -60.0 -53.65 45.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -54.26 -45.1 72.32 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.819 1.191 . . . . 0.0 111.015 -174.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.407 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -71.65 -24.5 76.67 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-O 117.273 -1.849 . . . . 0.0 112.882 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -79.71 -37.48 35.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.569 2.185 . . . . 0.0 111.632 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -91.21 -70.4 0.69 Allowed 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.486 -0.759 . . . . 0.0 109.5 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.15 -50.44 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 125.087 1.355 . . . . 0.0 108.342 -172.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.572 HD21 ' SD ' ' A' ' 76' ' ' MET . 57.4 mt -95.73 -37.18 10.89 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.612 -170.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.61 6.03 86.08 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 118.501 0.591 . . . . 0.0 113.713 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.6 mt -92.02 173.74 7.68 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.993 1.717 . . . . 0.0 109.438 -172.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 t -63.66 154.14 33.91 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.549 0.69 . . . . 0.0 109.845 164.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -62.98 -22.84 67.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.343 1.457 . . . . 0.0 111.449 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.09 -59.9 4.43 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 171.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.1 m -49.47 -52.57 28.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 116.728 -1.606 . . . . 0.0 112.041 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.407 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.8 m -66.38 -37.87 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 121.495 1.952 . . . . 0.0 113.375 177.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.8 t -60.2 -34.93 74.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 118.419 -0.8 . . . . 0.0 110.521 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -57.96 -48.98 78.36 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.073 0.851 . . . . 0.0 110.758 168.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.432 HG23 ' CZ ' ' A' ' 73' ' ' PHE . 5.5 mt -58.16 -39.63 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.2 mt -77.65 -35.06 52.9 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.964 1.306 . . . . 0.0 113.779 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.5 -60.45 3.13 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -134.67 72.7 68.9 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 125.064 1.346 . . . . 0.0 108.792 -165.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.04 108.0 1.23 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.57 2.18 . . . . 0.0 106.655 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -66.92 159.66 74.52 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 163.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.26 149.2 81.3 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 122.529 2.153 . . . . 0.0 109.316 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -45.48 -46.71 13.86 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.56 1.544 . . . . 0.0 111.148 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -56.74 -32.38 65.51 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -71.52 -29.46 64.81 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.389 0.995 . . . . 0.0 111.319 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.4 mt -80.93 157.89 25.43 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.439 0.638 . . . . 0.0 111.249 -160.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.9 p -78.9 175.45 10.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.716 0.806 . . . . 0.0 108.917 165.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -53.79 -50.65 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.001 1.32 . . . . 0.0 112.39 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -72.6 -19.78 61.41 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 120.146 -1.596 . . . . 0.0 112.251 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.84 96.78 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 163.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -85.3 -28.17 25.46 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 117.215 -1.374 . . . . 0.0 113.089 -176.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -45.04 -52.26 20.36 Favored Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 124.564 1.146 . . . . 0.0 111.964 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.76 -52.02 4.21 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.374 1.383 . . . . 0.0 110.065 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CZ ' HG23 ' A' ' 55' ' ' ILE . 78.4 m-85 -59.51 -32.86 70.68 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 117.71 -1.138 . . . . 0.0 113.082 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.4 mt -61.16 -56.5 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -53.71 -43.79 69.31 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.541 1.136 . . . . 0.0 111.089 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.572 ' SD ' HD21 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -66.24 -45.25 81.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.12 -1.613 . . . . 0.0 114.711 172.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -63.48 -33.77 76.3 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.343 -1.473 . . . . 0.0 109.911 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -62.44 -49.57 74.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.224 1.809 . . . . 0.0 110.074 172.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -51.52 -48.7 62.9 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.25 1.42 . . . . 0.0 110.332 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.85 -8.57 29.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.382 1.073 . . . . 0.0 113.882 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -68.99 -25.07 64.34 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.183 -0.948 . . . . 0.0 111.942 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -147.45 141.11 25.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.913 1.233 . . . . 0.0 108.958 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.474 ' O ' HG12 ' A' ' 86' ' ' VAL . 18.9 tt0 -62.32 -32.68 73.47 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.237 1.015 . . . . 0.0 111.194 -175.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.645 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -56.18 -30.05 61.7 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.827 -1.171 . . . . 0.0 110.864 -175.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -64.0 -36.13 82.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 118.687 0.676 . . . . 0.0 110.245 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 83' ' ' GLU . 10.0 p -77.37 -31.5 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.114 -0.991 . . . . 0.0 110.469 175.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 84' ' ' GLN . 42.1 mt -61.85 -41.4 97.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.838 0.855 . . . . 0.0 109.827 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.78 84.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.218 0.607 . . . . 0.0 110.106 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -30.24 70.22 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.158 177.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.417 ' CG ' HD11 ' A' ' 35' ' ' ILE . 71.3 mtp180 -61.0 -43.64 98.59 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 119.612 1.096 . . . . 0.0 109.835 174.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.5 m -53.09 -49.16 67.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.324 0.65 . . . . 0.0 110.094 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.3 mt -64.55 -34.4 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.417 -0.802 . . . . 0.0 110.423 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.05 177.396 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.404 ' HB3' HD11 ' A' ' 22' ' ' ILE . 8.4 mt . . . . . 0 C--O 1.238 0.473 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.76 95.74 4.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 122.372 1.082 . . . . 0.0 108.483 175.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.6 p -61.21 -42.55 98.8 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.287 -0.883 . . . . 0.0 111.374 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.52 -34.91 73.23 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.973 0.909 . . . . 0.0 110.92 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -70.82 -54.18 12.54 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.404 HD11 ' HB3' ' A' ' 17' ' ' LEU . 67.1 mt -55.93 -42.75 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -177.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.98 -55.78 28.65 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.159 0.984 . . . . 0.0 110.765 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -53.08 -62.73 1.47 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.117 1.367 . . . . 0.0 110.276 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -55.47 -36.61 66.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.059 1.743 . . . . 0.0 113.381 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.448 HG23 HD11 ' A' ' 80' ' ' LEU . 24.1 t -63.9 -47.59 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -58.14 -37.93 75.6 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 116.986 -1.483 . . . . 0.0 110.465 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -61.11 -58.11 9.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.4 1.0 . . . . 0.0 110.559 173.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -61.66 -34.23 75.36 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.214 -0.929 . . . . 0.0 112.127 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.3 mt -72.08 -33.87 68.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.174 1.79 . . . . 0.0 109.753 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 mt -65.45 -37.63 87.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 120.06 1.3 . . . . 0.0 112.177 168.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.48 ' HZ2' ' CE1' ' A' ' 33' ' ' HIS . 55.0 tttm -58.26 -36.38 73.16 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.107 1.763 . . . . 0.0 113.459 -163.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.48 ' CE1' ' HZ2' ' A' ' 32' ' ' LYS . 78.9 m-70 -124.41 12.3 8.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.915 2.486 . . . . 0.0 111.406 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 m120 44.18 78.48 0.06 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.874 2.469 . . . . 0.0 111.506 -171.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.1 mt -116.87 151.68 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.88 151.01 19.92 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.706 0.615 . . . . 0.0 111.735 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -57.81 -38.05 74.85 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.237 1.415 . . . . 0.0 110.668 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -56.76 -61.14 2.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.614 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.96 -49.0 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 119.48 1.036 . . . . 0.0 109.358 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.36 -47.1 79.56 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.918 0.781 . . . . 0.0 111.541 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.429 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -70.17 -31.19 69.17 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-O 118.275 -1.291 . . . . 0.0 111.264 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -71.09 -30.07 66.08 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.738 1.769 . . . . 0.0 111.056 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -108.39 -57.83 2.07 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.189 0.995 . . . . 0.0 113.035 -171.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.6 -48.27 53.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -175.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.481 HD21 ' HG2' ' A' ' 76' ' ' MET . 20.9 mt -93.17 -29.5 15.7 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 122.045 -0.409 . . . . 0.0 111.737 -171.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.06 19.76 79.72 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.374 -0.681 . . . . 0.0 112.149 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.4 mt -109.14 165.03 11.91 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.005 1.322 . . . . 0.0 107.603 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.53 162.06 29.97 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.071 0.939 . . . . 0.0 109.342 174.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -49.72 75.78 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.071 0.948 . . . . 0.0 110.692 -172.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.57 -41.56 95.61 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.4 m -55.95 -67.17 0.32 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 117.459 -1.258 . . . . 0.0 110.886 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.429 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.8 m -55.46 -36.24 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 121.261 1.846 . . . . 0.0 112.884 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 m -68.87 -23.69 64.25 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.669 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -66.67 -45.69 78.09 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.481 1.491 . . . . 0.0 108.552 162.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 mt -60.81 -40.42 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt -74.56 -31.5 62.11 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.399 1.079 . . . . 0.0 112.589 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.12 -50.31 64.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.536 0.734 . . . . 0.0 109.704 173.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 mtp85 -136.9 78.32 41.81 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 125.23 1.412 . . . . 0.0 108.516 -166.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.15 107.67 1.98 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.151 1.901 . . . . 0.0 107.39 169.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -64.32 173.51 1.48 Allowed Pre-proline 0 N--CA 1.442 -0.856 0 C-N-CA 124.342 1.057 . . . . 0.0 109.022 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -59.3 142.37 99.03 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.826 1.684 . . . . 0.0 108.699 165.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -54.37 -49.18 70.43 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.829 1.195 . . . . 0.0 110.494 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -21.32 4.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 mmtm -77.47 -31.06 53.47 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 120.359 -1.463 . . . . 0.0 111.383 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 mt -70.24 151.46 45.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.746 0.784 . . . . 0.0 109.549 -172.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.7 t -84.47 179.53 7.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 160.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.05 -57.11 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.098 1.359 . . . . 0.0 110.782 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -64.86 -19.44 65.89 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.836 -1.165 . . . . 0.0 112.863 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.16 -50.01 69.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 126.118 1.818 . . . . 0.0 111.769 165.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -74.62 -25.58 59.32 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 125.046 1.339 . . . . 0.0 112.338 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -43.72 -54.77 9.97 Favored Pre-proline 0 N--CA 1.446 -0.669 0 C-N-CA 127.083 2.153 . . . . 0.0 112.094 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.15 -47.83 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.083 1.856 . . . . 0.0 110.557 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -59.88 -36.6 77.28 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.901 -1.047 . . . . 0.0 112.73 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.7 mt -60.75 -55.02 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 174.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -55.75 -45.85 77.96 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.389 0.675 . . . . 0.0 109.751 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.481 ' HG2' HD21 ' A' ' 45' ' ' LEU . 66.3 mtm -59.5 -52.74 64.27 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 123.403 0.681 . . . . 0.0 111.437 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -60.01 -40.05 87.91 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.983 -1.073 . . . . 0.0 111.589 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -70.03 -31.96 69.86 Favored 'General case' 0 C--O 1.229 -0.025 0 C-N-CA 123.588 0.755 . . . . 0.0 111.42 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.521 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 22.8 t80 -61.56 -50.91 70.73 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.722 1.209 . . . . 0.0 108.123 171.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.448 HD11 HG23 ' A' ' 26' ' ' VAL . 36.1 mt -72.43 4.54 3.69 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.959 1.703 . . . . 0.0 113.241 175.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -91.02 -6.37 54.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 117.722 -1.132 . . . . 0.0 110.773 168.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.79 107.05 1.28 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.329 1.422 . . . . 0.0 109.389 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -55.13 -20.76 10.92 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.983 1.313 . . . . 0.0 113.945 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -58.94 -23.57 61.62 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 121.248 1.84 . . . . 0.0 111.204 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.521 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 65.4 m-80 -64.85 -48.2 75.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 173.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.1 p -65.45 -37.36 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.088 1.313 . . . . 0.0 109.565 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.5 mt -65.72 -30.1 70.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.586 0.754 . . . . 0.0 110.036 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.22 -45.46 73.22 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.849 0.86 . . . . 0.0 111.23 170.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.443 HD22 HD12 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -66.23 -24.25 66.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.497 1.119 . . . . 0.0 111.15 -175.385 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mtm105 -55.15 -52.88 61.89 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.827 0.74 . . . . 0.0 109.929 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.5 m -54.95 -41.29 70.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.486 1.514 . . . . 0.0 110.245 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.443 HD12 HD22 ' A' ' 89' ' ' LEU . 58.5 mt -67.52 -35.58 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.243 -0.911 . . . . 0.0 110.111 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-N 119.097 0.862 . . . . 0.0 110.774 177.783 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.534 ' HB3' HD11 ' A' ' 22' ' ' ILE . 12.5 mt . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.29 97.79 3.65 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.414 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 23.3 p -59.58 -36.32 76.01 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.175 -0.953 . . . . 0.0 112.173 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 -28.45 66.42 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.912 0.778 . . . . 0.0 110.998 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -77.79 -49.42 14.39 Favored 'General case' 0 C--O 1.215 -0.753 0 C-N-CA 125.188 1.395 . . . . 0.0 108.423 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 17' ' ' LEU . 74.8 mt -56.32 -46.52 81.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.0 -53.17 59.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.533 -0.729 . . . . 0.0 110.492 174.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -57.45 -58.07 9.88 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.241 1.016 . . . . 0.0 111.174 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -56.39 -39.03 72.31 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.356 2.262 . . . . 0.0 111.02 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.513 HG23 HD11 ' A' ' 80' ' ' LEU . 16.8 t -63.73 -51.77 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 120.227 -1.546 . . . . 0.0 110.002 172.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -59.4 -43.67 92.93 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.84 -0.537 . . . . 0.0 110.348 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.58 -49.7 76.47 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.355 0.662 . . . . 0.0 109.918 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -54.91 -47.58 74.19 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.307 1.843 . . . . 0.0 113.645 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.7 mt -60.8 -43.51 98.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 121.12 -0.987 . . . . 0.0 108.479 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -41.81 99.28 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 120.026 1.285 . . . . 0.0 112.406 172.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -58.37 -39.91 80.86 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.763 2.825 . . . . 0.0 111.051 -173.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -115.07 13.23 16.84 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.246 0.619 . . . . 0.0 112.319 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.7 t30 38.7 77.2 0.05 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.189 2.596 . . . . 0.0 112.859 -170.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.553 HG23 HE21 ' A' ' 93' ' ' GLN . 85.8 mt -119.0 149.89 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.527 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -89.57 142.56 16.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.905 0.764 . . . . 0.0 111.378 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -36.47 77.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.323 1.049 . . . . 0.0 112.874 -175.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -55.92 -57.32 12.57 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 119.211 0.914 . . . . 0.0 110.022 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -57.9 -44.06 85.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 118.518 0.599 . . . . 0.0 109.689 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -54.54 -50.61 67.5 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.679 -0.638 . . . . 0.0 112.005 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.436 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -71.57 -26.03 73.97 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-O 117.697 -1.613 . . . . 0.0 112.145 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -79.11 -32.09 44.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.649 1.725 . . . . 0.0 111.271 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -108.33 -44.95 4.0 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.238 1.015 . . . . 0.0 113.319 -174.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.01 -46.07 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.51 HD21 ' HG2' ' A' ' 76' ' ' MET . 21.7 mt -98.05 -30.85 12.45 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.068 0.23 . . . . 0.0 111.489 -171.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.29 4.21 90.27 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 123.97 0.794 . . . . 0.0 112.662 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 73.4 mt -93.23 178.63 5.67 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.61 1.564 . . . . 0.0 109.512 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 p -72.75 159.65 33.47 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.655 -0.653 . . . . 0.0 109.701 169.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -51.95 -44.2 63.84 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.952 1.301 . . . . 0.0 109.378 167.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.4 -54.88 31.52 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.073 1.32 . . . . 0.0 111.697 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.2 m -56.46 -64.85 0.73 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 117.684 -1.15 . . . . 0.0 110.697 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.436 HG11 ' HA3' ' A' ' 41' ' ' GLY . 4.2 m -58.08 -36.82 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 120.524 1.511 . . . . 0.0 111.872 -172.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.2 m -62.91 -29.28 70.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.09 -1.433 . . . . 0.0 112.979 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.02 -48.71 77.61 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 120.363 1.438 . . . . 0.0 108.887 166.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.7 -42.6 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.9 mt -77.83 -27.27 49.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.784 0.834 . . . . 0.0 113.0 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.71 -41.91 61.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.067 1.347 . . . . 0.0 111.257 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.32 82.43 9.72 Favored Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 126.813 2.045 . . . . 0.0 107.352 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.49 95.66 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.648 2.232 . . . . 0.0 107.484 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -61.76 157.44 49.04 Favored Pre-proline 0 N--CA 1.443 -0.81 0 O-C-N 121.016 -1.052 . . . . 0.0 108.799 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.05 149.14 92.41 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 122.725 2.284 . . . . 0.0 108.536 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.409 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 66.4 t-105 -56.21 -44.05 79.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.524 0.602 . . . . 0.0 110.573 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -12.63 9.26 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.57 -7.05 45.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.713 1.605 . . . . 0.0 113.61 175.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.5 mt -106.4 151.14 25.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.622 0.769 . . . . 0.0 110.517 -173.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 p -85.68 179.06 7.16 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.218 1.007 . . . . 0.0 109.784 171.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 t -52.07 -43.46 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.199 -0.938 . . . . 0.0 111.339 165.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -63.91 -42.1 97.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 118.52 0.6 . . . . 0.0 109.981 175.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.88 -31.34 67.91 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-O 119.193 -0.782 . . . . 0.0 113.526 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -91.37 -18.55 24.1 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.733 1.613 . . . . 0.0 111.987 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -42.22 -56.33 5.52 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 127.05 2.14 . . . . 0.0 111.874 175.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -66.86 -45.05 4.68 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.502 1.468 . . . . 0.0 110.349 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 58.9 m-85 -64.86 -34.42 78.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.316 -1.326 . . . . 0.0 112.517 -173.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.88 -53.94 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 120.068 1.304 . . . . 0.0 107.683 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -53.04 -45.79 68.18 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.757 0.823 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.51 ' HG2' HD21 ' A' ' 45' ' ' LEU . 69.9 mtm -63.44 -49.75 72.47 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.274 -0.891 . . . . 0.0 111.787 176.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.492 ' HD2' HD22 ' A' ' 17' ' ' LEU . 18.7 tttm -58.59 -40.56 83.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.02 -1.05 . . . . 0.0 110.343 -178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -64.77 -44.75 89.0 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.527 1.131 . . . . 0.0 110.23 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.472 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 51.6 t80 -52.38 -45.05 65.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.49 1.116 . . . . 0.0 110.919 173.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.513 HD11 HG23 ' A' ' 26' ' ' VAL . 57.8 mt -78.26 -9.72 59.35 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.819 1.248 . . . . 0.0 113.686 -176.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.3 t -75.66 -11.99 60.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.762 0.825 . . . . 0.0 111.014 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -162.86 95.43 0.88 Allowed 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.989 -1.069 . . . . 0.0 108.279 -155.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.74 -29.34 18.21 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.904 1.282 . . . . 0.0 111.098 -173.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -54.25 -22.86 12.78 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.256 -1.527 . . . . 0.0 113.884 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.472 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 33.4 m-80 -66.34 -44.52 83.06 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.447 1.021 . . . . 0.0 111.917 171.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.17 -36.6 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 120.572 -1.33 . . . . 0.0 109.755 -175.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -34.97 71.2 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.788 2.035 . . . . 0.0 110.521 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.83 -45.01 60.71 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.637 1.175 . . . . 0.0 111.978 172.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.57 -29.43 67.94 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 120.93 -1.106 . . . . 0.0 110.793 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.427 ' HG3' HD11 ' A' ' 35' ' ' ILE . 38.8 mtp-105 -61.76 -41.04 97.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 118.406 -0.807 . . . . 0.0 110.225 173.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -58.31 -45.63 87.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.267 1.394 . . . . 0.0 109.784 173.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.8 mt -60.16 -32.68 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.927 0.785 . . . . 0.0 109.886 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.553 HE21 HG23 ' A' ' 35' ' ' ILE . 11.5 tp-100 . . . . . 0 N--CA 1.448 -0.53 0 O-C-N 121.036 -1.04 . . . . 0.0 112.458 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.703 HD22 ' HD2' ' A' ' 77' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--O 1.234 0.265 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.54 101.38 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.099 -1.001 . . . . 0.0 110.068 175.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.416 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 24.1 p -65.25 -40.98 94.7 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 120.679 -1.263 . . . . 0.0 112.689 -172.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.03 -29.53 70.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.836 0.744 . . . . 0.0 110.854 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -76.71 -50.95 12.41 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.498 2.319 . . . . 0.0 108.522 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt -56.83 -45.96 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.94 0.896 . . . . 0.0 109.119 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.85 72.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.986 -1.071 . . . . 0.0 110.696 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -54.19 -65.94 0.48 Allowed 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.917 1.287 . . . . 0.0 109.057 177.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -44.04 -44.31 7.32 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.687 1.995 . . . . 0.0 112.556 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.97 -43.94 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 O-C-N 121.345 -0.847 . . . . 0.0 111.283 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG3' HD22 ' A' ' 56' ' ' LEU . 41.9 mtmt -55.24 -35.56 65.1 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.561 1.073 . . . . 0.0 109.593 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -67.61 -56.58 8.87 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 123.36 0.664 . . . . 0.0 110.937 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -59.21 -39.38 82.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.582 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.42 -46.96 86.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 119.757 1.162 . . . . 0.0 108.091 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.18 -41.41 79.26 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.232 0.924 . . . . 0.0 111.472 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -53.98 -31.76 51.83 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.723 1.609 . . . . 0.0 114.072 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -119.77 7.21 10.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.95 1.3 . . . . 0.0 112.524 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m120 51.38 79.47 0.1 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 127.939 2.496 . . . . 0.0 111.226 -170.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.3 mt -119.64 137.27 54.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.638 0.732 . . . . 0.0 109.376 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.83 132.94 12.79 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 126.486 1.993 . . . . 0.0 109.805 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.549 HE21 HD12 ' A' ' 56' ' ' LEU . 8.1 mt-30 -54.01 -31.77 52.19 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.064 1.346 . . . . 0.0 113.265 -175.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -58.08 -48.56 79.78 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.576 -1.202 . . . . 0.0 111.341 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -60.27 -50.23 81.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 119.665 1.12 . . . . 0.0 108.839 -176.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -56.96 -40.59 76.75 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.656 -0.653 . . . . 0.0 111.665 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.4 ' CA ' HG11 ' A' ' 52' ' ' VAL . . . -71.23 -34.31 64.34 Favored Glycine 0 N--CA 1.437 -1.298 0 CA-C-O 117.596 -1.669 . . . . 0.0 111.592 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -70.02 -38.76 76.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.102 1.951 . . . . 0.0 110.548 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -97.61 -58.88 1.89 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.74 0.7 . . . . 0.0 112.667 -171.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.4 t -72.35 -47.13 54.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -172.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.505 HD21 ' SD ' ' A' ' 76' ' ' MET . 45.2 mt -89.31 -40.34 12.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 119.075 -0.488 . . . . 0.0 110.667 -174.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.47 22.01 71.21 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.766 -1.019 . . . . 0.0 111.753 -174.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.5 mt -110.62 160.05 17.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.424 1.89 . . . . 0.0 109.397 -174.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 m -63.72 152.6 38.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.575 1.15 . . . . 0.0 109.541 174.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -53.33 -43.06 67.35 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.11 0.964 . . . . 0.0 111.248 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.38 -10.4 80.02 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 118.076 -1.402 . . . . 0.0 113.368 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 m -68.26 -68.59 0.38 Allowed 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.869 1.835 . . . . 0.0 106.996 161.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.445 ' CG1' HD12 ' A' ' 45' ' ' LEU . 1.5 m -56.14 -37.7 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.449 1.477 . . . . 0.0 113.692 -171.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -42.84 94.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.859 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -47.01 74.83 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.448 1.022 . . . . 0.0 109.666 171.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 55' ' ' ILE . 13.7 mt -60.12 -43.96 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.549 HD12 HE21 ' A' ' 37' ' ' GLN . 92.8 mt -70.85 -35.72 72.54 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.747 1.219 . . . . 0.0 111.802 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.92 -51.7 30.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.059 1.744 . . . . 0.0 110.509 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -133.36 81.87 54.22 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 124.693 1.197 . . . . 0.0 108.898 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -69.3 95.55 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.707 2.938 . . . . 0.0 108.443 171.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -62.0 156.55 57.16 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 171.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -61.73 152.53 73.6 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.551 2.167 . . . . 0.0 108.218 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -53.75 -47.63 70.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.634 0.774 . . . . 0.0 110.038 175.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.429 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -63.6 3.66 0.32 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 173.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 2.2 mmpt? -107.41 -13.83 15.01 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 119.759 -1.838 . . . . 0.0 112.983 167.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.6 mt -92.77 150.41 20.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 119.084 0.856 . . . . 0.0 109.145 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t -94.15 -179.96 5.12 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 167.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 t -49.76 -49.45 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.238 1.415 . . . . 0.0 111.306 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -64.72 -28.26 69.47 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 120.208 1.367 . . . . 0.0 112.386 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.0 -40.11 73.51 Favored Glycine 0 CA--C 1.527 0.783 0 O-C-N 120.99 -1.069 . . . . 0.0 112.41 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -77.18 -25.61 52.03 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 126.908 2.083 . . . . 0.0 112.068 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 11.8 tt0 -41.64 -54.24 6.81 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 128.72 2.808 . . . . 0.0 112.116 -177.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 71' ' ' GLU . 19.1 Cg_endo -59.67 -58.6 0.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.247 2.631 . . . . 0.0 111.28 173.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.416 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 77.4 m-85 -56.19 -33.29 65.15 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -171.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.0 mt -58.01 -58.35 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -52.61 -52.13 56.81 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 124.588 1.155 . . . . 0.0 109.007 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.505 ' SD ' HD21 ' A' ' 45' ' ' LEU . 1.0 OUTLIER -57.96 -48.64 79.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 178.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.703 ' HD2' HD22 ' A' ' 17' ' ' LEU . 10.3 tttt -58.89 -42.63 89.99 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -71.16 -32.9 69.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.513 0.725 . . . . 0.0 110.857 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -59.19 -46.58 88.05 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.975 1.31 . . . . 0.0 109.402 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.1 mt -66.57 -21.5 66.14 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.0 m -82.89 1.14 40.89 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.981 0.81 . . . . 0.0 112.644 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -148.38 99.04 2.98 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 120.348 1.431 . . . . 0.0 108.747 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -61.87 -22.03 65.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.574 0.75 . . . . 0.0 112.743 -168.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -57.29 -23.16 46.66 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.523 -1.36 . . . . 0.0 112.878 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -64.47 -47.31 79.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.195 0.907 . . . . 0.0 110.508 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.0 p -72.1 -31.98 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.404 -0.81 . . . . 0.0 110.506 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.9 mt -69.7 -23.01 63.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.781 0.832 . . . . 0.0 111.097 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.51 -36.05 29.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.808 0.843 . . . . 0.0 110.499 171.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -66.23 -38.04 86.95 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 120.664 -1.273 . . . . 0.0 110.601 -176.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -62.95 -35.49 80.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.212 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.0 m -54.7 -51.33 65.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.768 0.713 . . . . 0.0 109.507 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 89' ' ' LEU . 70.6 mt -59.69 -39.29 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 122.946 0.498 . . . . 0.0 110.357 -175.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.593 0 C-N-CA 124.614 1.166 . . . . 0.0 111.502 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.748 HD22 ' HD2' ' A' ' 77' ' ' LYS . 7.4 mt . . . . . 0 C--O 1.238 0.478 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -80.76 100.78 8.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 174.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.0 p -62.94 -36.54 83.78 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.257 -0.902 . . . . 0.0 111.491 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.94 -24.67 61.66 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.824 1.193 . . . . 0.0 111.445 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 12.8 tt0 -72.52 -55.67 6.59 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 173.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.43 HD11 ' HB3' ' A' ' 17' ' ' LEU . 53.4 mt -54.36 -51.39 49.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.95 -49.02 72.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.592 0.757 . . . . 0.0 111.604 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.41 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 66.2 t80 -55.97 -61.45 2.37 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 124.725 1.21 . . . . 0.0 109.419 175.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -52.86 -39.83 62.9 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.499 2.32 . . . . 0.0 112.08 -176.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.1 -51.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 121.455 -0.778 . . . . 0.0 109.661 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 45.8 mtmt -53.26 -39.55 63.95 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 116.811 -1.566 . . . . 0.0 110.642 175.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.93 -59.32 5.56 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.724 1.21 . . . . 0.0 110.671 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -62.16 -36.34 81.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.265 1.026 . . . . 0.0 111.574 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 mt -65.09 -51.62 60.35 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -55.9 -39.36 71.48 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.025 1.284 . . . . 0.0 112.014 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -51.33 -50.65 59.0 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.894 2.078 . . . . 0.0 109.786 -177.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -104.86 12.84 32.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.386 1.074 . . . . 0.0 111.458 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 t30 38.38 58.71 1.56 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 130.792 3.637 . . . . 0.0 112.011 -171.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 82.7 mt -93.01 156.8 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.413 1.485 . . . . 0.0 108.305 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.424 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -98.98 151.22 19.46 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.741 0.686 . . . . 0.0 112.202 -175.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.564 HE21 HD12 ' A' ' 56' ' ' LEU . 1.2 mt-30 -70.92 -30.12 66.36 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 117.825 -1.083 . . . . 0.0 113.752 -174.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -59.06 -59.14 5.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 120.357 1.435 . . . . 0.0 109.377 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.2 t -59.73 -43.46 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 123.478 0.486 . . . . 0.0 109.864 -174.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -56.18 -47.75 77.7 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.244 0.929 . . . . 0.0 110.973 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.426 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -70.93 -30.52 67.88 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-O 118.144 -1.364 . . . . 0.0 112.391 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -72.07 -29.97 64.66 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.165 1.482 . . . . 0.0 111.274 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -105.48 -68.87 0.84 Allowed 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.705 0.802 . . . . 0.0 111.122 -176.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.64 -38.59 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 123.301 0.64 . . . . 0.0 109.391 -169.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.508 HD21 ' HG2' ' A' ' 76' ' ' MET . 28.0 mt -95.79 -42.03 8.55 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.47 32.77 67.86 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.3 mt -110.49 165.15 12.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.651 1.581 . . . . 0.0 107.111 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.61 161.65 30.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.706 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -46.6 86.85 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.637 0.775 . . . . 0.0 111.527 -171.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.85 -32.24 82.18 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.3 m -59.44 -65.56 0.65 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 118.169 -0.919 . . . . 0.0 108.576 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.426 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.7 m -59.65 -37.22 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 120.143 1.338 . . . . 0.0 112.893 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 t -57.47 -40.54 78.78 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.642 -0.661 . . . . 0.0 111.102 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.37 -45.13 95.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.468 0.707 . . . . 0.0 110.563 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.0 mt -60.28 -43.05 92.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.564 HD12 HE21 ' A' ' 37' ' ' GLN . 74.5 mt -70.57 -35.89 73.3 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 123.743 0.817 . . . . 0.0 112.491 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.41 -45.71 79.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.308 1.043 . . . . 0.0 110.269 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -134.68 79.48 52.87 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 125.364 1.466 . . . . 0.0 109.336 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -72.03 103.96 1.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.733 2.289 . . . . 0.0 106.968 168.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -80.71 163.8 54.38 Favored Pre-proline 0 N--CA 1.443 -0.82 0 C-N-CA 125.335 1.454 . . . . 0.0 108.195 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -56.68 139.94 89.41 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.093 2.529 . . . . 0.0 108.83 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.412 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 33.0 t-105 -50.65 -47.49 58.54 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.589 1.086 . . . . 0.0 110.537 173.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -21.38 32.83 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 176.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -77.74 -35.14 52.2 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.513 1.506 . . . . 0.0 110.418 177.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.4 mt -78.77 163.82 25.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.072 0.949 . . . . 0.0 108.756 -174.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.7 p -123.52 -177.33 3.69 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.449 1.9 . . . . 0.0 107.282 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.3 m -44.61 -53.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 121.855 2.116 . . . . 0.0 113.821 -170.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 -21.73 59.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.912 0.863 . . . . 0.0 112.844 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.25 -38.18 87.33 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.352 1.453 . . . . 0.0 112.624 165.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -90.58 -27.15 19.31 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.311 1.844 . . . . 0.0 112.204 -172.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -37.05 -58.39 1.12 Allowed Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 129.781 3.232 . . . . 0.0 111.282 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.47 -49.54 3.32 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.999 1.799 . . . . 0.0 110.431 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -58.93 -34.92 72.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.006 -0.997 . . . . 0.0 112.568 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.03 -54.52 33.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 119.423 1.01 . . . . 0.0 108.59 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -56.2 -50.52 70.99 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 124.224 1.009 . . . . 0.0 108.989 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.508 ' HG2' HD21 ' A' ' 45' ' ' LEU . 65.3 mtm -59.57 -48.97 79.56 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.856 -0.527 . . . . 0.0 111.991 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.748 ' HD2' HD22 ' A' ' 17' ' ' LEU . 8.8 tttm -58.4 -37.16 74.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.438 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -74.51 -38.1 62.93 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.086 1.312 . . . . 0.0 111.376 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.5 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 4.9 t80 -56.38 -40.06 73.96 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.556 1.142 . . . . 0.0 109.163 173.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.4 mt -73.46 -19.8 60.86 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 117.706 -1.14 . . . . 0.0 113.015 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.6 m -61.29 -32.44 72.28 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.642 1.565 . . . . 0.0 111.098 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -137.89 117.01 12.55 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.981 1.312 . . . . 0.0 108.549 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -57.86 -16.41 11.7 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.695 1.598 . . . . 0.0 112.84 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.46 ' HA ' HD12 ' A' ' 87' ' ' LEU . 16.8 mm-40 -57.78 -21.67 42.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 120.274 -1.516 . . . . 0.0 112.798 171.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.5 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 63.6 m-80 -70.43 -49.42 48.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.781 1.173 . . . . 0.0 110.813 177.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.24 -33.54 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 119.587 1.085 . . . . 0.0 110.572 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 84' ' ' GLN . 38.4 mt -62.31 -43.47 98.74 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.92 -2.76 13.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.267 1.427 . . . . 0.0 113.851 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.86 -18.79 20.08 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.584 1.538 . . . . 0.0 115.145 167.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -65.96 -51.12 61.32 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.431 1.469 . . . . 0.0 111.484 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 m -53.99 -36.72 63.22 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 117.322 -1.323 . . . . 0.0 110.685 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.7 mt -64.62 -34.5 70.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 CA-C-N 120.622 1.556 . . . . 0.0 110.532 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.424 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 9.7 tp-100 . . . . . 0 N--CA 1.455 -0.224 0 O-C-N 121.113 -0.992 . . . . 0.0 110.662 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.541 HD22 ' CD ' ' A' ' 77' ' ' LYS . 8.3 mt . . . . . 0 N--CA 1.455 -0.211 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.45 100.98 10.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 122.373 1.082 . . . . 0.0 109.031 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 p -59.42 -47.77 84.18 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.138 1.375 . . . . 0.0 111.415 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.66 -24.2 66.59 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.553 0.741 . . . . 0.0 111.529 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -80.57 -55.75 4.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 117.454 -1.26 . . . . 0.0 108.588 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.489 HD11 ' HB3' ' A' ' 17' ' ' LEU . 57.0 mt -48.98 -51.82 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 120.03 1.287 . . . . 0.0 108.426 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.68 -49.15 65.86 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.632 1.173 . . . . 0.0 111.741 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -62.86 -50.76 69.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.814 0.846 . . . . 0.0 110.301 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -60.21 -39.52 86.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.773 1.229 . . . . 0.0 111.537 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.5 HG21 ' SD ' ' A' ' 76' ' ' MET . 90.6 t -61.29 -49.73 83.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 O-C-N 120.902 -1.123 . . . . 0.0 108.82 172.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -59.99 -30.31 69.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 116.604 -1.665 . . . . 0.0 112.119 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.6 -65.25 0.71 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.514 1.506 . . . . 0.0 108.848 169.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.563 ' HB3' HG21 ' A' ' 86' ' ' VAL . 5.1 mm-40 -56.35 -39.71 73.3 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.66 1.184 . . . . 0.0 113.286 -171.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.8 mt -61.75 -51.03 70.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.58 -29.92 70.34 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.375 0.67 . . . . 0.0 112.276 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -57.95 -25.7 61.29 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.304 1.442 . . . . 0.0 111.645 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -128.34 16.51 6.59 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.074 1.35 . . . . 0.0 112.042 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 m120 35.88 70.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 128.478 2.711 . . . . 0.0 111.926 -167.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.0 mt -100.93 147.54 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.519 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -88.38 133.37 11.77 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -177.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -35.04 68.77 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.704 0.802 . . . . 0.0 112.987 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.4 ttt-85 -54.41 -54.68 37.44 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.299 0.64 . . . . 0.0 111.158 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.83 -47.93 87.81 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.13 -47.27 75.27 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.714 0.688 . . . . 0.0 111.229 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.4 -27.1 70.38 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-O 117.112 -1.938 . . . . 0.0 112.443 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -70.89 -45.41 64.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.061 2.431 . . . . 0.0 110.431 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -87.67 -67.84 0.8 Allowed 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 121.766 -0.584 . . . . 0.0 111.091 -170.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.45 -44.03 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -171.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.0 mt -99.06 -39.99 8.24 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.169 0.588 . . . . 0.0 111.983 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.91 50.36 53.23 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -172.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -129.12 167.84 16.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.648 1.979 . . . . 0.0 107.25 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 t -66.69 157.02 33.69 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.968 0.89 . . . . 0.0 109.629 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -59.89 -27.32 66.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.915 0.886 . . . . 0.0 111.445 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.04 -48.34 26.87 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -54.38 -63.7 1.07 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.601 1.16 . . . . 0.0 110.211 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -58.45 -39.01 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 119.294 0.952 . . . . 0.0 111.767 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -62.06 -38.43 88.73 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.24 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -59.41 -47.57 84.95 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.937 1.244 . . . . 0.0 108.993 169.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.437 HG21 HD13 ' A' ' 55' ' ' ILE . 16.6 mt -60.13 -41.56 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -176.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -70.13 -40.79 74.61 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 124.525 1.13 . . . . 0.0 111.537 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.77 -37.39 86.21 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.114 1.366 . . . . 0.0 110.747 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -139.16 70.38 40.97 Favored Pre-proline 0 C--O 1.235 0.295 0 C-N-CA 126.815 2.046 . . . . 0.0 107.658 -171.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.39 93.36 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.01 2.474 . . . . 0.0 107.609 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -67.11 160.36 71.19 Favored Pre-proline 0 N--CA 1.436 -1.157 0 O-C-N 121.736 -0.602 . . . . 0.0 109.557 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -58.44 144.65 96.41 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.367 2.044 . . . . 0.0 108.486 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.498 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 65.6 t-105 -52.77 -49.58 65.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.529 0.604 . . . . 0.0 110.734 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.6 -25.71 11.42 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 176.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.52 -18.74 47.57 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 120.005 1.275 . . . . 0.0 113.27 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.7 mt -86.95 162.57 17.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.451 0.643 . . . . 0.0 111.424 -169.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.6 p -94.04 -178.86 4.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.97 2.108 . . . . 0.0 109.892 168.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.4 m -58.57 -45.17 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 119.331 0.969 . . . . 0.0 111.724 169.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -60.31 -33.11 71.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 119.519 -0.276 . . . . 0.0 111.631 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.66 96.76 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.103 1.335 . . . . 0.0 112.516 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 91.1 mttt -79.61 -26.91 41.09 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.472 1.509 . . . . 0.0 112.934 -175.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -43.69 -57.8 5.33 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 125.892 1.677 . . . . 0.0 110.441 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.49 -43.49 13.58 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.727 1.618 . . . . 0.0 112.366 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -64.61 -36.45 84.27 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 120.273 -1.517 . . . . 0.0 112.24 -174.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.35 -55.28 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -51.52 -48.7 62.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.064 0.946 . . . . 0.0 110.204 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.5 ' SD ' HG21 ' A' ' 26' ' ' VAL . 62.7 mtm -61.86 -46.52 89.07 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 120.966 -1.084 . . . . 0.0 112.394 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.541 ' CD ' HD22 ' A' ' 17' ' ' LEU . 16.9 tttm -63.18 -39.65 95.26 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.07 -1.019 . . . . 0.0 110.936 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -67.2 -36.83 82.57 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.216 1.007 . . . . 0.0 110.107 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.496 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.2 t80 -61.21 -40.5 94.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.917 0.887 . . . . 0.0 110.517 174.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.4 mt -72.77 -8.82 57.28 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.346 1.058 . . . . 0.0 112.666 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.42 -13.1 59.42 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.871 1.269 . . . . 0.0 111.887 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -157.28 119.03 3.74 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.052 -1.03 . . . . 0.0 109.419 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -25.65 65.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.163 0.985 . . . . 0.0 113.645 -170.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -64.41 -18.64 64.9 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 119.705 -1.872 . . . . 0.0 111.909 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.496 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 55.2 m-80 -59.71 -48.52 81.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.826 0.739 . . . . 0.0 111.003 176.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.563 HG21 ' HB3' ' A' ' 29' ' ' GLN . 4.0 p -71.55 -33.82 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 121.811 -0.555 . . . . 0.0 109.87 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 mt -63.54 -42.4 98.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.87 73.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.057 0.39 . . . . 0.0 111.567 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.49 HD22 HD12 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -70.51 -24.64 62.87 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.947 0.899 . . . . 0.0 112.234 178.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.5 mtp-105 -61.97 -47.89 82.84 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 118.827 0.74 . . . . 0.0 110.298 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.0 m -51.78 -46.83 64.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.899 0.88 . . . . 0.0 109.318 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.49 HD12 HD22 ' A' ' 89' ' ' LEU . 53.6 mt -64.86 -35.24 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 122.908 0.483 . . . . 0.0 110.277 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.519 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 6.5 tp-100 . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 117.922 -1.037 . . . . 0.0 111.066 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.421 ' HB3' HD11 ' A' ' 22' ' ' ILE . 3.8 mt . . . . . 0 C--O 1.234 0.254 0 N-CA-C 110.77 -0.085 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -71.96 105.44 3.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.876 0.846 . . . . 0.0 109.399 177.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.452 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 19.2 p -68.72 -40.63 79.83 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.513 -0.742 . . . . 0.0 112.268 -177.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.83 66.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.928 0.785 . . . . 0.0 111.044 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 4.0 tt0 -81.03 -52.78 7.04 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.319 1.448 . . . . 0.0 109.068 176.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' A' ' 17' ' ' LEU . 66.7 mt -56.13 -44.39 78.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 119.099 0.863 . . . . 0.0 109.916 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.57 85.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.551 0.74 . . . . 0.0 110.867 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.437 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 48.3 t80 -61.91 -53.92 49.11 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.078 0.951 . . . . 0.0 110.835 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -56.91 -38.98 73.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.114 1.365 . . . . 0.0 110.543 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.18 -50.76 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 120.68 -1.263 . . . . 0.0 109.81 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 40.9 mtmt -54.52 -48.22 72.18 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 116.991 -1.481 . . . . 0.0 110.726 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -47.41 71.44 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 116.944 -1.503 . . . . 0.0 111.402 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -56.37 -45.07 80.67 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 121.044 1.747 . . . . 0.0 112.48 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.2 -49.25 72.74 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.72 -33.49 70.26 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.454 1.025 . . . . 0.0 111.948 174.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -59.1 -20.27 51.96 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 126.114 1.766 . . . . 0.0 111.992 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -128.69 15.62 6.45 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 169.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 44.96 60.48 2.94 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 128.042 2.537 . . . . 0.0 111.765 -168.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.6 mt -98.32 154.05 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 174.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.54 150.8 18.09 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.921 0.772 . . . . 0.0 111.725 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -73.99 -14.36 61.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.96 1.304 . . . . 0.0 114.359 -177.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -70.97 -57.72 4.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.502 1.501 . . . . 0.0 109.973 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -56.0 -48.07 79.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -57.95 -41.31 82.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.758 1.163 . . . . 0.0 111.179 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.3 -26.54 67.96 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-O 117.184 -1.898 . . . . 0.0 112.58 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -74.32 -40.76 62.01 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.35 2.075 . . . . 0.0 110.658 173.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -90.93 -64.11 1.18 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.541 1.137 . . . . 0.0 111.803 -169.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.29 -36.85 74.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.3 mt -109.21 -43.86 4.06 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.062 0.545 . . . . 0.0 110.865 -166.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.45 31.79 53.35 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.093 0.854 . . . . 0.0 112.146 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.9 mt -109.08 159.39 16.91 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.578 1.551 . . . . 0.0 108.824 -175.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t -63.0 160.56 14.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.461 0.648 . . . . 0.0 110.114 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -54.11 -42.48 69.47 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.426 1.09 . . . . 0.0 112.528 -165.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.02 -10.01 57.81 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 118.427 -1.207 . . . . 0.0 113.637 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 m -62.4 -57.96 9.39 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.343 1.571 . . . . 0.0 108.99 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.31 -35.47 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.193 0.906 . . . . 0.0 112.081 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.6 t -59.28 -40.34 85.78 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.007 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.4 -46.49 88.53 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 119.311 0.96 . . . . 0.0 109.779 169.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.487 HG23 ' CZ ' ' A' ' 73' ' ' PHE . 1.7 mt -58.18 -30.41 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.114 1.325 . . . . 0.0 110.022 -176.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -87.73 -26.11 23.1 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.985 0.914 . . . . 0.0 113.122 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.98 -41.72 22.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.684 1.594 . . . . 0.0 110.798 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 mmt-85 -135.27 73.62 63.58 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 129.635 3.174 . . . . 0.0 106.367 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -69.68 95.25 0.54 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 N-CA-C 105.825 -2.414 . . . . 0.0 105.825 168.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -67.05 155.9 89.14 Favored Pre-proline 0 N--CA 1.432 -1.373 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.481 ' HD2' ' HG3' ' A' ' 64' ' ' LYS . 6.1 Cg_exo -58.28 149.61 72.11 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.628 2.219 . . . . 0.0 109.889 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -51.21 -50.25 59.46 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.52 0.328 . . . . 0.0 110.261 172.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.417 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -64.24 2.1 0.63 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 176.152 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HG3' ' HD2' ' A' ' 61' ' ' PRO . 14.6 mmmt -98.76 -20.7 16.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.522 1.51 . . . . 0.0 112.014 167.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.6 mt -99.81 149.84 22.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.627 0.649 . . . . 0.0 109.629 -164.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.3 t -87.53 179.39 6.56 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.3 p -43.14 -58.54 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 124.693 1.197 . . . . 0.0 112.101 173.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.78 -17.0 63.79 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.85 -39.61 23.97 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 126.34 1.924 . . . . 0.0 112.953 167.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -83.5 -25.12 31.36 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.451 2.301 . . . . 0.0 111.961 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -45.78 -53.29 21.03 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 128.219 2.608 . . . . 0.0 111.61 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.17 -48.4 10.12 Favored 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 121.338 1.359 . . . . 0.0 109.851 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 55' ' ' ILE . 69.1 m-85 -63.35 -33.39 75.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.437 -174.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.8 mt -60.46 -54.51 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.969 1.259 . . . . 0.0 108.081 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -54.05 -51.42 64.1 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.803 0.841 . . . . 0.0 109.689 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.3 mtm -60.8 -47.04 88.14 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.833 0.853 . . . . 0.0 112.02 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -59.0 -38.79 80.01 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.953 -1.092 . . . . 0.0 110.492 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -71.05 -37.97 72.52 Favored 'General case' 0 C--O 1.227 -0.108 0 O-C-N 121.702 -0.624 . . . . 0.0 111.361 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.494 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 16.8 t80 -54.31 -42.96 70.71 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.664 1.186 . . . . 0.0 109.57 171.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.8 mt -74.89 -13.16 60.51 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.615 -0.678 . . . . 0.0 112.448 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 m -80.9 2.64 25.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.667 0.787 . . . . 0.0 112.294 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -157.3 132.3 8.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.984 1.266 . . . . 0.0 108.269 162.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.22 -26.59 60.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.793 0.837 . . . . 0.0 112.174 175.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.412 ' HA ' HD12 ' A' ' 87' ' ' LEU . 14.2 mm-40 -54.1 -28.6 40.37 Favored 'General case' 0 C--N 1.338 0.106 0 O-C-N 120.027 -1.671 . . . . 0.0 113.559 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.494 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 52.4 m-80 -64.9 -50.27 67.17 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 119.289 0.949 . . . . 0.0 110.135 177.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.64 -34.98 68.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 O-C-N 121.529 -0.732 . . . . 0.0 110.464 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 84' ' ' GLN . 83.8 mt -59.68 -48.63 80.9 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.49 85.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 122.943 0.497 . . . . 0.0 111.666 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.426 HD22 HD12 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -64.85 -24.4 67.53 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.583 1.153 . . . . 0.0 111.683 -178.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -58.47 -49.12 78.49 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 119.048 0.84 . . . . 0.0 110.242 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 m -55.94 -44.8 78.75 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.098 0.408 . . . . 0.0 110.161 177.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.426 HD12 HD22 ' A' ' 89' ' ' LEU . 18.3 mt -63.07 -31.19 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.234 -0.917 . . . . 0.0 111.131 -177.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 . . . . . 0 N--CA 1.45 -0.469 0 C-N-CA 123.376 0.67 . . . . 0.0 111.465 176.81 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.499 ' HB3' HD11 ' A' ' 22' ' ' ILE . 5.8 mt . . . . . 0 C--O 1.235 0.297 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -71.76 99.79 2.23 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 122.295 1.045 . . . . 0.0 108.572 176.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 24.2 p -59.57 -40.58 87.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.156 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.76 -31.05 72.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 119.102 -0.475 . . . . 0.0 111.908 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -74.96 -50.27 17.25 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.664 1.186 . . . . 0.0 108.907 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 17' ' ' LEU . 67.2 mt -56.11 -47.39 80.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.31 92.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.269 -0.894 . . . . 0.0 111.987 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -62.92 -66.66 0.51 Allowed 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.461 1.504 . . . . 0.0 109.183 172.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -49.83 -38.67 35.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.24 1.816 . . . . 0.0 112.985 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 t -63.75 -43.53 98.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 121.293 -0.88 . . . . 0.0 110.25 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -60.44 -43.63 96.62 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.683 0.674 . . . . 0.0 109.413 175.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -57.01 -49.13 76.73 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.076 0.551 . . . . 0.0 110.467 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -63.25 -38.05 89.64 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.915 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mt -62.46 -43.07 99.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 120.515 1.507 . . . . 0.0 109.915 172.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.05 -45.33 79.29 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.992 0.815 . . . . 0.0 111.337 168.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -52.94 -40.81 63.93 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.626 1.97 . . . . 0.0 113.96 -168.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -121.83 16.19 10.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.963 1.305 . . . . 0.0 111.282 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 43.41 72.22 0.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.244 2.618 . . . . 0.0 111.561 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.3 mt -112.49 155.8 13.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.62 144.41 17.28 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 124.207 0.908 . . . . 0.0 110.935 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -62.52 -37.52 86.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.902 1.681 . . . . 0.0 112.194 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.8 ttt-85 -57.43 -54.51 46.06 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 117.66 -1.162 . . . . 0.0 109.822 173.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.3 -36.13 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.63 1.559 . . . . 0.0 111.338 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -61.11 -55.86 27.55 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.492 -0.755 . . . . 0.0 111.25 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.41 -26.31 74.67 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-O 118.008 -1.44 . . . . 0.0 112.458 -174.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -78.75 -27.81 44.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 120.083 1.942 . . . . 0.0 110.784 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -106.73 -62.25 1.42 Allowed 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.925 0.89 . . . . 0.0 112.049 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.57 -45.77 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.48 HD21 ' HG2' ' A' ' 76' ' ' MET . 28.9 mt -94.99 -37.44 11.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.113 -174.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.18 2.66 90.58 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.682 0.658 . . . . 0.0 112.747 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.6 mt -89.77 168.18 12.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.048 1.424 . . . . 0.0 107.794 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.0 m -76.39 162.19 28.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.473 -0.767 . . . . 0.0 110.785 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -56.95 -46.9 81.8 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.667 0.787 . . . . 0.0 111.868 -172.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.49 73.12 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 119.57 -0.572 . . . . 0.0 112.022 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 m -65.41 -62.35 1.58 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.035 0.918 . . . . 0.0 109.454 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.69 -34.62 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 119.789 1.177 . . . . 0.0 112.041 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -57.0 -42.1 79.65 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.013 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.0 -44.91 87.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.48 0.582 . . . . 0.0 109.672 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 mt -62.28 -38.56 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -174.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.0 mt -83.98 -15.07 49.11 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.056 0.943 . . . . 0.0 112.771 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.7 -52.64 6.25 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.596 1.558 . . . . 0.0 108.525 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.9 81.45 58.0 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 127.972 2.509 . . . . 0.0 107.568 -173.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.43 101.83 0.91 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 N-CA-C 106.426 -2.182 . . . . 0.0 106.426 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -67.49 161.72 62.79 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -56.19 144.24 81.82 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.526 2.817 . . . . 0.0 109.505 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -52.11 -50.64 61.26 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.253 0.621 . . . . 0.0 109.808 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -17.91 12.57 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 175.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 1.9 mmpt? -82.84 -31.66 27.94 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.429 1.468 . . . . 0.0 111.103 174.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.6 mt -71.88 174.77 6.49 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.814 1.292 . . . . 0.0 111.591 -167.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 p -111.19 179.89 3.91 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.779 1.232 . . . . 0.0 108.135 167.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.7 m -52.67 -45.6 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.366 1.439 . . . . 0.0 113.02 169.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -66.4 -22.23 66.23 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.632 1.56 . . . . 0.0 111.888 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.42 -47.62 27.67 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 124.816 1.198 . . . . 0.0 111.548 171.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -71.95 -31.35 66.22 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.742 1.217 . . . . 0.0 111.398 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -42.8 -57.65 4.67 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 127.918 2.487 . . . . 0.0 111.109 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.5 -52.01 3.62 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.0 1.8 . . . . 0.0 110.594 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 19' ' ' THR . 57.3 m-85 -55.08 -38.08 67.62 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.938 1.244 . . . . 0.0 113.345 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.6 mt -58.74 -56.47 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 124.709 1.204 . . . . 0.0 107.993 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -56.91 -42.5 80.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.218 1.007 . . . . 0.0 109.679 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.48 ' HG2' HD21 ' A' ' 45' ' ' LEU . 66.4 mtm -65.14 -51.26 62.3 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 124.299 1.04 . . . . 0.0 112.336 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -62.29 -36.01 80.79 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.028 -1.045 . . . . 0.0 110.296 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -66.12 -42.07 89.69 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.807 -0.558 . . . . 0.0 109.85 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.48 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 14.5 t80 -57.39 -39.06 75.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.163 0.985 . . . . 0.0 110.068 175.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.5 mt -76.57 -12.27 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.7 m -83.17 -21.33 33.56 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.195 -0.941 . . . . 0.0 113.075 -174.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -132.72 130.09 39.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 170.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.15 -46.17 90.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.347 -171.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.671 ' HA ' HD23 ' A' ' 87' ' ' LEU . 9.5 mm-40 -53.95 -18.52 3.53 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.103 2.161 . . . . 0.0 113.321 -166.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.48 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 68.2 m-80 -53.81 -41.82 67.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.086 0.955 . . . . 0.0 111.658 170.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.712 HG12 HD22 ' A' ' 87' ' ' LEU . 4.8 p -73.35 -35.34 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 119.782 1.174 . . . . 0.0 110.97 178.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.712 HD22 HG12 ' A' ' 86' ' ' VAL . 2.5 mm? -64.85 -26.77 68.48 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.436 1.094 . . . . 0.0 109.782 -175.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.45 60.22 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.396 1.078 . . . . 0.0 112.698 167.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -31.44 71.64 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.039 0.936 . . . . 0.0 110.768 -178.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.6 mtm105 -53.98 -42.79 69.37 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.274 0.488 . . . . 0.0 110.015 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.5 m -66.05 -43.36 87.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.646 0.778 . . . . 0.0 110.053 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.8 mt -69.03 -32.35 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.533 -0.73 . . . . 0.0 109.769 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 118.728 -0.654 . . . . 0.0 110.931 174.533 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.48 ' HB3' HD11 ' A' ' 22' ' ' ILE . 7.8 mt . . . . . 0 C--O 1.236 0.389 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.74 107.49 6.87 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 122.155 0.978 . . . . 0.0 110.256 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.429 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 24.5 p -63.11 -44.23 96.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.722 0.809 . . . . 0.0 110.555 -173.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.63 -8.72 56.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.783 0.833 . . . . 0.0 111.732 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.42 -54.47 4.17 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.797 1.239 . . . . 0.0 108.904 167.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 17' ' ' LEU . 68.7 mt -52.32 -50.72 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.204 1.366 . . . . 0.0 109.286 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.56 -33.29 65.98 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.24 1.016 . . . . 0.0 112.95 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -75.56 -57.86 3.63 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.128 0.971 . . . . 0.0 108.496 174.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -52.35 -32.76 39.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.339 1.456 . . . . 0.0 112.034 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.524 HG23 HD11 ' A' ' 80' ' ' LEU . 53.8 t -67.66 -57.09 10.73 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 C-N-CA 124.393 1.077 . . . . 0.0 110.729 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -51.52 -41.43 61.01 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.495 1.043 . . . . 0.0 111.116 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -53.11 -59.36 4.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.008 1.323 . . . . 0.0 110.128 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -62.03 -38.81 90.1 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.474 1.109 . . . . 0.0 113.351 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.1 mt -61.12 -48.09 83.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.08 -37.66 85.87 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.156 0.889 . . . . 0.0 112.856 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -55.87 -33.56 64.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.435 1.894 . . . . 0.0 110.674 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -123.49 11.31 9.24 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.286 1.034 . . . . 0.0 113.073 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 49.03 68.44 0.71 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.64 1.976 . . . . 0.0 112.136 -172.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt -112.23 156.29 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 121.264 -0.897 . . . . 0.0 110.047 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.56 130.71 10.44 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.958 2.218 . . . . 0.0 110.721 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -51.75 -35.79 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.42 1.488 . . . . 0.0 112.096 174.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -58.3 -54.28 48.75 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.773 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.62 -44.63 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -55.69 -51.78 66.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.636 0.255 . . . . 0.0 110.794 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.65 78.27 Favored Glycine 0 N--CA 1.428 -1.86 0 CA-C-O 116.338 -2.368 . . . . 0.0 111.563 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -78.31 -30.79 48.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.812 2.806 . . . . 0.0 111.956 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -101.56 -51.63 3.41 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 123.054 0.542 . . . . 0.0 111.384 -170.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.73 -46.29 24.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -175.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.481 HD21 ' HG2' ' A' ' 76' ' ' MET . 34.0 mt -95.94 -34.53 11.77 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.924 -172.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.72 4.96 88.37 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.389 0.519 . . . . 0.0 112.913 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.5 mt -98.49 158.55 15.53 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.361 1.464 . . . . 0.0 107.41 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.6 m -71.64 164.43 25.92 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.433 -0.792 . . . . 0.0 110.239 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -58.56 -49.59 76.87 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.83 69.73 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.584 -0.564 . . . . 0.0 111.899 -178.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 m -70.88 -62.85 1.24 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.863 1.265 . . . . 0.0 111.357 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 m -60.07 -30.83 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 121.089 1.768 . . . . 0.0 112.273 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.7 t -58.06 -39.23 77.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.52 -1.229 . . . . 0.0 110.394 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.72 -43.28 85.13 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.023 1.283 . . . . 0.0 110.176 171.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.415 HG23 ' CE2' ' A' ' 73' ' ' PHE . 12.0 mt -64.79 -42.59 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -173.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.2 mt -77.1 -29.57 54.92 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.465 0.706 . . . . 0.0 111.848 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.25 -56.41 6.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.746 1.618 . . . . 0.0 111.078 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -135.52 59.39 30.83 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 124.245 1.018 . . . . 0.0 109.708 -165.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -63.35 104.49 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.883 3.056 . . . . 0.0 110.281 -173.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -63.63 157.94 62.86 Favored Pre-proline 0 N--CA 1.434 -1.252 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -65.81 153.87 76.33 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.645 2.896 . . . . 0.0 110.471 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.451 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 73.4 t-105 -55.44 -43.85 75.78 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.368 1.067 . . . . 0.0 111.288 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.529 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -60.77 -19.98 60.43 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 176.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.55 -23.31 27.71 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.558 1.072 . . . . 0.0 112.327 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 29.6 mt -89.38 152.42 21.51 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 119.071 0.851 . . . . 0.0 109.302 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.8 p -105.07 -172.05 2.03 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.933 1.293 . . . . 0.0 109.666 172.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.1 t -47.7 -58.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 120.785 1.63 . . . . 0.0 110.49 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -71.68 -3.08 19.78 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.78 -42.35 6.08 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.881 1.705 . . . . 0.0 112.097 165.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 85.3 mttt -80.88 -25.04 37.89 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.895 2.078 . . . . 0.0 111.844 -174.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.33 -56.31 12.98 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 125.482 1.513 . . . . 0.0 111.328 -175.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.33 -44.53 18.36 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 121.423 1.416 . . . . 0.0 110.311 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.429 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 70.4 m-85 -62.43 -37.46 85.92 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.993 1.269 . . . . 0.0 113.229 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.04 -49.38 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.634 1.106 . . . . 0.0 108.031 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -57.65 -53.29 59.9 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.664 0.786 . . . . 0.0 109.558 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.481 ' HG2' HD21 ' A' ' 45' ' ' LEU . 58.5 mtm -56.75 -50.55 71.91 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.4 0.68 . . . . 0.0 112.27 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tttp -61.72 -40.3 94.58 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.574 -0.704 . . . . 0.0 110.35 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -70.53 -32.06 69.37 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.327 0.967 . . . . 0.0 111.086 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.449 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 11.0 t80 -60.94 -43.23 98.97 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.524 HD11 HG23 ' A' ' 26' ' ' VAL . 19.8 mt -71.89 -9.88 58.97 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.194 0.997 . . . . 0.0 112.413 177.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.8 m -89.44 -2.35 58.36 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.297 1.439 . . . . 0.0 112.543 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -149.73 123.45 9.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 120.141 1.337 . . . . 0.0 109.35 163.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.98 -18.72 64.56 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.821 0.343 . . . . 0.0 111.283 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -68.35 -11.17 59.15 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 119.795 -1.816 . . . . 0.0 113.731 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.449 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 69.0 m-80 -71.82 -57.08 4.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 167.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.41 -34.05 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 O-C-N 121.12 -0.987 . . . . 0.0 110.958 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.2 mt -65.22 -25.88 67.88 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.774 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.46 60.0 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.964 0.906 . . . . 0.0 110.967 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.31 -33.09 74.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.885 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -51.15 -50.58 58.64 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 118.706 0.684 . . . . 0.0 110.227 175.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.1 m -51.42 -50.12 60.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.768 1.227 . . . . 0.0 110.537 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.5 mt -62.94 -37.34 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.638 0.775 . . . . 0.0 109.902 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 . . . . . 0 N--CA 1.452 -0.334 0 O-C-N 121.622 -0.674 . . . . 0.0 110.9 -176.94 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.658 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.2 m 65.5 111.12 0.03 OUTLIER 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.6 1.56 . . . . 0.0 111.867 -174.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 t -131.8 -88.25 0.46 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.91 -177.24 37.37 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.2 p -160.44 131.84 5.8 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.864 0.832 . . . . 0.0 108.907 172.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.0 t -146.89 108.55 4.33 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.27 83.06 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.27 161.18 14.28 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.104 0.452 . . . . 0.0 110.105 174.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.52 71.81 0.04 OUTLIER Glycine 0 CA--C 1.526 0.759 0 CA-C-O 119.147 -0.807 . . . . 0.0 111.589 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -59.4 160.49 19.77 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.52 2.147 . . . . 0.0 110.253 170.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.45 166.82 39.89 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.57 56.01 1.22 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.248 1.419 . . . . 0.0 108.591 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.09 154.59 17.53 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.219 0.608 . . . . 0.0 109.439 167.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -76.38 132.52 39.77 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 147.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.88 179.41 5.87 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.047 1.339 . . . . 0.0 108.689 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -79.38 138.39 37.65 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 121.312 -0.868 . . . . 0.0 109.071 172.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.524 ' HB3' HD11 ' A' ' 22' ' ' ILE . 5.2 mt -128.51 134.39 48.68 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -177.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -72.94 104.17 3.99 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 122.004 0.906 . . . . 0.0 108.688 177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 p -66.84 -38.21 85.97 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 123.457 0.703 . . . . 0.0 110.02 -173.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.07 -29.07 67.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.757 0.708 . . . . 0.0 110.899 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -76.09 -49.28 17.84 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 127.032 2.133 . . . . 0.0 108.836 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' A' ' 17' ' ' LEU . 82.1 mt -57.01 -47.0 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 119.078 0.854 . . . . 0.0 109.293 174.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.426 ' O ' ' HE3' ' A' ' 27' ' ' LYS . . . -56.46 -53.93 51.65 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 118.784 -0.627 . . . . 0.0 109.417 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -51.94 -67.79 0.22 Allowed 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 126.222 1.809 . . . . 0.0 109.245 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -51.72 -37.58 51.51 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.653 1.981 . . . . 0.0 112.945 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.0 t -62.94 -52.39 59.94 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 CA-C-N 119.183 0.901 . . . . 0.0 109.446 174.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 23' ' ' ALA . 22.0 mtmt -55.15 -42.55 73.23 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.418 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -57.66 -56.34 23.18 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.556 0.743 . . . . 0.0 110.775 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -62.19 -35.07 77.72 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.901 0.88 . . . . 0.0 112.589 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.38 -51.39 60.74 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -35.56 73.24 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 119.372 0.987 . . . . 0.0 112.399 178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 tttt -49.95 -33.32 17.25 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 126.636 1.974 . . . . 0.0 110.869 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 -128.18 16.29 6.69 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.936 1.294 . . . . 0.0 112.027 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.3 m120 60.16 36.03 21.08 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.878 2.471 . . . . 0.0 112.128 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.5 mt -83.33 157.7 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.467 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -101.36 144.84 16.65 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.923 1.249 . . . . 0.0 112.48 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -55.97 -35.24 66.5 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.943 2.097 . . . . 0.0 113.882 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -59.73 -58.98 6.21 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 120.47 1.486 . . . . 0.0 109.744 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 t -56.44 -44.43 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 119.256 0.934 . . . . 0.0 109.697 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -57.68 -49.7 75.63 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.538 0.608 . . . . 0.0 111.184 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.469 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -72.94 -24.99 74.93 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-O 118.093 -1.393 . . . . 0.0 111.887 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -77.95 -43.15 30.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 118.989 1.394 . . . . 0.0 109.632 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.422 ' CE1' HG21 ' A' ' 92' ' ' ILE . 36.3 m-85 -87.62 -68.19 0.77 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.654 0.381 . . . . 0.0 111.259 -177.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.7 t -62.79 -42.44 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 124.308 1.043 . . . . 0.0 108.268 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.445 HD21 ' HG2' ' A' ' 76' ' ' MET . 28.8 mt -96.08 -43.92 7.55 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.811 -172.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.23 20.16 57.62 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 123.798 0.686 . . . . 0.0 111.863 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.2 mt -107.81 173.05 6.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.748 1.219 . . . . 0.0 107.9 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.4 m -68.59 159.54 31.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.055 -1.028 . . . . 0.0 111.539 166.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -48.42 -55.14 11.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.496 1.518 . . . . 0.0 110.337 168.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.53 -34.14 87.35 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 m -62.46 -64.6 0.88 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 116.842 -1.551 . . . . 0.0 110.176 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.469 HG11 ' HA3' ' A' ' 41' ' ' GLY . 3.9 m -60.2 -36.25 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 120.943 1.701 . . . . 0.0 111.867 -176.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.2 t -53.71 -42.33 67.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.585 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.25 -46.73 89.16 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 119.079 0.854 . . . . 0.0 109.805 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.446 HD13 HG21 ' A' ' 55' ' ' ILE . 6.7 mt -61.86 -38.08 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.1 mt -72.53 -32.8 66.41 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.878 1.271 . . . . 0.0 111.346 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.6 -52.3 27.33 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.19 1.396 . . . . 0.0 110.018 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -133.81 71.83 73.88 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 125.792 1.637 . . . . 0.0 108.436 -162.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.11 78.27 3.24 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 124.411 3.407 . . . . 0.0 110.584 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -54.77 157.13 5.75 Favored Pre-proline 0 N--CA 1.442 -0.859 0 C-N-CA 124.481 1.112 . . . . 0.0 110.306 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -55.34 143.8 74.88 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.132 2.555 . . . . 0.0 110.253 -172.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -55.11 -48.76 73.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 118.395 0.543 . . . . 0.0 109.935 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -26.28 32.52 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 172.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -34.62 45.87 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 119.703 1.138 . . . . 0.0 111.986 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.2 mt -77.73 148.02 35.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.959 0.885 . . . . 0.0 110.331 -171.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -82.54 178.16 8.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.848 1.659 . . . . 0.0 108.823 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.81 -47.64 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 120.883 1.674 . . . . 0.0 109.177 170.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -66.17 -8.74 25.93 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.878 -1.139 . . . . 0.0 113.724 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.43 -39.09 6.06 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 126.186 1.851 . . . . 0.0 111.655 169.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -78.6 -22.15 47.49 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.531 1.532 . . . . 0.0 111.565 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -44.94 -58.1 6.04 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 127.176 2.191 . . . . 0.0 110.681 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.59 -49.55 7.04 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.613 2.209 . . . . 0.0 111.562 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -60.09 -35.69 75.75 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 117.685 -1.15 . . . . 0.0 112.816 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.92 -54.41 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 174.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -56.42 -42.59 78.29 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.485 1.114 . . . . 0.0 110.69 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.445 ' HG2' HD21 ' A' ' 45' ' ' LEU . 71.1 mtm -67.47 -49.38 63.83 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 123.787 0.835 . . . . 0.0 111.984 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.494 ' HD2' HD22 ' A' ' 17' ' ' LEU . 15.6 tttm -64.12 -36.11 82.95 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.781 -1.2 . . . . 0.0 110.286 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -63.47 -42.84 98.6 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.397 1.479 . . . . 0.0 110.882 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.53 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 35.5 t80 -54.08 -51.57 63.69 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.684 1.193 . . . . 0.0 108.508 172.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.7 mt -68.51 -13.68 62.48 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.5 m -72.45 -10.05 59.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.938 1.245 . . . . 0.0 112.178 172.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -154.46 115.96 4.13 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.715 1.143 . . . . 0.0 110.17 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -56.41 -26.81 54.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.504 1.522 . . . . 0.0 113.786 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -60.21 -25.05 65.31 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 120.321 1.419 . . . . 0.0 111.838 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.53 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 60.8 m-80 -59.53 -45.41 91.85 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 118.425 0.557 . . . . 0.0 110.972 176.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 p -71.39 -36.15 59.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 CA-C-N 118.543 0.611 . . . . 0.0 109.893 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.0 mt -63.13 -42.39 99.5 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.17 -32.56 73.73 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.33 -25.78 66.99 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.154 -0.966 . . . . 0.0 111.771 176.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -61.74 -41.25 97.41 Favored 'General case' 0 C--O 1.228 -0.065 0 CA-C-N 119.223 0.919 . . . . 0.0 110.116 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.5 m -55.65 -46.52 77.46 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.689 1.196 . . . . 0.0 110.008 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.422 HG21 ' CE1' ' A' ' 43' ' ' TYR . 44.4 mt -64.19 -33.91 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 O-C-N 121.911 -0.493 . . . . 0.0 110.133 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.467 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 8.5 tp-100 -65.88 -24.12 66.79 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.152 -0.967 . . . . 0.0 113.088 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.2 t -70.26 -59.58 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 166.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -77.11 30.41 0.14 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.266 2.226 . . . . 0.0 112.807 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.0 t -84.76 -0.03 52.3 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.274 -0.891 . . . . 0.0 110.855 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 161.1 -172.45 37.36 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 108.039 -2.025 . . . . 0.0 108.039 -163.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.92 75.09 4.96 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.516 2.811 . . . . 0.0 111.748 -174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.1 t -77.73 79.18 4.22 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 164.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 14.6 m 63.9 171.07 0.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.553 1.941 . . . . 0.0 112.033 -164.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 N-CA-C 104.819 -3.312 . . . . 0.0 104.819 150.298 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.914 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m 67.06 175.29 0.25 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.712 1.205 . . . . 0.0 110.33 -167.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 t -145.77 155.89 43.24 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 164.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.5 116.97 0.61 Allowed Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 107.498 -2.241 . . . . 0.0 107.498 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.9 t -107.41 -48.07 3.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.0 m 59.25 -175.33 0.1 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.306 1.442 . . . . 0.0 111.738 -165.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.47 -95.65 2.05 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 106.893 -2.483 . . . . 0.0 106.893 -172.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 55.83 8.19 0.33 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.611 1.964 . . . . 0.0 115.369 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.81 102.41 2.06 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 117.685 -1.62 . . . . 0.0 111.069 -170.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -72.49 -159.71 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.238 3.292 . . . . 0.0 110.093 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.32 104.11 0.18 Allowed Glycine 0 C--N 1.337 0.586 0 O-C-N 120.487 -1.383 . . . . 0.0 110.494 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.5 176.73 5.06 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.563 1.145 . . . . 0.0 110.64 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 48.81 -155.09 0.09 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.027 1.331 . . . . 0.0 110.746 -172.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -107.44 174.35 5.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.926 1.69 . . . . 0.0 107.236 163.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -146.59 -175.09 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.187 0.995 . . . . 0.0 110.121 174.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -72.28 125.49 27.47 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.566 ' HB3' HD11 ' A' ' 22' ' ' ILE . 5.0 mt -117.49 114.83 24.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.1 107.61 1.32 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.121 0.486 . . . . 0.0 110.464 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.9 p -68.91 -39.56 79.62 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 121.707 -0.62 . . . . 0.0 111.976 -169.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.01 73.1 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.992 0.815 . . . . 0.0 110.191 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -78.09 -51.36 10.41 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.225 1.41 . . . . 0.0 108.463 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.566 HD11 ' HB3' ' A' ' 17' ' ' LEU . 74.8 mt -55.94 -43.71 75.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 119.209 0.913 . . . . 0.0 109.095 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.28 -53.45 58.1 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 123.359 0.664 . . . . 0.0 110.397 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -55.85 -51.14 68.57 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.332 1.053 . . . . 0.0 111.263 178.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -64.59 -39.74 94.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.698 1.599 . . . . 0.0 110.708 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.6 t -60.85 -49.12 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 O-C-N 120.942 -1.098 . . . . 0.0 109.643 171.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -62.34 -46.18 89.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 117.929 -1.034 . . . . 0.0 111.075 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -64.21 -42.86 96.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.116 0.871 . . . . 0.0 111.223 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -58.1 -44.55 87.7 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.486 1.114 . . . . 0.0 111.481 174.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 mt -63.55 -49.73 72.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -49.13 -43.51 41.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.509 0.724 . . . . 0.0 111.684 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -60.37 -21.7 62.45 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.469 1.508 . . . . 0.0 113.634 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -128.33 13.25 6.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.892 1.277 . . . . 0.0 113.329 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.5 m120 50.74 71.22 0.44 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.955 2.102 . . . . 0.0 111.561 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.0 mt -118.92 155.41 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 120.658 -1.276 . . . . 0.0 108.392 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.27 145.98 16.74 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.463 1.03 . . . . 0.0 111.177 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -56.89 -34.96 68.4 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.095 1.358 . . . . 0.0 111.69 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -51.78 -61.89 1.97 Allowed 'General case' 0 C--N 1.337 0.063 0 C-N-CA 123.784 0.834 . . . . 0.0 111.606 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.26 -46.68 94.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 118.921 0.782 . . . . 0.0 109.588 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -54.85 -46.7 74.71 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.029 0.831 . . . . 0.0 111.762 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.551 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -72.11 -30.95 64.58 Favored Glycine 0 N--CA 1.432 -1.573 0 CA-C-O 118.25 -1.305 . . . . 0.0 111.752 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -69.81 -36.99 76.12 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.379 1.59 . . . . 0.0 110.54 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -96.22 -67.93 0.82 Allowed 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.999 0.92 . . . . 0.0 111.34 -173.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.7 t -62.68 -60.45 2.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -172.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.529 HD21 ' HG2' ' A' ' 76' ' ' MET . 24.0 mt -76.28 -36.62 58.3 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.929 -172.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.71 16.09 73.93 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.446 -1.196 . . . . 0.0 112.355 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.8 mt -110.64 166.41 11.03 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 126.239 1.815 . . . . 0.0 109.931 -171.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -60.21 152.61 24.26 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.536 0.684 . . . . 0.0 110.822 168.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -55.29 -38.9 69.22 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.088 1.355 . . . . 0.0 110.338 175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.89 -63.95 4.83 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 m -42.4 -69.33 0.14 Allowed 'General case' 0 C--N 1.342 0.268 0 CA-C-O 117.065 -1.445 . . . . 0.0 110.8 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.551 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.2 m -57.75 -42.09 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 120.832 1.651 . . . . 0.0 112.951 -171.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.0 t -60.13 -38.6 83.57 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.286 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -60.08 -47.76 84.55 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.275 1.03 . . . . 0.0 109.868 168.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.2 mt -56.57 -42.39 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.59 -27.52 41.12 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.614 1.166 . . . . 0.0 112.302 -176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.7 -44.5 56.37 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.495 1.518 . . . . 0.0 110.546 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -133.3 73.85 73.29 Favored Pre-proline 0 C--O 1.236 0.359 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 -172.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.46 87.76 1.06 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.174 1.916 . . . . 0.0 107.197 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -57.53 157.04 14.6 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.06 155.86 67.97 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 121.429 1.419 . . . . 0.0 109.23 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -55.33 -42.61 74.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.7 0.4 . . . . 0.0 111.195 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.65 -9.86 40.27 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 175.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -93.58 7.11 45.94 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.314 -1.491 . . . . 0.0 112.922 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.6 mt -124.39 153.8 41.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.463 1.105 . . . . 0.0 108.479 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.1 p -100.56 -175.36 2.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.714 0.806 . . . . 0.0 109.001 172.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.2 t -45.38 -45.35 3.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 CA-C-N 119.154 0.888 . . . . 0.0 110.897 169.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -70.48 -38.29 74.36 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.898 1.226 . . . . 0.0 112.873 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.64 -35.01 84.4 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.82 0.724 . . . . 0.0 112.079 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -90.67 -19.69 23.33 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 125.568 1.547 . . . . 0.0 111.723 -174.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -43.28 -55.7 7.7 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 127.572 2.349 . . . . 0.0 109.384 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.61 -50.38 2.53 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.291 1.994 . . . . 0.0 111.354 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -58.0 -35.96 71.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 120.222 1.374 . . . . 0.0 113.702 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.6 mt -57.59 -60.3 2.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.591 1.556 . . . . 0.0 107.474 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -52.27 -52.04 55.02 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.421 1.089 . . . . 0.0 110.212 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.529 ' HG2' HD21 ' A' ' 45' ' ' LEU . 63.8 mtm -55.39 -51.59 66.34 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.694 0.797 . . . . 0.0 111.464 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -59.75 -38.75 82.62 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.196 -0.94 . . . . 0.0 111.226 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -65.98 -45.09 82.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.423 1.01 . . . . 0.0 110.427 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.455 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 19.6 t80 -49.31 -46.91 47.23 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.963 1.705 . . . . 0.0 110.301 172.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.1 mt -71.84 -13.82 61.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.32 1.11 34.06 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.809 1.644 . . . . 0.0 112.45 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -160.03 118.55 2.7 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.891 1.223 . . . . 0.0 108.635 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -63.1 -19.45 64.44 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.69 1.196 . . . . 0.0 111.781 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -57.23 -30.05 64.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 120.157 -1.589 . . . . 0.0 112.054 172.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 75.1 m-80 -65.42 -38.21 89.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 119.018 -0.515 . . . . 0.0 110.174 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -76.83 -34.77 23.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 119.258 0.936 . . . . 0.0 110.317 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.9 mt -63.14 -40.77 98.56 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 123.261 0.624 . . . . 0.0 109.858 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.47 92.89 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 122.98 0.512 . . . . 0.0 111.252 173.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.482 HD22 HD12 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -65.46 -26.31 67.89 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.08 0.952 . . . . 0.0 112.2 -177.121 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 -61.68 -45.19 95.07 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 118.489 0.586 . . . . 0.0 109.561 176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.9 m -49.77 -50.05 46.03 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.215 1.006 . . . . 0.0 109.442 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.482 HD12 HD22 ' A' ' 89' ' ' LEU . 46.0 mt -65.57 -37.44 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.771 -173.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -60.68 -46.04 91.85 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.48 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.4 m -61.64 -39.39 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 120.119 1.327 . . . . 0.0 109.745 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -76.95 -0.3 23.81 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.05 -1.031 . . . . 0.0 113.016 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.9 t -64.67 -37.44 87.57 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 120.265 1.393 . . . . 0.0 111.363 -173.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.6 -178.16 47.93 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.152 0.887 . . . . 0.0 112.498 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.27 -176.01 2.49 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.309 3.339 . . . . 0.0 111.406 173.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.3 t 62.11 -167.42 0.2 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.396 1.478 . . . . 0.0 110.043 -162.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.4 t -138.03 -168.38 2.34 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 125.883 1.673 . . . . 0.0 108.762 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 N-CA-C 106.896 -2.481 . . . . 0.0 106.896 -177.368 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.552 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.63 166.07 33.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.271 1.428 . . . . 0.0 107.378 173.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.3 p -109.32 156.22 20.24 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 164.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.52 131.55 1.88 Allowed Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 106.113 -2.795 . . . . 0.0 106.113 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.4 m -154.7 93.72 1.6 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.175 0.987 . . . . 0.0 108.386 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.78 169.25 13.39 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 122.034 -0.416 . . . . 0.0 110.598 171.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.21 -160.96 25.87 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 163.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.44 164.36 21.03 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.332 -0.511 . . . . 0.0 109.993 150.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.52 71.08 0.36 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 172.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.24 107.36 2.42 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.583 2.855 . . . . 0.0 111.571 -168.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.11 -153.52 20.24 Favored Glycine 0 C--O 1.243 0.682 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 165.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.34 159.43 41.02 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.412 1.485 . . . . 0.0 108.728 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 50.7 -151.57 0.21 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.146 1.779 . . . . 0.0 111.771 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.56 119.47 22.57 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.453 ' HG3' HD23 ' A' ' 17' ' ' LEU . 11.7 pt-20 -127.4 -147.61 0.36 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.405 1.082 . . . . 0.0 108.535 -173.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -112.48 118.65 35.74 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.894 1.678 . . . . 0.0 106.619 171.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.53 HD22 ' HD2' ' A' ' 77' ' ' LYS . 3.3 mt -109.09 142.53 39.7 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.41 101.46 4.8 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 122.291 1.043 . . . . 0.0 109.256 171.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.0 p -62.95 -38.96 93.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.586 -0.696 . . . . 0.0 111.477 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.92 -29.77 70.72 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 119.107 0.867 . . . . 0.0 111.9 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -75.39 -53.05 9.35 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.357 1.463 . . . . 0.0 108.124 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 17' ' ' LEU . 72.0 mt -55.34 -44.02 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.35 0.66 . . . . 0.0 109.306 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.26 -47.88 83.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.406 0.682 . . . . 0.0 111.008 176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.422 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 27.5 t80 -60.68 -50.22 74.38 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.329 1.052 . . . . 0.0 110.345 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -59.69 -45.4 92.2 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.746 1.618 . . . . 0.0 110.327 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 t -59.95 -50.83 78.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 O-C-N 120.424 -1.422 . . . . 0.0 109.077 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 50.0 mtmt -54.99 -41.88 71.76 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 117.622 -1.18 . . . . 0.0 111.455 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.41 -36.71 68.71 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 117.471 -1.252 . . . . 0.0 113.336 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.423 ' HB3' HG21 ' A' ' 86' ' ' VAL . 4.6 mm-40 -62.3 -41.23 98.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.415 1.916 . . . . 0.0 111.608 174.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.27 -44.71 95.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.21 -0.932 . . . . 0.0 108.54 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -58.07 -48.04 81.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 171.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -55.56 -30.3 60.54 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 127.051 2.141 . . . . 0.0 111.791 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -128.27 11.91 6.47 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.62 64.27 1.91 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.779 2.032 . . . . 0.0 112.111 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -107.63 150.84 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.521 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -82.8 135.3 13.83 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.79 1.186 . . . . 0.0 110.876 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -54.07 -37.37 64.13 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.609 0.764 . . . . 0.0 110.552 169.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -54.05 -64.48 0.81 Allowed 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.409 -1.281 . . . . 0.0 111.198 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 t -52.74 -48.12 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 120.141 1.337 . . . . 0.0 110.07 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -55.3 -46.4 76.22 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.431 0.56 . . . . 0.0 111.88 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.536 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -73.39 -34.64 57.29 Favored Glycine 0 N--CA 1.435 -1.423 0 CA-C-O 118.081 -1.4 . . . . 0.0 111.597 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.92 -32.23 73.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 119.331 1.565 . . . . 0.0 109.505 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.414 ' CE1' HG21 ' A' ' 92' ' ' ILE . 40.7 m-85 -103.15 -72.57 0.69 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.563 1.145 . . . . 0.0 111.907 -175.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.75 -43.85 97.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.169 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -168.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.527 HD21 ' HG2' ' A' ' 76' ' ' MET . 28.7 mt -96.48 -33.4 11.87 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -171.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.03 30.32 38.64 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 123.439 0.462 . . . . 0.0 112.017 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.7 mt -125.07 157.8 35.37 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.765 1.283 . . . . 0.0 110.464 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.8 t -60.39 160.48 8.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.683 1.193 . . . . 0.0 110.367 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.82 -55.82 26.07 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.342 1.057 . . . . 0.0 110.886 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -67.18 -30.42 75.61 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-O 119.095 -0.836 . . . . 0.0 111.711 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.9 m -58.84 -57.81 11.4 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 116.832 -1.556 . . . . 0.0 109.856 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.536 HG11 ' HA3' ' A' ' 41' ' ' GLY . 3.0 m -66.78 -36.69 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 121.857 2.117 . . . . 0.0 113.617 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.1 t -62.43 -31.22 71.9 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.694 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -59.81 -49.72 76.61 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.857 1.208 . . . . 0.0 110.964 164.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 mt -55.44 -43.94 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 119.062 0.846 . . . . 0.0 108.986 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -79.3 -13.72 59.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.501 1.121 . . . . 0.0 112.861 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.86 -58.07 2.68 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.717 1.607 . . . . 0.0 109.905 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 26.3 mtp85 -124.64 78.29 63.47 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 125.089 1.355 . . . . 0.0 107.876 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.33 93.76 0.75 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.07 2.513 . . . . 0.0 107.523 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -63.26 165.85 9.98 Favored Pre-proline 0 N--CA 1.436 -1.146 0 C-N-CA 123.79 0.836 . . . . 0.0 110.266 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -56.13 142.45 86.37 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.611 2.207 . . . . 0.0 110.331 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -53.3 -47.31 69.32 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.964 0.802 . . . . 0.0 109.804 173.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -20.31 33.87 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 174.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -85.15 -24.37 28.0 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.874 1.215 . . . . 0.0 111.77 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.6 mt -86.38 167.34 14.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.42 0.688 . . . . 0.0 109.155 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.5 p -129.12 -172.25 2.69 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 117.081 -1.437 . . . . 0.0 108.62 172.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.5 t -43.58 -56.43 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 120.756 1.616 . . . . 0.0 111.63 -175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -74.51 -15.87 60.86 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.234 -1.541 . . . . 0.0 113.665 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.68 -42.42 47.01 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.374 1.464 . . . . 0.0 111.45 167.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -85.81 -26.13 25.91 Favored 'General case' 0 C--O 1.22 -0.48 0 C-N-CA 127.045 2.138 . . . . 0.0 111.669 -173.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -42.15 -57.28 4.48 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 127.817 2.447 . . . . 0.0 111.475 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.07 -49.71 4.6 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.531 1.487 . . . . 0.0 109.69 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -57.23 -39.38 75.42 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-O 117.654 -1.165 . . . . 0.0 112.976 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 73.3 mt -57.69 -55.52 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 124.559 1.144 . . . . 0.0 108.367 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -59.51 -45.06 92.79 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.032 0.533 . . . . 0.0 109.592 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.527 ' HG2' HD21 ' A' ' 45' ' ' LEU . 67.0 mtm -57.8 -50.08 74.47 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 123.505 0.722 . . . . 0.0 111.07 175.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.53 ' HD2' HD22 ' A' ' 17' ' ' LEU . 19.1 tttm -59.8 -44.1 94.12 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.794 -0.566 . . . . 0.0 110.278 -175.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -73.82 -28.04 61.42 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.298 -0.876 . . . . 0.0 112.133 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.443 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 34.3 t80 -60.87 -53.15 60.82 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.926 1.291 . . . . 0.0 107.943 169.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.0 mt -64.82 -22.4 66.98 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.319 1.047 . . . . 0.0 113.307 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.9 m -62.8 -21.58 65.99 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.914 1.234 . . . . 0.0 111.0 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -143.99 115.8 8.25 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.112 1.323 . . . . 0.0 109.947 -173.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.7 -18.56 64.13 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.569 1.148 . . . . 0.0 111.861 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -64.68 -21.14 66.67 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.482 -2.011 . . . . 0.0 112.181 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.443 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 69.9 m-80 -67.36 -53.36 30.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.854 1.206 . . . . 0.0 110.053 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 29' ' ' GLN . 12.5 p -60.87 -35.09 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.033 -1.042 . . . . 0.0 111.133 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.58 -34.66 78.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.661 0.664 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.45 81.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.09 0.471 . . . . 0.0 111.533 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.95 -26.02 68.4 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.399 -0.813 . . . . 0.0 110.873 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 mtp-105 -60.18 -50.89 71.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 118.529 0.604 . . . . 0.0 110.581 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 99.0 m -50.06 -45.69 52.61 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.032 0.833 . . . . 0.0 110.163 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.414 HG21 ' CE1' ' A' ' 43' ' ' TYR . 66.1 mt -64.51 -32.97 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 121.871 -0.518 . . . . 0.0 111.117 -178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.521 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 6.9 tp-100 -65.4 -40.67 93.69 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.186 -0.946 . . . . 0.0 111.373 177.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.471 HG12 ' HB3' ' A' ' 100' ' ' SER . 0.8 OUTLIER -65.13 -36.65 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -83.27 33.04 0.45 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.18 1.792 . . . . 0.0 111.186 171.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.6 t -122.54 -17.45 6.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.167 1.387 . . . . 0.0 109.744 170.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 157.46 -179.04 33.51 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.6 1.572 . . . . 0.0 110.14 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.69 99.79 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.127 2.551 . . . . 0.0 109.2 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 58.5 m -165.0 168.63 17.25 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 129.181 2.992 . . . . 0.0 106.724 166.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.471 ' HB3' HG12 ' A' ' 94' ' ' VAL . 7.1 t 57.38 80.33 0.17 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.778 1.231 . . . . 0.0 111.665 175.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 174.332 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.572 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 m 58.75 -179.15 0.08 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 117.698 0.749 . . . . 0.0 110.514 -164.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.1 m 53.69 2.78 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 119.004 2.964 . . . . 0.0 119.004 162.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.63 142.39 3.77 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 121.927 2.149 . . . . 0.0 111.736 172.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.7 m -144.52 101.54 3.69 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.843 1.657 . . . . 0.0 107.178 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.7 m -147.78 114.67 6.11 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 124.083 0.953 . . . . 0.0 108.792 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.75 100.86 0.53 Allowed Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.84 155.98 39.24 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 117.565 0.682 . . . . 0.0 109.512 164.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.22 118.34 4.94 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 168.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -81.93 154.76 17.42 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 CA-C-N 120.702 2.251 . . . . 0.0 110.495 172.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.2 -148.78 17.04 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -170.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.2 -105.41 0.27 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.989 1.715 . . . . 0.0 111.697 -175.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -125.28 -166.97 1.61 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.652 1.181 . . . . 0.0 109.883 -172.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -79.0 76.64 5.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.806 1.642 . . . . 0.0 110.034 -167.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -62.1 161.61 10.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 127.483 2.313 . . . . 0.0 110.814 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.426 ' HA ' ' CD1' ' A' ' 62' ' ' TRP . 10.0 mp0 -97.27 87.47 4.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 169.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt -56.72 134.57 54.94 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -69.75 98.38 1.2 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.052 0.453 . . . . 0.0 110.03 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 p -63.38 -41.15 98.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 121.529 -0.732 . . . . 0.0 111.818 -175.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.02 77.74 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.847 0.749 . . . . 0.0 111.334 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -75.12 -47.89 26.42 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 126.218 1.807 . . . . 0.0 108.653 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.3 mt -55.08 -50.86 59.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.51 -52.17 62.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.64 0.776 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -52.52 -69.79 0.1 Allowed 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 126.533 1.933 . . . . 0.0 108.666 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -49.8 -40.41 41.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.645 1.978 . . . . 0.0 112.897 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 40' ' ' PHE . 67.2 t -64.75 -51.43 67.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 CA-C-N 118.976 0.807 . . . . 0.0 109.645 174.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -49.85 -38.34 34.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.356 0.98 . . . . 0.0 109.785 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.93 -53.63 43.36 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 119.466 1.03 . . . . 0.0 111.68 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.64 -43.88 80.72 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.366 0.53 . . . . 0.0 111.142 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.9 mt -63.36 -43.46 97.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.29 -27.81 69.29 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.446 1.021 . . . . 0.0 112.69 174.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -59.73 -32.81 70.9 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.822 1.249 . . . . 0.0 111.419 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -128.42 16.72 6.53 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.387 1.475 . . . . 0.0 112.196 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 39.75 75.59 0.08 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 128.783 2.833 . . . . 0.0 112.417 -169.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.4 mt -110.05 147.54 14.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 121.386 -0.821 . . . . 0.0 109.826 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.05 127.75 8.4 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -58.45 -29.6 66.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.748 0.819 . . . . 0.0 111.242 171.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -55.6 -53.98 49.73 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 117.789 -1.101 . . . . 0.0 111.508 167.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -60.18 -51.27 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 119.526 1.057 . . . . 0.0 109.114 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.43 ' CE2' HG11 ' A' ' 26' ' ' VAL . 89.3 t80 -54.38 -46.48 73.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 118.325 0.511 . . . . 0.0 111.347 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.464 ' CA ' HG11 ' A' ' 52' ' ' VAL . . . -71.08 -34.97 64.52 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-O 117.417 -1.768 . . . . 0.0 111.967 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -64.49 -29.67 70.71 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 120.398 2.099 . . . . 0.0 110.887 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.414 ' CE1' HG21 ' A' ' 92' ' ' ILE . 38.8 m-85 -106.63 -78.73 0.58 Allowed 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.458 1.103 . . . . 0.0 111.654 -172.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 74.1 t -56.5 -38.75 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 C-N-CA 125.531 1.532 . . . . 0.0 109.363 -170.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.429 HD21 ' CG ' ' A' ' 76' ' ' MET . 37.6 mt -102.19 -33.24 9.72 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.582 -0.723 . . . . 0.0 110.853 -173.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.74 30.59 61.54 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.52 168.66 10.47 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.078 1.351 . . . . 0.0 109.175 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.0 163.6 27.59 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.456 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -59.56 -46.76 87.97 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.414 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.42 -30.96 77.49 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.001 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.6 m -61.03 -67.06 0.44 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.832 0.816 . . . . 0.0 109.328 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.464 HG11 ' CA ' ' A' ' 41' ' ' GLY . 3.0 m -58.66 -35.77 56.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 CA-C-N 119.893 1.224 . . . . 0.0 112.438 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.3 t -54.95 -43.36 73.36 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.369 1.068 . . . . 0.0 111.708 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -57.36 -49.37 76.37 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 120.084 1.311 . . . . 0.0 110.106 168.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.3 mt -58.95 -39.64 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.6 mt -76.76 -29.56 56.17 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.901 1.281 . . . . 0.0 112.413 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.33 -57.58 4.69 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.652 1.581 . . . . 0.0 109.997 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -123.57 84.6 53.07 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 125.604 1.562 . . . . 0.0 107.399 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 84.04 1.4 Allowed 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 122.245 1.963 . . . . 0.0 107.525 171.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.412 ' HB2' HD21 ' A' ' 65' ' ' LEU . 14.3 mtpt -59.41 153.27 50.08 Favored Pre-proline 0 N--CA 1.436 -1.161 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 60' ' ' LYS . 36.0 Cg_endo -67.01 147.54 80.16 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.296 1.997 . . . . 0.0 107.363 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.426 ' CD1' ' HA ' ' A' ' 16' ' ' GLN . 67.2 t-105 -51.93 -38.94 58.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.127 0.571 . . . . 0.0 111.143 -175.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -28.11 69.05 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -26.79 62.37 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.789 -1.195 . . . . 0.0 111.633 173.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 60' ' ' LYS . 70.6 mt -83.79 167.16 17.36 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.456 0.646 . . . . 0.0 110.526 -168.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.2 p -117.78 -171.61 2.09 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.689 2.395 . . . . 0.0 109.533 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.7 p -47.16 -63.41 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 119.648 1.113 . . . . 0.0 111.543 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -72.94 -10.35 59.71 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.43 -52.12 32.89 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.157 -0.964 . . . . 0.0 110.707 162.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -87.54 -23.83 24.24 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 126.016 1.727 . . . . 0.0 112.298 -166.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -44.55 -55.6 9.95 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 126.334 1.854 . . . . 0.0 111.669 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.46 -45.86 13.52 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.498 1.466 . . . . 0.0 110.835 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -61.19 -38.23 85.8 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.88 1.218 . . . . 0.0 113.044 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.6 mt -55.61 -54.44 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -58.77 -50.66 73.1 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.931 1.292 . . . . 0.0 110.516 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.429 ' CG ' HD21 ' A' ' 45' ' ' LEU . 58.0 mtm -55.52 -47.89 75.53 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.135 0.974 . . . . 0.0 111.974 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 tttp -61.64 -46.03 91.51 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.94 -0.475 . . . . 0.0 110.263 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -61.26 -42.53 98.8 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.666 0.787 . . . . 0.0 111.198 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.466 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 44.6 t80 -53.17 -38.39 62.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.033 1.733 . . . . 0.0 110.719 175.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.2 mt -73.71 -23.75 59.83 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.378 -0.826 . . . . 0.0 113.082 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -77.97 0.25 25.05 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 120.134 1.334 . . . . 0.0 113.069 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -145.52 115.22 7.28 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 125.391 1.476 . . . . 0.0 107.173 170.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -69.49 -15.64 63.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.556 0.342 . . . . 0.0 111.816 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -67.06 -16.48 64.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 120.294 -1.504 . . . . 0.0 112.353 174.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.466 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 75.2 m-20 -66.51 -47.38 73.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 119.61 1.096 . . . . 0.0 109.591 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.8 -30.86 51.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 120.665 -1.272 . . . . 0.0 111.299 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.35 -24.04 64.76 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.753 -0.592 . . . . 0.0 110.808 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.6 -39.47 31.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.21 -0.931 . . . . 0.0 111.381 168.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.81 -29.76 68.18 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 120.013 -1.68 . . . . 0.0 110.5 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.3 ptt85 -66.6 -36.75 83.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.394 0.997 . . . . 0.0 111.672 169.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.3 m -56.01 -36.65 68.17 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.743 0.817 . . . . 0.0 110.167 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.414 HG21 ' CE1' ' A' ' 43' ' ' TYR . 69.0 mt -80.24 -29.29 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.701 1.6 . . . . 0.0 111.494 177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -58.1 -45.16 87.68 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 120.578 -1.326 . . . . 0.0 109.646 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -27.63 41.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.879 -0.513 . . . . 0.0 110.557 177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -80.7 -2.61 47.48 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.678 1.991 . . . . 0.0 112.167 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 17.6 t -69.06 -47.32 65.64 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.539 1.518 . . . . 0.0 109.176 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -154.66 -177.2 27.76 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -77.43 46.99 2.14 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 124.647 3.565 . . . . 0.0 111.626 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.5 t -62.15 143.08 57.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 t -125.46 108.7 11.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -168.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 C-N-CA 123.977 0.798 . . . . 0.0 111.114 -171.404 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.972 0 N-CA-C 105.6 -3.0 . . . . 0.0 105.6 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p 174.69 108.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 -140.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -157.66 178.29 10.43 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.42 1.488 . . . . 0.0 107.658 -172.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.85 63.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.3 p -147.73 62.64 1.13 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.797 1.639 . . . . 0.0 107.46 -176.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t -112.56 96.26 5.89 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.552 1.141 . . . . 0.0 110.193 -161.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.28 -172.75 36.28 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 125.846 1.689 . . . . 0.0 109.699 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 66.82 168.14 0.23 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.661 2.384 . . . . 0.0 112.502 -174.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.83 74.86 0.28 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 108.016 -2.034 . . . . 0.0 108.016 -172.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.07 105.38 1.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.323 2.682 . . . . 0.0 110.238 -165.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.88 93.34 0.16 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 107.154 -2.379 . . . . 0.0 107.154 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.49 92.5 1.06 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 126.798 2.039 . . . . 0.0 107.149 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -139.71 179.6 6.48 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.521 1.528 . . . . 0.0 109.303 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -75.8 127.0 32.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 163.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -119.5 164.03 16.39 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.58 1.552 . . . . 0.0 108.275 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -78.2 113.0 15.75 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 119.732 1.151 . . . . 0.0 109.714 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.738 HD22 ' HD2' ' A' ' 77' ' ' LYS . 9.2 mt -86.72 162.86 17.65 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.406 1.482 . . . . 0.0 108.766 173.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.58 104.56 17.03 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.452 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 21.2 p -59.77 -40.97 89.99 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.344 -0.847 . . . . 0.0 111.51 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.47 -33.21 75.07 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.234 -0.888 . . . . 0.0 111.182 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.27 -52.24 20.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.91 1.284 . . . . 0.0 108.337 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 85.2 mt -52.9 -49.48 48.11 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.84 -52.83 63.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.259 0.624 . . . . 0.0 110.355 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -55.81 -57.75 10.74 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.939 1.296 . . . . 0.0 110.486 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -49.75 -51.54 38.28 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 127.391 2.276 . . . . 0.0 111.688 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.472 HG11 ' CE2' ' A' ' 40' ' ' PHE . 72.3 t -63.58 -44.04 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.906 -1.121 . . . . 0.0 109.015 178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -57.47 -37.56 73.1 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-O 117.202 -1.38 . . . . 0.0 110.589 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.58 -54.67 36.23 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.948 1.299 . . . . 0.0 110.551 174.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -61.45 -43.1 99.46 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.978 1.311 . . . . 0.0 111.513 -173.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.58 -46.6 78.8 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.62 -43.92 65.71 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.569 0.748 . . . . 0.0 111.123 173.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -50.47 -44.44 55.74 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 126.364 1.865 . . . . 0.0 111.684 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -112.76 9.42 19.11 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.993 0.917 . . . . 0.0 112.297 -173.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 46.62 71.76 0.28 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.428 2.291 . . . . 0.0 112.183 -166.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 79.2 mt -111.22 151.02 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 172.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.57 142.13 15.42 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -57.74 -31.59 66.62 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.674 1.59 . . . . 0.0 113.345 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ttp-105 -56.41 -59.38 5.05 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 120.029 1.286 . . . . 0.0 109.691 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -58.98 -47.27 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -176.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.472 ' CE2' HG11 ' A' ' 26' ' ' VAL . 93.2 t80 -55.46 -47.15 76.53 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.831 0.741 . . . . 0.0 111.725 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.441 ' CA ' HG11 ' A' ' 52' ' ' VAL . . . -71.5 -33.72 63.84 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-O 117.797 -1.557 . . . . 0.0 111.806 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -69.88 -33.08 71.74 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.635 1.718 . . . . 0.0 110.524 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -96.73 -76.98 0.5 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.048 0.939 . . . . 0.0 111.217 -174.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.55 -40.48 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.176 0 C-N-CA 124.729 1.212 . . . . 0.0 109.151 -170.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.426 HD21 ' HG2' ' A' ' 76' ' ' MET . 25.3 mt -93.9 -46.79 7.03 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 123.758 0.661 . . . . 0.0 109.803 -173.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.01 19.08 48.39 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.636 0.636 . . . . 0.0 112.691 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.0 mt -114.42 164.96 13.24 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.501 1.52 . . . . 0.0 108.988 -172.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 m -62.08 156.58 21.09 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.167 0.508 . . . . 0.0 110.841 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -56.92 -34.82 68.35 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.075 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -64.04 -62.05 5.55 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.8 m -43.91 -66.77 0.34 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.942 1.697 . . . . 0.0 112.522 -173.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.441 HG11 ' CA ' ' A' ' 41' ' ' GLY . 3.2 m -57.09 -38.83 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-N 120.283 1.401 . . . . 0.0 111.674 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.9 m -61.6 -41.28 97.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.858 -1.068 . . . . 0.0 110.818 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.82 -45.84 78.25 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.629 1.104 . . . . 0.0 110.007 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.489 HD13 HG21 ' A' ' 55' ' ' ILE . 32.8 mt -57.52 -46.46 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 -177.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.27 -31.8 64.29 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.97 1.708 . . . . 0.0 112.656 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.9 -47.4 71.89 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.934 1.694 . . . . 0.0 110.096 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mtp-105 -137.94 82.98 24.37 Favored Pre-proline 0 C--O 1.239 0.506 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -63.75 102.63 0.36 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.103 2.535 . . . . 0.0 108.34 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -63.06 157.39 62.24 Favored Pre-proline 0 N--CA 1.429 -1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.523 167.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.82 151.96 36.5 Favored 'Trans proline' 0 N--CA 1.441 -1.572 0 C-N-CA 122.64 2.227 . . . . 0.0 107.428 -172.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.522 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 62.0 t-105 -51.78 -41.93 62.02 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 123.692 0.797 . . . . 0.0 111.532 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.428 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -65.25 -23.09 66.96 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 5.0 mmpt? -74.06 -25.76 60.02 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 120.23 1.377 . . . . 0.0 111.72 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.4 mt -93.25 153.28 18.68 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.162 0.892 . . . . 0.0 110.34 -158.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.8 t -90.38 -179.97 5.73 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 171.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.45 -42.65 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 O-C-N 120.999 -1.063 . . . . 0.0 112.419 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -69.8 -14.9 62.99 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.755 -1.216 . . . . 0.0 113.585 173.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.77 -37.43 26.32 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 125.45 1.5 . . . . 0.0 110.936 169.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.86 -25.92 40.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 117.847 -1.073 . . . . 0.0 112.344 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -43.83 -60.98 2.2 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 125.691 1.596 . . . . 0.0 110.445 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.28 -45.49 15.17 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 121.394 1.396 . . . . 0.0 110.032 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.452 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 64.2 m-85 -64.04 -35.25 80.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 119.752 1.16 . . . . 0.0 113.337 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.1 mt -59.16 -57.19 12.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 171.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -52.88 -43.18 65.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.175 0.99 . . . . 0.0 110.45 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.426 ' HG2' HD21 ' A' ' 45' ' ' LEU . 64.7 mtm -66.76 -50.29 63.19 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.891 1.276 . . . . 0.0 112.567 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.738 ' HD2' HD22 ' A' ' 17' ' ' LEU . 27.2 tttt -60.62 -41.33 94.64 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.816 -1.177 . . . . 0.0 110.193 -177.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.79 -26.63 57.49 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.839 0.456 . . . . 0.0 111.441 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.428 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 35.9 t80 -57.25 -50.98 71.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.917 0.887 . . . . 0.0 109.112 167.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.2 mt -64.02 -20.14 65.7 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.466 1.106 . . . . 0.0 113.439 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 39.4 m -61.53 -33.4 73.77 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.279 0.945 . . . . 0.0 111.531 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -130.49 104.77 7.43 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.637 -0.665 . . . . 0.0 109.988 -170.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -53.61 -29.2 36.73 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.204 1.401 . . . . 0.0 111.716 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -55.19 -25.93 35.91 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 119.803 -1.81 . . . . 0.0 112.45 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.428 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 85.2 m-20 -66.08 -50.56 63.66 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.529 0.732 . . . . 0.0 110.817 175.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.43 -37.19 78.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 119.221 0.919 . . . . 0.0 109.568 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 78.0 mt -64.55 -34.12 77.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.17 0.588 . . . . 0.0 110.481 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.98 -32.5 59.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.92 0.888 . . . . 0.0 111.43 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -27.85 66.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.298 1.039 . . . . 0.0 110.691 176.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.1 mtm105 -56.8 -54.15 49.66 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 119.092 0.86 . . . . 0.0 109.464 169.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -52.87 -36.66 59.38 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.853 0.751 . . . . 0.0 111.319 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 52.1 mt -73.68 -38.23 51.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.865 -1.147 . . . . 0.0 110.338 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -63.74 -47.62 80.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.668 1.587 . . . . 0.0 111.001 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.1 p -59.69 -33.6 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 118.547 0.612 . . . . 0.0 110.917 173.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -80.4 8.88 6.68 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.351 1.46 . . . . 0.0 113.359 176.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.6 t -58.45 131.57 51.11 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.914 1.234 . . . . 0.0 109.117 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.71 -164.68 50.69 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 122.982 0.325 . . . . 0.0 113.179 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -69.91 174.24 9.92 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.594 2.196 . . . . 0.0 109.558 165.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 56.4 m -82.77 -61.45 1.87 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 155.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 t 68.44 109.44 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.043 1.737 . . . . 0.0 108.433 -165.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.515 0 CA-C-O 117.704 -1.609 . . . . 0.0 109.246 -179.96 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.736 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.6 t -174.51 -70.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.441 2.296 . . . . 0.0 105.016 172.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 m -59.87 150.17 29.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.336 1.854 . . . . 0.0 111.445 -169.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.0 78.2 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.9 p -144.81 144.78 31.32 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.137 0.575 . . . . 0.0 110.12 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.7 m 69.37 157.97 0.16 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 128.204 2.602 . . . . 0.0 112.141 -177.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.13 72.33 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 123.645 0.641 . . . . 0.0 111.913 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -137.64 143.94 41.65 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.829 0.852 . . . . 0.0 109.134 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.33 77.01 0.09 OUTLIER Glycine 0 CA--C 1.523 0.567 0 CA-C-O 118.772 -1.015 . . . . 0.0 110.764 -177.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.59 -175.08 0.64 Allowed 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.57 2.847 . . . . 0.0 110.935 170.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 129.75 75.85 0.16 Allowed Glycine 0 C--N 1.333 0.362 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.9 147.55 34.17 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.558 1.179 . . . . 0.0 110.213 167.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.77 -172.57 0.09 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.415 1.886 . . . . 0.0 111.774 -177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -87.3 106.27 17.81 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 168.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -125.35 -174.61 3.1 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.742 1.617 . . . . 0.0 108.603 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -75.86 113.8 13.75 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.481 -0.762 . . . . 0.0 109.635 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.731 HD22 ' HD2' ' A' ' 77' ' ' LYS . 9.6 mt -98.39 144.65 27.54 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.641 1.176 . . . . 0.0 107.968 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -77.8 99.27 5.85 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 122.014 0.911 . . . . 0.0 109.079 179.226 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 p -63.16 -38.98 93.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 120.818 -1.176 . . . . 0.0 111.402 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.05 -31.83 70.35 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.543 -0.741 . . . . 0.0 111.434 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 5.8 tt0 -78.92 -55.57 5.04 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.016 2.126 . . . . 0.0 108.758 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 17' ' ' LEU . 75.8 mt -54.57 -44.2 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.91 -49.06 78.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.529 0.732 . . . . 0.0 111.273 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -61.07 -53.36 58.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.839 1.256 . . . . 0.0 110.283 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -60.56 -39.7 88.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.68 1.992 . . . . 0.0 111.772 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.9 t -60.91 -47.12 94.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 O-C-N 120.691 -1.255 . . . . 0.0 109.374 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -61.14 -27.49 68.42 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 117.373 -1.299 . . . . 0.0 111.548 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -65.04 -63.12 1.18 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 120.125 1.329 . . . . 0.0 109.805 170.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -63.78 -29.08 70.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.058 0.845 . . . . 0.0 111.806 -170.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.52 -37.78 74.18 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.976 1.262 . . . . 0.0 109.587 174.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.26 -37.35 85.27 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.186 1.357 . . . . 0.0 111.862 169.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -58.59 -32.75 69.25 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 126.952 2.101 . . . . 0.0 113.707 -170.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -126.39 15.93 7.7 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.482 1.913 . . . . 0.0 111.214 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.8 m120 42.33 72.73 0.16 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.282 2.233 . . . . 0.0 111.41 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.466 HD11 ' CG ' ' A' ' 90' ' ' ARG . 93.4 mt -106.26 153.84 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.69 131.64 10.87 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.801 1.191 . . . . 0.0 110.556 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -36.05 74.6 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.428 1.491 . . . . 0.0 111.71 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.6 ptt85 -53.5 -56.06 20.18 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.351 1.06 . . . . 0.0 111.965 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.46 -39.7 81.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -63.29 -45.68 90.26 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 121.091 -1.006 . . . . 0.0 109.573 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.41 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -67.35 -24.61 73.63 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-O 117.352 -1.804 . . . . 0.0 112.518 173.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -78.12 -21.02 51.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 120.788 2.294 . . . . 0.0 112.076 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -121.99 -61.1 1.52 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 119.484 1.038 . . . . 0.0 111.436 -174.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.7 t -63.46 -36.98 78.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.493 HD21 ' HG2' ' A' ' 76' ' ' MET . 21.4 mt -106.49 -34.95 7.23 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.423 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.55 31.5 78.84 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.13 161.62 18.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.352 1.461 . . . . 0.0 107.932 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.9 m -59.67 147.95 35.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.765 1.226 . . . . 0.0 110.599 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -63.67 -16.73 61.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.633 1.573 . . . . 0.0 114.06 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -83.54 -56.63 2.61 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 166.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.7 m -43.65 -59.57 2.14 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 125.851 1.66 . . . . 0.0 113.21 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.41 HG11 ' HA3' ' A' ' 41' ' ' GLY . 4.1 m -55.65 -34.62 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 121.017 1.735 . . . . 0.0 114.074 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.9 t -63.2 -36.24 82.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.243 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.36 -41.78 80.79 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.792 1.633 . . . . 0.0 109.736 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.432 HG23 ' CE2' ' A' ' 73' ' ' PHE . 15.3 mt -62.79 -45.35 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -174.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.8 -32.03 61.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.779 0.832 . . . . 0.0 111.628 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.24 -53.94 31.02 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.628 1.971 . . . . 0.0 111.042 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -134.45 71.78 71.15 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -168.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -68.41 98.91 0.58 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.937 2.425 . . . . 0.0 107.985 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -69.06 160.63 77.63 Favored Pre-proline 0 N--CA 1.439 -1.004 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -59.34 150.49 74.44 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.351 2.701 . . . . 0.0 109.109 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.449 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 70.4 t-105 -52.79 -52.54 56.37 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.664 0.786 . . . . 0.0 111.5 177.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.432 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -61.4 -5.99 2.02 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 174.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -116.31 18.98 15.06 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.414 1.886 . . . . 0.0 110.842 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.1 mt -124.05 149.44 46.11 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.564 1.546 . . . . 0.0 106.874 166.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.2 t -90.73 -177.72 5.07 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.641 1.176 . . . . 0.0 108.852 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 p -46.33 -54.01 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.446 1.098 . . . . 0.0 111.16 172.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -74.73 -4.88 40.15 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.25 -35.19 15.31 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 126.326 1.917 . . . . 0.0 111.297 163.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -87.91 -23.27 23.98 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.566 1.546 . . . . 0.0 112.971 -173.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -39.14 -59.91 1.35 Allowed Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.15 1.78 . . . . 0.0 110.36 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.27 -51.11 2.91 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.467 2.112 . . . . 0.0 111.489 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CE2' HG23 ' A' ' 55' ' ' ILE . 44.1 m-85 -59.58 -38.15 80.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 117.441 -1.266 . . . . 0.0 112.528 -175.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.2 mt -55.85 -54.02 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -60.7 -46.57 89.87 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.35 1.06 . . . . 0.0 110.498 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.493 ' HG2' HD21 ' A' ' 45' ' ' LEU . 63.9 mtm -59.37 -46.07 89.69 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 124.075 0.95 . . . . 0.0 111.299 177.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.731 ' HD2' HD22 ' A' ' 17' ' ' LEU . 13.8 tttm -60.96 -45.76 93.43 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.39 -0.819 . . . . 0.0 110.183 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -59.61 -43.99 93.57 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.723 0.809 . . . . 0.0 110.314 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.54 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 37.7 t80 -53.61 -51.36 63.31 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.103 1.761 . . . . 0.0 110.127 178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.8 mt -66.27 -18.94 65.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.357 0.663 . . . . 0.0 112.133 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -6.52 47.29 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.253 1.421 . . . . 0.0 112.681 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -156.86 115.75 3.36 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.885 1.274 . . . . 0.0 109.139 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.22 -27.81 68.7 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.851 1.26 . . . . 0.0 112.431 -169.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -60.71 -19.28 58.34 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 120.768 -1.208 . . . . 0.0 112.525 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.54 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 38.1 m-80 -60.33 -50.9 71.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 119.993 1.269 . . . . 0.0 110.181 174.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.424 HG22 HD12 ' A' ' 35' ' ' ILE . 3.2 p -71.28 -30.67 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 120.851 -1.155 . . . . 0.0 110.135 -177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 66.9 mt -64.2 -37.38 87.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.15 69.83 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.402 0.546 . . . . 0.0 111.649 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.08 -28.49 62.33 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.245 -0.91 . . . . 0.0 111.37 176.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.466 ' CG ' HD11 ' A' ' 35' ' ' ILE . 63.5 mtp180 -58.26 -37.04 74.14 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.017 0.826 . . . . 0.0 110.207 173.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 m -55.95 -56.32 22.12 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.327 1.051 . . . . 0.0 110.086 175.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.1 mt -65.13 -31.78 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 123.463 0.705 . . . . 0.0 110.008 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -61.34 -39.59 91.12 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 121.689 -0.632 . . . . 0.0 111.728 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -67.7 -29.43 45.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 118.785 0.72 . . . . 0.0 109.66 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -79.77 10.86 3.63 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.792 1.637 . . . . 0.0 111.934 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.8 t -52.05 157.58 1.28 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.6 1.16 . . . . 0.0 109.981 167.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -122.19 -174.76 14.64 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.279 1.419 . . . . 0.0 112.128 -175.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.47 60.82 6.61 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 124.91 3.74 . . . . 0.0 111.914 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.1 m -66.15 112.68 4.04 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 167.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.4 t -145.78 -88.28 0.1 Allowed 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 170.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.153 -1.36 . . . . 0.0 110.056 -178.612 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.544 0 N-CA-C 107.511 -2.236 . . . . 0.0 107.511 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 t -144.15 -170.52 3.37 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.551 1.176 . . . . 0.0 109.069 -172.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.9 t -135.03 161.61 34.81 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.636 1.974 . . . . 0.0 106.915 164.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.87 139.7 6.89 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.11 82.73 1.26 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -166.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.0 m -151.45 164.43 36.77 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.241 1.416 . . . . 0.0 109.723 172.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.41 134.99 3.18 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 174.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -165.46 168.73 16.33 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.403 1.101 . . . . 0.0 109.049 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.56 164.93 37.62 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 167.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.08 151.15 72.97 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.946 2.431 . . . . 0.0 109.847 170.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.54 40.62 2.99 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-O 119.013 -0.881 . . . . 0.0 111.007 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.81 168.88 18.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.655 1.582 . . . . 0.0 107.459 171.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -63.52 -1.99 1.44 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 -155.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -130.43 103.74 6.84 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.952 1.701 . . . . 0.0 109.419 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -119.4 -176.53 3.16 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.365 0.666 . . . . 0.0 111.043 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.62 91.63 7.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.968 0.889 . . . . 0.0 109.181 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.624 HD22 ' HD2' ' A' ' 77' ' ' LYS . 3.2 mt -75.81 140.46 42.32 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.375 1.47 . . . . 0.0 109.021 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.52 103.17 8.29 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.96 -1.087 . . . . 0.0 110.916 -172.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 33.3 p -64.14 -46.23 84.99 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.983 -1.073 . . . . 0.0 112.93 -169.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.97 -18.57 64.09 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.289 0.636 . . . . 0.0 111.327 -176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.92 -56.74 4.05 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.764 1.626 . . . . 0.0 108.875 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.453 HD11 ' HB3' ' A' ' 17' ' ' LEU . 71.7 mt -51.6 -43.94 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 124.415 1.086 . . . . 0.0 109.992 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.66 -68.24 0.19 Allowed 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.378 1.071 . . . . 0.0 110.047 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -45.22 -56.46 4.8 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.167 1.787 . . . . 0.0 112.232 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -54.78 -43.68 73.03 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 127.942 2.497 . . . . 0.0 111.227 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.2 t -66.96 -48.32 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 O-C-N 120.806 -1.184 . . . . 0.0 108.628 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -57.45 -43.46 83.97 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.385 1.448 . . . . 0.0 110.128 -174.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -65.51 -44.87 85.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 118.718 0.69 . . . . 0.0 112.063 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -58.49 -46.75 86.05 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.299 1.04 . . . . 0.0 112.549 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.8 mt -58.78 -50.19 74.86 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -51.69 -45.68 63.59 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 120.261 1.391 . . . . 0.0 113.629 170.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.0 ttpt -53.93 -32.11 52.53 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.881 1.672 . . . . 0.0 112.927 -173.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -123.39 15.63 9.69 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.567 1.547 . . . . 0.0 111.452 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 43.95 41.95 4.3 Favored 'General case' 0 CA--C 1.542 0.641 1 C-N-CA 132.379 4.272 . . . . 0.0 114.612 -176.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.3 mt -84.41 131.11 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.079 0.952 . . . . 0.0 108.726 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.09 115.71 4.07 Favored Glycine 0 C--O 1.228 -0.219 0 C-N-CA 125.0 1.286 . . . . 0.0 111.691 -169.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -39.62 -35.99 0.36 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.405 2.282 . . . . 0.0 115.725 -167.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -50.06 -50.12 48.98 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.249 1.386 . . . . 0.0 111.507 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.75 -50.69 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 119.044 0.838 . . . . 0.0 109.242 -173.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -54.74 -46.94 74.37 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.772 -0.58 . . . . 0.0 111.065 176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.5 -15.52 68.42 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-O 117.026 -1.986 . . . . 0.0 113.232 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -94.25 -26.25 16.7 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 120.617 2.208 . . . . 0.0 112.575 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -118.44 -24.06 6.97 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -172.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.45 -37.74 6.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 124.138 0.975 . . . . 0.0 109.593 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.439 HD21 ' HG2' ' A' ' 76' ' ' MET . 29.3 mt -112.19 -30.73 7.1 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -171.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.39 13.16 83.12 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 123.961 0.791 . . . . 0.0 113.469 175.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 99.0 mt -101.84 170.33 8.22 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.254 1.822 . . . . 0.0 109.16 -174.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.09 166.57 13.6 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.411 -0.806 . . . . 0.0 112.025 173.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.2 tm0? -64.23 -44.34 92.18 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.31 -56.83 8.76 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 125.281 1.42 . . . . 0.0 112.068 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.7 m -52.13 -69.06 0.12 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 118.341 -0.838 . . . . 0.0 111.359 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.8 -37.1 70.01 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 CA-C-N 120.482 1.492 . . . . 0.0 111.566 -171.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 t -55.26 -38.52 68.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 117.828 -1.082 . . . . 0.0 112.115 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.14 -48.58 79.47 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.921 1.237 . . . . 0.0 110.202 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 mt -59.03 -35.07 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.0 mt -81.22 -37.23 28.94 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 123.603 0.761 . . . . 0.0 112.099 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.55 -48.12 83.16 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.977 0.911 . . . . 0.0 110.751 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -136.94 82.0 32.1 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.36 73.86 4.38 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.554 2.836 . . . . 0.0 109.096 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -56.34 148.39 43.23 Favored Pre-proline 0 N--CA 1.441 -0.911 0 C-N-CA 124.8 1.24 . . . . 0.0 109.103 -172.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.02 147.26 91.78 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 124.46 3.44 . . . . 0.0 109.098 -164.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.447 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 60.3 t-105 -54.13 -38.07 65.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.735 0.414 . . . . 0.0 110.555 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -25.75 67.12 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -37.2 65.27 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.66 -1.275 . . . . 0.0 110.212 173.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.7 mt -74.54 172.44 12.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.298 1.047 . . . . 0.0 110.13 -171.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.6 p -129.15 -175.98 3.73 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.774 2.83 . . . . 0.0 107.834 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 89.9 t -47.54 -57.52 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 120.543 1.519 . . . . 0.0 111.229 173.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -70.09 -27.56 64.7 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.342 -1.474 . . . . 0.0 112.855 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.8 97.24 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 170.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -88.24 -26.12 22.51 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 126.949 2.1 . . . . 0.0 111.974 -171.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -44.45 -54.66 11.7 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 125.705 1.602 . . . . 0.0 110.566 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.04 -48.77 4.59 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.994 1.796 . . . . 0.0 110.982 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -57.48 -37.63 73.23 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.458 1.026 . . . . 0.0 113.401 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.1 mt -58.0 -59.55 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 172.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -55.01 -38.89 68.48 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.099 0.56 . . . . 0.0 110.934 -177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.439 ' HG2' HD21 ' A' ' 45' ' ' LEU . 57.8 mtm -66.01 -50.56 63.83 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.768 0.827 . . . . 0.0 111.912 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.624 ' HD2' HD22 ' A' ' 17' ' ' LEU . 21.6 tttt -58.8 -41.26 86.3 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.908 -1.12 . . . . 0.0 110.778 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -70.29 -35.8 73.95 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.139 1.375 . . . . 0.0 110.576 -176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.473 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 44.0 t80 -56.5 -54.45 45.63 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.28 1.832 . . . . 0.0 109.105 171.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.3 mt -64.39 -18.15 64.41 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.709 0.803 . . . . 0.0 112.442 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.83 -10.13 59.4 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.532 -0.73 . . . . 0.0 111.604 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -144.41 110.13 5.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.368 0.985 . . . . 0.0 108.345 171.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' O ' HG12 ' A' ' 86' ' ' VAL . 38.6 tp10 -52.43 -30.44 29.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.833 1.253 . . . . 0.0 112.076 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -61.7 -16.04 45.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.149 -1.594 . . . . 0.0 112.969 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.473 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 71.3 m-80 -66.79 -50.28 63.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.834 1.197 . . . . 0.0 110.692 169.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 83' ' ' GLU . 9.1 p -64.06 -37.46 79.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 CA-C-N 119.359 0.982 . . . . 0.0 109.223 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.07 -39.91 93.91 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 118.241 0.473 . . . . 0.0 110.559 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.34 -34.39 76.01 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.858 0.463 . . . . 0.0 111.741 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.8 -27.81 66.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.84 0.856 . . . . 0.0 111.549 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 mtm105 -55.17 -50.36 69.53 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.5 m -53.3 -40.75 64.99 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.75 1.62 . . . . 0.0 109.348 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.2 mt -69.75 -31.4 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 O-C-N 120.656 -1.277 . . . . 0.0 111.21 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -63.63 -35.94 82.18 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 119.028 0.831 . . . . 0.0 110.873 170.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.18 -31.65 48.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 119.139 0.881 . . . . 0.0 109.81 176.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -76.78 27.06 0.13 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.925 1.69 . . . . 0.0 111.764 169.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 58.7 p -73.34 -15.17 61.39 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.756 1.616 . . . . 0.0 113.477 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -159.42 179.02 35.3 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -71.88 -23.25 22.38 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.463 2.108 . . . . 0.0 112.805 -170.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.0 p -69.69 11.6 0.26 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 129.473 3.109 . . . . 0.0 114.483 -174.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.7 t -73.26 83.22 1.37 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 CA-C-O 116.106 -2.497 . . . . 0.0 107.037 171.799 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.62 0 N-CA-C 106.744 -2.542 . . . . 0.0 106.744 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m 57.7 44.54 20.4 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 117.897 0.849 . . . . 0.0 111.366 144.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.6 m -145.65 153.84 41.46 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.937 1.295 . . . . 0.0 107.949 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.41 161.35 29.4 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 168.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.5 t -155.05 159.54 40.36 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.278 1.031 . . . . 0.0 109.23 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -155.02 166.9 32.13 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.013 1.725 . . . . 0.0 107.555 169.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.63 163.4 25.5 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 157.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -160.13 156.04 26.1 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.122 1.369 . . . . 0.0 107.793 166.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.01 73.7 0.1 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 173.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -78.06 136.88 15.03 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.294 1.996 . . . . 0.0 110.831 -171.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.34 -122.77 0.77 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 59.75 148.27 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.89 2.876 . . . . 0.0 114.717 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -163.63 158.68 20.83 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.118 1.367 . . . . 0.0 109.238 -170.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -75.21 105.48 6.25 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -145.46 177.9 8.51 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.809 -1.182 . . . . 0.0 110.185 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -73.51 119.69 18.09 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.7 mt -111.45 142.27 43.93 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.628 1.571 . . . . 0.0 107.878 -177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.92 102.48 5.59 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 123.06 1.41 . . . . 0.0 109.489 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.442 HG22 ' CD1' ' A' ' 73' ' ' PHE . 5.4 p -70.23 -35.06 73.59 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.722 -174.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.57 65.94 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 120.262 1.392 . . . . 0.0 110.914 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -77.84 -50.88 11.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.856 2.062 . . . . 0.0 108.981 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -54.03 -53.24 29.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.83 -46.23 78.17 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.313 0.645 . . . . 0.0 112.096 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -58.54 -66.48 0.48 Allowed 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 124.382 1.073 . . . . 0.0 108.23 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -47.29 -40.6 17.21 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.354 1.462 . . . . 0.0 112.643 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.522 HG21 ' SD ' ' A' ' 76' ' ' MET . 38.7 t -57.98 -53.8 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 C-N-CA 123.684 0.794 . . . . 0.0 109.873 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -52.71 -51.09 61.87 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -59.29 -44.41 92.49 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.765 0.826 . . . . 0.0 112.582 -175.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.456 ' HG3' ' CD2' ' A' ' 80' ' ' LEU . 9.9 mm-40 -61.32 -49.59 76.37 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.954 1.702 . . . . 0.0 112.349 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.49 -49.47 77.67 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.48 -42.91 67.74 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.833 1.253 . . . . 0.0 114.056 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -53.83 -28.31 34.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.676 1.19 . . . . 0.0 111.568 -177.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -124.76 15.66 8.69 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.872 1.669 . . . . 0.0 112.579 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 38.4 54.31 1.81 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.727 2.811 . . . . 0.0 113.893 -172.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.5 mt -89.89 151.7 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.29 131.9 10.8 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 126.236 1.874 . . . . 0.0 111.681 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -60.43 -20.1 58.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.216 1.006 . . . . 0.0 113.211 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -65.68 -60.82 2.51 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 119.775 1.171 . . . . 0.0 109.222 171.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.9 t -54.73 -47.54 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 C-N-CA 123.632 0.773 . . . . 0.0 109.97 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -53.55 -51.04 64.17 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.653 0.66 . . . . 0.0 111.907 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -68.48 -28.85 72.98 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-O 117.845 -1.531 . . . . 0.0 112.061 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -72.38 -23.55 61.13 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.794 1.797 . . . . 0.0 112.023 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -116.27 -60.32 1.87 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.751 1.159 . . . . 0.0 112.841 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.16 -44.67 87.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -172.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.562 HD21 ' HG2' ' A' ' 76' ' ' MET . 35.9 mt -95.1 -41.76 8.95 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.21 0.604 . . . . 0.0 110.755 -173.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.92 30.19 44.04 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.179 0.895 . . . . 0.0 112.223 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' A' ' 45' ' ' LEU . 24.8 mt -121.13 164.42 16.88 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 126.725 2.01 . . . . 0.0 107.802 -173.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.2 t -65.4 162.41 17.79 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.518 0.675 . . . . 0.0 110.737 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -58.85 -54.06 51.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.806 0.842 . . . . 0.0 109.586 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.55 -42.88 99.85 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.0 m -52.56 -60.42 3.27 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.805 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.426 HG11 ' HA3' ' A' ' 41' ' ' GLY . 3.3 m -63.58 -39.31 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 120.885 1.675 . . . . 0.0 113.984 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.32 -35.97 78.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 119.179 0.899 . . . . 0.0 109.376 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.18 -44.13 87.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.516 0.726 . . . . 0.0 111.212 169.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.403 HG23 ' CE2' ' A' ' 73' ' ' PHE . 3.2 mt -59.98 -40.04 81.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.8 -38.26 62.15 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.754 0.822 . . . . 0.0 111.042 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.16 -49.52 56.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.402 1.881 . . . . 0.0 112.204 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -127.32 75.21 77.28 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 127.023 2.129 . . . . 0.0 108.111 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.33 103.0 0.61 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 N-CA-C 106.429 -2.181 . . . . 0.0 106.429 167.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -66.61 170.96 4.87 Favored Pre-proline 0 N--CA 1.439 -0.992 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.4 146.26 79.86 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.112 2.542 . . . . 0.0 109.681 168.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -55.26 -48.33 74.15 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.88 0.872 . . . . 0.0 110.773 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.461 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -52.72 -21.22 3.81 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 172.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -94.89 5.27 52.37 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 120.219 -1.551 . . . . 0.0 112.51 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.414 ' HB3' ' HA3' ' A' ' 69' ' ' GLY . 82.4 mt -113.71 174.94 5.68 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 125.687 1.595 . . . . 0.0 109.215 173.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -128.13 -173.98 3.09 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.14 1.776 . . . . 0.0 108.313 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 96.8 t -47.28 -55.56 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 119.908 1.231 . . . . 0.0 111.015 175.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -60.54 -32.21 71.27 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 120.862 -1.149 . . . . 0.0 112.926 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 65' ' ' LEU . . . -58.8 -45.48 94.86 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.666 1.127 . . . . 0.0 112.428 171.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -90.69 -17.85 26.08 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.707 2.003 . . . . 0.0 112.266 -164.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 1.5 tt0 -41.6 -53.62 7.29 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 127.308 2.243 . . . . 0.0 111.648 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 71' ' ' GLU . 22.2 Cg_endo -65.84 -50.77 1.53 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.341 2.027 . . . . 0.0 111.129 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CD1' HG22 ' A' ' 19' ' ' THR . 43.0 m-85 -57.62 -38.96 75.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 117.69 -1.148 . . . . 0.0 112.481 -174.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 74.1 mt -58.01 -54.29 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -56.35 -47.41 78.87 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.769 0.827 . . . . 0.0 110.486 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.562 ' HG2' HD21 ' A' ' 45' ' ' LEU . 64.7 mtm -61.42 -47.86 83.85 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 123.066 0.546 . . . . 0.0 110.705 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -58.72 -40.99 85.31 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.57 -0.707 . . . . 0.0 111.339 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.71 -41.56 92.17 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 119.063 0.847 . . . . 0.0 111.008 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.492 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.6 t80 -56.57 -41.65 77.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.557 0.743 . . . . 0.0 109.48 177.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.456 ' CD2' ' HG3' ' A' ' 29' ' ' GLN . 81.7 mt -75.75 -15.24 60.3 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.765 1.226 . . . . 0.0 113.938 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.9 m -81.65 -14.19 56.97 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.234 0.924 . . . . 0.0 111.035 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -145.24 97.12 2.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -47.31 -25.63 1.04 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.192 1.797 . . . . 0.0 112.746 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -58.41 -28.77 65.53 Favored 'General case' 0 C--N 1.343 0.285 0 O-C-N 119.643 -1.911 . . . . 0.0 112.138 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.492 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 66.7 m-80 -62.06 -54.23 44.33 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.19 -37.49 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.1 -0.375 . . . . 0.0 110.15 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.6 -39.4 93.63 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.42 0.688 . . . . 0.0 110.703 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.92 -35.29 67.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.558 0.743 . . . . 0.0 111.996 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.99 -25.09 66.63 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.132 0.973 . . . . 0.0 110.774 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -58.06 -49.53 76.6 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 118.359 0.527 . . . . 0.0 109.915 175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 m -60.29 -38.26 83.06 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.403 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mt -63.04 -42.33 96.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 119.68 1.127 . . . . 0.0 109.692 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -59.0 -45.99 89.29 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.445 0.698 . . . . 0.0 111.273 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.274 1.4 p -68.72 -30.06 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 118.915 0.779 . . . . 0.0 111.196 174.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -76.69 1.35 17.31 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 116.671 -1.633 . . . . 0.0 112.932 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.39 155.29 0.53 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-N 120.589 1.54 . . . . 0.0 113.86 -174.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.3 176.1 10.59 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.334 166.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -78.18 62.92 8.19 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.707 2.938 . . . . 0.0 111.516 -168.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.4 m -151.26 130.84 13.03 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 120.291 -1.506 . . . . 0.0 107.633 173.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.7 p -149.29 108.54 3.94 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.069 0.948 . . . . 0.0 108.802 -170.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 N-CA-C 107.237 -2.345 . . . . 0.0 107.237 -168.96 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.845 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.8 m -146.27 159.04 43.88 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.025 0.93 . . . . 0.0 108.965 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.0 m 54.48 174.65 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.711 1.204 . . . . 0.0 111.828 -161.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.51 -149.17 15.74 Favored Glycine 0 C--N 1.332 0.336 0 O-C-N 120.789 -1.194 . . . . 0.0 110.174 -166.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.7 m -54.42 120.99 7.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.161 1.384 . . . . 0.0 110.656 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.8 t -157.8 176.82 12.08 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.601 1.96 . . . . 0.0 107.819 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.25 71.37 0.89 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -133.44 119.93 20.24 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.115 0.966 . . . . 0.0 109.124 -171.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.84 85.02 0.37 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -174.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.87 -12.75 31.23 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.694 2.263 . . . . 0.0 114.153 -165.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 137.27 -147.81 19.44 Favored Glycine 0 C--O 1.237 0.316 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.82 26.49 10.3 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.675 1.59 . . . . 0.0 111.367 -166.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -81.26 -176.22 5.87 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.945 1.298 . . . . 0.0 111.248 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -126.94 115.23 18.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.628 1.971 . . . . 0.0 107.218 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -154.15 178.72 9.67 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.446 1.498 . . . . 0.0 110.502 -154.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -71.86 95.77 1.58 Allowed 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.894 0.77 . . . . 0.0 111.058 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.544 HD22 ' CD ' ' A' ' 77' ' ' LYS . 5.5 mt -78.91 154.93 29.28 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.801 1.24 . . . . 0.0 108.263 168.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -85.33 104.07 14.83 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 123.029 1.395 . . . . 0.0 108.122 162.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.481 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 19.4 p -56.2 -41.65 75.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.988 172.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 -37.74 71.95 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.475 0.71 . . . . 0.0 111.558 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -71.14 -54.77 9.87 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.328 1.451 . . . . 0.0 108.434 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -54.09 -51.05 50.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.36 -49.82 63.59 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.826 0.85 . . . . 0.0 111.362 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -55.42 -63.75 1.06 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.483 1.113 . . . . 0.0 109.617 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -50.88 -41.24 58.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.566 1.946 . . . . 0.0 112.933 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.424 HG21 ' SD ' ' A' ' 76' ' ' MET . 75.3 t -62.54 -47.85 91.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 121.011 -1.056 . . . . 0.0 110.079 176.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -55.89 -39.61 71.81 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.657 -1.163 . . . . 0.0 109.337 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -59.39 -55.81 29.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.45 1.023 . . . . 0.0 112.024 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -63.86 -39.66 94.74 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 112.318 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.9 mt -62.12 -46.43 89.06 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 120.091 1.314 . . . . 0.0 107.601 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -16.73 64.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.06 0.846 . . . . 0.0 113.263 175.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -66.8 -30.66 70.92 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.083 -1.011 . . . . 0.0 110.832 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -127.99 10.35 6.43 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.322 1.049 . . . . 0.0 111.699 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 41.01 85.11 0.02 OUTLIER 'General case' 0 C--O 1.234 0.256 0 C-N-CA 128.24 2.616 . . . . 0.0 111.171 -164.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.451 HD11 ' CG ' ' A' ' 90' ' ' ARG . 92.2 mt -115.99 150.96 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.971 0.909 . . . . 0.0 108.921 174.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.96 142.14 17.45 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 123.954 0.788 . . . . 0.0 111.499 -176.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -66.09 -33.46 75.84 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 118.57 -0.729 . . . . 0.0 111.965 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -59.97 -46.72 88.52 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 118.832 0.742 . . . . 0.0 109.767 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.2 t -61.88 -54.04 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 119.151 0.887 . . . . 0.0 109.294 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -51.3 -47.87 62.47 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.668 0.27 . . . . 0.0 111.714 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.499 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -78.34 -27.71 57.11 Favored Glycine 0 N--CA 1.429 -1.813 0 CA-C-O 117.017 -1.991 . . . . 0.0 112.573 -175.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -78.81 -26.75 44.29 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.738 2.269 . . . . 0.0 110.769 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -96.31 -78.5 0.46 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.68 0.792 . . . . 0.0 109.386 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.3 t -53.42 -52.28 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 C-N-CA 126.489 1.916 . . . . 0.0 107.896 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.498 HD21 ' HG2' ' A' ' 76' ' ' MET . 37.9 mt -90.17 -34.44 15.84 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 118.026 -0.988 . . . . 0.0 111.595 -170.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.97 12.72 80.72 Favored Glycine 0 CA--C 1.533 1.183 0 O-C-N 124.2 0.937 . . . . 0.0 112.791 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.0 mt -102.79 172.29 6.92 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.172 1.389 . . . . 0.0 109.688 -171.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 63.5 p -67.33 159.79 28.56 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.291 -0.881 . . . . 0.0 109.594 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -61.22 -46.43 90.45 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.017 -1.052 . . . . 0.0 109.209 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.88 -32.68 70.83 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.83 -0.984 . . . . 0.0 112.043 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.2 m -60.19 -69.36 0.22 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 118.919 1.359 . . . . 0.0 108.69 169.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.499 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.7 m -57.25 -40.05 71.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 120.09 1.314 . . . . 0.0 113.63 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.0 t -55.01 -45.72 75.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.753 0.821 . . . . 0.0 109.638 176.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -57.42 -46.07 83.94 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 119.361 0.982 . . . . 0.0 110.702 172.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.42 ' CG2' ' CZ ' ' A' ' 73' ' ' PHE . 5.1 mt -58.72 -41.21 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -70.41 -41.51 72.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.444 1.098 . . . . 0.0 111.174 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.69 -48.89 73.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.878 2.071 . . . . 0.0 112.557 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.3 79.38 61.36 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.48 95.77 0.63 Allowed 'Trans proline' 0 N--CA 1.445 -1.325 0 N-CA-C 106.987 -1.966 . . . . 0.0 106.987 173.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -62.54 154.73 71.98 Favored Pre-proline 0 N--CA 1.436 -1.125 0 O-C-N 120.945 -1.097 . . . . 0.0 108.099 172.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -65.09 150.2 88.15 Favored 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 122.139 1.893 . . . . 0.0 108.368 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -52.25 -43.67 64.48 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.786 0.834 . . . . 0.0 110.789 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -21.59 52.02 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -83.46 -28.86 28.47 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.943 1.247 . . . . 0.0 113.039 175.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.9 mt -85.21 157.18 20.7 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.902 0.774 . . . . 0.0 109.436 -169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.1 t -97.63 -178.44 4.12 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 166.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -47.28 -51.09 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 125.358 1.463 . . . . 0.0 111.356 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.401 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 0.7 OUTLIER -63.88 -22.75 67.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 178.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.1 -40.22 17.22 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 125.732 1.634 . . . . 0.0 111.44 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -76.63 -26.44 54.93 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 125.65 1.58 . . . . 0.0 111.742 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -46.1 -55.8 12.35 Favored Pre-proline 0 N--CA 1.455 -0.195 0 C-N-CA 126.485 1.914 . . . . 0.0 112.184 -176.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.64 -48.62 8.75 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 121.434 1.423 . . . . 0.0 110.025 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.481 ' CZ ' ' HB ' ' A' ' 19' ' ' THR . 64.5 m-85 -58.9 -37.75 77.33 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 117.508 -1.234 . . . . 0.0 113.133 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 53.1 mt -57.72 -58.77 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 C-N-CA 124.45 1.1 . . . . 0.0 108.06 173.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.5 mttt -52.46 -45.7 66.19 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.881 0.872 . . . . 0.0 110.173 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.498 ' HG2' HD21 ' A' ' 45' ' ' LEU . 64.7 mtm -65.54 -46.7 78.55 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.478 -0.764 . . . . 0.0 112.213 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.544 ' CD ' HD22 ' A' ' 17' ' ' LEU . 21.1 tttp -62.66 -38.45 90.37 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.034 -1.041 . . . . 0.0 110.252 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -66.47 -40.4 89.33 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.043 1.337 . . . . 0.0 110.502 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.486 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.9 t80 -57.34 -51.7 68.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.27 1.428 . . . . 0.0 108.394 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.2 mt -66.8 -10.91 52.63 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.72 1.208 . . . . 0.0 113.868 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -38.69 87.52 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.174 -0.954 . . . . 0.0 109.975 171.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -132.34 112.03 11.85 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 119.385 0.993 . . . . 0.0 110.147 -176.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -53.82 -22.29 9.3 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.729 1.612 . . . . 0.0 112.413 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -53.86 -28.55 36.69 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 119.85 -1.781 . . . . 0.0 113.016 171.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.486 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 51.6 m-80 -62.04 -48.85 78.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 122.964 0.505 . . . . 0.0 110.031 175.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -37.16 79.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 CA-C-N 119.237 0.926 . . . . 0.0 109.814 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.4 mt -66.69 -35.05 79.22 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.836 0.454 . . . . 0.0 110.182 -173.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.42 -35.42 70.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.493 0.717 . . . . 0.0 112.052 172.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.39 -27.34 69.24 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 123.845 0.858 . . . . 0.0 111.338 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.451 ' CG ' HD11 ' A' ' 35' ' ' ILE . 77.8 mtp180 -59.26 -44.46 92.41 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.44 176.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.1 m -50.8 -46.53 59.77 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.282 0.946 . . . . 0.0 110.967 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.4 mt -67.84 -32.44 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 123.474 0.71 . . . . 0.0 110.134 -174.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -65.54 -34.58 78.58 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.68 0.792 . . . . 0.0 110.795 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 90' ' ' ARG . 0.9 OUTLIER -76.19 -5.99 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.387 0.675 . . . . 0.0 111.8 174.227 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -106.13 4.2 28.83 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.468 1.507 . . . . 0.0 111.233 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.9 t -56.67 -64.76 0.76 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.975 1.71 . . . . 0.0 111.137 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.88 -172.99 42.8 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.24 -0.913 . . . . 0.0 111.504 -168.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.53 105.92 1.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.022 3.148 . . . . 0.0 110.075 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 t 64.71 167.31 0.17 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.217 2.207 . . . . 0.0 112.09 -163.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.1 m -138.25 121.62 17.11 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 157.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.776 0 CA-C-O 117.303 -1.831 . . . . 0.0 111.538 -177.28 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.063 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 m 62.91 170.52 0.14 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.818 1.247 . . . . 0.0 111.617 -168.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -172.48 178.26 2.8 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.587 2.755 . . . . 0.0 105.839 174.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.2 134.02 1.63 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 172.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.2 m -169.29 116.55 0.61 Allowed 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 126.664 1.986 . . . . 0.0 106.702 172.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.3 m -160.27 161.19 33.32 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.014 1.326 . . . . 0.0 108.99 169.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.97 87.66 1.79 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 170.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -132.82 151.81 51.94 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 169.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.92 71.66 0.17 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.13 168.88 16.34 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.893 2.395 . . . . 0.0 111.232 167.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.58 145.7 35.43 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 124.542 1.068 . . . . 0.0 112.709 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.4 78.03 3.92 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.14 0.976 . . . . 0.0 108.673 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 39.77 -135.2 0.16 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 126.044 1.738 . . . . 0.0 110.94 -173.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -128.73 114.08 16.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.06 1.344 . . . . 0.0 108.314 -174.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -92.41 -158.35 0.58 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.576 1.551 . . . . 0.0 110.998 -169.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -117.61 93.59 4.22 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 126.976 2.11 . . . . 0.0 108.676 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.649 HD22 ' HD2' ' A' ' 77' ' ' LYS . 1.4 mt -75.54 151.3 37.95 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.797 0.839 . . . . 0.0 110.394 -172.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -78.5 93.95 4.87 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.2 p -58.13 -40.49 81.41 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.96 -1.088 . . . . 0.0 111.635 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.96 -34.79 76.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 122.94 0.496 . . . . 0.0 110.315 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -71.83 -55.44 7.55 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.564 1.145 . . . . 0.0 108.779 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.415 HD11 ' HB3' ' A' ' 17' ' ' LEU . 52.3 mt -56.25 -44.38 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.49 -48.61 78.76 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.735 -0.603 . . . . 0.0 111.536 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.493 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 29.7 t80 -56.36 -64.97 0.69 Allowed 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 124.231 1.012 . . . . 0.0 108.999 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -54.57 -35.63 63.51 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 127.106 2.162 . . . . 0.0 112.935 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.1 t -61.76 -53.13 52.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 119.191 0.905 . . . . 0.0 110.188 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 47.1 mtmt -52.38 -42.51 64.05 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 117.6 -1.191 . . . . 0.0 109.185 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.47 -58.1 10.1 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.238 1.015 . . . . 0.0 110.556 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -62.08 -34.17 75.79 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.67 -50.33 72.91 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 170.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.64 -42.41 74.96 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.107 0.867 . . . . 0.0 110.981 176.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -54.39 -30.1 51.0 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.129 2.171 . . . . 0.0 113.006 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -127.23 14.82 7.25 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.614 1.565 . . . . 0.0 110.928 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.7 m120 44.76 43.31 6.71 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 129.036 2.934 . . . . 0.0 113.073 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -82.15 147.17 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.81 -1.182 . . . . 0.0 109.421 -176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.13 130.99 10.17 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -56.62 -37.0 70.1 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.992 1.317 . . . . 0.0 112.512 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.2 ttp85 -54.63 -50.13 68.85 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.133 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.54 -49.41 83.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 119.107 0.867 . . . . 0.0 109.565 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -54.13 -49.2 69.73 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.446 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -72.18 -29.08 67.06 Favored Glycine 0 C--O 1.216 -0.987 0 CA-C-O 117.45 -1.75 . . . . 0.0 113.576 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -78.57 -30.08 46.57 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 120.729 2.265 . . . . 0.0 111.568 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.4 -58.44 1.88 Allowed 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.553 0.741 . . . . 0.0 110.393 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.54 HG22 HD21 ' A' ' 89' ' ' LEU . 11.3 t -68.23 -53.42 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -172.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.61 HD21 ' HG2' ' A' ' 76' ' ' MET . 46.0 mt -89.47 -37.08 15.04 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.2 0.6 . . . . 0.0 110.528 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.14 36.25 60.39 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.7 mt -121.51 163.43 18.84 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.731 1.612 . . . . 0.0 108.534 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.2 t -54.6 144.48 21.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.473 1.109 . . . . 0.0 109.919 174.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -58.28 -26.97 63.62 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 117.775 0.261 . . . . 0.0 110.841 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.59 -36.29 43.91 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 124.346 0.974 . . . . 0.0 112.054 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.1 m -67.56 -59.56 3.26 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.081 176.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.446 HG11 ' HA3' ' A' ' 41' ' ' GLY . 3.5 m -58.75 -35.18 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 120.381 1.446 . . . . 0.0 113.691 -177.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.2 p -61.88 -38.82 89.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.981 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.3 -38.59 68.86 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.742 1.155 . . . . 0.0 110.104 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.458 HG23 ' CZ ' ' A' ' 73' ' ' PHE . 14.9 mt -68.54 -47.22 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -173.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.8 mt -73.45 -30.36 63.14 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.145 0.578 . . . . 0.0 111.857 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.2 -57.46 5.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.02 1.728 . . . . 0.0 110.969 173.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -130.25 74.42 80.4 Favored Pre-proline 0 CA--C 1.519 -0.24 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -170.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.68 97.2 0.53 Allowed 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 122.709 2.272 . . . . 0.0 107.167 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -63.68 159.53 51.96 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -70.31 150.05 64.31 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.093 1.862 . . . . 0.0 107.328 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.423 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 67.4 t-105 -51.69 -42.15 61.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -14.66 52.67 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.96 -16.95 34.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.144 1.793 . . . . 0.0 112.363 171.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.64 149.37 21.29 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.44 1.018 . . . . 0.0 108.85 -169.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -98.03 179.93 4.61 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 165.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.8 t -49.05 -51.05 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 119.649 1.113 . . . . 0.0 112.163 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt -59.56 -34.48 72.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.46 1.482 . . . . 0.0 112.569 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.78 -35.2 90.61 Favored Glycine 0 CA--C 1.529 0.92 0 O-C-N 121.35 -0.844 . . . . 0.0 112.705 173.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.423 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 93.5 mttt -80.4 -27.91 38.0 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.348 1.459 . . . . 0.0 112.162 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -42.18 -52.64 9.48 Favored Pre-proline 0 N--CA 1.448 -0.563 0 C-N-CA 128.365 2.666 . . . . 0.0 111.883 -174.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.97 -56.08 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.103 1.869 . . . . 0.0 110.27 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.458 ' CZ ' HG23 ' A' ' 55' ' ' ILE . 80.5 m-85 -58.05 -32.03 67.62 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 117.482 -1.247 . . . . 0.0 113.303 -173.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.23 -58.81 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 119.449 1.022 . . . . 0.0 108.278 171.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -53.85 -48.85 69.58 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.61 ' HG2' HD21 ' A' ' 45' ' ' LEU . 58.3 mtm -72.31 -33.68 67.55 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 119.713 1.142 . . . . 0.0 113.034 -168.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.649 ' HD2' HD22 ' A' ' 17' ' ' LEU . 3.5 tttm -62.21 -41.44 98.38 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.622 171.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -66.72 -35.04 79.19 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.579 1.152 . . . . 0.0 111.644 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -58.65 -57.28 13.67 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 126.312 1.845 . . . . 0.0 108.062 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 mt -66.03 -4.8 7.9 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.445 1.498 . . . . 0.0 113.124 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.7 -7.64 59.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.771 1.228 . . . . 0.0 112.729 171.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -152.26 134.39 15.02 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.223 1.829 . . . . 0.0 111.538 171.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 86' ' ' VAL . 2.1 tp10 -60.4 -35.71 76.4 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.249 1.42 . . . . 0.0 111.104 176.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -58.2 -27.07 63.54 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.545 -0.722 . . . . 0.0 110.555 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -63.27 -42.61 99.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.227 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 83' ' ' GLU . 5.3 p -75.8 -33.6 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 119.731 1.151 . . . . 0.0 110.267 176.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.6 mt -66.53 -38.72 87.77 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.647 0.658 . . . . 0.0 110.277 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.37 97.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.204 0.526 . . . . 0.0 110.791 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.54 HD21 HG22 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -65.51 -27.41 68.45 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.964 0.905 . . . . 0.0 111.234 -178.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -57.0 -38.59 73.29 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.165 0.893 . . . . 0.0 109.649 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -65.83 -46.35 78.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.762 0.71 . . . . 0.0 111.232 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.445 HD12 HD22 ' A' ' 89' ' ' LEU . 47.9 mt -62.83 -32.01 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 119.307 0.958 . . . . 0.0 110.538 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -55.97 -44.26 78.34 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.499 0.72 . . . . 0.0 110.767 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.8 -32.23 55.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.658 0.742 . . . . 0.0 110.024 178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -76.58 -3.17 36.19 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.648 1.179 . . . . 0.0 111.625 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 t -61.46 -21.98 64.64 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.696 1.134 . . . . 0.0 112.289 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.52 174.26 37.19 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.022 1.296 . . . . 0.0 110.333 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -86.87 51.58 2.45 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.575 3.516 . . . . 0.0 111.173 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 69.86 157.4 0.16 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.617 1.967 . . . . 0.0 112.576 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.2 t 73.22 139.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 127.408 2.283 . . . . 0.0 111.803 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.423 0 C-N-CA 124.886 1.232 . . . . 0.0 111.048 -179.164 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.102 0 CA-C-O 118.991 -0.894 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.3 113.44 6.89 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 102.775 -3.046 . . . . 0.0 102.775 171.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.2 m -155.94 114.27 3.4 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.59 166.35 21.98 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 175.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 m -157.53 52.76 0.47 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.147 0.979 . . . . 0.0 108.79 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t -77.34 -170.88 1.89 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.153 0.981 . . . . 0.0 110.461 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.69 129.78 6.46 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 176.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.95 137.21 31.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 169.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.11 89.11 0.07 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.09 152.95 67.82 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.292 1.994 . . . . 0.0 110.937 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.41 170.57 34.0 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 128.058 2.742 . . . . 0.0 106.668 169.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.89 -6.27 0.09 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.578 1.189 . . . . 0.0 113.784 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.65 -177.43 3.36 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.339 1.056 . . . . 0.0 108.867 -173.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -73.89 111.18 8.8 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 154.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -123.56 -147.99 0.39 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.197 1.399 . . . . 0.0 108.487 -171.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -118.74 138.47 52.63 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.289 1.436 . . . . 0.0 107.528 169.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.75 HD22 ' HD2' ' A' ' 77' ' ' LYS . 7.8 mt -129.35 146.21 51.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -173.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -85.25 111.57 19.97 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 119.624 1.102 . . . . 0.0 108.577 171.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.9 p -69.18 -39.43 78.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 121.22 -0.925 . . . . 0.0 111.915 -175.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 -21.49 63.83 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.508 1.049 . . . . 0.0 112.119 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 2.5 tp10 -75.67 -55.36 5.72 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.727 1.611 . . . . 0.0 107.088 172.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.468 HD11 ' HB3' ' A' ' 17' ' ' LEU . 84.3 mt -53.96 -44.22 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 119.779 1.172 . . . . 0.0 109.427 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.63 -53.76 50.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.754 1.221 . . . . 0.0 111.248 173.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -57.57 -53.46 57.9 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.284 1.034 . . . . 0.0 110.539 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -58.48 -43.43 88.98 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.618 2.367 . . . . 0.0 110.624 -176.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.64 -55.03 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.112 0 O-C-N 120.861 -1.15 . . . . 0.0 109.023 172.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -51.47 -46.06 62.96 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.324 0.965 . . . . 0.0 110.932 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.97 -40.03 75.62 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 116.565 -1.683 . . . . 0.0 111.927 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -64.35 -36.16 83.23 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 121.627 2.012 . . . . 0.0 111.451 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.5 mt -61.07 -52.07 66.5 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 174.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 mt -65.02 -28.46 69.51 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -58.24 -36.34 73.05 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 124.963 1.305 . . . . 0.0 109.809 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -121.77 8.27 9.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.248 1.019 . . . . 0.0 112.405 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 52.3 79.29 0.11 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 128.04 2.536 . . . . 0.0 111.876 -169.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.563 HD11 ' HG3' ' A' ' 90' ' ' ARG . 70.7 mt -121.89 150.37 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.72 141.88 15.76 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.931 0.777 . . . . 0.0 111.269 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -57.81 -33.1 68.22 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.21 1.404 . . . . 0.0 112.253 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.7 ttt-85 -59.01 -62.8 1.61 Allowed 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.274 174.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.49 -36.48 64.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 119.968 1.258 . . . . 0.0 111.066 -176.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -59.78 -53.93 52.18 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 120.531 -1.356 . . . . 0.0 110.637 172.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.483 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -68.11 -24.22 74.62 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-O 118.017 -1.435 . . . . 0.0 112.62 -177.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -81.3 -20.45 40.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.838 1.819 . . . . 0.0 111.429 -176.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -120.94 -51.42 2.13 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.327 0.967 . . . . 0.0 112.289 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.1 t -68.84 -52.16 37.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.6 mt -93.89 -29.06 15.49 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.208 -173.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.08 18.12 76.21 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 122.892 0.282 . . . . 0.0 112.563 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.7 169.9 8.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.558 1.543 . . . . 0.0 107.789 -178.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.3 156.78 37.0 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 168.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -53.78 -51.15 64.33 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.205 0.602 . . . . 0.0 110.024 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.5 -26.44 68.2 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.321 -0.71 . . . . 0.0 112.54 -174.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 m -63.74 -69.05 0.3 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.483 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.2 m -56.65 -35.93 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 120.367 1.44 . . . . 0.0 112.59 -175.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t -60.78 -40.2 91.68 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.272 1.829 . . . . 0.0 110.576 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.84 -47.0 87.49 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.139 1.336 . . . . 0.0 109.272 167.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.0 mt -61.43 -31.8 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 99.3 mt -84.7 -22.66 29.68 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.944 0.897 . . . . 0.0 112.608 176.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.45 -49.16 23.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.802 1.241 . . . . 0.0 110.121 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.9 mtt85 -135.04 86.84 30.87 Favored Pre-proline 0 CA--C 1.516 -0.339 0 C-N-CA 125.373 1.469 . . . . 0.0 107.865 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.24 93.56 0.48 Allowed 'Trans proline' 0 N--CA 1.445 -1.335 0 N-CA-C 107.05 -1.942 . . . . 0.0 107.05 167.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -65.53 158.44 73.66 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -72.33 152.17 55.03 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.04 2.494 . . . . 0.0 108.958 -167.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.42 ' CD2' ' HE2' ' A' ' 70' ' ' LYS . 74.7 t-105 -52.43 -41.28 63.11 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.649 0.38 . . . . 0.0 111.478 175.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -18.02 58.11 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -89.03 -37.1 15.41 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 120.831 -1.168 . . . . 0.0 110.852 177.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.7 mt -74.69 146.15 42.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.543 0.687 . . . . 0.0 110.656 -162.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 t -71.3 174.59 6.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.289 1.035 . . . . 0.0 110.671 166.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.0 p -49.69 -56.09 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 C-N-CA 124.423 1.089 . . . . 0.0 111.586 170.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -70.12 -5.07 24.42 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.62 -41.63 7.21 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.814 1.673 . . . . 0.0 110.288 167.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HE2' ' CD2' ' A' ' 62' ' ' TRP . 88.1 mttt -76.84 -26.1 53.92 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 126.264 1.825 . . . . 0.0 112.497 -178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -40.99 -62.04 1.12 Allowed Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 127.266 2.226 . . . . 0.0 110.698 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -61.73 -44.5 21.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.393 2.062 . . . . 0.0 110.365 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -60.63 -39.93 90.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 117.67 -1.157 . . . . 0.0 112.845 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.9 mt -56.14 -51.59 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -59.65 -46.9 87.63 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.456 1.102 . . . . 0.0 110.861 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 70.5 mtm -61.84 -48.14 81.88 Favored 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 123.868 0.867 . . . . 0.0 110.823 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.75 ' HD2' HD22 ' A' ' 17' ' ' LEU . 10.3 tttt -60.78 -40.89 94.27 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.116 -0.99 . . . . 0.0 110.494 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -67.55 -36.01 80.15 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.116 0.967 . . . . 0.0 111.232 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 24.4 t80 -57.25 -48.04 79.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.011 0.925 . . . . 0.0 109.015 173.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.8 mt -71.07 -13.14 61.87 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.791 1.236 . . . . 0.0 113.631 -177.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -25.73 68.21 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.146 0.885 . . . . 0.0 111.947 173.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -145.72 105.17 3.95 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -162.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -61.13 -23.24 65.38 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.382 0.673 . . . . 0.0 111.011 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -60.09 -23.42 63.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 119.783 -1.823 . . . . 0.0 112.036 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.446 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 71.3 m-80 -62.45 -38.89 91.52 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.066 1.303 . . . . 0.0 111.48 175.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 p -73.19 -35.4 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.608 1.094 . . . . 0.0 109.506 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.9 mt -70.52 -23.65 62.68 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.288 1.035 . . . . 0.0 111.283 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.3 -49.26 35.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.125 0.97 . . . . 0.0 110.615 167.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.88 -28.93 69.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.336 1.454 . . . . 0.0 111.549 -170.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.563 ' HG3' HD11 ' A' ' 35' ' ' ILE . 68.4 mtp180 -57.45 -46.15 83.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.4 m -60.54 -37.51 81.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.653 0.781 . . . . 0.0 110.362 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mt -68.28 -30.3 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.353 0.978 . . . . 0.0 109.974 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -69.99 -45.54 67.09 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.684 -0.635 . . . . 0.0 111.372 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.254 0.3 OUTLIER -63.31 -20.9 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 120.085 1.311 . . . . 0.0 111.165 172.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.8 mtt85 -87.86 20.22 3.17 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.536 1.535 . . . . 0.0 112.208 171.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 85.3 p -77.64 17.76 0.51 Allowed 'General case' 0 CA--C 1.547 0.854 0 O-C-N 119.985 -1.697 . . . . 0.0 113.575 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -140.84 -178.38 17.17 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 127.545 2.498 . . . . 0.0 109.326 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -79.65 57.9 6.71 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 124.381 3.387 . . . . 0.0 109.324 173.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.1 m 56.52 161.66 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.049 1.74 . . . . 0.0 113.134 -152.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.1 m 52.15 32.19 10.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.802 1.641 . . . . 0.0 114.621 171.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.349 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 151.254 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.658 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.4 m -150.04 165.8 31.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.868 1.267 . . . . 0.0 107.868 169.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.93 -177.41 6.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 172.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.34 -172.94 36.08 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 -167.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 p -147.67 150.09 33.7 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 117.449 0.624 . . . . 0.0 109.666 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.7 m -159.57 154.93 25.43 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.826 2.05 . . . . 0.0 110.019 167.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.16 76.56 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 107.049 -2.42 . . . . 0.0 107.049 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -158.18 108.35 2.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -174.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.63 82.52 0.11 Allowed Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.32 -1.267 . . . . 0.0 110.994 -173.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -66.49 166.03 23.11 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.024 2.483 . . . . 0.0 109.923 172.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 175.78 100.45 0.13 Allowed Glycine 0 C--N 1.333 0.398 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.68 -169.2 2.35 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.404 1.481 . . . . 0.0 107.893 174.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 58.86 -164.58 0.2 Allowed 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.522 0.729 . . . . 0.0 111.213 -178.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -100.33 101.79 12.86 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -105.23 -145.3 0.38 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 127.595 2.358 . . . . 0.0 110.263 -162.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -108.52 124.19 50.07 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.891 1.276 . . . . 0.0 108.465 168.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.456 ' HB3' HD11 ' A' ' 22' ' ' ILE . 5.3 mt -109.66 144.14 38.42 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.95 98.35 4.9 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.371 0.987 . . . . 0.0 108.571 175.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.4 p -58.34 -43.42 88.3 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.678 -1.264 . . . . 0.0 112.241 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.1 -26.24 66.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 118.805 -0.617 . . . . 0.0 110.992 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -70.86 -57.87 4.18 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 171.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.456 HD11 ' HB3' ' A' ' 17' ' ' LEU . 64.0 mt -54.92 -44.76 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.659 1.118 . . . . 0.0 109.936 -173.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.35 -51.73 68.66 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.914 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.537 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 81.9 t80 -53.19 -68.66 0.15 Allowed 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 125.292 1.437 . . . . 0.0 108.556 175.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -41.79 -46.04 3.76 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.955 2.502 . . . . 0.0 112.458 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.65 -50.08 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.951 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 47.9 mtmt -48.26 -45.85 34.99 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.421 1.464 . . . . 0.0 109.864 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.59 -54.8 30.31 Favored 'General case' 0 C--O 1.225 -0.186 0 O-C-N 124.451 1.094 . . . . 0.0 110.688 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -56.02 -40.58 73.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.889 1.676 . . . . 0.0 112.433 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.2 mt -65.57 -49.67 68.0 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.8 -37.35 65.98 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.824 0.738 . . . . 0.0 111.831 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -55.39 -25.33 34.9 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 126.832 2.053 . . . . 0.0 112.922 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -126.45 16.43 7.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.153 0.981 . . . . 0.0 111.909 175.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.4 m120 40.22 75.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 129.686 3.194 . . . . 0.0 111.481 -166.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.417 HD11 ' CG ' ' A' ' 90' ' ' ARG . 91.8 mt -114.66 152.22 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -99.22 172.64 25.58 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -95.09 -20.19 19.51 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -172.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -58.82 -55.24 37.64 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 118.854 0.752 . . . . 0.0 110.229 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 t -60.0 -53.65 45.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -54.26 -45.1 72.32 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.819 1.191 . . . . 0.0 111.015 -174.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.407 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -71.65 -24.5 76.67 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-O 117.273 -1.849 . . . . 0.0 112.882 177.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -79.71 -37.48 35.55 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.569 2.185 . . . . 0.0 111.632 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -91.21 -70.4 0.69 Allowed 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.486 -0.759 . . . . 0.0 109.5 -176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.9 t -58.15 -50.44 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 125.087 1.355 . . . . 0.0 108.342 -172.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.572 HD21 ' SD ' ' A' ' 76' ' ' MET . 57.4 mt -95.73 -37.18 10.89 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.612 -170.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.61 6.03 86.08 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 118.501 0.591 . . . . 0.0 113.713 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 77.6 mt -92.02 173.74 7.68 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.993 1.717 . . . . 0.0 109.438 -172.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 t -63.66 154.14 33.91 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.549 0.69 . . . . 0.0 109.845 164.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -62.98 -22.84 67.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.343 1.457 . . . . 0.0 111.449 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.09 -59.9 4.43 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 171.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.1 m -49.47 -52.57 28.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 116.728 -1.606 . . . . 0.0 112.041 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.407 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.8 m -66.38 -37.87 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 121.495 1.952 . . . . 0.0 113.375 177.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.8 t -60.2 -34.93 74.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 118.419 -0.8 . . . . 0.0 110.521 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -57.96 -48.98 78.36 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.073 0.851 . . . . 0.0 110.758 168.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.432 HG23 ' CZ ' ' A' ' 73' ' ' PHE . 5.5 mt -58.16 -39.63 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.2 mt -77.65 -35.06 52.9 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.964 1.306 . . . . 0.0 113.779 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.5 -60.45 3.13 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 176.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -134.67 72.7 68.9 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 125.064 1.346 . . . . 0.0 108.792 -165.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.04 108.0 1.23 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 122.57 2.18 . . . . 0.0 106.655 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -66.92 159.66 74.52 Favored Pre-proline 0 N--CA 1.439 -1.001 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 163.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -67.26 149.2 81.3 Favored 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 122.529 2.153 . . . . 0.0 109.316 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -45.48 -46.71 13.86 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.56 1.544 . . . . 0.0 111.148 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -56.74 -32.38 65.51 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -71.52 -29.46 64.81 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.389 0.995 . . . . 0.0 111.319 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.4 mt -80.93 157.89 25.43 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.439 0.638 . . . . 0.0 111.249 -160.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.9 p -78.9 175.45 10.52 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.716 0.806 . . . . 0.0 108.917 165.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.4 m -53.79 -50.65 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.001 1.32 . . . . 0.0 112.39 170.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -72.6 -19.78 61.41 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 120.146 -1.596 . . . . 0.0 112.251 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.84 96.78 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 163.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -85.3 -28.17 25.46 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 117.215 -1.374 . . . . 0.0 113.089 -176.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -45.04 -52.26 20.36 Favored Pre-proline 0 N--CA 1.468 0.435 0 C-N-CA 124.564 1.146 . . . . 0.0 111.964 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.76 -52.02 4.21 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 121.374 1.383 . . . . 0.0 110.065 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CZ ' HG23 ' A' ' 55' ' ' ILE . 78.4 m-85 -59.51 -32.86 70.68 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 117.71 -1.138 . . . . 0.0 113.082 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.4 mt -61.16 -56.5 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 171.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -53.71 -43.79 69.31 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.541 1.136 . . . . 0.0 111.089 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.572 ' SD ' HD21 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -66.24 -45.25 81.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 120.12 -1.613 . . . . 0.0 114.711 172.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.8 tttm -63.48 -33.77 76.3 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.343 -1.473 . . . . 0.0 109.911 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -62.44 -49.57 74.92 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.224 1.809 . . . . 0.0 110.074 172.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -51.52 -48.7 62.9 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.25 1.42 . . . . 0.0 110.332 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.85 -8.57 29.83 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.382 1.073 . . . . 0.0 113.882 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.6 t -68.99 -25.07 64.34 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.183 -0.948 . . . . 0.0 111.942 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -147.45 141.11 25.59 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.913 1.233 . . . . 0.0 108.958 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.474 ' O ' HG12 ' A' ' 86' ' ' VAL . 18.9 tt0 -62.32 -32.68 73.47 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.237 1.015 . . . . 0.0 111.194 -175.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.645 ' HA ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -56.18 -30.05 61.7 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.827 -1.171 . . . . 0.0 110.864 -175.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -64.0 -36.13 82.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 118.687 0.676 . . . . 0.0 110.245 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 83' ' ' GLU . 10.0 p -77.37 -31.5 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.114 -0.991 . . . . 0.0 110.469 175.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 84' ' ' GLN . 42.1 mt -61.85 -41.4 97.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.838 0.855 . . . . 0.0 109.827 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.78 84.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 123.218 0.607 . . . . 0.0 110.106 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.09 -30.24 70.22 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.158 177.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.417 ' CG ' HD11 ' A' ' 35' ' ' ILE . 71.3 mtp180 -61.0 -43.64 98.59 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 119.612 1.096 . . . . 0.0 109.835 174.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.5 m -53.09 -49.16 67.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.324 0.65 . . . . 0.0 110.094 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.3 mt -64.55 -34.4 69.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.417 -0.802 . . . . 0.0 110.423 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -67.25 -35.27 79.2 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.05 177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.2 m -64.08 -39.21 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 120.147 1.34 . . . . 0.0 108.854 168.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 mtt85 -76.21 8.04 3.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.796 0.838 . . . . 0.0 112.296 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.7 t -70.82 142.82 51.27 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.17 -164.13 12.63 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.261 1.41 . . . . 0.0 111.977 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -66.86 156.75 64.69 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.569 2.846 . . . . 0.0 110.595 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.1 t 146.27 131.0 0.0 OUTLIER 'General case' 0 C--O 1.236 0.379 0 C-N-CA 130.718 3.607 . . . . 0.0 106.053 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.8 t -146.97 157.83 43.74 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 167.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.758 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -172.682 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.875 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 t -162.41 146.07 11.69 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 -176.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.4 t -157.65 179.8 8.89 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.25 0.932 . . . . 0.0 108.97 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.05 144.03 11.12 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 125.546 1.546 . . . . 0.0 112.993 171.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -149.52 -49.76 0.14 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.191 0.997 . . . . 0.0 110.452 166.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 m 57.42 -175.38 0.07 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.485 1.114 . . . . 0.0 110.976 -158.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.18 98.02 0.52 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -136.68 126.84 26.25 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.267 1.827 . . . . 0.0 108.519 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.21 73.88 0.42 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-O 118.731 -1.038 . . . . 0.0 111.453 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.38 143.78 59.34 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 122.004 1.802 . . . . 0.0 110.565 171.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.45 -173.64 16.9 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 127.242 2.353 . . . . 0.0 109.044 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.8 15.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.255 1.822 . . . . 0.0 112.141 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -129.92 174.46 9.72 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 120.339 -1.475 . . . . 0.0 110.867 -175.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -66.72 113.17 4.63 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 162.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -130.74 -152.24 0.5 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.662 1.985 . . . . 0.0 109.685 -168.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -100.31 110.13 22.35 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.243 1.017 . . . . 0.0 110.845 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.404 ' HB3' HD11 ' A' ' 22' ' ' ILE . 8.4 mt -99.28 149.85 22.7 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.037 0.935 . . . . 0.0 109.577 -173.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.76 95.74 4.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 122.372 1.082 . . . . 0.0 108.483 175.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.6 p -61.21 -42.55 98.8 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.287 -0.883 . . . . 0.0 111.374 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.52 -34.91 73.23 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.973 0.909 . . . . 0.0 110.92 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -70.82 -54.18 12.54 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.404 HD11 ' HB3' ' A' ' 17' ' ' LEU . 67.1 mt -55.93 -42.75 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -177.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.98 -55.78 28.65 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.159 0.984 . . . . 0.0 110.765 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -53.08 -62.73 1.47 Allowed 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.117 1.367 . . . . 0.0 110.276 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -55.47 -36.61 66.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.059 1.743 . . . . 0.0 113.381 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.448 HG23 HD11 ' A' ' 80' ' ' LEU . 24.1 t -63.9 -47.59 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 174.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -58.14 -37.93 75.6 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 116.986 -1.483 . . . . 0.0 110.465 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -61.11 -58.11 9.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.4 1.0 . . . . 0.0 110.559 173.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -61.66 -34.23 75.36 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.214 -0.929 . . . . 0.0 112.127 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.3 mt -72.08 -33.87 68.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.174 1.79 . . . . 0.0 109.753 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 mt -65.45 -37.63 87.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 120.06 1.3 . . . . 0.0 112.177 168.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.48 ' HZ2' ' CE1' ' A' ' 33' ' ' HIS . 55.0 tttm -58.26 -36.38 73.16 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.107 1.763 . . . . 0.0 113.459 -163.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.48 ' CE1' ' HZ2' ' A' ' 32' ' ' LYS . 78.9 m-70 -124.41 12.3 8.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.915 2.486 . . . . 0.0 111.406 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.3 m120 44.18 78.48 0.06 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.874 2.469 . . . . 0.0 111.506 -171.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.1 mt -116.87 151.68 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 173.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.88 151.01 19.92 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.706 0.615 . . . . 0.0 111.735 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -57.81 -38.05 74.85 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.237 1.415 . . . . 0.0 110.668 174.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -56.76 -61.14 2.64 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.801 -1.095 . . . . 0.0 110.614 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 t -55.96 -49.0 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 119.48 1.036 . . . . 0.0 109.358 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.36 -47.1 79.56 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.918 0.781 . . . . 0.0 111.541 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.429 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -70.17 -31.19 69.17 Favored Glycine 0 N--CA 1.433 -1.542 0 CA-C-O 118.275 -1.291 . . . . 0.0 111.264 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -71.09 -30.07 66.08 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.738 1.769 . . . . 0.0 111.056 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -108.39 -57.83 2.07 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 124.189 0.995 . . . . 0.0 113.035 -171.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.0 t -71.6 -48.27 53.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -175.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.481 HD21 ' HG2' ' A' ' 76' ' ' MET . 20.9 mt -93.17 -29.5 15.7 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 122.045 -0.409 . . . . 0.0 111.737 -171.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.06 19.76 79.72 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 119.374 -0.681 . . . . 0.0 112.149 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.4 mt -109.14 165.03 11.91 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 125.005 1.322 . . . . 0.0 107.603 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.53 162.06 29.97 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.071 0.939 . . . . 0.0 109.342 174.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -49.72 75.78 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.071 0.948 . . . . 0.0 110.692 -172.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.57 -41.56 95.61 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.4 m -55.95 -67.17 0.32 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 117.459 -1.258 . . . . 0.0 110.886 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.429 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.8 m -55.46 -36.24 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 121.261 1.846 . . . . 0.0 112.884 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.1 m -68.87 -23.69 64.25 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 117.792 -1.099 . . . . 0.0 112.669 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -66.67 -45.69 78.09 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.481 1.491 . . . . 0.0 108.552 162.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.2 mt -60.81 -40.42 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt -74.56 -31.5 62.11 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.399 1.079 . . . . 0.0 112.589 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.12 -50.31 64.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.536 0.734 . . . . 0.0 109.704 173.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.4 mtp85 -136.9 78.32 41.81 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 125.23 1.412 . . . . 0.0 108.516 -166.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.15 107.67 1.98 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.151 1.901 . . . . 0.0 107.39 169.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -64.32 173.51 1.48 Allowed Pre-proline 0 N--CA 1.442 -0.856 0 C-N-CA 124.342 1.057 . . . . 0.0 109.022 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -59.3 142.37 99.03 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.826 1.684 . . . . 0.0 108.699 165.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -54.37 -49.18 70.43 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.829 1.195 . . . . 0.0 110.494 172.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -21.32 4.73 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 mmtm -77.47 -31.06 53.47 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 120.359 -1.463 . . . . 0.0 111.383 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 mt -70.24 151.46 45.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.746 0.784 . . . . 0.0 109.549 -172.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.7 t -84.47 179.53 7.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 160.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.05 -57.11 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 125.098 1.359 . . . . 0.0 110.782 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -64.86 -19.44 65.89 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.836 -1.165 . . . . 0.0 112.863 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.16 -50.01 69.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 126.118 1.818 . . . . 0.0 111.769 165.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -74.62 -25.58 59.32 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 125.046 1.339 . . . . 0.0 112.338 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -43.72 -54.77 9.97 Favored Pre-proline 0 N--CA 1.446 -0.669 0 C-N-CA 127.083 2.153 . . . . 0.0 112.094 -174.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.15 -47.83 5.77 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.083 1.856 . . . . 0.0 110.557 177.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -59.88 -36.6 77.28 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 117.901 -1.047 . . . . 0.0 112.73 -176.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.7 mt -60.75 -55.02 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 174.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -55.75 -45.85 77.96 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 123.389 0.675 . . . . 0.0 109.751 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.481 ' HG2' HD21 ' A' ' 45' ' ' LEU . 66.3 mtm -59.5 -52.74 64.27 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 123.403 0.681 . . . . 0.0 111.437 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -60.01 -40.05 87.91 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.983 -1.073 . . . . 0.0 111.589 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -70.03 -31.96 69.86 Favored 'General case' 0 C--O 1.229 -0.025 0 C-N-CA 123.588 0.755 . . . . 0.0 111.42 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.521 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 22.8 t80 -61.56 -50.91 70.73 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.722 1.209 . . . . 0.0 108.123 171.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.448 HD11 HG23 ' A' ' 26' ' ' VAL . 36.1 mt -72.43 4.54 3.69 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.959 1.703 . . . . 0.0 113.241 175.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -91.02 -6.37 54.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 117.722 -1.132 . . . . 0.0 110.773 168.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.79 107.05 1.28 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 120.329 1.422 . . . . 0.0 109.389 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -55.13 -20.76 10.92 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.983 1.313 . . . . 0.0 113.945 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -58.94 -23.57 61.62 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 121.248 1.84 . . . . 0.0 111.204 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.521 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 65.4 m-80 -64.85 -48.2 75.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.163 0.985 . . . . 0.0 111.325 173.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.1 p -65.45 -37.36 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.088 1.313 . . . . 0.0 109.565 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.5 mt -65.72 -30.1 70.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.586 0.754 . . . . 0.0 110.036 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.22 -45.46 73.22 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.849 0.86 . . . . 0.0 111.23 170.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.443 HD22 HD12 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -66.23 -24.25 66.57 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.497 1.119 . . . . 0.0 111.15 -175.385 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 28.5 mtm105 -55.15 -52.88 61.89 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.827 0.74 . . . . 0.0 109.929 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.5 m -54.95 -41.29 70.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.486 1.514 . . . . 0.0 110.245 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.443 HD12 HD22 ' A' ' 89' ' ' LEU . 58.5 mt -67.52 -35.58 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.243 -0.911 . . . . 0.0 110.111 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -60.67 -47.51 85.92 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.097 0.862 . . . . 0.0 110.774 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 94' ' ' VAL . 2.0 p -68.07 -19.73 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 O-C-N 121.852 -0.53 . . . . 0.0 111.676 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.08 16.91 16.71 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.872 -1.143 . . . . 0.0 111.849 168.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.8 t -59.63 146.1 42.2 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 120.305 1.411 . . . . 0.0 107.717 171.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.38 -167.57 21.85 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 126.199 1.856 . . . . 0.0 112.082 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.15 155.95 47.98 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.067 1.845 . . . . 0.0 109.322 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 75.8 m -125.85 -179.85 4.87 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.039 1.336 . . . . 0.0 107.706 172.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.4 p -142.73 35.65 1.43 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.052 0.941 . . . . 0.0 108.846 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -176.101 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.791 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.7 t -156.4 122.76 5.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.689 1.595 . . . . 0.0 107.746 -174.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 t 58.09 112.14 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.854 2.462 . . . . 0.0 110.187 -163.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.12 109.4 0.4 Allowed Glycine 0 C--N 1.339 0.727 0 O-C-N 121.317 -0.864 . . . . 0.0 113.567 -167.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.3 m -63.87 -41.34 97.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.215 1.006 . . . . 0.0 113.322 170.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 32.71 51.59 0.26 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.871 2.068 . . . . 0.0 113.46 -172.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.5 157.37 29.71 Favored Glycine 0 C--N 1.335 0.498 0 O-C-N 120.618 -1.301 . . . . 0.0 112.441 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -144.01 94.26 2.56 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 174.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 69.76 -164.43 51.3 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 -169.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -56.27 171.42 0.88 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 123.361 2.707 . . . . 0.0 114.448 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.92 174.16 27.73 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 172.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.13 -168.77 1.82 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.061 2.144 . . . . 0.0 107.857 177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.53 ' HG2' ' H ' ' A' ' 14' ' ' GLU . 8.4 tt0 56.11 -153.98 0.33 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.88 1.272 . . . . 0.0 110.983 -176.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.53 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 15.7 pt-20 -112.12 142.83 44.09 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 169.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -150.91 179.48 8.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.234 1.014 . . . . 0.0 108.488 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -66.81 136.29 55.22 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.288 0.495 . . . . 0.0 110.505 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.534 ' HB3' HD11 ' A' ' 22' ' ' ILE . 12.5 mt -127.86 141.21 51.62 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -75.29 97.79 3.65 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.414 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 23.3 p -59.58 -36.32 76.01 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 121.175 -0.953 . . . . 0.0 112.173 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.18 -28.45 66.42 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 118.912 0.778 . . . . 0.0 110.998 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -77.79 -49.42 14.39 Favored 'General case' 0 C--O 1.215 -0.753 0 C-N-CA 125.188 1.395 . . . . 0.0 108.423 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 17' ' ' LEU . 74.8 mt -56.32 -46.52 81.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.0 -53.17 59.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 121.533 -0.729 . . . . 0.0 110.492 174.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -57.45 -58.07 9.88 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.241 1.016 . . . . 0.0 111.174 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -56.39 -39.03 72.31 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.356 2.262 . . . . 0.0 111.02 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.513 HG23 HD11 ' A' ' 80' ' ' LEU . 16.8 t -63.73 -51.77 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 120.227 -1.546 . . . . 0.0 110.002 172.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -59.4 -43.67 92.93 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.84 -0.537 . . . . 0.0 110.348 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.58 -49.7 76.47 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.355 0.662 . . . . 0.0 109.918 178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -54.91 -47.58 74.19 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.307 1.843 . . . . 0.0 113.645 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.7 mt -60.8 -43.51 98.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 121.12 -0.987 . . . . 0.0 108.479 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -41.81 99.28 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 120.026 1.285 . . . . 0.0 112.406 172.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -58.37 -39.91 80.86 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.763 2.825 . . . . 0.0 111.051 -173.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -115.07 13.23 16.84 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.246 0.619 . . . . 0.0 112.319 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 49.7 t30 38.7 77.2 0.05 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.189 2.596 . . . . 0.0 112.859 -170.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.553 HG23 HE21 ' A' ' 93' ' ' GLN . 85.8 mt -119.0 149.89 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.527 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -89.57 142.56 16.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.905 0.764 . . . . 0.0 111.378 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -36.47 77.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.323 1.049 . . . . 0.0 112.874 -175.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -55.92 -57.32 12.57 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 119.211 0.914 . . . . 0.0 110.022 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -57.9 -44.06 85.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 118.518 0.599 . . . . 0.0 109.689 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -54.54 -50.61 67.5 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.679 -0.638 . . . . 0.0 112.005 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.436 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -71.57 -26.03 73.97 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-O 117.697 -1.613 . . . . 0.0 112.145 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -79.11 -32.09 44.41 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.649 1.725 . . . . 0.0 111.271 -176.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -108.33 -44.95 4.0 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.238 1.015 . . . . 0.0 113.319 -174.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.0 t -79.01 -46.07 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.51 HD21 ' HG2' ' A' ' 76' ' ' MET . 21.7 mt -98.05 -30.85 12.45 Favored 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.068 0.23 . . . . 0.0 111.489 -171.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.29 4.21 90.27 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 123.97 0.794 . . . . 0.0 112.662 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 73.4 mt -93.23 178.63 5.67 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.61 1.564 . . . . 0.0 109.512 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 p -72.75 159.65 33.47 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.655 -0.653 . . . . 0.0 109.701 169.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -51.95 -44.2 63.84 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.952 1.301 . . . . 0.0 109.378 167.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -55.4 -54.88 31.52 Favored Glycine 0 C--N 1.338 0.686 0 C-N-CA 125.073 1.32 . . . . 0.0 111.697 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.2 m -56.46 -64.85 0.73 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 117.684 -1.15 . . . . 0.0 110.697 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.436 HG11 ' HA3' ' A' ' 41' ' ' GLY . 4.2 m -58.08 -36.82 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 120.524 1.511 . . . . 0.0 111.872 -172.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.2 m -62.91 -29.28 70.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 117.09 -1.433 . . . . 0.0 112.979 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.02 -48.71 77.61 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 120.363 1.438 . . . . 0.0 108.887 166.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.7 -42.6 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 69.9 mt -77.83 -27.27 49.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.784 0.834 . . . . 0.0 113.0 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.71 -41.91 61.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.067 1.347 . . . . 0.0 111.257 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.32 82.43 9.72 Favored Pre-proline 0 N--CA 1.452 -0.353 0 C-N-CA 126.813 2.045 . . . . 0.0 107.352 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.49 95.66 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.648 2.232 . . . . 0.0 107.484 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -61.76 157.44 49.04 Favored Pre-proline 0 N--CA 1.443 -0.81 0 O-C-N 121.016 -1.052 . . . . 0.0 108.799 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.05 149.14 92.41 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 122.725 2.284 . . . . 0.0 108.536 -174.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.409 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 66.4 t-105 -56.21 -44.05 79.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.524 0.602 . . . . 0.0 110.573 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -12.63 9.26 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.57 -7.05 45.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.713 1.605 . . . . 0.0 113.61 175.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.5 mt -106.4 151.14 25.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.622 0.769 . . . . 0.0 110.517 -173.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 p -85.68 179.06 7.16 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.218 1.007 . . . . 0.0 109.784 171.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 t -52.07 -43.46 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 121.199 -0.938 . . . . 0.0 111.339 165.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -63.91 -42.1 97.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 118.52 0.6 . . . . 0.0 109.981 175.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.88 -31.34 67.91 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-O 119.193 -0.782 . . . . 0.0 113.526 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -91.37 -18.55 24.1 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.733 1.613 . . . . 0.0 111.987 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -42.22 -56.33 5.52 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 127.05 2.14 . . . . 0.0 111.874 175.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -66.86 -45.05 4.68 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.502 1.468 . . . . 0.0 110.349 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 58.9 m-85 -64.86 -34.42 78.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.316 -1.326 . . . . 0.0 112.517 -173.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.88 -53.94 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 120.068 1.304 . . . . 0.0 107.683 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -53.04 -45.79 68.18 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.757 0.823 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.51 ' HG2' HD21 ' A' ' 45' ' ' LEU . 69.9 mtm -63.44 -49.75 72.47 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.274 -0.891 . . . . 0.0 111.787 176.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.492 ' HD2' HD22 ' A' ' 17' ' ' LEU . 18.7 tttm -58.59 -40.56 83.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.02 -1.05 . . . . 0.0 110.343 -178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -64.77 -44.75 89.0 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.527 1.131 . . . . 0.0 110.23 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.472 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 51.6 t80 -52.38 -45.05 65.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.49 1.116 . . . . 0.0 110.919 173.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.513 HD11 HG23 ' A' ' 26' ' ' VAL . 57.8 mt -78.26 -9.72 59.35 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.819 1.248 . . . . 0.0 113.686 -176.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.3 t -75.66 -11.99 60.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.762 0.825 . . . . 0.0 111.014 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -162.86 95.43 0.88 Allowed 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 120.989 -1.069 . . . . 0.0 108.279 -155.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.74 -29.34 18.21 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.904 1.282 . . . . 0.0 111.098 -173.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -54.25 -22.86 12.78 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.256 -1.527 . . . . 0.0 113.884 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.472 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 33.4 m-80 -66.34 -44.52 83.06 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.447 1.021 . . . . 0.0 111.917 171.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.17 -36.6 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 120.572 -1.33 . . . . 0.0 109.755 -175.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -34.97 71.2 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.788 2.035 . . . . 0.0 110.521 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.83 -45.01 60.71 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.637 1.175 . . . . 0.0 111.978 172.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.57 -29.43 67.94 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 120.93 -1.106 . . . . 0.0 110.793 177.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.427 ' HG3' HD11 ' A' ' 35' ' ' ILE . 38.8 mtp-105 -61.76 -41.04 97.18 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 118.406 -0.807 . . . . 0.0 110.225 173.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 m -58.31 -45.63 87.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 120.267 1.394 . . . . 0.0 109.784 173.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.8 mt -60.16 -32.68 51.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 118.927 0.785 . . . . 0.0 109.886 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.553 HE21 HG23 ' A' ' 35' ' ' ILE . 11.5 tp-100 -72.54 -42.24 64.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.036 -1.04 . . . . 0.0 112.458 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.254 0.2 OUTLIER -68.05 -19.74 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 119.659 1.118 . . . . 0.0 110.763 170.606 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -85.88 -2.03 57.86 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.626 1.17 . . . . 0.0 113.288 170.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 45.5 t -66.75 -26.09 66.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.527 1.058 . . . . 0.0 112.17 -165.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.7 -168.85 32.21 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.44 87.48 0.41 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.959 2.439 . . . . 0.0 110.743 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.6 t 54.88 49.6 17.45 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.246 1.818 . . . . 0.0 112.317 168.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.1 m -52.54 -45.06 66.19 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -170.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -167.313 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.877 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.64 -67.51 0.48 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.488 1.144 . . . . 0.0 109.276 173.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -68.37 153.19 44.25 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.876 0.846 . . . . 0.0 110.154 175.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.0 158.07 42.01 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 159.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.1 t -63.83 -50.78 67.53 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.918 0.487 . . . . 0.0 110.937 -174.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t 50.53 175.26 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.772 0.829 . . . . 0.0 111.343 -144.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.52 163.26 2.75 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.974 1.274 . . . . 0.0 115.69 171.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 178.12 74.79 0.01 OUTLIER 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.47 2.308 . . . . 0.0 109.817 172.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 153.22 156.77 7.74 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.466 1.031 . . . . 0.0 112.47 160.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.51 113.18 3.05 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.949 2.433 . . . . 0.0 109.373 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.83 99.58 0.37 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 124.79 1.186 . . . . 0.0 111.395 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.64 -177.08 6.24 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.841 2.057 . . . . 0.0 110.36 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 57.33 -179.86 0.05 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.212 1.805 . . . . 0.0 113.421 177.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -105.8 114.45 28.61 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 162.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.417 ' CG ' HD23 ' A' ' 17' ' ' LEU . 11.5 pt-20 -112.51 -155.44 0.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.287 2.235 . . . . 0.0 109.508 -176.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -110.51 85.49 2.12 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 168.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.703 HD22 ' HD2' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -63.4 154.62 31.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.112 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.54 101.38 14.07 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.099 -1.001 . . . . 0.0 110.068 175.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.416 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 24.1 p -65.25 -40.98 94.7 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 120.679 -1.263 . . . . 0.0 112.689 -172.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.03 -29.53 70.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.836 0.744 . . . . 0.0 110.854 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -76.71 -50.95 12.41 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.498 2.319 . . . . 0.0 108.522 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.0 mt -56.83 -45.96 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.94 0.896 . . . . 0.0 109.119 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.85 72.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.986 -1.071 . . . . 0.0 110.696 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -54.19 -65.94 0.48 Allowed 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.917 1.287 . . . . 0.0 109.057 177.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -44.04 -44.31 7.32 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.687 1.995 . . . . 0.0 112.556 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.97 -43.94 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 O-C-N 121.345 -0.847 . . . . 0.0 111.283 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG3' HD22 ' A' ' 56' ' ' LEU . 41.9 mtmt -55.24 -35.56 65.1 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.561 1.073 . . . . 0.0 109.593 175.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -67.61 -56.58 8.87 Favored 'General case' 0 CA--C 1.522 -0.121 0 C-N-CA 123.36 0.664 . . . . 0.0 110.937 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -59.21 -39.38 82.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.287 -0.863 . . . . 0.0 112.582 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.3 mt -62.42 -46.96 86.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 119.757 1.162 . . . . 0.0 108.091 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.18 -41.41 79.26 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.232 0.924 . . . . 0.0 111.472 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -53.98 -31.76 51.83 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.723 1.609 . . . . 0.0 114.072 -174.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -119.77 7.21 10.97 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.95 1.3 . . . . 0.0 112.524 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m120 51.38 79.47 0.1 Allowed 'General case' 0 C--O 1.232 0.18 0 C-N-CA 127.939 2.496 . . . . 0.0 111.226 -170.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.3 mt -119.64 137.27 54.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.638 0.732 . . . . 0.0 109.376 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.83 132.94 12.79 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 126.486 1.993 . . . . 0.0 109.805 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.549 HE21 HD12 ' A' ' 56' ' ' LEU . 8.1 mt-30 -54.01 -31.77 52.19 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.064 1.346 . . . . 0.0 113.265 -175.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -58.08 -48.56 79.78 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 117.576 -1.202 . . . . 0.0 111.341 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.8 t -60.27 -50.23 81.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 119.665 1.12 . . . . 0.0 108.839 -176.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -56.96 -40.59 76.75 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.656 -0.653 . . . . 0.0 111.665 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.4 ' CA ' HG11 ' A' ' 52' ' ' VAL . . . -71.23 -34.31 64.34 Favored Glycine 0 N--CA 1.437 -1.298 0 CA-C-O 117.596 -1.669 . . . . 0.0 111.592 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -70.02 -38.76 76.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.102 1.951 . . . . 0.0 110.548 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -97.61 -58.88 1.89 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.74 0.7 . . . . 0.0 112.667 -171.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.4 t -72.35 -47.13 54.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -172.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.505 HD21 ' SD ' ' A' ' 76' ' ' MET . 45.2 mt -89.31 -40.34 12.86 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 119.075 -0.488 . . . . 0.0 110.667 -174.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.47 22.01 71.21 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.766 -1.019 . . . . 0.0 111.753 -174.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.5 mt -110.62 160.05 17.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.424 1.89 . . . . 0.0 109.397 -174.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 m -63.72 152.6 38.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.575 1.15 . . . . 0.0 109.541 174.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -53.33 -43.06 67.35 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.11 0.964 . . . . 0.0 111.248 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.38 -10.4 80.02 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 118.076 -1.402 . . . . 0.0 113.368 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 m -68.26 -68.59 0.38 Allowed 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 119.869 1.835 . . . . 0.0 106.996 161.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.445 ' CG1' HD12 ' A' ' 45' ' ' LEU . 1.5 m -56.14 -37.7 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.449 1.477 . . . . 0.0 113.692 -171.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -42.84 94.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.859 177.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -47.01 74.83 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.448 1.022 . . . . 0.0 109.666 171.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 55' ' ' ILE . 13.7 mt -60.12 -43.96 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.549 HD12 HE21 ' A' ' 37' ' ' GLN . 92.8 mt -70.85 -35.72 72.54 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 124.747 1.219 . . . . 0.0 111.802 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.92 -51.7 30.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.059 1.744 . . . . 0.0 110.509 -177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -133.36 81.87 54.22 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 124.693 1.197 . . . . 0.0 108.898 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -69.3 95.55 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.707 2.938 . . . . 0.0 108.443 171.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -62.0 156.55 57.16 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 171.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -61.73 152.53 73.6 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.551 2.167 . . . . 0.0 108.218 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -53.75 -47.63 70.48 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.634 0.774 . . . . 0.0 110.038 175.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.429 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -63.6 3.66 0.32 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 173.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 2.2 mmpt? -107.41 -13.83 15.01 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 119.759 -1.838 . . . . 0.0 112.983 167.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.6 mt -92.77 150.41 20.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 119.084 0.856 . . . . 0.0 109.145 -175.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t -94.15 -179.96 5.12 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 167.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 t -49.76 -49.45 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.238 1.415 . . . . 0.0 111.306 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -64.72 -28.26 69.47 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 120.208 1.367 . . . . 0.0 112.386 175.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.0 -40.11 73.51 Favored Glycine 0 CA--C 1.527 0.783 0 O-C-N 120.99 -1.069 . . . . 0.0 112.41 174.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -77.18 -25.61 52.03 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 126.908 2.083 . . . . 0.0 112.068 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 11.8 tt0 -41.64 -54.24 6.81 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 128.72 2.808 . . . . 0.0 112.116 -177.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 71' ' ' GLU . 19.1 Cg_endo -59.67 -58.6 0.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.247 2.631 . . . . 0.0 111.28 173.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.416 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 77.4 m-85 -56.19 -33.29 65.15 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -171.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.0 mt -58.01 -58.35 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -52.61 -52.13 56.81 Favored 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 124.588 1.155 . . . . 0.0 109.007 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.505 ' SD ' HD21 ' A' ' 45' ' ' LEU . 1.0 OUTLIER -57.96 -48.64 79.36 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 178.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.703 ' HD2' HD22 ' A' ' 17' ' ' LEU . 10.3 tttt -58.89 -42.63 89.99 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -71.16 -32.9 69.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.513 0.725 . . . . 0.0 110.857 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -59.19 -46.58 88.05 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.975 1.31 . . . . 0.0 109.402 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.1 mt -66.57 -21.5 66.14 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.355 0.662 . . . . 0.0 112.069 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.0 m -82.89 1.14 40.89 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.981 0.81 . . . . 0.0 112.644 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -148.38 99.04 2.98 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 120.348 1.431 . . . . 0.0 108.747 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -61.87 -22.03 65.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.574 0.75 . . . . 0.0 112.743 -168.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -57.29 -23.16 46.66 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.523 -1.36 . . . . 0.0 112.878 172.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -64.47 -47.31 79.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 119.195 0.907 . . . . 0.0 110.508 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.0 p -72.1 -31.98 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.404 -0.81 . . . . 0.0 110.506 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 50.9 mt -69.7 -23.01 63.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.781 0.832 . . . . 0.0 111.097 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.51 -36.05 29.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.808 0.843 . . . . 0.0 110.499 171.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -66.23 -38.04 86.95 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 120.664 -1.273 . . . . 0.0 110.601 -176.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -62.95 -35.49 80.3 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.212 178.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.0 m -54.7 -51.33 65.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.768 0.713 . . . . 0.0 109.507 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 89' ' ' LEU . 70.6 mt -59.69 -39.29 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 122.946 0.498 . . . . 0.0 110.357 -175.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -45.91 84.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.614 1.166 . . . . 0.0 111.502 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.291 0.2 OUTLIER -64.85 -38.58 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.832 1.196 . . . . 0.0 109.841 172.518 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -76.82 24.9 0.15 Allowed 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.426 1.091 . . . . 0.0 112.798 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.2 t -71.94 156.38 39.32 Favored 'General case' 0 C--O 1.234 0.253 0 O-C-N 120.364 -1.46 . . . . 0.0 109.602 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.22 -165.57 46.05 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.64 87.32 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 124.399 3.399 . . . . 0.0 111.577 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.5 t -138.77 83.32 1.95 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.566 1.546 . . . . 0.0 108.814 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.4 t -147.8 -164.5 2.02 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 166.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 170.746 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.837 0 N-CA-C 105.759 -2.936 . . . . 0.0 105.759 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.76 163.56 3.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -153.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 p -149.3 -79.43 0.13 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.94 -179.7 41.18 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.8 m -155.4 174.89 14.59 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.793 1.637 . . . . 0.0 107.234 172.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.0 t 57.82 -160.44 0.25 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.792 0.837 . . . . 0.0 111.184 -172.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.4 106.31 1.38 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -170.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.1 -172.34 3.46 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.798 0.839 . . . . 0.0 111.569 -172.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.01 165.5 26.57 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 126.097 1.808 . . . . 0.0 110.575 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.9 167.75 14.25 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 124.504 3.47 . . . . 0.0 111.438 -176.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.81 127.07 1.61 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 173.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.12 80.75 1.78 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.999 1.319 . . . . 0.0 108.04 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -145.12 174.32 11.16 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.964 1.706 . . . . 0.0 108.779 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -62.89 139.6 58.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 157.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -146.2 179.64 7.37 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 172.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -74.97 150.86 38.9 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.905 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.748 HD22 ' HD2' ' A' ' 77' ' ' LYS . 7.4 mt -137.18 149.62 47.36 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -175.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -80.76 100.78 8.94 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 174.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.0 p -62.94 -36.54 83.78 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.257 -0.902 . . . . 0.0 111.491 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.94 -24.67 61.66 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.824 1.193 . . . . 0.0 111.445 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 12.8 tt0 -72.52 -55.67 6.59 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 173.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.43 HD11 ' HB3' ' A' ' 17' ' ' LEU . 53.4 mt -54.36 -51.39 49.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.95 -49.02 72.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.592 0.757 . . . . 0.0 111.604 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.41 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 66.2 t80 -55.97 -61.45 2.37 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 124.725 1.21 . . . . 0.0 109.419 175.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -52.86 -39.83 62.9 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.499 2.32 . . . . 0.0 112.08 -176.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.1 -51.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 121.455 -0.778 . . . . 0.0 109.661 172.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 45.8 mtmt -53.26 -39.55 63.95 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 116.811 -1.566 . . . . 0.0 110.642 175.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.93 -59.32 5.56 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.724 1.21 . . . . 0.0 110.671 176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -62.16 -36.34 81.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.265 1.026 . . . . 0.0 111.574 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 mt -65.09 -51.62 60.35 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 mt -55.9 -39.36 71.48 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.025 1.284 . . . . 0.0 112.014 175.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -51.33 -50.65 59.0 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.894 2.078 . . . . 0.0 109.786 -177.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -104.86 12.84 32.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.386 1.074 . . . . 0.0 111.458 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.7 t30 38.38 58.71 1.56 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 130.792 3.637 . . . . 0.0 112.011 -171.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 82.7 mt -93.01 156.8 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.413 1.485 . . . . 0.0 108.305 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.424 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -98.98 151.22 19.46 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.741 0.686 . . . . 0.0 112.202 -175.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.564 HE21 HD12 ' A' ' 56' ' ' LEU . 1.2 mt-30 -70.92 -30.12 66.36 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 117.825 -1.083 . . . . 0.0 113.752 -174.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -59.06 -59.14 5.95 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 120.357 1.435 . . . . 0.0 109.377 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 36.2 t -59.73 -43.46 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 123.478 0.486 . . . . 0.0 109.864 -174.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -56.18 -47.75 77.7 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.244 0.929 . . . . 0.0 110.973 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' HA3' HG11 ' A' ' 52' ' ' VAL . . . -70.93 -30.52 67.88 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-O 118.144 -1.364 . . . . 0.0 112.391 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -72.07 -29.97 64.66 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.165 1.482 . . . . 0.0 111.274 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -105.48 -68.87 0.84 Allowed 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.705 0.802 . . . . 0.0 111.122 -176.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.64 -38.59 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 123.301 0.64 . . . . 0.0 109.391 -169.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.508 HD21 ' HG2' ' A' ' 76' ' ' MET . 28.0 mt -95.79 -42.03 8.55 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -177.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.47 32.77 67.86 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.3 mt -110.49 165.15 12.02 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.651 1.581 . . . . 0.0 107.111 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.61 161.65 30.34 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.706 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -46.6 86.85 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.637 0.775 . . . . 0.0 111.527 -171.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.85 -32.24 82.18 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.3 m -59.44 -65.56 0.65 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 118.169 -0.919 . . . . 0.0 108.576 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.426 HG11 ' HA3' ' A' ' 41' ' ' GLY . 2.7 m -59.65 -37.22 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 120.143 1.338 . . . . 0.0 112.893 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 t -57.47 -40.54 78.78 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.642 -0.661 . . . . 0.0 111.102 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.37 -45.13 95.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.468 0.707 . . . . 0.0 110.563 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.0 mt -60.28 -43.05 92.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.564 HD12 HE21 ' A' ' 37' ' ' GLN . 74.5 mt -70.57 -35.89 73.3 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 123.743 0.817 . . . . 0.0 112.491 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.41 -45.71 79.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.308 1.043 . . . . 0.0 110.269 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -134.68 79.48 52.87 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 125.364 1.466 . . . . 0.0 109.336 -172.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -72.03 103.96 1.57 Allowed 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.733 2.289 . . . . 0.0 106.968 168.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -80.71 163.8 54.38 Favored Pre-proline 0 N--CA 1.443 -0.82 0 C-N-CA 125.335 1.454 . . . . 0.0 108.195 175.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -56.68 139.94 89.41 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.093 2.529 . . . . 0.0 108.83 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.412 ' CZ3' HD12 ' A' ' 17' ' ' LEU . 33.0 t-105 -50.65 -47.49 58.54 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.589 1.086 . . . . 0.0 110.537 173.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -21.38 32.83 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 176.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -77.74 -35.14 52.2 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.513 1.506 . . . . 0.0 110.418 177.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.4 mt -78.77 163.82 25.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.072 0.949 . . . . 0.0 108.756 -174.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.7 p -123.52 -177.33 3.69 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.449 1.9 . . . . 0.0 107.282 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.3 m -44.61 -53.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 121.855 2.116 . . . . 0.0 113.821 -170.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 -21.73 59.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.912 0.863 . . . . 0.0 112.844 -175.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.25 -38.18 87.33 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.352 1.453 . . . . 0.0 112.624 165.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -90.58 -27.15 19.31 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 126.311 1.844 . . . . 0.0 112.204 -172.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -37.05 -58.39 1.12 Allowed Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 129.781 3.232 . . . . 0.0 111.282 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.47 -49.54 3.32 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.999 1.799 . . . . 0.0 110.431 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -58.93 -34.92 72.28 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.006 -0.997 . . . . 0.0 112.568 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.03 -54.52 33.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 119.423 1.01 . . . . 0.0 108.59 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -56.2 -50.52 70.99 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 124.224 1.009 . . . . 0.0 108.989 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.508 ' HG2' HD21 ' A' ' 45' ' ' LEU . 65.3 mtm -59.57 -48.97 79.56 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.856 -0.527 . . . . 0.0 111.991 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.748 ' HD2' HD22 ' A' ' 17' ' ' LEU . 8.8 tttm -58.4 -37.16 74.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 118.948 -0.549 . . . . 0.0 110.438 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -74.51 -38.1 62.93 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.086 1.312 . . . . 0.0 111.376 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.5 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 4.9 t80 -56.38 -40.06 73.96 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.556 1.142 . . . . 0.0 109.163 173.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.4 mt -73.46 -19.8 60.86 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 117.706 -1.14 . . . . 0.0 113.015 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.6 m -61.29 -32.44 72.28 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.642 1.565 . . . . 0.0 111.098 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -137.89 117.01 12.55 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.981 1.312 . . . . 0.0 108.549 -178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -57.86 -16.41 11.7 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.695 1.598 . . . . 0.0 112.84 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.46 ' HA ' HD12 ' A' ' 87' ' ' LEU . 16.8 mm-40 -57.78 -21.67 42.96 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 120.274 -1.516 . . . . 0.0 112.798 171.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.5 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 63.6 m-80 -70.43 -49.42 48.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.781 1.173 . . . . 0.0 110.813 177.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.24 -33.54 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 119.587 1.085 . . . . 0.0 110.572 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 84' ' ' GLN . 38.4 mt -62.31 -43.47 98.74 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.92 -2.76 13.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.267 1.427 . . . . 0.0 113.851 173.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.86 -18.79 20.08 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.584 1.538 . . . . 0.0 115.145 167.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.1 mtm105 -65.96 -51.12 61.32 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.431 1.469 . . . . 0.0 111.484 -174.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 m -53.99 -36.72 63.22 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 117.322 -1.323 . . . . 0.0 110.685 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.7 mt -64.62 -34.5 70.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 CA-C-N 120.622 1.556 . . . . 0.0 110.532 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.424 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 9.7 tp-100 -66.09 -44.62 83.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.113 -0.992 . . . . 0.0 110.662 -175.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.342 0.1 OUTLIER -67.48 -0.85 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 125.213 1.405 . . . . 0.0 111.939 170.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.7 mtt-85 -117.59 16.87 14.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.618 1.967 . . . . 0.0 111.644 170.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 46.6 p -66.57 170.94 5.54 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.651 1.114 . . . . 0.0 109.401 163.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -161.8 177.95 37.85 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -62.4 131.16 32.78 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.171 2.58 . . . . 0.0 108.697 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 72.0 m 40.4 71.41 0.19 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.093 1.357 . . . . 0.0 111.64 -172.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.38 90.64 0.24 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 168.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 C-N-CA 128.251 2.834 . . . . 0.0 106.419 -171.096 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.68 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -142.62 -51.16 0.37 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.386 1.093 . . . . 0.0 110.855 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.8 m -57.72 146.23 31.81 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 119.533 1.06 . . . . 0.0 112.031 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.07 33.79 0.76 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.837 2.16 . . . . 0.0 113.946 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.7 t -52.93 94.46 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.952 2.501 . . . . 0.0 108.347 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.7 m -164.46 95.23 0.73 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.078 1.751 . . . . 0.0 107.79 -171.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.53 152.43 16.63 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 173.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -141.0 100.45 3.82 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.536 1.534 . . . . 0.0 109.96 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.81 126.25 6.41 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 106.385 -2.686 . . . . 0.0 106.385 164.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -79.0 46.69 2.26 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 123.461 2.774 . . . . 0.0 111.29 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.63 126.12 24.05 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 125.759 1.647 . . . . 0.0 110.806 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.56 8.53 2.4 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.661 0.784 . . . . 0.0 112.992 -176.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -110.34 -178.0 3.39 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.527 1.058 . . . . 0.0 109.173 173.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -67.31 107.38 2.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 166.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -121.8 175.31 6.34 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.146 1.778 . . . . 0.0 110.607 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 62' ' ' TRP . 4.9 mm-40 -80.77 90.79 5.85 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.844 0.858 . . . . 0.0 109.638 -169.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.541 HD22 ' CD ' ' A' ' 77' ' ' LYS . 8.3 mt -76.4 146.91 38.37 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.611 0.765 . . . . 0.0 109.016 178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.45 100.98 10.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 122.373 1.082 . . . . 0.0 109.031 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 p -59.42 -47.77 84.18 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.138 1.375 . . . . 0.0 111.415 -178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.66 -24.2 66.59 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.553 0.741 . . . . 0.0 111.529 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -80.57 -55.75 4.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 117.454 -1.26 . . . . 0.0 108.588 175.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.489 HD11 ' HB3' ' A' ' 17' ' ' LEU . 57.0 mt -48.98 -51.82 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 120.03 1.287 . . . . 0.0 108.426 177.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.68 -49.15 65.86 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.632 1.173 . . . . 0.0 111.741 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -62.86 -50.76 69.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.814 0.846 . . . . 0.0 110.301 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -60.21 -39.52 86.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.773 1.229 . . . . 0.0 111.537 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.5 HG21 ' SD ' ' A' ' 76' ' ' MET . 90.6 t -61.29 -49.73 83.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 O-C-N 120.902 -1.123 . . . . 0.0 108.82 172.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -59.99 -30.31 69.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 116.604 -1.665 . . . . 0.0 112.119 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -63.6 -65.25 0.71 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.514 1.506 . . . . 0.0 108.848 169.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.563 ' HB3' HG21 ' A' ' 86' ' ' VAL . 5.1 mm-40 -56.35 -39.71 73.3 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.66 1.184 . . . . 0.0 113.286 -171.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.8 mt -61.75 -51.03 70.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.58 -29.92 70.34 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.375 0.67 . . . . 0.0 112.276 178.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -57.95 -25.7 61.29 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.304 1.442 . . . . 0.0 111.645 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -128.34 16.51 6.59 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.074 1.35 . . . . 0.0 112.042 175.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 m120 35.88 70.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 128.478 2.711 . . . . 0.0 111.926 -167.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.0 mt -100.93 147.54 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.519 ' H ' ' NE2' ' A' ' 93' ' ' GLN . . . -88.38 133.37 11.77 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -177.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -35.04 68.77 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.704 0.802 . . . . 0.0 112.987 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.4 ttt-85 -54.41 -54.68 37.44 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.299 0.64 . . . . 0.0 111.158 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.83 -47.93 87.81 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.13 -47.27 75.27 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.714 0.688 . . . . 0.0 111.229 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -72.4 -27.1 70.38 Favored Glycine 0 N--CA 1.437 -1.249 0 CA-C-O 117.112 -1.938 . . . . 0.0 112.443 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -70.89 -45.41 64.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.061 2.431 . . . . 0.0 110.431 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -87.67 -67.84 0.8 Allowed 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 121.766 -0.584 . . . . 0.0 111.091 -170.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.45 -44.03 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -171.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.0 mt -99.06 -39.99 8.24 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.169 0.588 . . . . 0.0 111.983 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.91 50.36 53.23 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 -172.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -129.12 167.84 16.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.648 1.979 . . . . 0.0 107.25 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 t -66.69 157.02 33.69 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.968 0.89 . . . . 0.0 109.629 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -59.89 -27.32 66.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.915 0.886 . . . . 0.0 111.445 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.04 -48.34 26.87 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -54.38 -63.7 1.07 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.601 1.16 . . . . 0.0 110.211 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -58.45 -39.01 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 119.294 0.952 . . . . 0.0 111.767 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 t -62.06 -38.43 88.73 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.24 179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -59.41 -47.57 84.95 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 119.937 1.244 . . . . 0.0 108.993 169.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.437 HG21 HD13 ' A' ' 55' ' ' ILE . 16.6 mt -60.13 -41.56 87.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -176.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -70.13 -40.79 74.61 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 124.525 1.13 . . . . 0.0 111.537 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.77 -37.39 86.21 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.114 1.366 . . . . 0.0 110.747 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -139.16 70.38 40.97 Favored Pre-proline 0 C--O 1.235 0.295 0 C-N-CA 126.815 2.046 . . . . 0.0 107.658 -171.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -78.39 93.36 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 123.01 2.474 . . . . 0.0 107.609 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -67.11 160.36 71.19 Favored Pre-proline 0 N--CA 1.436 -1.157 0 O-C-N 121.736 -0.602 . . . . 0.0 109.557 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -58.44 144.65 96.41 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.367 2.044 . . . . 0.0 108.486 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.498 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 65.6 t-105 -52.77 -49.58 65.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.529 0.604 . . . . 0.0 110.734 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.6 -25.71 11.42 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 176.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.52 -18.74 47.57 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 120.005 1.275 . . . . 0.0 113.27 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.7 mt -86.95 162.57 17.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.451 0.643 . . . . 0.0 111.424 -169.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.6 p -94.04 -178.86 4.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.97 2.108 . . . . 0.0 109.892 168.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.4 m -58.57 -45.17 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 119.331 0.969 . . . . 0.0 111.724 169.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -60.31 -33.11 71.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 119.519 -0.276 . . . . 0.0 111.631 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.66 96.76 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.103 1.335 . . . . 0.0 112.516 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 91.1 mttt -79.61 -26.91 41.09 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.472 1.509 . . . . 0.0 112.934 -175.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -43.69 -57.8 5.33 Favored Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 125.892 1.677 . . . . 0.0 110.441 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.49 -43.49 13.58 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.727 1.618 . . . . 0.0 112.366 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -64.61 -36.45 84.27 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 120.273 -1.517 . . . . 0.0 112.24 -174.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.35 -55.28 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -51.52 -48.7 62.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.064 0.946 . . . . 0.0 110.204 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.5 ' SD ' HG21 ' A' ' 26' ' ' VAL . 62.7 mtm -61.86 -46.52 89.07 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 120.966 -1.084 . . . . 0.0 112.394 178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.541 ' CD ' HD22 ' A' ' 17' ' ' LEU . 16.9 tttm -63.18 -39.65 95.26 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.07 -1.019 . . . . 0.0 110.936 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -67.2 -36.83 82.57 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.216 1.007 . . . . 0.0 110.107 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.496 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 7.2 t80 -61.21 -40.5 94.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.917 0.887 . . . . 0.0 110.517 174.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.4 mt -72.77 -8.82 57.28 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.346 1.058 . . . . 0.0 112.666 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.42 -13.1 59.42 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.871 1.269 . . . . 0.0 111.887 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -157.28 119.03 3.74 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.052 -1.03 . . . . 0.0 109.419 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -25.65 65.9 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.163 0.985 . . . . 0.0 113.645 -170.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -64.41 -18.64 64.9 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 119.705 -1.872 . . . . 0.0 111.909 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.496 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 55.2 m-80 -59.71 -48.52 81.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.826 0.739 . . . . 0.0 111.003 176.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.563 HG21 ' HB3' ' A' ' 29' ' ' GLN . 4.0 p -71.55 -33.82 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 121.811 -0.555 . . . . 0.0 109.87 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.3 mt -63.54 -42.4 98.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.87 73.26 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.057 0.39 . . . . 0.0 111.567 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.49 HD22 HD12 ' A' ' 92' ' ' ILE . 1.0 OUTLIER -70.51 -24.64 62.87 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.947 0.899 . . . . 0.0 112.234 178.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 31.5 mtp-105 -61.97 -47.89 82.84 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 118.827 0.74 . . . . 0.0 110.298 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.0 m -51.78 -46.83 64.31 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.899 0.88 . . . . 0.0 109.318 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.49 HD12 HD22 ' A' ' 89' ' ' LEU . 53.6 mt -64.86 -35.24 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 122.908 0.483 . . . . 0.0 110.277 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.519 ' NE2' ' H ' ' A' ' 36' ' ' GLY . 6.5 tp-100 -63.41 -51.24 66.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 117.922 -1.037 . . . . 0.0 111.066 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . 0.275 0.2 OUTLIER -60.3 -39.84 82.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 119.727 1.149 . . . . 0.0 109.69 175.214 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.617 ' HB3' HH11 ' A' ' 95' ' ' ARG . 0.0 OUTLIER -76.14 9.76 2.33 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.983 -1.008 . . . . 0.0 113.137 179.401 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 39.2 p -65.34 -18.22 65.14 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.999 1.727 . . . . 0.0 112.383 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.78 -161.6 10.24 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 127.552 2.501 . . . . 0.0 107.91 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -65.53 170.07 11.67 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.065 1.843 . . . . 0.0 110.2 168.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.9 m -112.96 -177.44 3.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.029 1.332 . . . . 0.0 110.022 173.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 p -141.76 134.59 28.72 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.223 1.409 . . . . 0.0 107.651 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.7 0 N-CA-C 105.46 -3.056 . . . . 0.0 105.46 154.219 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.844 0 CA-C-O 119.108 -0.829 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -27.0 114.68 0.06 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 129.473 3.109 . . . . 0.0 114.307 -170.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -160.2 153.61 22.19 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 126.048 1.739 . . . . 0.0 110.271 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.25 -164.67 32.52 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 126.263 1.887 . . . . 0.0 110.256 -176.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.5 m 62.78 89.81 0.08 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.422 1.889 . . . . 0.0 113.392 171.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.43 165.73 26.6 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.817 1.647 . . . . 0.0 107.295 161.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.46 33.19 0.05 OUTLIER Glycine 0 CA--C 1.527 0.821 0 CA-C-N 119.414 1.007 . . . . 0.0 113.849 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -126.82 163.88 22.61 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.941 1.37 . . . . 0.0 108.392 167.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.96 84.1 0.08 OUTLIER Glycine 0 CA--C 1.527 0.81 0 CA-C-O 118.73 -1.039 . . . . 0.0 111.276 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.25 -170.09 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.195 2.597 . . . . 0.0 110.748 168.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.7 104.66 0.2 Allowed Glycine 0 C--N 1.332 0.359 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.33 159.16 41.08 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.738 1.215 . . . . 0.0 110.123 167.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.252 15.0 tt0 36.85 -117.44 0.14 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.744 2.418 . . . . 0.0 111.049 178.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -107.39 122.43 46.59 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 155.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -133.02 177.94 7.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.268 0.627 . . . . 0.0 110.182 167.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -99.7 68.93 1.57 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.379 0.671 . . . . 0.0 109.234 -152.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.421 ' HB3' HD11 ' A' ' 22' ' ' ILE . 3.8 mt -55.86 135.29 52.11 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.976 0.91 . . . . 0.0 110.77 -168.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 21' ' ' GLU . 0.8 OUTLIER -71.96 105.44 3.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.876 0.846 . . . . 0.0 109.399 177.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.452 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 19.2 p -68.72 -40.63 79.83 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.513 -0.742 . . . . 0.0 112.268 -177.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.77 -21.83 66.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.928 0.785 . . . . 0.0 111.044 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . 4.0 tt0 -81.03 -52.78 7.04 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.319 1.448 . . . . 0.0 109.068 176.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' A' ' 17' ' ' LEU . 66.7 mt -56.13 -44.39 78.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 119.099 0.863 . . . . 0.0 109.916 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.57 85.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.551 0.74 . . . . 0.0 110.867 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.437 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 48.3 t80 -61.91 -53.92 49.11 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.078 0.951 . . . . 0.0 110.835 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -56.91 -38.98 73.6 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.114 1.365 . . . . 0.0 110.543 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.18 -50.76 72.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 120.68 -1.263 . . . . 0.0 109.81 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 24' ' ' PHE . 40.9 mtmt -54.52 -48.22 72.18 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 116.991 -1.481 . . . . 0.0 110.726 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -47.41 71.44 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 116.944 -1.503 . . . . 0.0 111.402 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -56.37 -45.07 80.67 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 121.044 1.747 . . . . 0.0 112.48 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.2 -49.25 72.74 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.72 -33.49 70.26 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.454 1.025 . . . . 0.0 111.948 174.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -59.1 -20.27 51.96 Favored 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 126.114 1.766 . . . . 0.0 111.992 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -128.69 15.62 6.45 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 169.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 44.96 60.48 2.94 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 128.042 2.537 . . . . 0.0 111.765 -168.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.6 mt -98.32 154.05 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 174.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.54 150.8 18.09 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.921 0.772 . . . . 0.0 111.725 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -73.99 -14.36 61.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.96 1.304 . . . . 0.0 114.359 -177.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -70.97 -57.72 4.28 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 120.502 1.501 . . . . 0.0 109.973 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -56.0 -48.07 79.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -57.95 -41.31 82.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.758 1.163 . . . . 0.0 111.179 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -74.3 -26.54 67.96 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-O 117.184 -1.898 . . . . 0.0 112.58 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -74.32 -40.76 62.01 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 120.35 2.075 . . . . 0.0 110.658 173.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -90.93 -64.11 1.18 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 124.541 1.137 . . . . 0.0 111.803 -169.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.29 -36.85 74.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.3 mt -109.21 -43.86 4.06 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.062 0.545 . . . . 0.0 110.865 -166.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.45 31.79 53.35 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.093 0.854 . . . . 0.0 112.146 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.9 mt -109.08 159.39 16.91 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.578 1.551 . . . . 0.0 108.824 -175.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t -63.0 160.56 14.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.461 0.648 . . . . 0.0 110.114 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -54.11 -42.48 69.47 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.426 1.09 . . . . 0.0 112.528 -165.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.02 -10.01 57.81 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 118.427 -1.207 . . . . 0.0 113.637 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 m -62.4 -57.96 9.39 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.343 1.571 . . . . 0.0 108.99 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 m -62.31 -35.47 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 119.193 0.906 . . . . 0.0 112.081 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.6 t -59.28 -40.34 85.78 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.007 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -59.4 -46.49 88.53 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 119.311 0.96 . . . . 0.0 109.779 169.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.487 HG23 ' CZ ' ' A' ' 73' ' ' PHE . 1.7 mt -58.18 -30.41 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 120.114 1.325 . . . . 0.0 110.022 -176.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -87.73 -26.11 23.1 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.985 0.914 . . . . 0.0 113.122 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.98 -41.72 22.33 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.684 1.594 . . . . 0.0 110.798 177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.6 mmt-85 -135.27 73.62 63.58 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 129.635 3.174 . . . . 0.0 106.367 -175.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -69.68 95.25 0.54 Allowed 'Trans proline' 0 N--CA 1.444 -1.387 0 N-CA-C 105.825 -2.414 . . . . 0.0 105.825 168.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -67.05 155.9 89.14 Favored Pre-proline 0 N--CA 1.432 -1.373 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.481 ' HD2' ' HG3' ' A' ' 64' ' ' LYS . 6.1 Cg_exo -58.28 149.61 72.11 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.628 2.219 . . . . 0.0 109.889 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -51.21 -50.25 59.46 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.52 0.328 . . . . 0.0 110.261 172.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.417 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -64.24 2.1 0.63 Allowed 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 176.152 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HG3' ' HD2' ' A' ' 61' ' ' PRO . 14.6 mmmt -98.76 -20.7 16.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.522 1.51 . . . . 0.0 112.014 167.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.6 mt -99.81 149.84 22.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 118.627 0.649 . . . . 0.0 109.629 -164.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.3 t -87.53 179.39 6.56 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.3 p -43.14 -58.54 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 124.693 1.197 . . . . 0.0 112.101 173.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -64.78 -17.0 63.79 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.85 -39.61 23.97 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 126.34 1.924 . . . . 0.0 112.953 167.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -83.5 -25.12 31.36 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 127.451 2.301 . . . . 0.0 111.961 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -45.78 -53.29 21.03 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 128.219 2.608 . . . . 0.0 111.61 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.17 -48.4 10.12 Favored 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 121.338 1.359 . . . . 0.0 109.851 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 55' ' ' ILE . 69.1 m-85 -63.35 -33.39 75.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.437 -174.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.8 mt -60.46 -54.51 34.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 119.969 1.259 . . . . 0.0 108.081 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -54.05 -51.42 64.1 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.803 0.841 . . . . 0.0 109.689 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 66.3 mtm -60.8 -47.04 88.14 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.833 0.853 . . . . 0.0 112.02 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -59.0 -38.79 80.01 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.953 -1.092 . . . . 0.0 110.492 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -71.05 -37.97 72.52 Favored 'General case' 0 C--O 1.227 -0.108 0 O-C-N 121.702 -0.624 . . . . 0.0 111.361 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.494 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 16.8 t80 -54.31 -42.96 70.71 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.664 1.186 . . . . 0.0 109.57 171.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.8 mt -74.89 -13.16 60.51 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.615 -0.678 . . . . 0.0 112.448 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 m -80.9 2.64 25.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.667 0.787 . . . . 0.0 112.294 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -157.3 132.3 8.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.984 1.266 . . . . 0.0 108.269 162.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.22 -26.59 60.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.793 0.837 . . . . 0.0 112.174 175.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.412 ' HA ' HD12 ' A' ' 87' ' ' LEU . 14.2 mm-40 -54.1 -28.6 40.37 Favored 'General case' 0 C--N 1.338 0.106 0 O-C-N 120.027 -1.671 . . . . 0.0 113.559 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.494 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 52.4 m-80 -64.9 -50.27 67.17 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 119.289 0.949 . . . . 0.0 110.135 177.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.64 -34.98 68.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 O-C-N 121.529 -0.732 . . . . 0.0 110.464 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 84' ' ' GLN . 83.8 mt -59.68 -48.63 80.9 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.85 -38.49 85.71 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 122.943 0.497 . . . . 0.0 111.666 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.426 HD22 HD12 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -64.85 -24.4 67.53 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.583 1.153 . . . . 0.0 111.683 -178.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -58.47 -49.12 78.49 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 119.048 0.84 . . . . 0.0 110.242 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 m -55.94 -44.8 78.75 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.098 0.408 . . . . 0.0 110.161 177.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.426 HD12 HD22 ' A' ' 89' ' ' LEU . 18.3 mt -63.07 -31.19 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 O-C-N 121.234 -0.917 . . . . 0.0 111.131 -177.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -71.14 -31.64 67.97 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.376 0.67 . . . . 0.0 111.465 176.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -67.02 -39.96 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 119.554 1.07 . . . . 0.0 108.75 169.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 -76.62 11.93 1.47 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.759 1.623 . . . . 0.0 111.962 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.9 t -73.82 165.67 24.7 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.422 -1.424 . . . . 0.0 108.792 171.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.33 171.19 36.99 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.386 0.517 . . . . 0.0 113.551 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -63.28 -65.35 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.803 3.002 . . . . 0.0 112.13 -164.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.1 p 49.04 84.33 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.236 1.414 . . . . 0.0 111.802 -170.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 24.1 p -130.59 102.99 6.37 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.325 1.05 . . . . 0.0 108.403 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.327 0 N-CA-C 106.793 -2.523 . . . . 0.0 106.793 -162.124 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.059 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 m 65.36 175.21 0.21 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.647 1.179 . . . . 0.0 110.926 -169.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m 60.14 179.04 0.09 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.37 1.468 . . . . 0.0 111.801 -166.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 112.78 135.46 6.39 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -173.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.5 t -163.46 162.21 24.6 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 126.345 1.858 . . . . 0.0 106.115 167.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.6 m -158.86 161.81 36.9 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.369 1.068 . . . . 0.0 108.81 174.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.58 97.44 0.13 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 108.107 -1.997 . . . . 0.0 108.107 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -138.77 89.99 2.41 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.79 101.08 0.15 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-O 118.463 -1.187 . . . . 0.0 110.331 -174.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -77.88 38.34 0.67 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 124.685 3.59 . . . . 0.0 111.243 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.28 -123.56 14.54 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -169.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.23 101.98 0.96 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 128.353 2.661 . . . . 0.0 104.267 167.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.5 176.43 10.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 168.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.47 105.97 0.49 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 166.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -82.67 -168.19 1.93 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.009 1.323 . . . . 0.0 112.669 -176.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -101.41 107.26 18.53 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 123.979 0.912 . . . . 0.0 108.728 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.499 ' HB3' HD11 ' A' ' 22' ' ' ILE . 5.8 mt -92.56 134.37 35.05 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -71.76 99.79 2.23 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 122.295 1.045 . . . . 0.0 108.572 176.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.423 ' HB ' ' CZ ' ' A' ' 73' ' ' PHE . 24.2 p -59.57 -40.58 87.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.156 -177.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.76 -31.05 72.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 119.102 -0.475 . . . . 0.0 111.908 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -74.96 -50.27 17.25 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.664 1.186 . . . . 0.0 108.907 177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 17' ' ' LEU . 67.2 mt -56.11 -47.39 80.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.31 92.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.269 -0.894 . . . . 0.0 111.987 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -62.92 -66.66 0.51 Allowed 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.461 1.504 . . . . 0.0 109.183 172.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -49.83 -38.67 35.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.24 1.816 . . . . 0.0 112.985 -176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 t -63.75 -43.53 98.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 O-C-N 121.293 -0.88 . . . . 0.0 110.25 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -60.44 -43.63 96.62 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.683 0.674 . . . . 0.0 109.413 175.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -57.01 -49.13 76.73 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.076 0.551 . . . . 0.0 110.467 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -63.25 -38.05 89.64 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.915 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mt -62.46 -43.07 99.7 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 120.515 1.507 . . . . 0.0 109.915 172.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.05 -45.33 79.29 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.992 0.815 . . . . 0.0 111.337 168.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -52.94 -40.81 63.93 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.626 1.97 . . . . 0.0 113.96 -168.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -121.83 16.19 10.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.963 1.305 . . . . 0.0 111.282 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 43.41 72.22 0.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.244 2.618 . . . . 0.0 111.561 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.3 mt -112.49 155.8 13.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -97.62 144.41 17.28 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 124.207 0.908 . . . . 0.0 110.935 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -62.52 -37.52 86.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.902 1.681 . . . . 0.0 112.194 -176.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.8 ttt-85 -57.43 -54.51 46.06 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 117.66 -1.162 . . . . 0.0 109.822 173.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.3 -36.13 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.63 1.559 . . . . 0.0 111.338 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -61.11 -55.86 27.55 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.492 -0.755 . . . . 0.0 111.25 171.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -69.41 -26.31 74.67 Favored Glycine 0 N--CA 1.438 -1.199 0 CA-C-O 118.008 -1.44 . . . . 0.0 112.458 -174.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -78.75 -27.81 44.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 120.083 1.942 . . . . 0.0 110.784 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -106.73 -62.25 1.42 Allowed 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 123.925 0.89 . . . . 0.0 112.049 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.57 -45.77 87.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.48 HD21 ' HG2' ' A' ' 76' ' ' MET . 28.9 mt -94.99 -37.44 11.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.113 -174.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.18 2.66 90.58 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.682 0.658 . . . . 0.0 112.747 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.6 mt -89.77 168.18 12.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.048 1.424 . . . . 0.0 107.794 -174.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.0 m -76.39 162.19 28.07 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.473 -0.767 . . . . 0.0 110.785 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -56.95 -46.9 81.8 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.667 0.787 . . . . 0.0 111.868 -172.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.64 -28.49 73.12 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 119.57 -0.572 . . . . 0.0 112.022 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 m -65.41 -62.35 1.58 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 118.035 0.918 . . . . 0.0 109.454 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.69 -34.62 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 119.789 1.177 . . . . 0.0 112.041 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -57.0 -42.1 79.65 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.509 -0.758 . . . . 0.0 111.013 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.0 -44.91 87.5 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.48 0.582 . . . . 0.0 109.672 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.4 mt -62.28 -38.56 81.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -174.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.0 mt -83.98 -15.07 49.11 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.056 0.943 . . . . 0.0 112.771 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.7 -52.64 6.25 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.596 1.558 . . . . 0.0 108.525 173.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.9 81.45 58.0 Favored Pre-proline 0 N--CA 1.45 -0.467 0 C-N-CA 127.972 2.509 . . . . 0.0 107.568 -173.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.43 101.83 0.91 Allowed 'Trans proline' 0 N--CA 1.446 -1.32 0 N-CA-C 106.426 -2.182 . . . . 0.0 106.426 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -67.49 161.72 62.79 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 171.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -56.19 144.24 81.82 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.526 2.817 . . . . 0.0 109.505 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -52.11 -50.64 61.26 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.253 0.621 . . . . 0.0 109.808 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -17.91 12.57 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 175.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 1.9 mmpt? -82.84 -31.66 27.94 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 120.429 1.468 . . . . 0.0 111.103 174.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.6 mt -71.88 174.77 6.49 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.814 1.292 . . . . 0.0 111.591 -167.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.4 p -111.19 179.89 3.91 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.779 1.232 . . . . 0.0 108.135 167.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.7 m -52.67 -45.6 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.366 1.439 . . . . 0.0 113.02 169.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -66.4 -22.23 66.23 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.632 1.56 . . . . 0.0 111.888 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.42 -47.62 27.67 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 124.816 1.198 . . . . 0.0 111.548 171.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -71.95 -31.35 66.22 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.742 1.217 . . . . 0.0 111.398 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -42.8 -57.65 4.67 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 127.918 2.487 . . . . 0.0 111.109 -174.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.5 -52.01 3.62 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.0 1.8 . . . . 0.0 110.594 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.423 ' CZ ' ' HB ' ' A' ' 19' ' ' THR . 57.3 m-85 -55.08 -38.08 67.62 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.938 1.244 . . . . 0.0 113.345 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.6 mt -58.74 -56.47 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 124.709 1.204 . . . . 0.0 107.993 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -56.91 -42.5 80.07 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.218 1.007 . . . . 0.0 109.679 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.48 ' HG2' HD21 ' A' ' 45' ' ' LEU . 66.4 mtm -65.14 -51.26 62.3 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 124.299 1.04 . . . . 0.0 112.336 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -62.29 -36.01 80.79 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.028 -1.045 . . . . 0.0 110.296 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -66.12 -42.07 89.69 Favored 'General case' 0 C--O 1.226 -0.16 0 O-C-N 121.807 -0.558 . . . . 0.0 109.85 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.48 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 14.5 t80 -57.39 -39.06 75.27 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.163 0.985 . . . . 0.0 110.068 175.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 72.5 mt -76.57 -12.27 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 178.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.7 m -83.17 -21.33 33.56 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.195 -0.941 . . . . 0.0 113.075 -174.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -132.72 130.09 39.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 170.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -60.15 -46.17 90.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.347 -171.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.671 ' HA ' HD23 ' A' ' 87' ' ' LEU . 9.5 mm-40 -53.95 -18.52 3.53 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.103 2.161 . . . . 0.0 113.321 -166.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.48 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 68.2 m-80 -53.81 -41.82 67.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.086 0.955 . . . . 0.0 111.658 170.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.712 HG12 HD22 ' A' ' 87' ' ' LEU . 4.8 p -73.35 -35.34 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 119.782 1.174 . . . . 0.0 110.97 178.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.712 HD22 HG12 ' A' ' 86' ' ' VAL . 2.5 mm? -64.85 -26.77 68.48 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 124.436 1.094 . . . . 0.0 109.782 -175.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.46 -43.45 60.22 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.396 1.078 . . . . 0.0 112.698 167.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -31.44 71.64 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.039 0.936 . . . . 0.0 110.768 -178.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.6 mtm105 -53.98 -42.79 69.37 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.274 0.488 . . . . 0.0 110.015 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.5 m -66.05 -43.36 87.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.646 0.778 . . . . 0.0 110.053 -176.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.8 mt -69.03 -32.35 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.533 -0.73 . . . . 0.0 109.769 -177.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.0 tp60 -58.0 -42.83 86.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.728 -0.654 . . . . 0.0 110.931 174.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -30.99 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 119.171 0.896 . . . . 0.0 110.269 176.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -76.46 -4.77 44.32 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.31 1.044 . . . . 0.0 111.877 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 t -61.95 161.24 10.91 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.812 1.187 . . . . 0.0 111.157 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.39 -176.98 39.5 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.062 1.315 . . . . 0.0 109.961 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -81.86 51.54 3.86 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 125.29 3.994 . . . . 0.0 110.614 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.6 t -80.63 92.37 5.96 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.0 t -172.42 81.96 0.06 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.212 2.205 . . . . 0.0 105.457 -170.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.616 0 N-CA-C 105.464 -3.054 . . . . 0.0 105.464 166.998 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.343 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 t -159.46 -150.24 0.23 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.696 2.398 . . . . 0.0 106.022 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -4.84 -79.78 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 130.968 3.707 . . . . 0.0 113.084 171.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.88 174.19 33.42 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 121.472 -0.768 . . . . 0.0 113.14 172.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.3 m -133.36 21.43 4.01 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.078 1.351 . . . . 0.0 111.38 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 p -62.16 163.05 8.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 162.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.99 99.93 2.64 Favored Glycine 0 C--O 1.239 0.411 0 N-CA-C 106.309 -2.717 . . . . 0.0 106.309 -162.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -149.85 166.12 30.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.541 0.736 . . . . 0.0 110.612 175.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 139.23 93.31 0.26 Allowed Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.07 169.35 22.78 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 CA-C-N 119.921 1.86 . . . . 0.0 109.682 164.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.42 174.58 45.59 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.65 156.54 42.17 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 166.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 57.24 -179.17 0.05 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.745 1.218 . . . . 0.0 111.071 -167.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -72.27 122.33 20.92 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 171.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -105.75 -168.15 1.41 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.904 1.282 . . . . 0.0 109.565 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -97.53 135.2 39.72 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.654 0.782 . . . . 0.0 109.216 172.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.48 ' HB3' HD11 ' A' ' 22' ' ' ILE . 7.8 mt -124.89 129.93 51.36 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -170.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.74 107.49 6.87 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 122.155 0.978 . . . . 0.0 110.256 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.429 ' HB ' ' CE1' ' A' ' 73' ' ' PHE . 24.5 p -63.11 -44.23 96.22 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.722 0.809 . . . . 0.0 110.555 -173.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.63 -8.72 56.69 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.783 0.833 . . . . 0.0 111.732 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -88.42 -54.47 4.17 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.797 1.239 . . . . 0.0 108.904 167.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 17' ' ' LEU . 68.7 mt -52.32 -50.72 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 120.204 1.366 . . . . 0.0 109.286 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.56 -33.29 65.98 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.24 1.016 . . . . 0.0 112.95 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -75.56 -57.86 3.63 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.128 0.971 . . . . 0.0 108.496 174.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -52.35 -32.76 39.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.339 1.456 . . . . 0.0 112.034 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.524 HG23 HD11 ' A' ' 80' ' ' LEU . 53.8 t -67.66 -57.09 10.73 Favored 'Isoleucine or valine' 0 C--O 1.23 0.061 0 C-N-CA 124.393 1.077 . . . . 0.0 110.729 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.4 mtmt -51.52 -41.43 61.01 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.495 1.043 . . . . 0.0 111.116 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -53.11 -59.36 4.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.008 1.323 . . . . 0.0 110.128 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -62.03 -38.81 90.1 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.474 1.109 . . . . 0.0 113.351 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.1 mt -61.12 -48.09 83.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.08 -37.66 85.87 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.156 0.889 . . . . 0.0 112.856 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -55.87 -33.56 64.68 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.435 1.894 . . . . 0.0 110.674 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -123.49 11.31 9.24 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.286 1.034 . . . . 0.0 113.073 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 49.03 68.44 0.71 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.64 1.976 . . . . 0.0 112.136 -172.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.1 mt -112.23 156.29 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 O-C-N 121.264 -0.897 . . . . 0.0 110.047 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.56 130.71 10.44 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 126.958 2.218 . . . . 0.0 110.721 176.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -51.75 -35.79 44.84 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.42 1.488 . . . . 0.0 112.096 174.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -58.3 -54.28 48.75 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.773 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.62 -44.63 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -55.69 -51.78 66.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.636 0.255 . . . . 0.0 110.794 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.65 78.27 Favored Glycine 0 N--CA 1.428 -1.86 0 CA-C-O 116.338 -2.368 . . . . 0.0 111.563 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -78.31 -30.79 48.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 121.812 2.806 . . . . 0.0 111.956 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -101.56 -51.63 3.41 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 123.054 0.542 . . . . 0.0 111.384 -170.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.3 t -78.73 -46.29 24.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -175.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.481 HD21 ' HG2' ' A' ' 76' ' ' MET . 34.0 mt -95.94 -34.53 11.77 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 119.315 -0.374 . . . . 0.0 110.924 -172.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.72 4.96 88.37 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.389 0.519 . . . . 0.0 112.913 -176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.5 mt -98.49 158.55 15.53 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.361 1.464 . . . . 0.0 107.41 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.6 m -71.64 164.43 25.92 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 121.433 -0.792 . . . . 0.0 110.239 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -58.56 -49.59 76.87 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.83 69.73 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.584 -0.564 . . . . 0.0 111.899 -178.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.4 m -70.88 -62.85 1.24 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.863 1.265 . . . . 0.0 111.357 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 m -60.07 -30.83 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 121.089 1.768 . . . . 0.0 112.273 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.7 t -58.06 -39.23 77.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.52 -1.229 . . . . 0.0 110.394 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -57.72 -43.28 85.13 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.023 1.283 . . . . 0.0 110.176 171.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.415 HG23 ' CE2' ' A' ' 73' ' ' PHE . 12.0 mt -64.79 -42.59 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -173.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.2 mt -77.1 -29.57 54.92 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.465 0.706 . . . . 0.0 111.848 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.25 -56.41 6.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.746 1.618 . . . . 0.0 111.078 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -135.52 59.39 30.83 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 124.245 1.018 . . . . 0.0 109.708 -165.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -63.35 104.49 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.883 3.056 . . . . 0.0 110.281 -173.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -63.63 157.94 62.86 Favored Pre-proline 0 N--CA 1.434 -1.252 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -65.81 153.87 76.33 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.645 2.896 . . . . 0.0 110.471 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.451 ' CE2' ' HE2' ' A' ' 70' ' ' LYS . 73.4 t-105 -55.44 -43.85 75.78 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.368 1.067 . . . . 0.0 111.288 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.529 ' H ' ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -60.77 -19.98 60.43 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 176.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.55 -23.31 27.71 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.558 1.072 . . . . 0.0 112.327 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 29.6 mt -89.38 152.42 21.51 Favored 'General case' 0 C--O 1.226 -0.149 0 CA-C-N 119.071 0.851 . . . . 0.0 109.302 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.8 p -105.07 -172.05 2.03 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.933 1.293 . . . . 0.0 109.666 172.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.1 t -47.7 -58.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 120.785 1.63 . . . . 0.0 110.49 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -71.68 -3.08 19.78 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -87.78 -42.35 6.08 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.881 1.705 . . . . 0.0 112.097 165.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.451 ' HE2' ' CE2' ' A' ' 62' ' ' TRP . 85.3 mttt -80.88 -25.04 37.89 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 126.895 2.078 . . . . 0.0 111.844 -174.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.33 -56.31 12.98 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 125.482 1.513 . . . . 0.0 111.328 -175.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -62.33 -44.53 18.36 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 C-N-CA 121.423 1.416 . . . . 0.0 110.311 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.429 ' CE1' ' HB ' ' A' ' 19' ' ' THR . 70.4 m-85 -62.43 -37.46 85.92 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.993 1.269 . . . . 0.0 113.229 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.04 -49.38 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.634 1.106 . . . . 0.0 108.031 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -57.65 -53.29 59.9 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.664 0.786 . . . . 0.0 109.558 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.481 ' HG2' HD21 ' A' ' 45' ' ' LEU . 58.5 mtm -56.75 -50.55 71.91 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.4 0.68 . . . . 0.0 112.27 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tttp -61.72 -40.3 94.58 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.574 -0.704 . . . . 0.0 110.35 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -70.53 -32.06 69.37 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.327 0.967 . . . . 0.0 111.086 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.449 ' CD2' ' HB3' ' A' ' 85' ' ' ASN . 11.0 t80 -60.94 -43.23 98.97 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.524 HD11 HG23 ' A' ' 26' ' ' VAL . 19.8 mt -71.89 -9.88 58.97 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.194 0.997 . . . . 0.0 112.413 177.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.8 m -89.44 -2.35 58.36 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.297 1.439 . . . . 0.0 112.543 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -149.73 123.45 9.22 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 120.141 1.337 . . . . 0.0 109.35 163.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.98 -18.72 64.56 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.821 0.343 . . . . 0.0 111.283 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -68.35 -11.17 59.15 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 119.795 -1.816 . . . . 0.0 113.731 174.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.449 ' HB3' ' CD2' ' A' ' 79' ' ' PHE . 69.0 m-80 -71.82 -57.08 4.65 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 167.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 p -63.41 -34.05 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 O-C-N 121.12 -0.987 . . . . 0.0 110.958 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.2 mt -65.22 -25.88 67.88 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.774 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.46 60.0 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.964 0.906 . . . . 0.0 110.967 172.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.31 -33.09 74.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.885 -177.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -51.15 -50.58 58.64 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 118.706 0.684 . . . . 0.0 110.227 175.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.1 m -51.42 -50.12 60.29 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.768 1.227 . . . . 0.0 110.537 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.5 mt -62.94 -37.34 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.638 0.775 . . . . 0.0 109.902 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -62.15 -52.07 65.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.622 -0.674 . . . . 0.0 110.9 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.79 -27.12 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 118.593 0.633 . . . . 0.0 110.264 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -76.54 -3.57 38.19 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 117.88 -1.057 . . . . 0.0 113.155 175.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.0 p -57.82 -29.2 64.74 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 120.362 1.437 . . . . 0.0 113.186 -174.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.84 -172.73 41.35 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 121.163 -0.96 . . . . 0.0 111.152 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.41 160.47 39.12 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.706 2.937 . . . . 0.0 111.464 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.8 m 54.09 -178.05 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.655 1.182 . . . . 0.0 111.316 -171.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.4 p -154.69 -178.52 7.25 Favored 'General case' 0 C--O 1.239 0.506 0 O-C-N 120.886 -1.134 . . . . 0.0 108.739 162.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.987 0 N-CA-C 105.752 -2.939 . . . . 0.0 105.752 163.913 . . . . . . . . 0 0 . 1 stop_ save_